data_1c07_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c07 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 12' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.96 0.886 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.561 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 2.3 p -115.57 156.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 174.36 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.731 -1.231 . . . . 0.0 112.335 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' SER . 48.5 Cg_endo -67.43 -145.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.272 1.143 . . . . 0.0 110.559 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.2 -49.67 0.08 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.455 0.645 . . . . 0.0 111.588 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 4.9 mt-10 -49.13 -60.79 2.49 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.418 -0.801 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.3 tmtp? -54.24 -32.96 57.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.964 -1.085 . . . . 0.0 109.981 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.45 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 108.95 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 23' ' ' ILE . 6.1 ttpt -54.53 -28.93 48.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.579 -0.7 . . . . 0.0 109.393 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 4.2 m-30 -90.59 -52.19 5.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 110.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 20' ' ' TYR . 53.1 t0 -45.28 -33.82 2.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 25' ' ' LEU . 30.7 mm-40 -76.39 -32.54 58.61 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.334 -0.854 . . . . 0.0 108.906 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.565 HG23 ' CE2' ' A' ' 74' ' ' PHE . 46.9 mt -77.77 -41.87 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.388 -0.82 . . . . 0.0 110.073 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 59.9 t80 -48.67 -32.68 8.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.571 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.0 mt -65.52 -28.91 69.52 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -100.18 -12.71 19.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.574 ' CG2' HD11 ' A' ' 43' ' ' ILE . 2.6 m -89.74 -55.74 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.745 . . . . 0.0 109.372 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' HG23 ' A' ' 35' ' ' VAL . 38.3 t0 -63.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.703 -0.623 . . . . 0.0 109.361 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.7 mmtt -51.8 -17.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 111.219 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.484 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.0 m-20 -98.23 1.68 47.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 mtm 43.26 45.35 4.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.706 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.2 p30 -115.8 26.5 9.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 109.956 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.92 12.77 44.43 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.17 100.82 2.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -1.058 . . . . 0.0 110.111 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 39' ' ' GLU . 14.5 p -88.86 139.42 17.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.925 -1.109 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 37' ' ' GLY . 1.8 t -95.31 151.85 18.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.067 -1.021 . . . . 0.0 110.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.71 -25.16 0.82 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.1 mm? -67.49 -29.96 69.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.218 -1.166 . . . . 0.0 110.975 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 19.4 mt-10 -91.05 -61.7 1.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.829 -1.169 . . . . 0.0 108.306 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG23 HG22 ' A' ' 43' ' ' ILE . 1.1 p -53.02 -18.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -42.21 -75.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.705 -0.622 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' N ' HD11 ' A' ' 45' ' ' LEU . 11.3 mt-10 -43.23 -47.97 6.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 108.717 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.574 HD11 ' CG2' ' A' ' 27' ' ' THR . 2.2 mt -55.44 -41.28 62.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.664 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -77.25 -28.27 53.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 42' ' ' GLU . 19.1 mt -73.76 -23.68 59.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -0.928 . . . . 0.0 109.003 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 49.0 mttt -81.27 -13.77 58.11 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.546 0.688 . . . . 0.0 109.489 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.528 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 p -65.2 -54.07 35.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 0.0 109.969 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.42 14.68 7.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 1.9 mm? -93.5 153.71 41.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.479 -1.012 . . . . 0.0 110.663 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HD2' HD21 ' A' ' 53' ' ' LEU . 40.7 Cg_endo -66.13 147.64 84.22 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.945 1.498 . . . . 0.0 110.623 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 52' ' ' THR . 82.3 p -44.86 -64.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.726 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 51' ' ' SER . 13.7 m -42.47 -58.09 2.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.967 . . . . 0.0 110.878 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -52.64 -50.2 63.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 0.0 110.342 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.11 -39.46 75.12 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.307 -0.87 . . . . 0.0 109.295 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.52 65.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 20.4 t60 -73.15 -29.63 63.0 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.489 HG21 HG13 ' A' ' 81' ' ' ILE . 8.8 mt -77.33 -28.51 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.1 -42.93 93.54 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.811 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.67 59.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . 7.0 tp -74.46 -17.04 60.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 62' ' ' ASP . 22.4 p -115.16 -35.5 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.456 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.485 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 12.2 t70 -66.61 56.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 110.551 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.463 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.43 -24.01 64.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -61.09 -16.11 40.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.664 -0.648 . . . . 0.0 110.337 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.6 t0 39.84 51.19 2.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 110.325 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.88 -14.5 6.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.853 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.68 -1.32 27.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 14.1 mttt -136.33 171.23 14.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -1.222 . . . . 0.0 110.601 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.1 mt -107.5 101.4 10.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.13 -179.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.602 -1.311 . . . . 0.0 110.511 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.88 -52.47 43.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 14.8 p-10 -79.37 -15.23 58.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.904 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.557 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 42.2 mm-40 -77.51 -40.16 43.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.927 -1.108 . . . . 0.0 110.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 23' ' ' ILE . 17.0 t80 -63.87 -17.54 63.28 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.279 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.7 -18.56 37.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.421 -0.8 . . . . 0.0 109.034 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.588 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 9.6 tt -84.27 -21.92 30.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' CA ' ' HB3' ' A' ' 61' ' ' CYS . . . -75.41 -46.45 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.172 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.4 m-85 -57.28 -29.64 64.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 108.81 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 50.7 t60 -54.2 -22.59 11.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 HD11 ' CD2' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -99.67 -60.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.664 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 9.9 mt -48.33 -52.26 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.821 -0.549 . . . . 0.0 109.84 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -52.42 -40.01 61.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 88' ' ' GLY . 5.1 mt-30 -60.02 -21.2 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' CB ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.85 -18.01 25.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.0 110.788 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.8 mt -88.52 -38.46 14.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 111.172 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -119.88 -14.67 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.997 . . . . 0.0 110.737 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 1.2 mmpt? -119.17 -2.5 10.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 110.616 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 41.34 59.36 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -126.36 132.59 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.087 -1.243 . . . . 0.0 110.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 15.6 p-10 -60.08 170.25 1.29 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HD3' HD13 ' A' ' 53' ' ' LEU . 43.8 Cg_endo -79.32 152.08 23.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.772 1.406 . . . . 0.0 110.374 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.59 ' C ' ' CG ' ' A' ' 93' ' ' HIS . 42.8 Cg_endo -68.78 63.91 1.27 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.01 1.532 . . . . 0.0 110.38 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.59 ' CG ' ' C ' ' A' ' 92' ' ' PRO . 8.8 p-80 35.94 -109.63 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.72 -0.613 . . . . 0.0 111.099 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.496 ' C ' ' CD1' ' A' ' 60' ' ' LEU . 5.3 m -102.71 -165.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.93 -1.106 . . . . 0.0 111.218 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -69.5 147.86 50.28 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.735 0.778 . . . . 0.0 111.414 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 68.9 p -125.71 166.97 18.1 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.0 Cg_endo -67.32 -23.28 44.84 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.477 1.251 . . . . 0.0 109.638 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.502 ' HB3' HG11 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -82.21 -18.31 43.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.588 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 35.4 ttm -92.21 -47.1 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.72 0.771 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.475 HG13 HD12 ' A' ' 95' ' ' LEU . 1.1 mt -50.05 134.48 22.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.545 -0.722 . . . . 0.0 110.212 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.694 -179.641 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG2' HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 121.117 0.484 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 ' CG2' ' A' ' 11' ' ' VAL . 7.7 p 36.76 66.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.578 -0.701 . . . . 0.0 111.122 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.2 t -107.12 -41.62 0.14 Allowed Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 13' ' ' SER . 51.8 Cg_endo -77.13 -147.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 122.928 0.962 . . . . 0.0 111.959 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.78 -59.13 0.11 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -37.77 -54.76 1.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.0 110.49 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.62 -42.93 68.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 109.797 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.76 -46.59 84.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.742 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -56.37 -29.18 61.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.524 -0.735 . . . . 0.0 109.971 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 13.3 m-85 -89.46 -52.38 5.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.429 -0.795 . . . . 0.0 110.05 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 5.5 t70 -44.53 -31.23 1.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.13 -34.75 37.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 26' ' ' LYS . 39.5 mt -78.91 -37.22 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.482 -0.761 . . . . 0.0 110.285 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.564 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 52.6 t80 -48.85 -30.6 5.99 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.356 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.4 mt -67.76 -25.76 65.78 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -98.74 -13.74 20.07 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.601 HG23 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.25 -55.47 3.66 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.729 0.776 . . . . 0.0 109.23 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 59.1 t0 -72.48 68.27 0.78 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 3.5 mttm -55.98 -13.82 2.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -96.6 13.83 26.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.563 -1.335 . . . . 0.0 110.96 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.4 mtm 43.16 26.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 34.4 p30 -98.56 22.37 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 56.49 19.85 28.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.46 105.46 3.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -1.146 . . . . 0.0 110.754 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p -89.0 130.01 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.865 -1.147 . . . . 0.0 109.018 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.452 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 p -87.15 152.66 22.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.092 -1.005 . . . . 0.0 109.808 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.74 -22.68 0.79 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.9 mm? -65.34 -37.32 86.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 111.263 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' OE2' ' OD1' ' A' ' 30' ' ' ASP . 15.1 mt-10 -86.45 -62.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.861 -1.149 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -50.83 -20.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.623 0.725 . . . . 0.0 109.491 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -44.92 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 110.645 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 14.6 mt-10 -44.04 -38.37 3.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.23 -0.919 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.504 HD13 HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -58.61 -42.56 85.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 110.265 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.9 m-85 -80.95 -29.65 35.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.163 -0.961 . . . . 0.0 110.166 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 42' ' ' GLU . 17.0 mt -65.85 -15.38 62.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.989 -1.069 . . . . 0.0 109.386 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 59.8 mttt -82.86 -13.51 56.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 81' ' ' ILE . 82.8 p -63.04 -10.86 15.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.75 . . . . 0.0 110.793 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.33 69.39 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 107.734 -2.146 . . . . 0.0 107.734 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 ' HB3' HD22 ' A' ' 53' ' ' LEU . 4.4 mp -100.51 173.11 3.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.866 -0.785 . . . . 0.0 110.679 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 40.7 Cg_endo -67.86 -153.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.217 1.64 . . . . 0.0 109.711 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.5 t -104.58 -65.11 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.216 . . . . 0.0 111.484 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -54.12 -38.1 65.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.082 -1.011 . . . . 0.0 111.284 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -47.62 -53.21 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.089 -1.007 . . . . 0.0 111.399 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 HD23 ' CB ' ' A' ' 49' ' ' LEU . 2.5 mm? -62.54 -46.37 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.021 -1.05 . . . . 0.0 109.35 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.94 81.95 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' THR . 28.5 t60 -72.41 -29.32 63.62 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 81' ' ' ILE . 6.9 mt -76.65 -22.46 15.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.592 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.1 t-105 -65.32 -45.06 85.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 108.9 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -31.63 64.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.399 -0.813 . . . . 0.0 109.119 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 5.8 tp -71.39 -22.1 61.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.76 . . . . 0.0 109.259 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 15.9 p -105.13 -30.77 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 49.6 t0 -74.71 54.32 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.49 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 5.4 p -54.83 -34.32 62.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.076 -1.015 . . . . 0.0 109.077 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 7.6 mptt -56.5 -17.09 7.17 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.604 -0.685 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 48.2 m-20 41.94 54.65 3.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.766 . . . . 0.0 110.155 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 41.4 t -119.99 8.6 11.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.16 -16.76 50.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 25.3 mttt -123.9 179.2 4.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 110.157 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.592 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -111.76 118.17 34.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.008 . . . . 0.0 110.713 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.494 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -75.34 175.46 8.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.952 -1.093 . . . . 0.0 109.369 179.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.51 -84.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.431 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 71' ' ' LYS . 3.6 m-20 -42.12 -38.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 110.849 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.49 ' OE1' ' OG1' ' A' ' 63' ' ' THR . 46.4 mm-40 -60.8 -60.08 4.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.056 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CE1' HG23 ' A' ' 27' ' ' THR . 28.5 t80 -51.14 -33.16 25.51 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.63 -10.52 59.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.606 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 5.6 tt -90.54 -35.34 15.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.434 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -58.91 -37.94 77.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.746 -1.221 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.676 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 29.0 m-85 -64.09 -35.31 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 79.1 t60 -51.36 -23.11 3.38 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.366 -0.834 . . . . 0.0 108.835 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -95.91 -22.72 17.25 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 8.3 mm -75.04 -54.13 14.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -37.54 10.92 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.593 -0.692 . . . . 0.0 110.389 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' ILE . 3.8 mt-30 -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 109.97 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -90.95 -20.95 21.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 0.0 110.313 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.5 mt -90.45 -59.78 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 111.439 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 86' ' ' ILE . 2.7 mm -92.88 -6.02 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.02 . . . . 0.0 111.626 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -125.88 -19.46 4.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.625 -1.297 . . . . 0.0 110.712 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.05 3.4 64.53 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.8 mt -81.95 160.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.293 -1.122 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 11.6 p-10 -102.81 166.34 12.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 109.841 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 41.2 Cg_endo -68.0 145.86 69.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.679 1.358 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.502 ' O ' ' C ' ' A' ' 93' ' ' HIS . 40.8 Cg_endo -68.6 127.88 16.24 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.037 1.546 . . . . 0.0 109.935 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.502 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -28.14 -67.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.137 0.494 . . . . 0.0 111.513 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 m -115.36 -165.61 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.965 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -93.74 163.42 13.54 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 70.6 p -122.55 169.06 10.37 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.8 Cg_endo -67.38 -15.02 44.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.343 1.18 . . . . 0.0 109.62 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.1 mp0 -88.42 -16.5 32.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 108.854 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.606 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 31.4 ttm -96.98 -31.61 12.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.5 mt -72.08 139.0 82.01 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.609 -0.682 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.47 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 45.6 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.384 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.544 HG11 ' CG2' ' A' ' 11' ' ' VAL . 7.7 p 31.27 99.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.565 0.697 . . . . 0.0 111.209 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.514 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.25 -62.18 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.869 -1.144 . . . . 0.0 113.509 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 13' ' ' SER . 40.6 Cg_endo -61.98 -143.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 122.936 0.966 . . . . 0.0 111.818 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.65 -60.74 0.1 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.735 -0.603 . . . . 0.0 112.552 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 23.0 mt-10 -37.49 -60.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.57 -0.706 . . . . 0.0 111.145 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 13' ' ' SER . 1.8 tmtt? -54.65 -34.4 62.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.99 -1.069 . . . . 0.0 110.1 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -67.86 -46.89 70.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.6 ttpt -57.26 -30.43 64.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.646 -0.659 . . . . 0.0 110.197 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 9.1 m-85 -84.77 -50.01 7.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.8 t70 -50.31 -32.6 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 0.0 109.597 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.96 -35.01 43.81 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.203 -0.935 . . . . 0.0 108.974 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 62.9 mt -77.74 -41.06 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.775 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.596 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 49.2 t80 -48.55 -26.57 2.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.042 -1.036 . . . . 0.0 108.809 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 17.6 mt -76.88 -28.62 55.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -98.53 -9.06 25.52 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.576 HG23 ' CE2' ' A' ' 74' ' ' PHE . 3.1 m -90.9 -57.24 2.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.236 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.3 80.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.664 -0.647 . . . . 0.0 109.708 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 1.1 mttt -78.48 12.32 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 111.798 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 68.4 m-20 -109.31 12.31 24.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.823 -1.173 . . . . 0.0 110.411 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 42.68 34.85 0.61 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.173 -0.954 . . . . 0.0 110.21 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 26.5 p30 -111.21 4.09 18.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.168 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 13.67 70.13 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.572 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -147.77 105.47 3.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -1.047 . . . . 0.0 110.323 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 69' ' ' LEU . 9.6 p -89.78 135.65 25.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 108.696 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.497 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -103.83 176.22 5.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.0 111.096 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' CD2' ' A' ' 38' ' ' LEU . . . -69.3 54.66 0.62 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.2 mt -139.93 -41.08 0.44 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 12.4 mt-10 -91.08 -61.67 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 36' ' ' SER . 1.1 p -51.71 -22.82 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 1.2 ptt180 -47.36 -54.4 11.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.615 -0.678 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.589 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 3.0 tt0 -60.85 -43.11 98.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.238 . . . . 0.0 107.753 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.568 HD11 ' CG2' ' A' ' 27' ' ' THR 0.256 1.1 mt -54.13 -40.79 48.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.87 -46.17 31.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' HG3' ' A' ' 41' ' ' ARG . 13.5 mt -50.83 -24.11 3.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 108.967 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 44.3 mttm -73.3 -16.33 61.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.204 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 44' ' ' PHE . 58.9 p -70.07 -19.54 63.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.409 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.14 26.94 67.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB3' HD23 ' A' ' 53' ' ' LEU . 6.5 mp -96.08 164.59 18.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.713 -0.875 . . . . 0.0 110.428 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 43.9 Cg_endo -74.05 172.87 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.976 1.514 . . . . 0.0 110.476 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 t -66.84 -67.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.612 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' LEU . 26.0 m -43.01 -62.59 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -0.86 . . . . 0.0 111.165 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.56 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -42.51 -55.68 3.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.182 -0.949 . . . . 0.0 110.936 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 44' ' ' PHE . 94.9 mt -52.87 -35.58 57.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.637 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.95 -33.77 57.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 108.739 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -73.7 -34.12 64.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -72.85 -19.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 57.6 t-105 -70.83 -44.56 66.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.471 -0.768 . . . . 0.0 109.948 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.495 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -70.34 -28.38 65.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.06 179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 45.4 mt -73.98 -12.68 60.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' CA ' ' A' ' 77' ' ' ALA . 17.1 p -116.06 -31.9 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.138 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 19.7 t0 -84.33 54.79 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.538 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 16.6 p -50.73 -31.66 17.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HG3' ' HB2' ' A' ' 70' ' ' SER . 9.1 mmtt -49.97 -21.09 1.08 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.425 0.631 . . . . 0.0 110.167 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 45.66 51.92 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.842 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.7 -5.09 7.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.29 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.97 58.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 11.4 mttm -116.4 -178.12 3.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -1.188 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.6 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -118.47 99.2 6.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.458 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.572 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.85 -171.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 110.296 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.596 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.32 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.056 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.49 -20.92 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 110.722 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.538 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 4.6 mm100 -72.98 -49.63 27.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 23' ' ' ILE . 9.5 t80 -61.21 -26.52 67.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.026 . . . . 0.0 109.467 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -78.39 -13.85 59.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.591 -0.693 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 2.8 tt -90.61 -28.74 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 110.759 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' CA ' ' HB3' ' A' ' 61' ' ' CYS . . . -63.59 -51.61 64.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 110.052 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ ' ' A' ' 74' ' ' PHE . 13.5 m-85 -51.38 -34.02 32.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 109.795 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.4 t60 -57.51 -20.94 34.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.324 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 60' ' ' LEU . 2.7 mt -99.42 -31.61 11.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.226 -0.922 . . . . 0.0 109.16 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.648 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 68.2 mt -63.18 -58.29 8.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.2 -37.03 1.96 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.596 -0.69 . . . . 0.0 110.785 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -58.78 -30.95 67.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.929 -1.107 . . . . 0.0 110.555 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -90.47 -21.76 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.793 -1.192 . . . . 0.0 111.023 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 49' ' ' LEU . 5.0 mt -86.73 -47.49 9.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 111.496 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 86' ' ' ILE . 3.1 mm -110.97 -10.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.917 -1.114 . . . . 0.0 111.194 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -118.3 -10.28 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.797 -1.189 . . . . 0.0 110.459 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 62.47 11.87 36.84 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 90' ' ' ASP . 6.1 mt -90.6 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.253 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.4 m-20 -114.7 162.73 22.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.539 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 43.1 Cg_endo -68.03 158.58 56.79 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.982 1.517 . . . . 0.0 110.315 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' O ' HD13 ' A' ' 60' ' ' LEU . 45.1 Cg_endo -72.04 178.66 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.867 1.456 . . . . 0.0 110.157 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.464 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -64.08 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.1 -1.0 . . . . 0.0 109.67 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.458 ' HA ' HD22 ' A' ' 60' ' ' LEU . 13.5 m -117.74 -165.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 11.7 mt -77.18 152.33 34.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.834 0.826 . . . . 0.0 111.687 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 45.1 p -123.7 169.95 9.41 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.5 Cg_endo -66.06 -26.31 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.297 1.157 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 11' ' ' VAL . 2.1 mt-10 -79.34 -6.97 57.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 108.924 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.577 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 33.6 ttm -107.6 -32.66 7.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.4 mt -69.6 111.83 10.14 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.627 -0.67 . . . . 0.0 109.705 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 43.9 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 124.03 1.542 . . . . 0.0 114.108 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.547 ' CG2' HG12 ' A' ' 12' ' ' VAL . 1.1 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.19 0.519 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' CG2' ' A' ' 11' ' ' VAL . 3.4 p 21.48 80.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-O 121.296 0.57 . . . . 0.0 112.166 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.533 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -109.45 -40.57 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 113.398 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.4 Cg_endo -80.05 -152.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 122.836 0.914 . . . . 0.0 112.35 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.94 -54.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 40.1 mt-10 -37.98 -60.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.679 -0.638 . . . . 0.0 110.572 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -55.95 -36.75 68.15 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.633 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -67.07 -48.82 67.08 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.702 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -55.33 -30.96 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.449 -0.782 . . . . 0.0 109.561 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.8 m-85 -85.37 -38.06 19.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.62 -35.6 74.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.458 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.9 -40.96 53.37 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 42.2 mt -69.25 -38.1 77.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.519 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 47.5 t80 -46.78 -31.32 2.93 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.491 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.2 -32.0 69.71 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 23' ' ' ILE . 11.9 mtmt -89.73 -15.91 31.49 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' HD12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -89.53 -51.86 5.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 20.7 t0 -71.4 56.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 97.6 mttt -44.57 -23.78 0.14 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.91 . . . . 0.0 111.618 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.469 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.6 m-20 -89.58 1.13 56.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.134 . . . . 0.0 110.571 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt 47.16 53.76 10.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.484 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 3.0 p30 -125.42 23.28 7.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.943 . . . . 0.0 109.951 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 64.9 12.09 52.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.563 ' CZ ' ' OG ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -151.02 108.44 3.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.238 . . . . 0.0 111.381 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 69' ' ' LEU . 2.0 p -92.98 134.16 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.065 -1.022 . . . . 0.0 109.081 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.5 t -87.32 153.67 21.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.91 -26.18 1.91 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.38 -41.99 99.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.43 -1.041 . . . . 0.0 111.636 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.8 mt-10 -81.24 -61.76 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 108.887 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.672 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -52.56 -20.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.533 0.683 . . . . 0.0 109.436 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -46.81 -73.15 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.2 -42.38 4.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.1 mt -58.81 -44.86 91.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.701 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 m-85 -80.45 -31.58 37.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.61 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 42' ' ' GLU . 57.9 mt -60.9 -16.78 45.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.0 109.357 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mttt -80.17 -22.44 41.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.194 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 81' ' ' ILE . 33.2 p -56.37 -25.39 49.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 110.472 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.95 83.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -88.91 160.6 43.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.966 . . . . 0.0 110.436 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HD2' HD23 ' A' ' 53' ' ' LEU . 40.8 Cg_endo -67.83 132.39 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.953 1.502 . . . . 0.0 110.226 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -39.33 -54.72 1.83 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.723 . . . . 0.0 110.862 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -47.98 -52.17 20.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 110.277 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -55.77 -51.54 67.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.853 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 mt -58.92 -40.14 83.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -45.75 69.08 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 41.4 t60 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 57' ' ' ILE . 3.1 mt -80.37 -27.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.604 ' CZ3' HD13 ' A' ' 69' ' ' LEU . 22.9 t-105 -68.61 -47.98 65.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 108.968 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -61.48 -28.67 69.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 1.6 tp -67.61 -47.5 69.48 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . 17.6 p -80.97 -35.02 32.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.012 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.501 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 39.2 t0 -65.5 59.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.501 -0.749 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 1.1 p -64.61 -30.34 71.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 1.4 mptp? -66.14 -10.78 44.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 t70 42.43 54.87 4.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 m -120.66 4.82 10.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.35 -10.93 69.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -120.91 -170.8 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.28 -1.129 . . . . 0.0 109.949 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.604 HD13 ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -122.55 109.47 14.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.988 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.563 ' OG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -61.7 -178.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 109.459 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.1 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.45 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.3 m-20 -46.14 -25.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 110.277 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 64' ' ' LYS . 9.5 mt-30 -68.75 -57.04 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.878 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.684 ' CZ ' ' CZ ' ' A' ' 78' ' ' PHE . 17.3 t80 -52.57 -21.42 3.84 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.347 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.85 -10.08 55.95 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.19 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 4.6 tp -91.33 -43.61 9.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.481 -0.762 . . . . 0.0 110.324 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 61' ' ' CYS . . . -58.06 -31.4 67.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.998 -1.064 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 20.0 m-85 -72.39 -35.26 68.4 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.225 -0.922 . . . . 0.0 108.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 73.5 t60 -53.44 -23.85 11.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.121 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -93.19 -42.2 9.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.51 HG23 ' CD2' ' A' ' 49' ' ' LEU . 1.2 mm -55.28 -56.41 11.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.581 -0.699 . . . . 0.0 109.307 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -46.73 6.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 110.585 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.9 mt-30 -55.38 -24.61 30.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.974 -1.078 . . . . 0.0 110.007 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 81' ' ' ILE . 8.0 tptp -90.22 -18.59 25.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.695 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.4 mt -90.73 -47.01 7.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.49 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.6 -18.86 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.932 -1.105 . . . . 0.0 111.232 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -109.72 -17.35 13.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.934 -1.104 . . . . 0.0 110.645 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 69.74 11.84 66.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -93.22 141.86 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.337 -1.096 . . . . 0.0 110.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.528 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -81.78 -172.0 0.33 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 0.0 108.79 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 90' ' ' ASP . 43.4 Cg_endo -78.33 158.93 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.415 1.219 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.7 Cg_endo -72.9 47.01 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.879 1.463 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.518 ' O ' HD11 ' A' ' 60' ' ' LEU . 19.1 m170 55.89 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.272 -0.893 . . . . 0.0 111.003 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -117.23 -161.75 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 110.58 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.58 ' CD1' ' HG ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.76 164.23 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.114 0.959 . . . . 0.0 111.175 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 1.5 p -127.96 -177.83 0.69 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.1 Cg_endo -75.05 -5.17 16.44 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.253 1.133 . . . . 0.0 109.667 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HB3' HG11 ' A' ' 11' ' ' VAL . 11.5 mt-10 -96.07 -18.33 20.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.855 0.836 . . . . 0.0 109.113 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 95' ' ' LEU . 4.0 mtp -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.855 0.836 . . . . 0.0 108.897 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 96' ' ' THR . 2.0 mt -61.0 128.65 89.55 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.887 -0.508 . . . . 0.0 109.743 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 C--N 1.306 -1.702 0 O-C-N 123.833 1.438 . . . . 0.0 110.635 -179.454 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.573 HG23 ' CD2' ' A' ' 79' ' ' HIS . 2.8 m . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.466 0.65 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 11' ' ' VAL . 1.4 p -143.33 70.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.503 -0.748 . . . . 0.0 110.182 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -104.89 -31.96 0.2 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.192 -0.943 . . . . 0.0 113.49 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 13' ' ' SER . 53.2 Cg_endo -75.09 -150.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 122.575 0.776 . . . . 0.0 110.788 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.9 -46.57 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.803 -0.561 . . . . 0.0 111.903 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -51.79 -59.55 4.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 9.1 tmtt? -52.16 -40.85 62.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 109.816 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -30.22 60.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 109.682 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 18.6 m-85 -88.59 -41.66 12.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.422 -0.799 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' OD2' ' NZ ' ' A' ' 71' ' ' LYS . 8.6 t70 -50.59 -39.79 50.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.252 -0.905 . . . . 0.0 109.178 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.42 -47.2 64.87 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' LYS . 20.3 mt -63.65 -39.26 84.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.432 -0.792 . . . . 0.0 109.413 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 66.7 t80 -49.24 -24.62 1.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.73 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.29 -26.07 60.92 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 1.8 tttt -97.95 -15.44 20.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.529 HG22 ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -88.83 -55.77 3.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.451 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 20.9 t0 -69.57 58.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 39' ' ' GLU . 0.3 OUTLIER -36.72 -46.0 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.521 -0.737 . . . . 0.0 112.729 -178.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' MET . 5.1 p-10 -94.52 15.6 17.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.617 -1.302 . . . . 0.0 111.994 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 30' ' ' ASP . 9.5 mtm 35.08 56.04 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.481 -0.762 . . . . 0.0 111.271 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 13.6 p30 -101.49 4.38 41.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 110.241 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.14 -33.22 4.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 1.3 p90 -146.76 146.46 30.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -1.094 . . . . 0.0 110.74 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.3 p -90.45 127.99 42.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.7 151.82 39.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.599 -1.313 . . . . 0.0 109.588 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.5 -23.88 0.95 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.3 mt -61.56 -46.39 90.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.755 -0.85 . . . . 0.0 111.805 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 8.3 mt-10 -80.39 -57.17 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.455 -1.403 . . . . 0.0 109.171 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.5 p -56.88 -20.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.848 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -75.97 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 110.152 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' N ' HD13 ' A' ' 45' ' ' LEU . 8.0 mp0 -42.78 -46.47 5.2 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.761 0.791 . . . . 0.0 109.021 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 27' ' ' THR . 1.0 OUTLIER -52.27 -37.82 23.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -80.99 -43.78 19.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.785 . . . . 0.0 109.145 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 42' ' ' GLU . 14.0 mt -52.65 -23.76 7.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 24.4 mtpt -78.55 -5.64 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.695 . . . . 0.0 109.817 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.537 ' CB ' HD13 ' A' ' 49' ' ' LEU . 43.5 p -76.76 -7.99 56.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.866 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.93 15.65 79.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 9.4 mp -88.21 165.26 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.996 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 46.2 Cg_endo -74.93 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.983 1.517 . . . . 0.0 109.225 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.99 -73.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.949 -1.094 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 53' ' ' LEU . 1.3 m -41.42 -58.0 2.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 111.088 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.559 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -40.86 -50.34 3.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.145 -0.972 . . . . 0.0 110.843 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.583 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -57.22 -41.61 79.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.862 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.21 92.85 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.829 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.428 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 82.0 t60 -64.36 -40.11 95.2 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' A' ' 44' ' ' PHE . 2.4 mt -69.0 -31.28 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.352 -0.842 . . . . 0.0 108.827 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 69' ' ' LEU . 53.9 t-105 -63.19 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.544 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -74.84 -25.61 59.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -74.78 -25.53 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.825 . . . . 0.0 109.317 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.502 ' HB3' ' CA ' ' A' ' 77' ' ' ALA . 29.8 p -100.78 -32.74 10.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 108.692 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.562 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 53.2 t0 -72.52 61.0 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.716 -0.615 . . . . 0.0 109.899 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 1.5 p -51.65 -34.95 40.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -60.51 -13.7 15.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.459 -0.775 . . . . 0.0 110.053 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 40.75 56.32 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.516 -0.74 . . . . 0.0 110.293 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 7.58 3.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.85 75.2 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -127.55 170.12 12.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.323 -1.104 . . . . 0.0 109.987 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 1.1 mt -118.2 98.58 6.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.082 -1.011 . . . . 0.0 110.512 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.665 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 1.2 p -46.18 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.333 -0.855 . . . . 0.0 109.407 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.54 -56.98 10.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.504 -1.373 . . . . 0.0 109.628 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.482 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -64.25 -49.0 73.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 110.704 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.562 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 26.0 mt-30 -44.45 -42.98 7.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 111.184 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.489 ' HA ' HD11 ' A' ' 69' ' ' LEU . 63.2 t80 -55.02 -44.93 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.15 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . . . -68.6 -9.49 50.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.988 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.501 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.8 tt -90.81 -35.29 14.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 111.219 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' CA ' ' HB3' ' A' ' 61' ' ' CYS . . . -58.64 -46.09 87.87 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 17.6 m-85 -56.74 -37.34 70.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.996 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.573 ' CD2' HG23 ' A' ' 11' ' ' VAL . 49.3 t60 -49.39 -21.66 0.94 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.07 -1.019 . . . . 0.0 109.65 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.532 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 5.8 mt -98.29 -24.6 15.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.807 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 18.3 mt -74.51 -58.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -30.44 7.62 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.603 -0.686 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -69.12 -21.98 63.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HE2' ' CD1' ' A' ' 57' ' ' ILE . 9.3 mttm -90.99 -25.74 19.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.1 mt -86.39 -65.49 1.01 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 86' ' ' ILE . 4.8 mm -84.64 -6.08 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.001 . . . . 0.0 110.703 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' CD ' HD12 ' A' ' 89' ' ' ILE . 1.3 mmtt -126.68 -28.89 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.933 -1.104 . . . . 0.0 110.491 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 68.55 18.79 72.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.547 HD12 ' CD ' ' A' ' 87' ' ' LYS . 7.7 mt -89.31 141.22 14.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.276 -1.132 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.27 167.51 33.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.558 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.474 ' HD3' ' HE3' ' A' ' 84' ' ' LYS . 44.4 Cg_endo -75.25 146.68 32.06 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.184 1.623 . . . . 0.0 110.574 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 93' ' ' HIS . 45.2 Cg_endo -72.25 102.0 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.989 1.52 . . . . 0.0 110.289 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.578 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -5.07 -70.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -122.13 -173.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.086 -1.009 . . . . 0.0 110.977 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -84.33 170.78 13.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 111.815 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 1.3 p -135.03 177.26 2.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.0 Cg_endo -70.99 -12.62 30.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.324 1.17 . . . . 0.0 110.2 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.502 ' HB3' HG13 ' A' ' 11' ' ' VAL . 81.7 mt-10 -87.38 -18.34 30.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 108.711 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.542 ' SD ' ' HA ' ' A' ' 95' ' ' LEU . 4.4 mtp -90.12 -43.19 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.719 0.771 . . . . 0.0 109.073 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 96' ' ' THR . 1.3 mt -53.34 137.16 50.23 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.772 -0.58 . . . . 0.0 109.98 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.082 1.57 . . . . 0.0 110.75 -179.498 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 98' ' ' GLU . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.549 ' CG2' HG23 ' A' ' 11' ' ' VAL . 2.3 t -97.44 161.43 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 170.96 -54.61 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.354 -0.841 . . . . 0.0 111.156 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.4 Cg_endo -71.83 -153.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.716 1.377 . . . . 0.0 110.45 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.89 -56.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.448 0.642 . . . . 0.0 111.408 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -39.42 -64.57 0.46 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.664 -0.648 . . . . 0.0 110.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 8.0 tmtm? -50.91 -44.27 60.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -44.84 89.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -61.67 -26.85 68.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.434 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.612 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 11.5 m-85 -90.47 -51.09 5.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.623 -0.673 . . . . 0.0 109.978 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -45.62 -36.84 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.632 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HA ' HD11 ' A' ' 25' ' ' LEU . 71.5 mt-10 -74.66 -40.29 61.54 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.576 HG21 ' CE2' ' A' ' 74' ' ' PHE . 36.5 mt -70.09 -35.18 62.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.842 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.599 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 73.3 t80 -48.82 -38.93 23.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.739 -1.225 . . . . 0.0 108.04 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 22' ' ' GLU . 8.3 mt -62.79 -26.67 68.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.15 -13.72 20.77 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.583 ' CG2' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -89.2 -55.47 3.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 34' ' ' PHE . 21.5 t0 -63.29 73.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 65.9 mmtt -52.45 -19.79 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.303 -0.873 . . . . 0.0 111.22 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -97.0 3.15 52.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 110.793 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.76 27.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 7.6 p-10 -92.92 11.5 27.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.125 -0.984 . . . . 0.0 110.194 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.34 5.45 89.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 70' ' ' SER . 1.9 m-85 -147.26 109.3 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 0.0 110.316 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.583 HG22 ' CG2' ' A' ' 27' ' ' THR . 4.2 p -88.86 126.59 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.49 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -81.82 148.63 28.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 110.136 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.19 -26.44 0.54 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.489 -1.007 . . . . 0.0 110.857 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.534 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 98.9 mt-10 -85.98 -58.79 2.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.774 -1.204 . . . . 0.0 108.927 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.529 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.5 p -58.54 -13.84 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.503 0.668 . . . . 0.0 109.815 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HG2' ' N ' ' A' ' 42' ' ' GLU . 10.6 ttm180 -50.93 -70.27 0.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.638 -0.664 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -45.0 -44.17 9.72 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.557 HD11 ' CG2' ' A' ' 27' ' ' THR . 1.4 mt -59.13 -41.27 83.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.608 ' CZ ' ' CD1' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.29 -19.94 52.57 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.592 -0.692 . . . . 0.0 109.211 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 42' ' ' GLU . 12.9 mt -76.42 -29.8 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.149 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 19.3 mttm -73.76 -9.61 58.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.507 -0.746 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 72.3 p -64.85 -51.53 61.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.76 21.01 5.87 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.558 ' CG ' HD12 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -85.63 172.94 7.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.941 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 39.2 Cg_endo -66.16 -93.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.777 1.409 . . . . 0.0 110.596 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -158.66 -73.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.863 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -29.73 68.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.538 HD13 ' CE ' ' A' ' 84' ' ' LYS . 1.1 tp -51.18 -60.1 3.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.606 ' HG ' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.6 -35.12 53.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 108.974 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.6 -38.47 80.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 21.7 t60 -68.84 -35.12 76.56 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.478 HG21 HD12 ' A' ' 57' ' ' ILE . 7.8 mt -69.84 -23.03 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.602 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.66 -46.28 79.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.483 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.424 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -68.57 -29.59 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.567 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 1.2 mp -74.89 -18.45 60.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' CB ' ' CB ' ' A' ' 77' ' ' ALA . 14.0 p -108.22 -30.04 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.179 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 63' ' ' THR . 67.0 t0 -78.64 49.02 0.84 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.572 -0.705 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 2.4 p -46.99 -29.18 1.93 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.522 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -55.01 -19.42 6.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.302 0.573 . . . . 0.0 109.605 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 m-20 38.85 55.27 2.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.579 -0.7 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.4 t -128.54 -30.4 2.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.97 0.99 4.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -142.51 170.62 15.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.174 -1.192 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.6 mt -104.15 104.07 13.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.421 -0.799 . . . . 0.0 110.094 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.08 -168.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 110.004 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.599 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.45 -67.98 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.722 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.52 -21.42 65.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.844 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 12.2 mm100 -69.29 -56.0 8.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.873 -1.142 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 23' ' ' ILE . 29.6 t80 -51.56 -22.0 2.93 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.226 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.24 -13.12 55.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.133 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.537 ' CD2' ' HG3' ' A' ' 99' ' ' MET . 2.2 tp -90.03 -42.98 10.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' CB ' ' CB ' ' A' ' 61' ' ' CYS . . . -55.81 -49.12 74.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.064 -1.022 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 1.2 m-85 -50.2 -36.42 30.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 59.2 t60 -56.69 -30.49 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.504 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 8.3 mt -87.1 -24.01 24.7 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.608 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 3.0 mm -76.65 -62.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -51.12 -26.03 6.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 110.342 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLY . 3.4 mt-30 -64.85 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 110.446 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.538 ' CE ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -90.25 -12.41 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 111.109 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.0 mt -87.19 -47.71 8.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.442 HG21 HD11 ' A' ' 86' ' ' ILE . 3.9 mm -111.48 -25.71 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 1.1 mmpt? -104.33 -2.59 25.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.643 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 45.54 35.02 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -106.31 130.42 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.154 -1.203 . . . . 0.0 110.089 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.4 p-10 -70.95 -175.79 0.33 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 43.0 Cg_endo -81.72 155.39 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.641 1.338 . . . . 0.0 110.044 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.4 Cg_endo -70.56 56.31 1.72 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.032 1.543 . . . . 0.0 110.598 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.467 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.3 m-70 42.58 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.497 -0.752 . . . . 0.0 110.793 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 92' ' ' PRO . 6.0 m -104.56 -169.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.667 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 4.3 mm? -74.0 162.12 29.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 43.6 p -138.57 165.21 34.47 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.0 Cg_endo -65.98 -41.18 14.19 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.555 1.292 . . . . 0.0 108.752 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.3 tt0 -67.55 -7.37 25.49 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.641 -0.662 . . . . 0.0 109.438 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.537 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 13.7 ttm -111.56 -26.84 8.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.77 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 96' ' ' THR . 3.3 mt -78.0 116.76 61.27 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.432 -0.793 . . . . 0.0 110.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.536 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 47.5 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.896 1.472 . . . . 0.0 110.201 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG21 ' N ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 120.985 0.421 . . . . 0.0 109.892 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.546 ' O ' HG11 ' A' ' 12' ' ' VAL . 14.9 p 33.41 100.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 111.525 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.96 -68.47 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 112.107 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 40.3 Cg_endo -62.87 -141.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.392 1.207 . . . . 0.0 112.354 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.6 -57.41 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.685 -0.634 . . . . 0.0 112.351 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 17.6 mt-10 -40.59 -63.45 0.64 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.426 -0.796 . . . . 0.0 110.599 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.81 -30.95 66.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.121 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.19 -44.57 45.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.572 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -61.17 -28.27 69.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 109.604 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 9.0 m-85 -87.01 -53.1 5.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.856 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -46.8 -28.74 1.65 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.002 . . . . 0.0 108.96 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -80.74 -42.58 21.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' LYS . 30.7 mt -71.38 -33.89 51.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ILE . 48.8 t80 -48.62 -33.03 9.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.468 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.4 -24.74 67.29 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 23' ' ' ILE . 35.0 mtpt -100.76 -12.89 18.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.474 -0.766 . . . . 0.0 108.969 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.556 ' CG2' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.23 -53.87 4.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.67 0.748 . . . . 0.0 109.076 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 49.9 t0 -67.8 62.17 0.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.632 -0.667 . . . . 0.0 109.37 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 5.2 mptp? -47.78 -25.08 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.172 -0.955 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 4.8 m-20 -91.39 7.59 40.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.788 -1.195 . . . . 0.0 111.142 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.444 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt 46.65 31.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.206 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 3.9 p-10 -100.39 19.84 15.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 110.287 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 65.28 12.56 55.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 2.0 m-85 -150.2 108.83 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 0.0 110.664 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 40' ' ' VAL . 2.1 p -89.26 132.56 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.051 -1.03 . . . . 0.0 108.623 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -88.46 156.74 18.94 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.848 -1.158 . . . . 0.0 109.979 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -49.68 -21.32 3.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.49 -35.19 77.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.13 . . . . 0.0 111.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 25.5 mt-10 -88.19 -60.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 44' ' ' PHE . 1.5 p -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.581 0.705 . . . . 0.0 109.283 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.71 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.762 -0.586 . . . . 0.0 110.601 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' LEU . 1.1 mt-10 -45.28 -43.33 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -54.1 -42.47 55.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.655 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 2.7 m-85 -83.77 -28.6 28.05 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 42' ' ' GLU . 40.7 mt -63.72 -22.3 66.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 21.7 mtpp -75.81 -8.82 57.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.641 -0.662 . . . . 0.0 109.467 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' HG21 ' A' ' 81' ' ' ILE . 54.0 p -68.46 -45.16 73.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 110.152 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.27 15.07 10.88 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -97.71 167.62 11.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.559 -0.965 . . . . 0.0 110.553 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HD2' HD21 ' A' ' 53' ' ' LEU . 45.2 Cg_endo -73.85 169.34 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 52' ' ' THR . 55.4 p -67.18 -55.67 13.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.261 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.7 m -49.14 -65.51 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -41.9 -54.7 3.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 49' ' ' LEU . 50.9 mt -59.14 -44.15 92.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.852 . . . . 0.0 109.693 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.51 -41.91 98.51 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.51 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 7.2 t60 -64.95 -30.31 71.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 HD13 ' CD1' ' A' ' 81' ' ' ILE . 7.6 mt -73.16 -24.91 21.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.607 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 36.0 t-105 -66.59 -48.48 69.42 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.047 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.42 -33.91 76.77 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.019 -1.05 . . . . 0.0 108.408 178.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.55 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 2.4 tp -70.76 -5.95 33.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 3.1 p -118.3 -35.58 3.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 59' ' ' SER . 4.4 p-10 -71.07 50.72 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.738 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 73' ' ' GLN . 1.8 p -51.41 -29.07 14.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.747 -1.221 . . . . 0.0 108.266 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE3' ' NE2' ' A' ' 73' ' ' GLN . 6.6 mmtt -53.59 -19.4 3.85 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.464 0.649 . . . . 0.0 109.996 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 44.63 53.1 7.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 t -126.28 -12.33 6.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.471 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.39 -7.48 37.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 6.0 ptpt -129.98 -172.0 2.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -1.191 . . . . 0.0 110.342 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -123.41 103.46 8.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.146 -0.971 . . . . 0.0 111.063 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.34 -169.15 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.668 -1.27 . . . . 0.0 109.851 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -62.61 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.349 -0.844 . . . . 0.0 110.639 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' ALA . 4.0 m-20 -41.98 -67.43 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.531 ' CG ' ' OG1' ' A' ' 63' ' ' THR . 15.5 mp0 -39.75 -39.34 0.77 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.518 -0.739 . . . . 0.0 111.2 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 69' ' ' LEU . 14.8 t80 -66.73 -35.61 80.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.744 -1.222 . . . . 0.0 108.683 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' ASP . . . -74.79 -6.75 50.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 109.375 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' CD1' ' HG3' ' A' ' 99' ' ' MET . 4.2 tp -90.36 -44.43 9.67 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.358 -0.839 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -52.12 -51.88 55.08 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.703 -1.248 . . . . 0.0 109.815 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 9.7 m-85 -54.45 -36.75 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 110.262 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 78.4 t60 -53.92 -20.21 5.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.902 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 3.1 mt -100.22 -19.57 16.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 0.0 109.034 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.612 HG13 ' CE2' ' A' ' 44' ' ' PHE . 18.1 mm -72.38 -66.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' ILE . 79.0 p -41.01 -29.91 0.12 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.737 -0.602 . . . . 0.0 110.107 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 10.8 mt-30 -61.94 -38.7 89.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 110.04 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.495 ' CG ' HD13 ' A' ' 49' ' ' LEU . 10.3 tptt -85.72 -14.51 45.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.929 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.539 ' CD2' HD21 ' A' ' 49' ' ' LEU . 4.4 mt -83.84 -64.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.984 -1.073 . . . . 0.0 110.719 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 86' ' ' ILE . 10.4 mm -95.89 -35.92 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.205 -0.935 . . . . 0.0 110.73 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 3.6 mmpt? -90.06 -0.99 57.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 43.91 24.99 0.56 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 5.5 mt -95.19 150.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.817 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.1 m-20 -92.91 159.6 35.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.007 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 44.7 Cg_endo -71.25 154.9 61.45 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.948 1.499 . . . . 0.0 109.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.545 ' O ' ' CD2' ' A' ' 60' ' ' LEU . 43.2 Cg_endo -70.43 142.14 44.22 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.988 1.52 . . . . 0.0 110.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 92' ' ' PRO . 4.1 m-70 -40.72 -57.92 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 110.444 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.51 -162.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 110.884 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -95.5 132.99 40.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.535 -0.728 . . . . 0.0 111.492 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 43.6 p -87.44 167.66 20.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.6 Cg_endo -66.81 -16.89 51.39 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.406 1.214 . . . . 0.0 109.403 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.464 ' HB3' HG12 ' A' ' 11' ' ' VAL . 6.3 mt-10 -85.87 -27.31 25.12 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.582 ' HG3' ' CD1' ' A' ' 76' ' ' LEU . 36.8 ttm -83.86 -12.57 55.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.532 0.682 . . . . 0.0 109.306 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.17 115.19 65.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.621 -0.674 . . . . 0.0 110.081 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 C--N 1.304 -1.813 0 O-C-N 123.759 1.399 . . . . 0.0 110.32 179.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.562 HG11 ' CB ' ' A' ' 99' ' ' MET . 4.1 m . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 76' ' ' LEU . 2.1 p -160.31 72.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.212 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 94.5 p -108.43 -22.36 0.17 Allowed Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 13' ' ' SER . 56.8 Cg_endo -76.62 -157.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 122.294 0.628 . . . . 0.0 111.473 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.22 -51.77 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.325 0.583 . . . . 0.0 111.671 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 55.2 mt-10 -39.42 -63.09 0.59 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.75 -32.12 67.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 110.069 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.31 -41.13 61.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -29.7 69.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.425 -0.797 . . . . 0.0 109.552 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.8 m-30 -81.29 -41.06 22.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.468 -0.77 . . . . 0.0 109.414 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.41 -31.54 15.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.58 -35.78 52.67 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 42.1 mt -74.5 -42.17 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.624 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 53.1 t80 -45.83 -28.92 1.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.464 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.0 -34.53 77.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 38.0 mtmt -93.68 -9.47 37.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.578 HG23 ' CE1' ' A' ' 74' ' ' PHE . 1.1 m -89.56 -56.01 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.718 0.771 . . . . 0.0 109.018 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 51.1 t0 -70.13 70.43 0.38 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.628 -0.67 . . . . 0.0 109.313 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 76.1 mttt -62.34 -8.13 5.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 111.588 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -95.25 -2.94 48.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.879 -1.138 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mmt 57.08 18.61 4.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 110.16 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 24.7 p30 -92.28 18.96 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.193 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 63.68 15.81 58.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.595 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.84 112.61 4.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.083 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.591 HG13 ' CE1' ' A' ' 24' ' ' PHE . 2.1 p -89.63 130.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.017 -1.052 . . . . 0.0 109.587 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 38' ' ' LEU . 2.9 p -85.3 148.93 25.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 109.391 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.05 -26.53 0.5 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -62.0 -35.31 78.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.643 -0.916 . . . . 0.0 111.019 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 19.7 mt-10 -89.13 -63.35 1.3 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.648 -1.283 . . . . 0.0 109.192 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.636 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.2 p -49.07 -21.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.321 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -43.02 -62.1 1.12 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 6.9 mt-10 -51.94 -45.87 64.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 108.476 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.56 HD13 ' CG2' ' A' ' 27' ' ' THR . 1.0 OUTLIER -54.65 -33.54 27.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.636 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 2.7 m-85 -85.17 -35.39 21.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 109.558 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 11.2 mt -60.3 -15.36 24.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 38.8 mttt -85.4 -10.19 56.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.653 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.531 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 44.6 p -73.68 -55.82 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.08 -7.98 9.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.543 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 1.7 mm? -69.89 161.92 71.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.369 -1.077 . . . . 0.0 110.245 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.5 Cg_endo -71.72 143.36 41.6 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' PRO . 56.2 p -40.41 -46.99 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.377 -0.827 . . . . 0.0 110.982 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.2 m -62.53 -61.57 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.981 . . . . 0.0 110.952 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.624 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.89 -47.6 11.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 44' ' ' PHE . 65.4 mt -55.9 -37.56 69.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.018 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.88 -43.55 75.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.465 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 20.7 t60 -61.36 -37.78 84.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.394 -0.816 . . . . 0.0 108.799 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 81' ' ' ILE . 13.8 mt -71.84 -28.51 30.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.551 -0.718 . . . . 0.0 109.079 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.629 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 15.2 t-105 -64.85 -37.8 88.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.552 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.476 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -75.14 -25.08 58.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 108.973 179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . 1.1 mp -77.67 -17.99 57.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.344 -0.847 . . . . 0.0 108.784 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.507 ' CB ' ' HB1' ' A' ' 77' ' ' ALA . 14.7 p -104.69 -29.38 10.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.751 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 59' ' ' SER . 5.5 p-10 -71.08 55.42 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.948 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.453 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -50.58 -30.07 12.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 109.524 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -63.99 -10.25 20.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.52 -0.737 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.28 56.64 2.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.375 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 t -128.0 -31.01 2.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.43 -5.64 7.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -127.0 172.67 10.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -1.147 . . . . 0.0 109.659 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.629 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -108.43 111.13 22.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.03 -1.044 . . . . 0.0 111.017 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.595 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -62.82 -178.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.992 . . . . 0.0 110.164 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HE2' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.8 -77.66 0.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 111.322 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.403 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 35.7 m-20 -54.31 -28.02 39.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.195 -0.941 . . . . 0.0 111.032 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' CG ' ' OG ' ' A' ' 70' ' ' SER . 36.1 mm-40 -66.08 -47.32 74.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 110.459 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.588 ' CZ ' HG23 ' A' ' 23' ' ' ILE . 23.9 t80 -56.5 -30.17 62.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.439 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . . . -76.92 -13.82 59.94 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.57 0.7 . . . . 0.0 109.413 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.52 -32.96 19.13 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.51 -0.744 . . . . 0.0 109.657 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 61' ' ' CYS . . . -63.55 -51.0 67.31 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 109.62 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 5.2 m-85 -47.65 -41.7 22.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.917 . . . . 0.0 109.627 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -52.07 -29.21 20.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 2.7 mt -83.89 -30.93 25.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -0.993 . . . . 0.0 108.726 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.558 ' CD1' HD11 ' A' ' 57' ' ' ILE . 8.3 mm -65.12 -57.64 10.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.454 0.645 . . . . 0.0 109.315 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.62 -36.19 2.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.593 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 45.1 mt-30 -58.06 -33.59 69.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.837 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.517 ' CG ' HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -89.12 -28.85 19.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.0 111.224 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 4.2 mt -77.4 -63.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.929 -1.107 . . . . 0.0 110.865 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.92 -12.99 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' CD ' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -122.45 -17.02 7.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 110.943 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 84' ' ' LYS . . . 58.51 25.05 57.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.564 HD13 ' CD ' ' A' ' 87' ' ' LYS . 17.1 mt -98.48 165.74 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -1.06 . . . . 0.0 110.05 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 89' ' ' ILE . 4.6 m-20 -96.19 164.1 19.27 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -69.49 162.89 40.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.186 1.624 . . . . 0.0 110.694 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.48 69.05 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.114 1.586 . . . . 0.0 111.779 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.511 ' O ' HD13 ' A' ' 60' ' ' LEU . 3.2 m170 32.41 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.772 -0.58 . . . . 0.0 111.87 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 92' ' ' PRO . 3.2 m -110.66 -164.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.171 -0.956 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.29 151.87 42.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.82 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 60.8 p -129.32 163.02 49.09 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.304 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 45.2 Cg_endo -71.39 -6.27 18.81 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.832 1.438 . . . . 0.0 110.682 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' C ' HG12 ' A' ' 11' ' ' VAL . 11.5 mt-10 -95.96 -28.93 14.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.562 ' CB ' HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -94.5 -12.57 27.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 110.031 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' THR . 5.5 mt -79.36 142.17 58.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' A' ' 100' ' ' ILE . 42.4 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.857 1.451 . . . . 0.0 110.175 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 98' ' ' GLU . 1.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.121 0.486 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 76' ' ' LEU . 2.4 p -152.24 67.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 111.012 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -105.72 -28.85 0.2 Allowed Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.9 Cg_endo -75.84 -155.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.577 0.777 . . . . 0.0 111.459 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.98 -48.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.432 0.634 . . . . 0.0 111.905 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 9.9 mt-10 -46.35 -60.97 2.0 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -52.67 -41.46 63.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.06 . . . . 0.0 110.063 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.41 96.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.465 -0.772 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.3 ttpt -58.91 -30.43 67.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.498 -0.751 . . . . 0.0 109.801 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 5.8 m-85 -85.07 -49.65 8.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.728 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -44.09 -36.68 2.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.879 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -36.8 70.09 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.569 HG21 ' CE2' ' A' ' 74' ' ' PHE . 45.2 mt -72.32 -40.84 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.491 -0.756 . . . . 0.0 109.84 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 31.3 t80 -48.12 -37.4 15.33 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.201 -1.0 . . . . 0.0 108.538 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.09 -23.18 67.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' ILE . 3.0 mmmt -102.86 -14.2 16.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.561 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.76 -56.69 3.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.621 -0.675 . . . . 0.0 109.354 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 47.6 t0 -61.33 77.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.663 -0.648 . . . . 0.0 109.279 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' THR . 5.8 mttm -67.04 -1.63 4.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.184 -0.948 . . . . 0.0 112.236 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 90.9 m-20 -104.65 -2.78 24.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.707 -1.246 . . . . 0.0 110.631 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mmt 57.56 18.27 4.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 110.899 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.7 p30 -90.24 0.08 57.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.093 . . . . 0.0 110.091 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 83.46 12.98 77.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -147.43 105.02 3.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 110.065 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.546 HG23 ' CG2' ' A' ' 27' ' ' THR . 8.8 p -89.19 133.79 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.034 -1.041 . . . . 0.0 109.502 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -86.72 157.17 19.69 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.047 -1.033 . . . . 0.0 110.196 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -51.22 -21.81 6.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.5 mm? -72.75 -31.84 65.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -1.039 . . . . 0.0 111.352 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.5 mt-10 -83.05 -55.27 4.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.68 -1.263 . . . . 0.0 108.373 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -61.05 -10.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG3' ' CD1' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -50.55 -73.06 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -42.5 -41.27 2.91 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.1 mt -60.14 -41.94 88.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.651 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 5.7 m-30 -81.9 -32.57 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.424 -0.797 . . . . 0.0 109.308 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.62 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 32.6 mt -58.58 -26.63 63.83 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.109 -0.994 . . . . 0.0 108.649 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -70.98 -8.88 56.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.513 -0.742 . . . . 0.0 109.076 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.56 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 28.7 p -78.36 -35.66 47.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.508 -0.745 . . . . 0.0 110.195 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.01 34.12 6.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.533 ' HB3' HD21 ' A' ' 53' ' ' LEU . 10.1 mp -105.63 157.12 35.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.828 -0.807 . . . . 0.0 110.717 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 45.4 Cg_endo -75.2 178.16 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.803 1.423 . . . . 0.0 110.201 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -57.79 3.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.123 -0.986 . . . . 0.0 111.06 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -52.1 -45.32 64.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -57.86 -51.38 69.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 110.005 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 11.3 mt -55.28 -41.32 72.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.195 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.517 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 13.1 t60 -69.08 -36.04 77.15 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 57' ' ' ILE . 6.9 mt -71.65 -34.48 52.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.593 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 38.6 t-105 -65.1 -47.41 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 109.879 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -31.19 72.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.197 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 14.8 mt -71.02 -9.82 58.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 109.184 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 63' ' ' THR . 29.4 m -119.57 -36.63 3.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 109.909 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 13.0 t0 -66.06 61.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.604 -0.685 . . . . 0.0 109.672 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 61' ' ' CYS . 11.6 p -58.33 -36.03 72.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.376 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -55.33 -16.2 3.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.04 53.12 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 -34.05 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -0.44 4.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 34' ' ' PHE . 9.9 mttt -132.7 175.55 9.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -1.164 . . . . 0.0 109.988 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.593 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.8 OUTLIER -105.64 110.86 23.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.496 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -62.81 179.09 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.327 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HE3' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.31 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 110.654 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 3.8 m-20 -52.89 -43.37 66.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.979 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 22.0 mt-30 -43.6 -62.72 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.021 -1.049 . . . . 0.0 110.355 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 23' ' ' ILE . 11.9 t80 -49.17 -36.11 18.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.837 -1.164 . . . . 0.0 109.016 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.57 -6.14 29.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.421 -0.8 . . . . 0.0 109.66 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.601 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 1.1 tt -90.34 -38.55 13.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.505 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 44' ' ' PHE . . . -55.92 -39.83 72.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 110.196 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 53.1 m-85 -57.33 -29.43 63.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 45.3 t60 -63.73 -26.55 68.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.79 -48.28 4.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.651 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 82.4 mt -60.67 -33.6 55.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.734 -0.603 . . . . 0.0 110.338 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 21.0 t -72.36 -18.67 61.73 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.212 -0.93 . . . . 0.0 111.005 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -90.52 -14.71 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.024 -1.048 . . . . 0.0 111.459 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 1.4 tptt -90.37 -15.27 31.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.664 -1.272 . . . . 0.0 111.136 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 6.8 mt -90.26 -56.65 3.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 111.554 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.62 -19.74 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.924 -1.11 . . . . 0.0 110.676 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.566 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.5 OUTLIER -109.08 -16.07 14.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.754 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 60.05 36.89 91.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 2.6 mt -104.61 154.38 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.273 . . . . 0.0 109.468 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.29 165.27 15.12 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 110.598 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 47.3 Cg_endo -72.34 155.04 56.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.191 1.627 . . . . 0.0 110.236 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.509 ' O ' HD11 ' A' ' 60' ' ' LEU . 42.1 Cg_endo -69.35 -179.34 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.981 1.517 . . . . 0.0 110.003 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.479 ' O ' HD21 ' A' ' 60' ' ' LEU . 54.0 m-70 -64.46 -99.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.9 -1.125 . . . . 0.0 110.19 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.451 ' HA ' HD22 ' A' ' 60' ' ' LEU . 7.4 m -108.26 -168.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 120.987 -1.071 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 2.0 tp -61.79 148.27 43.64 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.91 0.862 . . . . 0.0 111.458 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 71.0 p -130.08 166.73 24.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.0 Cg_endo -67.86 -25.38 39.18 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.511 1.269 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.459 ' HB3' HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -80.59 -12.01 59.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 109.101 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.601 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 32.5 ttm -103.9 -30.23 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.639 -0.663 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 96' ' ' THR . 3.0 mt -74.54 126.66 88.49 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.487 -0.758 . . . . 0.0 110.405 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.827 1.435 . . . . 0.0 110.458 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.55 HG21 ' CG2' ' A' ' 11' ' ' VAL . 37.6 t 57.65 121.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.5 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t -157.41 -64.91 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.685 -1.26 . . . . 0.0 112.438 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 46.7 Cg_endo -68.42 -149.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.494 1.26 . . . . 0.0 110.82 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.71 -43.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.31 0.576 . . . . 0.0 111.516 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 6.3 mt-10 -44.66 -62.78 1.08 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 109.864 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -56.69 -30.63 63.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -70.1 -51.32 32.64 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HE2' ' CA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -57.23 -32.49 66.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.28 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.3 m-30 -83.21 -28.11 29.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.671 -0.643 . . . . 0.0 110.483 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 11.2 t0 -72.07 -32.84 67.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 2.7 mt-10 -81.85 -26.9 33.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -0.91 . . . . 0.0 108.577 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 65.4 mt -82.31 -42.15 18.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.647 -0.658 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 53.2 t80 -49.98 -25.03 2.94 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.69 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 20.1 mt -71.93 -26.96 62.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 23' ' ' ILE . 13.2 mttt -101.28 -12.59 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.539 ' CG2' HD12 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -89.05 -55.38 3.71 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 4.0 t0 -70.62 81.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.4 mttt -81.17 10.31 5.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.066 -1.021 . . . . 0.0 112.179 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 73.5 m-20 -111.78 10.46 20.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 110.024 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.1 mtm 48.19 23.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.088 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 28.6 p30 -97.85 15.79 22.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.85 52.46 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.08 112.45 4.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -1.042 . . . . 0.0 110.009 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 24' ' ' PHE . 2.3 p -88.72 133.19 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.94 -1.1 . . . . 0.0 109.889 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 40' ' ' VAL . 17.2 t -90.93 153.45 20.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 110.095 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -25.52 0.54 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.6 mt -64.88 -38.73 91.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -1.117 . . . . 0.0 111.693 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 27' ' ' THR . 11.4 mt-10 -85.13 -55.82 3.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.862 -1.149 . . . . 0.0 108.974 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -59.77 -13.74 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HG2' ' N ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -56.28 -67.59 0.29 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 109.751 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 11.7 mm-40 -45.24 -32.19 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.884 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.539 HD12 ' CG2' ' A' ' 27' ' ' THR 0.268 1.3 mt -69.89 -41.83 79.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.24 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.675 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -74.58 -29.55 61.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.055 . . . . 0.0 109.196 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD11 ' CG ' ' A' ' 41' ' ' ARG . 15.1 mt -64.4 -18.48 64.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -79.58 -8.01 58.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 108.864 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 44' ' ' PHE . 28.3 p -79.84 -23.16 42.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 110.413 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.51 -17.09 58.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.554 ' HB3' HD23 ' A' ' 53' ' ' LEU . 7.2 mp -54.82 168.62 0.48 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.698 -0.883 . . . . 0.0 110.569 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 46.1 Cg_endo -81.58 -175.1 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.933 1.491 . . . . 0.0 109.392 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -61.6 1.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.422 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 53' ' ' LEU . 17.2 m -46.89 -64.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.554 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -40.53 -44.82 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.372 -0.83 . . . . 0.0 110.666 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -58.95 -43.37 91.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -66.18 -38.55 88.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 108.889 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 74.9 t60 -66.78 -41.79 87.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.48 -0.762 . . . . 0.0 108.95 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.553 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 3.3 mt -67.2 -29.81 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.595 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 21.4 t-105 -63.93 -44.61 92.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.477 ' O ' HD13 ' A' ' 95' ' ' LEU . 5.5 t -70.29 -33.62 71.78 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 108.898 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.529 HD12 ' CA ' ' A' ' 94' ' ' VAL . 1.1 tp -67.28 -21.65 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 109.809 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 18.1 p -106.62 -29.46 9.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD2' ' CZ2' ' A' ' 58' ' ' TRP . 26.1 t0 -80.47 52.59 1.66 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 110.042 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.536 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 7.7 p -46.25 -29.83 1.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.043 0.925 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.548 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 2.3 mmtm -58.92 -17.49 24.88 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.227 0.537 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 37.33 56.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.676 -0.64 . . . . 0.0 110.612 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 9.84 6.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.521 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.14 -18.27 54.48 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.576 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 14.8 pttt -125.1 175.03 7.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.053 -1.263 . . . . 0.0 110.03 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.595 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.4 mt -111.73 118.03 34.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.942 . . . . 0.0 111.028 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.643 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -64.32 -172.02 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.181 . . . . 0.0 109.459 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.43 -80.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 111.078 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -53.13 -18.62 2.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.514 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 10.1 mm100 -74.44 -40.64 61.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 23' ' ' ILE . 30.3 t80 -65.15 -23.0 67.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.083 . . . . 0.0 109.041 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -78.4 -12.37 60.0 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.504 -0.748 . . . . 0.0 109.736 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' CD1' ' CG ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -85.69 -38.36 18.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 110.61 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 61' ' ' CYS . . . -57.06 -44.48 83.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 6.4 m-85 -60.38 -23.49 64.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 83.6 t60 -64.28 -20.33 66.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 0.0 109.611 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 1.7 mt -99.69 -31.09 11.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 109.036 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 36.2 mt -61.11 -57.32 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.175 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -39.19 -34.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.695 -0.628 . . . . 0.0 110.828 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 21.0 mt-30 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.838 -1.164 . . . . 0.0 110.714 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' ILE . 19.9 tptp -89.89 -10.31 45.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.3 mt -88.37 -58.7 2.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.073 . . . . 0.0 110.918 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.07 -25.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 0.0 110.794 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -103.62 -8.7 19.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.973 . . . . 0.0 110.422 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 50.85 20.82 4.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 4.6 mt -86.67 142.0 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.972 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 7.5 p-10 -80.16 164.55 51.87 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 38.6 Cg_endo -66.45 159.8 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.042 1.548 . . . . 0.0 110.278 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.17 58.57 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 0.0 110.616 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.558 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.4 OUTLIER 39.35 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.631 -0.668 . . . . 0.0 111.235 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 92' ' ' PRO . 5.7 m -101.67 -164.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 111.305 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -95.3 164.84 12.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.878 0.847 . . . . 0.0 111.802 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 14.6 p -133.65 171.65 8.73 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.3 Cg_endo -68.94 -36.19 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.291 1.153 . . . . 0.0 109.632 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.1 tt0 -63.4 -18.41 63.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.218 -0.926 . . . . 0.0 109.106 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.568 ' CG ' ' CD1' ' A' ' 76' ' ' LEU . 24.4 ttm -97.04 -26.42 15.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.456 -0.777 . . . . 0.0 109.526 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 96' ' ' THR . 6.0 mt -82.29 115.3 57.02 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.304 -1.81 0 O-C-N 123.955 1.503 . . . . 0.0 110.309 179.896 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.544 ' CG2' HG21 ' A' ' 12' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.582 0.706 . . . . 0.0 109.127 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.544 HG21 ' CG2' ' A' ' 11' ' ' VAL . 6.2 t -103.75 159.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.588 -0.695 . . . . 0.0 109.693 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 169.25 -52.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.197 -0.939 . . . . 0.0 111.839 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 13' ' ' SER . 52.4 Cg_endo -70.51 -153.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.534 1.281 . . . . 0.0 110.819 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.23 -48.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.272 0.558 . . . . 0.0 111.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.559 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 1.6 mt-10 -50.97 -60.4 3.13 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.302 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -53.48 -36.3 61.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -67.6 -50.84 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.395 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -53.75 -29.58 40.43 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.51 -0.743 . . . . 0.0 109.546 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CZ ' ' CB ' ' A' ' 78' ' ' PHE . 10.9 m-85 -90.47 -47.85 7.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 12.9 t70 -49.76 -31.59 11.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 32.6 mt-10 -78.41 -36.23 45.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.7 mt -76.66 -39.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 70' ' ' SER . 74.7 t80 -47.21 -31.66 3.84 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.365 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.02 -31.52 71.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' ILE . 2.3 tttt -97.0 -10.18 26.71 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.553 ' CG2' HG23 ' A' ' 35' ' ' VAL . 1.5 m -90.22 -46.49 8.4 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.596 0.712 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 32' ' ' ASP . 27.6 t0 -73.47 62.25 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.227 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -45.87 -20.91 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.126 -0.983 . . . . 0.0 111.354 -178.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.484 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 7.5 m-20 -88.94 -5.15 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.929 -1.107 . . . . 0.0 110.363 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.05 44.58 29.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 14.8 p-10 -120.7 24.47 10.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.15 47.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.597 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.39 99.27 2.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -1.201 . . . . 0.0 110.639 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 27' ' ' THR . 7.4 p -90.73 142.09 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 0.0 109.354 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.28 152.47 19.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.069 -1.02 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.21 -26.49 0.93 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' SER . 71.2 mt -66.11 -41.23 90.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.474 -1.016 . . . . 0.0 110.891 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 19.9 mt-10 -78.6 -58.85 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.35 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' CG2' ' A' ' 27' ' ' THR . 1.7 p -61.08 -14.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.279 0.561 . . . . 0.0 110.141 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -45.41 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.441 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -42.71 -42.6 3.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 0.0 109.233 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.0 OUTLIER -55.7 -48.24 78.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.657 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -73.33 -38.88 65.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 76.2 mt -60.25 -21.66 62.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.48 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -73.6 -20.09 60.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.225 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 61.2 p -55.38 -24.45 29.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.21 56.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 49' ' ' LEU . 6.9 mp -90.94 170.88 9.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 110.299 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 53' ' ' LEU . 46.4 Cg_endo -74.03 -159.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.85 1.447 . . . . 0.0 110.309 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -94.05 -55.7 3.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.741 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.8 m -56.7 -57.12 13.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -41.25 -46.48 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.601 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 44' ' ' PHE . 25.0 mt -60.48 -42.05 95.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.954 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.25 89.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.13 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.531 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 12.9 t60 -65.22 -32.15 73.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 4.2 mt -73.64 -27.87 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.657 ' CZ3' ' CD1' ' A' ' 69' ' ' LEU . 29.6 t-105 -64.72 -43.67 92.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.493 ' O ' HD22 ' A' ' 95' ' ' LEU . 25.5 m -67.52 -35.23 78.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.126 -0.983 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 17.9 mt -67.59 -23.06 65.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 16.2 p -102.66 -35.48 8.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.06 -1.025 . . . . 0.0 108.866 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 61.1 t0 -70.25 54.4 0.14 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -56.74 -22.29 34.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.048 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.587 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 22.6 mmmt -57.03 -16.21 6.66 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.338 0.59 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.44 48.99 8.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.0 t -128.45 -22.1 3.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.357 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.28 -11.12 14.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 13.0 mtpt -124.81 -177.06 3.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -1.116 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.657 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.8 mt -116.81 107.26 14.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.628 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -58.65 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.48 -1.388 . . . . 0.0 109.994 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -76.57 -68.1 0.63 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.373 -0.829 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -61.95 -66.97 0.46 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.369 -0.832 . . . . 0.0 112.289 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -39.83 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 0.0 111.516 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.584 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 30.9 t80 -72.39 -38.66 68.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.476 -1.39 . . . . 0.0 108.692 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 20' ' ' TYR . . . -67.04 -8.87 33.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.476 0.655 . . . . 0.0 109.554 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 0.3 OUTLIER -85.85 -45.38 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.448 -0.782 . . . . 0.0 110.02 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 61' ' ' CYS . . . -42.35 -47.34 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 66.8 m-85 -61.36 -25.7 67.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.498 ' HB2' HG23 ' A' ' 12' ' ' VAL . 66.1 t60 -62.21 -20.98 64.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.446 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.439 HD13 ' HB3' ' A' ' 60' ' ' LEU . 4.7 mt -94.92 -21.77 18.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.657 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 11.4 mt -73.4 -62.69 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -39.39 -33.47 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.811 -0.556 . . . . 0.0 110.33 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 89' ' ' ILE . 24.4 mt-30 -59.61 -36.69 76.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' ILE . 5.3 tptp -89.86 -16.57 29.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.896 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 8.0 mt -81.33 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.015 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.88 -33.15 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.495 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 2.3 mmpt? -94.93 -2.84 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.434 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 47.81 22.21 1.86 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 12.2 mt -92.76 170.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -1.192 . . . . 0.0 109.791 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -102.65 172.73 4.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 110.109 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.531 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 45.8 Cg_endo -71.13 158.73 54.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.064 1.56 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' A' ' 60' ' ' LEU . 42.0 Cg_endo -68.73 173.59 9.81 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.959 1.505 . . . . 0.0 109.502 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -74.62 -50.68 16.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.994 -1.067 . . . . 0.0 109.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.436 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 27.9 m -141.67 -159.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 3.9 mm? -82.21 176.53 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.793 0.806 . . . . 0.0 110.894 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 30.9 p -150.96 166.64 14.63 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -70.59 -12.86 31.98 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 123.575 1.303 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.2 mt-10 -96.89 -19.53 18.78 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.748 0.785 . . . . 0.0 109.081 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.553 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 14.1 ttm -101.44 -6.62 23.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 110.224 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 96' ' ' THR . 10.6 mt -86.05 112.82 48.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.545 -0.722 . . . . 0.0 110.151 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 99' ' ' MET . 41.9 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 O-C-N 123.765 1.402 . . . . 0.0 113.322 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.62 ' CG2' ' CD2' ' A' ' 79' ' ' HIS . 2.0 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.423 0.63 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 2.1 p -140.43 67.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 109.969 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.2 t -103.49 -27.81 0.21 Allowed Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.8 Cg_endo -76.11 -156.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 122.559 0.768 . . . . 0.0 110.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.55 -57.33 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.305 0.574 . . . . 0.0 111.625 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 13.2 mt-10 -39.78 -63.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.694 -0.629 . . . . 0.0 110.74 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' CE ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.36 -45.19 88.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -28.04 68.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.766 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 23.5 m-85 -89.38 -48.46 7.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -47.25 -34.81 6.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.573 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.5 -36.05 60.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.011 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' LYS . 41.5 mt -69.82 -39.4 77.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.442 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -48.56 -33.48 9.76 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.645 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.8 -25.37 65.55 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' ILE . 9.4 mttp -98.9 -12.73 20.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.515 HG21 ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -89.91 -54.52 4.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.563 -0.711 . . . . 0.0 109.508 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.46 90.27 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 108.666 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -83.45 -17.98 40.2 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.054 -1.029 . . . . 0.0 112.6 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -92.23 13.16 19.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.632 -1.293 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.6 mtm 53.05 36.47 22.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.1 p-10 -113.05 22.63 14.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 110.348 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' ASP . . . 47.88 26.47 4.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.85 101.1 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.88 -0.776 . . . . 0.0 109.926 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.0 p -88.93 125.37 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.979 -1.075 . . . . 0.0 109.321 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 37' ' ' GLY . 1.8 p -83.17 157.6 22.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 109.819 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.75 -25.13 0.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 38' ' ' LEU . 4.3 mp -59.63 -48.27 82.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -1.02 . . . . 0.0 111.964 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 12.2 mt-10 -78.65 -57.88 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.624 -1.298 . . . . 0.0 109.237 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 2.1 p -56.93 -16.76 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.983 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 1.4 ttt-85 -50.05 -77.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.003 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -41.12 -37.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.906 0.86 . . . . 0.0 108.954 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 40' ' ' VAL 0.251 1.0 OUTLIER -64.74 -51.02 72.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.201 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.646 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -72.68 -41.18 65.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.051 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.502 HD13 ' N ' ' A' ' 42' ' ' GLU . 87.5 mt -49.5 -24.17 1.93 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -72.71 -19.81 61.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.612 -0.68 . . . . 0.0 109.558 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.498 ' CG2' HG21 ' A' ' 81' ' ' ILE . 61.9 p -64.39 -13.86 53.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.385 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.43 ' C ' HD11 ' A' ' 49' ' ' LEU . . . 76.34 23.78 70.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 53' ' ' LEU . 6.1 mp -100.11 163.99 17.26 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 110.414 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 48.0 Cg_endo -76.18 140.73 22.63 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.039 1.547 . . . . 0.0 110.338 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -45.63 -46.58 14.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -57.37 -52.83 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.637 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -53.25 -41.5 65.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.03 . . . . 0.0 110.023 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 24.1 mt -66.2 -41.49 90.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.935 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -64.14 -41.01 97.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.519 ' NE2' HD13 ' A' ' 60' ' ' LEU . 45.3 t60 -70.63 -35.03 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 81' ' ' ILE . 4.8 mt -73.89 -22.52 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.617 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 37.5 t-105 -68.98 -44.82 72.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.534 -0.729 . . . . 0.0 109.534 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -69.83 -28.88 66.07 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.144 -0.973 . . . . 0.0 108.69 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 11.2 mt -72.86 -10.25 59.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.519 -0.738 . . . . 0.0 109.084 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 63' ' ' THR . 13.7 p -117.46 -34.4 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.736 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 23.5 t0 -65.63 60.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.454 -0.779 . . . . 0.0 109.961 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -58.98 -27.81 65.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -68.35 -5.81 20.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.059 -1.026 . . . . 0.0 110.771 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 65' ' ' ASP . 3.4 p-10 37.85 54.78 1.59 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.45 -0.781 . . . . 0.0 111.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 -24.66 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.102 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.5 -9.89 8.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 62.8 mttp -125.0 -174.47 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 0.0 110.127 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -115.53 113.26 23.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.145 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -77.12 -177.24 4.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.114 . . . . 0.0 110.276 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.8 m-20 -44.25 -33.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.559 ' CD ' ' N ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -58.36 -40.84 83.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 1.6 t80 -66.52 -41.54 88.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -63.57 -10.86 20.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.832 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -80.2 -43.27 21.79 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -64.4 -52.18 59.49 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 5.5 m-85 -49.05 -39.41 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.78 . . . . 0.0 109.618 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.62 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 33.6 t60 -54.67 -25.68 28.61 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 60' ' ' LEU . 6.9 mt -90.54 -23.82 20.79 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 17.3 mm -73.86 -56.58 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.806 -0.757 . . . . 0.0 108.985 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -46.79 -28.19 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.526 -0.734 . . . . 0.0 110.027 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -77.2 -22.59 52.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.102 -0.999 . . . . 0.0 110.187 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.469 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -91.63 -30.96 16.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.524 ' CD2' HD12 ' A' ' 49' ' ' LEU . 3.9 mt -81.02 -58.93 2.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.066 -1.021 . . . . 0.0 111.018 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.529 HG21 ' CE ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -80.18 -42.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.953 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -94.34 -35.45 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 111.202 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 85.84 3.43 85.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 2.5 mt -66.86 165.5 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.186 -1.185 . . . . 0.0 109.885 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -102.31 164.12 16.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 0.0 110.292 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.477 ' HD3' HD12 ' A' ' 53' ' ' LEU . 47.5 Cg_endo -74.51 145.33 33.34 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' O ' HD11 ' A' ' 60' ' ' LEU . 43.9 Cg_endo -71.45 177.52 6.64 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.993 1.522 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.458 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -64.7 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 110.01 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 5.2 m -109.81 -167.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 110.274 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -81.88 175.33 10.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 111.299 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 2.2 p -139.71 179.44 1.28 Allowed Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.5 Cg_endo -71.1 -20.39 28.69 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.189 1.1 . . . . 0.0 109.626 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 11' ' ' VAL . 4.8 mt-10 -75.01 -28.34 60.46 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 95' ' ' LEU . 2.9 mtt -80.77 -49.27 11.35 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.024 0.916 . . . . 0.0 108.733 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 96' ' ' THR . 3.2 mt -56.71 136.31 78.23 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.779 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.302 -1.871 0 O-C-N 123.952 1.501 . . . . 0.0 109.949 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 12' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.536 ' C ' ' O ' ' A' ' 11' ' ' VAL . 2.6 p 15.21 69.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -103.96 -35.68 0.2 Allowed Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -75.85 -153.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 122.825 0.908 . . . . 0.0 111.999 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' ALA . . . -28.01 -52.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.594 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 34.7 mt-10 -38.47 -62.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.667 -0.645 . . . . 0.0 110.273 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -55.92 -34.58 65.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.081 -1.012 . . . . 0.0 109.44 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -68.95 -49.12 60.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 110.137 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -60.44 -30.82 69.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 7.8 m-30 -81.52 -48.57 11.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.516 -0.74 . . . . 0.0 109.813 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.487 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 25.1 t0 -46.39 -31.53 2.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.95 . . . . 0.0 109.046 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -78.51 -36.64 44.68 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.573 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 43.6 mt -74.47 -40.3 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 58.7 t80 -50.72 -24.52 3.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.177 -0.952 . . . . 0.0 108.876 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 38.6 mt -72.37 -24.74 61.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' ILE . 72.9 mttt -102.11 -13.64 17.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 53.9 t0 -68.35 91.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 109.516 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -88.39 0.9 55.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.041 -1.037 . . . . 0.0 111.747 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 34.9 m-20 -110.36 5.27 21.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.884 -1.135 . . . . 0.0 110.93 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 44.97 26.19 0.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 109.957 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 34' ' ' PHE . 2.5 p30 -90.18 -4.9 56.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.421 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.7 -16.45 23.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD2' ' CB ' ' A' ' 68' ' ' LYS . 2.3 p90 -148.82 151.64 35.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.267 -1.137 . . . . 0.0 110.649 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p -97.42 128.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 38' ' ' LEU . 1.3 t -79.56 151.04 30.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.329 -1.482 . . . . 0.0 109.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.25 -25.9 0.31 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 7.4 mp -62.02 -39.24 91.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -1.086 . . . . 0.0 111.288 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 6.9 mt-10 -86.63 -55.23 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.481 -1.387 . . . . 0.0 109.513 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -58.82 -15.63 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.635 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -44.34 -72.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 110.308 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 4.7 tt0 -44.39 -44.19 8.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.5 mt -58.27 -48.63 84.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.586 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -71.17 -27.7 63.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 42' ' ' GLU . 34.9 mt -70.87 -16.78 62.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 109.87 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 8.4 mtpp -86.95 -4.87 59.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 81.9 p -72.01 -15.06 62.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.872 . . . . 0.0 111.126 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.89 5.15 83.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 8.6 mp -77.19 173.91 6.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -80.55 -160.33 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.85 1.448 . . . . 0.0 110.075 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -93.87 -49.81 5.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.005 -1.06 . . . . 0.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -63.81 -51.96 62.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.554 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -46.69 -52.39 13.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 111.04 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.581 ' CD1' ' CD2' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.8 -43.47 76.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.942 -1.099 . . . . 0.0 109.307 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.37 85.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.677 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 67.4 t60 -71.24 -37.75 71.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.573 ' CD1' ' CD1' ' A' ' 81' ' ' ILE . 8.6 mt -70.46 -26.55 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.609 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 38.4 t-105 -63.29 -39.37 94.38 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.836 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.416 ' O ' HD22 ' A' ' 95' ' ' LEU . 2.3 t -72.16 -29.05 63.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.408 -0.808 . . . . 0.0 109.566 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . 3.8 mt -72.6 -18.85 61.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.26 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 58' ' ' TRP . 21.2 p -112.19 -28.31 8.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 109.108 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.54 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 30.6 t0 -78.09 52.25 1.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.462 -0.774 . . . . 0.0 109.662 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -52.35 -22.08 4.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 109.755 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -45.25 -26.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.735 0.778 . . . . 0.0 109.117 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.81 50.18 10.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.562 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.455 ' SG ' ' HE2' ' A' ' 68' ' ' LYS . 11.9 t -150.01 -30.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.577 -0.702 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.03 13.91 2.34 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.239 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.668 ' CB ' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -132.4 177.3 7.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.083 -1.245 . . . . 0.0 110.044 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.609 HD12 ' CZ3' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -120.29 94.04 4.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.297 -179.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -44.77 173.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.725 -1.235 . . . . 0.0 110.112 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.58 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.63 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 0.0 111.055 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 23.6 p-10 -53.85 -30.9 47.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.04 -1.037 . . . . 0.0 110.399 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 8.1 mt-30 -56.32 -53.45 57.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.472 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CZ ' HG23 ' A' ' 23' ' ' ILE . 42.1 t80 -50.01 -31.9 13.95 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -76.75 -11.73 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 109.795 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.532 ' CD2' ' HG3' ' A' ' 99' ' ' MET . 6.0 tt -89.18 -21.72 23.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 110.458 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 80' ' ' LEU . . . -72.9 -53.24 11.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.044 -1.035 . . . . 0.0 109.577 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 6.8 m-85 -49.54 -32.39 12.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.927 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 85.1 t60 -55.23 -26.18 37.94 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.509 -0.745 . . . . 0.0 109.453 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -93.8 -32.53 13.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 2.8 mm -69.27 -54.43 19.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.9 -30.65 1.04 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.85 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.2 mp0 -78.08 -19.27 54.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 110.428 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 81' ' ' ILE . 22.0 tptp -90.41 -21.9 21.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 110.673 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.4 mt -89.45 -59.45 2.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.102 -0.999 . . . . 0.0 110.527 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.534 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.4 -25.02 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 111.425 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' CG ' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.05 -14.82 9.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.764 -1.21 . . . . 0.0 111.376 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 58.49 28.03 61.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 ' CG ' ' A' ' 87' ' ' LYS . 1.6 mt -88.05 156.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -1.17 . . . . 0.0 109.668 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' N ' HG23 ' A' ' 89' ' ' ILE . 10.9 m-20 -89.54 164.85 27.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.52 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 47.3 Cg_endo -73.51 158.18 48.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.954 1.502 . . . . 0.0 110.451 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HG3' ' HE1' ' A' ' 99' ' ' MET . 47.0 Cg_endo -72.29 58.29 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.697 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.581 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 5.9 m170 45.65 -98.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 110.588 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.46 ' HA ' HD23 ' A' ' 60' ' ' LEU . 12.9 m -109.1 -163.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 111.249 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.47 155.52 40.59 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.651 0.738 . . . . 0.0 111.635 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 59.0 p -133.56 166.58 28.23 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -68.18 -28.94 33.59 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.446 1.235 . . . . 0.0 109.848 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.33 -9.83 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.099 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.532 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 25.3 ttm -106.33 -28.17 10.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.3 mt -71.52 115.13 34.2 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.497 -0.752 . . . . 0.0 110.572 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 -179.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.578 ' O ' ' C ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.578 ' C ' ' O ' ' A' ' 11' ' ' VAL . 2.7 p 12.15 61.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.235 0.541 . . . . 0.0 112.013 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.9 m -102.35 -33.03 0.22 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -74.97 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 122.729 0.857 . . . . 0.0 110.948 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.86 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.295 0.569 . . . . 0.0 111.706 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 22.6 mt-10 -46.67 -61.02 2.02 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.26 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -53.42 -37.11 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.94 -1.1 . . . . 0.0 109.745 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -68.96 -49.99 53.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.449 -0.782 . . . . 0.0 109.392 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -55.3 -29.72 58.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.525 -0.734 . . . . 0.0 109.456 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.673 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 7.0 m-85 -88.36 -47.61 8.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.003 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 4.0 t70 -49.27 -33.72 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.411 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 3.5 mm-40 -77.3 -39.26 48.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.425 -0.797 . . . . 0.0 108.913 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.58 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 30.6 mt -67.37 -37.15 78.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.435 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.611 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 57.8 t80 -48.92 -36.46 17.33 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.278 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.64 -26.97 68.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 10.7 mtmt -100.86 -14.27 18.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.577 ' CG2' HG23 ' A' ' 35' ' ' VAL . 1.1 m -89.18 -55.11 3.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 30.7 t70 -72.08 88.36 1.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 109.07 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' ' OE2' ' A' ' 39' ' ' GLU . 4.1 mttm -86.11 -6.07 59.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.962 -1.086 . . . . 0.0 111.665 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' MET . 66.7 m-20 -91.23 12.42 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.873 -1.142 . . . . 0.0 110.709 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' ASP . 7.7 mmt 41.69 35.54 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.39 12.18 20.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.177 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.04 12.78 68.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CE2' ' OG ' ' A' ' 70' ' ' SER . 1.1 m-85 -148.12 112.17 5.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 110.42 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 27' ' ' THR . 14.1 p -89.43 135.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 108.9 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.454 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.23 152.3 22.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.371 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -46.82 -24.62 1.96 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -68.94 -30.31 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.363 -1.08 . . . . 0.0 110.799 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.3 mt-10 -86.67 -60.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.793 -1.192 . . . . 0.0 108.066 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.2 p -56.15 -16.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 4.5 ttt180 -42.24 -73.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 110.016 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' N ' HD12 ' A' ' 45' ' ' LEU . 2.6 mt-10 -44.32 -46.87 9.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 108.777 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.547 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.5 mt -55.86 -42.71 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.105 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.647 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 2.9 m-30 -80.58 -24.16 39.37 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.566 -0.709 . . . . 0.0 109.38 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 42' ' ' GLU . 43.1 mt -73.5 -19.77 60.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.294 -0.879 . . . . 0.0 108.848 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 34.6 mtpt -81.79 -9.52 59.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.424 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 52.0 p -68.41 -17.72 64.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.812 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.02 61.88 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 7.5 mp -102.64 171.61 5.08 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.674 -0.898 . . . . 0.0 110.372 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 48.3 Cg_endo -80.92 -163.95 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.866 1.456 . . . . 0.0 109.943 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -62.38 1.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.957 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -45.95 -42.86 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 1.2 tp -56.48 -55.58 31.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 19.4 mt -57.24 -36.92 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.385 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.56 76.95 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.842 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 6.3 t60 -66.29 -25.25 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 HG22 ' CG1' ' A' ' 81' ' ' ILE . 1.8 mt -82.11 -32.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.608 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 20.3 t-105 -62.81 -38.67 91.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 p -76.0 -25.4 55.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.576 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 7.0 mt -77.08 -9.63 58.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.219 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' TRP . 16.4 p -116.18 -29.37 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.146 -0.971 . . . . 0.0 109.238 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -74.48 52.54 0.5 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.51 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 1.4 p -51.86 -28.92 17.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.123 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HG3' ' CG ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -59.06 -15.22 12.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 0.0 110.414 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 43.88 55.68 5.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.98 5.92 5.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.51 -12.12 61.89 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HD3' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -120.45 -172.68 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -1.196 . . . . 0.0 110.493 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.8 OUTLIER -122.99 102.37 7.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.4 -0.812 . . . . 0.0 109.783 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.558 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -58.84 -172.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.447 -1.408 . . . . 0.0 109.374 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.611 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.95 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.958 -1.089 . . . . 0.0 109.991 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 5.0 t70 -43.73 -32.8 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.386 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -59.68 -57.38 13.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 110.323 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 4.4 t80 -50.49 -30.38 12.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.944 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.33 -6.96 53.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -84.89 -40.49 17.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 44' ' ' PHE . . . -64.09 -38.18 90.14 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.743 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.673 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 3.7 m-85 -58.35 -31.13 67.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.181 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 81.1 t60 -61.21 -27.76 68.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.151 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.05 -57.59 2.31 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 40.3 mt -47.53 -31.22 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.486 0.66 . . . . 0.0 109.391 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 6.8 t -58.88 -53.49 57.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.728 -0.608 . . . . 0.0 110.935 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -66.85 -7.44 21.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.97 . . . . 0.0 110.697 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.482 ' CB ' HD22 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -90.72 -12.63 36.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.005 . . . . 0.0 110.897 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 47' ' ' THR . 6.3 mt -90.63 -66.78 0.9 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 111.204 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.91 -34.29 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.875 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 7.9 mmpt? -89.36 -25.3 21.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.945 . . . . 0.0 110.36 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 67.77 5.46 38.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 23.5 mt -72.87 153.1 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 120.914 -1.345 . . . . 0.0 110.06 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.521 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -82.21 176.77 3.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.739 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 42.2 Cg_endo -70.81 168.31 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.984 1.518 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' VAL . 52.8 Cg_endo -78.84 38.37 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.048 1.552 . . . . 0.0 111.33 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 55.97 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.06 . . . . 0.0 111.043 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' CA ' HD22 ' A' ' 60' ' ' LEU . 12.2 m -116.83 -161.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.68 -1.262 . . . . 0.0 111.795 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 2.9 mm? -96.45 149.18 22.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.524 ' OG1' ' HG3' ' A' ' 99' ' ' MET . 0.8 OUTLIER -117.19 173.46 3.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.3 Cg_endo -72.91 -12.17 26.02 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.593 1.312 . . . . 0.0 110.153 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -97.39 -7.37 31.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.676 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.569 ' CG ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -116.1 10.84 15.11 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.053 -1.029 . . . . 0.0 108.955 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 96' ' ' THR 0.25 19.5 mt -106.48 138.24 19.67 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.638 -0.663 . . . . 0.0 110.828 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.495 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 48.3 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' A' ' 12' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.916 0.865 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 6.1 p -111.99 159.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER 171.28 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.684 -1.26 . . . . 0.0 111.696 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 13' ' ' SER . 44.2 Cg_endo -67.92 -149.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.528 1.278 . . . . 0.0 110.612 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.69 -44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.266 0.555 . . . . 0.0 111.813 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.5 mt-10 -53.08 -62.09 1.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -53.01 -37.75 61.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.013 . . . . 0.0 109.915 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.87 64.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.792 . . . . 0.0 109.696 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.1 ttpt -53.37 -29.27 33.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.09 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 3.7 m-85 -91.07 -52.92 4.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 110.102 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' TYR . 30.9 t70 -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.862 . . . . 0.0 109.551 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -75.26 -37.35 61.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.479 -0.763 . . . . 0.0 108.964 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' LYS . 64.7 mt -74.27 -38.15 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.441 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 74.8 t80 -48.65 -40.11 26.64 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.913 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -64.4 -23.48 67.3 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.459 -0.897 . . . . 0.0 108.721 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' ILE . 37.6 mttt -102.62 -11.27 18.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.71 . . . . 0.0 109.134 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.526 ' CG2' ' HB ' ' A' ' 40' ' ' VAL . 1.6 m -88.87 -54.78 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 21.4 t0 -68.0 89.5 0.3 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 26' ' ' LYS . 2.3 mttt -93.55 -12.43 29.6 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.998 -1.064 . . . . 0.0 112.591 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 31' ' ' MET . 25.5 p-10 -96.16 -12.39 24.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.61 -1.306 . . . . 0.0 110.755 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 62.0 63.76 1.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 27.2 p30 -120.14 -4.42 10.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.752 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.55 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 122.77 -41.56 1.78 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -140.22 154.07 46.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.961 . . . . 0.0 109.042 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 39' ' ' GLU . 2.1 p -88.25 127.21 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -79.49 149.56 31.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.348 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -40.17 -27.84 0.15 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -59.13 -46.06 89.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.847 -0.796 . . . . 0.0 111.562 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.569 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 2.2 mt-10 -81.13 -52.41 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.404 -1.435 . . . . 0.0 108.7 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -65.27 -10.38 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.796 0.808 . . . . 0.0 109.384 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.8 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 110.692 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -43.19 -37.28 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 40' ' ' VAL . 1.4 mt -62.35 -50.11 81.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.661 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -73.5 -33.83 64.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 108.902 178.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.444 HD13 ' HG2' ' A' ' 41' ' ' ARG . 91.7 mt -65.1 -16.79 63.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.791 . . . . 0.0 109.367 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -86.76 -11.58 50.63 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.425 -0.797 . . . . 0.0 109.783 179.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 68.1 p -68.25 -17.87 64.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.51 13.95 69.32 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 49' ' ' LEU . 10.4 mp -84.26 166.52 32.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.974 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -77.19 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.086 1.572 . . . . 0.0 109.271 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -94.54 -70.82 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.848 -1.157 . . . . 0.0 110.323 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 51' ' ' SER . 1.0 OUTLIER -42.38 -57.59 2.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.567 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 1.3 tp -43.5 -52.25 6.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.894 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 49' ' ' LEU . 1.2 tp -57.66 -46.57 84.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.022 . . . . 0.0 109.503 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.9 -33.29 75.37 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.584 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 70.7 t60 -73.04 -43.84 61.51 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.56 ' CG2' ' CZ ' ' A' ' 44' ' ' PHE . 3.1 mt -63.41 -24.06 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 61.9 t-105 -66.59 -52.26 47.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.94 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.495 ' O ' HD21 ' A' ' 95' ' ' LEU . 27.8 t -63.85 -33.94 76.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 3.7 tp -64.46 -32.19 73.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.633 -0.667 . . . . 0.0 109.731 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 62' ' ' ASP . 17.6 p -96.02 -36.25 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.721 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 55.3 t0 -68.03 56.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.523 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.6 -31.05 70.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.121 -0.987 . . . . 0.0 109.65 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -58.55 -15.12 9.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 44.18 55.08 5.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 110.158 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 -39.85 2.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.16 -13.06 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 34' ' ' PHE . 3.5 mttm -139.71 -169.45 2.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.325 -1.103 . . . . 0.0 109.315 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 3.6 mt -108.5 122.69 47.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 111.304 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.562 ' CB ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -73.82 -172.97 1.4 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.05 -1.031 . . . . 0.0 109.178 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.16 -89.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.75 -1.219 . . . . 0.0 110.282 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -47.84 -36.28 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 110.105 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.562 ' HG3' ' CB ' ' A' ' 70' ' ' SER . 5.5 mm-40 -60.05 -35.06 74.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.997 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HA ' ' CD2' ' A' ' 69' ' ' LEU . 25.9 t80 -71.09 -32.11 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 108.918 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -69.18 -8.12 42.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.551 ' CD2' ' HG3' ' A' ' 99' ' ' MET . 3.9 tt -90.42 -36.92 14.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 110.54 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 81' ' ' ILE . . . -55.22 -46.15 75.95 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.002 -1.061 . . . . 0.0 109.716 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 11.5 m-85 -60.43 -34.38 73.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 110.162 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.492 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 76.7 t60 -53.15 -21.43 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.802 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 4.4 mt -98.18 -24.78 15.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 0.0 108.784 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.661 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 13.1 mt -69.94 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' ILE . 9.4 t -40.98 -32.14 0.22 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.704 -0.623 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -75.16 -24.99 57.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.919 -1.113 . . . . 0.0 110.314 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ILE . 20.5 tptt -90.07 -18.0 26.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 111.331 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.3 mt -88.76 -62.8 1.4 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.953 -1.092 . . . . 0.0 111.282 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 86' ' ' ILE . 17.0 mm -92.7 -19.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.112 -0.993 . . . . 0.0 111.337 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 1.5 mmpt? -108.43 -7.86 15.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.989 -1.069 . . . . 0.0 110.843 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.07 20.91 4.95 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 6.5 mt -90.32 134.95 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.2 p-10 -71.38 169.92 13.65 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.872 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 42.9 Cg_endo -71.43 155.79 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.846 1.445 . . . . 0.0 110.644 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.506 ' HD2' HD22 ' A' ' 60' ' ' LEU . 40.4 Cg_endo -67.53 59.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.584 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER 37.32 -93.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.673 -0.642 . . . . 0.0 111.617 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.479 ' CA ' HD13 ' A' ' 60' ' ' LEU . 13.1 m -106.92 -164.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.249 -0.907 . . . . 0.0 111.476 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -76.28 163.34 27.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.793 0.806 . . . . 0.0 111.256 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 50.5 p -140.57 167.02 19.15 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -69.4 -26.65 29.07 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.434 1.229 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 11' ' ' VAL . 16.1 mp0 -79.44 -20.14 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 108.886 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.551 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 29.9 ttm -98.29 -6.21 31.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.644 -0.66 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 96' ' ' THR . 38.5 mt -102.88 107.81 56.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.397 -0.814 . . . . 0.0 110.428 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 123.897 1.472 . . . . 0.0 112.942 179.683 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 12' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 11' ' ' VAL . 9.9 t 49.1 101.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.064 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.29 -67.35 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.744 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.768 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 48.8 Cg_endo -67.97 -149.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.366 1.193 . . . . 0.0 112.068 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.79 -51.06 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.963 -0.461 . . . . 0.0 112.142 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -40.34 -61.98 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 110.672 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -56.59 -32.53 65.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.807 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.15 -48.43 43.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 109.749 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -29.66 69.33 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.683 0.754 . . . . 0.0 109.51 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 m-30 -84.39 -45.76 12.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.613 -0.679 . . . . 0.0 110.681 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -54.91 -39.89 69.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.815 -1.178 . . . . 0.0 109.352 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.41 -50.35 46.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.29 -0.881 . . . . 0.0 109.072 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 26' ' ' LYS . 65.9 mt -63.83 -39.08 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.151 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.607 ' CZ ' ' HG2' ' A' ' 71' ' ' LYS . 85.0 t80 -46.74 -36.33 7.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.584 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.79 -21.24 64.34 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.383 -0.823 . . . . 0.0 109.163 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 12.2 mttt -101.14 -11.46 19.55 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.585 0.707 . . . . 0.0 109.162 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.575 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -89.83 -50.37 6.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.535 0.683 . . . . 0.0 109.801 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 40.1 t0 -66.52 71.04 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.572 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 27' ' ' THR . 3.6 mptp? -62.23 -12.99 23.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.273 -0.892 . . . . 0.0 111.432 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 74.5 m-20 -93.98 -0.31 55.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.911 -1.118 . . . . 0.0 110.474 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.0 mtm 45.29 27.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.813 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.57 ' OD2' ' CZ ' ' A' ' 34' ' ' PHE . 12.1 p-10 -90.22 2.86 54.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.6 12.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.711 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 38.9 p90 -150.47 162.51 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.143 . . . . 0.0 110.525 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 39' ' ' GLU . 2.4 p -99.86 146.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.445 -0.785 . . . . 0.0 110.995 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.473 ' O ' HG11 ' A' ' 40' ' ' VAL . 80.6 p -94.57 155.16 17.03 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' ' CH2' ' A' ' 58' ' ' TRP . . . -52.94 -18.41 5.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.495 ' N ' HD21 ' A' ' 38' ' ' LEU . 5.8 mt -73.5 -30.46 63.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 111.024 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 39.2 mt-10 -87.68 -60.16 2.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.52 ' HB ' ' CG2' ' A' ' 27' ' ' THR . 1.4 p -54.3 -17.44 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.672 0.749 . . . . 0.0 109.659 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -46.66 -75.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.315 -0.866 . . . . 0.0 110.087 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.8 mt-10 -44.57 -37.29 3.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.551 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 27' ' ' THR . 1.1 mt -61.6 -46.94 95.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.644 -0.66 . . . . 0.0 109.392 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 78' ' ' PHE . 0.7 OUTLIER -79.76 -27.32 40.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 109.469 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 42' ' ' GLU . 62.2 mt -60.07 -16.7 33.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.858 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mtpp -80.39 -25.19 39.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.707 -0.62 . . . . 0.0 109.938 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' CG2' HG23 ' A' ' 81' ' ' ILE . 69.9 p -52.63 -26.44 13.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.9 -11.56 71.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 49' ' ' LEU . 4.6 mp -67.96 167.28 17.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.465 -1.02 . . . . 0.0 110.136 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -72.15 153.37 56.99 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.855 1.45 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 52' ' ' THR . 19.0 t -59.04 -63.2 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.605 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 51' ' ' SER . 51.7 m -40.07 -48.66 2.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.548 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.39 -56.49 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.936 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 81' ' ' ILE . 35.2 mt -54.22 -36.88 63.97 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.264 -0.897 . . . . 0.0 109.052 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.56 85.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.445 ' NE2' HD13 ' A' ' 60' ' ' LEU . 23.1 t60 -68.08 -26.6 65.91 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 57' ' ' ILE . 3.3 mt -76.64 -29.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.63 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 50.2 t-105 -64.34 -45.85 86.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.179 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.423 ' O ' HD22 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -70.52 -37.58 74.13 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.564 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 5.3 mt -66.29 -14.57 62.22 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD2' ' A' ' 69' ' ' LEU . 17.2 t -110.04 -41.69 4.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.771 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.8 t0 -62.92 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.667 -0.646 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 61' ' ' CYS . 4.4 p -65.06 -35.49 81.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.11 -0.994 . . . . 0.0 110.36 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -56.28 -17.05 6.5 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.924 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 49.63 52.95 13.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.78 8.85 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.24 27.48 57.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -150.52 173.6 13.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -1.111 . . . . 0.0 110.036 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.1 mt -114.99 93.37 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.551 ' HA ' ' CB ' ' A' ' 34' ' ' PHE . 21.0 p -50.73 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.463 -0.773 . . . . 0.0 110.635 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -68.19 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.94 -1.1 . . . . 0.0 111.111 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 73' ' ' GLN . 2.3 p30 -42.57 -28.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 110.825 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.562 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 14.9 mt-30 -64.11 -59.17 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.072 -1.017 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 27' ' ' THR . 41.9 t80 -45.74 -29.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.834 -1.167 . . . . 0.0 109.778 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -80.41 -13.82 58.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -89.87 -34.23 16.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.529 -0.732 . . . . 0.0 110.313 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -58.58 -46.93 85.88 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.904 -1.123 . . . . 0.0 110.379 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 10.6 m-85 -59.39 -31.61 69.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.186 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 40.1 t60 -57.43 -25.8 60.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 109.927 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.31 -29.48 18.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 1.3 mm -74.09 -50.33 28.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.592 0.711 . . . . 0.0 109.1 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -27.31 33.33 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.638 -0.664 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -72.59 -24.59 61.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 0.0 110.269 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -29.03 20.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 111.421 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.516 ' CD2' HD11 ' A' ' 49' ' ' LEU . 3.9 mt -76.79 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.978 -1.077 . . . . 0.0 110.832 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -93.8 -15.64 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.428 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 89' ' ' ILE . 1.3 mptt -117.45 -11.54 10.52 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 51.68 21.97 7.76 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 87' ' ' LYS . 18.5 mt -89.94 143.97 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.533 -0.981 . . . . 0.0 109.718 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.0 m-20 -82.33 165.74 40.76 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 38.3 Cg_endo -66.37 157.5 59.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.053 1.554 . . . . 0.0 110.821 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' VAL . 44.9 Cg_endo -72.69 56.56 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.196 1.629 . . . . 0.0 111.134 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.474 ' O ' HD11 ' A' ' 60' ' ' LEU . 5.4 m-70 38.12 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 111.25 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 92' ' ' PRO . 6.5 m -106.86 -170.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.117 -0.989 . . . . 0.0 111.286 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 4.1 mm? -75.37 167.83 21.15 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.927 0.87 . . . . 0.0 111.863 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 23.2 p -145.5 166.61 16.95 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.4 Cg_endo -69.52 -29.18 25.44 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.479 1.252 . . . . 0.0 109.831 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.5 mt-10 -75.33 -20.32 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 108.79 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.553 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 6.5 ttm -94.73 -46.6 6.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 110.501 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 96' ' ' THR . 1.6 mt -51.82 142.77 24.01 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.409 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.444 ' HD3' HG21 ' A' ' 63' ' ' THR . 57.0 Cg_endo . . . . . 0 CA--C 1.56 1.821 0 O-C-N 123.964 1.507 . . . . 0.0 108.249 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.575 ' CG1' ' O ' ' A' ' 98' ' ' GLU . 2.3 m . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.573 0.701 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.543 HG11 ' CG2' ' A' ' 11' ' ' VAL . 8.6 p 34.87 62.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 111.362 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -102.42 -39.61 0.21 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 0.0 113.222 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -78.94 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.109 1.057 . . . . 0.0 112.029 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.83 -53.16 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 12.8 mt-10 -39.53 -58.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.476 -0.765 . . . . 0.0 110.315 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -54.49 -38.3 66.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.019 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.52 -47.09 74.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -62.51 -29.15 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 17.5 m-85 -85.94 -38.27 18.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.483 -0.761 . . . . 0.0 109.589 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -53.53 -39.72 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.082 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.43 -41.71 75.95 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.423 -0.798 . . . . 0.0 109.042 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.6 mt -66.5 -40.2 85.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 60.6 t80 -48.56 -36.89 16.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.162 -0.961 . . . . 0.0 108.799 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.32 -21.85 66.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -99.92 -14.88 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.591 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.6 -55.13 3.77 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.565 0.698 . . . . 0.0 109.621 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -66.33 76.73 0.1 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.671 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -61.91 -9.68 7.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.0 111.449 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 11.2 m-20 -105.16 -4.51 21.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.789 -1.195 . . . . 0.0 110.415 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.524 ' HA ' ' CE ' ' A' ' 31' ' ' MET . 1.0 OUTLIER 57.87 25.39 11.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 11.9 p30 -92.59 19.28 7.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.58 13.54 58.84 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.62 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -151.02 108.25 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -1.086 . . . . 0.0 110.867 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.1 p -89.11 140.85 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.472 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 45.6 t -96.75 161.62 13.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.771 -1.205 . . . . 0.0 110.632 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 41' ' ' ARG . . . -55.21 -16.74 9.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 38' ' ' LEU . 4.0 mm? -74.86 -29.7 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 35' ' ' VAL . 17.5 mt-10 -91.92 -64.02 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.999 -1.063 . . . . 0.0 108.828 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HB ' ' CG2' ' A' ' 27' ' ' THR . 1.3 p -52.27 -20.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.012 0.91 . . . . 0.0 109.579 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -41.71 -60.53 1.32 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.672 -0.643 . . . . 0.0 110.977 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -58.06 -41.39 83.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.924 -1.11 . . . . 0.0 108.975 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.52 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.2 mt -56.56 -36.18 47.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.366 0.603 . . . . 0.0 109.414 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.651 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.77 -23.03 25.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.865 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 25.8 mt -78.51 -23.99 46.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 109.219 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.06 -4.38 58.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.736 . . . . 0.0 109.987 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 66.6 p -72.94 -15.78 61.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.51 46.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 49' ' ' LEU . 9.0 mp -95.74 172.72 4.97 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.763 -0.845 . . . . 0.0 110.366 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -84.68 -157.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.156 1.608 . . . . 0.0 109.76 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.982 -1.074 . . . . 0.0 110.639 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -59.1 -54.68 44.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.538 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.0 -42.25 5.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 0.0 110.407 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 1.1 mp -62.97 -52.5 62.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 109.537 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.51 70.13 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 67.1 t60 -73.44 -32.76 64.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.621 ' CG2' ' CZ ' ' A' ' 44' ' ' PHE . 5.2 mt -77.34 -29.86 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.543 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 55.5 t-105 -63.97 -43.84 94.56 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.831 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -71.85 -28.95 63.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 11.4 mt -71.42 -11.46 60.9 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.543 ' SG ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 t -118.87 -41.7 2.76 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.474 -0.766 . . . . 0.0 109.316 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.07 69.17 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.9 p -59.89 -37.56 79.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.653 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -59.39 -13.9 10.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.452 -0.78 . . . . 0.0 109.922 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.9 p-10 38.62 50.2 1.55 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.423 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -10.08 9.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.567 -0.708 . . . . 0.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.8 -11.72 27.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 mttm -115.96 -171.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -1.137 . . . . 0.0 110.098 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.543 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -129.91 108.67 10.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -53.66 -170.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -78.92 -78.29 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.06 . . . . 0.0 110.515 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -44.34 -46.47 9.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 76' ' ' LEU . 2.1 mt-30 -50.84 -52.98 36.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.1 t80 -44.73 -34.85 2.41 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.212 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -78.06 -14.39 59.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.088 -1.007 . . . . 0.0 109.741 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 7.3 tt -85.19 -23.35 28.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.682 -0.636 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.39 -54.62 13.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 109.587 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 19.1 m-85 -52.76 -34.03 51.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.661 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 17.2 t60 -51.43 -21.81 2.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' A' ' 79' ' ' HIS . 2.9 mt -98.48 -22.96 15.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 108.924 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.651 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 14.3 mt -73.51 -52.69 20.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.592 -0.693 . . . . 0.0 110.282 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ILE . 4.1 mt-30 -71.69 -25.03 61.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -90.08 -19.9 23.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 111.214 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.6 mt -84.92 -60.8 1.94 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.114 . . . . 0.0 111.402 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.9 mm -95.91 -35.95 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.073 -1.017 . . . . 0.0 110.999 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.5 OUTLIER -89.41 -13.96 36.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.045 -1.034 . . . . 0.0 110.813 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 53.83 18.8 8.97 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 23.6 mt -86.61 161.28 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.16 -1.2 . . . . 0.0 109.721 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.51 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 2.7 p-10 -90.39 169.35 12.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -70.21 156.25 62.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.88 1.463 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' HIS . 42.7 Cg_endo -70.13 62.93 2.0 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.125 1.592 . . . . 0.0 111.365 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.47 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.8 OUTLIER 40.08 -112.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 111.001 179.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 3.8 m -101.97 -172.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.744 -1.222 . . . . 0.0 111.245 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.94 164.37 8.26 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 111.396 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 30.0 p -145.85 167.88 13.15 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -70.09 -23.17 29.62 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.486 1.256 . . . . 0.0 109.266 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.575 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 2.0 mt-10 -82.41 -2.11 52.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.423 -0.798 . . . . 0.0 109.127 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.591 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 30.7 ttm -119.08 5.09 11.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.479 HG13 ' CD1' ' A' ' 95' ' ' LEU 0.253 33.4 mt -108.47 100.53 38.49 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.665 -0.647 . . . . 0.0 110.486 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 O-C-N 123.759 1.4 . . . . 0.0 113.017 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 99' ' ' MET . 2.4 m . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.786 0.803 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' N ' HG23 ' A' ' 11' ' ' VAL . 2.4 p -123.65 146.34 29.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -167.02 -59.64 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.845 -1.16 . . . . 0.0 112.675 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 15' ' ' ALA . 40.9 Cg_endo -63.24 -141.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.34 1.179 . . . . 0.0 110.807 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.83 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 112.217 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -36.28 -63.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -52.21 -33.81 42.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.086 . . . . 0.0 110.418 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.54 -48.16 70.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -56.27 -31.0 63.2 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.6 m-85 -91.65 -52.06 4.94 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.704 -0.623 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 10.3 t0 -42.74 -39.77 2.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.649 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -71.66 -35.5 70.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.407 -0.808 . . . . 0.0 109.072 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 26' ' ' LYS . 31.7 mt -72.43 -41.75 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.805 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 47.1 t80 -46.44 -28.58 1.41 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.543 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.08 -33.16 65.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 23' ' ' ILE . 24.3 mttp -93.72 -10.05 35.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.563 ' CG2' HG23 ' A' ' 35' ' ' VAL . 1.1 m -89.53 -58.84 2.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.451 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 55.2 t0 -66.13 82.59 0.08 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -75.41 11.41 1.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.93 -1.106 . . . . 0.0 112.332 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.479 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 2.9 m-20 -116.67 5.74 13.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.3 mmt 46.08 35.52 2.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 111.055 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.8 p30 -108.06 12.78 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.55 12.47 80.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -150.84 109.93 3.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.286 . . . . 0.0 110.8 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG23 ' CG2' ' A' ' 27' ' ' THR . 13.2 p -89.6 137.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.982 . . . . 0.0 108.495 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.2 p -85.87 153.59 22.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.103 -0.998 . . . . 0.0 111.172 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -50.99 -21.7 5.53 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 38' ' ' LEU . 49.3 mt -73.07 -32.31 64.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -1.054 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 36.6 mt-10 -82.67 -54.06 5.44 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -66.86 -14.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.342 0.591 . . . . 0.0 109.735 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -47.24 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.154 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -43.61 -44.5 6.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.503 HD12 ' CG2' ' A' ' 27' ' ' THR . 0.9 OUTLIER -50.75 -40.95 20.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.664 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.6 m-30 -83.2 -38.65 22.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.86 -18.5 8.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.356 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 83.0 mttt -79.61 -13.57 59.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 109.323 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.519 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 64.1 p -66.23 -16.77 64.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.26 66.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.537 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -100.13 171.94 5.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.641 -0.917 . . . . 0.0 110.085 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 48.4 Cg_endo -77.19 155.64 33.2 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.723 1.381 . . . . 0.0 110.073 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.02 67.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.967 . . . . 0.0 110.995 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -45.38 73.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.995 . . . . 0.0 111.24 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -54.99 -51.17 67.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.89 -1.131 . . . . 0.0 110.478 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 35.3 mt -59.85 -36.6 77.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.34 -48.19 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -60.56 -37.77 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.488 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 12.8 mt -64.74 -37.25 79.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.61 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 40.3 t-105 -57.13 -52.84 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -33.59 71.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.168 -0.957 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 93' ' ' HIS . 15.9 tp -67.0 -23.62 65.95 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.253 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 56.0 m -105.74 -36.09 7.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 68' ' ' LYS . 51.8 t0 -67.01 58.37 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 109.155 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.4 p -53.76 -29.57 40.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -62.69 -11.1 15.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.436 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.7 p30 37.02 55.49 1.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.615 -0.678 . . . . 0.0 110.465 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 71.9 m -118.73 -11.18 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 110.594 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.18 -21.09 27.49 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 16.3 mmtm -114.68 -176.41 2.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.406 -1.055 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.61 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -114.54 108.57 17.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.933 -1.105 . . . . 0.0 110.562 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -64.56 167.69 6.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 109.373 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -56.04 -72.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.558 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -44.42 -37.52 3.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 110.637 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 44.4 mm-40 -67.33 -49.6 63.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.037 -1.04 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 8.9 t80 -56.61 -26.92 57.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.72 -1.238 . . . . 0.0 108.588 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . . . -80.52 -11.4 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.598 0.713 . . . . 0.0 109.277 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD1' ' HG3' ' A' ' 99' ' ' MET . 6.1 tp -88.64 -42.41 12.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 110.087 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.614 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -62.89 -26.39 68.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.298 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 1.4 m-85 -76.12 -20.36 57.7 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.741 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.3 t60 -73.29 -22.56 60.34 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.557 -0.714 . . . . 0.0 109.172 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -99.72 -38.46 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.435 -0.79 . . . . 0.0 108.894 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.664 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 76.6 mt -66.66 -46.99 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -62.69 -16.76 58.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.492 -0.755 . . . . 0.0 109.915 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -77.8 -24.01 48.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 110.032 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -10.52 47.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 47' ' ' THR . 6.0 mt -89.99 -55.37 3.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.065 -1.022 . . . . 0.0 110.749 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 86' ' ' ILE . 7.2 mm -108.9 -17.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.092 -1.005 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -108.44 -2.73 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.949 -1.094 . . . . 0.0 110.45 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 42.22 53.93 4.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 2.4 mt -125.63 168.37 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.302 -1.117 . . . . 0.0 109.832 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.7 m-20 -113.32 171.54 4.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 40.8 Cg_endo -70.46 151.68 65.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.897 1.472 . . . . 0.0 109.999 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.6 Cg_endo -70.85 51.64 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.938 1.494 . . . . 0.0 111.168 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER 50.2 -83.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.426 -0.796 . . . . 0.0 111.679 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 92' ' ' PRO . 11.5 m -108.36 -162.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 2.0 mm? -86.71 144.0 27.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.739 0.781 . . . . 0.0 111.243 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.537 ' OG1' ' CB ' ' A' ' 99' ' ' MET . 39.3 p -111.12 168.09 8.09 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.7 Cg_endo -68.38 -38.43 11.6 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 123.289 1.152 . . . . 0.0 109.863 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.472 ' CB ' HG11 ' A' ' 11' ' ' VAL . 1.7 mt-10 -71.26 -27.2 63.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 108.611 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.638 ' HG3' ' CD1' ' A' ' 76' ' ' LEU . 24.1 ttm -84.66 -25.52 28.41 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.422 0.63 . . . . 0.0 109.624 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 96' ' ' THR . 7.5 mt -87.01 135.82 34.71 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.097 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG3' ' HE3' ' A' ' 64' ' ' LYS . 41.6 Cg_endo . . . . . 0 C--N 1.302 -1.879 0 O-C-N 123.771 1.406 . . . . 0.0 109.695 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.584 ' CG2' ' N ' ' A' ' 12' ' ' VAL . 1.7 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.701 0.763 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.584 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 3.0 p -115.66 166.13 10.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.573 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER 167.06 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.074 -1.016 . . . . 0.0 111.926 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 13' ' ' SER . 45.6 Cg_endo -66.28 -146.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.263 1.139 . . . . 0.0 110.81 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.96 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 111.524 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 43.7 mt-10 -54.09 -64.13 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -54.04 -32.67 55.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.902 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.46 -52.31 16.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.32 -30.15 62.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.007 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.6 m-30 -89.56 -50.51 6.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 17' ' ' LYS . 8.9 t0 -43.27 -40.64 3.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 109.41 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.25 -34.96 75.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 108.882 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.557 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 60.6 mt -74.66 -38.77 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.459 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.542 ' CE1' HG13 ' A' ' 35' ' ' VAL . 68.4 t80 -50.1 -33.08 17.5 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.87 -24.86 66.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.69 -16.09 19.14 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.523 ' OG1' ' CE2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -88.75 -52.98 4.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.502 -0.749 . . . . 0.0 109.8 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 67.6 t0 -67.14 63.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 109.29 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 11.1 mttm -65.5 -3.82 4.97 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.383 -0.823 . . . . 0.0 111.966 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 39' ' ' GLU . 45.9 m-20 -103.36 -11.06 18.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.683 -1.261 . . . . 0.0 110.672 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER 57.42 37.45 27.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 19.5 p30 -103.11 1.32 33.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 110.68 -32.56 6.49 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.66 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -135.68 147.08 48.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.57 HG12 ' CB ' ' A' ' 69' ' ' LEU . 1.4 p -88.94 135.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.344 -0.848 . . . . 0.0 108.733 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 38' ' ' LEU . 7.8 p -86.58 151.02 23.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 0.0 110.426 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -24.95 0.45 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 80.9 mt -65.07 -41.28 95.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -1.06 . . . . 0.0 111.591 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 5.5 mt-10 -81.03 -58.4 3.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.195 . . . . 0.0 108.769 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.5 p -57.01 -16.43 4.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.547 0.689 . . . . 0.0 109.639 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -43.94 -76.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.476 -0.765 . . . . 0.0 110.823 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' ARG . 7.7 mt-10 -44.63 -46.58 10.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.071 . . . . 0.0 108.59 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.5 mt -53.09 -37.27 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.9 m-30 -85.76 -45.79 11.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.655 -0.653 . . . . 0.0 109.438 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.2 mt -51.48 -27.58 10.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 3.2 ptmt -73.86 -5.37 40.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.662 -0.649 . . . . 0.0 109.751 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 65.3 p -78.97 -18.06 54.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.844 . . . . 0.0 110.015 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.85 86.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.8 mp -81.01 166.99 35.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 48.0 Cg_endo -78.36 176.5 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.915 1.481 . . . . 0.0 110.56 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -44.03 61.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.636 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 53' ' ' LEU . 5.3 m -65.6 -59.0 4.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.702 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.531 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -44.54 -39.71 5.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.97 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.38 -53.24 46.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.38 68.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -74.97 -38.41 61.68 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 HG22 HG13 ' A' ' 81' ' ' ILE . 3.8 mt -71.68 -28.51 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 71.7 t-105 -61.56 -44.24 97.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.274 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.481 ' O ' HD23 ' A' ' 95' ' ' LEU . 1.2 t -71.12 -33.67 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.26 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 12.3 mt -67.05 -27.53 67.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.566 -0.709 . . . . 0.0 109.466 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.554 ' CB ' ' CB ' ' A' ' 77' ' ' ALA . 19.4 p -102.12 -35.13 9.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.447 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 45.7 t0 -75.4 57.13 0.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.582 -0.699 . . . . 0.0 110.004 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.461 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 4.6 p -52.49 -33.04 43.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -63.03 -12.38 25.83 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.67 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 4.1 t70 40.81 53.84 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.789 . . . . 0.0 110.139 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.85 7.9 10.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.453 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.55 -12.69 62.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' CA ' ' HZ2' ' A' ' 58' ' ' TRP . 32.4 mttt -126.43 175.44 7.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.177 . . . . 0.0 109.766 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 2.9 mt -113.35 114.88 27.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.809 -1.182 . . . . 0.0 111.707 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.6 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -64.02 -172.85 0.07 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.983 -1.073 . . . . 0.0 110.219 179.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -70.5 -46.2 64.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 111.361 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.24 -3.28 58.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.072 -1.018 . . . . 0.0 111.199 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.6 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 34.3 mm-40 -89.03 -43.69 10.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.901 -1.124 . . . . 0.0 109.596 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 14.6 t80 -61.38 -24.72 66.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.23 -13.96 58.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.514 -0.741 . . . . 0.0 109.084 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 99' ' ' MET . 1.8 tp -90.33 -49.15 6.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.477 -0.764 . . . . 0.0 109.415 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.554 ' CB ' ' CB ' ' A' ' 61' ' ' CYS . . . -48.0 -46.54 32.97 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 3.1 m-85 -51.91 -39.76 59.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 83.3 t60 -51.38 -24.87 5.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.06 -34.89 9.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 0.0 109.247 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 45.8 mt -77.63 -35.16 21.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.528 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 2.8 p -67.77 -29.74 69.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 110.079 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -83.87 -5.49 59.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.077 -1.015 . . . . 0.0 109.982 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.456 ' HD3' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.9 -24.65 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.406 -0.809 . . . . 0.0 110.91 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 47' ' ' THR . 3.9 mt -90.0 -71.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.0 111.299 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 mm -82.08 3.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.795 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -126.81 -47.27 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.941 -1.099 . . . . 0.0 110.573 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 87.1 6.19 79.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 87' ' ' LYS . 3.5 mt -77.42 139.37 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.231 -1.158 . . . . 0.0 109.823 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.2 170.96 13.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.217 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 40.4 Cg_endo -70.88 158.29 55.91 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.191 1.627 . . . . 0.0 110.675 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.511 ' CG ' ' HE3' ' A' ' 99' ' ' MET . 46.7 Cg_endo -75.06 47.02 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.098 1.578 . . . . 0.0 111.676 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 -85.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.077 -1.015 . . . . 0.0 111.643 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.513 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 33.4 m -117.47 -163.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.607 -1.308 . . . . 0.0 112.208 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 4.0 mm? -81.03 165.1 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.785 0.802 . . . . 0.0 111.603 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 p -147.15 170.25 8.06 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.6 Cg_endo -69.6 -38.03 8.71 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.183 1.097 . . . . 0.0 109.527 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.498 ' HB3' HG11 ' A' ' 11' ' ' VAL . 13.4 mt-10 -70.08 -10.83 60.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 108.96 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.538 ' CG ' HD22 ' A' ' 76' ' ' LEU . 28.0 ttm -102.54 -38.21 7.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.3 mt -64.68 143.13 98.66 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.864 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.462 ' HD2' HG22 ' A' ' 100' ' ' ILE . 44.6 Cg_endo . . . . . 0 C--N 1.304 -1.783 0 O-C-N 123.891 1.469 . . . . 0.0 110.706 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.453 0.644 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -139.04 73.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 109.787 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 t -102.73 -31.67 0.21 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -76.38 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 122.756 0.872 . . . . 0.0 111.101 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.67 -61.28 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.904 -0.497 . . . . 0.0 112.197 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 15.2 mt-10 -38.65 -57.33 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.73 . . . . 0.0 110.64 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.18 -35.17 64.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.97 . . . . 0.0 109.867 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.29 -48.61 69.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -29.42 64.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.529 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 12.2 m-85 -87.95 -51.69 5.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.558 -0.714 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -45.56 -39.56 7.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.927 -1.108 . . . . 0.0 109.356 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 5.6 mm-40 -67.51 -47.27 70.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 108.99 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' LYS . 26.1 mt -62.26 -40.5 87.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 29.4 t80 -46.95 -27.65 1.35 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 70.3 mt -70.64 -31.72 68.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -97.83 -12.8 21.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.845 . . . . 0.0 108.82 178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.547 ' CG2' HG22 ' A' ' 35' ' ' VAL . 1.3 m -89.06 -51.43 5.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 31' ' ' MET . 23.0 t70 -65.04 82.53 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -62.44 0.07 0.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 44.8 p-10 -122.77 3.47 9.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.219 -1.55 . . . . 0.0 110.787 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.471 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 1.2 mmt 55.92 39.08 30.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.294 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 3.9 p-10 -110.35 26.44 10.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.34 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.48 11.17 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.86 99.49 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -1.104 . . . . 0.0 110.309 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 27' ' ' THR . 10.8 p -89.71 135.66 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.94 -1.1 . . . . 0.0 109.004 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.474 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 82.6 p -90.06 147.81 23.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 110.825 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.94 -27.59 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.7 mp -65.04 -30.59 71.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.108 . . . . 0.0 110.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 49.0 mt-10 -86.84 -62.24 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.891 -1.131 . . . . 0.0 108.306 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.639 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -58.49 -15.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.29 0.566 . . . . 0.0 110.023 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.618 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -42.58 -44.67 4.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.008 . . . . 0.0 109.82 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 27' ' ' THR . 0.9 OUTLIER -51.27 -40.01 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.55 -0.719 . . . . 0.0 109.072 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.639 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 1.4 m-85 -87.28 -28.45 22.29 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.592 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 42' ' ' GLU . 72.1 mt -68.06 -17.38 64.37 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 108.961 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 10.2 mtpt -75.75 -21.32 57.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.559 0.695 . . . . 0.0 109.49 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.558 ' OG1' ' HG ' ' A' ' 49' ' ' LEU . 39.1 p -50.2 -58.14 6.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.43 21.41 4.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.649 ' HB2' HD23 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -101.05 -172.34 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.511 -0.994 . . . . 0.0 108.542 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -74.3 -171.64 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.388 1.204 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -47.8 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.859 -1.151 . . . . 0.0 111.328 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -63.14 -32.11 73.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.673 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.649 HD23 ' HB2' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -59.87 -62.68 1.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 110.819 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 53' ' ' LEU . 2.8 mm? -50.08 -29.71 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.816 -1.178 . . . . 0.0 108.953 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -79.65 -39.36 31.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.529 ' NE2' HD11 ' A' ' 60' ' ' LEU . 21.3 t60 -67.49 -24.58 65.6 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' HD12 ' A' ' 81' ' ' ILE . 4.9 mt -78.3 -23.04 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 69' ' ' LEU . 19.5 t-105 -71.48 -45.63 61.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.471 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.5 p -69.44 -27.61 65.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 108.645 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.552 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 9.0 mt -74.68 -4.65 38.58 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 61.6 m -128.58 -35.48 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.75 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.532 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.9 t70 -65.81 59.35 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.63 -0.669 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' CYS . 24.7 p -55.54 -36.84 67.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -0.991 . . . . 0.0 109.881 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' CD ' ' OE1' ' A' ' 73' ' ' GLN . 11.7 mptt -56.25 -16.98 6.24 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 110.04 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.08 54.76 2.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 110.438 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.0 t -123.13 -13.96 7.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.311 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.24 -0.25 25.24 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.608 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 3.7 mtmt -129.78 -176.25 3.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.133 -1.216 . . . . 0.0 110.087 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.596 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -123.7 97.94 5.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.099 -1.001 . . . . 0.0 111.163 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.512 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -55.56 172.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.746 -1.221 . . . . 0.0 109.34 178.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -56.46 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.958 -1.089 . . . . 0.0 110.544 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' LYS . 32.3 m-20 -39.38 -42.65 1.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.594 -0.691 . . . . 0.0 110.549 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.539 ' OE1' ' CD ' ' A' ' 64' ' ' LYS . 25.9 mt-30 -61.03 -49.49 77.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' A' ' 23' ' ' ILE . 11.2 t80 -54.76 -37.43 65.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' O ' HG13 ' A' ' 12' ' ' VAL . . . -73.42 -6.75 48.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.636 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -90.35 -40.52 12.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.373 -0.829 . . . . 0.0 110.071 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 44' ' ' PHE . . . -64.63 -58.84 5.23 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.238 -0.913 . . . . 0.0 109.041 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.2 m-85 -45.67 -32.17 2.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.603 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 47.2 t60 -66.22 -30.41 70.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 76' ' ' LEU . 14.2 mt -84.8 -16.79 40.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 109.187 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.524 HD12 ' CD1' ' A' ' 57' ' ' ILE . 13.6 mm -73.51 -57.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.48 -0.763 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -47.98 -32.39 6.45 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.444 -0.785 . . . . 0.0 109.982 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -64.64 -24.18 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -91.13 -21.48 21.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.222 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.2 mt -89.43 -67.71 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -82.19 -10.04 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.0 110.873 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HG2' ' CD1' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.48 -7.32 10.18 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.927 -1.108 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 47.23 24.49 2.3 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 87' ' ' LYS . 16.2 mt -97.16 173.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.496 -1.002 . . . . 0.0 109.858 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 25.0 m-20 -115.37 164.79 15.97 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 110.256 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 43.5 Cg_endo -70.47 153.91 65.32 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.16 1.61 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.48 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.7 Cg_endo -71.92 151.93 57.1 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.013 1.533 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.32 -59.76 2.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.166 -0.959 . . . . 0.0 110.277 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.486 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 30.4 m -125.87 -166.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 111.264 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -89.89 -175.81 4.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.897 0.856 . . . . 0.0 111.564 -179.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 2.2 p -143.07 -179.23 0.91 Allowed Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 46.6 Cg_endo -76.17 -5.77 16.59 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.332 1.175 . . . . 0.0 109.929 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HB3' HG11 ' A' ' 11' ' ' VAL . 20.9 mt-10 -93.66 -23.11 18.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 109.277 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 2.4 mtp -86.37 -36.19 19.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.992 0.901 . . . . 0.0 108.698 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.2 mt -65.23 124.77 87.84 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.883 -0.51 . . . . 0.0 110.654 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HG2' ' NZ ' ' A' ' 64' ' ' LYS . 47.7 Cg_endo . . . . . 0 C--N 1.305 -1.732 0 O-C-N 123.931 1.49 . . . . 0.0 109.906 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 10' ' ' TRP . 4.4 m . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.285 0.564 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -175.0 129.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 110.265 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 12' ' ' VAL . 2.4 m -49.55 -40.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.96 0.886 . . . . 0.0 109.422 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.563 ' O ' ' CE3' ' A' ' 10' ' ' TRP . 2.3 p -115.57 156.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 174.36 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.731 -1.231 . . . . 0.0 112.335 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' SER . 48.5 Cg_endo -67.43 -145.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.272 1.143 . . . . 0.0 110.559 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.2 -49.67 0.08 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.455 0.645 . . . . 0.0 111.588 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 4.9 mt-10 -49.13 -60.79 2.49 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.418 -0.801 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.3 tmtp? -54.24 -32.96 57.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.964 -1.085 . . . . 0.0 109.981 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.45 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 108.95 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 23' ' ' ILE . 6.1 ttpt -54.53 -28.93 48.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.579 -0.7 . . . . 0.0 109.393 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 4.2 m-30 -90.59 -52.19 5.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 110.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 20' ' ' TYR . 53.1 t0 -45.28 -33.82 2.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 25' ' ' LEU . 30.7 mm-40 -76.39 -32.54 58.61 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.334 -0.854 . . . . 0.0 108.906 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.565 HG23 ' CE2' ' A' ' 74' ' ' PHE . 46.9 mt -77.77 -41.87 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.388 -0.82 . . . . 0.0 110.073 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 59.9 t80 -48.67 -32.68 8.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.571 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.0 mt -65.52 -28.91 69.52 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -100.18 -12.71 19.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.574 ' CG2' HD11 ' A' ' 43' ' ' ILE . 2.6 m -89.74 -55.74 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.745 . . . . 0.0 109.372 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' HG23 ' A' ' 35' ' ' VAL . 38.3 t0 -63.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.703 -0.623 . . . . 0.0 109.361 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.7 mmtt -51.8 -17.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 111.219 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.484 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.0 m-20 -98.23 1.68 47.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 mtm 43.26 45.35 4.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.706 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.2 p30 -115.8 26.5 9.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 109.956 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.92 12.77 44.43 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.17 100.82 2.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -1.058 . . . . 0.0 110.111 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 39' ' ' GLU . 14.5 p -88.86 139.42 17.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.925 -1.109 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 37' ' ' GLY . 1.8 t -95.31 151.85 18.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.067 -1.021 . . . . 0.0 110.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.71 -25.16 0.82 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.1 mm? -67.49 -29.96 69.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.218 -1.166 . . . . 0.0 110.975 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 19.4 mt-10 -91.05 -61.7 1.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.829 -1.169 . . . . 0.0 108.306 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG23 HG22 ' A' ' 43' ' ' ILE . 1.1 p -53.02 -18.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -42.21 -75.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.705 -0.622 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' N ' HD11 ' A' ' 45' ' ' LEU . 11.3 mt-10 -43.23 -47.97 6.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 108.717 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.574 HD11 ' CG2' ' A' ' 27' ' ' THR . 2.2 mt -55.44 -41.28 62.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.664 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -77.25 -28.27 53.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 42' ' ' GLU . 19.1 mt -73.76 -23.68 59.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -0.928 . . . . 0.0 109.003 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 49.0 mttt -81.27 -13.77 58.11 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.546 0.688 . . . . 0.0 109.489 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.528 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 p -65.2 -54.07 35.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 0.0 109.969 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.42 14.68 7.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 1.9 mm? -93.5 153.71 41.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.479 -1.012 . . . . 0.0 110.663 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HD2' HD21 ' A' ' 53' ' ' LEU . 40.7 Cg_endo -66.13 147.64 84.22 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.945 1.498 . . . . 0.0 110.623 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 52' ' ' THR . 82.3 p -44.86 -64.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.726 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 51' ' ' SER . 13.7 m -42.47 -58.09 2.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.967 . . . . 0.0 110.878 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -52.64 -50.2 63.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 0.0 110.342 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.11 -39.46 75.12 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.307 -0.87 . . . . 0.0 109.295 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.52 65.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 20.4 t60 -73.15 -29.63 63.0 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.489 HG21 HG13 ' A' ' 81' ' ' ILE . 8.8 mt -77.33 -28.51 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.1 -42.93 93.54 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.811 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.67 59.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . 7.0 tp -74.46 -17.04 60.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 62' ' ' ASP . 22.4 p -115.16 -35.5 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.456 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.485 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 12.2 t70 -66.61 56.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 110.551 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.463 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.43 -24.01 64.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -61.09 -16.11 40.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.664 -0.648 . . . . 0.0 110.337 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.6 t0 39.84 51.19 2.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 110.325 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.88 -14.5 6.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.853 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.68 -1.32 27.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 14.1 mttt -136.33 171.23 14.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -1.222 . . . . 0.0 110.601 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.1 mt -107.5 101.4 10.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.13 -179.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.602 -1.311 . . . . 0.0 110.511 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.88 -52.47 43.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 14.8 p-10 -79.37 -15.23 58.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.904 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.557 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 42.2 mm-40 -77.51 -40.16 43.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.927 -1.108 . . . . 0.0 110.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 23' ' ' ILE . 17.0 t80 -63.87 -17.54 63.28 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.279 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.7 -18.56 37.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.421 -0.8 . . . . 0.0 109.034 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.588 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 9.6 tt -84.27 -21.92 30.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' CA ' ' HB3' ' A' ' 61' ' ' CYS . . . -75.41 -46.45 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.172 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.4 m-85 -57.28 -29.64 64.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 108.81 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 50.7 t60 -54.2 -22.59 11.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 HD11 ' CD2' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -99.67 -60.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.664 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 9.9 mt -48.33 -52.26 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.821 -0.549 . . . . 0.0 109.84 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -52.42 -40.01 61.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 88' ' ' GLY . 5.1 mt-30 -60.02 -21.2 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' CB ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.85 -18.01 25.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.0 110.788 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.8 mt -88.52 -38.46 14.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 111.172 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -119.88 -14.67 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.997 . . . . 0.0 110.737 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 1.2 mmpt? -119.17 -2.5 10.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 110.616 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 41.34 59.36 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -126.36 132.59 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.087 -1.243 . . . . 0.0 110.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 15.6 p-10 -60.08 170.25 1.29 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HD3' HD13 ' A' ' 53' ' ' LEU . 43.8 Cg_endo -79.32 152.08 23.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.772 1.406 . . . . 0.0 110.374 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' C ' ' CG ' ' A' ' 93' ' ' HIS . 42.8 Cg_endo -68.78 63.91 1.27 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.01 1.532 . . . . 0.0 110.38 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.59 ' CG ' ' C ' ' A' ' 92' ' ' PRO . 8.8 p-80 35.94 -109.63 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.72 -0.613 . . . . 0.0 111.099 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.496 ' C ' ' CD1' ' A' ' 60' ' ' LEU . 5.3 m -102.71 -165.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.93 -1.106 . . . . 0.0 111.218 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -69.5 147.86 50.28 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.735 0.778 . . . . 0.0 111.414 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 68.9 p -125.71 166.97 18.1 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.0 Cg_endo -67.32 -23.28 44.84 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.477 1.251 . . . . 0.0 109.638 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' HB3' HG11 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -82.21 -18.31 43.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.588 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 35.4 ttm -92.21 -47.1 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.72 0.771 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.475 HG13 HD12 ' A' ' 95' ' ' LEU . 1.1 mt -50.05 134.48 22.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.545 -0.722 . . . . 0.0 110.212 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.69 164.72 31.61 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.694 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.97 142.45 17.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.058 1.557 . . . . 0.0 110.215 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 110.127 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 9' ' ' THR . 4.5 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -80.45 149.15 30.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 109.36 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG2' HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -69.67 -168.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.78 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 ' CG2' ' A' ' 11' ' ' VAL . 7.7 p 36.76 66.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.578 -0.701 . . . . 0.0 111.122 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.2 t -107.12 -41.62 0.14 Allowed Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 13' ' ' SER . 51.8 Cg_endo -77.13 -147.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 122.928 0.962 . . . . 0.0 111.959 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.78 -59.13 0.11 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -37.77 -54.76 1.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.0 110.49 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.62 -42.93 68.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 109.797 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.76 -46.59 84.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.742 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -56.37 -29.18 61.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.524 -0.735 . . . . 0.0 109.971 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 13.3 m-85 -89.46 -52.38 5.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.429 -0.795 . . . . 0.0 110.05 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 5.5 t70 -44.53 -31.23 1.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.13 -34.75 37.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 26' ' ' LYS . 39.5 mt -78.91 -37.22 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.482 -0.761 . . . . 0.0 110.285 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.564 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 52.6 t80 -48.85 -30.6 5.99 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.356 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.4 mt -67.76 -25.76 65.78 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -98.74 -13.74 20.07 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.601 HG23 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.25 -55.47 3.66 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.729 0.776 . . . . 0.0 109.23 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 59.1 t0 -72.48 68.27 0.78 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 3.5 mttm -55.98 -13.82 2.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -96.6 13.83 26.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.563 -1.335 . . . . 0.0 110.96 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.4 mtm 43.16 26.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 34.4 p30 -98.56 22.37 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 56.49 19.85 28.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.46 105.46 3.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -1.146 . . . . 0.0 110.754 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p -89.0 130.01 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.865 -1.147 . . . . 0.0 109.018 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.452 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 p -87.15 152.66 22.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.092 -1.005 . . . . 0.0 109.808 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.74 -22.68 0.79 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.9 mm? -65.34 -37.32 86.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 111.263 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' OE2' ' OD1' ' A' ' 30' ' ' ASP . 15.1 mt-10 -86.45 -62.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.861 -1.149 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -50.83 -20.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.623 0.725 . . . . 0.0 109.491 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -44.92 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 110.645 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 14.6 mt-10 -44.04 -38.37 3.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.23 -0.919 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.504 HD13 HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -58.61 -42.56 85.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 110.265 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.9 m-85 -80.95 -29.65 35.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.163 -0.961 . . . . 0.0 110.166 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 42' ' ' GLU . 17.0 mt -65.85 -15.38 62.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.989 -1.069 . . . . 0.0 109.386 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 59.8 mttt -82.86 -13.51 56.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 81' ' ' ILE . 82.8 p -63.04 -10.86 15.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.75 . . . . 0.0 110.793 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.33 69.39 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 107.734 -2.146 . . . . 0.0 107.734 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 ' HB3' HD22 ' A' ' 53' ' ' LEU . 4.4 mp -100.51 173.11 3.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.866 -0.785 . . . . 0.0 110.679 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 40.7 Cg_endo -67.86 -153.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.217 1.64 . . . . 0.0 109.711 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.5 t -104.58 -65.11 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.216 . . . . 0.0 111.484 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -54.12 -38.1 65.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.082 -1.011 . . . . 0.0 111.284 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -47.62 -53.21 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.089 -1.007 . . . . 0.0 111.399 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 HD23 ' CB ' ' A' ' 49' ' ' LEU . 2.5 mm? -62.54 -46.37 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.021 -1.05 . . . . 0.0 109.35 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.94 81.95 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' THR . 28.5 t60 -72.41 -29.32 63.62 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 81' ' ' ILE . 6.9 mt -76.65 -22.46 15.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.592 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.1 t-105 -65.32 -45.06 85.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 108.9 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -31.63 64.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.399 -0.813 . . . . 0.0 109.119 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 5.8 tp -71.39 -22.1 61.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.76 . . . . 0.0 109.259 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 15.9 p -105.13 -30.77 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 49.6 t0 -74.71 54.32 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.49 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 5.4 p -54.83 -34.32 62.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.076 -1.015 . . . . 0.0 109.077 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 7.6 mptt -56.5 -17.09 7.17 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.604 -0.685 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 48.2 m-20 41.94 54.65 3.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.766 . . . . 0.0 110.155 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 41.4 t -119.99 8.6 11.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.16 -16.76 50.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 25.3 mttt -123.9 179.2 4.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 110.157 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.592 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -111.76 118.17 34.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.008 . . . . 0.0 110.713 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.494 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -75.34 175.46 8.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.952 -1.093 . . . . 0.0 109.369 179.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.51 -84.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.431 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 71' ' ' LYS . 3.6 m-20 -42.12 -38.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 110.849 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.49 ' OE1' ' OG1' ' A' ' 63' ' ' THR . 46.4 mm-40 -60.8 -60.08 4.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.056 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CE1' HG23 ' A' ' 27' ' ' THR . 28.5 t80 -51.14 -33.16 25.51 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.63 -10.52 59.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.606 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 5.6 tt -90.54 -35.34 15.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.434 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -58.91 -37.94 77.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.746 -1.221 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.676 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 29.0 m-85 -64.09 -35.31 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 79.1 t60 -51.36 -23.11 3.38 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.366 -0.834 . . . . 0.0 108.835 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.522 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -95.91 -22.72 17.25 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 8.3 mm -75.04 -54.13 14.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -37.54 10.92 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.593 -0.692 . . . . 0.0 110.389 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' ILE . 3.8 mt-30 -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 109.97 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -90.95 -20.95 21.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 0.0 110.313 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.5 mt -90.45 -59.78 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 111.439 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 86' ' ' ILE . 2.7 mm -92.88 -6.02 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.02 . . . . 0.0 111.626 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -125.88 -19.46 4.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.625 -1.297 . . . . 0.0 110.712 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.05 3.4 64.53 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.8 mt -81.95 160.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.293 -1.122 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 11.6 p-10 -102.81 166.34 12.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 109.841 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 41.2 Cg_endo -68.0 145.86 69.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.679 1.358 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.502 ' O ' ' C ' ' A' ' 93' ' ' HIS . 40.8 Cg_endo -68.6 127.88 16.24 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.037 1.546 . . . . 0.0 109.935 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.502 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -28.14 -67.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.137 0.494 . . . . 0.0 111.513 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 m -115.36 -165.61 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.965 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -93.74 163.42 13.54 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 70.6 p -122.55 169.06 10.37 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.8 Cg_endo -67.38 -15.02 44.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.343 1.18 . . . . 0.0 109.62 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 1.1 mp0 -88.42 -16.5 32.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 108.854 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.606 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 31.4 ttm -96.98 -31.61 12.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.5 mt -72.08 139.0 82.01 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.609 -0.682 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 45.6 Cg_endo -73.83 175.33 10.92 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.384 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 44.7 Cg_endo -71.91 -160.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 102' ' ' PRO . 24.5 t . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 9' ' ' THR . 3.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -51.55 163.53 0.28 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -83.13 -167.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.055 . . . . 0.0 109.816 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.598 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 7.7 p 31.27 99.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.565 0.697 . . . . 0.0 111.209 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.514 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.25 -62.18 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.869 -1.144 . . . . 0.0 113.509 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 13' ' ' SER . 40.6 Cg_endo -61.98 -143.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 122.936 0.966 . . . . 0.0 111.818 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.65 -60.74 0.1 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.735 -0.603 . . . . 0.0 112.552 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 23.0 mt-10 -37.49 -60.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.57 -0.706 . . . . 0.0 111.145 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 13' ' ' SER . 1.8 tmtt? -54.65 -34.4 62.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.99 -1.069 . . . . 0.0 110.1 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -67.86 -46.89 70.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.6 ttpt -57.26 -30.43 64.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.646 -0.659 . . . . 0.0 110.197 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 9.1 m-85 -84.77 -50.01 7.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.8 t70 -50.31 -32.6 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 0.0 109.597 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.96 -35.01 43.81 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.203 -0.935 . . . . 0.0 108.974 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 62.9 mt -77.74 -41.06 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.775 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.596 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 49.2 t80 -48.55 -26.57 2.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.042 -1.036 . . . . 0.0 108.809 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 17.6 mt -76.88 -28.62 55.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -98.53 -9.06 25.52 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.576 HG23 ' CE2' ' A' ' 74' ' ' PHE . 3.1 m -90.9 -57.24 2.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.236 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.3 80.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.664 -0.647 . . . . 0.0 109.708 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 1.1 mttt -78.48 12.32 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 111.798 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 68.4 m-20 -109.31 12.31 24.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.823 -1.173 . . . . 0.0 110.411 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 42.68 34.85 0.61 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.173 -0.954 . . . . 0.0 110.21 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 26.5 p30 -111.21 4.09 18.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.168 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 13.67 70.13 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.572 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -147.77 105.47 3.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -1.047 . . . . 0.0 110.323 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 69' ' ' LEU . 9.6 p -89.78 135.65 25.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 108.696 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.497 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -103.83 176.22 5.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.0 111.096 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' CD2' ' A' ' 38' ' ' LEU . . . -69.3 54.66 0.62 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.2 mt -139.93 -41.08 0.44 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 12.4 mt-10 -91.08 -61.67 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 36' ' ' SER . 1.1 p -51.71 -22.82 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 1.2 ptt180 -47.36 -54.4 11.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.615 -0.678 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.589 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 3.0 tt0 -60.85 -43.11 98.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.238 . . . . 0.0 107.753 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.568 HD11 ' CG2' ' A' ' 27' ' ' THR 0.256 1.1 mt -54.13 -40.79 48.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.87 -46.17 31.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' HG3' ' A' ' 41' ' ' ARG . 13.5 mt -50.83 -24.11 3.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 108.967 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 44.3 mttm -73.3 -16.33 61.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.204 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 44' ' ' PHE . 58.9 p -70.07 -19.54 63.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.409 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.14 26.94 67.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB3' HD23 ' A' ' 53' ' ' LEU . 6.5 mp -96.08 164.59 18.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.713 -0.875 . . . . 0.0 110.428 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 43.9 Cg_endo -74.05 172.87 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.976 1.514 . . . . 0.0 110.476 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 t -66.84 -67.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.612 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' LEU . 26.0 m -43.01 -62.59 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -0.86 . . . . 0.0 111.165 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.56 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -42.51 -55.68 3.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.182 -0.949 . . . . 0.0 110.936 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 44' ' ' PHE . 94.9 mt -52.87 -35.58 57.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.637 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.95 -33.77 57.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 108.739 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -73.7 -34.12 64.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -72.85 -19.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 57.6 t-105 -70.83 -44.56 66.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.471 -0.768 . . . . 0.0 109.948 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.495 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -70.34 -28.38 65.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.06 179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 45.4 mt -73.98 -12.68 60.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' CA ' ' A' ' 77' ' ' ALA . 17.1 p -116.06 -31.9 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.138 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 19.7 t0 -84.33 54.79 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.538 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 16.6 p -50.73 -31.66 17.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HG3' ' HB2' ' A' ' 70' ' ' SER . 9.1 mmtt -49.97 -21.09 1.08 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.425 0.631 . . . . 0.0 110.167 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 45.66 51.92 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.842 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.7 -5.09 7.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.29 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.97 58.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 11.4 mttm -116.4 -178.12 3.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -1.188 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.6 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -118.47 99.2 6.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.458 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.572 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.85 -171.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 110.296 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.596 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.32 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.056 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.49 -20.92 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 110.722 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.538 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 4.6 mm100 -72.98 -49.63 27.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 23' ' ' ILE . 9.5 t80 -61.21 -26.52 67.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.026 . . . . 0.0 109.467 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -78.39 -13.85 59.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.591 -0.693 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 2.8 tt -90.61 -28.74 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 110.759 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' CA ' ' HB3' ' A' ' 61' ' ' CYS . . . -63.59 -51.61 64.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 110.052 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ ' ' A' ' 74' ' ' PHE . 13.5 m-85 -51.38 -34.02 32.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 109.795 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.4 t60 -57.51 -20.94 34.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.324 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 60' ' ' LEU . 2.7 mt -99.42 -31.61 11.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.226 -0.922 . . . . 0.0 109.16 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.648 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 68.2 mt -63.18 -58.29 8.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.2 -37.03 1.96 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.596 -0.69 . . . . 0.0 110.785 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -58.78 -30.95 67.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.929 -1.107 . . . . 0.0 110.555 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -90.47 -21.76 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.793 -1.192 . . . . 0.0 111.023 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 49' ' ' LEU . 5.0 mt -86.73 -47.49 9.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 111.496 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 86' ' ' ILE . 3.1 mm -110.97 -10.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.917 -1.114 . . . . 0.0 111.194 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -118.3 -10.28 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.797 -1.189 . . . . 0.0 110.459 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 62.47 11.87 36.84 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 90' ' ' ASP . 6.1 mt -90.6 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.253 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.4 m-20 -114.7 162.73 22.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 43.1 Cg_endo -68.03 158.58 56.79 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.982 1.517 . . . . 0.0 110.315 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' O ' HD13 ' A' ' 60' ' ' LEU . 45.1 Cg_endo -72.04 178.66 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.867 1.456 . . . . 0.0 110.157 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.464 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -64.08 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.1 -1.0 . . . . 0.0 109.67 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.458 ' HA ' HD22 ' A' ' 60' ' ' LEU . 13.5 m -117.74 -165.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 11.7 mt -77.18 152.33 34.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.834 0.826 . . . . 0.0 111.687 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 45.1 p -123.7 169.95 9.41 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.5 Cg_endo -66.06 -26.31 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.297 1.157 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 11' ' ' VAL . 2.1 mt-10 -79.34 -6.97 57.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 108.924 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.577 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 33.6 ttm -107.6 -32.66 7.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.4 mt -69.6 111.83 10.14 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.627 -0.67 . . . . 0.0 109.705 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.608 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 43.9 Cg_endo -75.03 -29.07 8.57 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.03 1.542 . . . . 0.0 114.108 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 43.9 Cg_endo -70.17 93.38 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 122.466 0.719 . . . . 0.0 110.673 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.678 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.548 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.518 ' CZ2' ' HG3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -169.16 152.93 5.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 110.163 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.547 ' CG2' HG12 ' A' ' 12' ' ' VAL . 1.1 m -80.1 -158.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.239 -0.913 . . . . 0.0 111.108 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' CG2' ' A' ' 11' ' ' VAL . 3.4 p 21.48 80.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-O 121.296 0.57 . . . . 0.0 112.166 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.533 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -109.45 -40.57 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 113.398 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.4 Cg_endo -80.05 -152.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 122.836 0.914 . . . . 0.0 112.35 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.94 -54.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 40.1 mt-10 -37.98 -60.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.679 -0.638 . . . . 0.0 110.572 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.518 ' HG3' ' CZ2' ' A' ' 10' ' ' TRP . 7.3 tmtt? -55.95 -36.75 68.15 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.633 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -67.07 -48.82 67.08 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.702 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -55.33 -30.96 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.449 -0.782 . . . . 0.0 109.561 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.8 m-85 -85.37 -38.06 19.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.62 -35.6 74.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.458 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.9 -40.96 53.37 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 42.2 mt -69.25 -38.1 77.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.519 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 47.5 t80 -46.78 -31.32 2.93 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.491 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.2 -32.0 69.71 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 23' ' ' ILE . 11.9 mtmt -89.73 -15.91 31.49 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' HD12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -89.53 -51.86 5.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 20.7 t0 -71.4 56.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 97.6 mttt -44.57 -23.78 0.14 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.91 . . . . 0.0 111.618 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.469 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.6 m-20 -89.58 1.13 56.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.134 . . . . 0.0 110.571 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt 47.16 53.76 10.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.484 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 3.0 p30 -125.42 23.28 7.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.943 . . . . 0.0 109.951 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 64.9 12.09 52.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.563 ' CZ ' ' OG ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -151.02 108.44 3.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.238 . . . . 0.0 111.381 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 69' ' ' LEU . 2.0 p -92.98 134.16 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.065 -1.022 . . . . 0.0 109.081 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.5 t -87.32 153.67 21.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.91 -26.18 1.91 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.38 -41.99 99.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.43 -1.041 . . . . 0.0 111.636 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.8 mt-10 -81.24 -61.76 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 108.887 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.672 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -52.56 -20.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.533 0.683 . . . . 0.0 109.436 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -46.81 -73.15 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.2 -42.38 4.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.1 mt -58.81 -44.86 91.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.701 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 m-85 -80.45 -31.58 37.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.61 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 42' ' ' GLU . 57.9 mt -60.9 -16.78 45.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.0 109.357 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mttt -80.17 -22.44 41.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.194 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 81' ' ' ILE . 33.2 p -56.37 -25.39 49.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 110.472 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.95 83.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -88.91 160.6 43.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.966 . . . . 0.0 110.436 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HD2' HD23 ' A' ' 53' ' ' LEU . 40.8 Cg_endo -67.83 132.39 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.953 1.502 . . . . 0.0 110.226 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -39.33 -54.72 1.83 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.723 . . . . 0.0 110.862 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -47.98 -52.17 20.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 110.277 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -55.77 -51.54 67.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.853 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.8 mt -58.92 -40.14 83.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -45.75 69.08 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 41.4 t60 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 57' ' ' ILE . 3.1 mt -80.37 -27.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.604 ' CZ3' HD13 ' A' ' 69' ' ' LEU . 22.9 t-105 -68.61 -47.98 65.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 108.968 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -61.48 -28.67 69.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 1.6 tp -67.61 -47.5 69.48 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . 17.6 p -80.97 -35.02 32.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.012 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 39.2 t0 -65.5 59.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.501 -0.749 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 1.1 p -64.61 -30.34 71.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 1.4 mptp? -66.14 -10.78 44.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 t70 42.43 54.87 4.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 m -120.66 4.82 10.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.35 -10.93 69.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -120.91 -170.8 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.28 -1.129 . . . . 0.0 109.949 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.604 HD13 ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -122.55 109.47 14.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.988 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.563 ' OG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -61.7 -178.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 109.459 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.1 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.45 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.3 m-20 -46.14 -25.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 110.277 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 64' ' ' LYS . 9.5 mt-30 -68.75 -57.04 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.878 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.684 ' CZ ' ' CZ ' ' A' ' 78' ' ' PHE . 17.3 t80 -52.57 -21.42 3.84 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.347 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.85 -10.08 55.95 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.19 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 4.6 tp -91.33 -43.61 9.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.481 -0.762 . . . . 0.0 110.324 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 61' ' ' CYS . . . -58.06 -31.4 67.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.998 -1.064 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 20.0 m-85 -72.39 -35.26 68.4 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.225 -0.922 . . . . 0.0 108.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 73.5 t60 -53.44 -23.85 11.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.121 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -93.19 -42.2 9.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.51 HG23 ' CD2' ' A' ' 49' ' ' LEU . 1.2 mm -55.28 -56.41 11.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.581 -0.699 . . . . 0.0 109.307 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -46.73 6.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 110.585 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.9 mt-30 -55.38 -24.61 30.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.974 -1.078 . . . . 0.0 110.007 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 81' ' ' ILE . 8.0 tptp -90.22 -18.59 25.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.695 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.4 mt -90.73 -47.01 7.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.49 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.6 -18.86 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.932 -1.105 . . . . 0.0 111.232 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -109.72 -17.35 13.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.934 -1.104 . . . . 0.0 110.645 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 69.74 11.84 66.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -93.22 141.86 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.337 -1.096 . . . . 0.0 110.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.528 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -81.78 -172.0 0.33 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 0.0 108.79 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 90' ' ' ASP . 43.4 Cg_endo -78.33 158.93 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.415 1.219 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.7 Cg_endo -72.9 47.01 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.879 1.463 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.518 ' O ' HD11 ' A' ' 60' ' ' LEU . 19.1 m170 55.89 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.272 -0.893 . . . . 0.0 111.003 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -117.23 -161.75 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 110.58 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.58 ' CD1' ' HG ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.76 164.23 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.114 0.959 . . . . 0.0 111.175 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 1.5 p -127.96 -177.83 0.69 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.1 Cg_endo -75.05 -5.17 16.44 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.253 1.133 . . . . 0.0 109.667 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' TRP . 11.5 mt-10 -96.07 -18.33 20.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.855 0.836 . . . . 0.0 109.113 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 95' ' ' LEU . 4.0 mtp -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.855 0.836 . . . . 0.0 108.897 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 96' ' ' THR . 2.0 mt -61.0 128.65 89.55 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.887 -0.508 . . . . 0.0 109.743 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.12 141.03 42.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.833 1.438 . . . . 0.0 110.635 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 103' ' ' SER . 47.2 Cg_endo -76.21 -90.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.127 1.593 . . . . 0.0 110.471 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 102' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.404 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.153 0.502 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.566 ' CZ3' ' HG3' ' A' ' 17' ' ' LYS . 5.1 t90 -76.41 128.96 35.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.573 HG23 ' CD2' ' A' ' 79' ' ' HIS . 2.8 m -57.62 -19.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.252 -0.905 . . . . 0.0 109.888 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 11' ' ' VAL . 1.4 p -143.33 70.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.503 -0.748 . . . . 0.0 110.182 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -104.89 -31.96 0.2 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.192 -0.943 . . . . 0.0 113.49 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 13' ' ' SER . 53.2 Cg_endo -75.09 -150.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 122.575 0.776 . . . . 0.0 110.788 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.9 -46.57 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.803 -0.561 . . . . 0.0 111.903 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -51.79 -59.55 4.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' HG3' ' CZ3' ' A' ' 10' ' ' TRP . 9.1 tmtt? -52.16 -40.85 62.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 109.816 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -30.22 60.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 109.682 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 18.6 m-85 -88.59 -41.66 12.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.422 -0.799 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' OD2' ' NZ ' ' A' ' 71' ' ' LYS . 8.6 t70 -50.59 -39.79 50.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.252 -0.905 . . . . 0.0 109.178 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.42 -47.2 64.87 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' LYS . 20.3 mt -63.65 -39.26 84.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.432 -0.792 . . . . 0.0 109.413 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 66.7 t80 -49.24 -24.62 1.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.73 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.29 -26.07 60.92 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 1.8 tttt -97.95 -15.44 20.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 HG22 ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -88.83 -55.77 3.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.451 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 20.9 t0 -69.57 58.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 39' ' ' GLU . 0.3 OUTLIER -36.72 -46.0 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.521 -0.737 . . . . 0.0 112.729 -178.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' MET . 5.1 p-10 -94.52 15.6 17.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.617 -1.302 . . . . 0.0 111.994 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 30' ' ' ASP . 9.5 mtm 35.08 56.04 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.481 -0.762 . . . . 0.0 111.271 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 13.6 p30 -101.49 4.38 41.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 110.241 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.14 -33.22 4.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 1.3 p90 -146.76 146.46 30.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -1.094 . . . . 0.0 110.74 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.3 p -90.45 127.99 42.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.7 151.82 39.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.599 -1.313 . . . . 0.0 109.588 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.5 -23.88 0.95 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.3 mt -61.56 -46.39 90.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.755 -0.85 . . . . 0.0 111.805 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 8.3 mt-10 -80.39 -57.17 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.455 -1.403 . . . . 0.0 109.171 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.5 p -56.88 -20.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.848 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -75.97 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 110.152 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' N ' HD13 ' A' ' 45' ' ' LEU . 8.0 mp0 -42.78 -46.47 5.2 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.761 0.791 . . . . 0.0 109.021 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 27' ' ' THR . 1.0 OUTLIER -52.27 -37.82 23.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -80.99 -43.78 19.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.785 . . . . 0.0 109.145 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 42' ' ' GLU . 14.0 mt -52.65 -23.76 7.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 24.4 mtpt -78.55 -5.64 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.695 . . . . 0.0 109.817 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.537 ' CB ' HD13 ' A' ' 49' ' ' LEU . 43.5 p -76.76 -7.99 56.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.866 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.93 15.65 79.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 9.4 mp -88.21 165.26 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.996 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 46.2 Cg_endo -74.93 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.983 1.517 . . . . 0.0 109.225 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.99 -73.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.949 -1.094 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 53' ' ' LEU . 1.3 m -41.42 -58.0 2.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 111.088 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.559 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -40.86 -50.34 3.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.145 -0.972 . . . . 0.0 110.843 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.583 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -57.22 -41.61 79.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.862 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.21 92.85 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.829 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.428 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 82.0 t60 -64.36 -40.11 95.2 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' A' ' 44' ' ' PHE . 2.4 mt -69.0 -31.28 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.352 -0.842 . . . . 0.0 108.827 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 69' ' ' LEU . 53.9 t-105 -63.19 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.544 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -74.84 -25.61 59.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -74.78 -25.53 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.825 . . . . 0.0 109.317 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.502 ' HB3' ' CA ' ' A' ' 77' ' ' ALA . 29.8 p -100.78 -32.74 10.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 108.692 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.562 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 53.2 t0 -72.52 61.0 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.716 -0.615 . . . . 0.0 109.899 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 1.5 p -51.65 -34.95 40.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -60.51 -13.7 15.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.459 -0.775 . . . . 0.0 110.053 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 40.75 56.32 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.516 -0.74 . . . . 0.0 110.293 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 7.58 3.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.85 75.2 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -127.55 170.12 12.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.323 -1.104 . . . . 0.0 109.987 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 1.1 mt -118.2 98.58 6.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.082 -1.011 . . . . 0.0 110.512 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.665 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 1.2 p -46.18 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.333 -0.855 . . . . 0.0 109.407 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.54 -56.98 10.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.504 -1.373 . . . . 0.0 109.628 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.482 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -64.25 -49.0 73.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 110.704 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.562 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 26.0 mt-30 -44.45 -42.98 7.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 111.184 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.489 ' HA ' HD11 ' A' ' 69' ' ' LEU . 63.2 t80 -55.02 -44.93 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.15 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . . . -68.6 -9.49 50.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.988 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.501 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.8 tt -90.81 -35.29 14.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 111.219 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' CA ' ' HB3' ' A' ' 61' ' ' CYS . . . -58.64 -46.09 87.87 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 17.6 m-85 -56.74 -37.34 70.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.996 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.573 ' CD2' HG23 ' A' ' 11' ' ' VAL . 49.3 t60 -49.39 -21.66 0.94 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.07 -1.019 . . . . 0.0 109.65 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.532 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 5.8 mt -98.29 -24.6 15.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.807 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 18.3 mt -74.51 -58.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -30.44 7.62 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.603 -0.686 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -69.12 -21.98 63.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HE2' ' CD1' ' A' ' 57' ' ' ILE . 9.3 mttm -90.99 -25.74 19.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.1 mt -86.39 -65.49 1.01 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 86' ' ' ILE . 4.8 mm -84.64 -6.08 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.001 . . . . 0.0 110.703 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' CD ' HD12 ' A' ' 89' ' ' ILE . 1.3 mmtt -126.68 -28.89 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.933 -1.104 . . . . 0.0 110.491 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 68.55 18.79 72.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.547 HD12 ' CD ' ' A' ' 87' ' ' LYS . 7.7 mt -89.31 141.22 14.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.276 -1.132 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.27 167.51 33.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.558 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.474 ' HD3' ' HE3' ' A' ' 84' ' ' LYS . 44.4 Cg_endo -75.25 146.68 32.06 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.184 1.623 . . . . 0.0 110.574 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 93' ' ' HIS . 45.2 Cg_endo -72.25 102.0 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.989 1.52 . . . . 0.0 110.289 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.578 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -5.07 -70.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -122.13 -173.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.086 -1.009 . . . . 0.0 110.977 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -84.33 170.78 13.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 111.815 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 1.3 p -135.03 177.26 2.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.0 Cg_endo -70.99 -12.62 30.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.324 1.17 . . . . 0.0 110.2 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' HB3' HG13 ' A' ' 11' ' ' VAL . 81.7 mt-10 -87.38 -18.34 30.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 108.711 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.542 ' SD ' ' HA ' ' A' ' 95' ' ' LEU . 4.4 mtp -90.12 -43.19 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.719 0.771 . . . . 0.0 109.073 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 96' ' ' THR . 1.3 mt -53.34 137.16 50.23 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.772 -0.58 . . . . 0.0 109.98 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.26 113.07 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.082 1.57 . . . . 0.0 110.75 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.63 168.57 24.44 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.46 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 179.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 98' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.833 0.825 . . . . 0.0 111.223 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 1.9 t90 -150.5 136.95 18.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.35 0.595 . . . . 0.0 109.732 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 98' ' ' GLU . 3.1 m -69.01 -36.69 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.773 . . . . 0.0 110.493 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.549 ' CG2' HG23 ' A' ' 11' ' ' VAL . 2.3 t -97.44 161.43 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 170.96 -54.61 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.354 -0.841 . . . . 0.0 111.156 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.4 Cg_endo -71.83 -153.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.716 1.377 . . . . 0.0 110.45 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.89 -56.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.448 0.642 . . . . 0.0 111.408 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -39.42 -64.57 0.46 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.664 -0.648 . . . . 0.0 110.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 8.0 tmtm? -50.91 -44.27 60.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -44.84 89.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -61.67 -26.85 68.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.434 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.612 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 11.5 m-85 -90.47 -51.09 5.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.623 -0.673 . . . . 0.0 109.978 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -45.62 -36.84 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.632 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HA ' HD11 ' A' ' 25' ' ' LEU . 71.5 mt-10 -74.66 -40.29 61.54 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.576 HG21 ' CE2' ' A' ' 74' ' ' PHE . 36.5 mt -70.09 -35.18 62.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.842 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.599 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 73.3 t80 -48.82 -38.93 23.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.739 -1.225 . . . . 0.0 108.04 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 22' ' ' GLU . 8.3 mt -62.79 -26.67 68.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.15 -13.72 20.77 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.583 ' CG2' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -89.2 -55.47 3.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 34' ' ' PHE . 21.5 t0 -63.29 73.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 65.9 mmtt -52.45 -19.79 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.303 -0.873 . . . . 0.0 111.22 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -97.0 3.15 52.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 110.793 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.76 27.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 7.6 p-10 -92.92 11.5 27.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.125 -0.984 . . . . 0.0 110.194 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.34 5.45 89.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 70' ' ' SER . 1.9 m-85 -147.26 109.3 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 0.0 110.316 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.583 HG22 ' CG2' ' A' ' 27' ' ' THR . 4.2 p -88.86 126.59 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.49 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -81.82 148.63 28.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 110.136 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.19 -26.44 0.54 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.489 -1.007 . . . . 0.0 110.857 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.534 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 98.9 mt-10 -85.98 -58.79 2.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.774 -1.204 . . . . 0.0 108.927 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.5 p -58.54 -13.84 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.503 0.668 . . . . 0.0 109.815 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HG2' ' N ' ' A' ' 42' ' ' GLU . 10.6 ttm180 -50.93 -70.27 0.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.638 -0.664 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -45.0 -44.17 9.72 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.557 HD11 ' CG2' ' A' ' 27' ' ' THR . 1.4 mt -59.13 -41.27 83.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.608 ' CZ ' ' CD1' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.29 -19.94 52.57 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.592 -0.692 . . . . 0.0 109.211 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 42' ' ' GLU . 12.9 mt -76.42 -29.8 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.149 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 19.3 mttm -73.76 -9.61 58.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.507 -0.746 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 72.3 p -64.85 -51.53 61.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.76 21.01 5.87 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.558 ' CG ' HD12 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -85.63 172.94 7.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.941 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 39.2 Cg_endo -66.16 -93.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.777 1.409 . . . . 0.0 110.596 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -158.66 -73.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.863 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -29.73 68.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.538 HD13 ' CE ' ' A' ' 84' ' ' LYS . 1.1 tp -51.18 -60.1 3.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.606 ' HG ' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.6 -35.12 53.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 108.974 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.6 -38.47 80.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 21.7 t60 -68.84 -35.12 76.56 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.478 HG21 HD12 ' A' ' 57' ' ' ILE . 7.8 mt -69.84 -23.03 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.602 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.66 -46.28 79.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.483 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.424 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -68.57 -29.59 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.567 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 1.2 mp -74.89 -18.45 60.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' CB ' ' CB ' ' A' ' 77' ' ' ALA . 14.0 p -108.22 -30.04 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.179 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 63' ' ' THR . 67.0 t0 -78.64 49.02 0.84 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.572 -0.705 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 2.4 p -46.99 -29.18 1.93 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -55.01 -19.42 6.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.302 0.573 . . . . 0.0 109.605 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 m-20 38.85 55.27 2.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.579 -0.7 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.4 t -128.54 -30.4 2.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.97 0.99 4.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -142.51 170.62 15.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.174 -1.192 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.6 mt -104.15 104.07 13.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.421 -0.799 . . . . 0.0 110.094 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.08 -168.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 110.004 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.599 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.45 -67.98 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.722 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.52 -21.42 65.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.844 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 12.2 mm100 -69.29 -56.0 8.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.873 -1.142 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 23' ' ' ILE . 29.6 t80 -51.56 -22.0 2.93 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.226 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.24 -13.12 55.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.133 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.537 ' CD2' ' HG3' ' A' ' 99' ' ' MET . 2.2 tp -90.03 -42.98 10.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' CB ' ' CB ' ' A' ' 61' ' ' CYS . . . -55.81 -49.12 74.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.064 -1.022 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 1.2 m-85 -50.2 -36.42 30.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 59.2 t60 -56.69 -30.49 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.504 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 8.3 mt -87.1 -24.01 24.7 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.608 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 3.0 mm -76.65 -62.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -51.12 -26.03 6.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 110.342 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLY . 3.4 mt-30 -64.85 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 110.446 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.538 ' CE ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -90.25 -12.41 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 111.109 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.0 mt -87.19 -47.71 8.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.442 HG21 HD11 ' A' ' 86' ' ' ILE . 3.9 mm -111.48 -25.71 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 1.1 mmpt? -104.33 -2.59 25.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.643 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 45.54 35.02 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -106.31 130.42 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.154 -1.203 . . . . 0.0 110.089 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.4 p-10 -70.95 -175.79 0.33 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 43.0 Cg_endo -81.72 155.39 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.641 1.338 . . . . 0.0 110.044 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.4 Cg_endo -70.56 56.31 1.72 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.032 1.543 . . . . 0.0 110.598 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.467 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.3 m-70 42.58 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.497 -0.752 . . . . 0.0 110.793 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 92' ' ' PRO . 6.0 m -104.56 -169.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.667 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 4.3 mm? -74.0 162.12 29.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 43.6 p -138.57 165.21 34.47 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.0 Cg_endo -65.98 -41.18 14.19 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.555 1.292 . . . . 0.0 108.752 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 11' ' ' VAL . 4.3 tt0 -67.55 -7.37 25.49 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.641 -0.662 . . . . 0.0 109.438 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.537 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 13.7 ttm -111.56 -26.84 8.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.77 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 96' ' ' THR . 3.3 mt -78.0 116.76 61.27 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.432 -0.793 . . . . 0.0 110.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.536 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 47.5 Cg_endo -82.19 118.18 2.94 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.896 1.472 . . . . 0.0 110.201 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 103' ' ' SER . 48.6 Cg_endo -80.65 -70.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.905 1.476 . . . . 0.0 111.163 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 102' ' ' PRO . 1.4 t . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.34 -0.85 . . . . 0.0 110.82 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.13 0.49 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.568 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 1.4 p-90 -51.37 136.17 25.77 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.354 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG21 ' N ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -55.55 -173.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.314 -0.866 . . . . 0.0 109.892 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.568 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 14.9 p 33.41 100.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 111.525 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.96 -68.47 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 112.107 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 40.3 Cg_endo -62.87 -141.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.392 1.207 . . . . 0.0 112.354 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.6 -57.41 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.685 -0.634 . . . . 0.0 112.351 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 17.6 mt-10 -40.59 -63.45 0.64 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.426 -0.796 . . . . 0.0 110.599 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.81 -30.95 66.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.121 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.19 -44.57 45.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.572 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -61.17 -28.27 69.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 109.604 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 9.0 m-85 -87.01 -53.1 5.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.856 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -46.8 -28.74 1.65 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.002 . . . . 0.0 108.96 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -80.74 -42.58 21.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' LYS . 30.7 mt -71.38 -33.89 51.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ILE . 48.8 t80 -48.62 -33.03 9.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.468 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.4 -24.74 67.29 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 23' ' ' ILE . 35.0 mtpt -100.76 -12.89 18.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.474 -0.766 . . . . 0.0 108.969 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.556 ' CG2' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.23 -53.87 4.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.67 0.748 . . . . 0.0 109.076 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 49.9 t0 -67.8 62.17 0.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.632 -0.667 . . . . 0.0 109.37 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 5.2 mptp? -47.78 -25.08 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.172 -0.955 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 4.8 m-20 -91.39 7.59 40.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.788 -1.195 . . . . 0.0 111.142 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.444 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt 46.65 31.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.206 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 3.9 p-10 -100.39 19.84 15.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 110.287 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 65.28 12.56 55.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 2.0 m-85 -150.2 108.83 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 0.0 110.664 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 40' ' ' VAL . 2.1 p -89.26 132.56 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.051 -1.03 . . . . 0.0 108.623 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -88.46 156.74 18.94 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.848 -1.158 . . . . 0.0 109.979 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -49.68 -21.32 3.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.49 -35.19 77.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.13 . . . . 0.0 111.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 25.5 mt-10 -88.19 -60.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 44' ' ' PHE . 1.5 p -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.581 0.705 . . . . 0.0 109.283 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.71 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.762 -0.586 . . . . 0.0 110.601 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' LEU . 1.1 mt-10 -45.28 -43.33 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -54.1 -42.47 55.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.655 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 2.7 m-85 -83.77 -28.6 28.05 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 42' ' ' GLU . 40.7 mt -63.72 -22.3 66.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 21.7 mtpp -75.81 -8.82 57.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.641 -0.662 . . . . 0.0 109.467 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' HG21 ' A' ' 81' ' ' ILE . 54.0 p -68.46 -45.16 73.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 110.152 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.27 15.07 10.88 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -97.71 167.62 11.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.559 -0.965 . . . . 0.0 110.553 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HD2' HD21 ' A' ' 53' ' ' LEU . 45.2 Cg_endo -73.85 169.34 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 52' ' ' THR . 55.4 p -67.18 -55.67 13.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.261 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.7 m -49.14 -65.51 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -41.9 -54.7 3.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 49' ' ' LEU . 50.9 mt -59.14 -44.15 92.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.852 . . . . 0.0 109.693 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.51 -41.91 98.51 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.51 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 7.2 t60 -64.95 -30.31 71.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 HD13 ' CD1' ' A' ' 81' ' ' ILE . 7.6 mt -73.16 -24.91 21.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.607 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 36.0 t-105 -66.59 -48.48 69.42 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.047 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.42 -33.91 76.77 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.019 -1.05 . . . . 0.0 108.408 178.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.55 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 2.4 tp -70.76 -5.95 33.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 3.1 p -118.3 -35.58 3.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 59' ' ' SER . 4.4 p-10 -71.07 50.72 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.738 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 73' ' ' GLN . 1.8 p -51.41 -29.07 14.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.747 -1.221 . . . . 0.0 108.266 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE3' ' NE2' ' A' ' 73' ' ' GLN . 6.6 mmtt -53.59 -19.4 3.85 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.464 0.649 . . . . 0.0 109.996 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 44.63 53.1 7.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 t -126.28 -12.33 6.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.471 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.39 -7.48 37.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 6.0 ptpt -129.98 -172.0 2.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -1.191 . . . . 0.0 110.342 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -123.41 103.46 8.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.146 -0.971 . . . . 0.0 111.063 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.34 -169.15 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.668 -1.27 . . . . 0.0 109.851 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -62.61 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.349 -0.844 . . . . 0.0 110.639 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' ALA . 4.0 m-20 -41.98 -67.43 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.531 ' CG ' ' OG1' ' A' ' 63' ' ' THR . 15.5 mp0 -39.75 -39.34 0.77 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.518 -0.739 . . . . 0.0 111.2 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 69' ' ' LEU . 14.8 t80 -66.73 -35.61 80.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.744 -1.222 . . . . 0.0 108.683 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' ASP . . . -74.79 -6.75 50.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 109.375 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' CD1' ' HG3' ' A' ' 99' ' ' MET . 4.2 tp -90.36 -44.43 9.67 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.358 -0.839 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -52.12 -51.88 55.08 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.703 -1.248 . . . . 0.0 109.815 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 9.7 m-85 -54.45 -36.75 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 110.262 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 78.4 t60 -53.92 -20.21 5.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.902 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 3.1 mt -100.22 -19.57 16.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 0.0 109.034 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.612 HG13 ' CE2' ' A' ' 44' ' ' PHE . 18.1 mm -72.38 -66.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' ILE . 79.0 p -41.01 -29.91 0.12 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.737 -0.602 . . . . 0.0 110.107 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 10.8 mt-30 -61.94 -38.7 89.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 110.04 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.495 ' CG ' HD13 ' A' ' 49' ' ' LEU . 10.3 tptt -85.72 -14.51 45.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.929 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.539 ' CD2' HD21 ' A' ' 49' ' ' LEU . 4.4 mt -83.84 -64.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.984 -1.073 . . . . 0.0 110.719 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 86' ' ' ILE . 10.4 mm -95.89 -35.92 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.205 -0.935 . . . . 0.0 110.73 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 3.6 mmpt? -90.06 -0.99 57.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 43.91 24.99 0.56 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 5.5 mt -95.19 150.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.817 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.1 m-20 -92.91 159.6 35.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.007 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 44.7 Cg_endo -71.25 154.9 61.45 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.948 1.499 . . . . 0.0 109.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.545 ' O ' ' CD2' ' A' ' 60' ' ' LEU . 43.2 Cg_endo -70.43 142.14 44.22 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.988 1.52 . . . . 0.0 110.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 92' ' ' PRO . 4.1 m-70 -40.72 -57.92 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 110.444 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.51 -162.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 110.884 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -95.5 132.99 40.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.535 -0.728 . . . . 0.0 111.492 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 43.6 p -87.44 167.66 20.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.6 Cg_endo -66.81 -16.89 51.39 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.406 1.214 . . . . 0.0 109.403 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.464 ' HB3' HG12 ' A' ' 11' ' ' VAL . 6.3 mt-10 -85.87 -27.31 25.12 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.582 ' HG3' ' CD1' ' A' ' 76' ' ' LEU . 36.8 ttm -83.86 -12.57 55.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.532 0.682 . . . . 0.0 109.306 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.17 115.19 65.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.621 -0.674 . . . . 0.0 110.081 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.48 154.73 60.36 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.759 1.399 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.0 158.69 51.98 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.945 1.497 . . . . 0.0 110.521 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 110.537 -179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 9' ' ' THR . 15.9 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.133 0.492 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.604 ' CZ3' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -96.87 161.56 13.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.791 -1.193 . . . . 0.0 110.042 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG11 ' CB ' ' A' ' 99' ' ' MET . 4.1 m -89.25 -8.36 10.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.35 -0.844 . . . . 0.0 110.549 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CZ3' ' A' ' 10' ' ' TRP . 2.1 p -160.31 72.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.212 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 94.5 p -108.43 -22.36 0.17 Allowed Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 13' ' ' SER . 56.8 Cg_endo -76.62 -157.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 122.294 0.628 . . . . 0.0 111.473 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.22 -51.77 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.325 0.583 . . . . 0.0 111.671 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 55.2 mt-10 -39.42 -63.09 0.59 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.75 -32.12 67.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 110.069 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.31 -41.13 61.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -29.7 69.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.425 -0.797 . . . . 0.0 109.552 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.8 m-30 -81.29 -41.06 22.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.468 -0.77 . . . . 0.0 109.414 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.41 -31.54 15.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.58 -35.78 52.67 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 42.1 mt -74.5 -42.17 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.624 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 53.1 t80 -45.83 -28.92 1.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.464 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.0 -34.53 77.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 38.0 mtmt -93.68 -9.47 37.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.578 HG23 ' CE1' ' A' ' 74' ' ' PHE . 1.1 m -89.56 -56.01 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.718 0.771 . . . . 0.0 109.018 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 51.1 t0 -70.13 70.43 0.38 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.628 -0.67 . . . . 0.0 109.313 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 76.1 mttt -62.34 -8.13 5.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 111.588 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -95.25 -2.94 48.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.879 -1.138 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mmt 57.08 18.61 4.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 110.16 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 24.7 p30 -92.28 18.96 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.193 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 63.68 15.81 58.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.595 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.84 112.61 4.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.083 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG13 ' CE1' ' A' ' 24' ' ' PHE . 2.1 p -89.63 130.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.017 -1.052 . . . . 0.0 109.587 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 38' ' ' LEU . 2.9 p -85.3 148.93 25.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 109.391 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.05 -26.53 0.5 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -62.0 -35.31 78.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.643 -0.916 . . . . 0.0 111.019 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 19.7 mt-10 -89.13 -63.35 1.3 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.648 -1.283 . . . . 0.0 109.192 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.636 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.2 p -49.07 -21.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.321 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -43.02 -62.1 1.12 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 6.9 mt-10 -51.94 -45.87 64.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 108.476 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.56 HD13 ' CG2' ' A' ' 27' ' ' THR . 1.0 OUTLIER -54.65 -33.54 27.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.636 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 2.7 m-85 -85.17 -35.39 21.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 109.558 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 11.2 mt -60.3 -15.36 24.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 38.8 mttt -85.4 -10.19 56.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.653 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.531 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 44.6 p -73.68 -55.82 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.08 -7.98 9.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 1.7 mm? -69.89 161.92 71.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.369 -1.077 . . . . 0.0 110.245 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.5 Cg_endo -71.72 143.36 41.6 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' PRO . 56.2 p -40.41 -46.99 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.377 -0.827 . . . . 0.0 110.982 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.2 m -62.53 -61.57 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.981 . . . . 0.0 110.952 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.624 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.89 -47.6 11.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 44' ' ' PHE . 65.4 mt -55.9 -37.56 69.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.018 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.88 -43.55 75.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.465 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 20.7 t60 -61.36 -37.78 84.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.394 -0.816 . . . . 0.0 108.799 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 81' ' ' ILE . 13.8 mt -71.84 -28.51 30.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.551 -0.718 . . . . 0.0 109.079 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.629 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 15.2 t-105 -64.85 -37.8 88.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.552 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.476 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -75.14 -25.08 58.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 108.973 179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . 1.1 mp -77.67 -17.99 57.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.344 -0.847 . . . . 0.0 108.784 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.507 ' CB ' ' HB1' ' A' ' 77' ' ' ALA . 14.7 p -104.69 -29.38 10.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.751 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 59' ' ' SER . 5.5 p-10 -71.08 55.42 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.948 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.453 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -50.58 -30.07 12.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 109.524 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -63.99 -10.25 20.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.52 -0.737 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.28 56.64 2.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.375 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 t -128.0 -31.01 2.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.43 -5.64 7.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -127.0 172.67 10.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -1.147 . . . . 0.0 109.659 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.629 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -108.43 111.13 22.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.03 -1.044 . . . . 0.0 111.017 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.595 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -62.82 -178.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.992 . . . . 0.0 110.164 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HE2' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.8 -77.66 0.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 111.322 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.403 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 35.7 m-20 -54.31 -28.02 39.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.195 -0.941 . . . . 0.0 111.032 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' CG ' ' OG ' ' A' ' 70' ' ' SER . 36.1 mm-40 -66.08 -47.32 74.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 110.459 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.588 ' CZ ' HG23 ' A' ' 23' ' ' ILE . 23.9 t80 -56.5 -30.17 62.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.439 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . . . -76.92 -13.82 59.94 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.57 0.7 . . . . 0.0 109.413 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.52 -32.96 19.13 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.51 -0.744 . . . . 0.0 109.657 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 61' ' ' CYS . . . -63.55 -51.0 67.31 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 109.62 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 5.2 m-85 -47.65 -41.7 22.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.917 . . . . 0.0 109.627 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -52.07 -29.21 20.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 2.7 mt -83.89 -30.93 25.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -0.993 . . . . 0.0 108.726 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.558 ' CD1' HD11 ' A' ' 57' ' ' ILE . 8.3 mm -65.12 -57.64 10.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.454 0.645 . . . . 0.0 109.315 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.62 -36.19 2.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.593 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 45.1 mt-30 -58.06 -33.59 69.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.837 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.517 ' CG ' HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -89.12 -28.85 19.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.0 111.224 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 4.2 mt -77.4 -63.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.929 -1.107 . . . . 0.0 110.865 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.92 -12.99 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' CD ' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -122.45 -17.02 7.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 110.943 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 84' ' ' LYS . . . 58.51 25.05 57.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.564 HD13 ' CD ' ' A' ' 87' ' ' LYS . 17.1 mt -98.48 165.74 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -1.06 . . . . 0.0 110.05 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 89' ' ' ILE . 4.6 m-20 -96.19 164.1 19.27 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -69.49 162.89 40.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.186 1.624 . . . . 0.0 110.694 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.48 69.05 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.114 1.586 . . . . 0.0 111.779 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.511 ' O ' HD13 ' A' ' 60' ' ' LEU . 3.2 m170 32.41 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.772 -0.58 . . . . 0.0 111.87 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 92' ' ' PRO . 3.2 m -110.66 -164.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.171 -0.956 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.29 151.87 42.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.82 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 60.8 p -129.32 163.02 49.09 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.304 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 45.2 Cg_endo -71.39 -6.27 18.81 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.832 1.438 . . . . 0.0 110.682 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 11.5 mt-10 -95.96 -28.93 14.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.562 ' CB ' HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -94.5 -12.57 27.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 110.031 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' THR . 5.5 mt -79.36 142.17 58.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' A' ' 100' ' ' ILE . 42.4 Cg_endo -68.49 172.57 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.857 1.451 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 44.3 Cg_endo -71.56 134.97 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.966 1.508 . . . . 0.0 110.828 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.385 -0.822 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.001 0.429 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CZ3' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.76 160.45 32.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.88 -1.138 . . . . 0.0 109.897 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 98' ' ' GLU . 1.3 m -90.93 -14.47 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.712 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' ' CZ3' ' A' ' 10' ' ' TRP . 2.4 p -152.24 67.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 111.012 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -105.72 -28.85 0.2 Allowed Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.9 Cg_endo -75.84 -155.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.577 0.777 . . . . 0.0 111.459 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.98 -48.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.432 0.634 . . . . 0.0 111.905 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 9.9 mt-10 -46.35 -60.97 2.0 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -52.67 -41.46 63.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.06 . . . . 0.0 110.063 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.41 96.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.465 -0.772 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.3 ttpt -58.91 -30.43 67.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.498 -0.751 . . . . 0.0 109.801 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 5.8 m-85 -85.07 -49.65 8.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.728 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -44.09 -36.68 2.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.879 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -36.8 70.09 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.569 HG21 ' CE2' ' A' ' 74' ' ' PHE . 45.2 mt -72.32 -40.84 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.491 -0.756 . . . . 0.0 109.84 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 31.3 t80 -48.12 -37.4 15.33 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.201 -1.0 . . . . 0.0 108.538 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.09 -23.18 67.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' ILE . 3.0 mmmt -102.86 -14.2 16.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.561 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.76 -56.69 3.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.621 -0.675 . . . . 0.0 109.354 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 47.6 t0 -61.33 77.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.663 -0.648 . . . . 0.0 109.279 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' THR . 5.8 mttm -67.04 -1.63 4.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.184 -0.948 . . . . 0.0 112.236 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 90.9 m-20 -104.65 -2.78 24.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.707 -1.246 . . . . 0.0 110.631 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mmt 57.56 18.27 4.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 110.899 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.7 p30 -90.24 0.08 57.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.093 . . . . 0.0 110.091 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 83.46 12.98 77.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -147.43 105.02 3.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 110.065 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG23 ' CG2' ' A' ' 27' ' ' THR . 8.8 p -89.19 133.79 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.034 -1.041 . . . . 0.0 109.502 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -86.72 157.17 19.69 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.047 -1.033 . . . . 0.0 110.196 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -51.22 -21.81 6.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.5 mm? -72.75 -31.84 65.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -1.039 . . . . 0.0 111.352 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.5 mt-10 -83.05 -55.27 4.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.68 -1.263 . . . . 0.0 108.373 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -61.05 -10.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG3' ' CD1' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -50.55 -73.06 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -42.5 -41.27 2.91 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.1 mt -60.14 -41.94 88.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.651 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 5.7 m-30 -81.9 -32.57 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.424 -0.797 . . . . 0.0 109.308 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.62 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 32.6 mt -58.58 -26.63 63.83 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.109 -0.994 . . . . 0.0 108.649 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -70.98 -8.88 56.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.513 -0.742 . . . . 0.0 109.076 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.56 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 28.7 p -78.36 -35.66 47.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.508 -0.745 . . . . 0.0 110.195 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.01 34.12 6.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' HB3' HD21 ' A' ' 53' ' ' LEU . 10.1 mp -105.63 157.12 35.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.828 -0.807 . . . . 0.0 110.717 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 45.4 Cg_endo -75.2 178.16 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.803 1.423 . . . . 0.0 110.201 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -57.79 3.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.123 -0.986 . . . . 0.0 111.06 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -52.1 -45.32 64.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -57.86 -51.38 69.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 110.005 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 11.3 mt -55.28 -41.32 72.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.195 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.517 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 13.1 t60 -69.08 -36.04 77.15 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 57' ' ' ILE . 6.9 mt -71.65 -34.48 52.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.593 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 38.6 t-105 -65.1 -47.41 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 109.879 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -31.19 72.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.197 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 14.8 mt -71.02 -9.82 58.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 109.184 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 63' ' ' THR . 29.4 m -119.57 -36.63 3.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 109.909 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 13.0 t0 -66.06 61.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.604 -0.685 . . . . 0.0 109.672 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 61' ' ' CYS . 11.6 p -58.33 -36.03 72.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.376 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -55.33 -16.2 3.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.04 53.12 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 -34.05 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -0.44 4.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 34' ' ' PHE . 9.9 mttt -132.7 175.55 9.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -1.164 . . . . 0.0 109.988 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.593 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.8 OUTLIER -105.64 110.86 23.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.496 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -62.81 179.09 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.327 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HE3' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.31 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 110.654 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 3.8 m-20 -52.89 -43.37 66.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.979 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 22.0 mt-30 -43.6 -62.72 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.021 -1.049 . . . . 0.0 110.355 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 23' ' ' ILE . 11.9 t80 -49.17 -36.11 18.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.837 -1.164 . . . . 0.0 109.016 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.57 -6.14 29.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.421 -0.8 . . . . 0.0 109.66 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.601 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 1.1 tt -90.34 -38.55 13.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.505 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 44' ' ' PHE . . . -55.92 -39.83 72.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 110.196 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 53.1 m-85 -57.33 -29.43 63.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 45.3 t60 -63.73 -26.55 68.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.79 -48.28 4.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.651 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 82.4 mt -60.67 -33.6 55.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.734 -0.603 . . . . 0.0 110.338 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 21.0 t -72.36 -18.67 61.73 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.212 -0.93 . . . . 0.0 111.005 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -90.52 -14.71 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.024 -1.048 . . . . 0.0 111.459 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 1.4 tptt -90.37 -15.27 31.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.664 -1.272 . . . . 0.0 111.136 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 6.8 mt -90.26 -56.65 3.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 111.554 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.62 -19.74 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.924 -1.11 . . . . 0.0 110.676 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.566 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.5 OUTLIER -109.08 -16.07 14.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.754 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 60.05 36.89 91.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 2.6 mt -104.61 154.38 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.273 . . . . 0.0 109.468 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.29 165.27 15.12 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 110.598 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 47.3 Cg_endo -72.34 155.04 56.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.191 1.627 . . . . 0.0 110.236 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.509 ' O ' HD11 ' A' ' 60' ' ' LEU . 42.1 Cg_endo -69.35 -179.34 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.981 1.517 . . . . 0.0 110.003 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.479 ' O ' HD21 ' A' ' 60' ' ' LEU . 54.0 m-70 -64.46 -99.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.9 -1.125 . . . . 0.0 110.19 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.451 ' HA ' HD22 ' A' ' 60' ' ' LEU . 7.4 m -108.26 -168.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 120.987 -1.071 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 2.0 tp -61.79 148.27 43.64 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.91 0.862 . . . . 0.0 111.458 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 71.0 p -130.08 166.73 24.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.0 Cg_endo -67.86 -25.38 39.18 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.511 1.269 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -80.59 -12.01 59.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 109.101 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.601 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 32.5 ttm -103.9 -30.23 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.639 -0.663 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 96' ' ' THR . 3.0 mt -74.54 126.66 88.49 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.487 -0.758 . . . . 0.0 110.405 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.57 162.99 34.87 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.827 1.435 . . . . 0.0 110.458 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.96 154.34 47.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.028 1.541 . . . . 0.0 110.109 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.905 . . . . 0.0 110.394 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -53.67 120.4 6.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 108.963 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -64.44 -173.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.861 -1.149 . . . . 0.0 108.707 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.582 ' O ' ' CZ2' ' A' ' 10' ' ' TRP . 37.6 t 57.65 121.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.5 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t -157.41 -64.91 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.685 -1.26 . . . . 0.0 112.438 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 46.7 Cg_endo -68.42 -149.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.494 1.26 . . . . 0.0 110.82 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.71 -43.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.31 0.576 . . . . 0.0 111.516 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 6.3 mt-10 -44.66 -62.78 1.08 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 109.864 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -56.69 -30.63 63.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -70.1 -51.32 32.64 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HE2' ' CA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -57.23 -32.49 66.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.28 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.3 m-30 -83.21 -28.11 29.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.671 -0.643 . . . . 0.0 110.483 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 11.2 t0 -72.07 -32.84 67.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 2.7 mt-10 -81.85 -26.9 33.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -0.91 . . . . 0.0 108.577 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 65.4 mt -82.31 -42.15 18.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.647 -0.658 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 53.2 t80 -49.98 -25.03 2.94 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.69 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 20.1 mt -71.93 -26.96 62.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 23' ' ' ILE . 13.2 mttt -101.28 -12.59 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.539 ' CG2' HD12 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -89.05 -55.38 3.71 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 4.0 t0 -70.62 81.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.4 mttt -81.17 10.31 5.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.066 -1.021 . . . . 0.0 112.179 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 73.5 m-20 -111.78 10.46 20.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 110.024 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.1 mtm 48.19 23.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.088 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 28.6 p30 -97.85 15.79 22.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.85 52.46 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.08 112.45 4.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -1.042 . . . . 0.0 110.009 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 24' ' ' PHE . 2.3 p -88.72 133.19 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.94 -1.1 . . . . 0.0 109.889 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 40' ' ' VAL . 17.2 t -90.93 153.45 20.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 110.095 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -25.52 0.54 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.6 mt -64.88 -38.73 91.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -1.117 . . . . 0.0 111.693 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 27' ' ' THR . 11.4 mt-10 -85.13 -55.82 3.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.862 -1.149 . . . . 0.0 108.974 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -59.77 -13.74 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HG2' ' N ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -56.28 -67.59 0.29 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 109.751 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 11.7 mm-40 -45.24 -32.19 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.884 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.539 HD12 ' CG2' ' A' ' 27' ' ' THR 0.268 1.3 mt -69.89 -41.83 79.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.24 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.675 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -74.58 -29.55 61.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.055 . . . . 0.0 109.196 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD11 ' CG ' ' A' ' 41' ' ' ARG . 15.1 mt -64.4 -18.48 64.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -79.58 -8.01 58.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 108.864 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 44' ' ' PHE . 28.3 p -79.84 -23.16 42.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 110.413 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.51 -17.09 58.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.554 ' HB3' HD23 ' A' ' 53' ' ' LEU . 7.2 mp -54.82 168.62 0.48 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.698 -0.883 . . . . 0.0 110.569 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 46.1 Cg_endo -81.58 -175.1 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.933 1.491 . . . . 0.0 109.392 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -61.6 1.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.422 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 53' ' ' LEU . 17.2 m -46.89 -64.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.554 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -40.53 -44.82 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.372 -0.83 . . . . 0.0 110.666 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -58.95 -43.37 91.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -66.18 -38.55 88.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 108.889 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 74.9 t60 -66.78 -41.79 87.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.48 -0.762 . . . . 0.0 108.95 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.553 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 3.3 mt -67.2 -29.81 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.595 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 21.4 t-105 -63.93 -44.61 92.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.477 ' O ' HD13 ' A' ' 95' ' ' LEU . 5.5 t -70.29 -33.62 71.78 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 108.898 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.529 HD12 ' CA ' ' A' ' 94' ' ' VAL . 1.1 tp -67.28 -21.65 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 109.809 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 18.1 p -106.62 -29.46 9.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD2' ' CZ2' ' A' ' 58' ' ' TRP . 26.1 t0 -80.47 52.59 1.66 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 110.042 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.536 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 7.7 p -46.25 -29.83 1.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.043 0.925 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.548 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 2.3 mmtm -58.92 -17.49 24.88 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.227 0.537 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 37.33 56.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.676 -0.64 . . . . 0.0 110.612 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 9.84 6.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.521 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.14 -18.27 54.48 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.576 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 14.8 pttt -125.1 175.03 7.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.053 -1.263 . . . . 0.0 110.03 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.595 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.4 mt -111.73 118.03 34.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.942 . . . . 0.0 111.028 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.643 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -64.32 -172.02 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.181 . . . . 0.0 109.459 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.43 -80.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 111.078 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -53.13 -18.62 2.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.514 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 10.1 mm100 -74.44 -40.64 61.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 23' ' ' ILE . 30.3 t80 -65.15 -23.0 67.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.083 . . . . 0.0 109.041 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -78.4 -12.37 60.0 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.504 -0.748 . . . . 0.0 109.736 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' CD1' ' CG ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -85.69 -38.36 18.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 110.61 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 61' ' ' CYS . . . -57.06 -44.48 83.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 6.4 m-85 -60.38 -23.49 64.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 83.6 t60 -64.28 -20.33 66.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 0.0 109.611 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 1.7 mt -99.69 -31.09 11.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 109.036 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 36.2 mt -61.11 -57.32 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.175 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -39.19 -34.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.695 -0.628 . . . . 0.0 110.828 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 21.0 mt-30 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.838 -1.164 . . . . 0.0 110.714 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' ILE . 19.9 tptp -89.89 -10.31 45.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.3 mt -88.37 -58.7 2.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.073 . . . . 0.0 110.918 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.07 -25.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 0.0 110.794 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -103.62 -8.7 19.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.973 . . . . 0.0 110.422 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 50.85 20.82 4.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 4.6 mt -86.67 142.0 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.972 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 7.5 p-10 -80.16 164.55 51.87 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 38.6 Cg_endo -66.45 159.8 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.042 1.548 . . . . 0.0 110.278 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.17 58.57 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 0.0 110.616 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.558 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.4 OUTLIER 39.35 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.631 -0.668 . . . . 0.0 111.235 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 92' ' ' PRO . 5.7 m -101.67 -164.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 111.305 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -95.3 164.84 12.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.878 0.847 . . . . 0.0 111.802 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 14.6 p -133.65 171.65 8.73 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.3 Cg_endo -68.94 -36.19 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.291 1.153 . . . . 0.0 109.632 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.1 tt0 -63.4 -18.41 63.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.218 -0.926 . . . . 0.0 109.106 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.568 ' CG ' ' CD1' ' A' ' 76' ' ' LEU . 24.4 ttm -97.04 -26.42 15.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.456 -0.777 . . . . 0.0 109.526 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 96' ' ' THR . 6.0 mt -82.29 115.3 57.02 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -75.58 163.2 34.5 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.955 1.503 . . . . 0.0 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.59 94.99 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.983 1.518 . . . . 0.0 110.426 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.46 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 8.7 t90 -88.56 137.67 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 110.428 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.544 ' CG2' HG21 ' A' ' 12' ' ' VAL . 2.4 m -62.1 -31.13 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.078 -1.014 . . . . 0.0 109.127 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.544 HG21 ' CG2' ' A' ' 11' ' ' VAL . 6.2 t -103.75 159.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.588 -0.695 . . . . 0.0 109.693 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 169.25 -52.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.197 -0.939 . . . . 0.0 111.839 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 13' ' ' SER . 52.4 Cg_endo -70.51 -153.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.534 1.281 . . . . 0.0 110.819 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.23 -48.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.272 0.558 . . . . 0.0 111.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.559 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 1.6 mt-10 -50.97 -60.4 3.13 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.302 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -53.48 -36.3 61.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -67.6 -50.84 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.395 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -53.75 -29.58 40.43 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.51 -0.743 . . . . 0.0 109.546 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CZ ' ' CB ' ' A' ' 78' ' ' PHE . 10.9 m-85 -90.47 -47.85 7.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 12.9 t70 -49.76 -31.59 11.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 32.6 mt-10 -78.41 -36.23 45.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.7 mt -76.66 -39.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 70' ' ' SER . 74.7 t80 -47.21 -31.66 3.84 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.365 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.02 -31.52 71.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' ILE . 2.3 tttt -97.0 -10.18 26.71 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.553 ' CG2' HG23 ' A' ' 35' ' ' VAL . 1.5 m -90.22 -46.49 8.4 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.596 0.712 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 32' ' ' ASP . 27.6 t0 -73.47 62.25 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.227 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -45.87 -20.91 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.126 -0.983 . . . . 0.0 111.354 -178.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.484 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 7.5 m-20 -88.94 -5.15 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.929 -1.107 . . . . 0.0 110.363 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.05 44.58 29.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 14.8 p-10 -120.7 24.47 10.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.15 47.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.597 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.39 99.27 2.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -1.201 . . . . 0.0 110.639 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 27' ' ' THR . 7.4 p -90.73 142.09 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 0.0 109.354 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.28 152.47 19.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.069 -1.02 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.21 -26.49 0.93 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' SER . 71.2 mt -66.11 -41.23 90.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.474 -1.016 . . . . 0.0 110.891 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 19.9 mt-10 -78.6 -58.85 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.35 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' CG2' ' A' ' 27' ' ' THR . 1.7 p -61.08 -14.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.279 0.561 . . . . 0.0 110.141 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -45.41 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.441 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -42.71 -42.6 3.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 0.0 109.233 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.0 OUTLIER -55.7 -48.24 78.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.657 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -73.33 -38.88 65.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 76.2 mt -60.25 -21.66 62.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.48 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -73.6 -20.09 60.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.225 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 61.2 p -55.38 -24.45 29.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.21 56.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.9 mp -90.94 170.88 9.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 110.299 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 53' ' ' LEU . 46.4 Cg_endo -74.03 -159.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.85 1.447 . . . . 0.0 110.309 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -94.05 -55.7 3.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.741 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.8 m -56.7 -57.12 13.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -41.25 -46.48 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.601 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 44' ' ' PHE . 25.0 mt -60.48 -42.05 95.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.954 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.25 89.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.13 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.531 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 12.9 t60 -65.22 -32.15 73.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 4.2 mt -73.64 -27.87 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.657 ' CZ3' ' CD1' ' A' ' 69' ' ' LEU . 29.6 t-105 -64.72 -43.67 92.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.493 ' O ' HD22 ' A' ' 95' ' ' LEU . 25.5 m -67.52 -35.23 78.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.126 -0.983 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 17.9 mt -67.59 -23.06 65.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 16.2 p -102.66 -35.48 8.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.06 -1.025 . . . . 0.0 108.866 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 61.1 t0 -70.25 54.4 0.14 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -56.74 -22.29 34.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.048 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.587 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 22.6 mmmt -57.03 -16.21 6.66 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.338 0.59 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.44 48.99 8.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.0 t -128.45 -22.1 3.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.357 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.28 -11.12 14.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 13.0 mtpt -124.81 -177.06 3.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -1.116 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.657 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.8 mt -116.81 107.26 14.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.628 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -58.65 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.48 -1.388 . . . . 0.0 109.994 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -76.57 -68.1 0.63 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.373 -0.829 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -61.95 -66.97 0.46 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.369 -0.832 . . . . 0.0 112.289 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -39.83 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 0.0 111.516 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.584 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 30.9 t80 -72.39 -38.66 68.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.476 -1.39 . . . . 0.0 108.692 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 20' ' ' TYR . . . -67.04 -8.87 33.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.476 0.655 . . . . 0.0 109.554 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 0.3 OUTLIER -85.85 -45.38 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.448 -0.782 . . . . 0.0 110.02 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 61' ' ' CYS . . . -42.35 -47.34 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 66.8 m-85 -61.36 -25.7 67.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.498 ' HB2' HG23 ' A' ' 12' ' ' VAL . 66.1 t60 -62.21 -20.98 64.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.446 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.439 HD13 ' HB3' ' A' ' 60' ' ' LEU . 4.7 mt -94.92 -21.77 18.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.657 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 11.4 mt -73.4 -62.69 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -39.39 -33.47 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.811 -0.556 . . . . 0.0 110.33 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 89' ' ' ILE . 24.4 mt-30 -59.61 -36.69 76.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' ILE . 5.3 tptp -89.86 -16.57 29.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.896 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 8.0 mt -81.33 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.015 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.88 -33.15 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.495 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 2.3 mmpt? -94.93 -2.84 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.434 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 47.81 22.21 1.86 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 12.2 mt -92.76 170.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -1.192 . . . . 0.0 109.791 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -102.65 172.73 4.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 110.109 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.531 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 45.8 Cg_endo -71.13 158.73 54.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.064 1.56 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' A' ' 60' ' ' LEU . 42.0 Cg_endo -68.73 173.59 9.81 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.959 1.505 . . . . 0.0 109.502 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -74.62 -50.68 16.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.994 -1.067 . . . . 0.0 109.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.436 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 27.9 m -141.67 -159.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 3.9 mm? -82.21 176.53 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.793 0.806 . . . . 0.0 110.894 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 30.9 p -150.96 166.64 14.63 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -70.59 -12.86 31.98 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 123.575 1.303 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' THR . 2.2 mt-10 -96.89 -19.53 18.78 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.748 0.785 . . . . 0.0 109.081 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.553 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 14.1 ttm -101.44 -6.62 23.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 110.224 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.51 ' CG2' ' HD2' ' A' ' 102' ' ' PRO . 10.6 mt -86.05 112.82 48.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.545 -0.722 . . . . 0.0 110.151 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.9 Cg_endo -73.65 -29.01 11.19 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.765 1.402 . . . . 0.0 113.322 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 49.3 Cg_endo -74.75 170.3 20.64 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 122.613 0.796 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.93 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.433 0.635 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.633 ' CZ3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER 177.34 101.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.62 ' CG2' ' CD2' ' A' ' 79' ' ' HIS . 2.0 m -78.16 -14.72 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.382 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.633 ' CG1' ' CZ3' ' A' ' 10' ' ' TRP . 2.1 p -140.43 67.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 109.969 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.2 t -103.49 -27.81 0.21 Allowed Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.8 Cg_endo -76.11 -156.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 122.559 0.768 . . . . 0.0 110.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.55 -57.33 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.305 0.574 . . . . 0.0 111.625 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 13.2 mt-10 -39.78 -63.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.694 -0.629 . . . . 0.0 110.74 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' CE ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.36 -45.19 88.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -28.04 68.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.766 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 23.5 m-85 -89.38 -48.46 7.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -47.25 -34.81 6.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.573 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.5 -36.05 60.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.011 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' LYS . 41.5 mt -69.82 -39.4 77.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.442 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -48.56 -33.48 9.76 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.645 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.8 -25.37 65.55 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' ILE . 9.4 mttp -98.9 -12.73 20.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.515 HG21 ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -89.91 -54.52 4.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.563 -0.711 . . . . 0.0 109.508 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.46 90.27 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 108.666 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -83.45 -17.98 40.2 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.054 -1.029 . . . . 0.0 112.6 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -92.23 13.16 19.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.632 -1.293 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.6 mtm 53.05 36.47 22.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.1 p-10 -113.05 22.63 14.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 110.348 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' ASP . . . 47.88 26.47 4.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.85 101.1 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.88 -0.776 . . . . 0.0 109.926 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.0 p -88.93 125.37 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.979 -1.075 . . . . 0.0 109.321 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 37' ' ' GLY . 1.8 p -83.17 157.6 22.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 109.819 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.75 -25.13 0.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 38' ' ' LEU . 4.3 mp -59.63 -48.27 82.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -1.02 . . . . 0.0 111.964 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 12.2 mt-10 -78.65 -57.88 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.624 -1.298 . . . . 0.0 109.237 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.646 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 2.1 p -56.93 -16.76 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.983 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 1.4 ttt-85 -50.05 -77.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.003 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -41.12 -37.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.906 0.86 . . . . 0.0 108.954 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 40' ' ' VAL 0.251 1.0 OUTLIER -64.74 -51.02 72.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.201 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.646 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -72.68 -41.18 65.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.051 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.502 HD13 ' N ' ' A' ' 42' ' ' GLU . 87.5 mt -49.5 -24.17 1.93 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -72.71 -19.81 61.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.612 -0.68 . . . . 0.0 109.558 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.498 ' CG2' HG21 ' A' ' 81' ' ' ILE . 61.9 p -64.39 -13.86 53.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.385 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' C ' HD11 ' A' ' 49' ' ' LEU . . . 76.34 23.78 70.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 53' ' ' LEU . 6.1 mp -100.11 163.99 17.26 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 110.414 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 48.0 Cg_endo -76.18 140.73 22.63 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.039 1.547 . . . . 0.0 110.338 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -45.63 -46.58 14.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -57.37 -52.83 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.637 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -53.25 -41.5 65.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.03 . . . . 0.0 110.023 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 24.1 mt -66.2 -41.49 90.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.935 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -64.14 -41.01 97.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.519 ' NE2' HD13 ' A' ' 60' ' ' LEU . 45.3 t60 -70.63 -35.03 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 81' ' ' ILE . 4.8 mt -73.89 -22.52 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.617 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 37.5 t-105 -68.98 -44.82 72.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.534 -0.729 . . . . 0.0 109.534 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -69.83 -28.88 66.07 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.144 -0.973 . . . . 0.0 108.69 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 11.2 mt -72.86 -10.25 59.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.519 -0.738 . . . . 0.0 109.084 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 63' ' ' THR . 13.7 p -117.46 -34.4 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.736 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 23.5 t0 -65.63 60.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.454 -0.779 . . . . 0.0 109.961 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 61' ' ' CYS . 0.4 OUTLIER -58.98 -27.81 65.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -68.35 -5.81 20.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.059 -1.026 . . . . 0.0 110.771 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 65' ' ' ASP . 3.4 p-10 37.85 54.78 1.59 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.45 -0.781 . . . . 0.0 111.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 -24.66 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.102 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.5 -9.89 8.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 62.8 mttp -125.0 -174.47 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 0.0 110.127 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -115.53 113.26 23.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.145 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -77.12 -177.24 4.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.114 . . . . 0.0 110.276 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.8 m-20 -44.25 -33.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.559 ' CD ' ' N ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -58.36 -40.84 83.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 1.6 t80 -66.52 -41.54 88.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -63.57 -10.86 20.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.832 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -80.2 -43.27 21.79 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -64.4 -52.18 59.49 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 5.5 m-85 -49.05 -39.41 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.78 . . . . 0.0 109.618 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.62 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 33.6 t60 -54.67 -25.68 28.61 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 60' ' ' LEU . 6.9 mt -90.54 -23.82 20.79 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 17.3 mm -73.86 -56.58 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.806 -0.757 . . . . 0.0 108.985 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -46.79 -28.19 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.526 -0.734 . . . . 0.0 110.027 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -77.2 -22.59 52.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.102 -0.999 . . . . 0.0 110.187 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.469 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -91.63 -30.96 16.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.524 ' CD2' HD12 ' A' ' 49' ' ' LEU . 3.9 mt -81.02 -58.93 2.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.066 -1.021 . . . . 0.0 111.018 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.529 HG21 ' CE ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -80.18 -42.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.953 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -94.34 -35.45 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 111.202 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 85.84 3.43 85.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 2.5 mt -66.86 165.5 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.186 -1.185 . . . . 0.0 109.885 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -102.31 164.12 16.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 0.0 110.292 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.477 ' HD3' HD12 ' A' ' 53' ' ' LEU . 47.5 Cg_endo -74.51 145.33 33.34 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' O ' HD11 ' A' ' 60' ' ' LEU . 43.9 Cg_endo -71.45 177.52 6.64 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.993 1.522 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.458 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -64.7 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 110.01 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 5.2 m -109.81 -167.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 110.274 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -81.88 175.33 10.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 111.299 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 2.2 p -139.71 179.44 1.28 Allowed Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.5 Cg_endo -71.1 -20.39 28.69 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.189 1.1 . . . . 0.0 109.626 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 11' ' ' VAL . 4.8 mt-10 -75.01 -28.34 60.46 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 95' ' ' LEU . 2.9 mtt -80.77 -49.27 11.35 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.024 0.916 . . . . 0.0 108.733 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 96' ' ' THR . 3.2 mt -56.71 136.31 78.23 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.779 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 39.3 Cg_endo -66.49 175.42 5.13 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.952 1.501 . . . . 0.0 109.949 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 41.2 Cg_endo -67.0 72.84 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.802 1.422 . . . . 0.0 110.639 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.209 0.528 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 99' ' ' MET . 6.8 t90 -162.64 140.23 8.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.125 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 12' ' ' VAL . 1.2 m -72.21 -156.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.103 -0.998 . . . . 0.0 109.797 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.536 ' C ' ' O ' ' A' ' 11' ' ' VAL . 2.6 p 15.21 69.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -103.96 -35.68 0.2 Allowed Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -75.85 -153.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 122.825 0.908 . . . . 0.0 111.999 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' ALA . . . -28.01 -52.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.594 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 34.7 mt-10 -38.47 -62.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.667 -0.645 . . . . 0.0 110.273 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -55.92 -34.58 65.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.081 -1.012 . . . . 0.0 109.44 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -68.95 -49.12 60.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 110.137 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -60.44 -30.82 69.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 7.8 m-30 -81.52 -48.57 11.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.516 -0.74 . . . . 0.0 109.813 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.487 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 25.1 t0 -46.39 -31.53 2.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.95 . . . . 0.0 109.046 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -78.51 -36.64 44.68 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.573 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 43.6 mt -74.47 -40.3 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 58.7 t80 -50.72 -24.52 3.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.177 -0.952 . . . . 0.0 108.876 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 38.6 mt -72.37 -24.74 61.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' ILE . 72.9 mttt -102.11 -13.64 17.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 53.9 t0 -68.35 91.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 109.516 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -88.39 0.9 55.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.041 -1.037 . . . . 0.0 111.747 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 34.9 m-20 -110.36 5.27 21.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.884 -1.135 . . . . 0.0 110.93 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 44.97 26.19 0.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 109.957 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 34' ' ' PHE . 2.5 p30 -90.18 -4.9 56.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.421 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.7 -16.45 23.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD2' ' CB ' ' A' ' 68' ' ' LYS . 2.3 p90 -148.82 151.64 35.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.267 -1.137 . . . . 0.0 110.649 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p -97.42 128.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 38' ' ' LEU . 1.3 t -79.56 151.04 30.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.329 -1.482 . . . . 0.0 109.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.25 -25.9 0.31 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 7.4 mp -62.02 -39.24 91.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -1.086 . . . . 0.0 111.288 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 6.9 mt-10 -86.63 -55.23 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.481 -1.387 . . . . 0.0 109.513 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -58.82 -15.63 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.635 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -44.34 -72.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 110.308 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 4.7 tt0 -44.39 -44.19 8.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.5 mt -58.27 -48.63 84.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.586 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -71.17 -27.7 63.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 42' ' ' GLU . 34.9 mt -70.87 -16.78 62.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 109.87 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 8.4 mtpp -86.95 -4.87 59.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 81.9 p -72.01 -15.06 62.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.872 . . . . 0.0 111.126 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.89 5.15 83.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 8.6 mp -77.19 173.91 6.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -80.55 -160.33 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.85 1.448 . . . . 0.0 110.075 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -93.87 -49.81 5.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.005 -1.06 . . . . 0.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -63.81 -51.96 62.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.554 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -46.69 -52.39 13.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 111.04 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.581 ' CD1' ' CD2' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.8 -43.47 76.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.942 -1.099 . . . . 0.0 109.307 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.37 85.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.677 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 67.4 t60 -71.24 -37.75 71.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.573 ' CD1' ' CD1' ' A' ' 81' ' ' ILE . 8.6 mt -70.46 -26.55 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.609 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 38.4 t-105 -63.29 -39.37 94.38 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.836 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.416 ' O ' HD22 ' A' ' 95' ' ' LEU . 2.3 t -72.16 -29.05 63.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.408 -0.808 . . . . 0.0 109.566 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . 3.8 mt -72.6 -18.85 61.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.26 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 58' ' ' TRP . 21.2 p -112.19 -28.31 8.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 109.108 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.54 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 30.6 t0 -78.09 52.25 1.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.462 -0.774 . . . . 0.0 109.662 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -52.35 -22.08 4.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 109.755 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -45.25 -26.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.735 0.778 . . . . 0.0 109.117 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.81 50.18 10.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.562 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.455 ' SG ' ' HE2' ' A' ' 68' ' ' LYS . 11.9 t -150.01 -30.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.577 -0.702 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.03 13.91 2.34 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.239 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.668 ' CB ' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -132.4 177.3 7.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.083 -1.245 . . . . 0.0 110.044 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.609 HD12 ' CZ3' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -120.29 94.04 4.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.297 -179.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -44.77 173.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.725 -1.235 . . . . 0.0 110.112 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.58 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.63 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 0.0 111.055 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 23.6 p-10 -53.85 -30.9 47.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.04 -1.037 . . . . 0.0 110.399 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 8.1 mt-30 -56.32 -53.45 57.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.472 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CZ ' HG23 ' A' ' 23' ' ' ILE . 42.1 t80 -50.01 -31.9 13.95 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -76.75 -11.73 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 109.795 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.532 ' CD2' ' HG3' ' A' ' 99' ' ' MET . 6.0 tt -89.18 -21.72 23.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 110.458 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 80' ' ' LEU . . . -72.9 -53.24 11.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.044 -1.035 . . . . 0.0 109.577 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 6.8 m-85 -49.54 -32.39 12.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.927 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 85.1 t60 -55.23 -26.18 37.94 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.509 -0.745 . . . . 0.0 109.453 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -93.8 -32.53 13.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 2.8 mm -69.27 -54.43 19.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.9 -30.65 1.04 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.85 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.2 mp0 -78.08 -19.27 54.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 110.428 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 81' ' ' ILE . 22.0 tptp -90.41 -21.9 21.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 110.673 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.4 mt -89.45 -59.45 2.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.102 -0.999 . . . . 0.0 110.527 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.534 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.4 -25.02 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 111.425 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' CG ' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.05 -14.82 9.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.764 -1.21 . . . . 0.0 111.376 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 58.49 28.03 61.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 ' CG ' ' A' ' 87' ' ' LYS . 1.6 mt -88.05 156.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -1.17 . . . . 0.0 109.668 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' N ' HG23 ' A' ' 89' ' ' ILE . 10.9 m-20 -89.54 164.85 27.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.52 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 47.3 Cg_endo -73.51 158.18 48.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.954 1.502 . . . . 0.0 110.451 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HG3' ' HE1' ' A' ' 99' ' ' MET . 47.0 Cg_endo -72.29 58.29 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.697 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.581 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 5.9 m170 45.65 -98.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 110.588 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.46 ' HA ' HD23 ' A' ' 60' ' ' LEU . 12.9 m -109.1 -163.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 111.249 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.47 155.52 40.59 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.651 0.738 . . . . 0.0 111.635 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 59.0 p -133.56 166.58 28.23 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -68.18 -28.94 33.59 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.446 1.235 . . . . 0.0 109.848 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.33 -9.83 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.099 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.532 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 25.3 ttm -106.33 -28.17 10.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.3 mt -71.52 115.13 34.2 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.497 -0.752 . . . . 0.0 110.572 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 122.17 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.99 -47.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.886 1.466 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.371 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.236 0.541 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.524 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 9.0 t90 -174.15 155.33 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.578 ' O ' ' C ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -81.25 -163.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.818 -1.176 . . . . 0.0 109.221 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.578 ' C ' ' O ' ' A' ' 11' ' ' VAL . 2.7 p 12.15 61.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.235 0.541 . . . . 0.0 112.013 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.9 m -102.35 -33.03 0.22 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -74.97 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 122.729 0.857 . . . . 0.0 110.948 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.86 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.295 0.569 . . . . 0.0 111.706 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 22.6 mt-10 -46.67 -61.02 2.02 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.26 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -53.42 -37.11 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.94 -1.1 . . . . 0.0 109.745 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -68.96 -49.99 53.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.449 -0.782 . . . . 0.0 109.392 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -55.3 -29.72 58.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.525 -0.734 . . . . 0.0 109.456 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.673 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 7.0 m-85 -88.36 -47.61 8.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.003 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 4.0 t70 -49.27 -33.72 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.411 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 3.5 mm-40 -77.3 -39.26 48.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.425 -0.797 . . . . 0.0 108.913 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.58 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 30.6 mt -67.37 -37.15 78.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.435 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.611 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 57.8 t80 -48.92 -36.46 17.33 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.278 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.64 -26.97 68.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 10.7 mtmt -100.86 -14.27 18.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.577 ' CG2' HG23 ' A' ' 35' ' ' VAL . 1.1 m -89.18 -55.11 3.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 30.7 t70 -72.08 88.36 1.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 109.07 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' ' OE2' ' A' ' 39' ' ' GLU . 4.1 mttm -86.11 -6.07 59.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.962 -1.086 . . . . 0.0 111.665 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' MET . 66.7 m-20 -91.23 12.42 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.873 -1.142 . . . . 0.0 110.709 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' ASP . 7.7 mmt 41.69 35.54 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.39 12.18 20.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.177 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.04 12.78 68.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CE2' ' OG ' ' A' ' 70' ' ' SER . 1.1 m-85 -148.12 112.17 5.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 110.42 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 27' ' ' THR . 14.1 p -89.43 135.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 108.9 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.454 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.23 152.3 22.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.371 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -46.82 -24.62 1.96 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -68.94 -30.31 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.363 -1.08 . . . . 0.0 110.799 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.3 mt-10 -86.67 -60.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.793 -1.192 . . . . 0.0 108.066 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.2 p -56.15 -16.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 4.5 ttt180 -42.24 -73.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 110.016 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' N ' HD12 ' A' ' 45' ' ' LEU . 2.6 mt-10 -44.32 -46.87 9.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 108.777 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.547 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.5 mt -55.86 -42.71 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.105 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.647 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 2.9 m-30 -80.58 -24.16 39.37 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.566 -0.709 . . . . 0.0 109.38 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 42' ' ' GLU . 43.1 mt -73.5 -19.77 60.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.294 -0.879 . . . . 0.0 108.848 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 34.6 mtpt -81.79 -9.52 59.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.424 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 52.0 p -68.41 -17.72 64.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.812 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.02 61.88 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 7.5 mp -102.64 171.61 5.08 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.674 -0.898 . . . . 0.0 110.372 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 48.3 Cg_endo -80.92 -163.95 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.866 1.456 . . . . 0.0 109.943 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -62.38 1.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.957 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -45.95 -42.86 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 1.2 tp -56.48 -55.58 31.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 19.4 mt -57.24 -36.92 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.385 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.56 76.95 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.842 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 6.3 t60 -66.29 -25.25 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 HG22 ' CG1' ' A' ' 81' ' ' ILE . 1.8 mt -82.11 -32.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.608 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 20.3 t-105 -62.81 -38.67 91.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 p -76.0 -25.4 55.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.576 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 7.0 mt -77.08 -9.63 58.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.219 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 58' ' ' TRP . 16.4 p -116.18 -29.37 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.146 -0.971 . . . . 0.0 109.238 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -74.48 52.54 0.5 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.51 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 1.4 p -51.86 -28.92 17.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.123 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HG3' ' CG ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -59.06 -15.22 12.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 0.0 110.414 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 43.88 55.68 5.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.98 5.92 5.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.51 -12.12 61.89 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HD3' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -120.45 -172.68 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -1.196 . . . . 0.0 110.493 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.8 OUTLIER -122.99 102.37 7.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.4 -0.812 . . . . 0.0 109.783 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.558 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -58.84 -172.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.447 -1.408 . . . . 0.0 109.374 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.611 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.95 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.958 -1.089 . . . . 0.0 109.991 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' OD2' ' CH2' ' A' ' 10' ' ' TRP . 5.0 t70 -43.73 -32.8 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.386 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -59.68 -57.38 13.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 110.323 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 4.4 t80 -50.49 -30.38 12.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.944 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.33 -6.96 53.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -84.89 -40.49 17.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 44' ' ' PHE . . . -64.09 -38.18 90.14 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.743 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.673 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 3.7 m-85 -58.35 -31.13 67.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.181 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 81.1 t60 -61.21 -27.76 68.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.151 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.05 -57.59 2.31 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 40.3 mt -47.53 -31.22 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.486 0.66 . . . . 0.0 109.391 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 6.8 t -58.88 -53.49 57.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.728 -0.608 . . . . 0.0 110.935 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -66.85 -7.44 21.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.97 . . . . 0.0 110.697 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' CB ' HD22 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -90.72 -12.63 36.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.005 . . . . 0.0 110.897 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 47' ' ' THR . 6.3 mt -90.63 -66.78 0.9 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 111.204 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.91 -34.29 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.875 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 7.9 mmpt? -89.36 -25.3 21.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.945 . . . . 0.0 110.36 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 67.77 5.46 38.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 23.5 mt -72.87 153.1 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 120.914 -1.345 . . . . 0.0 110.06 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.521 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -82.21 176.77 3.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.739 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 42.2 Cg_endo -70.81 168.31 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.984 1.518 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' VAL . 52.8 Cg_endo -78.84 38.37 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.048 1.552 . . . . 0.0 111.33 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 55.97 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.06 . . . . 0.0 111.043 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' CA ' HD22 ' A' ' 60' ' ' LEU . 12.2 m -116.83 -161.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.68 -1.262 . . . . 0.0 111.795 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 2.9 mm? -96.45 149.18 22.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.524 ' OG1' ' HG3' ' A' ' 99' ' ' MET . 0.8 OUTLIER -117.19 173.46 3.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.3 Cg_endo -72.91 -12.17 26.02 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.593 1.312 . . . . 0.0 110.153 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -97.39 -7.37 31.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.676 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.569 ' CG ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -116.1 10.84 15.11 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.053 -1.029 . . . . 0.0 108.955 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 96' ' ' THR 0.25 19.5 mt -106.48 138.24 19.67 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.638 -0.663 . . . . 0.0 110.828 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 48.3 Cg_endo -75.69 134.65 16.93 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 103' ' ' SER . 45.2 Cg_endo -73.13 107.16 2.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.877 1.461 . . . . 0.0 110.424 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 102' ' ' PRO . 1.4 m . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.044 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -124.53 144.88 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.471 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' A' ' 12' ' ' VAL . 1.5 m -66.1 -42.4 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.916 0.865 . . . . 0.0 109.31 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 6.1 p -111.99 159.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER 171.28 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.684 -1.26 . . . . 0.0 111.696 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 13' ' ' SER . 44.2 Cg_endo -67.92 -149.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.528 1.278 . . . . 0.0 110.612 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.69 -44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.266 0.555 . . . . 0.0 111.813 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.5 mt-10 -53.08 -62.09 1.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -53.01 -37.75 61.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.013 . . . . 0.0 109.915 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.87 64.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.792 . . . . 0.0 109.696 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.1 ttpt -53.37 -29.27 33.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.09 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 3.7 m-85 -91.07 -52.92 4.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 110.102 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 30.9 t70 -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.862 . . . . 0.0 109.551 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -75.26 -37.35 61.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.479 -0.763 . . . . 0.0 108.964 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' LYS . 64.7 mt -74.27 -38.15 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.441 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 74.8 t80 -48.65 -40.11 26.64 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.913 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -64.4 -23.48 67.3 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.459 -0.897 . . . . 0.0 108.721 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' ILE . 37.6 mttt -102.62 -11.27 18.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.71 . . . . 0.0 109.134 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.526 ' CG2' ' HB ' ' A' ' 40' ' ' VAL . 1.6 m -88.87 -54.78 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 21.4 t0 -68.0 89.5 0.3 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 26' ' ' LYS . 2.3 mttt -93.55 -12.43 29.6 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.998 -1.064 . . . . 0.0 112.591 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 31' ' ' MET . 25.5 p-10 -96.16 -12.39 24.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.61 -1.306 . . . . 0.0 110.755 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 62.0 63.76 1.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 27.2 p30 -120.14 -4.42 10.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.752 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.55 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 122.77 -41.56 1.78 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -140.22 154.07 46.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.961 . . . . 0.0 109.042 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 39' ' ' GLU . 2.1 p -88.25 127.21 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -79.49 149.56 31.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.348 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -40.17 -27.84 0.15 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -59.13 -46.06 89.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.847 -0.796 . . . . 0.0 111.562 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.569 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 2.2 mt-10 -81.13 -52.41 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.404 -1.435 . . . . 0.0 108.7 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -65.27 -10.38 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.796 0.808 . . . . 0.0 109.384 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.8 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 110.692 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -43.19 -37.28 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 40' ' ' VAL . 1.4 mt -62.35 -50.11 81.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.661 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -73.5 -33.83 64.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 108.902 178.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.444 HD13 ' HG2' ' A' ' 41' ' ' ARG . 91.7 mt -65.1 -16.79 63.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.791 . . . . 0.0 109.367 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -86.76 -11.58 50.63 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.425 -0.797 . . . . 0.0 109.783 179.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 68.1 p -68.25 -17.87 64.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.51 13.95 69.32 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 49' ' ' LEU . 10.4 mp -84.26 166.52 32.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.974 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -77.19 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.086 1.572 . . . . 0.0 109.271 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -94.54 -70.82 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.848 -1.157 . . . . 0.0 110.323 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 51' ' ' SER . 1.0 OUTLIER -42.38 -57.59 2.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.567 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 1.3 tp -43.5 -52.25 6.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.894 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 49' ' ' LEU . 1.2 tp -57.66 -46.57 84.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.022 . . . . 0.0 109.503 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.9 -33.29 75.37 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.584 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 70.7 t60 -73.04 -43.84 61.51 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.56 ' CG2' ' CZ ' ' A' ' 44' ' ' PHE . 3.1 mt -63.41 -24.06 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 61.9 t-105 -66.59 -52.26 47.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.94 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.495 ' O ' HD21 ' A' ' 95' ' ' LEU . 27.8 t -63.85 -33.94 76.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 3.7 tp -64.46 -32.19 73.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.633 -0.667 . . . . 0.0 109.731 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 17.6 p -96.02 -36.25 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.721 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 55.3 t0 -68.03 56.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.523 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.6 -31.05 70.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.121 -0.987 . . . . 0.0 109.65 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -58.55 -15.12 9.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 44.18 55.08 5.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 110.158 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 -39.85 2.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.16 -13.06 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 34' ' ' PHE . 3.5 mttm -139.71 -169.45 2.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.325 -1.103 . . . . 0.0 109.315 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 3.6 mt -108.5 122.69 47.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 111.304 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.562 ' CB ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -73.82 -172.97 1.4 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.05 -1.031 . . . . 0.0 109.178 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.16 -89.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.75 -1.219 . . . . 0.0 110.282 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -47.84 -36.28 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 110.105 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.562 ' HG3' ' CB ' ' A' ' 70' ' ' SER . 5.5 mm-40 -60.05 -35.06 74.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.997 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HA ' ' CD2' ' A' ' 69' ' ' LEU . 25.9 t80 -71.09 -32.11 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 108.918 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -69.18 -8.12 42.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.551 ' CD2' ' HG3' ' A' ' 99' ' ' MET . 3.9 tt -90.42 -36.92 14.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 110.54 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 81' ' ' ILE . . . -55.22 -46.15 75.95 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.002 -1.061 . . . . 0.0 109.716 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 11.5 m-85 -60.43 -34.38 73.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 110.162 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 76.7 t60 -53.15 -21.43 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.802 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 60' ' ' LEU . 4.4 mt -98.18 -24.78 15.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 0.0 108.784 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.661 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 13.1 mt -69.94 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' ILE . 9.4 t -40.98 -32.14 0.22 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.704 -0.623 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -75.16 -24.99 57.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.919 -1.113 . . . . 0.0 110.314 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ILE . 20.5 tptt -90.07 -18.0 26.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 111.331 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.3 mt -88.76 -62.8 1.4 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.953 -1.092 . . . . 0.0 111.282 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.527 HG23 HD13 ' A' ' 86' ' ' ILE . 17.0 mm -92.7 -19.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.112 -0.993 . . . . 0.0 111.337 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 1.5 mmpt? -108.43 -7.86 15.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.989 -1.069 . . . . 0.0 110.843 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.07 20.91 4.95 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 6.5 mt -90.32 134.95 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.2 p-10 -71.38 169.92 13.65 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.872 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 42.9 Cg_endo -71.43 155.79 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.846 1.445 . . . . 0.0 110.644 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.506 ' HD2' HD22 ' A' ' 60' ' ' LEU . 40.4 Cg_endo -67.53 59.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.584 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER 37.32 -93.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.673 -0.642 . . . . 0.0 111.617 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.479 ' CA ' HD13 ' A' ' 60' ' ' LEU . 13.1 m -106.92 -164.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.249 -0.907 . . . . 0.0 111.476 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -76.28 163.34 27.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.793 0.806 . . . . 0.0 111.256 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 50.5 p -140.57 167.02 19.15 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -69.4 -26.65 29.07 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.434 1.229 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 11' ' ' VAL . 16.1 mp0 -79.44 -20.14 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 108.886 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.551 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 29.9 ttm -98.29 -6.21 31.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.644 -0.66 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.469 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 38.5 mt -102.88 107.81 56.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.397 -0.814 . . . . 0.0 110.428 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 42.1 Cg_endo -73.27 -29.61 11.26 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.897 1.472 . . . . 0.0 112.942 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.4 Cg_endo -71.6 -170.75 0.55 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.559 0.768 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.168 0.509 . . . . 0.0 110.188 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER 60.5 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.802 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 12' ' ' VAL . 1.5 m -71.67 -159.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.009 -1.057 . . . . 0.0 109.197 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 11' ' ' VAL . 9.9 t 49.1 101.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.064 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.29 -67.35 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.744 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.768 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 48.8 Cg_endo -67.97 -149.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.366 1.193 . . . . 0.0 112.068 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.79 -51.06 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.963 -0.461 . . . . 0.0 112.142 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -40.34 -61.98 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 110.672 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -56.59 -32.53 65.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.807 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.15 -48.43 43.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 109.749 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -29.66 69.33 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.683 0.754 . . . . 0.0 109.51 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.0 m-30 -84.39 -45.76 12.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.613 -0.679 . . . . 0.0 110.681 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -54.91 -39.89 69.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.815 -1.178 . . . . 0.0 109.352 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.41 -50.35 46.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.29 -0.881 . . . . 0.0 109.072 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 26' ' ' LYS . 65.9 mt -63.83 -39.08 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.151 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.607 ' CZ ' ' HG2' ' A' ' 71' ' ' LYS . 85.0 t80 -46.74 -36.33 7.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.584 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.79 -21.24 64.34 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.383 -0.823 . . . . 0.0 109.163 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 12.2 mttt -101.14 -11.46 19.55 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.585 0.707 . . . . 0.0 109.162 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.575 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -89.83 -50.37 6.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.535 0.683 . . . . 0.0 109.801 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 40.1 t0 -66.52 71.04 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.572 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 27' ' ' THR . 3.6 mptp? -62.23 -12.99 23.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.273 -0.892 . . . . 0.0 111.432 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 74.5 m-20 -93.98 -0.31 55.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.911 -1.118 . . . . 0.0 110.474 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.0 mtm 45.29 27.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.813 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.57 ' OD2' ' CZ ' ' A' ' 34' ' ' PHE . 12.1 p-10 -90.22 2.86 54.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.6 12.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.711 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 38.9 p90 -150.47 162.51 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.143 . . . . 0.0 110.525 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 39' ' ' GLU . 2.4 p -99.86 146.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.445 -0.785 . . . . 0.0 110.995 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.473 ' O ' HG11 ' A' ' 40' ' ' VAL . 80.6 p -94.57 155.16 17.03 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' ' CH2' ' A' ' 58' ' ' TRP . . . -52.94 -18.41 5.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 38' ' ' LEU . 5.8 mt -73.5 -30.46 63.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 111.024 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 39.2 mt-10 -87.68 -60.16 2.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' HB ' ' CG2' ' A' ' 27' ' ' THR . 1.4 p -54.3 -17.44 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.672 0.749 . . . . 0.0 109.659 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -46.66 -75.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.315 -0.866 . . . . 0.0 110.087 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.8 mt-10 -44.57 -37.29 3.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.551 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.524 HD11 ' CG2' ' A' ' 27' ' ' THR . 1.1 mt -61.6 -46.94 95.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.644 -0.66 . . . . 0.0 109.392 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 78' ' ' PHE . 0.7 OUTLIER -79.76 -27.32 40.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 109.469 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 42' ' ' GLU . 62.2 mt -60.07 -16.7 33.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.858 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mtpp -80.39 -25.19 39.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.707 -0.62 . . . . 0.0 109.938 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' CG2' HG23 ' A' ' 81' ' ' ILE . 69.9 p -52.63 -26.44 13.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.9 -11.56 71.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.6 mp -67.96 167.28 17.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.465 -1.02 . . . . 0.0 110.136 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -72.15 153.37 56.99 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.855 1.45 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 52' ' ' THR . 19.0 t -59.04 -63.2 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.605 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 51' ' ' SER . 51.7 m -40.07 -48.66 2.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.548 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.39 -56.49 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.936 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 81' ' ' ILE . 35.2 mt -54.22 -36.88 63.97 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.264 -0.897 . . . . 0.0 109.052 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.56 85.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.445 ' NE2' HD13 ' A' ' 60' ' ' LEU . 23.1 t60 -68.08 -26.6 65.91 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 57' ' ' ILE . 3.3 mt -76.64 -29.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.63 ' CZ3' ' CG ' ' A' ' 69' ' ' LEU . 50.2 t-105 -64.34 -45.85 86.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.179 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.423 ' O ' HD22 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -70.52 -37.58 74.13 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.564 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 5.3 mt -66.29 -14.57 62.22 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD2' ' A' ' 69' ' ' LEU . 17.2 t -110.04 -41.69 4.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.771 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.8 t0 -62.92 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.667 -0.646 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 61' ' ' CYS . 4.4 p -65.06 -35.49 81.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.11 -0.994 . . . . 0.0 110.36 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -56.28 -17.05 6.5 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.924 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 49.63 52.95 13.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.78 8.85 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.136 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.24 27.48 57.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -150.52 173.6 13.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -1.111 . . . . 0.0 110.036 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' CG ' ' CZ3' ' A' ' 58' ' ' TRP . 1.1 mt -114.99 93.37 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.551 ' HA ' ' CB ' ' A' ' 34' ' ' PHE . 21.0 p -50.73 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.463 -0.773 . . . . 0.0 110.635 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -68.19 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.94 -1.1 . . . . 0.0 111.111 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 73' ' ' GLN . 2.3 p30 -42.57 -28.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 110.825 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.562 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 14.9 mt-30 -64.11 -59.17 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.072 -1.017 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 27' ' ' THR . 41.9 t80 -45.74 -29.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.834 -1.167 . . . . 0.0 109.778 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . . . -80.41 -13.82 58.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -89.87 -34.23 16.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.529 -0.732 . . . . 0.0 110.313 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 44' ' ' PHE . . . -58.58 -46.93 85.88 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.904 -1.123 . . . . 0.0 110.379 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 10.6 m-85 -59.39 -31.61 69.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.186 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 40.1 t60 -57.43 -25.8 60.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 109.927 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.31 -29.48 18.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 1.3 mm -74.09 -50.33 28.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.592 0.711 . . . . 0.0 109.1 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -27.31 33.33 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.638 -0.664 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -72.59 -24.59 61.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 0.0 110.269 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -29.03 20.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 111.421 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.516 ' CD2' HD11 ' A' ' 49' ' ' LEU . 3.9 mt -76.79 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.978 -1.077 . . . . 0.0 110.832 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -93.8 -15.64 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.428 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 89' ' ' ILE . 1.3 mptt -117.45 -11.54 10.52 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 51.68 21.97 7.76 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 87' ' ' LYS . 18.5 mt -89.94 143.97 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.533 -0.981 . . . . 0.0 109.718 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.0 m-20 -82.33 165.74 40.76 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 38.3 Cg_endo -66.37 157.5 59.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.053 1.554 . . . . 0.0 110.821 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' VAL . 44.9 Cg_endo -72.69 56.56 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.196 1.629 . . . . 0.0 111.134 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.474 ' O ' HD11 ' A' ' 60' ' ' LEU . 5.4 m-70 38.12 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 111.25 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 92' ' ' PRO . 6.5 m -106.86 -170.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.117 -0.989 . . . . 0.0 111.286 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 4.1 mm? -75.37 167.83 21.15 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.927 0.87 . . . . 0.0 111.863 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 23.2 p -145.5 166.61 16.95 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.4 Cg_endo -69.52 -29.18 25.44 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.479 1.252 . . . . 0.0 109.831 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' VAL . 1.5 mt-10 -75.33 -20.32 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 108.79 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.553 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 6.5 ttm -94.73 -46.6 6.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 110.501 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 96' ' ' THR . 1.6 mt -51.82 142.77 24.01 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.409 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.836 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 57.0 Cg_endo -70.96 -118.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 O-C-N 123.964 1.507 . . . . 0.0 108.249 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.836 ' CD ' ' HB2' ' A' ' 101' ' ' PRO . 47.0 Cg_endo -70.52 -165.4 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 121.845 1.694 . . . . 0.0 110.164 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.12 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.282 0.563 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.584 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -146.17 157.08 43.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.944 -1.097 . . . . 0.0 110.365 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.575 ' CG1' ' O ' ' A' ' 98' ' ' GLU . 2.3 m -89.96 -159.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.011 -1.055 . . . . 0.0 111.413 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.543 HG11 ' CG2' ' A' ' 11' ' ' VAL . 8.6 p 34.87 62.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 111.362 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -102.42 -39.61 0.21 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 0.0 113.222 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -78.94 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.109 1.057 . . . . 0.0 112.029 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.83 -53.16 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 12.8 mt-10 -39.53 -58.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.476 -0.765 . . . . 0.0 110.315 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -54.49 -38.3 66.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.019 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.52 -47.09 74.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -62.51 -29.15 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 17.5 m-85 -85.94 -38.27 18.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.483 -0.761 . . . . 0.0 109.589 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -53.53 -39.72 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.082 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.43 -41.71 75.95 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.423 -0.798 . . . . 0.0 109.042 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.6 mt -66.5 -40.2 85.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 60.6 t80 -48.56 -36.89 16.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.162 -0.961 . . . . 0.0 108.799 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.32 -21.85 66.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -99.92 -14.88 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.591 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.6 -55.13 3.77 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.565 0.698 . . . . 0.0 109.621 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -66.33 76.73 0.1 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.671 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -61.91 -9.68 7.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.0 111.449 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 11.2 m-20 -105.16 -4.51 21.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.789 -1.195 . . . . 0.0 110.415 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.524 ' HA ' ' CE ' ' A' ' 31' ' ' MET . 1.0 OUTLIER 57.87 25.39 11.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 11.9 p30 -92.59 19.28 7.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.58 13.54 58.84 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.62 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -151.02 108.25 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -1.086 . . . . 0.0 110.867 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.1 p -89.11 140.85 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.472 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 45.6 t -96.75 161.62 13.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.771 -1.205 . . . . 0.0 110.632 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 41' ' ' ARG . . . -55.21 -16.74 9.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.506 ' N ' HD23 ' A' ' 38' ' ' LEU . 4.0 mm? -74.86 -29.7 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 35' ' ' VAL . 17.5 mt-10 -91.92 -64.02 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.999 -1.063 . . . . 0.0 108.828 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HB ' ' CG2' ' A' ' 27' ' ' THR . 1.3 p -52.27 -20.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.012 0.91 . . . . 0.0 109.579 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -41.71 -60.53 1.32 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.672 -0.643 . . . . 0.0 110.977 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -58.06 -41.39 83.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.924 -1.11 . . . . 0.0 108.975 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.52 HD12 ' CG2' ' A' ' 27' ' ' THR . 1.2 mt -56.56 -36.18 47.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.366 0.603 . . . . 0.0 109.414 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.651 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.77 -23.03 25.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.865 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 25.8 mt -78.51 -23.99 46.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 109.219 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.06 -4.38 58.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.736 . . . . 0.0 109.987 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 66.6 p -72.94 -15.78 61.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.02 18.51 46.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 9.0 mp -95.74 172.72 4.97 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.763 -0.845 . . . . 0.0 110.366 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -84.68 -157.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.156 1.608 . . . . 0.0 109.76 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.982 -1.074 . . . . 0.0 110.639 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -59.1 -54.68 44.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.0 -42.25 5.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 0.0 110.407 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 1.1 mp -62.97 -52.5 62.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 109.537 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.51 70.13 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 67.1 t60 -73.44 -32.76 64.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.621 ' CG2' ' CZ ' ' A' ' 44' ' ' PHE . 5.2 mt -77.34 -29.86 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.543 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 55.5 t-105 -63.97 -43.84 94.56 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.831 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -71.85 -28.95 63.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 11.4 mt -71.42 -11.46 60.9 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.543 ' SG ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 t -118.87 -41.7 2.76 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.474 -0.766 . . . . 0.0 109.316 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.07 69.17 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.9 p -59.89 -37.56 79.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.653 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -59.39 -13.9 10.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.452 -0.78 . . . . 0.0 109.922 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.9 p-10 38.62 50.2 1.55 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.423 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -10.08 9.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.567 -0.708 . . . . 0.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.8 -11.72 27.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 mttm -115.96 -171.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -1.137 . . . . 0.0 110.098 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.543 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -129.91 108.67 10.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -53.66 -170.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -78.92 -78.29 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.06 . . . . 0.0 110.515 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -44.34 -46.47 9.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 76' ' ' LEU . 2.1 mt-30 -50.84 -52.98 36.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.1 t80 -44.73 -34.85 2.41 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.212 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -78.06 -14.39 59.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.088 -1.007 . . . . 0.0 109.741 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD2' ' CG ' ' A' ' 99' ' ' MET . 7.3 tt -85.19 -23.35 28.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.682 -0.636 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.39 -54.62 13.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 109.587 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 19.1 m-85 -52.76 -34.03 51.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.661 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 17.2 t60 -51.43 -21.81 2.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' A' ' 79' ' ' HIS . 2.9 mt -98.48 -22.96 15.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 108.924 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.651 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 14.3 mt -73.51 -52.69 20.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.592 -0.693 . . . . 0.0 110.282 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ILE . 4.1 mt-30 -71.69 -25.03 61.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -90.08 -19.9 23.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 111.214 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.6 mt -84.92 -60.8 1.94 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.114 . . . . 0.0 111.402 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.9 mm -95.91 -35.95 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.073 -1.017 . . . . 0.0 110.999 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.5 OUTLIER -89.41 -13.96 36.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.045 -1.034 . . . . 0.0 110.813 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 53.83 18.8 8.97 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 23.6 mt -86.61 161.28 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.16 -1.2 . . . . 0.0 109.721 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.51 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 2.7 p-10 -90.39 169.35 12.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -70.21 156.25 62.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.88 1.463 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' HIS . 42.7 Cg_endo -70.13 62.93 2.0 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.125 1.592 . . . . 0.0 111.365 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.47 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.8 OUTLIER 40.08 -112.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 111.001 179.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 3.8 m -101.97 -172.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.744 -1.222 . . . . 0.0 111.245 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.94 164.37 8.26 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 111.396 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 30.0 p -145.85 167.88 13.15 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -70.09 -23.17 29.62 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.486 1.256 . . . . 0.0 109.266 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 2.0 mt-10 -82.41 -2.11 52.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.423 -0.798 . . . . 0.0 109.127 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.591 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 30.7 ttm -119.08 5.09 11.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.479 HG13 ' CD1' ' A' ' 95' ' ' LEU 0.253 33.4 mt -108.47 100.53 38.49 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.665 -0.647 . . . . 0.0 110.486 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.617 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 40.3 Cg_endo -72.96 -30.45 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.759 1.4 . . . . 0.0 113.017 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 50.4 Cg_endo -73.01 145.08 39.18 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.574 0.776 . . . . 0.0 110.342 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.931 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.445 0.641 . . . . 0.0 111.243 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.644 ' CZ3' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 61.89 93.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.749 . . . . 0.0 109.65 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 99' ' ' MET . 2.4 m -70.92 -32.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -0.872 . . . . 0.0 109.804 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG11 ' CZ3' ' A' ' 10' ' ' TRP . 2.4 p -123.65 146.34 29.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -167.02 -59.64 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.845 -1.16 . . . . 0.0 112.675 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 15' ' ' ALA . 40.9 Cg_endo -63.24 -141.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.34 1.179 . . . . 0.0 110.807 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.83 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 112.217 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -36.28 -63.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -52.21 -33.81 42.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.086 . . . . 0.0 110.418 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.54 -48.16 70.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -56.27 -31.0 63.2 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.6 m-85 -91.65 -52.06 4.94 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.704 -0.623 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 10.3 t0 -42.74 -39.77 2.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.649 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -71.66 -35.5 70.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.407 -0.808 . . . . 0.0 109.072 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 26' ' ' LYS . 31.7 mt -72.43 -41.75 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.805 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 47.1 t80 -46.44 -28.58 1.41 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.543 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.08 -33.16 65.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 23' ' ' ILE . 24.3 mttp -93.72 -10.05 35.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.563 ' CG2' HG23 ' A' ' 35' ' ' VAL . 1.1 m -89.53 -58.84 2.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.451 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 55.2 t0 -66.13 82.59 0.08 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -75.41 11.41 1.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.93 -1.106 . . . . 0.0 112.332 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.479 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 2.9 m-20 -116.67 5.74 13.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.3 mmt 46.08 35.52 2.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 111.055 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.8 p30 -108.06 12.78 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.55 12.47 80.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -150.84 109.93 3.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.286 . . . . 0.0 110.8 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG23 ' CG2' ' A' ' 27' ' ' THR . 13.2 p -89.6 137.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.982 . . . . 0.0 108.495 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.2 p -85.87 153.59 22.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.103 -0.998 . . . . 0.0 111.172 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -50.99 -21.7 5.53 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 38' ' ' LEU . 49.3 mt -73.07 -32.31 64.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -1.054 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 36.6 mt-10 -82.67 -54.06 5.44 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -66.86 -14.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.342 0.591 . . . . 0.0 109.735 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -47.24 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.154 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -43.61 -44.5 6.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.503 HD12 ' CG2' ' A' ' 27' ' ' THR . 0.9 OUTLIER -50.75 -40.95 20.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.664 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.6 m-30 -83.2 -38.65 22.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.86 -18.5 8.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.356 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 83.0 mttt -79.61 -13.57 59.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 109.323 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.519 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 64.1 p -66.23 -16.77 64.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.26 66.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.537 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -100.13 171.94 5.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.641 -0.917 . . . . 0.0 110.085 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 48.4 Cg_endo -77.19 155.64 33.2 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.723 1.381 . . . . 0.0 110.073 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.02 67.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.967 . . . . 0.0 110.995 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -45.38 73.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.995 . . . . 0.0 111.24 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -54.99 -51.17 67.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.89 -1.131 . . . . 0.0 110.478 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 35.3 mt -59.85 -36.6 77.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.34 -48.19 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -60.56 -37.77 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.488 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 12.8 mt -64.74 -37.25 79.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.61 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 40.3 t-105 -57.13 -52.84 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -33.59 71.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.168 -0.957 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 93' ' ' HIS . 15.9 tp -67.0 -23.62 65.95 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.253 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 56.0 m -105.74 -36.09 7.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 68' ' ' LYS . 51.8 t0 -67.01 58.37 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 109.155 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.4 p -53.76 -29.57 40.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -62.69 -11.1 15.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.436 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.7 p30 37.02 55.49 1.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.615 -0.678 . . . . 0.0 110.465 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 71.9 m -118.73 -11.18 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 110.594 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.18 -21.09 27.49 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 16.3 mmtm -114.68 -176.41 2.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.406 -1.055 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.61 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -114.54 108.57 17.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.933 -1.105 . . . . 0.0 110.562 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -64.56 167.69 6.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 109.373 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -56.04 -72.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.558 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -44.42 -37.52 3.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 110.637 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 44.4 mm-40 -67.33 -49.6 63.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.037 -1.04 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 8.9 t80 -56.61 -26.92 57.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.72 -1.238 . . . . 0.0 108.588 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . . . -80.52 -11.4 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.598 0.713 . . . . 0.0 109.277 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD1' ' HG3' ' A' ' 99' ' ' MET . 6.1 tp -88.64 -42.41 12.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 110.087 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.614 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -62.89 -26.39 68.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.298 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 1.4 m-85 -76.12 -20.36 57.7 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.741 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.3 t60 -73.29 -22.56 60.34 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.557 -0.714 . . . . 0.0 109.172 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -99.72 -38.46 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.435 -0.79 . . . . 0.0 108.894 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.664 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 76.6 mt -66.66 -46.99 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -62.69 -16.76 58.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.492 -0.755 . . . . 0.0 109.915 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -77.8 -24.01 48.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 110.032 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -10.52 47.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 47' ' ' THR . 6.0 mt -89.99 -55.37 3.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.065 -1.022 . . . . 0.0 110.749 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 86' ' ' ILE . 7.2 mm -108.9 -17.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.092 -1.005 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -108.44 -2.73 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.949 -1.094 . . . . 0.0 110.45 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 42.22 53.93 4.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 2.4 mt -125.63 168.37 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.302 -1.117 . . . . 0.0 109.832 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.7 m-20 -113.32 171.54 4.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 40.8 Cg_endo -70.46 151.68 65.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.897 1.472 . . . . 0.0 109.999 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.6 Cg_endo -70.85 51.64 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.938 1.494 . . . . 0.0 111.168 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER 50.2 -83.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.426 -0.796 . . . . 0.0 111.679 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 92' ' ' PRO . 11.5 m -108.36 -162.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 2.0 mm? -86.71 144.0 27.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.739 0.781 . . . . 0.0 111.243 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.537 ' OG1' ' CB ' ' A' ' 99' ' ' MET . 39.3 p -111.12 168.09 8.09 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.7 Cg_endo -68.38 -38.43 11.6 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 123.289 1.152 . . . . 0.0 109.863 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.472 ' CB ' HG11 ' A' ' 11' ' ' VAL . 1.7 mt-10 -71.26 -27.2 63.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 108.611 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.638 ' HG3' ' CD1' ' A' ' 76' ' ' LEU . 24.1 ttm -84.66 -25.52 28.41 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.422 0.63 . . . . 0.0 109.624 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 96' ' ' THR . 7.5 mt -87.01 135.82 34.71 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.097 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG3' ' HE3' ' A' ' 64' ' ' LYS . 41.6 Cg_endo -69.56 116.82 4.72 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.771 1.406 . . . . 0.0 109.695 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.45 -91.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.797 1.419 . . . . 0.0 111.107 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 110.45 -179.465 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.251 0.548 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -134.6 139.94 45.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.584 ' CG2' ' N ' ' A' ' 12' ' ' VAL . 1.7 m -58.07 -44.71 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' ' CE3' ' A' ' 10' ' ' TRP . 3.0 p -115.66 166.13 10.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.573 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER 167.06 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.074 -1.016 . . . . 0.0 111.926 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 13' ' ' SER . 45.6 Cg_endo -66.28 -146.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.263 1.139 . . . . 0.0 110.81 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.96 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 111.524 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 43.7 mt-10 -54.09 -64.13 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -54.04 -32.67 55.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.902 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.46 -52.31 16.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.32 -30.15 62.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.007 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.6 m-30 -89.56 -50.51 6.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 17' ' ' LYS . 8.9 t0 -43.27 -40.64 3.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 109.41 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.25 -34.96 75.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 108.882 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.557 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 60.6 mt -74.66 -38.77 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.459 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.542 ' CE1' HG13 ' A' ' 35' ' ' VAL . 68.4 t80 -50.1 -33.08 17.5 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.87 -24.86 66.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.69 -16.09 19.14 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.523 ' OG1' ' CE2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -88.75 -52.98 4.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.502 -0.749 . . . . 0.0 109.8 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 67.6 t0 -67.14 63.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 109.29 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 11.1 mttm -65.5 -3.82 4.97 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.383 -0.823 . . . . 0.0 111.966 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 39' ' ' GLU . 45.9 m-20 -103.36 -11.06 18.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.683 -1.261 . . . . 0.0 110.672 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER 57.42 37.45 27.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 19.5 p30 -103.11 1.32 33.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 110.68 -32.56 6.49 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.66 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -135.68 147.08 48.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.57 HG12 ' CB ' ' A' ' 69' ' ' LEU . 1.4 p -88.94 135.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.344 -0.848 . . . . 0.0 108.733 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 38' ' ' LEU . 7.8 p -86.58 151.02 23.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 0.0 110.426 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -24.95 0.45 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 80.9 mt -65.07 -41.28 95.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -1.06 . . . . 0.0 111.591 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 5.5 mt-10 -81.03 -58.4 3.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.195 . . . . 0.0 108.769 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' CG1' ' HA2' ' A' ' 37' ' ' GLY . 1.5 p -57.01 -16.43 4.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.547 0.689 . . . . 0.0 109.639 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -43.94 -76.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.476 -0.765 . . . . 0.0 110.823 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' ARG . 7.7 mt-10 -44.63 -46.58 10.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.071 . . . . 0.0 108.59 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.5 mt -53.09 -37.27 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.9 m-30 -85.76 -45.79 11.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.655 -0.653 . . . . 0.0 109.438 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.2 mt -51.48 -27.58 10.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 3.2 ptmt -73.86 -5.37 40.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.662 -0.649 . . . . 0.0 109.751 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 65.3 p -78.97 -18.06 54.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.844 . . . . 0.0 110.015 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.85 86.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.8 mp -81.01 166.99 35.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 48.0 Cg_endo -78.36 176.5 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.915 1.481 . . . . 0.0 110.56 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -44.03 61.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.636 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 53' ' ' LEU . 5.3 m -65.6 -59.0 4.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.702 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.531 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -44.54 -39.71 5.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.97 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.38 -53.24 46.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.38 68.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -74.97 -38.41 61.68 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 HG22 HG13 ' A' ' 81' ' ' ILE . 3.8 mt -71.68 -28.51 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 71.7 t-105 -61.56 -44.24 97.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.274 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.481 ' O ' HD23 ' A' ' 95' ' ' LEU . 1.2 t -71.12 -33.67 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.26 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 12.3 mt -67.05 -27.53 67.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.566 -0.709 . . . . 0.0 109.466 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.554 ' CB ' ' CB ' ' A' ' 77' ' ' ALA . 19.4 p -102.12 -35.13 9.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.447 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 45.7 t0 -75.4 57.13 0.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.582 -0.699 . . . . 0.0 110.004 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.461 ' OG1' ' OE1' ' A' ' 73' ' ' GLN . 4.6 p -52.49 -33.04 43.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -63.03 -12.38 25.83 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.67 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 4.1 t70 40.81 53.84 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.789 . . . . 0.0 110.139 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.85 7.9 10.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.453 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.55 -12.69 62.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' CA ' ' HZ2' ' A' ' 58' ' ' TRP . 32.4 mttt -126.43 175.44 7.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.177 . . . . 0.0 109.766 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 2.9 mt -113.35 114.88 27.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.809 -1.182 . . . . 0.0 111.707 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.6 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -64.02 -172.85 0.07 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.983 -1.073 . . . . 0.0 110.219 179.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -70.5 -46.2 64.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 111.361 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.24 -3.28 58.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.072 -1.018 . . . . 0.0 111.199 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.6 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 34.3 mm-40 -89.03 -43.69 10.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.901 -1.124 . . . . 0.0 109.596 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 14.6 t80 -61.38 -24.72 66.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.23 -13.96 58.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.514 -0.741 . . . . 0.0 109.084 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 99' ' ' MET . 1.8 tp -90.33 -49.15 6.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.477 -0.764 . . . . 0.0 109.415 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' CB ' ' CB ' ' A' ' 61' ' ' CYS . . . -48.0 -46.54 32.97 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 3.1 m-85 -51.91 -39.76 59.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 83.3 t60 -51.38 -24.87 5.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.06 -34.89 9.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 0.0 109.247 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 45.8 mt -77.63 -35.16 21.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.528 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 2.8 p -67.77 -29.74 69.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 110.079 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -83.87 -5.49 59.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.077 -1.015 . . . . 0.0 109.982 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.456 ' HD3' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.9 -24.65 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.406 -0.809 . . . . 0.0 110.91 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 47' ' ' THR . 3.9 mt -90.0 -71.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.0 111.299 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 mm -82.08 3.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.795 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -126.81 -47.27 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.941 -1.099 . . . . 0.0 110.573 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 87.1 6.19 79.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 87' ' ' LYS . 3.5 mt -77.42 139.37 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.231 -1.158 . . . . 0.0 109.823 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.2 170.96 13.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.217 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 40.4 Cg_endo -70.88 158.29 55.91 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.191 1.627 . . . . 0.0 110.675 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.511 ' CG ' ' HE3' ' A' ' 99' ' ' MET . 46.7 Cg_endo -75.06 47.02 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.098 1.578 . . . . 0.0 111.676 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.08 -85.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.077 -1.015 . . . . 0.0 111.643 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.513 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 33.4 m -117.47 -163.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.607 -1.308 . . . . 0.0 112.208 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 4.0 mm? -81.03 165.1 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.785 0.802 . . . . 0.0 111.603 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 p -147.15 170.25 8.06 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.6 Cg_endo -69.6 -38.03 8.71 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.183 1.097 . . . . 0.0 109.527 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.498 ' HB3' HG11 ' A' ' 11' ' ' VAL . 13.4 mt-10 -70.08 -10.83 60.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 108.96 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.538 ' CG ' HD22 ' A' ' 76' ' ' LEU . 28.0 ttm -102.54 -38.21 7.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.3 mt -64.68 143.13 98.66 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.864 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.462 ' HD2' HG22 ' A' ' 100' ' ' ILE . 44.6 Cg_endo -71.49 120.84 7.22 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.891 1.469 . . . . 0.0 110.706 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.55 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.923 1.486 . . . . 0.0 110.377 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 179.804 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.295 0.569 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CZ3' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 69.15 98.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.909 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.09 -20.85 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 110.104 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.62 HG11 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -139.04 73.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 109.787 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 t -102.73 -31.67 0.21 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -76.38 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 122.756 0.872 . . . . 0.0 111.101 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.67 -61.28 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.904 -0.497 . . . . 0.0 112.197 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 15.2 mt-10 -38.65 -57.33 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.73 . . . . 0.0 110.64 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.18 -35.17 64.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.97 . . . . 0.0 109.867 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.29 -48.61 69.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -29.42 64.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.529 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 12.2 m-85 -87.95 -51.69 5.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.558 -0.714 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -45.56 -39.56 7.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.927 -1.108 . . . . 0.0 109.356 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 5.6 mm-40 -67.51 -47.27 70.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 108.99 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' LYS . 26.1 mt -62.26 -40.5 87.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 29.4 t80 -46.95 -27.65 1.35 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 70.3 mt -70.64 -31.72 68.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -97.83 -12.8 21.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.845 . . . . 0.0 108.82 178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.547 ' CG2' HG22 ' A' ' 35' ' ' VAL . 1.3 m -89.06 -51.43 5.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 31' ' ' MET . 23.0 t70 -65.04 82.53 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -62.44 0.07 0.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 44.8 p-10 -122.77 3.47 9.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.219 -1.55 . . . . 0.0 110.787 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.471 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 1.2 mmt 55.92 39.08 30.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.294 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 3.9 p-10 -110.35 26.44 10.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.34 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.48 11.17 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.86 99.49 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -1.104 . . . . 0.0 110.309 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 27' ' ' THR . 10.8 p -89.71 135.66 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.94 -1.1 . . . . 0.0 109.004 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.474 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 82.6 p -90.06 147.81 23.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 110.825 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.94 -27.59 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.7 mp -65.04 -30.59 71.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.108 . . . . 0.0 110.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 49.0 mt-10 -86.84 -62.24 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.891 -1.131 . . . . 0.0 108.306 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.639 ' CG2' ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -58.49 -15.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.29 0.566 . . . . 0.0 110.023 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.618 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -42.58 -44.67 4.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.008 . . . . 0.0 109.82 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 27' ' ' THR . 0.9 OUTLIER -51.27 -40.01 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.55 -0.719 . . . . 0.0 109.072 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.639 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 1.4 m-85 -87.28 -28.45 22.29 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.592 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 42' ' ' GLU . 72.1 mt -68.06 -17.38 64.37 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 108.961 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 10.2 mtpt -75.75 -21.32 57.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.559 0.695 . . . . 0.0 109.49 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.558 ' OG1' ' HG ' ' A' ' 49' ' ' LEU . 39.1 p -50.2 -58.14 6.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.43 21.41 4.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.649 ' HB2' HD23 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -101.05 -172.34 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.511 -0.994 . . . . 0.0 108.542 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -74.3 -171.64 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.388 1.204 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -47.8 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.859 -1.151 . . . . 0.0 111.328 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -63.14 -32.11 73.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.673 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.649 HD23 ' HB2' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -59.87 -62.68 1.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 110.819 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 53' ' ' LEU . 2.8 mm? -50.08 -29.71 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.816 -1.178 . . . . 0.0 108.953 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -79.65 -39.36 31.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.529 ' NE2' HD11 ' A' ' 60' ' ' LEU . 21.3 t60 -67.49 -24.58 65.6 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' HD12 ' A' ' 81' ' ' ILE . 4.9 mt -78.3 -23.04 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 69' ' ' LEU . 19.5 t-105 -71.48 -45.63 61.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.471 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.5 p -69.44 -27.61 65.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 108.645 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.552 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 9.0 mt -74.68 -4.65 38.58 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 61.6 m -128.58 -35.48 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.75 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.532 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.9 t70 -65.81 59.35 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.63 -0.669 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' CYS . 24.7 p -55.54 -36.84 67.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -0.991 . . . . 0.0 109.881 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' CD ' ' OE1' ' A' ' 73' ' ' GLN . 11.7 mptt -56.25 -16.98 6.24 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 110.04 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.08 54.76 2.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 110.438 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.0 t -123.13 -13.96 7.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.311 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.24 -0.25 25.24 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.608 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 3.7 mtmt -129.78 -176.25 3.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.133 -1.216 . . . . 0.0 110.087 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.596 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -123.7 97.94 5.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.099 -1.001 . . . . 0.0 111.163 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.512 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -55.56 172.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.746 -1.221 . . . . 0.0 109.34 178.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -56.46 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.958 -1.089 . . . . 0.0 110.544 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' LYS . 32.3 m-20 -39.38 -42.65 1.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.594 -0.691 . . . . 0.0 110.549 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' OE1' ' CD ' ' A' ' 64' ' ' LYS . 25.9 mt-30 -61.03 -49.49 77.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' A' ' 23' ' ' ILE . 11.2 t80 -54.76 -37.43 65.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB1' ' CH2' ' A' ' 10' ' ' TRP . . . -73.42 -6.75 48.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.636 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -90.35 -40.52 12.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.373 -0.829 . . . . 0.0 110.071 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 44' ' ' PHE . . . -64.63 -58.84 5.23 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.238 -0.913 . . . . 0.0 109.041 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.2 m-85 -45.67 -32.17 2.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.603 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 47.2 t60 -66.22 -30.41 70.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 76' ' ' LEU . 14.2 mt -84.8 -16.79 40.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 109.187 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.524 HD12 ' CD1' ' A' ' 57' ' ' ILE . 13.6 mm -73.51 -57.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.48 -0.763 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -47.98 -32.39 6.45 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.444 -0.785 . . . . 0.0 109.982 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -64.64 -24.18 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -91.13 -21.48 21.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.222 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.2 mt -89.43 -67.71 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -82.19 -10.04 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.0 110.873 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HG2' ' CD1' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.48 -7.32 10.18 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.927 -1.108 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 47.23 24.49 2.3 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 87' ' ' LYS . 16.2 mt -97.16 173.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.496 -1.002 . . . . 0.0 109.858 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 25.0 m-20 -115.37 164.79 15.97 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 110.256 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 43.5 Cg_endo -70.47 153.91 65.32 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.16 1.61 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.48 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.7 Cg_endo -71.92 151.93 57.1 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.013 1.533 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.32 -59.76 2.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.166 -0.959 . . . . 0.0 110.277 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.486 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 30.4 m -125.87 -166.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 111.264 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' CD2' ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -89.89 -175.81 4.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.897 0.856 . . . . 0.0 111.564 -179.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 2.2 p -143.07 -179.23 0.91 Allowed Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 46.6 Cg_endo -76.17 -5.77 16.59 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.332 1.175 . . . . 0.0 109.929 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.499 ' HA ' HG21 ' A' ' 9' ' ' THR . 20.9 mt-10 -93.66 -23.11 18.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 109.277 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 2.4 mtp -86.37 -36.19 19.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.992 0.901 . . . . 0.0 108.698 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CD1' ' O ' ' A' ' 96' ' ' THR . 2.2 mt -65.23 124.77 87.84 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.883 -0.51 . . . . 0.0 110.654 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 47.7 Cg_endo -73.76 174.89 11.54 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.931 1.49 . . . . 0.0 109.906 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 42.5 Cg_endo -68.63 179.48 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.781 1.411 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.524 -179.828 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.4 m . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.96 0.886 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.674 HG11 ' HA ' ' A' ' 76' ' ' LEU . 2.3 p -115.57 156.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 174.36 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.731 -1.231 . . . . 0.0 112.335 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' SER . 48.5 Cg_endo -67.43 -145.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.272 1.143 . . . . 0.0 110.559 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.2 -49.67 0.08 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.455 0.645 . . . . 0.0 111.588 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 4.9 mt-10 -49.13 -60.79 2.49 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.418 -0.801 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.3 tmtp? -54.24 -32.96 57.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.964 -1.085 . . . . 0.0 109.981 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.45 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 108.95 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' ILE . 6.1 ttpt -54.53 -28.93 48.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.579 -0.7 . . . . 0.0 109.393 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 4.2 m-30 -90.59 -52.19 5.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 110.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 20' ' ' TYR . 53.1 t0 -45.28 -33.82 2.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 25' ' ' LEU . 30.7 mm-40 -76.39 -32.54 58.61 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.334 -0.854 . . . . 0.0 108.906 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.832 HG22 ' OG1' ' A' ' 27' ' ' THR . 46.9 mt -77.77 -41.87 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.388 -0.82 . . . . 0.0 110.073 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HE1' HG12 ' A' ' 35' ' ' VAL . 59.9 t80 -48.67 -32.68 8.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.571 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.832 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.0 mt -65.52 -28.91 69.52 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -100.18 -12.71 19.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 2.6 m -89.74 -55.74 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.745 . . . . 0.0 109.372 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.534 ' HA ' HG23 ' A' ' 35' ' ' VAL . 38.3 t0 -63.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.703 -0.623 . . . . 0.0 109.361 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.7 mmtt -51.8 -17.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 111.219 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.0 m-20 -98.23 1.68 47.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 mtm 43.26 45.35 4.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.706 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.2 p30 -115.8 26.5 9.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 109.956 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.92 12.77 44.43 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.17 100.82 2.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -1.058 . . . . 0.0 110.111 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.0 HG21 HG22 ' A' ' 27' ' ' THR . 14.5 p -88.86 139.42 17.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.925 -1.109 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 t -95.31 151.85 18.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.067 -1.021 . . . . 0.0 110.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.71 -25.16 0.82 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 38' ' ' LEU . 3.1 mm? -67.49 -29.96 69.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.218 -1.166 . . . . 0.0 110.975 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.578 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 19.4 mt-10 -91.05 -61.7 1.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.829 -1.169 . . . . 0.0 108.306 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.614 ' HA ' HG23 ' A' ' 27' ' ' THR . 1.1 p -53.02 -18.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -42.21 -75.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.705 -0.622 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.3 mt-10 -43.23 -47.97 6.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 108.717 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR . 2.2 mt -55.44 -41.28 62.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.85 ' CE1' HD12 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -77.25 -28.27 53.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 42' ' ' GLU . 19.1 mt -73.76 -23.68 59.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -0.928 . . . . 0.0 109.003 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 49.0 mttt -81.27 -13.77 58.11 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.546 0.688 . . . . 0.0 109.489 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' ILE . 45.4 p -65.2 -54.07 35.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 0.0 109.969 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.42 14.68 7.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.9 mm? -93.5 153.71 41.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.479 -1.012 . . . . 0.0 110.663 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 40.7 Cg_endo -66.13 147.64 84.22 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.945 1.498 . . . . 0.0 110.623 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 52' ' ' THR . 82.3 p -44.86 -64.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.726 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 51' ' ' SER . 13.7 m -42.47 -58.09 2.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.967 . . . . 0.0 110.878 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -52.64 -50.2 63.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 0.0 110.342 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 22.9 mt -57.11 -39.46 75.12 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.307 -0.87 . . . . 0.0 109.295 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.52 65.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 20.4 t60 -73.15 -29.63 63.0 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.903 HD13 HG13 ' A' ' 81' ' ' ILE . 8.8 mt -77.33 -28.51 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.662 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 48.3 t-105 -65.1 -42.93 93.54 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.811 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.67 59.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.947 HD23 HD13 ' A' ' 80' ' ' LEU . 7.0 tp -74.46 -17.04 60.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.835 ' HA ' HD22 ' A' ' 76' ' ' LEU . 22.4 p -115.16 -35.5 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.456 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 12.2 t70 -66.61 56.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 110.551 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 61' ' ' CYS . 0.7 OUTLIER -60.43 -24.01 64.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -61.09 -16.11 40.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.664 -0.648 . . . . 0.0 110.337 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.6 t0 39.84 51.19 2.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 110.325 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.88 -14.5 6.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.853 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.68 -1.32 27.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 14.1 mttt -136.33 171.23 14.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -1.222 . . . . 0.0 110.601 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.1 mt -107.5 101.4 10.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.13 -179.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.602 -1.311 . . . . 0.0 110.511 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.88 -52.47 43.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 14.8 p-10 -79.37 -15.23 58.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.904 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.58 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 42.2 mm-40 -77.51 -40.16 43.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.927 -1.108 . . . . 0.0 110.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.763 ' N ' HD22 ' A' ' 69' ' ' LEU . 17.0 t80 -63.87 -17.54 63.28 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.279 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.7 -18.56 37.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.421 -0.8 . . . . 0.0 109.034 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CG ' ' A' ' 99' ' ' MET . 9.6 tt -84.27 -21.92 30.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -75.41 -46.45 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.172 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.4 m-85 -57.28 -29.64 64.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 108.81 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.552 ' CE1' ' HB ' ' A' ' 11' ' ' VAL . 16.0 t-80 -54.2 -22.59 11.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.947 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -99.67 -60.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.903 HG13 HD13 ' A' ' 57' ' ' ILE . 9.9 mt -48.33 -52.26 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.821 -0.549 . . . . 0.0 109.84 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -52.42 -40.01 61.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 88' ' ' GLY . 5.1 mt-30 -60.02 -21.2 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.588 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.85 -18.01 25.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.0 110.788 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -88.52 -38.46 14.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 111.172 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.6 mm -119.88 -14.67 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.997 . . . . 0.0 110.737 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.2 mmpt? -119.17 -2.5 10.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 110.616 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 41.34 59.36 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.803 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -126.36 132.59 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.087 -1.243 . . . . 0.0 110.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 15.6 p-10 -60.08 170.25 1.29 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.508 ' HD3' HD11 ' A' ' 53' ' ' LEU . 43.8 Cg_endo -79.32 152.08 23.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.772 1.406 . . . . 0.0 110.374 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.601 ' C ' ' CD2' ' A' ' 93' ' ' HIS . 42.8 Cg_endo -68.78 63.91 1.27 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.01 1.532 . . . . 0.0 110.38 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.601 ' CD2' ' C ' ' A' ' 92' ' ' PRO . 4.7 p80 35.94 -109.63 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.72 -0.613 . . . . 0.0 111.099 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.645 ' C ' HD11 ' A' ' 60' ' ' LEU . 5.3 m -102.71 -165.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.93 -1.106 . . . . 0.0 111.218 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.594 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -69.5 147.86 50.28 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.735 0.778 . . . . 0.0 111.414 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.945 ' O ' HD12 ' A' ' 100' ' ' ILE . 68.9 p -125.71 166.97 18.1 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.0 Cg_endo -67.32 -23.28 44.84 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.477 1.251 . . . . 0.0 109.638 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.656 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -82.21 -18.31 43.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.971 ' CG ' HD21 ' A' ' 76' ' ' LEU . 35.4 ttm -92.21 -47.1 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.72 0.771 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 96' ' ' THR . 1.1 mt -50.05 134.48 22.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.545 -0.722 . . . . 0.0 110.212 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.694 -179.641 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 121.117 0.484 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.605 HG12 ' C ' ' A' ' 11' ' ' VAL . 7.7 p 36.76 66.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.578 -0.701 . . . . 0.0 111.122 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.2 t -107.12 -41.62 0.14 Allowed Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 13' ' ' SER . 51.8 Cg_endo -77.13 -147.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 122.928 0.962 . . . . 0.0 111.959 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.78 -59.13 0.11 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -37.77 -54.76 1.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.0 110.49 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.62 -42.93 68.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 109.797 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.76 -46.59 84.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.742 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -56.37 -29.18 61.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.524 -0.735 . . . . 0.0 109.971 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 13.3 m-85 -89.46 -52.38 5.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.429 -0.795 . . . . 0.0 110.05 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 5.5 t70 -44.53 -31.23 1.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.8 mt-10 -80.13 -34.75 37.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 26' ' ' LYS . 39.5 mt -78.91 -37.22 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.482 -0.761 . . . . 0.0 110.285 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 52.6 t80 -48.85 -30.6 5.99 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.356 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.4 mt -67.76 -25.76 65.78 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -98.74 -13.74 20.07 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.081 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.25 -55.47 3.66 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.729 0.776 . . . . 0.0 109.23 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 59.1 t0 -72.48 68.27 0.78 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 3.5 mttm -55.98 -13.82 2.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.493 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -96.6 13.83 26.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.563 -1.335 . . . . 0.0 110.96 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.4 mtm 43.16 26.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 34.4 p30 -98.56 22.37 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 56.49 19.85 28.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.46 105.46 3.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -1.146 . . . . 0.0 110.754 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.957 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -89.0 130.01 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.865 -1.147 . . . . 0.0 109.018 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.637 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -87.15 152.66 22.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.092 -1.005 . . . . 0.0 109.808 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.74 -22.68 0.79 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 38' ' ' LEU . 2.9 mm? -65.34 -37.32 86.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 111.263 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 35' ' ' VAL . 15.1 mt-10 -86.45 -62.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.861 -1.149 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -50.83 -20.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.623 0.725 . . . . 0.0 109.491 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -44.92 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 110.645 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.6 mt-10 -44.04 -38.37 3.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.23 -0.919 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -58.61 -42.56 85.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 110.265 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.9 m-85 -80.95 -29.65 35.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.163 -0.961 . . . . 0.0 110.166 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 42' ' ' GLU . 17.0 mt -65.85 -15.38 62.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.989 -1.069 . . . . 0.0 109.386 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 59.8 mttt -82.86 -13.51 56.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.502 ' O ' HD13 ' A' ' 49' ' ' LEU . 82.8 p -63.04 -10.86 15.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.75 . . . . 0.0 110.793 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.33 69.39 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 107.734 -2.146 . . . . 0.0 107.734 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.733 HD23 ' CD2' ' A' ' 53' ' ' LEU . 4.4 mp -100.51 173.11 3.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.866 -0.785 . . . . 0.0 110.679 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HD2' HD22 ' A' ' 53' ' ' LEU . 40.7 Cg_endo -67.86 -153.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.217 1.64 . . . . 0.0 109.711 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.5 t -104.58 -65.11 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.216 . . . . 0.0 111.484 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -54.12 -38.1 65.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.082 -1.011 . . . . 0.0 111.284 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -47.62 -53.21 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.089 -1.007 . . . . 0.0 111.399 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 53' ' ' LEU . 2.5 mm? -62.54 -46.37 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.021 -1.05 . . . . 0.0 109.35 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.94 81.95 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' THR . 6.2 t-80 -72.41 -29.32 63.62 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.718 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 6.9 mt -76.65 -22.46 15.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.598 ' HZ3' HG11 ' A' ' 40' ' ' VAL . 48.1 t-105 -65.32 -45.06 85.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 108.9 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -31.63 64.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.399 -0.813 . . . . 0.0 109.119 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.062 HD23 HD13 ' A' ' 80' ' ' LEU . 5.8 tp -71.39 -22.1 61.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.76 . . . . 0.0 109.259 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.776 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 15.9 p -105.13 -30.77 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 49.6 t0 -74.71 54.32 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.744 ' CG2' HD22 ' A' ' 95' ' ' LEU . 5.4 p -54.83 -34.32 62.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.076 -1.015 . . . . 0.0 109.077 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 7.6 mptt -56.5 -17.09 7.17 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.604 -0.685 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 48.2 m-20 41.94 54.65 3.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.766 . . . . 0.0 110.155 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 41.4 t -119.99 8.6 11.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.16 -16.76 50.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 25.3 mttt -123.9 179.2 4.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 110.157 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -111.76 118.17 34.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.008 . . . . 0.0 110.713 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -75.34 175.46 8.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.952 -1.093 . . . . 0.0 109.369 179.148 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.51 -84.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.431 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 71' ' ' LYS . 3.6 m-20 -42.12 -38.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 110.849 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 46.4 mm-40 -60.8 -60.08 4.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.056 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 27' ' ' THR . 28.5 t80 -51.14 -33.16 25.51 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -77.63 -10.52 59.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.011 HD21 ' CG ' ' A' ' 99' ' ' MET . 5.6 tt -90.54 -35.34 15.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.434 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -58.91 -37.94 77.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.746 -1.221 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.676 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 29.0 m-85 -64.09 -35.31 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 79.1 t60 -51.36 -23.11 3.38 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.366 -0.834 . . . . 0.0 108.835 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.062 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -95.91 -22.72 17.25 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 57' ' ' ILE . 8.3 mm -75.04 -54.13 14.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -37.54 10.92 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.593 -0.692 . . . . 0.0 110.389 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' ILE . 3.8 mt-30 -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 109.97 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -90.95 -20.95 21.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 0.0 110.313 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.5 mt -90.45 -59.78 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 111.439 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.7 mm -92.88 -6.02 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.02 . . . . 0.0 111.626 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.97 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -125.88 -19.46 4.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.625 -1.297 . . . . 0.0 110.712 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.05 3.4 64.53 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.97 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.8 mt -81.95 160.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.293 -1.122 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 11.6 p-10 -102.81 166.34 12.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 109.841 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 41.2 Cg_endo -68.0 145.86 69.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.679 1.358 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.705 ' O ' HD21 ' A' ' 60' ' ' LEU . 40.8 Cg_endo -68.6 127.88 16.24 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.037 1.546 . . . . 0.0 109.935 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.502 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -28.14 -67.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.137 0.494 . . . . 0.0 111.513 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.647 ' C ' HD11 ' A' ' 60' ' ' LEU . 10.7 m -115.36 -165.61 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.965 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -93.74 163.42 13.54 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.044 ' O ' HD12 ' A' ' 100' ' ' ILE . 70.6 p -122.55 169.06 10.37 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.8 Cg_endo -67.38 -15.02 44.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.343 1.18 . . . . 0.0 109.62 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 mp0 -88.42 -16.5 32.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 108.854 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.011 ' CG ' HD21 ' A' ' 76' ' ' LEU . 31.4 ttm -96.98 -31.61 12.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.044 HD12 ' O ' ' A' ' 96' ' ' THR . 2.5 mt -72.08 139.0 82.01 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.609 -0.682 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 45.6 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.384 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.719 HG21 ' O ' ' A' ' 75' ' ' ALA . 7.7 p 31.27 99.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.565 0.697 . . . . 0.0 111.209 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.621 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.25 -62.18 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.869 -1.144 . . . . 0.0 113.509 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 13' ' ' SER . 40.6 Cg_endo -61.98 -143.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 122.936 0.966 . . . . 0.0 111.818 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.65 -60.74 0.1 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.735 -0.603 . . . . 0.0 112.552 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 23.0 mt-10 -37.49 -60.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.57 -0.706 . . . . 0.0 111.145 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 13' ' ' SER . 1.8 tmtt? -54.65 -34.4 62.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.99 -1.069 . . . . 0.0 110.1 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.86 -46.89 70.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.6 ttpt -57.26 -30.43 64.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.646 -0.659 . . . . 0.0 110.197 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.1 m-85 -84.77 -50.01 7.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.8 t70 -50.31 -32.6 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 0.0 109.597 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.7 mm-40 -78.96 -35.01 43.81 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.203 -0.935 . . . . 0.0 108.974 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.85 HG22 ' OG1' ' A' ' 27' ' ' THR . 62.9 mt -77.74 -41.06 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.775 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.629 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 49.2 t80 -48.55 -26.57 2.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.042 -1.036 . . . . 0.0 108.809 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 17.6 mt -76.88 -28.62 55.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -98.53 -9.06 25.52 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 3.1 m -90.9 -57.24 2.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.236 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.3 80.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.664 -0.647 . . . . 0.0 109.708 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 1.1 mttt -78.48 12.32 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 111.798 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 68.4 m-20 -109.31 12.31 24.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.823 -1.173 . . . . 0.0 110.411 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 42.68 34.85 0.61 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.173 -0.954 . . . . 0.0 110.21 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 26.5 p30 -111.21 4.09 18.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.168 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 13.67 70.13 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -147.77 105.47 3.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -1.047 . . . . 0.0 110.323 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.992 HG21 HG22 ' A' ' 27' ' ' THR . 9.6 p -89.78 135.65 25.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 108.696 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.635 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -103.83 176.22 5.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.0 111.096 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -69.3 54.66 0.62 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 37' ' ' GLY . 26.2 mt -139.93 -41.08 0.44 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 12.4 mt-10 -91.08 -61.67 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 36' ' ' SER . 1.1 p -51.71 -22.82 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 1.2 ptt180 -47.36 -54.4 11.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.615 -0.678 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.735 ' HA ' HD12 ' A' ' 45' ' ' LEU . 3.0 tt0 -60.85 -43.11 98.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.238 . . . . 0.0 107.753 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR 0.256 1.1 mt -54.13 -40.79 48.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.87 -46.17 31.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.735 HD12 ' HA ' ' A' ' 42' ' ' GLU . 13.5 mt -50.83 -24.11 3.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 108.967 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 44.3 mttm -73.3 -16.33 61.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.204 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 44' ' ' PHE . 58.9 p -70.07 -19.54 63.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.409 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.14 26.94 67.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 85' ' ' LEU . 6.5 mp -96.08 164.59 18.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.713 -0.875 . . . . 0.0 110.428 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.742 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.9 Cg_endo -74.05 172.87 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.976 1.514 . . . . 0.0 110.476 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 t -66.84 -67.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.612 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' LEU . 26.0 m -43.01 -62.59 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -0.86 . . . . 0.0 111.165 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.742 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -42.51 -55.68 3.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.182 -0.949 . . . . 0.0 110.936 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' A' ' 49' ' ' LEU . 94.9 mt -52.87 -35.58 57.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.637 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -76.95 -33.77 57.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 108.739 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.435 ' NE2' HD11 ' A' ' 60' ' ' LEU . 69.3 t60 -73.7 -34.12 64.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -72.85 -19.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 57.6 t-105 -70.83 -44.56 66.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.471 -0.768 . . . . 0.0 109.948 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -70.34 -28.38 65.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.06 179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 93' ' ' HIS . 45.4 mt -73.98 -12.68 60.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 17.1 p -116.06 -31.9 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.138 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 19.7 t0 -84.33 54.79 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.73 ' CG2' HD22 ' A' ' 95' ' ' LEU . 16.6 p -50.73 -31.66 17.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 70' ' ' SER . 9.1 mmtt -49.97 -21.09 1.08 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.425 0.631 . . . . 0.0 110.167 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 45.66 51.92 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.842 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.7 -5.09 7.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.29 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.97 58.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 11.4 mttm -116.4 -178.12 3.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -1.188 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -118.47 99.2 6.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.458 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.572 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.85 -171.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 110.296 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.32 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.056 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.49 -20.92 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 110.722 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.557 ' HG3' ' HG3' ' A' ' 64' ' ' LYS . 4.6 mm100 -72.98 -49.63 27.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.775 ' N ' HD22 ' A' ' 69' ' ' LEU . 9.5 t80 -61.21 -26.52 67.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.026 . . . . 0.0 109.467 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.719 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.39 -13.85 59.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.591 -0.693 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.861 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.8 tt -90.61 -28.74 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 110.759 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.59 -51.61 64.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 110.052 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 81' ' ' ILE . 13.5 m-85 -51.38 -34.02 32.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 109.795 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.4 t60 -57.51 -20.94 34.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.324 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 2.7 mt -99.42 -31.61 11.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.226 -0.922 . . . . 0.0 109.16 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CE1' ' A' ' 44' ' ' PHE . 68.2 mt -63.18 -58.29 8.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.2 -37.03 1.96 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.596 -0.69 . . . . 0.0 110.785 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -58.78 -30.95 67.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.929 -1.107 . . . . 0.0 110.555 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -90.47 -21.76 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.793 -1.192 . . . . 0.0 111.023 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.777 HD11 HG22 ' A' ' 81' ' ' ILE . 5.0 mt -86.73 -47.49 9.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 111.496 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' HA ' HD13 ' A' ' 86' ' ' ILE . 3.1 mm -110.97 -10.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.917 -1.114 . . . . 0.0 111.194 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -118.3 -10.28 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.797 -1.189 . . . . 0.0 110.459 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 62.47 11.87 36.84 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.1 mt -90.6 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.253 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' ' 89' ' ' ILE . 1.4 m-20 -114.7 162.73 22.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 43.1 Cg_endo -68.03 158.58 56.79 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.982 1.517 . . . . 0.0 110.315 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.1 Cg_endo -72.04 178.66 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.867 1.456 . . . . 0.0 110.157 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -64.08 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.1 -1.0 . . . . 0.0 109.67 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' HD21 ' A' ' 60' ' ' LEU . 13.5 m -117.74 -165.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CG2' ' A' ' 63' ' ' THR . 11.7 mt -77.18 152.33 34.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.834 0.826 . . . . 0.0 111.687 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.013 ' O ' HD12 ' A' ' 100' ' ' ILE . 45.1 p -123.7 169.95 9.41 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.5 Cg_endo -66.06 -26.31 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.297 1.157 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.964 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.1 mt-10 -79.34 -6.97 57.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 108.924 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.861 ' CG ' HD21 ' A' ' 76' ' ' LEU . 33.6 ttm -107.6 -32.66 7.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.013 HD12 ' O ' ' A' ' 96' ' ' THR . 2.4 mt -69.6 111.83 10.14 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.627 -0.67 . . . . 0.0 109.705 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 43.9 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 124.03 1.542 . . . . 0.0 114.108 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.975 HG23 HG12 ' A' ' 12' ' ' VAL . 1.1 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.19 0.519 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 11' ' ' VAL . 3.4 p 21.48 80.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-O 121.296 0.57 . . . . 0.0 112.166 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.546 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -109.45 -40.57 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 113.398 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 13' ' ' SER . 55.4 Cg_endo -80.05 -152.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 122.836 0.914 . . . . 0.0 112.35 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.94 -54.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HB3' HG23 ' A' ' 12' ' ' VAL . 40.1 mt-10 -37.98 -60.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.679 -0.638 . . . . 0.0 110.572 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -55.95 -36.75 68.15 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.633 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.07 -48.82 67.08 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.702 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -55.33 -30.96 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.449 -0.782 . . . . 0.0 109.561 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.8 m-85 -85.37 -38.06 19.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.62 -35.6 74.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.458 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 31.4 mt-10 -75.9 -40.96 53.37 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.693 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.2 mt -69.25 -38.1 77.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.519 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 47.5 t80 -46.78 -31.32 2.93 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.491 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.7 mt -70.2 -32.0 69.71 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 23' ' ' ILE . 11.9 mtmt -89.73 -15.91 31.49 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.999 HG22 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -89.53 -51.86 5.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 20.7 t0 -71.4 56.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 97.6 mttt -44.57 -23.78 0.14 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.91 . . . . 0.0 111.618 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.6 m-20 -89.58 1.13 56.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.134 . . . . 0.0 110.571 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt 47.16 53.76 10.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.484 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 3.0 p30 -125.42 23.28 7.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.943 . . . . 0.0 109.951 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 64.9 12.09 52.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -151.02 108.44 3.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.238 . . . . 0.0 111.381 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -92.98 134.16 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.065 -1.022 . . . . 0.0 109.081 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.748 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.5 t -87.32 153.67 21.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.91 -26.18 1.91 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.38 -41.99 99.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.43 -1.041 . . . . 0.0 111.636 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.8 mt-10 -81.24 -61.76 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 108.887 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -52.56 -20.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.533 0.683 . . . . 0.0 109.436 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -46.81 -73.15 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.2 -42.38 4.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -58.81 -44.86 91.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.2 m-85 -80.45 -31.58 37.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.61 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 42' ' ' GLU . 57.9 mt -60.9 -16.78 45.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.0 109.357 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mttt -80.17 -22.44 41.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.194 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 44' ' ' PHE . 33.2 p -56.37 -25.39 49.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 110.472 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.95 83.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.602 ' CD2' HG23 ' A' ' 81' ' ' ILE . 3.1 mp -88.91 160.6 43.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.966 . . . . 0.0 110.436 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 40.8 Cg_endo -67.83 132.39 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.953 1.502 . . . . 0.0 110.226 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -39.33 -54.72 1.83 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.723 . . . . 0.0 110.862 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -47.98 -52.17 20.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 110.277 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.598 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -55.77 -51.54 67.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.853 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 44' ' ' PHE . 53.8 mt -58.92 -40.14 83.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -45.75 69.08 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.538 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 9.8 t-80 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 81' ' ' ILE . 3.1 mt -80.37 -27.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.653 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 22.9 t-105 -68.61 -47.98 65.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 108.968 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -61.48 -28.67 69.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.981 HD23 HD13 ' A' ' 80' ' ' LEU . 1.6 tp -67.61 -47.5 69.48 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 17.6 p -80.97 -35.02 32.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.012 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.501 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 39.2 t0 -65.5 59.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.501 -0.749 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.1 p -64.61 -30.34 71.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 1.4 mptp? -66.14 -10.78 44.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 t70 42.43 54.87 4.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 m -120.66 4.82 10.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.35 -10.93 69.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -120.91 -170.8 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.28 -1.129 . . . . 0.0 109.949 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.741 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -122.55 109.47 14.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.988 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -61.7 -178.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 109.459 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.1 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.45 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.3 m-20 -46.14 -25.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 110.277 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 64' ' ' LYS . 9.5 mt-30 -68.75 -57.04 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.878 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.855 ' CE2' HG21 ' A' ' 27' ' ' THR . 17.3 t80 -52.57 -21.42 3.84 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.347 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -85.85 -10.08 55.95 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.19 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.6 tp -91.33 -43.61 9.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.481 -0.762 . . . . 0.0 110.324 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.06 -31.4 67.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.998 -1.064 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 20.0 m-85 -72.39 -35.26 68.4 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.225 -0.922 . . . . 0.0 108.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 27.8 t-80 -53.44 -23.85 11.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.121 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.981 HD13 HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -93.19 -42.2 9.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.659 HG22 HD11 ' A' ' 85' ' ' LEU . 1.2 mm -55.28 -56.41 11.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.581 -0.699 . . . . 0.0 109.307 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -46.73 6.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 110.585 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.9 mt-30 -55.38 -24.61 30.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.974 -1.078 . . . . 0.0 110.007 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -90.22 -18.59 25.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.695 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.659 HD11 HG22 ' A' ' 81' ' ' ILE . 5.4 mt -90.73 -47.01 7.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.49 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.6 -18.86 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.932 -1.105 . . . . 0.0 111.232 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.022 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -109.72 -17.35 13.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.934 -1.104 . . . . 0.0 110.645 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 69.74 11.84 66.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -93.22 141.86 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.337 -1.096 . . . . 0.0 110.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.587 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -81.78 -172.0 0.33 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 0.0 108.79 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 90' ' ' ASP . 43.4 Cg_endo -78.33 158.93 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.415 1.219 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.7 Cg_endo -72.9 47.01 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.879 1.463 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 19.1 m170 55.89 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.272 -0.893 . . . . 0.0 111.003 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -117.23 -161.75 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 110.58 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.76 164.23 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.114 0.959 . . . . 0.0 111.175 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.857 ' O ' HD12 ' A' ' 100' ' ' ILE . 1.5 p -127.96 -177.83 0.69 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.1 Cg_endo -75.05 -5.17 16.44 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.253 1.133 . . . . 0.0 109.667 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 11' ' ' VAL . 11.5 mt-10 -96.07 -18.33 20.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.855 0.836 . . . . 0.0 109.113 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.735 ' SD ' HG23 ' A' ' 96' ' ' THR . 4.0 mtp -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.855 0.836 . . . . 0.0 108.897 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 96' ' ' THR . 2.0 mt -61.0 128.65 89.55 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.887 -0.508 . . . . 0.0 109.743 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 C--N 1.306 -1.702 0 O-C-N 123.833 1.438 . . . . 0.0 110.635 -179.454 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.8 m . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.466 0.65 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG23 ' HB3' ' A' ' 16' ' ' GLU . 1.4 p -143.33 70.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.503 -0.748 . . . . 0.0 110.182 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -104.89 -31.96 0.2 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.192 -0.943 . . . . 0.0 113.49 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 13' ' ' SER . 53.2 Cg_endo -75.09 -150.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 122.575 0.776 . . . . 0.0 110.788 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.9 -46.57 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.803 -0.561 . . . . 0.0 111.903 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.924 ' HB3' HG23 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -51.79 -59.55 4.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 9.1 tmtt? -52.16 -40.85 62.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 109.816 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -30.22 60.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 109.682 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 18.6 m-85 -88.59 -41.66 12.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.422 -0.799 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD2' ' NZ ' ' A' ' 17' ' ' LYS . 8.6 t70 -50.59 -39.79 50.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.252 -0.905 . . . . 0.0 109.178 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.42 -47.2 64.87 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' LYS . 20.3 mt -63.65 -39.26 84.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.432 -0.792 . . . . 0.0 109.413 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 66.7 t80 -49.24 -24.62 1.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.73 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.29 -26.07 60.92 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 1.8 tttt -97.95 -15.44 20.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.001 HG22 HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.83 -55.77 3.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 20.9 t0 -69.57 58.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 0.3 OUTLIER -36.72 -46.0 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.521 -0.737 . . . . 0.0 112.729 -178.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' MET . 5.1 p-10 -94.52 15.6 17.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.617 -1.302 . . . . 0.0 111.994 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 30' ' ' ASP . 9.5 mtm 35.08 56.04 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.481 -0.762 . . . . 0.0 111.271 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 13.6 p30 -101.49 4.38 41.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 110.241 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.14 -33.22 4.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 1.3 p90 -146.76 146.46 30.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -1.094 . . . . 0.0 110.74 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.001 HG21 HG22 ' A' ' 27' ' ' THR . 1.3 p -90.45 127.99 42.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.699 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -74.7 151.82 39.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.599 -1.313 . . . . 0.0 109.588 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -45.5 -23.88 0.95 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.3 mt -61.56 -46.39 90.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.755 -0.85 . . . . 0.0 111.805 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.828 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.3 mt-10 -80.39 -57.17 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.455 -1.403 . . . . 0.0 109.171 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -56.88 -20.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.848 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -43.16 -75.97 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 110.152 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HA ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp0 -42.78 -46.47 5.2 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.761 0.791 . . . . 0.0 109.021 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -52.27 -37.82 23.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -80.99 -43.78 19.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.785 . . . . 0.0 109.145 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 42' ' ' GLU . 14.0 mt -52.65 -23.76 7.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 24.4 mtpt -78.55 -5.64 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.695 . . . . 0.0 109.817 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 44' ' ' PHE . 43.5 p -76.76 -7.99 56.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.866 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.93 15.65 79.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.721 ' HB3' HD13 ' A' ' 54' ' ' LEU . 9.4 mp -88.21 165.26 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.996 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.2 Cg_endo -74.93 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.983 1.517 . . . . 0.0 109.225 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.99 -73.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.949 -1.094 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 53' ' ' LEU . 1.3 m -41.42 -58.0 2.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 111.088 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -40.86 -50.34 3.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.145 -0.972 . . . . 0.0 110.843 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -57.22 -41.61 79.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.862 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.21 92.85 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.829 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -64.36 -40.11 95.2 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD11 ' HE2' ' A' ' 84' ' ' LYS . 2.4 mt -69.0 -31.28 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.352 -0.842 . . . . 0.0 108.827 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.85 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 53.9 t-105 -63.19 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.544 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -74.84 -25.61 59.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.818 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -74.78 -25.53 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.825 . . . . 0.0 109.317 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 29.8 p -100.78 -32.74 10.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 108.692 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.616 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 53.2 t0 -72.52 61.0 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.716 -0.615 . . . . 0.0 109.899 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 1.5 p -51.65 -34.95 40.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -60.51 -13.7 15.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.459 -0.775 . . . . 0.0 110.053 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 40.75 56.32 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.516 -0.74 . . . . 0.0 110.293 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 7.58 3.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.85 75.2 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.689 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -127.55 170.12 12.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.323 -1.104 . . . . 0.0 109.987 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.85 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 1.1 mt -118.2 98.58 6.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.082 -1.011 . . . . 0.0 110.512 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 1.2 p -46.18 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.333 -0.855 . . . . 0.0 109.407 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.54 -56.98 10.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.504 -1.373 . . . . 0.0 109.628 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -64.25 -49.0 73.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 110.704 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.616 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 26.0 mt-30 -44.45 -42.98 7.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 111.184 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.931 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.2 t80 -55.02 -44.93 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.15 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -68.6 -9.49 50.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.988 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 76' ' ' LEU . 2.8 tt -90.81 -35.29 14.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 111.219 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.64 -46.09 87.87 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 17.6 m-85 -56.74 -37.34 70.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.996 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.2 t-80 -49.39 -21.66 0.94 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.07 -1.019 . . . . 0.0 109.65 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.8 mt -98.29 -24.6 15.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.807 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.949 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 18.3 mt -74.51 -58.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -30.44 7.62 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.603 -0.686 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -69.12 -21.98 63.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.968 ' HE2' HD11 ' A' ' 57' ' ' ILE . 9.3 mttm -90.99 -25.74 19.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' HD23 ' A' ' 85' ' ' LEU . 5.1 mt -86.39 -65.49 1.01 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mm -84.64 -6.08 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.001 . . . . 0.0 110.703 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.975 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mmtt -126.68 -28.89 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.933 -1.104 . . . . 0.0 110.491 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 68.55 18.79 72.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.975 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.7 mt -89.31 141.22 14.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.276 -1.132 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.27 167.51 33.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.558 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' HE3' ' A' ' 84' ' ' LYS . 44.4 Cg_endo -75.25 146.68 32.06 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.184 1.623 . . . . 0.0 110.574 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.745 ' O ' HD21 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -72.25 102.0 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.989 1.52 . . . . 0.0 110.289 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.578 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -5.07 -70.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.586 ' CA ' HD11 ' A' ' 60' ' ' LEU . 4.5 m -122.13 -173.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.086 -1.009 . . . . 0.0 110.977 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -84.33 170.78 13.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 111.815 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.664 HG23 ' SD ' ' A' ' 99' ' ' MET . 1.3 p -135.03 177.26 2.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.0 Cg_endo -70.99 -12.62 30.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.324 1.17 . . . . 0.0 110.2 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.595 ' O ' HG13 ' A' ' 11' ' ' VAL . 81.7 mt-10 -87.38 -18.34 30.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 108.711 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.822 ' HB2' HD23 ' A' ' 95' ' ' LEU . 4.4 mtp -90.12 -43.19 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.719 0.771 . . . . 0.0 109.073 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' THR . 1.3 mt -53.34 137.16 50.23 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.772 -0.58 . . . . 0.0 109.98 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.082 1.57 . . . . 0.0 110.75 -179.498 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 98' ' ' GLU . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.692 HG23 ' CG2' ' A' ' 11' ' ' VAL . 2.3 t -97.44 161.43 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.551 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 170.96 -54.61 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.354 -0.841 . . . . 0.0 111.156 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.4 Cg_endo -71.83 -153.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.716 1.377 . . . . 0.0 110.45 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.89 -56.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.448 0.642 . . . . 0.0 111.408 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -39.42 -64.57 0.46 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.664 -0.648 . . . . 0.0 110.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 8.0 tmtm? -50.91 -44.27 60.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -44.84 89.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -61.67 -26.85 68.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.434 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.612 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 11.5 m-85 -90.47 -51.09 5.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.623 -0.673 . . . . 0.0 109.978 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -45.62 -36.84 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.632 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 25' ' ' LEU . 71.5 mt-10 -74.66 -40.29 61.54 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.692 HG22 ' OG1' ' A' ' 27' ' ' THR . 36.5 mt -70.09 -35.18 62.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.842 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 73.3 t80 -48.82 -38.93 23.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.739 -1.225 . . . . 0.0 108.04 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.3 mt -62.79 -26.67 68.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.15 -13.72 20.77 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.04 HG22 HG21 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -89.2 -55.47 3.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 34' ' ' PHE . 21.5 t0 -63.29 73.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 65.9 mmtt -52.45 -19.79 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.303 -0.873 . . . . 0.0 111.22 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -97.0 3.15 52.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 110.793 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.76 27.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 34' ' ' PHE . 7.6 p-10 -92.92 11.5 27.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.125 -0.984 . . . . 0.0 110.194 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.34 5.45 89.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 70' ' ' SER . 1.9 m-85 -147.26 109.3 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 0.0 110.316 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.04 HG21 HG22 ' A' ' 27' ' ' THR . 4.2 p -88.86 126.59 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.49 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -81.82 148.63 28.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 110.136 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.19 -26.44 0.54 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.489 -1.007 . . . . 0.0 110.857 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.9 mt-10 -85.98 -58.79 2.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.774 -1.204 . . . . 0.0 108.927 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.544 HG11 ' HZ3' ' A' ' 58' ' ' TRP . 1.5 p -58.54 -13.84 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.503 0.668 . . . . 0.0 109.815 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.678 ' HG3' HD11 ' A' ' 45' ' ' LEU . 10.6 ttm180 -50.93 -70.27 0.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.638 -0.664 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -45.0 -44.17 9.72 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.024 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -59.13 -41.27 83.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.881 ' CE2' HD11 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.29 -19.94 52.57 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.592 -0.692 . . . . 0.0 109.211 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 42' ' ' GLU . 12.9 mt -76.42 -29.8 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.149 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 19.3 mttm -73.76 -9.61 58.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.507 -0.746 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.711 ' OG1' HD23 ' A' ' 49' ' ' LEU . 72.3 p -64.85 -51.53 61.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.76 21.01 5.87 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.711 HD23 ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.63 172.94 7.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.941 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.767 ' HD2' HD22 ' A' ' 53' ' ' LEU . 39.2 Cg_endo -66.16 -93.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.777 1.409 . . . . 0.0 110.596 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -158.66 -73.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.863 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -59.66 -29.73 68.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.767 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.1 tp -51.18 -60.1 3.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.66 HD13 HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -52.6 -35.12 53.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 108.974 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' THR . . . -68.6 -38.47 80.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.61 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 5.0 t-80 -68.84 -35.12 76.56 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 mt -69.84 -23.03 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.66 -46.28 79.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.483 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.479 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -68.57 -29.59 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.567 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 94' ' ' VAL . 1.2 mp -74.89 -18.45 60.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.904 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 14.0 p -108.22 -30.04 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.179 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 63' ' ' THR . 67.0 t0 -78.64 49.02 0.84 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.572 -0.705 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 2.4 p -46.99 -29.18 1.93 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -55.01 -19.42 6.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.302 0.573 . . . . 0.0 109.605 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 m-20 38.85 55.27 2.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.579 -0.7 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.4 t -128.54 -30.4 2.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.97 0.99 4.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -142.51 170.62 15.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.174 -1.192 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.6 mt -104.15 104.07 13.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.421 -0.799 . . . . 0.0 110.094 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.08 -168.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 110.004 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.618 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.45 -67.98 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.722 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.52 -21.42 65.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.844 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 12.2 mm100 -69.29 -56.0 8.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.873 -1.142 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.86 ' N ' HD22 ' A' ' 69' ' ' LEU . 29.6 t80 -51.56 -22.0 2.93 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.226 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.24 -13.12 55.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.133 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.68 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.2 tp -90.03 -42.98 10.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.904 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.81 -49.12 74.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.064 -1.022 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 1.2 m-85 -50.2 -36.42 30.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB2' HG22 ' A' ' 12' ' ' VAL . 18.3 t-80 -56.69 -30.49 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.504 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.577 HD22 ' CD ' ' A' ' 92' ' ' PRO . 8.3 mt -87.1 -24.01 24.7 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 44' ' ' PHE . 3.0 mm -76.65 -62.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -51.12 -26.03 6.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 110.342 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.533 ' OE1' HG21 ' A' ' 89' ' ' ILE . 3.4 mt-30 -64.85 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 110.446 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.25 -12.41 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 111.109 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.0 mt -87.19 -47.71 8.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.9 mm -111.48 -25.71 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.038 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.1 mmpt? -104.33 -2.59 25.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.643 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 45.54 35.02 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.038 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -106.31 130.42 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.154 -1.203 . . . . 0.0 110.089 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.4 p-10 -70.95 -175.79 0.33 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' A' ' 56' ' ' HIS . 43.0 Cg_endo -81.72 155.39 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.641 1.338 . . . . 0.0 110.044 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.577 ' CD ' HD22 ' A' ' 80' ' ' LEU . 43.4 Cg_endo -70.56 56.31 1.72 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.032 1.543 . . . . 0.0 110.598 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 1.3 m-70 42.58 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.497 -0.752 . . . . 0.0 110.793 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.7 ' HA ' HD11 ' A' ' 60' ' ' LEU . 6.0 m -104.56 -169.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.667 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 60' ' ' LEU . 4.3 mm? -74.0 162.12 29.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.999 ' O ' HD12 ' A' ' 100' ' ' ILE . 43.6 p -138.57 165.21 34.47 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.0 Cg_endo -65.98 -41.18 14.19 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.555 1.292 . . . . 0.0 108.752 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.3 tt0 -67.55 -7.37 25.49 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.641 -0.662 . . . . 0.0 109.438 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.68 ' CG ' HD21 ' A' ' 76' ' ' LEU . 13.7 ttm -111.56 -26.84 8.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.77 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 96' ' ' THR . 3.3 mt -78.0 116.76 61.27 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.432 -0.793 . . . . 0.0 110.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.536 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 47.5 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.896 1.472 . . . . 0.0 110.201 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 120.985 0.421 . . . . 0.0 109.892 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.876 HG21 ' O ' ' A' ' 75' ' ' ALA . 14.9 p 33.41 100.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 111.525 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.96 -68.47 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 112.107 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 40.3 Cg_endo -62.87 -141.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.392 1.207 . . . . 0.0 112.354 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.6 -57.41 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.685 -0.634 . . . . 0.0 112.351 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 12' ' ' VAL . 17.6 mt-10 -40.59 -63.45 0.64 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.426 -0.796 . . . . 0.0 110.599 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.81 -30.95 66.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.121 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.19 -44.57 45.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.572 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -61.17 -28.27 69.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 109.604 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.0 m-85 -87.01 -53.1 5.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.856 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -46.8 -28.74 1.65 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.002 . . . . 0.0 108.96 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -80.74 -42.58 21.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' LYS . 30.7 mt -71.38 -33.89 51.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ILE . 48.8 t80 -48.62 -33.03 9.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.468 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.4 -24.74 67.29 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 23' ' ' ILE . 35.0 mtpt -100.76 -12.89 18.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.474 -0.766 . . . . 0.0 108.969 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.995 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.23 -53.87 4.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.67 0.748 . . . . 0.0 109.076 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 49.9 t0 -67.8 62.17 0.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.632 -0.667 . . . . 0.0 109.37 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 5.2 mptp? -47.78 -25.08 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.172 -0.955 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 4.8 m-20 -91.39 7.59 40.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.788 -1.195 . . . . 0.0 111.142 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 mtt 46.65 31.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.206 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 3.9 p-10 -100.39 19.84 15.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 110.287 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 65.28 12.56 55.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 2.0 m-85 -150.2 108.83 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 0.0 110.664 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.26 132.56 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.051 -1.03 . . . . 0.0 108.623 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.772 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -88.46 156.74 18.94 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.848 -1.158 . . . . 0.0 109.979 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -49.68 -21.32 3.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 38' ' ' LEU . 2.4 mm? -68.49 -35.19 77.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.13 . . . . 0.0 111.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.705 ' HB2' HG23 ' A' ' 35' ' ' VAL . 25.5 mt-10 -88.19 -60.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.581 0.705 . . . . 0.0 109.283 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.71 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.762 -0.586 . . . . 0.0 110.601 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.1 mt-10 -45.28 -43.33 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -54.1 -42.47 55.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 m-85 -83.77 -28.6 28.05 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 42' ' ' GLU . 40.7 mt -63.72 -22.3 66.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 21.7 mtpp -75.81 -8.82 57.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.641 -0.662 . . . . 0.0 109.467 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 44' ' ' PHE . 54.0 p -68.46 -45.16 73.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 110.152 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.27 15.07 10.88 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -97.71 167.62 11.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.559 -0.965 . . . . 0.0 110.553 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.2 Cg_endo -73.85 169.34 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 52' ' ' THR . 55.4 p -67.18 -55.67 13.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.261 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.7 m -49.14 -65.51 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.612 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -41.9 -54.7 3.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 50' ' ' PRO . 50.9 mt -59.14 -44.15 92.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.852 . . . . 0.0 109.693 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.51 -41.91 98.51 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 7.2 t60 -64.95 -30.31 71.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.757 ' CD1' HD13 ' A' ' 81' ' ' ILE . 7.6 mt -73.16 -24.91 21.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.684 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 36.0 t-105 -66.59 -48.48 69.42 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.047 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.42 -33.91 76.77 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.019 -1.05 . . . . 0.0 108.408 178.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.925 HD21 ' O ' ' A' ' 92' ' ' PRO . 2.4 tp -70.76 -5.95 33.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.783 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 3.1 p -118.3 -35.58 3.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 59' ' ' SER . 4.4 p-10 -71.07 50.72 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.738 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.807 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.8 p -51.41 -29.07 14.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.747 -1.221 . . . . 0.0 108.266 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE3' ' NE2' ' A' ' 73' ' ' GLN . 6.6 mmtt -53.59 -19.4 3.85 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.464 0.649 . . . . 0.0 109.996 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 44.63 53.1 7.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 t -126.28 -12.33 6.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.471 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.39 -7.48 37.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 6.0 ptpt -129.98 -172.0 2.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -1.191 . . . . 0.0 110.342 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -123.41 103.46 8.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.146 -0.971 . . . . 0.0 111.063 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.34 -169.15 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.668 -1.27 . . . . 0.0 109.851 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -62.61 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.349 -0.844 . . . . 0.0 110.639 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' ALA . 4.0 m-20 -41.98 -67.43 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.531 ' CG ' ' OG1' ' A' ' 63' ' ' THR . 15.5 mp0 -39.75 -39.34 0.77 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.518 -0.739 . . . . 0.0 111.2 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.651 ' CA ' HD22 ' A' ' 69' ' ' LEU . 14.8 t80 -66.73 -35.61 80.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.744 -1.222 . . . . 0.0 108.683 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.876 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -74.79 -6.75 50.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 109.375 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.77 HD21 ' HG2' ' A' ' 99' ' ' MET . 4.2 tp -90.36 -44.43 9.67 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.358 -0.839 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -52.12 -51.88 55.08 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.703 -1.248 . . . . 0.0 109.815 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 9.7 m-85 -54.45 -36.75 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 110.262 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.525 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 78.4 t60 -53.92 -20.21 5.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.902 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.621 HD13 HD23 ' A' ' 60' ' ' LEU . 3.1 mt -100.22 -19.57 16.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 0.0 109.034 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.757 HD13 ' CD1' ' A' ' 57' ' ' ILE . 18.1 mm -72.38 -66.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' ILE . 79.0 p -41.01 -29.91 0.12 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.737 -0.602 . . . . 0.0 110.107 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 31.4 mt-30 -61.94 -38.7 89.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 110.04 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 49' ' ' LEU . 10.3 tptt -85.72 -14.51 45.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.929 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 49' ' ' LEU . 4.4 mt -83.84 -64.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.984 -1.073 . . . . 0.0 110.719 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG22 ' HE3' ' A' ' 87' ' ' LYS . 10.4 mm -95.89 -35.92 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.205 -0.935 . . . . 0.0 110.73 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.047 ' HB3' HD12 ' A' ' 89' ' ' ILE . 3.6 mmpt? -90.06 -0.99 57.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 43.91 24.99 0.56 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.047 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.5 mt -95.19 150.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.817 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.1 m-20 -92.91 159.6 35.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.007 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 44.7 Cg_endo -71.25 154.9 61.45 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.948 1.499 . . . . 0.0 109.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.925 ' O ' HD21 ' A' ' 60' ' ' LEU . 43.2 Cg_endo -70.43 142.14 44.22 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.988 1.52 . . . . 0.0 110.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 92' ' ' PRO . 4.1 m-70 -40.72 -57.92 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 110.444 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.602 ' CA ' HD11 ' A' ' 60' ' ' LEU . 15.1 m -124.51 -162.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 110.884 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -95.5 132.99 40.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.535 -0.728 . . . . 0.0 111.492 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 43.6 p -87.44 167.66 20.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.6 Cg_endo -66.81 -16.89 51.39 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.406 1.214 . . . . 0.0 109.403 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 11' ' ' VAL . 6.3 mt-10 -85.87 -27.31 25.12 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.77 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.8 ttm -83.86 -12.57 55.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.532 0.682 . . . . 0.0 109.306 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.17 115.19 65.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.621 -0.674 . . . . 0.0 110.081 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 C--N 1.304 -1.813 0 O-C-N 123.759 1.399 . . . . 0.0 110.32 179.707 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.725 ' CG2' HG12 ' A' ' 12' ' ' VAL . 4.1 m . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -160.31 72.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.212 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 94.5 p -108.43 -22.36 0.17 Allowed Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 13' ' ' SER . 56.8 Cg_endo -76.62 -157.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 122.294 0.628 . . . . 0.0 111.473 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.22 -51.77 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.325 0.583 . . . . 0.0 111.671 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 55.2 mt-10 -39.42 -63.09 0.59 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -57.75 -32.12 67.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 110.069 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.31 -41.13 61.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -29.7 69.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.425 -0.797 . . . . 0.0 109.552 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.8 m-30 -81.29 -41.06 22.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.468 -0.77 . . . . 0.0 109.414 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.41 -31.54 15.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.58 -35.78 52.67 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.618 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.1 mt -74.5 -42.17 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 53.1 t80 -45.83 -28.92 1.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.464 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.0 -34.53 77.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 38.0 mtmt -93.68 -9.47 37.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.895 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.56 -56.01 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.718 0.771 . . . . 0.0 109.018 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 51.1 t0 -70.13 70.43 0.38 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.628 -0.67 . . . . 0.0 109.313 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 76.1 mttt -62.34 -8.13 5.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 111.588 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -95.25 -2.94 48.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.879 -1.138 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mmt 57.08 18.61 4.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 110.16 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 24.7 p30 -92.28 18.96 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.193 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 63.68 15.81 58.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.595 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.84 112.61 4.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.083 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.892 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.63 130.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.017 -1.052 . . . . 0.0 109.587 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.9 p -85.3 148.93 25.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 109.391 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.05 -26.53 0.5 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -62.0 -35.31 78.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.643 -0.916 . . . . 0.0 111.019 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.7 mt-10 -89.13 -63.35 1.3 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.648 -1.283 . . . . 0.0 109.192 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.847 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.2 p -49.07 -21.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.321 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.768 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -43.02 -62.1 1.12 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.9 mt-10 -51.94 -45.87 64.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 108.476 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.895 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -54.65 -33.54 27.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.847 ' CD2' HG22 ' A' ' 40' ' ' VAL . 2.7 m-85 -85.17 -35.39 21.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 109.558 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 42' ' ' GLU . 11.2 mt -60.3 -15.36 24.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 38.8 mttt -85.4 -10.19 56.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.653 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.537 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 44.6 p -73.68 -55.82 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.08 -7.98 9.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.753 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.7 mm? -69.89 161.92 71.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.369 -1.077 . . . . 0.0 110.245 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 43.5 Cg_endo -71.72 143.36 41.6 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' PRO . 56.2 p -40.41 -46.99 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.377 -0.827 . . . . 0.0 110.982 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.2 m -62.53 -61.57 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.981 . . . . 0.0 110.952 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.753 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -44.89 -47.6 11.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.561 HD22 ' CD1' ' A' ' 44' ' ' PHE . 65.4 mt -55.9 -37.56 69.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.018 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.88 -43.55 75.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.484 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 20.7 t60 -61.36 -37.78 84.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.394 -0.816 . . . . 0.0 108.799 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 81' ' ' ILE . 13.8 mt -71.84 -28.51 30.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.551 -0.718 . . . . 0.0 109.079 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.687 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 15.2 t-105 -64.85 -37.8 88.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.552 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' CG ' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -75.14 -25.08 58.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 108.973 179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' A' ' 95' ' ' LEU . 1.1 mp -77.67 -17.99 57.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.344 -0.847 . . . . 0.0 108.784 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.76 ' SG ' HD21 ' A' ' 69' ' ' LEU . 14.7 p -104.69 -29.38 10.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.751 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HA ' ' A' ' 59' ' ' SER . 5.5 p-10 -71.08 55.42 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.948 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -50.58 -30.07 12.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 109.524 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -63.99 -10.25 20.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.52 -0.737 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.28 56.64 2.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.375 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 t -128.0 -31.01 2.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.43 -5.64 7.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -127.0 172.67 10.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -1.147 . . . . 0.0 109.659 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -108.43 111.13 22.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.03 -1.044 . . . . 0.0 111.017 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.595 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -62.82 -178.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.992 . . . . 0.0 110.164 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.626 ' HE2' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.8 -77.66 0.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 111.322 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.403 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 35.7 m-20 -54.31 -28.02 39.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.195 -0.941 . . . . 0.0 111.032 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' CG ' ' OG ' ' A' ' 70' ' ' SER . 36.1 mm-40 -66.08 -47.32 74.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 110.459 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.779 ' CE1' HG21 ' A' ' 27' ' ' THR . 23.9 t80 -56.5 -30.17 62.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.439 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -76.92 -13.82 59.94 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.57 0.7 . . . . 0.0 109.413 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.03 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.52 -32.96 19.13 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.51 -0.744 . . . . 0.0 109.657 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.73 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.55 -51.0 67.31 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 109.62 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 5.2 m-85 -47.65 -41.7 22.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.917 . . . . 0.0 109.627 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -52.07 -29.21 20.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.613 HD12 HG23 ' A' ' 57' ' ' ILE . 2.7 mt -83.89 -30.93 25.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -0.993 . . . . 0.0 108.726 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 57' ' ' ILE . 8.3 mm -65.12 -57.64 10.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.454 0.645 . . . . 0.0 109.315 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.62 -36.19 2.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.593 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 45.1 mt-30 -58.06 -33.59 69.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.837 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -89.12 -28.85 19.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.0 111.224 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 85' ' ' LEU . 4.2 mt -77.4 -63.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.929 -1.107 . . . . 0.0 110.865 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.92 -12.99 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.965 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -122.45 -17.02 7.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 110.943 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 84' ' ' LYS . . . 58.51 25.05 57.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.965 HD12 ' HB3' ' A' ' 87' ' ' LYS . 17.1 mt -98.48 165.74 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -1.06 . . . . 0.0 110.05 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 4.6 m-20 -96.19 164.1 19.27 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -69.49 162.89 40.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.186 1.624 . . . . 0.0 110.694 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -71.48 69.05 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.114 1.586 . . . . 0.0 111.779 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.543 ' O ' HD11 ' A' ' 60' ' ' LEU . 3.2 m170 32.41 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.772 -0.58 . . . . 0.0 111.87 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 60' ' ' LEU . 3.2 m -110.66 -164.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.171 -0.956 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.718 HD13 ' SD ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -72.29 151.87 42.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.82 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.935 ' O ' HD12 ' A' ' 100' ' ' ILE . 60.8 p -129.32 163.02 49.09 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.304 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 45.2 Cg_endo -71.39 -6.27 18.81 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.832 1.438 . . . . 0.0 110.682 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.691 ' C ' HG13 ' A' ' 11' ' ' VAL . 11.5 mt-10 -95.96 -28.93 14.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.718 ' SD ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -94.5 -12.57 27.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 110.031 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 96' ' ' THR . 5.5 mt -79.36 142.17 58.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 100' ' ' ILE . 42.4 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.857 1.451 . . . . 0.0 110.175 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.121 0.486 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -152.24 67.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 111.012 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -105.72 -28.85 0.2 Allowed Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.9 Cg_endo -75.84 -155.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.577 0.777 . . . . 0.0 111.459 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.98 -48.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.432 0.634 . . . . 0.0 111.905 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 12' ' ' VAL . 9.9 mt-10 -46.35 -60.97 2.0 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -52.67 -41.46 63.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.06 . . . . 0.0 110.063 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.41 96.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.465 -0.772 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.3 ttpt -58.91 -30.43 67.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.498 -0.751 . . . . 0.0 109.801 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 5.8 m-85 -85.07 -49.65 8.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.728 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -44.09 -36.68 2.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.879 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 25' ' ' LEU . 22.3 mt-10 -71.91 -36.8 70.09 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.653 HG22 ' HG1' ' A' ' 27' ' ' THR . 45.2 mt -72.32 -40.84 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.491 -0.756 . . . . 0.0 109.84 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.501 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 31.3 t80 -48.12 -37.4 15.33 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.201 -1.0 . . . . 0.0 108.538 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.3 mt -64.09 -23.18 67.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' ILE . 3.0 mmmt -102.86 -14.2 16.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.095 HG23 HD12 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -88.76 -56.69 3.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.621 -0.675 . . . . 0.0 109.354 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.33 77.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.663 -0.648 . . . . 0.0 109.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' THR . 5.8 mttm -67.04 -1.63 4.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.184 -0.948 . . . . 0.0 112.236 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.507 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 90.9 m-20 -104.65 -2.78 24.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.707 -1.246 . . . . 0.0 110.631 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mmt 57.56 18.27 4.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 110.899 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.7 p30 -90.24 0.08 57.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.093 . . . . 0.0 110.091 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 12.98 77.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -147.43 105.02 3.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 110.065 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.978 HG21 HG22 ' A' ' 27' ' ' THR . 8.8 p -89.19 133.79 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.034 -1.041 . . . . 0.0 109.502 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -86.72 157.17 19.69 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.047 -1.033 . . . . 0.0 110.196 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -51.22 -21.81 6.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.5 mm? -72.75 -31.84 65.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -1.039 . . . . 0.0 111.352 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.564 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.5 mt-10 -83.05 -55.27 4.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.68 -1.263 . . . . 0.0 108.373 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -61.05 -10.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -50.55 -73.06 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -42.5 -41.27 2.91 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.095 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -60.14 -41.94 88.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.724 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 m-30 -81.9 -32.57 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.424 -0.797 . . . . 0.0 109.308 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.696 HD11 ' CG ' ' A' ' 41' ' ' ARG . 32.6 mt -58.58 -26.63 63.83 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.109 -0.994 . . . . 0.0 108.649 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -70.98 -8.88 56.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.513 -0.742 . . . . 0.0 109.076 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.7 p -78.36 -35.66 47.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.508 -0.745 . . . . 0.0 110.195 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 95.01 34.12 6.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.617 HD13 ' OG1' ' A' ' 47' ' ' THR . 10.1 mp -105.63 157.12 35.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.828 -0.807 . . . . 0.0 110.717 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.4 Cg_endo -75.2 178.16 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.803 1.423 . . . . 0.0 110.201 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -57.79 3.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.123 -0.986 . . . . 0.0 111.06 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -52.1 -45.32 64.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -57.86 -51.38 69.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 110.005 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 11.3 mt -55.28 -41.32 72.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.195 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 60' ' ' LEU . 13.1 t60 -69.08 -36.04 77.15 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 80' ' ' LEU . 6.9 mt -71.65 -34.48 52.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.591 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 38.6 t-105 -65.1 -47.41 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 109.879 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -31.19 72.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.197 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 ' O ' ' A' ' 93' ' ' HIS . 14.8 mt -71.02 -9.82 58.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 109.184 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' THR . 29.4 m -119.57 -36.63 3.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 109.909 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.542 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 13.0 t0 -66.06 61.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.604 -0.685 . . . . 0.0 109.672 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 1.022 HG22 HD21 ' A' ' 95' ' ' LEU . 11.6 p -58.33 -36.03 72.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.376 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -55.33 -16.2 3.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.04 53.12 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 -34.05 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -0.44 4.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 34' ' ' PHE . 9.9 mttt -132.7 175.55 9.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -1.164 . . . . 0.0 109.988 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.982 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -105.64 110.86 23.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.53 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -62.81 179.09 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.327 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HE3' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.31 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 110.654 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 3.8 m-20 -52.89 -43.37 66.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.979 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 22.0 mt-30 -43.6 -62.72 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.021 -1.049 . . . . 0.0 110.355 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.982 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.9 t80 -49.17 -36.11 18.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.837 -1.164 . . . . 0.0 109.016 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -69.57 -6.14 29.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.421 -0.8 . . . . 0.0 109.66 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.94 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.1 tt -90.34 -38.55 13.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.505 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -55.92 -39.83 72.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 110.196 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 53.1 m-85 -57.33 -29.43 63.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 13.5 t-80 -63.73 -26.55 68.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.79 -48.28 4.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.67 HG21 HG21 ' A' ' 47' ' ' THR . 82.4 mt -60.67 -33.6 55.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.734 -0.603 . . . . 0.0 110.338 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 21.0 t -72.36 -18.67 61.73 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.212 -0.93 . . . . 0.0 111.005 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -90.52 -14.71 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.024 -1.048 . . . . 0.0 111.459 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 1.4 tptt -90.37 -15.27 31.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.664 -1.272 . . . . 0.0 111.136 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 47' ' ' THR . 6.8 mt -90.26 -56.65 3.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 111.554 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.62 -19.74 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.924 -1.11 . . . . 0.0 110.676 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.024 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -109.08 -16.07 14.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.754 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 60.05 36.89 91.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.024 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.6 mt -104.61 154.38 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.273 . . . . 0.0 109.468 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.29 165.27 15.12 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 110.598 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 47.3 Cg_endo -72.34 155.04 56.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.191 1.627 . . . . 0.0 110.236 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.429 ' O ' HD11 ' A' ' 60' ' ' LEU . 42.1 Cg_endo -69.35 -179.34 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.981 1.517 . . . . 0.0 110.003 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.764 ' O ' HD21 ' A' ' 60' ' ' LEU . 54.0 m-70 -64.46 -99.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.9 -1.125 . . . . 0.0 110.19 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 60' ' ' LEU . 7.4 m -108.26 -168.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 120.987 -1.071 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 HG22 ' A' ' 63' ' ' THR . 2.0 tp -61.79 148.27 43.64 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.91 0.862 . . . . 0.0 111.458 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.063 ' O ' HD12 ' A' ' 100' ' ' ILE . 71.0 p -130.08 166.73 24.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.0 Cg_endo -67.86 -25.38 39.18 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.511 1.269 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -80.59 -12.01 59.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 109.101 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.94 ' CG ' HD21 ' A' ' 76' ' ' LEU . 32.5 ttm -103.9 -30.23 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.639 -0.663 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 96' ' ' THR . 3.0 mt -74.54 126.66 88.49 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.487 -0.758 . . . . 0.0 110.405 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.827 1.435 . . . . 0.0 110.458 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.99 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.99 HG23 ' CG2' ' A' ' 11' ' ' VAL . 37.6 t 57.65 121.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.5 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t -157.41 -64.91 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.685 -1.26 . . . . 0.0 112.438 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 46.7 Cg_endo -68.42 -149.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.494 1.26 . . . . 0.0 110.82 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.71 -43.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.31 0.576 . . . . 0.0 111.516 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 6.3 mt-10 -44.66 -62.78 1.08 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 109.864 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -56.69 -30.63 63.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -70.1 -51.32 32.64 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' HE2' ' CA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -57.23 -32.49 66.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.28 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.67 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 8.3 m-30 -83.21 -28.11 29.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.671 -0.643 . . . . 0.0 110.483 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 11.2 t0 -72.07 -32.84 67.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 2.7 mt-10 -81.85 -26.9 33.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -0.91 . . . . 0.0 108.577 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' OG1' ' A' ' 27' ' ' THR . 65.4 mt -82.31 -42.15 18.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.647 -0.658 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.642 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 53.2 t80 -49.98 -25.03 2.94 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.69 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 20.1 mt -71.93 -26.96 62.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 23' ' ' ILE . 13.2 mttt -101.28 -12.59 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.994 HG22 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -89.05 -55.38 3.71 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 4.0 t0 -70.62 81.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.4 mttt -81.17 10.31 5.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.066 -1.021 . . . . 0.0 112.179 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 73.5 m-20 -111.78 10.46 20.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 110.024 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.1 mtm 48.19 23.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.088 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 28.6 p30 -97.85 15.79 22.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.85 52.46 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.08 112.45 4.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -1.042 . . . . 0.0 110.009 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.994 HG21 HG22 ' A' ' 27' ' ' THR . 2.3 p -88.72 133.19 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.94 -1.1 . . . . 0.0 109.889 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.664 ' O ' HG12 ' A' ' 40' ' ' VAL . 17.2 t -90.93 153.45 20.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 110.095 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -43.54 -25.52 0.54 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.6 mt -64.88 -38.73 91.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -1.117 . . . . 0.0 111.693 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.796 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.4 mt-10 -85.13 -55.82 3.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.862 -1.149 . . . . 0.0 108.974 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -59.77 -13.74 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.698 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -56.28 -67.59 0.29 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 109.751 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.982 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.7 mm-40 -45.24 -32.19 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.884 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HG23 ' A' ' 27' ' ' THR 0.268 1.3 mt -69.89 -41.83 79.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.24 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.921 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -74.58 -29.55 61.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.055 . . . . 0.0 109.196 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.982 HD12 ' HA ' ' A' ' 42' ' ' GLU . 15.1 mt -64.4 -18.48 64.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -79.58 -8.01 58.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 108.864 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.3 p -79.84 -23.16 42.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 110.413 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.51 -17.09 58.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HB3' HD13 ' A' ' 54' ' ' LEU . 7.2 mp -54.82 168.62 0.48 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.698 -0.883 . . . . 0.0 110.569 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.1 Cg_endo -81.58 -175.1 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.933 1.491 . . . . 0.0 109.392 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -61.6 1.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.422 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 53' ' ' LEU . 17.2 m -46.89 -64.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -40.53 -44.82 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.372 -0.83 . . . . 0.0 110.666 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -58.95 -43.37 91.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -66.18 -38.55 88.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 108.889 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 37.4 t-80 -66.78 -41.79 87.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.48 -0.762 . . . . 0.0 108.95 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.611 HG21 ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt -67.2 -29.81 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 21.4 t-105 -63.93 -44.61 92.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.556 ' O ' HD11 ' A' ' 95' ' ' LEU . 5.5 t -70.29 -33.62 71.78 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 108.898 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.808 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.1 tp -67.28 -21.65 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 109.809 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.879 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 18.1 p -106.62 -29.46 9.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD2' ' CZ2' ' A' ' 58' ' ' TRP . 26.1 t0 -80.47 52.59 1.66 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 110.042 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.807 HG22 HD22 ' A' ' 95' ' ' LEU . 7.7 p -46.25 -29.83 1.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.043 0.925 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.561 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 2.3 mmtm -58.92 -17.49 24.88 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.227 0.537 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 37.33 56.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.676 -0.64 . . . . 0.0 110.612 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 9.84 6.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.521 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.14 -18.27 54.48 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 34' ' ' PHE . 14.8 pttt -125.1 175.03 7.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.053 -1.263 . . . . 0.0 110.03 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.769 HD12 ' CZ3' ' A' ' 58' ' ' TRP . 1.4 mt -111.73 118.03 34.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.942 . . . . 0.0 111.028 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.643 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -64.32 -172.02 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.181 . . . . 0.0 109.459 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.43 -80.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 111.078 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -53.13 -18.62 2.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.514 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.561 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 10.1 mm100 -74.44 -40.64 61.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.886 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.3 t80 -65.15 -23.0 67.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.083 . . . . 0.0 109.041 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 20' ' ' TYR . . . -78.4 -12.37 60.0 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.504 -0.748 . . . . 0.0 109.736 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.07 HD11 ' CG ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -85.69 -38.36 18.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 110.61 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.879 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -57.06 -44.48 83.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 6.4 m-85 -60.38 -23.49 64.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.626 ' HB2' HG22 ' A' ' 12' ' ' VAL . 45.3 t-80 -64.28 -20.33 66.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 0.0 109.611 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD13 HD23 ' A' ' 60' ' ' LEU . 1.7 mt -99.69 -31.09 11.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 109.036 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.921 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 36.2 mt -61.11 -57.32 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.175 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -39.19 -34.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.695 -0.628 . . . . 0.0 110.828 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' ILE . 21.0 mt-30 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.838 -1.164 . . . . 0.0 110.714 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' ILE . 19.9 tptp -89.89 -10.31 45.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.671 HD11 HG22 ' A' ' 81' ' ' ILE . 7.3 mt -88.37 -58.7 2.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.073 . . . . 0.0 110.918 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.07 -25.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 0.0 110.794 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.065 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -103.62 -8.7 19.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.973 . . . . 0.0 110.422 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 50.85 20.82 4.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.065 HD12 ' HB3' ' A' ' 87' ' ' LYS . 4.6 mt -86.67 142.0 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.972 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 7.5 p-10 -80.16 164.55 51.87 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HD3' HD11 ' A' ' 53' ' ' LEU . 38.6 Cg_endo -66.45 159.8 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.042 1.548 . . . . 0.0 110.278 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.17 58.57 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 0.0 110.616 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.617 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER 39.35 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.631 -0.668 . . . . 0.0 111.235 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 92' ' ' PRO . 5.7 m -101.67 -164.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 111.305 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.808 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -95.3 164.84 12.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.878 0.847 . . . . 0.0 111.802 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.617 ' O ' HD12 ' A' ' 100' ' ' ILE . 14.6 p -133.65 171.65 8.73 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.3 Cg_endo -68.94 -36.19 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.291 1.153 . . . . 0.0 109.632 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.67 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 tt0 -63.4 -18.41 63.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.218 -0.926 . . . . 0.0 109.106 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.07 ' CG ' HD11 ' A' ' 76' ' ' LEU . 24.4 ttm -97.04 -26.42 15.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.456 -0.777 . . . . 0.0 109.526 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 96' ' ' THR . 6.0 mt -82.29 115.3 57.02 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.304 -1.81 0 O-C-N 123.955 1.503 . . . . 0.0 110.309 179.896 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 12' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.582 0.706 . . . . 0.0 109.127 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 11' ' ' VAL . 6.2 t -103.75 159.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.588 -0.695 . . . . 0.0 109.693 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 169.25 -52.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.197 -0.939 . . . . 0.0 111.839 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 52.4 Cg_endo -70.51 -153.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.534 1.281 . . . . 0.0 110.819 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.23 -48.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.272 0.558 . . . . 0.0 111.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.559 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 1.6 mt-10 -50.97 -60.4 3.13 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.302 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -53.48 -36.3 61.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -67.6 -50.84 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.395 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -53.75 -29.58 40.43 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.51 -0.743 . . . . 0.0 109.546 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 10.9 m-85 -90.47 -47.85 7.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 12.9 t70 -49.76 -31.59 11.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 25' ' ' LEU . 32.6 mt-10 -78.41 -36.23 45.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.835 HG22 ' OG1' ' A' ' 27' ' ' THR . 37.7 mt -76.66 -39.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 70' ' ' SER . 74.7 t80 -47.21 -31.66 3.84 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.365 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.0 mt -68.02 -31.52 71.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' ILE . 2.3 tttt -97.0 -10.18 26.71 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.025 HG22 HG21 ' A' ' 35' ' ' VAL . 1.5 m -90.22 -46.49 8.4 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.596 0.712 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 32' ' ' ASP . 27.6 t0 -73.47 62.25 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.227 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -45.87 -20.91 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.126 -0.983 . . . . 0.0 111.354 -178.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 7.5 m-20 -88.94 -5.15 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.929 -1.107 . . . . 0.0 110.363 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.05 44.58 29.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 14.8 p-10 -120.7 24.47 10.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.15 47.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -150.39 99.27 2.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -1.201 . . . . 0.0 110.639 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.025 HG21 HG22 ' A' ' 27' ' ' THR . 7.4 p -90.73 142.09 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 0.0 109.354 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.759 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.28 152.47 19.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.069 -1.02 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.21 -26.49 0.93 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' SER . 71.2 mt -66.11 -41.23 90.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.474 -1.016 . . . . 0.0 110.891 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 19.9 mt-10 -78.6 -58.85 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.35 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 36' ' ' SER . 1.7 p -61.08 -14.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.279 0.561 . . . . 0.0 110.141 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -45.41 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.441 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -42.71 -42.6 3.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 0.0 109.233 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.952 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -55.7 -48.24 78.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.891 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -73.33 -38.88 65.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD23 ' CD1' ' A' ' 54' ' ' LEU . 76.2 mt -60.25 -21.66 62.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.48 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -73.6 -20.09 60.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.225 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.865 HG21 HD13 ' A' ' 81' ' ' ILE . 61.2 p -55.38 -24.45 29.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.21 56.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.9 mp -90.94 170.88 9.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 110.299 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.4 Cg_endo -74.03 -159.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.85 1.447 . . . . 0.0 110.309 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -94.05 -55.7 3.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.741 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.8 m -56.7 -57.12 13.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.694 HD11 ' HD3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -41.25 -46.48 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.601 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.759 HD22 ' HD1' ' A' ' 44' ' ' PHE . 25.0 mt -60.48 -42.05 95.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.954 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -65.7 -43.25 89.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.13 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.531 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 12.9 t60 -65.22 -32.15 73.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG21 ' CE1' ' A' ' 44' ' ' PHE . 4.2 mt -73.64 -27.87 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.799 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 29.6 t-105 -64.72 -43.67 92.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.487 ' O ' HD21 ' A' ' 95' ' ' LEU . 25.5 m -67.52 -35.23 78.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.126 -0.983 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.946 HD13 ' HG2' ' A' ' 92' ' ' PRO . 17.9 mt -67.59 -23.06 65.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.2 p -102.66 -35.48 8.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.06 -1.025 . . . . 0.0 108.866 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 61.1 t0 -70.25 54.4 0.14 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -56.74 -22.29 34.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.048 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 22.6 mmmt -57.03 -16.21 6.66 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.338 0.59 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.44 48.99 8.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.0 t -128.45 -22.1 3.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.357 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.28 -11.12 14.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.0 mtpt -124.81 -177.06 3.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -1.116 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.858 HD13 ' HD1' ' A' ' 74' ' ' PHE . 2.8 mt -116.81 107.26 14.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.628 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -58.65 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.48 -1.388 . . . . 0.0 109.994 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -76.57 -68.1 0.63 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.373 -0.829 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -61.95 -66.97 0.46 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.369 -0.832 . . . . 0.0 112.289 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -39.83 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 0.0 111.516 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.9 t80 -72.39 -38.66 68.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.476 -1.39 . . . . 0.0 108.692 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -67.04 -8.87 33.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.476 0.655 . . . . 0.0 109.554 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -85.85 -45.38 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.448 -0.782 . . . . 0.0 110.02 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB1' ' CZ ' ' A' ' 44' ' ' PHE . . . -42.35 -47.34 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 66.8 m-85 -61.36 -25.7 67.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 66.1 t60 -62.21 -20.98 64.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.446 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 57' ' ' ILE . 4.7 mt -94.92 -21.77 18.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 44' ' ' PHE . 11.4 mt -73.4 -62.69 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -39.39 -33.47 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.811 -0.556 . . . . 0.0 110.33 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 27.4 mt-30 -59.61 -36.69 76.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' ILE . 5.3 tptp -89.86 -16.57 29.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.896 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 81' ' ' ILE . 8.0 mt -81.33 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.015 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.88 -33.15 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.495 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.002 ' HB3' HD12 ' A' ' 89' ' ' ILE . 2.3 mmpt? -94.93 -2.84 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.434 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 47.81 22.21 1.86 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.002 HD12 ' HB3' ' A' ' 87' ' ' LYS . 12.2 mt -92.76 170.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -1.192 . . . . 0.0 109.791 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -102.65 172.73 4.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 110.109 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HD3' HD11 ' A' ' 53' ' ' LEU . 45.8 Cg_endo -71.13 158.73 54.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.064 1.56 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.946 ' HG2' HD13 ' A' ' 60' ' ' LEU . 42.0 Cg_endo -68.73 173.59 9.81 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.959 1.505 . . . . 0.0 109.502 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -74.62 -50.68 16.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.994 -1.067 . . . . 0.0 109.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.614 ' HA ' HD21 ' A' ' 60' ' ' LEU . 27.9 m -141.67 -159.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.86 HD11 ' O ' ' A' ' 60' ' ' LEU . 3.9 mm? -82.21 176.53 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.793 0.806 . . . . 0.0 110.894 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 95' ' ' LEU . 30.9 p -150.96 166.64 14.63 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -70.59 -12.86 31.98 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 123.575 1.303 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.711 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.2 mt-10 -96.89 -19.53 18.78 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.748 0.785 . . . . 0.0 109.081 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.568 ' CG ' HD21 ' A' ' 76' ' ' LEU . 14.1 ttm -101.44 -6.62 23.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 110.224 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' THR . 10.6 mt -86.05 112.82 48.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.545 -0.722 . . . . 0.0 110.151 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 99' ' ' MET . 41.9 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 O-C-N 123.765 1.402 . . . . 0.0 113.322 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.423 0.63 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -140.43 67.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 109.969 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.2 t -103.49 -27.81 0.21 Allowed Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.8 Cg_endo -76.11 -156.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 122.559 0.768 . . . . 0.0 110.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.55 -57.33 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.305 0.574 . . . . 0.0 111.625 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.661 ' HB3' HG23 ' A' ' 12' ' ' VAL . 13.2 mt-10 -39.78 -63.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.694 -0.629 . . . . 0.0 110.74 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' CE ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.36 -45.19 88.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -28.04 68.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.766 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 23.5 m-85 -89.38 -48.46 7.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -47.25 -34.81 6.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.573 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.659 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.3 mt-10 -75.5 -36.05 60.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.011 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 ' OG1' ' A' ' 27' ' ' THR . 41.5 mt -69.82 -39.4 77.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.442 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -48.56 -33.48 9.76 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.645 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 22' ' ' GLU . 15.3 mt -67.8 -25.37 65.55 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' ILE . 9.4 mttp -98.9 -12.73 20.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.986 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.91 -54.52 4.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.563 -0.711 . . . . 0.0 109.508 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.46 90.27 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 108.666 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -83.45 -17.98 40.2 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.054 -1.029 . . . . 0.0 112.6 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -92.23 13.16 19.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.632 -1.293 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.6 mtm 53.05 36.47 22.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 4.1 p-10 -113.05 22.63 14.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 110.348 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' ASP . . . 47.88 26.47 4.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.85 101.1 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.88 -0.776 . . . . 0.0 109.926 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 27' ' ' THR . 3.0 p -88.93 125.37 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.979 -1.075 . . . . 0.0 109.321 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -83.17 157.6 22.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 109.819 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.75 -25.13 0.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 36' ' ' SER . 4.3 mp -59.63 -48.27 82.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -1.02 . . . . 0.0 111.964 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.2 mt-10 -78.65 -57.88 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.624 -1.298 . . . . 0.0 109.237 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.709 HG22 ' CD2' ' A' ' 44' ' ' PHE . 2.1 p -56.93 -16.76 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.983 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 1.4 ttt-85 -50.05 -77.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.003 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -41.12 -37.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.906 0.86 . . . . 0.0 108.954 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 27' ' ' THR 0.251 1.0 OUTLIER -64.74 -51.02 72.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.201 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.709 ' CD2' HG22 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -72.68 -41.18 65.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.051 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.581 HD12 ' HA ' ' A' ' 42' ' ' GLU . 87.5 mt -49.5 -24.17 1.93 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -72.71 -19.81 61.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.612 -0.68 . . . . 0.0 109.558 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.686 ' CG2' HG21 ' A' ' 81' ' ' ILE . 61.9 p -64.39 -13.86 53.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.385 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.34 23.78 70.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.1 mp -100.11 163.99 17.26 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 110.414 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -76.18 140.73 22.63 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.039 1.547 . . . . 0.0 110.338 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -45.63 -46.58 14.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -57.37 -52.83 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.637 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.617 ' CD2' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -53.25 -41.5 65.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.03 . . . . 0.0 110.023 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 44' ' ' PHE . 24.1 mt -66.2 -41.49 90.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.935 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -64.14 -41.01 97.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -70.63 -35.03 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 81' ' ' ILE . 4.8 mt -73.89 -22.52 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 37.5 t-105 -68.98 -44.82 72.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.534 -0.729 . . . . 0.0 109.534 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -69.83 -28.88 66.07 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.144 -0.973 . . . . 0.0 108.69 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.2 mt -72.86 -10.25 59.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.519 -0.738 . . . . 0.0 109.084 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 13.7 p -117.46 -34.4 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.736 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 23.5 t0 -65.63 60.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.454 -0.779 . . . . 0.0 109.961 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.713 HG23 HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -58.98 -27.81 65.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' HG2' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -68.35 -5.81 20.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.059 -1.026 . . . . 0.0 110.771 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 3.4 p-10 37.85 54.78 1.59 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.45 -0.781 . . . . 0.0 111.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 -24.66 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.102 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.5 -9.89 8.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 62.8 mttp -125.0 -174.47 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 0.0 110.127 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.76 HD13 ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -115.53 113.26 23.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.145 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.522 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -77.12 -177.24 4.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.114 . . . . 0.0 110.276 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.25 -33.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.559 ' CD ' ' N ' ' A' ' 73' ' ' GLN . 0.5 OUTLIER -58.36 -40.84 83.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.6 t80 -66.52 -41.54 88.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -63.57 -10.86 20.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.832 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -80.2 -43.27 21.79 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -64.4 -52.18 59.49 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 5.5 m-85 -49.05 -39.41 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.78 . . . . 0.0 109.618 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.558 ' CE1' ' HB ' ' A' ' 11' ' ' VAL . 11.3 t-80 -54.67 -25.68 28.61 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 57' ' ' ILE . 6.9 mt -90.54 -23.82 20.79 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.803 HD11 HG21 ' A' ' 57' ' ' ILE . 17.3 mm -73.86 -56.58 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.806 -0.757 . . . . 0.0 108.985 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -46.79 -28.19 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.526 -0.734 . . . . 0.0 110.027 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -77.2 -22.59 52.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.102 -0.999 . . . . 0.0 110.187 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -91.63 -30.96 16.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.9 mt -81.02 -58.93 2.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.066 -1.021 . . . . 0.0 111.018 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.544 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -80.18 -42.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.953 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.077 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -94.34 -35.45 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 111.202 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 85.84 3.43 85.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.077 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.5 mt -66.86 165.5 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.186 -1.185 . . . . 0.0 109.885 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -102.31 164.12 16.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 0.0 110.292 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 53' ' ' LEU . 47.5 Cg_endo -74.51 145.33 33.34 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.721 ' O ' HD11 ' A' ' 60' ' ' LEU . 43.9 Cg_endo -71.45 177.52 6.64 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.993 1.522 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.738 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -64.7 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 110.01 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.527 ' CA ' HD21 ' A' ' 60' ' ' LEU . 5.2 m -109.81 -167.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 110.274 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -81.88 175.33 10.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 111.299 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.955 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -139.71 179.44 1.28 Allowed Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.5 Cg_endo -71.1 -20.39 28.69 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.189 1.1 . . . . 0.0 109.626 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.781 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.8 mt-10 -75.01 -28.34 60.46 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.729 ' CA ' HD21 ' A' ' 76' ' ' LEU . 2.9 mtt -80.77 -49.27 11.35 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.024 0.916 . . . . 0.0 108.733 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 96' ' ' THR . 3.2 mt -56.71 136.31 78.23 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.779 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.302 -1.871 0 O-C-N 123.952 1.501 . . . . 0.0 109.949 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.103 HG23 HG12 ' A' ' 12' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.103 HG12 HG23 ' A' ' 11' ' ' VAL . 2.6 p 15.21 69.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -103.96 -35.68 0.2 Allowed Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -75.85 -153.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 122.825 0.908 . . . . 0.0 111.999 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.01 -52.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.706 ' HB3' HG23 ' A' ' 12' ' ' VAL . 34.7 mt-10 -38.47 -62.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.667 -0.645 . . . . 0.0 110.273 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.633 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -55.92 -34.58 65.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.081 -1.012 . . . . 0.0 109.44 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -68.95 -49.12 60.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 110.137 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -60.44 -30.82 69.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 7.8 m-30 -81.52 -48.57 11.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.516 -0.74 . . . . 0.0 109.813 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 25.1 t0 -46.39 -31.53 2.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.95 . . . . 0.0 109.046 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -78.51 -36.64 44.68 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.61 HG22 ' OG1' ' A' ' 27' ' ' THR . 43.6 mt -74.47 -40.3 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 58.7 t80 -50.72 -24.52 3.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.177 -0.952 . . . . 0.0 108.876 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 38.6 mt -72.37 -24.74 61.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' ILE . 72.9 mttt -102.11 -13.64 17.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.978 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 53.9 t0 -68.35 91.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 109.516 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -88.39 0.9 55.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.041 -1.037 . . . . 0.0 111.747 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 34.9 m-20 -110.36 5.27 21.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.884 -1.135 . . . . 0.0 110.93 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 44.97 26.19 0.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 109.957 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 34' ' ' PHE . 2.5 p30 -90.18 -4.9 56.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.421 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.7 -16.45 23.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD2' ' CB ' ' A' ' 68' ' ' LYS . 2.3 p90 -148.82 151.64 35.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.267 -1.137 . . . . 0.0 110.649 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.899 HG21 HG22 ' A' ' 27' ' ' THR . 1.6 p -97.42 128.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.3 t -79.56 151.04 30.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.329 -1.482 . . . . 0.0 109.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.25 -25.9 0.31 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 7.4 mp -62.02 -39.24 91.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -1.086 . . . . 0.0 111.288 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.9 mt-10 -86.63 -55.23 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.481 -1.387 . . . . 0.0 109.513 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -58.82 -15.63 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.635 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -44.34 -72.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 110.308 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.682 ' HA ' HD12 ' A' ' 45' ' ' LEU . 4.7 tt0 -44.39 -44.19 8.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.978 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -58.27 -48.63 84.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.804 ' HZ ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -71.17 -27.7 63.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 42' ' ' GLU . 34.9 mt -70.87 -16.78 62.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 109.87 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 8.4 mtpp -86.95 -4.87 59.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.646 ' CG2' HG21 ' A' ' 81' ' ' ILE . 81.9 p -72.01 -15.06 62.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.872 . . . . 0.0 111.126 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.89 5.15 83.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 47' ' ' THR . 8.6 mp -77.19 173.91 6.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -80.55 -160.33 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.85 1.448 . . . . 0.0 110.075 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -93.87 -49.81 5.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.005 -1.06 . . . . 0.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -63.81 -51.96 62.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD23 HD23 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -46.69 -52.39 13.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 111.04 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.626 HD11 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.8 -43.47 76.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.942 -1.099 . . . . 0.0 109.307 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.37 85.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.677 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 67.4 t60 -71.24 -37.75 71.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 81' ' ' ILE . 8.6 mt -70.46 -26.55 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.777 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 38.4 t-105 -63.29 -39.37 94.38 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.836 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' HD23 ' A' ' 95' ' ' LEU . 2.3 t -72.16 -29.05 63.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.408 -0.808 . . . . 0.0 109.566 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.777 ' HA ' HD22 ' A' ' 95' ' ' LEU . 3.8 mt -72.6 -18.85 61.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.26 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 21.2 p -112.19 -28.31 8.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 109.108 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.592 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 30.6 t0 -78.09 52.25 1.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.462 -0.774 . . . . 0.0 109.662 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -52.35 -22.08 4.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 109.755 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HG2' ' NE2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -45.25 -26.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.735 0.778 . . . . 0.0 109.117 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.81 50.18 10.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.562 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 68' ' ' LYS . 11.9 t -150.01 -30.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.577 -0.702 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.03 13.91 2.34 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.239 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.668 ' CB ' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -132.4 177.3 7.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.083 -1.245 . . . . 0.0 110.044 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.777 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -120.29 94.04 4.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.297 -179.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.631 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -44.77 173.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.725 -1.235 . . . . 0.0 110.112 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.63 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 0.0 111.055 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 23.6 p-10 -53.85 -30.9 47.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.04 -1.037 . . . . 0.0 110.399 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.611 ' HB3' HD23 ' A' ' 69' ' ' LEU . 8.1 mt-30 -56.32 -53.45 57.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.472 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.744 ' N ' HD22 ' A' ' 69' ' ' LEU . 42.1 t80 -50.01 -31.9 13.95 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.759 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -76.75 -11.73 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 109.795 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.822 HD21 ' HG3' ' A' ' 99' ' ' MET . 6.0 tt -89.18 -21.72 23.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 110.458 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.804 ' HB1' ' HZ ' ' A' ' 44' ' ' PHE . . . -72.9 -53.24 11.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.044 -1.035 . . . . 0.0 109.577 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 6.8 m-85 -49.54 -32.39 12.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.927 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 12' ' ' VAL . 85.1 t60 -55.23 -26.18 37.94 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.509 -0.745 . . . . 0.0 109.453 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.9 HD12 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -93.8 -32.53 13.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 57' ' ' ILE . 2.8 mm -69.27 -54.43 19.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.9 -30.65 1.04 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.85 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.2 mp0 -78.08 -19.27 54.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 110.428 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 81' ' ' ILE . 22.0 tptp -90.41 -21.9 21.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 110.673 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 49' ' ' LEU . 3.4 mt -89.45 -59.45 2.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.102 -0.999 . . . . 0.0 110.527 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.557 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.4 -25.02 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 111.425 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.016 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.05 -14.82 9.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.764 -1.21 . . . . 0.0 111.376 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 58.49 28.03 61.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.016 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -88.05 156.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -1.17 . . . . 0.0 109.668 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 10.9 m-20 -89.54 164.85 27.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' LEU . 47.3 Cg_endo -73.51 158.18 48.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.954 1.502 . . . . 0.0 110.451 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.513 ' HG3' ' HE1' ' A' ' 99' ' ' MET . 47.0 Cg_endo -72.29 58.29 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.697 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.581 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 5.9 m170 45.65 -98.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 110.588 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.9 m -109.1 -163.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 111.249 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.47 155.52 40.59 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.651 0.738 . . . . 0.0 111.635 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.033 ' O ' HD12 ' A' ' 100' ' ' ILE . 59.0 p -133.56 166.58 28.23 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -68.18 -28.94 33.59 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.446 1.235 . . . . 0.0 109.848 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.921 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.33 -9.83 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.099 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 76' ' ' LEU . 25.3 ttm -106.33 -28.17 10.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -71.52 115.13 34.2 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.497 -0.752 . . . . 0.0 110.572 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 -179.909 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.079 HG11 ' SD ' ' A' ' 99' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 11' ' ' VAL . 2.7 p 12.15 61.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.235 0.541 . . . . 0.0 112.013 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.9 m -102.35 -33.03 0.22 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -74.97 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 122.729 0.857 . . . . 0.0 110.948 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.86 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.295 0.569 . . . . 0.0 111.706 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 12' ' ' VAL . 22.6 mt-10 -46.67 -61.02 2.02 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.26 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -53.42 -37.11 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.94 -1.1 . . . . 0.0 109.745 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -68.96 -49.99 53.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.449 -0.782 . . . . 0.0 109.392 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -55.3 -29.72 58.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.525 -0.734 . . . . 0.0 109.456 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.673 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 7.0 m-85 -88.36 -47.61 8.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.003 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 4.0 t70 -49.27 -33.72 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.411 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 3.5 mm-40 -77.3 -39.26 48.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.425 -0.797 . . . . 0.0 108.913 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.766 HG22 ' OG1' ' A' ' 27' ' ' THR . 30.6 mt -67.37 -37.15 78.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.435 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 57.8 t80 -48.92 -36.46 17.33 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.278 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.64 -26.97 68.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 10.7 mtmt -100.86 -14.27 18.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.061 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.18 -55.11 3.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 30.7 t70 -72.08 88.36 1.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 109.07 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' ' OE2' ' A' ' 39' ' ' GLU . 4.1 mttm -86.11 -6.07 59.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.962 -1.086 . . . . 0.0 111.665 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' MET . 66.7 m-20 -91.23 12.42 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.873 -1.142 . . . . 0.0 110.709 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' ASP . 7.7 mmt 41.69 35.54 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 13.8 p-10 -112.39 12.18 20.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.177 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.04 12.78 68.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.417 ' C ' ' OD1' ' A' ' 28' ' ' ASP . 1.1 m-85 -148.12 112.17 5.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 110.42 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.017 HG21 HG22 ' A' ' 27' ' ' THR . 14.1 p -89.43 135.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 108.9 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.592 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -88.23 152.3 22.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.371 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -46.82 -24.62 1.96 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -68.94 -30.31 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.363 -1.08 . . . . 0.0 110.799 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.3 mt-10 -86.67 -60.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.793 -1.192 . . . . 0.0 108.066 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 36' ' ' SER . 1.2 p -56.15 -16.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 45' ' ' LEU . 4.5 ttt180 -42.24 -73.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 110.016 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . 2.6 mt-10 -44.32 -46.87 9.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 108.777 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.061 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -55.86 -42.71 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.105 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.812 ' HB3' HD22 ' A' ' 54' ' ' LEU . 2.9 m-30 -80.58 -24.16 39.37 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.566 -0.709 . . . . 0.0 109.38 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.1 mt -73.5 -19.77 60.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.294 -0.879 . . . . 0.0 108.848 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 34.6 mtpt -81.79 -9.52 59.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.424 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.891 ' O ' HD22 ' A' ' 85' ' ' LEU . 52.0 p -68.41 -17.72 64.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.812 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 82.01 21.02 61.88 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' CD2' ' A' ' 53' ' ' LEU . 7.5 mp -102.64 171.61 5.08 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.674 -0.898 . . . . 0.0 110.372 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.3 Cg_endo -80.92 -163.95 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.866 1.456 . . . . 0.0 109.943 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -62.38 1.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.957 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -45.95 -42.86 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.697 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.2 tp -56.48 -55.58 31.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 44' ' ' PHE . 19.4 mt -57.24 -36.92 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.385 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.56 76.95 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.842 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.497 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 6.3 t60 -66.29 -25.25 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG21 ' CG1' ' A' ' 81' ' ' ILE . 1.8 mt -82.11 -32.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 20.3 t-105 -62.81 -38.67 91.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 p -76.0 -25.4 55.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 94' ' ' VAL . 7.0 mt -77.08 -9.63 58.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.219 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.773 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.4 p -116.18 -29.37 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.146 -0.971 . . . . 0.0 109.238 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -74.48 52.54 0.5 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.51 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 1.4 p -51.86 -28.92 17.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.123 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HG3' ' CG ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -59.06 -15.22 12.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 0.0 110.414 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 43.88 55.68 5.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.98 5.92 5.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.51 -12.12 61.89 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HD3' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -120.45 -172.68 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -1.196 . . . . 0.0 110.493 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -122.99 102.37 7.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.4 -0.812 . . . . 0.0 109.783 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -58.84 -172.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.447 -1.408 . . . . 0.0 109.374 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.627 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.95 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.958 -1.089 . . . . 0.0 109.991 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 5.0 t70 -43.73 -32.8 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.386 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.565 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -59.68 -57.38 13.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 110.323 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.852 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.4 t80 -50.49 -30.38 12.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.944 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -76.33 -6.96 53.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.673 HD21 ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -84.89 -40.49 17.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -64.09 -38.18 90.14 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.743 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.673 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 3.7 m-85 -58.35 -31.13 67.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.181 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' C ' HD23 ' A' ' 80' ' ' LEU . 47.9 t-80 -61.21 -27.76 68.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.151 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.05 -57.59 2.31 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.671 HD12 ' CE1' ' A' ' 44' ' ' PHE . 40.3 mt -47.53 -31.22 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.486 0.66 . . . . 0.0 109.391 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 6.8 t -58.88 -53.49 57.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.728 -0.608 . . . . 0.0 110.935 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -66.85 -7.44 21.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.97 . . . . 0.0 110.697 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.637 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -90.72 -12.63 36.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.005 . . . . 0.0 110.897 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 47' ' ' THR . 6.3 mt -90.63 -66.78 0.9 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 111.204 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.2 mm -89.91 -34.29 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.875 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD12 ' A' ' 89' ' ' ILE . 7.9 mmpt? -89.36 -25.3 21.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.945 . . . . 0.0 110.36 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 67.77 5.46 38.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.5 mt -72.87 153.1 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 120.914 -1.345 . . . . 0.0 110.06 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -82.21 176.77 3.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.739 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 42.2 Cg_endo -70.81 168.31 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.984 1.518 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.601 ' HD2' HD13 ' A' ' 60' ' ' LEU . 52.8 Cg_endo -78.84 38.37 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.048 1.552 . . . . 0.0 111.33 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.508 ' O ' HD21 ' A' ' 60' ' ' LEU . 84.9 m-70 55.97 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.06 . . . . 0.0 111.043 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.699 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.2 m -116.83 -161.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.68 -1.262 . . . . 0.0 111.795 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.652 ' CD2' HD23 ' A' ' 60' ' ' LEU . 2.9 mm? -96.45 149.18 22.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.551 ' OG1' ' HG3' ' A' ' 99' ' ' MET . 0.8 OUTLIER -117.19 173.46 3.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.254 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.3 Cg_endo -72.91 -12.17 26.02 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.593 1.312 . . . . 0.0 110.153 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -97.39 -7.37 31.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.676 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.079 ' SD ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -116.1 10.84 15.11 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.053 -1.029 . . . . 0.0 108.955 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 96' ' ' THR 0.25 19.5 mt -106.48 138.24 19.67 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.638 -0.663 . . . . 0.0 110.828 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 48.3 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.5 m . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.916 0.865 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 6.1 p -111.99 159.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER 171.28 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.684 -1.26 . . . . 0.0 111.696 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 44.2 Cg_endo -67.92 -149.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.528 1.278 . . . . 0.0 110.612 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.69 -44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.266 0.555 . . . . 0.0 111.813 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.5 mt-10 -53.08 -62.09 1.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.669 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.01 -37.75 61.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.013 . . . . 0.0 109.915 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.87 64.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.792 . . . . 0.0 109.696 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.1 ttpt -53.37 -29.27 33.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.09 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 3.7 m-85 -91.07 -52.92 4.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 110.102 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' TYR . 30.9 t70 -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.862 . . . . 0.0 109.551 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 66.5 mm-40 -75.26 -37.35 61.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.479 -0.763 . . . . 0.0 108.964 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.775 HG22 ' OG1' ' A' ' 27' ' ' THR . 64.7 mt -74.27 -38.15 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.441 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 74.8 t80 -48.65 -40.11 26.64 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.913 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 3.9 mt -64.4 -23.48 67.3 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.459 -0.897 . . . . 0.0 108.721 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' ILE . 37.6 mttt -102.62 -11.27 18.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.71 . . . . 0.0 109.134 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.059 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 m -88.87 -54.78 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 21.4 t0 -68.0 89.5 0.3 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 26' ' ' LYS . 2.3 mttt -93.55 -12.43 29.6 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.998 -1.064 . . . . 0.0 112.591 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 31' ' ' MET . 25.5 p-10 -96.16 -12.39 24.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.61 -1.306 . . . . 0.0 110.755 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 62.0 63.76 1.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 27.2 p30 -120.14 -4.42 10.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.752 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.55 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 122.77 -41.56 1.78 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -140.22 154.07 46.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.961 . . . . 0.0 109.042 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -88.25 127.21 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.598 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -79.49 149.56 31.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.348 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -40.17 -27.84 0.15 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -59.13 -46.06 89.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.847 -0.796 . . . . 0.0 111.562 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.917 ' HB2' HG23 ' A' ' 35' ' ' VAL . 2.2 mt-10 -81.13 -52.41 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.404 -1.435 . . . . 0.0 108.7 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG13 ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -65.27 -10.38 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.796 0.808 . . . . 0.0 109.384 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -45.8 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 110.692 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.19 -37.28 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -62.35 -50.11 81.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -73.5 -33.83 64.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 108.902 178.453 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 91.7 mt -65.1 -16.79 63.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.791 . . . . 0.0 109.367 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -86.76 -11.58 50.63 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.425 -0.797 . . . . 0.0 109.783 179.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.792 HG21 HD13 ' A' ' 81' ' ' ILE . 68.1 p -68.25 -17.87 64.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.51 13.95 69.32 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 85' ' ' LEU . 10.4 mp -84.26 166.52 32.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.974 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 53' ' ' LEU . 49.0 Cg_endo -77.19 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.086 1.572 . . . . 0.0 109.271 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -94.54 -70.82 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.848 -1.157 . . . . 0.0 110.323 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -42.38 -57.59 2.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.669 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.3 tp -43.5 -52.25 6.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.894 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 49' ' ' LEU . 1.2 tp -57.66 -46.57 84.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.022 . . . . 0.0 109.503 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.9 -33.29 75.37 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 30.1 t-80 -73.04 -43.84 61.51 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 3.1 mt -63.41 -24.06 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.626 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 61.9 t-105 -66.59 -52.26 47.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.94 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.583 ' O ' HD21 ' A' ' 95' ' ' LEU . 27.8 t -63.85 -33.94 76.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.839 ' O ' HD11 ' A' ' 95' ' ' LEU . 3.7 tp -64.46 -32.19 73.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.633 -0.667 . . . . 0.0 109.731 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.721 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.6 p -96.02 -36.25 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.721 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 55.3 t0 -68.03 56.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.523 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.6 -31.05 70.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.121 -0.987 . . . . 0.0 109.65 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -58.55 -15.12 9.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 44.18 55.08 5.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 110.158 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 -39.85 2.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.16 -13.06 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 34' ' ' PHE . 3.5 mttm -139.71 -169.45 2.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.325 -1.103 . . . . 0.0 109.315 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 74' ' ' PHE . 3.6 mt -108.5 122.69 47.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 111.304 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.571 ' CB ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -73.82 -172.97 1.4 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.05 -1.031 . . . . 0.0 109.178 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.16 -89.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.75 -1.219 . . . . 0.0 110.282 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -47.84 -36.28 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 110.105 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.571 ' HG3' ' CB ' ' A' ' 70' ' ' SER . 5.5 mm-40 -60.05 -35.06 74.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.997 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.939 ' HA ' HD22 ' A' ' 69' ' ' LEU . 25.9 t80 -71.09 -32.11 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 108.918 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -69.18 -8.12 42.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.826 HD21 ' HG3' ' A' ' 99' ' ' MET . 3.9 tt -90.42 -36.92 14.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 110.54 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.22 -46.15 75.95 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.002 -1.061 . . . . 0.0 109.716 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 11.5 m-85 -60.43 -34.38 73.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 110.162 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 76.7 t60 -53.15 -21.43 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.802 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.764 HD13 HD23 ' A' ' 60' ' ' LEU . 4.4 mt -98.18 -24.78 15.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 0.0 108.784 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 13.1 mt -69.94 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' ILE . 9.4 t -40.98 -32.14 0.22 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.704 -0.623 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -75.16 -24.99 57.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.919 -1.113 . . . . 0.0 110.314 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ILE . 20.5 tptt -90.07 -18.0 26.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 111.331 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HD11 ' A' ' 49' ' ' LEU . 5.3 mt -88.76 -62.8 1.4 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.953 -1.092 . . . . 0.0 111.282 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 86' ' ' ILE . 17.0 mm -92.7 -19.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.112 -0.993 . . . . 0.0 111.337 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 1.013 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.5 mmpt? -108.43 -7.86 15.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.989 -1.069 . . . . 0.0 110.843 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.07 20.91 4.95 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.013 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.5 mt -90.32 134.95 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.2 p-10 -71.38 169.92 13.65 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.872 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 53' ' ' LEU . 42.9 Cg_endo -71.43 155.79 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.846 1.445 . . . . 0.0 110.644 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.63 ' CD ' HD22 ' A' ' 80' ' ' LEU . 40.4 Cg_endo -67.53 59.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.566 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER 37.32 -93.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.673 -0.642 . . . . 0.0 111.617 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.769 ' C ' HD11 ' A' ' 60' ' ' LEU . 13.1 m -106.92 -164.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.249 -0.907 . . . . 0.0 111.476 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.839 HD11 ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -76.28 163.34 27.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.793 0.806 . . . . 0.0 111.256 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.615 ' O ' HD12 ' A' ' 100' ' ' ILE . 50.5 p -140.57 167.02 19.15 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -69.4 -26.65 29.07 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.434 1.229 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 11' ' ' VAL . 16.1 mp0 -79.44 -20.14 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 108.886 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.826 ' HG3' HD21 ' A' ' 76' ' ' LEU . 29.9 ttm -98.29 -6.21 31.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.644 -0.66 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 96' ' ' THR . 38.5 mt -102.88 107.81 56.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.397 -0.814 . . . . 0.0 110.428 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 123.897 1.472 . . . . 0.0 112.942 179.683 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.009 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 76' ' ' LEU . 9.9 t 49.1 101.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.064 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.29 -67.35 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.744 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.768 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 48.8 Cg_endo -67.97 -149.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.366 1.193 . . . . 0.0 112.068 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.79 -51.06 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.963 -0.461 . . . . 0.0 112.142 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -40.34 -61.98 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 110.672 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -56.59 -32.53 65.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.807 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.15 -48.43 43.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 109.749 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -29.66 69.33 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.683 0.754 . . . . 0.0 109.51 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 6.0 m-30 -84.39 -45.76 12.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.613 -0.679 . . . . 0.0 110.681 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -54.91 -39.89 69.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.815 -1.178 . . . . 0.0 109.352 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.3 mm-40 -69.41 -50.35 46.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.29 -0.881 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 26' ' ' LYS . 65.9 mt -63.83 -39.08 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.151 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 71' ' ' LYS . 85.0 t80 -46.74 -36.33 7.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.584 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 22' ' ' GLU . 6.3 mt -68.79 -21.24 64.34 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.383 -0.823 . . . . 0.0 109.163 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 12.2 mttt -101.14 -11.46 19.55 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.585 0.707 . . . . 0.0 109.162 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.933 HG23 HD12 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -89.83 -50.37 6.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.535 0.683 . . . . 0.0 109.801 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 40.1 t0 -66.52 71.04 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.572 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 27' ' ' THR . 3.6 mptp? -62.23 -12.99 23.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.273 -0.892 . . . . 0.0 111.432 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 74.5 m-20 -93.98 -0.31 55.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.911 -1.118 . . . . 0.0 110.474 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.0 mtm 45.29 27.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.813 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.57 ' OD2' ' CZ ' ' A' ' 34' ' ' PHE . 12.1 p-10 -90.22 2.86 54.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.6 12.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.735 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 38.9 p90 -150.47 162.51 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.143 . . . . 0.0 110.525 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.916 HG21 HG22 ' A' ' 27' ' ' THR . 2.4 p -99.86 146.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.445 -0.785 . . . . 0.0 110.995 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.714 ' O ' HG12 ' A' ' 40' ' ' VAL . 80.6 p -94.57 155.16 17.03 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' ' CH2' ' A' ' 58' ' ' TRP . . . -52.94 -18.41 5.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 38' ' ' LEU . 5.8 mt -73.5 -30.46 63.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 111.024 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.824 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.2 mt-10 -87.68 -60.16 2.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -54.3 -17.44 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.672 0.749 . . . . 0.0 109.659 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -46.66 -75.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.315 -0.866 . . . . 0.0 110.087 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.772 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.8 mt-10 -44.57 -37.29 3.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.551 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.933 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -61.6 -46.94 95.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.644 -0.66 . . . . 0.0 109.392 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -79.76 -27.32 40.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 109.469 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 42' ' ' GLU . 62.2 mt -60.07 -16.7 33.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.858 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 25.5 mtpp -80.39 -25.19 39.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.707 -0.62 . . . . 0.0 109.938 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' HG21 ' A' ' 81' ' ' ILE . 69.9 p -52.63 -26.44 13.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.9 -11.56 71.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.6 mp -67.96 167.28 17.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.465 -1.02 . . . . 0.0 110.136 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' HD22 ' A' ' 53' ' ' LEU . 44.5 Cg_endo -72.15 153.37 56.99 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.855 1.45 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 52' ' ' THR . 19.0 t -59.04 -63.2 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.605 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 51' ' ' SER . 51.7 m -40.07 -48.66 2.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.573 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -55.39 -56.49 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.936 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.2 mt -54.22 -36.88 63.97 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.264 -0.897 . . . . 0.0 109.052 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.56 85.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -68.08 -26.6 65.91 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 81' ' ' ILE . 3.3 mt -76.64 -29.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.768 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 50.2 t-105 -64.34 -45.85 86.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.179 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.422 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -70.52 -37.58 74.13 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.961 HD23 HD22 ' A' ' 95' ' ' LEU . 5.3 mt -66.29 -14.57 62.22 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.981 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.2 t -110.04 -41.69 4.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.771 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.8 t0 -62.92 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.667 -0.646 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.4 p -65.06 -35.49 81.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.11 -0.994 . . . . 0.0 110.36 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -56.28 -17.05 6.5 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.924 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 49.63 52.95 13.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -128.78 8.85 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.136 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.24 27.48 57.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.735 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -150.52 173.6 13.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -1.111 . . . . 0.0 110.036 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.981 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.1 mt -114.99 93.37 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 21.0 p -50.73 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.463 -0.773 . . . . 0.0 110.635 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -68.19 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.94 -1.1 . . . . 0.0 111.111 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 73' ' ' GLN . 2.3 p30 -42.57 -28.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 110.825 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.592 ' HB3' HD23 ' A' ' 69' ' ' LEU . 14.9 mt-30 -64.11 -59.17 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.072 -1.017 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 27' ' ' THR . 41.9 t80 -45.74 -29.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.834 -1.167 . . . . 0.0 109.778 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.809 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -80.41 -13.82 58.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.051 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -89.87 -34.23 16.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.529 -0.732 . . . . 0.0 110.313 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.58 -46.93 85.88 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.904 -1.123 . . . . 0.0 110.379 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 10.6 m-85 -59.39 -31.61 69.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.186 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.952 ' HB2' HG22 ' A' ' 12' ' ' VAL . 22.2 t-80 -57.43 -25.8 60.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 109.927 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -90.31 -29.48 18.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.604 HD12 ' CD1' ' A' ' 44' ' ' PHE . 1.3 mm -74.09 -50.33 28.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.592 0.711 . . . . 0.0 109.1 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -27.31 33.33 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.638 -0.664 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -72.59 -24.59 61.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 0.0 110.269 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -29.03 20.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 111.421 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -76.79 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.978 -1.077 . . . . 0.0 110.832 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -93.8 -15.64 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.428 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.775 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mptt -117.45 -11.54 10.52 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 51.68 21.97 7.76 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.775 HD12 ' HB3' ' A' ' 87' ' ' LYS . 18.5 mt -89.94 143.97 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.533 -0.981 . . . . 0.0 109.718 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.0 m-20 -82.33 165.74 40.76 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 38.3 Cg_endo -66.37 157.5 59.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.053 1.554 . . . . 0.0 110.821 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' VAL . 44.9 Cg_endo -72.69 56.56 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.196 1.629 . . . . 0.0 111.134 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.495 ' O ' HD11 ' A' ' 60' ' ' LEU . 5.4 m-70 38.12 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 111.25 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.653 ' CA ' HD21 ' A' ' 60' ' ' LEU . 6.5 m -106.86 -170.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.117 -0.989 . . . . 0.0 111.286 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.961 HD22 HD23 ' A' ' 60' ' ' LEU . 4.1 mm? -75.37 167.83 21.15 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.927 0.87 . . . . 0.0 111.863 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.027 ' O ' HD12 ' A' ' 100' ' ' ILE . 23.2 p -145.5 166.61 16.95 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.4 Cg_endo -69.52 -29.18 25.44 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.479 1.252 . . . . 0.0 109.831 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.605 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.5 mt-10 -75.33 -20.32 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 108.79 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 95' ' ' LEU . 6.5 ttm -94.73 -46.6 6.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 110.501 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.027 HD12 ' O ' ' A' ' 96' ' ' THR . 1.6 mt -51.82 142.77 24.01 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.409 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HD3' HG21 ' A' ' 63' ' ' THR . 57.0 Cg_endo . . . . . 0 CA--C 1.56 1.821 0 O-C-N 123.964 1.507 . . . . 0.0 108.249 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.3 m . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.573 0.701 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 75' ' ' ALA . 8.6 p 34.87 62.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 111.362 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -102.42 -39.61 0.21 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 0.0 113.222 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -78.94 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.109 1.057 . . . . 0.0 112.029 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.83 -53.16 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 12' ' ' VAL . 12.8 mt-10 -39.53 -58.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.476 -0.765 . . . . 0.0 110.315 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -54.49 -38.3 66.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.019 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.52 -47.09 74.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -62.51 -29.15 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.637 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 17.5 m-85 -85.94 -38.27 18.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.483 -0.761 . . . . 0.0 109.589 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -53.53 -39.72 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.082 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.1 mm-40 -69.43 -41.71 75.95 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.423 -0.798 . . . . 0.0 109.042 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.6 mt -66.5 -40.2 85.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 60.6 t80 -48.56 -36.89 16.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.162 -0.961 . . . . 0.0 108.799 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.8 mt -65.32 -21.85 66.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -99.92 -14.88 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.385 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.098 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.6 -55.13 3.77 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.565 0.698 . . . . 0.0 109.621 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -66.33 76.73 0.1 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.671 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -61.91 -9.68 7.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.0 111.449 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 11.2 m-20 -105.16 -4.51 21.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.789 -1.195 . . . . 0.0 110.415 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 31' ' ' MET . 1.0 OUTLIER 57.87 25.39 11.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 11.9 p30 -92.59 19.28 7.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.58 13.54 58.84 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.62 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -151.02 108.25 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -1.086 . . . . 0.0 110.867 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.982 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -89.11 140.85 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.867 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 t -96.75 161.62 13.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.771 -1.205 . . . . 0.0 110.632 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 41' ' ' ARG . . . -55.21 -16.74 9.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.0 mm? -74.86 -29.7 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.704 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.5 mt-10 -91.92 -64.02 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.999 -1.063 . . . . 0.0 108.828 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.867 HG12 ' O ' ' A' ' 36' ' ' SER . 1.3 p -52.27 -20.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.012 0.91 . . . . 0.0 109.579 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -41.71 -60.53 1.32 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.672 -0.643 . . . . 0.0 110.977 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -58.06 -41.39 83.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.924 -1.11 . . . . 0.0 108.975 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 HG23 ' A' ' 27' ' ' THR . 1.2 mt -56.56 -36.18 47.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.366 0.603 . . . . 0.0 109.414 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.77 -23.03 25.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.865 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 25.8 mt -78.51 -23.99 46.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 109.219 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.06 -4.38 58.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.736 . . . . 0.0 109.987 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.761 HG21 HD13 ' A' ' 81' ' ' ILE . 66.6 p -72.94 -15.78 61.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 91.02 18.51 46.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 85' ' ' LEU . 9.0 mp -95.74 172.72 4.97 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.763 -0.845 . . . . 0.0 110.366 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -84.68 -157.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.156 1.608 . . . . 0.0 109.76 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.982 -1.074 . . . . 0.0 110.639 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -59.1 -54.68 44.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.567 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.0 -42.25 5.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 0.0 110.407 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.597 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 1.1 mp -62.97 -52.5 62.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 109.537 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.51 70.13 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.432 ' NE2' HD11 ' A' ' 60' ' ' LEU . 67.1 t60 -73.44 -32.76 64.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.769 HG21 ' CE1' ' A' ' 44' ' ' PHE . 5.2 mt -77.34 -29.86 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.712 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 55.5 t-105 -63.97 -43.84 94.56 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.831 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -71.85 -28.95 63.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.4 mt -71.42 -11.46 60.9 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 69' ' ' LEU . 5.3 t -118.87 -41.7 2.76 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.474 -0.766 . . . . 0.0 109.316 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.07 69.17 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.9 p -59.89 -37.56 79.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.653 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -59.39 -13.9 10.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.452 -0.78 . . . . 0.0 109.922 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.9 p-10 38.62 50.2 1.55 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.423 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -10.08 9.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.567 -0.708 . . . . 0.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.8 -11.72 27.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 mttm -115.96 -171.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -1.137 . . . . 0.0 110.098 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.031 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -129.91 108.67 10.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -53.66 -170.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -78.92 -78.29 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.06 . . . . 0.0 110.515 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -44.34 -46.47 9.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 76' ' ' LEU . 2.1 mt-30 -50.84 -52.98 36.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.098 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.1 t80 -44.73 -34.85 2.41 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.212 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.003 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.06 -14.39 59.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.088 -1.007 . . . . 0.0 109.741 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.962 HD21 ' CG ' ' A' ' 99' ' ' MET . 7.3 tt -85.19 -23.35 28.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.682 -0.636 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -69.39 -54.62 13.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 109.587 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.736 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 19.1 m-85 -52.76 -34.03 51.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.661 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 6.5 t-80 -51.43 -21.81 2.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 57' ' ' ILE . 2.9 mt -98.48 -22.96 15.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 108.924 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 14.3 mt -73.51 -52.69 20.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.592 -0.693 . . . . 0.0 110.282 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ILE . 4.1 mt-30 -71.69 -25.03 61.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -90.08 -19.9 23.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 111.214 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 49' ' ' LEU . 5.6 mt -84.92 -60.8 1.94 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.114 . . . . 0.0 111.402 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.9 mm -95.91 -35.95 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.073 -1.017 . . . . 0.0 110.999 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -89.41 -13.96 36.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.045 -1.034 . . . . 0.0 110.813 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 53.83 18.8 8.97 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.6 mt -86.61 161.28 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.16 -1.2 . . . . 0.0 109.721 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 2.7 p-10 -90.39 169.35 12.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -70.21 156.25 62.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.88 1.463 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' HIS . 42.7 Cg_endo -70.13 62.93 2.0 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.125 1.592 . . . . 0.0 111.365 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.709 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.8 OUTLIER 40.08 -112.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 111.001 179.239 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 ' ND1' ' A' ' 93' ' ' HIS . 3.8 m -101.97 -172.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.744 -1.222 . . . . 0.0 111.245 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.679 HD13 ' H ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -62.94 164.37 8.26 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 111.396 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 95' ' ' LEU . 30.0 p -145.85 167.88 13.15 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -70.09 -23.17 29.62 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.486 1.256 . . . . 0.0 109.266 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.027 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.0 mt-10 -82.41 -2.11 52.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.423 -0.798 . . . . 0.0 109.127 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.962 ' CG ' HD21 ' A' ' 76' ' ' LEU . 30.7 ttm -119.08 5.09 11.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 95' ' ' LEU 0.253 33.4 mt -108.47 100.53 38.49 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.665 -0.647 . . . . 0.0 110.486 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 O-C-N 123.759 1.4 . . . . 0.0 113.017 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 98' ' ' GLU . 2.4 m . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.786 0.803 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 16' ' ' GLU . 2.4 p -123.65 146.34 29.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -167.02 -59.64 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.845 -1.16 . . . . 0.0 112.675 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 15' ' ' ALA . 40.9 Cg_endo -63.24 -141.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.34 1.179 . . . . 0.0 110.807 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.83 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 112.217 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -36.28 -63.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -52.21 -33.81 42.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.086 . . . . 0.0 110.418 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.54 -48.16 70.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -56.27 -31.0 63.2 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.6 m-85 -91.65 -52.06 4.94 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.704 -0.623 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 10.3 t0 -42.74 -39.77 2.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.649 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.3 mt-10 -71.66 -35.5 70.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.407 -0.808 . . . . 0.0 109.072 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 27' ' ' THR . 31.7 mt -72.43 -41.75 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.805 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 71' ' ' LYS . 47.1 t80 -46.44 -28.58 1.41 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.543 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 22' ' ' GLU . 12.8 mt -73.08 -33.16 65.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 23' ' ' ILE . 24.3 mttp -93.72 -10.05 35.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.081 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.53 -58.84 2.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 55.2 t0 -66.13 82.59 0.08 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -75.41 11.41 1.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.93 -1.106 . . . . 0.0 112.332 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 2.9 m-20 -116.67 5.74 13.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.3 mmt 46.08 35.52 2.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 111.055 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.8 p30 -108.06 12.78 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.55 12.47 80.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -150.84 109.93 3.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.286 . . . . 0.0 110.8 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.933 HG21 HG22 ' A' ' 27' ' ' THR . 13.2 p -89.6 137.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.982 . . . . 0.0 108.495 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.2 p -85.87 153.59 22.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.103 -0.998 . . . . 0.0 111.172 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -50.99 -21.7 5.53 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 mt -73.07 -32.31 64.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -1.054 . . . . 0.0 110.42 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 36.6 mt-10 -82.67 -54.06 5.44 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -66.86 -14.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.342 0.591 . . . . 0.0 109.735 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -47.24 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.154 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.71 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -43.61 -44.5 6.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.081 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -50.75 -40.95 20.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.783 ' HB3' HD22 ' A' ' 54' ' ' LEU . 1.6 m-30 -83.2 -38.65 22.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.3 mt -55.86 -18.5 8.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.356 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 83.0 mttt -79.61 -13.57 59.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 109.323 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.823 HG21 HG21 ' A' ' 81' ' ' ILE . 64.1 p -66.23 -16.77 64.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.26 66.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -100.13 171.94 5.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.641 -0.917 . . . . 0.0 110.085 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.621 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.4 Cg_endo -77.19 155.64 33.2 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.723 1.381 . . . . 0.0 110.073 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.02 67.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.967 . . . . 0.0 110.995 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -45.38 73.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.995 . . . . 0.0 111.24 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.621 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -54.99 -51.17 67.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.89 -1.131 . . . . 0.0 110.478 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.3 mt -59.85 -36.6 77.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.34 -48.19 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -60.56 -37.77 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.796 HD13 HG13 ' A' ' 81' ' ' ILE . 12.8 mt -64.74 -37.25 79.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 40.3 t-105 -57.13 -52.84 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -33.59 71.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.168 -0.957 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.757 HD11 ' C ' ' A' ' 94' ' ' VAL . 15.9 tp -67.0 -23.62 65.95 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.253 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 56.0 m -105.74 -36.09 7.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 68' ' ' LYS . 51.8 t0 -67.01 58.37 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 109.155 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.4 p -53.76 -29.57 40.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -62.69 -11.1 15.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.436 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.7 p30 37.02 55.49 1.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.615 -0.678 . . . . 0.0 110.465 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.73 -11.18 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.18 -21.09 27.49 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 16.3 mmtm -114.68 -176.41 2.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.406 -1.055 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -114.54 108.57 17.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.933 -1.105 . . . . 0.0 110.562 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -64.56 167.69 6.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 109.373 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -56.04 -72.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.558 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -44.42 -37.52 3.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 110.637 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 44.4 mm-40 -67.33 -49.6 63.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.037 -1.04 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 27' ' ' THR . 8.9 t80 -56.61 -26.92 57.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.72 -1.238 . . . . 0.0 108.588 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.52 -11.4 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.598 0.713 . . . . 0.0 109.277 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.816 HD21 ' CG ' ' A' ' 99' ' ' MET . 6.1 tp -88.64 -42.41 12.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 110.087 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.579 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -62.89 -26.39 68.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.298 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 1.4 m-85 -76.12 -20.36 57.7 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.741 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.642 ' C ' HD23 ' A' ' 80' ' ' LEU . 82.3 t60 -73.29 -22.56 60.34 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.557 -0.714 . . . . 0.0 109.172 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -99.72 -38.46 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.435 -0.79 . . . . 0.0 108.894 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 47' ' ' THR . 76.6 mt -66.66 -46.99 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -62.69 -16.76 58.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.492 -0.755 . . . . 0.0 109.915 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -77.8 -24.01 48.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 110.032 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -10.52 47.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 6.0 mt -89.99 -55.37 3.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.065 -1.022 . . . . 0.0 110.749 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.447 ' HA ' HD13 ' A' ' 86' ' ' ILE . 7.2 mm -108.9 -17.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.092 -1.005 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -108.44 -2.73 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.949 -1.094 . . . . 0.0 110.45 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 42.22 53.93 4.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.4 mt -125.63 168.37 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.302 -1.117 . . . . 0.0 109.832 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.7 m-20 -113.32 171.54 4.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.452 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 40.8 Cg_endo -70.46 151.68 65.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.897 1.472 . . . . 0.0 109.999 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.6 Cg_endo -70.85 51.64 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.938 1.494 . . . . 0.0 111.168 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.739 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 50.2 -83.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.426 -0.796 . . . . 0.0 111.679 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.757 ' C ' HD11 ' A' ' 60' ' ' LEU . 11.5 m -108.36 -162.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 60' ' ' LEU . 2.0 mm? -86.71 144.0 27.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.739 0.781 . . . . 0.0 111.243 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.877 ' O ' HD12 ' A' ' 100' ' ' ILE . 39.3 p -111.12 168.09 8.09 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.7 Cg_endo -68.38 -38.43 11.6 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 123.289 1.152 . . . . 0.0 109.863 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.486 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.7 mt-10 -71.26 -27.2 63.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 108.611 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.816 ' CG ' HD21 ' A' ' 76' ' ' LEU . 24.1 ttm -84.66 -25.52 28.41 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.422 0.63 . . . . 0.0 109.624 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 96' ' ' THR . 7.5 mt -87.01 135.82 34.71 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.097 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.44 ' HG3' ' HE3' ' A' ' 64' ' ' LYS . 41.6 Cg_endo . . . . . 0 C--N 1.302 -1.879 0 O-C-N 123.771 1.406 . . . . 0.0 109.695 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.7 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.701 0.763 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 76' ' ' LEU . 3.0 p -115.66 166.13 10.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER 167.06 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.074 -1.016 . . . . 0.0 111.926 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 13' ' ' SER . 45.6 Cg_endo -66.28 -146.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.263 1.139 . . . . 0.0 110.81 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.96 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 111.524 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 43.7 mt-10 -54.09 -64.13 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -54.04 -32.67 55.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.902 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.46 -52.31 16.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.32 -30.15 62.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.007 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.6 m-30 -89.56 -50.51 6.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 8.9 t0 -43.27 -40.64 3.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 109.41 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.2 mt-10 -69.25 -34.96 75.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 108.882 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HE2' ' A' ' 74' ' ' PHE . 60.6 mt -74.66 -38.77 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.459 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 70' ' ' SER . 68.4 t80 -50.1 -33.08 17.5 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 18.0 mt -65.87 -24.86 66.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.69 -16.09 19.14 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.96 ' CG2' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.75 -52.98 4.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.502 -0.749 . . . . 0.0 109.8 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 67.6 t0 -67.14 63.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 109.29 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 11.1 mttm -65.5 -3.82 4.97 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.383 -0.823 . . . . 0.0 111.966 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 39' ' ' GLU . 45.9 m-20 -103.36 -11.06 18.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.683 -1.261 . . . . 0.0 110.672 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 57.42 37.45 27.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 19.5 p30 -103.11 1.32 33.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 110.68 -32.56 6.49 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -135.68 147.08 48.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.96 HG21 ' CG2' ' A' ' 27' ' ' THR . 1.4 p -88.94 135.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.344 -0.848 . . . . 0.0 108.733 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 40' ' ' VAL . 7.8 p -86.58 151.02 23.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 0.0 110.426 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -24.95 0.45 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 80.9 mt -65.07 -41.28 95.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -1.06 . . . . 0.0 111.591 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.859 ' HB2' HG23 ' A' ' 35' ' ' VAL . 5.5 mt-10 -81.03 -58.4 3.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.195 . . . . 0.0 108.769 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -57.01 -16.43 4.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.547 0.689 . . . . 0.0 109.639 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -43.94 -76.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.476 -0.765 . . . . 0.0 110.823 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.7 mt-10 -44.63 -46.58 10.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.071 . . . . 0.0 108.59 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.863 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -53.09 -37.27 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.9 m-30 -85.76 -45.79 11.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.655 -0.653 . . . . 0.0 109.438 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 42' ' ' GLU . 27.2 mt -51.48 -27.58 10.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 3.2 ptmt -73.86 -5.37 40.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.662 -0.649 . . . . 0.0 109.751 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 44' ' ' PHE . 65.3 p -78.97 -18.06 54.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.844 . . . . 0.0 110.015 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.85 86.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.8 mp -81.01 166.99 35.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -78.36 176.5 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.915 1.481 . . . . 0.0 110.56 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -44.03 61.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.636 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 53' ' ' LEU . 5.3 m -65.6 -59.0 4.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.702 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -44.54 -39.71 5.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.97 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 54' ' ' LEU . 33.3 mt -65.38 -53.24 46.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.38 68.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 13.9 t-80 -74.97 -38.41 61.68 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.526 HD13 ' CG1' ' A' ' 81' ' ' ILE . 3.8 mt -71.68 -28.51 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.761 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 71.7 t-105 -61.56 -44.24 97.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.274 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.2 t -71.12 -33.67 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.26 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.895 HD23 HD22 ' A' ' 95' ' ' LEU . 12.3 mt -67.05 -27.53 67.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.566 -0.709 . . . . 0.0 109.466 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.93 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 19.4 p -102.12 -35.13 9.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.447 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.567 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 45.7 t0 -75.4 57.13 0.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.582 -0.699 . . . . 0.0 110.004 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.6 p -52.49 -33.04 43.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -63.03 -12.38 25.83 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.67 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 4.1 t70 40.81 53.84 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.789 . . . . 0.0 110.139 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.85 7.9 10.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.453 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.55 -12.69 62.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.584 ' CA ' ' HZ2' ' A' ' 58' ' ' TRP . 32.4 mttt -126.43 175.44 7.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.177 . . . . 0.0 109.766 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.761 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 2.9 mt -113.35 114.88 27.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.809 -1.182 . . . . 0.0 111.707 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.638 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -64.02 -172.85 0.07 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.983 -1.073 . . . . 0.0 110.219 179.153 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -70.5 -46.2 64.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 111.361 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.24 -3.28 58.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.072 -1.018 . . . . 0.0 111.199 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.638 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 34.3 mm-40 -89.03 -43.69 10.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.901 -1.124 . . . . 0.0 109.596 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE2' HG22 ' A' ' 23' ' ' ILE . 14.6 t80 -61.38 -24.72 66.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.23 -13.96 58.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.514 -0.741 . . . . 0.0 109.084 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.8 tp -90.33 -49.15 6.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.477 -0.764 . . . . 0.0 109.415 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -48.0 -46.54 32.97 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 3.1 m-85 -51.91 -39.76 59.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.543 ' C ' HD23 ' A' ' 80' ' ' LEU . 44.6 t-80 -51.38 -24.87 5.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.06 -34.89 9.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 0.0 109.247 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 45.8 mt -77.63 -35.16 21.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.528 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 2.8 p -67.77 -29.74 69.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 110.079 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.87 -5.49 59.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.077 -1.015 . . . . 0.0 109.982 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.487 ' HD3' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.9 -24.65 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.406 -0.809 . . . . 0.0 110.91 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -90.0 -71.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.0 111.299 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 mm -82.08 3.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.795 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.956 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -126.81 -47.27 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.941 -1.099 . . . . 0.0 110.573 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 87.1 6.19 79.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.956 HD12 ' HB3' ' A' ' 87' ' ' LYS . 3.5 mt -77.42 139.37 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.231 -1.158 . . . . 0.0 109.823 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.2 170.96 13.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.217 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 40.4 Cg_endo -70.88 158.29 55.91 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.191 1.627 . . . . 0.0 110.675 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 94' ' ' VAL . 46.7 Cg_endo -75.06 47.02 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.098 1.578 . . . . 0.0 111.676 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 54.08 -85.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.077 -1.015 . . . . 0.0 111.643 178.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.681 ' HA ' HD21 ' A' ' 60' ' ' LEU . 33.4 m -117.47 -163.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.607 -1.308 . . . . 0.0 112.208 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.895 HD22 HD23 ' A' ' 60' ' ' LEU . 4.0 mm? -81.03 165.1 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.785 0.802 . . . . 0.0 111.603 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.981 ' O ' HD12 ' A' ' 100' ' ' ILE . 35.7 p -147.15 170.25 8.06 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.6 Cg_endo -69.6 -38.03 8.71 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.183 1.097 . . . . 0.0 109.527 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.957 ' O ' HG13 ' A' ' 11' ' ' VAL . 13.4 mt-10 -70.08 -10.83 60.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 108.96 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.709 ' CG ' HD21 ' A' ' 76' ' ' LEU . 28.0 ttm -102.54 -38.21 7.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -64.68 143.13 98.66 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.864 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 100' ' ' ILE . 44.6 Cg_endo . . . . . 0 C--N 1.304 -1.783 0 O-C-N 123.891 1.469 . . . . 0.0 110.706 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.679 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.453 0.644 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -139.04 73.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 109.787 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 t -102.73 -31.67 0.21 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -76.38 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 122.756 0.872 . . . . 0.0 111.101 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.67 -61.28 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.904 -0.497 . . . . 0.0 112.197 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.73 ' HB3' HG23 ' A' ' 12' ' ' VAL . 15.2 mt-10 -38.65 -57.33 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.73 . . . . 0.0 110.64 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.18 -35.17 64.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.97 . . . . 0.0 109.867 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.29 -48.61 69.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -29.42 64.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.529 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 12.2 m-85 -87.95 -51.69 5.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.558 -0.714 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -45.56 -39.56 7.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.927 -1.108 . . . . 0.0 109.356 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 5.6 mm-40 -67.51 -47.27 70.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 108.99 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.762 HG22 ' OG1' ' A' ' 27' ' ' THR . 26.1 mt -62.26 -40.5 87.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 29.4 t80 -46.95 -27.65 1.35 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 70.3 mt -70.64 -31.72 68.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -97.83 -12.8 21.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.845 . . . . 0.0 108.82 178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.045 HG23 HD12 ' A' ' 43' ' ' ILE . 1.3 m -89.06 -51.43 5.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 31' ' ' MET . 23.0 t70 -65.04 82.53 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -62.44 0.07 0.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 44.8 p-10 -122.77 3.47 9.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.219 -1.55 . . . . 0.0 110.787 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.471 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 1.2 mmt 55.92 39.08 30.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.294 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 3.9 p-10 -110.35 26.44 10.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.34 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.48 11.17 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.86 99.49 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -1.104 . . . . 0.0 110.309 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 27' ' ' THR . 10.8 p -89.71 135.66 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.94 -1.1 . . . . 0.0 109.004 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.512 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 82.6 p -90.06 147.81 23.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 110.825 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -42.94 -27.59 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.7 mp -65.04 -30.59 71.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.108 . . . . 0.0 110.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.547 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 mt-10 -86.84 -62.24 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.891 -1.131 . . . . 0.0 108.306 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -58.49 -15.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.29 0.566 . . . . 0.0 110.023 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.618 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.58 -44.67 4.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.008 . . . . 0.0 109.82 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.045 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -51.27 -40.01 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.55 -0.719 . . . . 0.0 109.072 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.4 m-85 -87.28 -28.45 22.29 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.592 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 42' ' ' GLU . 72.1 mt -68.06 -17.38 64.37 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 108.961 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CD ' ' HA ' ' A' ' 43' ' ' ILE . 10.2 mtpt -75.75 -21.32 57.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.559 0.695 . . . . 0.0 109.49 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.586 ' OG1' ' HG ' ' A' ' 49' ' ' LEU . 39.1 p -50.2 -58.14 6.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.698 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 118.43 21.41 4.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -101.05 -172.34 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.511 -0.994 . . . . 0.0 108.542 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.0 Cg_endo -74.3 -171.64 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.388 1.204 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -47.8 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.859 -1.151 . . . . 0.0 111.328 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -63.14 -32.11 73.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.673 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.995 HD23 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -59.87 -62.68 1.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 110.819 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.995 HD22 HD23 ' A' ' 53' ' ' LEU . 2.8 mm? -50.08 -29.71 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.816 -1.178 . . . . 0.0 108.953 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -79.65 -39.36 31.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 21.3 t60 -67.49 -24.58 65.6 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CD1' HD13 ' A' ' 81' ' ' ILE . 4.9 mt -78.3 -23.04 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 69' ' ' LEU . 19.5 t-105 -71.48 -45.63 61.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -69.44 -27.61 65.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 108.645 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 92' ' ' PRO . 9.0 mt -74.68 -4.65 38.58 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 76' ' ' LEU . 61.6 m -128.58 -35.48 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.75 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.9 t70 -65.81 59.35 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.63 -0.669 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' CYS . 24.7 p -55.54 -36.84 67.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -0.991 . . . . 0.0 109.881 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' CD ' ' OE1' ' A' ' 73' ' ' GLN . 11.7 mptt -56.25 -16.98 6.24 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 110.04 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.08 54.76 2.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 110.438 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.0 t -123.13 -13.96 7.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.311 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.24 -0.25 25.24 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.608 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 3.7 mtmt -129.78 -176.25 3.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.133 -1.216 . . . . 0.0 110.087 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -123.7 97.94 5.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.099 -1.001 . . . . 0.0 111.163 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -55.56 172.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.746 -1.221 . . . . 0.0 109.34 178.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -56.46 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.958 -1.089 . . . . 0.0 110.544 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' LYS . 32.3 m-20 -39.38 -42.65 1.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.594 -0.691 . . . . 0.0 110.549 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 25.9 mt-30 -61.03 -49.49 77.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.687 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.2 t80 -54.76 -37.43 65.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.786 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -73.42 -6.75 48.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.636 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -90.35 -40.52 12.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.373 -0.829 . . . . 0.0 110.071 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HB3' ' HZ ' ' A' ' 44' ' ' PHE . . . -64.63 -58.84 5.23 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.238 -0.913 . . . . 0.0 109.041 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.2 m-85 -45.67 -32.17 2.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.603 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 11.3 t-80 -66.22 -30.41 70.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 76' ' ' LEU . 14.2 mt -84.8 -16.79 40.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 109.187 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 54' ' ' LEU . 13.6 mm -73.51 -57.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.48 -0.763 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -47.98 -32.39 6.45 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.444 -0.785 . . . . 0.0 109.982 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -64.64 -24.18 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.687 ' HG2' HD22 ' A' ' 49' ' ' LEU . 2.9 tppt? -91.13 -21.48 21.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.222 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 49' ' ' LEU . 5.2 mt -89.43 -67.71 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -82.19 -10.04 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.0 110.873 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.854 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.48 -7.32 10.18 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.927 -1.108 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 47.23 24.49 2.3 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HB3' ' A' ' 87' ' ' LYS . 16.2 mt -97.16 173.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.496 -1.002 . . . . 0.0 109.858 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.551 ' N ' HG22 ' A' ' 89' ' ' ILE . 25.0 m-20 -115.37 164.79 15.97 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 110.256 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 43.5 Cg_endo -70.47 153.91 65.32 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.16 1.61 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.877 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.7 Cg_endo -71.92 151.93 57.1 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.013 1.533 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.32 -59.76 2.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.166 -0.959 . . . . 0.0 110.277 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.53 ' CA ' HD21 ' A' ' 60' ' ' LEU . 30.4 m -125.87 -166.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 111.264 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.847 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -89.89 -175.81 4.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.897 0.856 . . . . 0.0 111.564 -179.111 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.035 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -143.07 -179.23 0.91 Allowed Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 46.6 Cg_endo -76.17 -5.77 16.59 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.332 1.175 . . . . 0.0 109.929 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 11' ' ' VAL . 20.9 mt-10 -93.66 -23.11 18.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 109.277 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.929 ' HB3' HD11 ' A' ' 76' ' ' LEU . 2.4 mtp -86.37 -36.19 19.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.992 0.901 . . . . 0.0 108.698 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.035 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mt -65.23 124.77 87.84 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.883 -0.51 . . . . 0.0 110.654 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HG2' ' NZ ' ' A' ' 64' ' ' LYS . 47.7 Cg_endo . . . . . 0 C--N 1.305 -1.732 0 O-C-N 123.931 1.49 . . . . 0.0 109.906 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.285 0.564 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -175.0 129.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 110.265 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.4 m -49.55 -40.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.96 0.886 . . . . 0.0 109.422 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.674 HG11 ' HA ' ' A' ' 76' ' ' LEU . 2.3 p -115.57 156.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 174.36 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.731 -1.231 . . . . 0.0 112.335 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' SER . 48.5 Cg_endo -67.43 -145.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.272 1.143 . . . . 0.0 110.559 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.2 -49.67 0.08 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.455 0.645 . . . . 0.0 111.588 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 4.9 mt-10 -49.13 -60.79 2.49 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.418 -0.801 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.3 tmtp? -54.24 -32.96 57.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.964 -1.085 . . . . 0.0 109.981 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.45 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 108.95 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' ILE . 6.1 ttpt -54.53 -28.93 48.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.579 -0.7 . . . . 0.0 109.393 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 4.2 m-30 -90.59 -52.19 5.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 110.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 20' ' ' TYR . 53.1 t0 -45.28 -33.82 2.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 25' ' ' LEU . 30.7 mm-40 -76.39 -32.54 58.61 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.334 -0.854 . . . . 0.0 108.906 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.832 HG22 ' OG1' ' A' ' 27' ' ' THR . 46.9 mt -77.77 -41.87 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.388 -0.82 . . . . 0.0 110.073 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HE1' HG12 ' A' ' 35' ' ' VAL . 59.9 t80 -48.67 -32.68 8.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.571 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.832 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.0 mt -65.52 -28.91 69.52 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -100.18 -12.71 19.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 2.6 m -89.74 -55.74 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.745 . . . . 0.0 109.372 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.534 ' HA ' HG23 ' A' ' 35' ' ' VAL . 38.3 t0 -63.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.703 -0.623 . . . . 0.0 109.361 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.7 mmtt -51.8 -17.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 111.219 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.0 m-20 -98.23 1.68 47.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 mtm 43.26 45.35 4.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.706 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.2 p30 -115.8 26.5 9.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 109.956 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.92 12.77 44.43 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.17 100.82 2.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -1.058 . . . . 0.0 110.111 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.0 HG21 HG22 ' A' ' 27' ' ' THR . 14.5 p -88.86 139.42 17.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.925 -1.109 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 t -95.31 151.85 18.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.067 -1.021 . . . . 0.0 110.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.71 -25.16 0.82 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 38' ' ' LEU . 3.1 mm? -67.49 -29.96 69.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.218 -1.166 . . . . 0.0 110.975 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.578 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 19.4 mt-10 -91.05 -61.7 1.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.829 -1.169 . . . . 0.0 108.306 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.614 ' HA ' HG23 ' A' ' 27' ' ' THR . 1.1 p -53.02 -18.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -42.21 -75.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.705 -0.622 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.3 mt-10 -43.23 -47.97 6.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 108.717 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR . 2.2 mt -55.44 -41.28 62.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.85 ' CE1' HD12 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -77.25 -28.27 53.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 42' ' ' GLU . 19.1 mt -73.76 -23.68 59.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -0.928 . . . . 0.0 109.003 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 49.0 mttt -81.27 -13.77 58.11 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.546 0.688 . . . . 0.0 109.489 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' ILE . 45.4 p -65.2 -54.07 35.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 0.0 109.969 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.42 14.68 7.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.9 mm? -93.5 153.71 41.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.479 -1.012 . . . . 0.0 110.663 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 40.7 Cg_endo -66.13 147.64 84.22 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.945 1.498 . . . . 0.0 110.623 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 52' ' ' THR . 82.3 p -44.86 -64.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.726 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 51' ' ' SER . 13.7 m -42.47 -58.09 2.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.967 . . . . 0.0 110.878 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -52.64 -50.2 63.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 0.0 110.342 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 22.9 mt -57.11 -39.46 75.12 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.307 -0.87 . . . . 0.0 109.295 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.52 65.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 20.4 t60 -73.15 -29.63 63.0 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.903 HD13 HG13 ' A' ' 81' ' ' ILE . 8.8 mt -77.33 -28.51 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.662 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 48.3 t-105 -65.1 -42.93 93.54 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.811 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.67 59.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.947 HD23 HD13 ' A' ' 80' ' ' LEU . 7.0 tp -74.46 -17.04 60.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.835 ' HA ' HD22 ' A' ' 76' ' ' LEU . 22.4 p -115.16 -35.5 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.456 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 12.2 t70 -66.61 56.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 110.551 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 61' ' ' CYS . 0.7 OUTLIER -60.43 -24.01 64.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -61.09 -16.11 40.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.664 -0.648 . . . . 0.0 110.337 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.6 t0 39.84 51.19 2.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 110.325 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.88 -14.5 6.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.853 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.68 -1.32 27.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 14.1 mttt -136.33 171.23 14.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -1.222 . . . . 0.0 110.601 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.1 mt -107.5 101.4 10.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.13 -179.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.602 -1.311 . . . . 0.0 110.511 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.88 -52.47 43.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 14.8 p-10 -79.37 -15.23 58.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.904 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.58 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 42.2 mm-40 -77.51 -40.16 43.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.927 -1.108 . . . . 0.0 110.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.763 ' N ' HD22 ' A' ' 69' ' ' LEU . 17.0 t80 -63.87 -17.54 63.28 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.279 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.7 -18.56 37.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.421 -0.8 . . . . 0.0 109.034 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CG ' ' A' ' 99' ' ' MET . 9.6 tt -84.27 -21.92 30.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -75.41 -46.45 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.172 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.4 m-85 -57.28 -29.64 64.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 108.81 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.552 ' CE1' ' HB ' ' A' ' 11' ' ' VAL . 16.0 t-80 -54.2 -22.59 11.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.947 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -99.67 -60.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.903 HG13 HD13 ' A' ' 57' ' ' ILE . 9.9 mt -48.33 -52.26 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.821 -0.549 . . . . 0.0 109.84 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -52.42 -40.01 61.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 88' ' ' GLY . 5.1 mt-30 -60.02 -21.2 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.588 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.85 -18.01 25.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.0 110.788 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -88.52 -38.46 14.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 111.172 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.6 mm -119.88 -14.67 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.997 . . . . 0.0 110.737 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.2 mmpt? -119.17 -2.5 10.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 110.616 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 41.34 59.36 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.803 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -126.36 132.59 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.087 -1.243 . . . . 0.0 110.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 15.6 p-10 -60.08 170.25 1.29 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' HD3' HD11 ' A' ' 53' ' ' LEU . 43.8 Cg_endo -79.32 152.08 23.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.772 1.406 . . . . 0.0 110.374 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.601 ' C ' ' CD2' ' A' ' 93' ' ' HIS . 42.8 Cg_endo -68.78 63.91 1.27 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.01 1.532 . . . . 0.0 110.38 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.601 ' CD2' ' C ' ' A' ' 92' ' ' PRO . 4.7 p80 35.94 -109.63 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.72 -0.613 . . . . 0.0 111.099 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.645 ' C ' HD11 ' A' ' 60' ' ' LEU . 5.3 m -102.71 -165.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.93 -1.106 . . . . 0.0 111.218 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.594 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -69.5 147.86 50.28 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.735 0.778 . . . . 0.0 111.414 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.945 ' O ' HD12 ' A' ' 100' ' ' ILE . 68.9 p -125.71 166.97 18.1 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.0 Cg_endo -67.32 -23.28 44.84 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.477 1.251 . . . . 0.0 109.638 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.656 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -82.21 -18.31 43.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.971 ' CG ' HD21 ' A' ' 76' ' ' LEU . 35.4 ttm -92.21 -47.1 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.72 0.771 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 96' ' ' THR . 1.1 mt -50.05 134.48 22.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.545 -0.722 . . . . 0.0 110.212 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.69 164.72 31.61 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.694 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.97 142.45 17.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.058 1.557 . . . . 0.0 110.215 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 110.127 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.779 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -80.45 149.15 30.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 109.36 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER -69.67 -168.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.78 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.605 HG12 ' C ' ' A' ' 11' ' ' VAL . 7.7 p 36.76 66.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.578 -0.701 . . . . 0.0 111.122 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.2 t -107.12 -41.62 0.14 Allowed Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 13' ' ' SER . 51.8 Cg_endo -77.13 -147.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 122.928 0.962 . . . . 0.0 111.959 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.78 -59.13 0.11 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -37.77 -54.76 1.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.0 110.49 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.62 -42.93 68.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 109.797 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.76 -46.59 84.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.742 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -56.37 -29.18 61.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.524 -0.735 . . . . 0.0 109.971 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 13.3 m-85 -89.46 -52.38 5.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.429 -0.795 . . . . 0.0 110.05 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 5.5 t70 -44.53 -31.23 1.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.8 mt-10 -80.13 -34.75 37.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 26' ' ' LYS . 39.5 mt -78.91 -37.22 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.482 -0.761 . . . . 0.0 110.285 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 52.6 t80 -48.85 -30.6 5.99 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.356 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.4 mt -67.76 -25.76 65.78 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -98.74 -13.74 20.07 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.081 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.25 -55.47 3.66 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.729 0.776 . . . . 0.0 109.23 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 59.1 t0 -72.48 68.27 0.78 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 3.5 mttm -55.98 -13.82 2.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.493 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -96.6 13.83 26.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.563 -1.335 . . . . 0.0 110.96 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.4 mtm 43.16 26.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 34.4 p30 -98.56 22.37 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 56.49 19.85 28.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.46 105.46 3.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -1.146 . . . . 0.0 110.754 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.957 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -89.0 130.01 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.865 -1.147 . . . . 0.0 109.018 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.637 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -87.15 152.66 22.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.092 -1.005 . . . . 0.0 109.808 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.74 -22.68 0.79 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 38' ' ' LEU . 2.9 mm? -65.34 -37.32 86.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 111.263 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 35' ' ' VAL . 15.1 mt-10 -86.45 -62.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.861 -1.149 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -50.83 -20.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.623 0.725 . . . . 0.0 109.491 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -44.92 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 110.645 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.6 mt-10 -44.04 -38.37 3.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.23 -0.919 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -58.61 -42.56 85.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 110.265 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.9 m-85 -80.95 -29.65 35.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.163 -0.961 . . . . 0.0 110.166 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 42' ' ' GLU . 17.0 mt -65.85 -15.38 62.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.989 -1.069 . . . . 0.0 109.386 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 59.8 mttt -82.86 -13.51 56.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.502 ' O ' HD13 ' A' ' 49' ' ' LEU . 82.8 p -63.04 -10.86 15.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.75 . . . . 0.0 110.793 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.33 69.39 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 107.734 -2.146 . . . . 0.0 107.734 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.733 HD23 ' CD2' ' A' ' 53' ' ' LEU . 4.4 mp -100.51 173.11 3.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.866 -0.785 . . . . 0.0 110.679 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HD2' HD22 ' A' ' 53' ' ' LEU . 40.7 Cg_endo -67.86 -153.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.217 1.64 . . . . 0.0 109.711 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.5 t -104.58 -65.11 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.216 . . . . 0.0 111.484 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -54.12 -38.1 65.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.082 -1.011 . . . . 0.0 111.284 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -47.62 -53.21 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.089 -1.007 . . . . 0.0 111.399 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 53' ' ' LEU . 2.5 mm? -62.54 -46.37 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.021 -1.05 . . . . 0.0 109.35 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.94 81.95 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' THR . 6.2 t-80 -72.41 -29.32 63.62 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.718 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 6.9 mt -76.65 -22.46 15.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.598 ' HZ3' HG11 ' A' ' 40' ' ' VAL . 48.1 t-105 -65.32 -45.06 85.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 108.9 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -31.63 64.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.399 -0.813 . . . . 0.0 109.119 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.062 HD23 HD13 ' A' ' 80' ' ' LEU . 5.8 tp -71.39 -22.1 61.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.76 . . . . 0.0 109.259 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.776 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 15.9 p -105.13 -30.77 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 49.6 t0 -74.71 54.32 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.744 ' CG2' HD22 ' A' ' 95' ' ' LEU . 5.4 p -54.83 -34.32 62.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.076 -1.015 . . . . 0.0 109.077 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 7.6 mptt -56.5 -17.09 7.17 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.604 -0.685 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 48.2 m-20 41.94 54.65 3.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.766 . . . . 0.0 110.155 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 41.4 t -119.99 8.6 11.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.16 -16.76 50.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 25.3 mttt -123.9 179.2 4.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 110.157 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -111.76 118.17 34.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.008 . . . . 0.0 110.713 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -75.34 175.46 8.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.952 -1.093 . . . . 0.0 109.369 179.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.51 -84.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.431 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 71' ' ' LYS . 3.6 m-20 -42.12 -38.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 110.849 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 46.4 mm-40 -60.8 -60.08 4.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.056 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 27' ' ' THR . 28.5 t80 -51.14 -33.16 25.51 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -77.63 -10.52 59.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.011 HD21 ' CG ' ' A' ' 99' ' ' MET . 5.6 tt -90.54 -35.34 15.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.434 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -58.91 -37.94 77.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.746 -1.221 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.676 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 29.0 m-85 -64.09 -35.31 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 79.1 t60 -51.36 -23.11 3.38 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.366 -0.834 . . . . 0.0 108.835 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.062 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -95.91 -22.72 17.25 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 57' ' ' ILE . 8.3 mm -75.04 -54.13 14.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -37.54 10.92 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.593 -0.692 . . . . 0.0 110.389 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' ILE . 3.8 mt-30 -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 109.97 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -90.95 -20.95 21.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 0.0 110.313 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.5 mt -90.45 -59.78 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 111.439 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.7 mm -92.88 -6.02 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.02 . . . . 0.0 111.626 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.97 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -125.88 -19.46 4.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.625 -1.297 . . . . 0.0 110.712 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.05 3.4 64.53 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.97 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.8 mt -81.95 160.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.293 -1.122 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 11.6 p-10 -102.81 166.34 12.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 109.841 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 41.2 Cg_endo -68.0 145.86 69.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.679 1.358 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.705 ' O ' HD21 ' A' ' 60' ' ' LEU . 40.8 Cg_endo -68.6 127.88 16.24 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.037 1.546 . . . . 0.0 109.935 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.502 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -28.14 -67.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.137 0.494 . . . . 0.0 111.513 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.647 ' C ' HD11 ' A' ' 60' ' ' LEU . 10.7 m -115.36 -165.61 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.965 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -93.74 163.42 13.54 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.044 ' O ' HD12 ' A' ' 100' ' ' ILE . 70.6 p -122.55 169.06 10.37 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.8 Cg_endo -67.38 -15.02 44.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.343 1.18 . . . . 0.0 109.62 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 mp0 -88.42 -16.5 32.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 108.854 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.011 ' CG ' HD21 ' A' ' 76' ' ' LEU . 31.4 ttm -96.98 -31.61 12.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.044 HD12 ' O ' ' A' ' 96' ' ' THR . 2.5 mt -72.08 139.0 82.01 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.609 -0.682 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.512 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 45.6 Cg_endo -73.83 175.33 10.92 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.384 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 44.7 Cg_endo -71.91 -160.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 102' ' ' PRO . 24.5 t . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 9' ' ' THR . 3.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -51.55 163.53 0.28 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER -83.13 -167.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.055 . . . . 0.0 109.816 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.719 HG21 ' O ' ' A' ' 75' ' ' ALA . 7.7 p 31.27 99.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.565 0.697 . . . . 0.0 111.209 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.621 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.25 -62.18 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.869 -1.144 . . . . 0.0 113.509 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 13' ' ' SER . 40.6 Cg_endo -61.98 -143.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 122.936 0.966 . . . . 0.0 111.818 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.65 -60.74 0.1 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.735 -0.603 . . . . 0.0 112.552 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 23.0 mt-10 -37.49 -60.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.57 -0.706 . . . . 0.0 111.145 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 13' ' ' SER . 1.8 tmtt? -54.65 -34.4 62.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.99 -1.069 . . . . 0.0 110.1 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.86 -46.89 70.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.6 ttpt -57.26 -30.43 64.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.646 -0.659 . . . . 0.0 110.197 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.1 m-85 -84.77 -50.01 7.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.8 t70 -50.31 -32.6 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 0.0 109.597 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.7 mm-40 -78.96 -35.01 43.81 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.203 -0.935 . . . . 0.0 108.974 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.85 HG22 ' OG1' ' A' ' 27' ' ' THR . 62.9 mt -77.74 -41.06 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.775 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.629 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 49.2 t80 -48.55 -26.57 2.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.042 -1.036 . . . . 0.0 108.809 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 17.6 mt -76.88 -28.62 55.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -98.53 -9.06 25.52 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 3.1 m -90.9 -57.24 2.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.236 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.3 80.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.664 -0.647 . . . . 0.0 109.708 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 1.1 mttt -78.48 12.32 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 111.798 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 68.4 m-20 -109.31 12.31 24.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.823 -1.173 . . . . 0.0 110.411 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 42.68 34.85 0.61 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.173 -0.954 . . . . 0.0 110.21 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 26.5 p30 -111.21 4.09 18.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.168 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 13.67 70.13 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -147.77 105.47 3.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -1.047 . . . . 0.0 110.323 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.992 HG21 HG22 ' A' ' 27' ' ' THR . 9.6 p -89.78 135.65 25.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 108.696 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.635 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -103.83 176.22 5.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.0 111.096 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -69.3 54.66 0.62 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 37' ' ' GLY . 26.2 mt -139.93 -41.08 0.44 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 12.4 mt-10 -91.08 -61.67 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 36' ' ' SER . 1.1 p -51.71 -22.82 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 1.2 ptt180 -47.36 -54.4 11.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.615 -0.678 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.735 ' HA ' HD12 ' A' ' 45' ' ' LEU . 3.0 tt0 -60.85 -43.11 98.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.238 . . . . 0.0 107.753 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR 0.256 1.1 mt -54.13 -40.79 48.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.87 -46.17 31.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.735 HD12 ' HA ' ' A' ' 42' ' ' GLU . 13.5 mt -50.83 -24.11 3.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 108.967 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 44.3 mttm -73.3 -16.33 61.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.204 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 44' ' ' PHE . 58.9 p -70.07 -19.54 63.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.409 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.14 26.94 67.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 85' ' ' LEU . 6.5 mp -96.08 164.59 18.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.713 -0.875 . . . . 0.0 110.428 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.742 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.9 Cg_endo -74.05 172.87 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.976 1.514 . . . . 0.0 110.476 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 t -66.84 -67.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.612 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' LEU . 26.0 m -43.01 -62.59 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -0.86 . . . . 0.0 111.165 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.742 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -42.51 -55.68 3.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.182 -0.949 . . . . 0.0 110.936 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' A' ' 49' ' ' LEU . 94.9 mt -52.87 -35.58 57.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.637 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -76.95 -33.77 57.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 108.739 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.435 ' NE2' HD11 ' A' ' 60' ' ' LEU . 69.3 t60 -73.7 -34.12 64.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -72.85 -19.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 57.6 t-105 -70.83 -44.56 66.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.471 -0.768 . . . . 0.0 109.948 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -70.34 -28.38 65.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.06 179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 93' ' ' HIS . 45.4 mt -73.98 -12.68 60.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 17.1 p -116.06 -31.9 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.138 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 19.7 t0 -84.33 54.79 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.73 ' CG2' HD22 ' A' ' 95' ' ' LEU . 16.6 p -50.73 -31.66 17.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 70' ' ' SER . 9.1 mmtt -49.97 -21.09 1.08 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.425 0.631 . . . . 0.0 110.167 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 45.66 51.92 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.842 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.7 -5.09 7.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.29 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.97 58.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 11.4 mttm -116.4 -178.12 3.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -1.188 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -118.47 99.2 6.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.458 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.572 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.85 -171.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 110.296 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.32 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.056 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.49 -20.92 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 110.722 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.557 ' HG3' ' HG3' ' A' ' 64' ' ' LYS . 4.6 mm100 -72.98 -49.63 27.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.775 ' N ' HD22 ' A' ' 69' ' ' LEU . 9.5 t80 -61.21 -26.52 67.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.026 . . . . 0.0 109.467 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.719 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.39 -13.85 59.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.591 -0.693 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.861 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.8 tt -90.61 -28.74 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 110.759 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.59 -51.61 64.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 110.052 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 81' ' ' ILE . 13.5 m-85 -51.38 -34.02 32.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 109.795 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.4 t60 -57.51 -20.94 34.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.324 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 2.7 mt -99.42 -31.61 11.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.226 -0.922 . . . . 0.0 109.16 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CE1' ' A' ' 44' ' ' PHE . 68.2 mt -63.18 -58.29 8.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.2 -37.03 1.96 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.596 -0.69 . . . . 0.0 110.785 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -58.78 -30.95 67.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.929 -1.107 . . . . 0.0 110.555 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -90.47 -21.76 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.793 -1.192 . . . . 0.0 111.023 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.777 HD11 HG22 ' A' ' 81' ' ' ILE . 5.0 mt -86.73 -47.49 9.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 111.496 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.1 mm -110.97 -10.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.917 -1.114 . . . . 0.0 111.194 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -118.3 -10.28 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.797 -1.189 . . . . 0.0 110.459 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 62.47 11.87 36.84 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.1 mt -90.6 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.253 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' ' 89' ' ' ILE . 1.4 m-20 -114.7 162.73 22.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 43.1 Cg_endo -68.03 158.58 56.79 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.982 1.517 . . . . 0.0 110.315 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.1 Cg_endo -72.04 178.66 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.867 1.456 . . . . 0.0 110.157 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -64.08 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.1 -1.0 . . . . 0.0 109.67 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' HD21 ' A' ' 60' ' ' LEU . 13.5 m -117.74 -165.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CG2' ' A' ' 63' ' ' THR . 11.7 mt -77.18 152.33 34.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.834 0.826 . . . . 0.0 111.687 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.013 ' O ' HD12 ' A' ' 100' ' ' ILE . 45.1 p -123.7 169.95 9.41 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.5 Cg_endo -66.06 -26.31 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.297 1.157 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.964 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.1 mt-10 -79.34 -6.97 57.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 108.924 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.861 ' CG ' HD21 ' A' ' 76' ' ' LEU . 33.6 ttm -107.6 -32.66 7.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.013 HD12 ' O ' ' A' ' 96' ' ' THR . 2.4 mt -69.6 111.83 10.14 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.627 -0.67 . . . . 0.0 109.705 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.639 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 43.9 Cg_endo -75.03 -29.07 8.57 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.03 1.542 . . . . 0.0 114.108 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 43.9 Cg_endo -70.17 93.38 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 122.466 0.719 . . . . 0.0 110.673 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.678 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.548 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -169.16 152.93 5.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 110.163 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.975 HG23 HG12 ' A' ' 12' ' ' VAL . 1.1 m -80.1 -158.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.239 -0.913 . . . . 0.0 111.108 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 11' ' ' VAL . 3.4 p 21.48 80.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-O 121.296 0.57 . . . . 0.0 112.166 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.546 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -109.45 -40.57 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 113.398 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 13' ' ' SER . 55.4 Cg_endo -80.05 -152.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 122.836 0.914 . . . . 0.0 112.35 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.94 -54.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HB3' HG23 ' A' ' 12' ' ' VAL . 40.1 mt-10 -37.98 -60.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.679 -0.638 . . . . 0.0 110.572 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.541 ' HG3' ' CZ2' ' A' ' 10' ' ' TRP . 7.3 tmtt? -55.95 -36.75 68.15 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.633 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.07 -48.82 67.08 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.702 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -55.33 -30.96 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.449 -0.782 . . . . 0.0 109.561 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.8 m-85 -85.37 -38.06 19.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.62 -35.6 74.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.458 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 31.4 mt-10 -75.9 -40.96 53.37 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.693 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.2 mt -69.25 -38.1 77.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.519 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 47.5 t80 -46.78 -31.32 2.93 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.491 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.7 mt -70.2 -32.0 69.71 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 23' ' ' ILE . 11.9 mtmt -89.73 -15.91 31.49 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.999 HG22 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -89.53 -51.86 5.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 20.7 t0 -71.4 56.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 97.6 mttt -44.57 -23.78 0.14 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.91 . . . . 0.0 111.618 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.6 m-20 -89.58 1.13 56.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.134 . . . . 0.0 110.571 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt 47.16 53.76 10.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.484 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 3.0 p30 -125.42 23.28 7.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.943 . . . . 0.0 109.951 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 64.9 12.09 52.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -151.02 108.44 3.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.238 . . . . 0.0 111.381 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -92.98 134.16 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.065 -1.022 . . . . 0.0 109.081 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.748 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.5 t -87.32 153.67 21.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.91 -26.18 1.91 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.38 -41.99 99.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.43 -1.041 . . . . 0.0 111.636 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.8 mt-10 -81.24 -61.76 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 108.887 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -52.56 -20.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.533 0.683 . . . . 0.0 109.436 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -46.81 -73.15 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.2 -42.38 4.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -58.81 -44.86 91.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.2 m-85 -80.45 -31.58 37.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.61 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 42' ' ' GLU . 57.9 mt -60.9 -16.78 45.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.0 109.357 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mttt -80.17 -22.44 41.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.194 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 44' ' ' PHE . 33.2 p -56.37 -25.39 49.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 110.472 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.95 83.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.602 ' CD2' HG23 ' A' ' 81' ' ' ILE . 3.1 mp -88.91 160.6 43.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.966 . . . . 0.0 110.436 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 40.8 Cg_endo -67.83 132.39 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.953 1.502 . . . . 0.0 110.226 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -39.33 -54.72 1.83 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.723 . . . . 0.0 110.862 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -47.98 -52.17 20.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 110.277 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.598 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -55.77 -51.54 67.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.853 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 44' ' ' PHE . 53.8 mt -58.92 -40.14 83.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -45.75 69.08 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.538 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 9.8 t-80 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 81' ' ' ILE . 3.1 mt -80.37 -27.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.653 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 22.9 t-105 -68.61 -47.98 65.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 108.968 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -61.48 -28.67 69.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.981 HD23 HD13 ' A' ' 80' ' ' LEU . 1.6 tp -67.61 -47.5 69.48 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 17.6 p -80.97 -35.02 32.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.012 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 39.2 t0 -65.5 59.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.501 -0.749 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.1 p -64.61 -30.34 71.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 1.4 mptp? -66.14 -10.78 44.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 t70 42.43 54.87 4.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 m -120.66 4.82 10.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.35 -10.93 69.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -120.91 -170.8 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.28 -1.129 . . . . 0.0 109.949 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.741 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -122.55 109.47 14.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.988 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -61.7 -178.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 109.459 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.1 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.45 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.3 m-20 -46.14 -25.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 110.277 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 64' ' ' LYS . 9.5 mt-30 -68.75 -57.04 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.878 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.855 ' CE2' HG21 ' A' ' 27' ' ' THR . 17.3 t80 -52.57 -21.42 3.84 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.347 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -85.85 -10.08 55.95 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.19 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.6 tp -91.33 -43.61 9.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.481 -0.762 . . . . 0.0 110.324 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.06 -31.4 67.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.998 -1.064 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 20.0 m-85 -72.39 -35.26 68.4 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.225 -0.922 . . . . 0.0 108.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 27.8 t-80 -53.44 -23.85 11.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.121 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.981 HD13 HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -93.19 -42.2 9.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.659 HG22 HD11 ' A' ' 85' ' ' LEU . 1.2 mm -55.28 -56.41 11.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.581 -0.699 . . . . 0.0 109.307 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -46.73 6.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 110.585 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.9 mt-30 -55.38 -24.61 30.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.974 -1.078 . . . . 0.0 110.007 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -90.22 -18.59 25.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.695 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.659 HD11 HG22 ' A' ' 81' ' ' ILE . 5.4 mt -90.73 -47.01 7.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.49 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.6 -18.86 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.932 -1.105 . . . . 0.0 111.232 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.022 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -109.72 -17.35 13.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.934 -1.104 . . . . 0.0 110.645 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 69.74 11.84 66.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -93.22 141.86 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.337 -1.096 . . . . 0.0 110.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.587 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -81.78 -172.0 0.33 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 0.0 108.79 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 90' ' ' ASP . 43.4 Cg_endo -78.33 158.93 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.415 1.219 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.7 Cg_endo -72.9 47.01 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.879 1.463 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 19.1 m170 55.89 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.272 -0.893 . . . . 0.0 111.003 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -117.23 -161.75 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 110.58 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.76 164.23 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.114 0.959 . . . . 0.0 111.175 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.857 ' O ' HD12 ' A' ' 100' ' ' ILE . 1.5 p -127.96 -177.83 0.69 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.1 Cg_endo -75.05 -5.17 16.44 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.253 1.133 . . . . 0.0 109.667 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 11.5 mt-10 -96.07 -18.33 20.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.855 0.836 . . . . 0.0 109.113 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.735 ' SD ' HG23 ' A' ' 96' ' ' THR . 4.0 mtp -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.855 0.836 . . . . 0.0 108.897 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 96' ' ' THR . 2.0 mt -61.0 128.65 89.55 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.887 -0.508 . . . . 0.0 109.743 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.12 141.03 42.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.833 1.438 . . . . 0.0 110.635 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 103' ' ' SER . 47.2 Cg_endo -76.21 -90.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.127 1.593 . . . . 0.0 110.471 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 102' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.404 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.153 0.502 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CZ3' ' HG3' ' A' ' 17' ' ' LYS . 5.1 t90 -76.41 128.96 35.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.8 m -57.62 -19.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.252 -0.905 . . . . 0.0 109.888 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG23 ' HB3' ' A' ' 16' ' ' GLU . 1.4 p -143.33 70.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.503 -0.748 . . . . 0.0 110.182 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -104.89 -31.96 0.2 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.192 -0.943 . . . . 0.0 113.49 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 13' ' ' SER . 53.2 Cg_endo -75.09 -150.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 122.575 0.776 . . . . 0.0 110.788 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.9 -46.57 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.803 -0.561 . . . . 0.0 111.903 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.924 ' HB3' HG23 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -51.79 -59.55 4.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.592 ' HG3' ' CZ3' ' A' ' 10' ' ' TRP . 9.1 tmtt? -52.16 -40.85 62.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 109.816 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -30.22 60.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 109.682 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 18.6 m-85 -88.59 -41.66 12.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.422 -0.799 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD2' ' NZ ' ' A' ' 17' ' ' LYS . 8.6 t70 -50.59 -39.79 50.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.252 -0.905 . . . . 0.0 109.178 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.42 -47.2 64.87 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' LYS . 20.3 mt -63.65 -39.26 84.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.432 -0.792 . . . . 0.0 109.413 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 66.7 t80 -49.24 -24.62 1.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.73 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.29 -26.07 60.92 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 1.8 tttt -97.95 -15.44 20.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.001 HG22 HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.83 -55.77 3.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 20.9 t0 -69.57 58.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 0.3 OUTLIER -36.72 -46.0 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.521 -0.737 . . . . 0.0 112.729 -178.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' MET . 5.1 p-10 -94.52 15.6 17.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.617 -1.302 . . . . 0.0 111.994 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 30' ' ' ASP . 9.5 mtm 35.08 56.04 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.481 -0.762 . . . . 0.0 111.271 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 13.6 p30 -101.49 4.38 41.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 110.241 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.14 -33.22 4.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 1.3 p90 -146.76 146.46 30.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -1.094 . . . . 0.0 110.74 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.001 HG21 HG22 ' A' ' 27' ' ' THR . 1.3 p -90.45 127.99 42.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.699 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -74.7 151.82 39.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.599 -1.313 . . . . 0.0 109.588 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -45.5 -23.88 0.95 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.3 mt -61.56 -46.39 90.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.755 -0.85 . . . . 0.0 111.805 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.828 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.3 mt-10 -80.39 -57.17 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.455 -1.403 . . . . 0.0 109.171 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -56.88 -20.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.848 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -43.16 -75.97 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 110.152 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HA ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp0 -42.78 -46.47 5.2 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.761 0.791 . . . . 0.0 109.021 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -52.27 -37.82 23.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -80.99 -43.78 19.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.785 . . . . 0.0 109.145 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 42' ' ' GLU . 14.0 mt -52.65 -23.76 7.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 24.4 mtpt -78.55 -5.64 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.695 . . . . 0.0 109.817 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 44' ' ' PHE . 43.5 p -76.76 -7.99 56.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.866 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.93 15.65 79.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.721 ' HB3' HD13 ' A' ' 54' ' ' LEU . 9.4 mp -88.21 165.26 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.996 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.2 Cg_endo -74.93 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.983 1.517 . . . . 0.0 109.225 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.99 -73.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.949 -1.094 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 53' ' ' LEU . 1.3 m -41.42 -58.0 2.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 111.088 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -40.86 -50.34 3.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.145 -0.972 . . . . 0.0 110.843 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -57.22 -41.61 79.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.862 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.21 92.85 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.829 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -64.36 -40.11 95.2 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD11 ' HE2' ' A' ' 84' ' ' LYS . 2.4 mt -69.0 -31.28 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.352 -0.842 . . . . 0.0 108.827 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.85 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 53.9 t-105 -63.19 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.544 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -74.84 -25.61 59.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.818 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -74.78 -25.53 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.825 . . . . 0.0 109.317 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 29.8 p -100.78 -32.74 10.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 108.692 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.616 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 53.2 t0 -72.52 61.0 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.716 -0.615 . . . . 0.0 109.899 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 1.5 p -51.65 -34.95 40.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -60.51 -13.7 15.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.459 -0.775 . . . . 0.0 110.053 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 40.75 56.32 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.516 -0.74 . . . . 0.0 110.293 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 7.58 3.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.85 75.2 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.689 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -127.55 170.12 12.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.323 -1.104 . . . . 0.0 109.987 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.85 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 1.1 mt -118.2 98.58 6.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.082 -1.011 . . . . 0.0 110.512 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 1.2 p -46.18 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.333 -0.855 . . . . 0.0 109.407 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.54 -56.98 10.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.504 -1.373 . . . . 0.0 109.628 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -64.25 -49.0 73.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 110.704 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.616 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 26.0 mt-30 -44.45 -42.98 7.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 111.184 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.931 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.2 t80 -55.02 -44.93 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.15 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -68.6 -9.49 50.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.988 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 76' ' ' LEU . 2.8 tt -90.81 -35.29 14.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 111.219 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.64 -46.09 87.87 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 17.6 m-85 -56.74 -37.34 70.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.996 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.2 t-80 -49.39 -21.66 0.94 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.07 -1.019 . . . . 0.0 109.65 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.8 mt -98.29 -24.6 15.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.807 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.949 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 18.3 mt -74.51 -58.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -30.44 7.62 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.603 -0.686 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -69.12 -21.98 63.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.968 ' HE2' HD11 ' A' ' 57' ' ' ILE . 9.3 mttm -90.99 -25.74 19.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' HD23 ' A' ' 85' ' ' LEU . 5.1 mt -86.39 -65.49 1.01 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mm -84.64 -6.08 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.001 . . . . 0.0 110.703 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.975 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mmtt -126.68 -28.89 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.933 -1.104 . . . . 0.0 110.491 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 68.55 18.79 72.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.975 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.7 mt -89.31 141.22 14.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.276 -1.132 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.27 167.51 33.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.558 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' HE3' ' A' ' 84' ' ' LYS . 44.4 Cg_endo -75.25 146.68 32.06 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.184 1.623 . . . . 0.0 110.574 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.745 ' O ' HD21 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -72.25 102.0 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.989 1.52 . . . . 0.0 110.289 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.578 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -5.07 -70.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.586 ' CA ' HD11 ' A' ' 60' ' ' LEU . 4.5 m -122.13 -173.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.086 -1.009 . . . . 0.0 110.977 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -84.33 170.78 13.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 111.815 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.664 HG23 ' SD ' ' A' ' 99' ' ' MET . 1.3 p -135.03 177.26 2.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.0 Cg_endo -70.99 -12.62 30.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.324 1.17 . . . . 0.0 110.2 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.595 ' O ' HG13 ' A' ' 11' ' ' VAL . 81.7 mt-10 -87.38 -18.34 30.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 108.711 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.822 ' HB2' HD23 ' A' ' 95' ' ' LEU . 4.4 mtp -90.12 -43.19 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.719 0.771 . . . . 0.0 109.073 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' THR . 1.3 mt -53.34 137.16 50.23 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.772 -0.58 . . . . 0.0 109.98 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.26 113.07 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.082 1.57 . . . . 0.0 110.75 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.63 168.57 24.44 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.46 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 179.907 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 98' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.833 0.825 . . . . 0.0 111.223 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.544 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.9 t90 -150.5 136.95 18.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.35 0.595 . . . . 0.0 109.732 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 98' ' ' GLU . 3.1 m -69.01 -36.69 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.773 . . . . 0.0 110.493 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.692 HG23 ' CG2' ' A' ' 11' ' ' VAL . 2.3 t -97.44 161.43 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.551 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 170.96 -54.61 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.354 -0.841 . . . . 0.0 111.156 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.4 Cg_endo -71.83 -153.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.716 1.377 . . . . 0.0 110.45 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.89 -56.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.448 0.642 . . . . 0.0 111.408 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -39.42 -64.57 0.46 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.664 -0.648 . . . . 0.0 110.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 8.0 tmtm? -50.91 -44.27 60.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -44.84 89.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -61.67 -26.85 68.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.434 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.612 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 11.5 m-85 -90.47 -51.09 5.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.623 -0.673 . . . . 0.0 109.978 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -45.62 -36.84 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.632 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 25' ' ' LEU . 71.5 mt-10 -74.66 -40.29 61.54 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.692 HG22 ' OG1' ' A' ' 27' ' ' THR . 36.5 mt -70.09 -35.18 62.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.842 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 73.3 t80 -48.82 -38.93 23.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.739 -1.225 . . . . 0.0 108.04 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.3 mt -62.79 -26.67 68.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.15 -13.72 20.77 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.04 HG22 HG21 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -89.2 -55.47 3.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 34' ' ' PHE . 21.5 t0 -63.29 73.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 65.9 mmtt -52.45 -19.79 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.303 -0.873 . . . . 0.0 111.22 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -97.0 3.15 52.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 110.793 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.76 27.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 34' ' ' PHE . 7.6 p-10 -92.92 11.5 27.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.125 -0.984 . . . . 0.0 110.194 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.34 5.45 89.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 70' ' ' SER . 1.9 m-85 -147.26 109.3 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 0.0 110.316 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.04 HG21 HG22 ' A' ' 27' ' ' THR . 4.2 p -88.86 126.59 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.49 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -81.82 148.63 28.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 110.136 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.19 -26.44 0.54 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.489 -1.007 . . . . 0.0 110.857 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.9 mt-10 -85.98 -58.79 2.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.774 -1.204 . . . . 0.0 108.927 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.544 HG11 ' HZ3' ' A' ' 58' ' ' TRP . 1.5 p -58.54 -13.84 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.503 0.668 . . . . 0.0 109.815 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.678 ' HG3' HD11 ' A' ' 45' ' ' LEU . 10.6 ttm180 -50.93 -70.27 0.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.638 -0.664 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -45.0 -44.17 9.72 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.024 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -59.13 -41.27 83.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.881 ' CE2' HD11 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.29 -19.94 52.57 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.592 -0.692 . . . . 0.0 109.211 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 42' ' ' GLU . 12.9 mt -76.42 -29.8 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.149 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 19.3 mttm -73.76 -9.61 58.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.507 -0.746 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.711 ' OG1' HD23 ' A' ' 49' ' ' LEU . 72.3 p -64.85 -51.53 61.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.76 21.01 5.87 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.711 HD23 ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.63 172.94 7.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.941 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.767 ' HD2' HD22 ' A' ' 53' ' ' LEU . 39.2 Cg_endo -66.16 -93.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.777 1.409 . . . . 0.0 110.596 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -158.66 -73.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.863 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -59.66 -29.73 68.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.767 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.1 tp -51.18 -60.1 3.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.66 HD13 HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -52.6 -35.12 53.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 108.974 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' THR . . . -68.6 -38.47 80.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.61 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 5.0 t-80 -68.84 -35.12 76.56 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 mt -69.84 -23.03 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.66 -46.28 79.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.483 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.479 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -68.57 -29.59 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.567 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 94' ' ' VAL . 1.2 mp -74.89 -18.45 60.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.904 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 14.0 p -108.22 -30.04 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.179 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 63' ' ' THR . 67.0 t0 -78.64 49.02 0.84 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.572 -0.705 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 2.4 p -46.99 -29.18 1.93 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -55.01 -19.42 6.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.302 0.573 . . . . 0.0 109.605 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 m-20 38.85 55.27 2.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.579 -0.7 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.4 t -128.54 -30.4 2.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.97 0.99 4.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -142.51 170.62 15.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.174 -1.192 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.6 mt -104.15 104.07 13.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.421 -0.799 . . . . 0.0 110.094 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.08 -168.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 110.004 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.618 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.45 -67.98 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.722 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.52 -21.42 65.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.844 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 12.2 mm100 -69.29 -56.0 8.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.873 -1.142 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.86 ' N ' HD22 ' A' ' 69' ' ' LEU . 29.6 t80 -51.56 -22.0 2.93 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.226 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.24 -13.12 55.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.133 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.68 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.2 tp -90.03 -42.98 10.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.904 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.81 -49.12 74.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.064 -1.022 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 1.2 m-85 -50.2 -36.42 30.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB2' HG22 ' A' ' 12' ' ' VAL . 18.3 t-80 -56.69 -30.49 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.504 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.577 HD22 ' CD ' ' A' ' 92' ' ' PRO . 8.3 mt -87.1 -24.01 24.7 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 44' ' ' PHE . 3.0 mm -76.65 -62.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -51.12 -26.03 6.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 110.342 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.533 ' OE1' HG21 ' A' ' 89' ' ' ILE . 3.4 mt-30 -64.85 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 110.446 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.25 -12.41 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 111.109 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.0 mt -87.19 -47.71 8.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.9 mm -111.48 -25.71 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.038 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.1 mmpt? -104.33 -2.59 25.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.643 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 45.54 35.02 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.038 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -106.31 130.42 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.154 -1.203 . . . . 0.0 110.089 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.4 p-10 -70.95 -175.79 0.33 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' A' ' 56' ' ' HIS . 43.0 Cg_endo -81.72 155.39 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.641 1.338 . . . . 0.0 110.044 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.577 ' CD ' HD22 ' A' ' 80' ' ' LEU . 43.4 Cg_endo -70.56 56.31 1.72 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.032 1.543 . . . . 0.0 110.598 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 1.3 m-70 42.58 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.497 -0.752 . . . . 0.0 110.793 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.7 ' HA ' HD11 ' A' ' 60' ' ' LEU . 6.0 m -104.56 -169.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.667 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 60' ' ' LEU . 4.3 mm? -74.0 162.12 29.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.999 ' O ' HD12 ' A' ' 100' ' ' ILE . 43.6 p -138.57 165.21 34.47 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.0 Cg_endo -65.98 -41.18 14.19 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.555 1.292 . . . . 0.0 108.752 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.3 tt0 -67.55 -7.37 25.49 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.641 -0.662 . . . . 0.0 109.438 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.68 ' CG ' HD21 ' A' ' 76' ' ' LEU . 13.7 ttm -111.56 -26.84 8.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.77 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 96' ' ' THR . 3.3 mt -78.0 116.76 61.27 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.432 -0.793 . . . . 0.0 110.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.536 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 47.5 Cg_endo -82.19 118.18 2.94 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.896 1.472 . . . . 0.0 110.201 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 103' ' ' SER . 48.6 Cg_endo -80.65 -70.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.905 1.476 . . . . 0.0 111.163 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 102' ' ' PRO . 1.4 t . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.34 -0.85 . . . . 0.0 110.82 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.13 0.49 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.568 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 1.4 p-90 -51.37 136.17 25.77 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.354 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -55.55 -173.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.314 -0.866 . . . . 0.0 109.892 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.876 HG21 ' O ' ' A' ' 75' ' ' ALA . 14.9 p 33.41 100.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 111.525 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.96 -68.47 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 112.107 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 40.3 Cg_endo -62.87 -141.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.392 1.207 . . . . 0.0 112.354 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.6 -57.41 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.685 -0.634 . . . . 0.0 112.351 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 12' ' ' VAL . 17.6 mt-10 -40.59 -63.45 0.64 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.426 -0.796 . . . . 0.0 110.599 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.81 -30.95 66.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.121 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.19 -44.57 45.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.572 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -61.17 -28.27 69.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 109.604 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.0 m-85 -87.01 -53.1 5.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.856 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -46.8 -28.74 1.65 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.002 . . . . 0.0 108.96 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -80.74 -42.58 21.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' LYS . 30.7 mt -71.38 -33.89 51.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ILE . 48.8 t80 -48.62 -33.03 9.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.468 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.4 -24.74 67.29 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 23' ' ' ILE . 35.0 mtpt -100.76 -12.89 18.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.474 -0.766 . . . . 0.0 108.969 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.995 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.23 -53.87 4.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.67 0.748 . . . . 0.0 109.076 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 49.9 t0 -67.8 62.17 0.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.632 -0.667 . . . . 0.0 109.37 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 5.2 mptp? -47.78 -25.08 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.172 -0.955 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 4.8 m-20 -91.39 7.59 40.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.788 -1.195 . . . . 0.0 111.142 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 mtt 46.65 31.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.206 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 3.9 p-10 -100.39 19.84 15.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 110.287 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 65.28 12.56 55.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 2.0 m-85 -150.2 108.83 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 0.0 110.664 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.26 132.56 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.051 -1.03 . . . . 0.0 108.623 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.772 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -88.46 156.74 18.94 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.848 -1.158 . . . . 0.0 109.979 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -49.68 -21.32 3.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 38' ' ' LEU . 2.4 mm? -68.49 -35.19 77.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.13 . . . . 0.0 111.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.705 ' HB2' HG23 ' A' ' 35' ' ' VAL . 25.5 mt-10 -88.19 -60.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.581 0.705 . . . . 0.0 109.283 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.71 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.762 -0.586 . . . . 0.0 110.601 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.1 mt-10 -45.28 -43.33 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -54.1 -42.47 55.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 m-85 -83.77 -28.6 28.05 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 42' ' ' GLU . 40.7 mt -63.72 -22.3 66.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 21.7 mtpp -75.81 -8.82 57.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.641 -0.662 . . . . 0.0 109.467 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 44' ' ' PHE . 54.0 p -68.46 -45.16 73.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 110.152 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.27 15.07 10.88 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -97.71 167.62 11.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.559 -0.965 . . . . 0.0 110.553 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.2 Cg_endo -73.85 169.34 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 52' ' ' THR . 55.4 p -67.18 -55.67 13.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.261 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.7 m -49.14 -65.51 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.612 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -41.9 -54.7 3.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 50' ' ' PRO . 50.9 mt -59.14 -44.15 92.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.852 . . . . 0.0 109.693 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.51 -41.91 98.51 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 7.2 t60 -64.95 -30.31 71.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.757 ' CD1' HD13 ' A' ' 81' ' ' ILE . 7.6 mt -73.16 -24.91 21.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.684 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 36.0 t-105 -66.59 -48.48 69.42 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.047 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.42 -33.91 76.77 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.019 -1.05 . . . . 0.0 108.408 178.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.925 HD21 ' O ' ' A' ' 92' ' ' PRO . 2.4 tp -70.76 -5.95 33.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.783 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 3.1 p -118.3 -35.58 3.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 59' ' ' SER . 4.4 p-10 -71.07 50.72 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.738 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.807 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.8 p -51.41 -29.07 14.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.747 -1.221 . . . . 0.0 108.266 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE3' ' NE2' ' A' ' 73' ' ' GLN . 6.6 mmtt -53.59 -19.4 3.85 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.464 0.649 . . . . 0.0 109.996 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 44.63 53.1 7.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 t -126.28 -12.33 6.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.471 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.39 -7.48 37.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 6.0 ptpt -129.98 -172.0 2.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -1.191 . . . . 0.0 110.342 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -123.41 103.46 8.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.146 -0.971 . . . . 0.0 111.063 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.34 -169.15 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.668 -1.27 . . . . 0.0 109.851 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -62.61 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.349 -0.844 . . . . 0.0 110.639 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' ALA . 4.0 m-20 -41.98 -67.43 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.531 ' CG ' ' OG1' ' A' ' 63' ' ' THR . 15.5 mp0 -39.75 -39.34 0.77 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.518 -0.739 . . . . 0.0 111.2 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.651 ' CA ' HD22 ' A' ' 69' ' ' LEU . 14.8 t80 -66.73 -35.61 80.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.744 -1.222 . . . . 0.0 108.683 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.876 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -74.79 -6.75 50.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 109.375 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.77 HD21 ' HG2' ' A' ' 99' ' ' MET . 4.2 tp -90.36 -44.43 9.67 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.358 -0.839 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -52.12 -51.88 55.08 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.703 -1.248 . . . . 0.0 109.815 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 9.7 m-85 -54.45 -36.75 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 110.262 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.525 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 78.4 t60 -53.92 -20.21 5.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.902 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.621 HD13 HD23 ' A' ' 60' ' ' LEU . 3.1 mt -100.22 -19.57 16.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 0.0 109.034 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.757 HD13 ' CD1' ' A' ' 57' ' ' ILE . 18.1 mm -72.38 -66.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' ILE . 79.0 p -41.01 -29.91 0.12 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.737 -0.602 . . . . 0.0 110.107 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 31.4 mt-30 -61.94 -38.7 89.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 110.04 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 49' ' ' LEU . 10.3 tptt -85.72 -14.51 45.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.929 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 49' ' ' LEU . 4.4 mt -83.84 -64.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.984 -1.073 . . . . 0.0 110.719 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG22 ' HE3' ' A' ' 87' ' ' LYS . 10.4 mm -95.89 -35.92 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.205 -0.935 . . . . 0.0 110.73 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.047 ' HB3' HD12 ' A' ' 89' ' ' ILE . 3.6 mmpt? -90.06 -0.99 57.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 43.91 24.99 0.56 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.047 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.5 mt -95.19 150.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.817 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.1 m-20 -92.91 159.6 35.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.007 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 44.7 Cg_endo -71.25 154.9 61.45 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.948 1.499 . . . . 0.0 109.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.925 ' O ' HD21 ' A' ' 60' ' ' LEU . 43.2 Cg_endo -70.43 142.14 44.22 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.988 1.52 . . . . 0.0 110.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 92' ' ' PRO . 4.1 m-70 -40.72 -57.92 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 110.444 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.602 ' CA ' HD11 ' A' ' 60' ' ' LEU . 15.1 m -124.51 -162.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 110.884 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -95.5 132.99 40.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.535 -0.728 . . . . 0.0 111.492 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 43.6 p -87.44 167.66 20.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.6 Cg_endo -66.81 -16.89 51.39 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.406 1.214 . . . . 0.0 109.403 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 11' ' ' VAL . 6.3 mt-10 -85.87 -27.31 25.12 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.77 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.8 ttm -83.86 -12.57 55.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.532 0.682 . . . . 0.0 109.306 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.17 115.19 65.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.621 -0.674 . . . . 0.0 110.081 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.48 154.73 60.36 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.759 1.399 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.0 158.69 51.98 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.945 1.497 . . . . 0.0 110.521 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 110.537 -179.751 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.711 ' O ' HG22 ' A' ' 9' ' ' THR . 15.9 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.133 0.492 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.604 ' CZ3' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -96.87 161.56 13.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.791 -1.193 . . . . 0.0 110.042 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.725 ' CG2' HG12 ' A' ' 12' ' ' VAL . 4.1 m -89.25 -8.36 10.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.35 -0.844 . . . . 0.0 110.549 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -160.31 72.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.212 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 94.5 p -108.43 -22.36 0.17 Allowed Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 13' ' ' SER . 56.8 Cg_endo -76.62 -157.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 122.294 0.628 . . . . 0.0 111.473 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.22 -51.77 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.325 0.583 . . . . 0.0 111.671 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 55.2 mt-10 -39.42 -63.09 0.59 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -57.75 -32.12 67.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 110.069 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.31 -41.13 61.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -29.7 69.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.425 -0.797 . . . . 0.0 109.552 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.8 m-30 -81.29 -41.06 22.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.468 -0.77 . . . . 0.0 109.414 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.41 -31.54 15.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.58 -35.78 52.67 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.618 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.1 mt -74.5 -42.17 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 53.1 t80 -45.83 -28.92 1.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.464 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.0 -34.53 77.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 38.0 mtmt -93.68 -9.47 37.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.895 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.56 -56.01 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.718 0.771 . . . . 0.0 109.018 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 51.1 t0 -70.13 70.43 0.38 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.628 -0.67 . . . . 0.0 109.313 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 76.1 mttt -62.34 -8.13 5.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 111.588 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -95.25 -2.94 48.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.879 -1.138 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mmt 57.08 18.61 4.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 110.16 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 24.7 p30 -92.28 18.96 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.193 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 63.68 15.81 58.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.595 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.84 112.61 4.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.083 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.892 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.63 130.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.017 -1.052 . . . . 0.0 109.587 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.9 p -85.3 148.93 25.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 109.391 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.05 -26.53 0.5 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -62.0 -35.31 78.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.643 -0.916 . . . . 0.0 111.019 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.7 mt-10 -89.13 -63.35 1.3 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.648 -1.283 . . . . 0.0 109.192 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.847 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.2 p -49.07 -21.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.321 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.768 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -43.02 -62.1 1.12 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.9 mt-10 -51.94 -45.87 64.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 108.476 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.895 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -54.65 -33.54 27.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.847 ' CD2' HG22 ' A' ' 40' ' ' VAL . 2.7 m-85 -85.17 -35.39 21.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 109.558 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 42' ' ' GLU . 11.2 mt -60.3 -15.36 24.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 38.8 mttt -85.4 -10.19 56.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.653 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.537 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 44.6 p -73.68 -55.82 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.08 -7.98 9.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.753 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.7 mm? -69.89 161.92 71.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.369 -1.077 . . . . 0.0 110.245 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 43.5 Cg_endo -71.72 143.36 41.6 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' PRO . 56.2 p -40.41 -46.99 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.377 -0.827 . . . . 0.0 110.982 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.2 m -62.53 -61.57 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.981 . . . . 0.0 110.952 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.753 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -44.89 -47.6 11.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.561 HD22 ' CD1' ' A' ' 44' ' ' PHE . 65.4 mt -55.9 -37.56 69.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.018 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.88 -43.55 75.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.484 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 20.7 t60 -61.36 -37.78 84.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.394 -0.816 . . . . 0.0 108.799 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 81' ' ' ILE . 13.8 mt -71.84 -28.51 30.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.551 -0.718 . . . . 0.0 109.079 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.687 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 15.2 t-105 -64.85 -37.8 88.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.552 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' CG ' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -75.14 -25.08 58.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 108.973 179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' A' ' 95' ' ' LEU . 1.1 mp -77.67 -17.99 57.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.344 -0.847 . . . . 0.0 108.784 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.76 ' SG ' HD21 ' A' ' 69' ' ' LEU . 14.7 p -104.69 -29.38 10.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.751 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HA ' ' A' ' 59' ' ' SER . 5.5 p-10 -71.08 55.42 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.948 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -50.58 -30.07 12.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 109.524 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -63.99 -10.25 20.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.52 -0.737 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.28 56.64 2.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.375 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 t -128.0 -31.01 2.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.43 -5.64 7.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -127.0 172.67 10.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -1.147 . . . . 0.0 109.659 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -108.43 111.13 22.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.03 -1.044 . . . . 0.0 111.017 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.595 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -62.82 -178.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.992 . . . . 0.0 110.164 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.626 ' HE2' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.8 -77.66 0.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 111.322 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.403 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 35.7 m-20 -54.31 -28.02 39.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.195 -0.941 . . . . 0.0 111.032 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' CG ' ' OG ' ' A' ' 70' ' ' SER . 36.1 mm-40 -66.08 -47.32 74.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 110.459 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.779 ' CE1' HG21 ' A' ' 27' ' ' THR . 23.9 t80 -56.5 -30.17 62.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.439 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -76.92 -13.82 59.94 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.57 0.7 . . . . 0.0 109.413 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.03 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.52 -32.96 19.13 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.51 -0.744 . . . . 0.0 109.657 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.73 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.55 -51.0 67.31 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 109.62 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 5.2 m-85 -47.65 -41.7 22.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.917 . . . . 0.0 109.627 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -52.07 -29.21 20.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.613 HD12 HG23 ' A' ' 57' ' ' ILE . 2.7 mt -83.89 -30.93 25.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -0.993 . . . . 0.0 108.726 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 57' ' ' ILE . 8.3 mm -65.12 -57.64 10.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.454 0.645 . . . . 0.0 109.315 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.62 -36.19 2.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.593 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 45.1 mt-30 -58.06 -33.59 69.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.837 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -89.12 -28.85 19.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.0 111.224 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 85' ' ' LEU . 4.2 mt -77.4 -63.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.929 -1.107 . . . . 0.0 110.865 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.92 -12.99 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.965 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -122.45 -17.02 7.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 110.943 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 84' ' ' LYS . . . 58.51 25.05 57.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.965 HD12 ' HB3' ' A' ' 87' ' ' LYS . 17.1 mt -98.48 165.74 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -1.06 . . . . 0.0 110.05 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 4.6 m-20 -96.19 164.1 19.27 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -69.49 162.89 40.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.186 1.624 . . . . 0.0 110.694 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -71.48 69.05 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.114 1.586 . . . . 0.0 111.779 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.543 ' O ' HD11 ' A' ' 60' ' ' LEU . 3.2 m170 32.41 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.772 -0.58 . . . . 0.0 111.87 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 60' ' ' LEU . 3.2 m -110.66 -164.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.171 -0.956 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.718 HD13 ' SD ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -72.29 151.87 42.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.82 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.935 ' O ' HD12 ' A' ' 100' ' ' ILE . 60.8 p -129.32 163.02 49.09 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.304 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 45.2 Cg_endo -71.39 -6.27 18.81 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.832 1.438 . . . . 0.0 110.682 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.691 ' C ' HG13 ' A' ' 11' ' ' VAL . 11.5 mt-10 -95.96 -28.93 14.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.718 ' SD ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -94.5 -12.57 27.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 110.031 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 96' ' ' THR . 5.5 mt -79.36 142.17 58.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 42.4 Cg_endo -68.49 172.57 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.857 1.451 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 44.3 Cg_endo -71.56 134.97 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.966 1.508 . . . . 0.0 110.828 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.385 -0.822 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.001 0.429 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CZ3' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.76 160.45 32.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.88 -1.138 . . . . 0.0 109.897 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.3 m -90.93 -14.47 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.712 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -152.24 67.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 111.012 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -105.72 -28.85 0.2 Allowed Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.9 Cg_endo -75.84 -155.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.577 0.777 . . . . 0.0 111.459 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.98 -48.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.432 0.634 . . . . 0.0 111.905 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 12' ' ' VAL . 9.9 mt-10 -46.35 -60.97 2.0 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -52.67 -41.46 63.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.06 . . . . 0.0 110.063 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.41 96.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.465 -0.772 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.3 ttpt -58.91 -30.43 67.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.498 -0.751 . . . . 0.0 109.801 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 5.8 m-85 -85.07 -49.65 8.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.728 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -44.09 -36.68 2.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.879 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 25' ' ' LEU . 22.3 mt-10 -71.91 -36.8 70.09 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.653 HG22 ' HG1' ' A' ' 27' ' ' THR . 45.2 mt -72.32 -40.84 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.491 -0.756 . . . . 0.0 109.84 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.501 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 31.3 t80 -48.12 -37.4 15.33 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.201 -1.0 . . . . 0.0 108.538 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.3 mt -64.09 -23.18 67.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' ILE . 3.0 mmmt -102.86 -14.2 16.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.095 HG23 HD12 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -88.76 -56.69 3.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.621 -0.675 . . . . 0.0 109.354 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.33 77.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.663 -0.648 . . . . 0.0 109.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' THR . 5.8 mttm -67.04 -1.63 4.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.184 -0.948 . . . . 0.0 112.236 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 90.9 m-20 -104.65 -2.78 24.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.707 -1.246 . . . . 0.0 110.631 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mmt 57.56 18.27 4.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 110.899 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.7 p30 -90.24 0.08 57.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.093 . . . . 0.0 110.091 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 12.98 77.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -147.43 105.02 3.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 110.065 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.978 HG21 HG22 ' A' ' 27' ' ' THR . 8.8 p -89.19 133.79 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.034 -1.041 . . . . 0.0 109.502 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -86.72 157.17 19.69 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.047 -1.033 . . . . 0.0 110.196 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -51.22 -21.81 6.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.5 mm? -72.75 -31.84 65.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -1.039 . . . . 0.0 111.352 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.564 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.5 mt-10 -83.05 -55.27 4.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.68 -1.263 . . . . 0.0 108.373 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -61.05 -10.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -50.55 -73.06 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -42.5 -41.27 2.91 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.095 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -60.14 -41.94 88.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.724 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 m-30 -81.9 -32.57 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.424 -0.797 . . . . 0.0 109.308 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.696 HD11 ' CG ' ' A' ' 41' ' ' ARG . 32.6 mt -58.58 -26.63 63.83 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.109 -0.994 . . . . 0.0 108.649 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -70.98 -8.88 56.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.513 -0.742 . . . . 0.0 109.076 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.7 p -78.36 -35.66 47.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.508 -0.745 . . . . 0.0 110.195 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 95.01 34.12 6.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.617 HD13 ' OG1' ' A' ' 47' ' ' THR . 10.1 mp -105.63 157.12 35.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.828 -0.807 . . . . 0.0 110.717 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.4 Cg_endo -75.2 178.16 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.803 1.423 . . . . 0.0 110.201 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -57.79 3.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.123 -0.986 . . . . 0.0 111.06 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -52.1 -45.32 64.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -57.86 -51.38 69.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 110.005 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 11.3 mt -55.28 -41.32 72.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.195 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 60' ' ' LEU . 13.1 t60 -69.08 -36.04 77.15 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 80' ' ' LEU . 6.9 mt -71.65 -34.48 52.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.591 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 38.6 t-105 -65.1 -47.41 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 109.879 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -31.19 72.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.197 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 ' O ' ' A' ' 93' ' ' HIS . 14.8 mt -71.02 -9.82 58.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 109.184 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' THR . 29.4 m -119.57 -36.63 3.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 109.909 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.542 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 13.0 t0 -66.06 61.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.604 -0.685 . . . . 0.0 109.672 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 1.022 HG22 HD21 ' A' ' 95' ' ' LEU . 11.6 p -58.33 -36.03 72.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.376 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -55.33 -16.2 3.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.04 53.12 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 -34.05 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -0.44 4.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 34' ' ' PHE . 9.9 mttt -132.7 175.55 9.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -1.164 . . . . 0.0 109.988 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.982 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -105.64 110.86 23.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.53 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -62.81 179.09 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.327 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HE3' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.31 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 110.654 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 3.8 m-20 -52.89 -43.37 66.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.979 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 22.0 mt-30 -43.6 -62.72 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.021 -1.049 . . . . 0.0 110.355 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.982 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.9 t80 -49.17 -36.11 18.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.837 -1.164 . . . . 0.0 109.016 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -69.57 -6.14 29.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.421 -0.8 . . . . 0.0 109.66 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.94 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.1 tt -90.34 -38.55 13.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.505 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -55.92 -39.83 72.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 110.196 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 53.1 m-85 -57.33 -29.43 63.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 13.5 t-80 -63.73 -26.55 68.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.79 -48.28 4.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.67 HG21 HG21 ' A' ' 47' ' ' THR . 82.4 mt -60.67 -33.6 55.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.734 -0.603 . . . . 0.0 110.338 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 21.0 t -72.36 -18.67 61.73 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.212 -0.93 . . . . 0.0 111.005 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -90.52 -14.71 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.024 -1.048 . . . . 0.0 111.459 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 1.4 tptt -90.37 -15.27 31.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.664 -1.272 . . . . 0.0 111.136 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 47' ' ' THR . 6.8 mt -90.26 -56.65 3.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 111.554 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.62 -19.74 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.924 -1.11 . . . . 0.0 110.676 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.024 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -109.08 -16.07 14.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.754 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 60.05 36.89 91.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.024 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.6 mt -104.61 154.38 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.273 . . . . 0.0 109.468 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.29 165.27 15.12 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 110.598 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 47.3 Cg_endo -72.34 155.04 56.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.191 1.627 . . . . 0.0 110.236 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' O ' HD11 ' A' ' 60' ' ' LEU . 42.1 Cg_endo -69.35 -179.34 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.981 1.517 . . . . 0.0 110.003 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.764 ' O ' HD21 ' A' ' 60' ' ' LEU . 54.0 m-70 -64.46 -99.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.9 -1.125 . . . . 0.0 110.19 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 60' ' ' LEU . 7.4 m -108.26 -168.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 120.987 -1.071 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 HG22 ' A' ' 63' ' ' THR . 2.0 tp -61.79 148.27 43.64 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.91 0.862 . . . . 0.0 111.458 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.063 ' O ' HD12 ' A' ' 100' ' ' ILE . 71.0 p -130.08 166.73 24.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.0 Cg_endo -67.86 -25.38 39.18 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.511 1.269 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -80.59 -12.01 59.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 109.101 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.94 ' CG ' HD21 ' A' ' 76' ' ' LEU . 32.5 ttm -103.9 -30.23 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.639 -0.663 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 96' ' ' THR . 3.0 mt -74.54 126.66 88.49 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.487 -0.758 . . . . 0.0 110.405 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.57 162.99 34.87 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.827 1.435 . . . . 0.0 110.458 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.96 154.34 47.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.028 1.541 . . . . 0.0 110.109 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.905 . . . . 0.0 110.394 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 98' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -53.67 120.4 6.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 108.963 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.99 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -64.44 -173.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.861 -1.149 . . . . 0.0 108.707 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.99 HG23 ' CG2' ' A' ' 11' ' ' VAL . 37.6 t 57.65 121.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.5 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t -157.41 -64.91 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.685 -1.26 . . . . 0.0 112.438 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 46.7 Cg_endo -68.42 -149.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.494 1.26 . . . . 0.0 110.82 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.71 -43.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.31 0.576 . . . . 0.0 111.516 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 6.3 mt-10 -44.66 -62.78 1.08 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 109.864 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -56.69 -30.63 63.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -70.1 -51.32 32.64 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' HE2' ' CA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -57.23 -32.49 66.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.28 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.67 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 8.3 m-30 -83.21 -28.11 29.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.671 -0.643 . . . . 0.0 110.483 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 11.2 t0 -72.07 -32.84 67.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 2.7 mt-10 -81.85 -26.9 33.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -0.91 . . . . 0.0 108.577 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' OG1' ' A' ' 27' ' ' THR . 65.4 mt -82.31 -42.15 18.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.647 -0.658 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.642 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 53.2 t80 -49.98 -25.03 2.94 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.69 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 20.1 mt -71.93 -26.96 62.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 23' ' ' ILE . 13.2 mttt -101.28 -12.59 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.994 HG22 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -89.05 -55.38 3.71 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 4.0 t0 -70.62 81.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.4 mttt -81.17 10.31 5.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.066 -1.021 . . . . 0.0 112.179 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 73.5 m-20 -111.78 10.46 20.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 110.024 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.1 mtm 48.19 23.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.088 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 28.6 p30 -97.85 15.79 22.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.85 52.46 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.08 112.45 4.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -1.042 . . . . 0.0 110.009 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.994 HG21 HG22 ' A' ' 27' ' ' THR . 2.3 p -88.72 133.19 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.94 -1.1 . . . . 0.0 109.889 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.664 ' O ' HG12 ' A' ' 40' ' ' VAL . 17.2 t -90.93 153.45 20.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 110.095 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -43.54 -25.52 0.54 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.6 mt -64.88 -38.73 91.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -1.117 . . . . 0.0 111.693 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.796 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.4 mt-10 -85.13 -55.82 3.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.862 -1.149 . . . . 0.0 108.974 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -59.77 -13.74 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.698 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -56.28 -67.59 0.29 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 109.751 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.982 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.7 mm-40 -45.24 -32.19 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.884 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HG23 ' A' ' 27' ' ' THR 0.268 1.3 mt -69.89 -41.83 79.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.24 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.921 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -74.58 -29.55 61.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.055 . . . . 0.0 109.196 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.982 HD12 ' HA ' ' A' ' 42' ' ' GLU . 15.1 mt -64.4 -18.48 64.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -79.58 -8.01 58.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 108.864 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.3 p -79.84 -23.16 42.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 110.413 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.51 -17.09 58.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HB3' HD13 ' A' ' 54' ' ' LEU . 7.2 mp -54.82 168.62 0.48 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.698 -0.883 . . . . 0.0 110.569 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.1 Cg_endo -81.58 -175.1 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.933 1.491 . . . . 0.0 109.392 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -61.6 1.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.422 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 53' ' ' LEU . 17.2 m -46.89 -64.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -40.53 -44.82 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.372 -0.83 . . . . 0.0 110.666 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -58.95 -43.37 91.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -66.18 -38.55 88.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 108.889 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 37.4 t-80 -66.78 -41.79 87.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.48 -0.762 . . . . 0.0 108.95 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.611 HG21 ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt -67.2 -29.81 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 21.4 t-105 -63.93 -44.61 92.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.556 ' O ' HD11 ' A' ' 95' ' ' LEU . 5.5 t -70.29 -33.62 71.78 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 108.898 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.808 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.1 tp -67.28 -21.65 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 109.809 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.879 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 18.1 p -106.62 -29.46 9.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD2' ' CZ2' ' A' ' 58' ' ' TRP . 26.1 t0 -80.47 52.59 1.66 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 110.042 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.807 HG22 HD22 ' A' ' 95' ' ' LEU . 7.7 p -46.25 -29.83 1.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.043 0.925 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.561 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 2.3 mmtm -58.92 -17.49 24.88 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.227 0.537 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 37.33 56.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.676 -0.64 . . . . 0.0 110.612 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 9.84 6.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.521 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.14 -18.27 54.48 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 34' ' ' PHE . 14.8 pttt -125.1 175.03 7.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.053 -1.263 . . . . 0.0 110.03 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.769 HD12 ' CZ3' ' A' ' 58' ' ' TRP . 1.4 mt -111.73 118.03 34.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.942 . . . . 0.0 111.028 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.643 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -64.32 -172.02 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.181 . . . . 0.0 109.459 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.43 -80.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 111.078 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -53.13 -18.62 2.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.514 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.561 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 10.1 mm100 -74.44 -40.64 61.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.886 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.3 t80 -65.15 -23.0 67.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.083 . . . . 0.0 109.041 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 20' ' ' TYR . . . -78.4 -12.37 60.0 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.504 -0.748 . . . . 0.0 109.736 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.07 HD11 ' CG ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -85.69 -38.36 18.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 110.61 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.879 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -57.06 -44.48 83.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 6.4 m-85 -60.38 -23.49 64.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.626 ' HB2' HG22 ' A' ' 12' ' ' VAL . 45.3 t-80 -64.28 -20.33 66.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 0.0 109.611 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.699 HD13 HD23 ' A' ' 60' ' ' LEU . 1.7 mt -99.69 -31.09 11.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 109.036 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.921 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 36.2 mt -61.11 -57.32 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.175 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -39.19 -34.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.695 -0.628 . . . . 0.0 110.828 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' ILE . 21.0 mt-30 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.838 -1.164 . . . . 0.0 110.714 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' ILE . 19.9 tptp -89.89 -10.31 45.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.671 HD11 HG22 ' A' ' 81' ' ' ILE . 7.3 mt -88.37 -58.7 2.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.073 . . . . 0.0 110.918 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.07 -25.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 0.0 110.794 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.065 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -103.62 -8.7 19.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.973 . . . . 0.0 110.422 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 50.85 20.82 4.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.065 HD12 ' HB3' ' A' ' 87' ' ' LYS . 4.6 mt -86.67 142.0 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.972 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 7.5 p-10 -80.16 164.55 51.87 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HD3' HD11 ' A' ' 53' ' ' LEU . 38.6 Cg_endo -66.45 159.8 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.042 1.548 . . . . 0.0 110.278 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.17 58.57 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 0.0 110.616 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.617 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER 39.35 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.631 -0.668 . . . . 0.0 111.235 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 92' ' ' PRO . 5.7 m -101.67 -164.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 111.305 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.808 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -95.3 164.84 12.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.878 0.847 . . . . 0.0 111.802 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.617 ' O ' HD12 ' A' ' 100' ' ' ILE . 14.6 p -133.65 171.65 8.73 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.3 Cg_endo -68.94 -36.19 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.291 1.153 . . . . 0.0 109.632 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.67 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 tt0 -63.4 -18.41 63.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.218 -0.926 . . . . 0.0 109.106 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.07 ' CG ' HD11 ' A' ' 76' ' ' LEU . 24.4 ttm -97.04 -26.42 15.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.456 -0.777 . . . . 0.0 109.526 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 96' ' ' THR . 6.0 mt -82.29 115.3 57.02 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -75.58 163.2 34.5 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.955 1.503 . . . . 0.0 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.59 94.99 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.983 1.518 . . . . 0.0 110.426 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 9' ' ' THR . 30.0 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' HH2' ' HB3' ' A' ' 75' ' ' ALA . 8.7 t90 -88.56 137.67 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 110.428 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 12' ' ' VAL . 2.4 m -62.1 -31.13 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.078 -1.014 . . . . 0.0 109.127 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 11' ' ' VAL . 6.2 t -103.75 159.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.588 -0.695 . . . . 0.0 109.693 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 169.25 -52.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.197 -0.939 . . . . 0.0 111.839 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 52.4 Cg_endo -70.51 -153.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.534 1.281 . . . . 0.0 110.819 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.23 -48.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.272 0.558 . . . . 0.0 111.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.559 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 1.6 mt-10 -50.97 -60.4 3.13 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.302 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -53.48 -36.3 61.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -67.6 -50.84 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.395 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -53.75 -29.58 40.43 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.51 -0.743 . . . . 0.0 109.546 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 10.9 m-85 -90.47 -47.85 7.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 12.9 t70 -49.76 -31.59 11.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 25' ' ' LEU . 32.6 mt-10 -78.41 -36.23 45.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.835 HG22 ' OG1' ' A' ' 27' ' ' THR . 37.7 mt -76.66 -39.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 70' ' ' SER . 74.7 t80 -47.21 -31.66 3.84 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.365 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.0 mt -68.02 -31.52 71.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' ILE . 2.3 tttt -97.0 -10.18 26.71 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.025 HG22 HG21 ' A' ' 35' ' ' VAL . 1.5 m -90.22 -46.49 8.4 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.596 0.712 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 32' ' ' ASP . 27.6 t0 -73.47 62.25 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.227 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -45.87 -20.91 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.126 -0.983 . . . . 0.0 111.354 -178.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 7.5 m-20 -88.94 -5.15 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.929 -1.107 . . . . 0.0 110.363 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.05 44.58 29.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 14.8 p-10 -120.7 24.47 10.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.15 47.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -150.39 99.27 2.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -1.201 . . . . 0.0 110.639 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.025 HG21 HG22 ' A' ' 27' ' ' THR . 7.4 p -90.73 142.09 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 0.0 109.354 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.759 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.28 152.47 19.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.069 -1.02 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.21 -26.49 0.93 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' SER . 71.2 mt -66.11 -41.23 90.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.474 -1.016 . . . . 0.0 110.891 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 19.9 mt-10 -78.6 -58.85 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.35 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 36' ' ' SER . 1.7 p -61.08 -14.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.279 0.561 . . . . 0.0 110.141 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -45.41 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.441 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -42.71 -42.6 3.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 0.0 109.233 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.952 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -55.7 -48.24 78.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.891 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -73.33 -38.88 65.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD23 ' CD1' ' A' ' 54' ' ' LEU . 76.2 mt -60.25 -21.66 62.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.48 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -73.6 -20.09 60.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.225 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.865 HG21 HD13 ' A' ' 81' ' ' ILE . 61.2 p -55.38 -24.45 29.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.21 56.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.9 mp -90.94 170.88 9.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 110.299 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.4 Cg_endo -74.03 -159.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.85 1.447 . . . . 0.0 110.309 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -94.05 -55.7 3.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.741 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.8 m -56.7 -57.12 13.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.694 HD11 ' HD3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -41.25 -46.48 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.601 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.759 HD22 ' HD1' ' A' ' 44' ' ' PHE . 25.0 mt -60.48 -42.05 95.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.954 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -65.7 -43.25 89.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.13 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.531 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 12.9 t60 -65.22 -32.15 73.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG21 ' CE1' ' A' ' 44' ' ' PHE . 4.2 mt -73.64 -27.87 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.799 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 29.6 t-105 -64.72 -43.67 92.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.487 ' O ' HD21 ' A' ' 95' ' ' LEU . 25.5 m -67.52 -35.23 78.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.126 -0.983 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.946 HD13 ' HG2' ' A' ' 92' ' ' PRO . 17.9 mt -67.59 -23.06 65.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.2 p -102.66 -35.48 8.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.06 -1.025 . . . . 0.0 108.866 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 61.1 t0 -70.25 54.4 0.14 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -56.74 -22.29 34.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.048 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 22.6 mmmt -57.03 -16.21 6.66 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.338 0.59 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.44 48.99 8.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.0 t -128.45 -22.1 3.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.357 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.28 -11.12 14.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.0 mtpt -124.81 -177.06 3.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -1.116 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.858 HD13 ' HD1' ' A' ' 74' ' ' PHE . 2.8 mt -116.81 107.26 14.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.628 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -58.65 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.48 -1.388 . . . . 0.0 109.994 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -76.57 -68.1 0.63 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.373 -0.829 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -61.95 -66.97 0.46 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.369 -0.832 . . . . 0.0 112.289 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -39.83 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 0.0 111.516 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.9 t80 -72.39 -38.66 68.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.476 -1.39 . . . . 0.0 108.692 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HH2' ' A' ' 10' ' ' TRP . . . -67.04 -8.87 33.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.476 0.655 . . . . 0.0 109.554 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -85.85 -45.38 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.448 -0.782 . . . . 0.0 110.02 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB1' ' CZ ' ' A' ' 44' ' ' PHE . . . -42.35 -47.34 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 66.8 m-85 -61.36 -25.7 67.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 66.1 t60 -62.21 -20.98 64.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.446 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 57' ' ' ILE . 4.7 mt -94.92 -21.77 18.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 44' ' ' PHE . 11.4 mt -73.4 -62.69 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -39.39 -33.47 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.811 -0.556 . . . . 0.0 110.33 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 27.4 mt-30 -59.61 -36.69 76.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' ILE . 5.3 tptp -89.86 -16.57 29.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.896 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 81' ' ' ILE . 8.0 mt -81.33 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.015 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.88 -33.15 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.495 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.002 ' HB3' HD12 ' A' ' 89' ' ' ILE . 2.3 mmpt? -94.93 -2.84 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.434 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 47.81 22.21 1.86 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.002 HD12 ' HB3' ' A' ' 87' ' ' LYS . 12.2 mt -92.76 170.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -1.192 . . . . 0.0 109.791 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -102.65 172.73 4.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 110.109 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HD3' HD11 ' A' ' 53' ' ' LEU . 45.8 Cg_endo -71.13 158.73 54.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.064 1.56 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.946 ' HG2' HD13 ' A' ' 60' ' ' LEU . 42.0 Cg_endo -68.73 173.59 9.81 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.959 1.505 . . . . 0.0 109.502 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -74.62 -50.68 16.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.994 -1.067 . . . . 0.0 109.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.614 ' HA ' HD21 ' A' ' 60' ' ' LEU . 27.9 m -141.67 -159.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.86 HD11 ' O ' ' A' ' 60' ' ' LEU . 3.9 mm? -82.21 176.53 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.793 0.806 . . . . 0.0 110.894 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 95' ' ' LEU . 30.9 p -150.96 166.64 14.63 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -70.59 -12.86 31.98 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 123.575 1.303 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.711 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.2 mt-10 -96.89 -19.53 18.78 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.748 0.785 . . . . 0.0 109.081 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.568 ' CG ' HD21 ' A' ' 76' ' ' LEU . 14.1 ttm -101.44 -6.62 23.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 110.224 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.608 HG23 ' HD2' ' A' ' 102' ' ' PRO . 10.6 mt -86.05 112.82 48.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.545 -0.722 . . . . 0.0 110.151 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.9 Cg_endo -73.65 -29.01 11.19 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.765 1.402 . . . . 0.0 113.322 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 49.3 Cg_endo -74.75 170.3 20.64 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 122.613 0.796 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.93 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.433 0.635 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.744 ' CZ3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 177.34 101.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.0 m -78.16 -14.72 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.382 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -140.43 67.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 109.969 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.2 t -103.49 -27.81 0.21 Allowed Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.8 Cg_endo -76.11 -156.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 122.559 0.768 . . . . 0.0 110.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.55 -57.33 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.305 0.574 . . . . 0.0 111.625 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.661 ' HB3' HG23 ' A' ' 12' ' ' VAL . 13.2 mt-10 -39.78 -63.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.694 -0.629 . . . . 0.0 110.74 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' CE ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.36 -45.19 88.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -28.04 68.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.766 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 23.5 m-85 -89.38 -48.46 7.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -47.25 -34.81 6.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.573 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.659 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.3 mt-10 -75.5 -36.05 60.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.011 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 ' OG1' ' A' ' 27' ' ' THR . 41.5 mt -69.82 -39.4 77.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.442 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -48.56 -33.48 9.76 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.645 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 22' ' ' GLU . 15.3 mt -67.8 -25.37 65.55 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' ILE . 9.4 mttp -98.9 -12.73 20.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.986 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.91 -54.52 4.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.563 -0.711 . . . . 0.0 109.508 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.46 90.27 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 108.666 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -83.45 -17.98 40.2 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.054 -1.029 . . . . 0.0 112.6 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -92.23 13.16 19.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.632 -1.293 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.6 mtm 53.05 36.47 22.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 4.1 p-10 -113.05 22.63 14.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 110.348 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' ASP . . . 47.88 26.47 4.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.85 101.1 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.88 -0.776 . . . . 0.0 109.926 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 27' ' ' THR . 3.0 p -88.93 125.37 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.979 -1.075 . . . . 0.0 109.321 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -83.17 157.6 22.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 109.819 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.75 -25.13 0.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 36' ' ' SER . 4.3 mp -59.63 -48.27 82.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -1.02 . . . . 0.0 111.964 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.2 mt-10 -78.65 -57.88 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.624 -1.298 . . . . 0.0 109.237 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.709 HG22 ' CD2' ' A' ' 44' ' ' PHE . 2.1 p -56.93 -16.76 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.983 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 1.4 ttt-85 -50.05 -77.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.003 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -41.12 -37.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.906 0.86 . . . . 0.0 108.954 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 27' ' ' THR 0.251 1.0 OUTLIER -64.74 -51.02 72.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.201 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.709 ' CD2' HG22 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -72.68 -41.18 65.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.051 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.581 HD12 ' HA ' ' A' ' 42' ' ' GLU . 87.5 mt -49.5 -24.17 1.93 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -72.71 -19.81 61.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.612 -0.68 . . . . 0.0 109.558 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.686 ' CG2' HG21 ' A' ' 81' ' ' ILE . 61.9 p -64.39 -13.86 53.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.385 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.34 23.78 70.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.1 mp -100.11 163.99 17.26 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 110.414 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -76.18 140.73 22.63 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.039 1.547 . . . . 0.0 110.338 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -45.63 -46.58 14.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -57.37 -52.83 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.637 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.617 ' CD2' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -53.25 -41.5 65.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.03 . . . . 0.0 110.023 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 44' ' ' PHE . 24.1 mt -66.2 -41.49 90.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.935 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -64.14 -41.01 97.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -70.63 -35.03 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 81' ' ' ILE . 4.8 mt -73.89 -22.52 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 37.5 t-105 -68.98 -44.82 72.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.534 -0.729 . . . . 0.0 109.534 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -69.83 -28.88 66.07 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.144 -0.973 . . . . 0.0 108.69 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.2 mt -72.86 -10.25 59.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.519 -0.738 . . . . 0.0 109.084 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 13.7 p -117.46 -34.4 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.736 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 23.5 t0 -65.63 60.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.454 -0.779 . . . . 0.0 109.961 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.713 HG23 HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -58.98 -27.81 65.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' HG2' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -68.35 -5.81 20.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.059 -1.026 . . . . 0.0 110.771 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 65' ' ' ASP . 3.4 p-10 37.85 54.78 1.59 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.45 -0.781 . . . . 0.0 111.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 -24.66 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.102 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.5 -9.89 8.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 62.8 mttp -125.0 -174.47 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 0.0 110.127 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.76 HD13 ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -115.53 113.26 23.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.145 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.522 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -77.12 -177.24 4.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.114 . . . . 0.0 110.276 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.25 -33.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 0.5 OUTLIER -58.36 -40.84 83.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.6 t80 -66.52 -41.54 88.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -63.57 -10.86 20.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.832 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -80.2 -43.27 21.79 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -64.4 -52.18 59.49 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 5.5 m-85 -49.05 -39.41 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.78 . . . . 0.0 109.618 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.558 ' CE1' ' HB ' ' A' ' 11' ' ' VAL . 11.3 t-80 -54.67 -25.68 28.61 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 57' ' ' ILE . 6.9 mt -90.54 -23.82 20.79 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.803 HD11 HG21 ' A' ' 57' ' ' ILE . 17.3 mm -73.86 -56.58 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.806 -0.757 . . . . 0.0 108.985 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -46.79 -28.19 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.526 -0.734 . . . . 0.0 110.027 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -77.2 -22.59 52.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.102 -0.999 . . . . 0.0 110.187 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -91.63 -30.96 16.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -81.02 -58.93 2.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.066 -1.021 . . . . 0.0 111.018 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.544 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -80.18 -42.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.953 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.077 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -94.34 -35.45 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 111.202 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 85.84 3.43 85.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.077 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.5 mt -66.86 165.5 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.186 -1.185 . . . . 0.0 109.885 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -102.31 164.12 16.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 0.0 110.292 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 53' ' ' LEU . 47.5 Cg_endo -74.51 145.33 33.34 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.721 ' O ' HD11 ' A' ' 60' ' ' LEU . 43.9 Cg_endo -71.45 177.52 6.64 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.993 1.522 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.738 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -64.7 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 110.01 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.527 ' CA ' HD21 ' A' ' 60' ' ' LEU . 5.2 m -109.81 -167.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 110.274 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -81.88 175.33 10.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 111.299 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.955 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -139.71 179.44 1.28 Allowed Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.5 Cg_endo -71.1 -20.39 28.69 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.189 1.1 . . . . 0.0 109.626 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.781 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.8 mt-10 -75.01 -28.34 60.46 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.729 ' CA ' HD21 ' A' ' 76' ' ' LEU . 2.9 mtt -80.77 -49.27 11.35 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.024 0.916 . . . . 0.0 108.733 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 96' ' ' THR . 3.2 mt -56.71 136.31 78.23 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.779 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 39.3 Cg_endo -66.49 175.42 5.13 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.952 1.501 . . . . 0.0 109.949 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 41.2 Cg_endo -67.0 72.84 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.802 1.422 . . . . 0.0 110.639 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.209 0.528 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.684 ' CZ2' HD12 ' A' ' 76' ' ' LEU . 6.8 t90 -162.64 140.23 8.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.125 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.103 HG23 HG12 ' A' ' 12' ' ' VAL . 1.2 m -72.21 -156.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.103 -0.998 . . . . 0.0 109.797 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.103 HG12 HG23 ' A' ' 11' ' ' VAL . 2.6 p 15.21 69.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -103.96 -35.68 0.2 Allowed Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -75.85 -153.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 122.825 0.908 . . . . 0.0 111.999 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.01 -52.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.706 ' HB3' HG23 ' A' ' 12' ' ' VAL . 34.7 mt-10 -38.47 -62.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.667 -0.645 . . . . 0.0 110.273 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.633 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -55.92 -34.58 65.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.081 -1.012 . . . . 0.0 109.44 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -68.95 -49.12 60.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 110.137 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -60.44 -30.82 69.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 7.8 m-30 -81.52 -48.57 11.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.516 -0.74 . . . . 0.0 109.813 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 25.1 t0 -46.39 -31.53 2.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.95 . . . . 0.0 109.046 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -78.51 -36.64 44.68 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.61 HG22 ' OG1' ' A' ' 27' ' ' THR . 43.6 mt -74.47 -40.3 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 58.7 t80 -50.72 -24.52 3.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.177 -0.952 . . . . 0.0 108.876 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 38.6 mt -72.37 -24.74 61.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' ILE . 72.9 mttt -102.11 -13.64 17.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.978 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 53.9 t0 -68.35 91.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 109.516 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -88.39 0.9 55.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.041 -1.037 . . . . 0.0 111.747 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 34.9 m-20 -110.36 5.27 21.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.884 -1.135 . . . . 0.0 110.93 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 44.97 26.19 0.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 109.957 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 34' ' ' PHE . 2.5 p30 -90.18 -4.9 56.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.421 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.7 -16.45 23.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD2' ' CB ' ' A' ' 68' ' ' LYS . 2.3 p90 -148.82 151.64 35.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.267 -1.137 . . . . 0.0 110.649 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.899 HG21 HG22 ' A' ' 27' ' ' THR . 1.6 p -97.42 128.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.3 t -79.56 151.04 30.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.329 -1.482 . . . . 0.0 109.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.25 -25.9 0.31 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 7.4 mp -62.02 -39.24 91.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -1.086 . . . . 0.0 111.288 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.9 mt-10 -86.63 -55.23 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.481 -1.387 . . . . 0.0 109.513 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -58.82 -15.63 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.635 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -44.34 -72.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 110.308 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.682 ' HA ' HD12 ' A' ' 45' ' ' LEU . 4.7 tt0 -44.39 -44.19 8.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.978 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -58.27 -48.63 84.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.804 ' HZ ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -71.17 -27.7 63.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 42' ' ' GLU . 34.9 mt -70.87 -16.78 62.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 109.87 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 8.4 mtpp -86.95 -4.87 59.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.646 ' CG2' HG21 ' A' ' 81' ' ' ILE . 81.9 p -72.01 -15.06 62.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.872 . . . . 0.0 111.126 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.89 5.15 83.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 47' ' ' THR . 8.6 mp -77.19 173.91 6.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -80.55 -160.33 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.85 1.448 . . . . 0.0 110.075 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -93.87 -49.81 5.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.005 -1.06 . . . . 0.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -63.81 -51.96 62.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD23 HD23 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -46.69 -52.39 13.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 111.04 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.626 HD11 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.8 -43.47 76.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.942 -1.099 . . . . 0.0 109.307 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.37 85.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.677 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 67.4 t60 -71.24 -37.75 71.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 81' ' ' ILE . 8.6 mt -70.46 -26.55 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.777 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 38.4 t-105 -63.29 -39.37 94.38 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.836 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' HD23 ' A' ' 95' ' ' LEU . 2.3 t -72.16 -29.05 63.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.408 -0.808 . . . . 0.0 109.566 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.777 ' HA ' HD22 ' A' ' 95' ' ' LEU . 3.8 mt -72.6 -18.85 61.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.26 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 21.2 p -112.19 -28.31 8.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 109.108 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.592 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 30.6 t0 -78.09 52.25 1.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.462 -0.774 . . . . 0.0 109.662 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -52.35 -22.08 4.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 109.755 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HG2' ' NE2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -45.25 -26.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.735 0.778 . . . . 0.0 109.117 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.81 50.18 10.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.562 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 68' ' ' LYS . 11.9 t -150.01 -30.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.577 -0.702 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.03 13.91 2.34 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.239 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.668 ' CB ' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -132.4 177.3 7.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.083 -1.245 . . . . 0.0 110.044 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.777 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -120.29 94.04 4.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.297 -179.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.631 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -44.77 173.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.725 -1.235 . . . . 0.0 110.112 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.63 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 0.0 111.055 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 23.6 p-10 -53.85 -30.9 47.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.04 -1.037 . . . . 0.0 110.399 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.611 ' HB3' HD23 ' A' ' 69' ' ' LEU . 8.1 mt-30 -56.32 -53.45 57.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.472 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.744 ' N ' HD22 ' A' ' 69' ' ' LEU . 42.1 t80 -50.01 -31.9 13.95 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.759 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -76.75 -11.73 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 109.795 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.822 HD21 ' HG3' ' A' ' 99' ' ' MET . 6.0 tt -89.18 -21.72 23.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 110.458 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.804 ' HB1' ' HZ ' ' A' ' 44' ' ' PHE . . . -72.9 -53.24 11.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.044 -1.035 . . . . 0.0 109.577 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 6.8 m-85 -49.54 -32.39 12.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.927 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 12' ' ' VAL . 85.1 t60 -55.23 -26.18 37.94 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.509 -0.745 . . . . 0.0 109.453 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.9 HD12 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -93.8 -32.53 13.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 57' ' ' ILE . 2.8 mm -69.27 -54.43 19.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.9 -30.65 1.04 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.85 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.2 mp0 -78.08 -19.27 54.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 110.428 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 81' ' ' ILE . 22.0 tptp -90.41 -21.9 21.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 110.673 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 49' ' ' LEU . 3.4 mt -89.45 -59.45 2.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.102 -0.999 . . . . 0.0 110.527 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.557 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.4 -25.02 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 111.425 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.016 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.05 -14.82 9.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.764 -1.21 . . . . 0.0 111.376 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 58.49 28.03 61.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.016 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -88.05 156.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -1.17 . . . . 0.0 109.668 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 10.9 m-20 -89.54 164.85 27.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' LEU . 47.3 Cg_endo -73.51 158.18 48.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.954 1.502 . . . . 0.0 110.451 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.513 ' HG3' ' HE1' ' A' ' 99' ' ' MET . 47.0 Cg_endo -72.29 58.29 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.697 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.581 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 5.9 m170 45.65 -98.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 110.588 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.9 m -109.1 -163.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 111.249 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.47 155.52 40.59 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.651 0.738 . . . . 0.0 111.635 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.033 ' O ' HD12 ' A' ' 100' ' ' ILE . 59.0 p -133.56 166.58 28.23 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -68.18 -28.94 33.59 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.446 1.235 . . . . 0.0 109.848 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.921 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.33 -9.83 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.099 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 76' ' ' LEU . 25.3 ttm -106.33 -28.17 10.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -71.52 115.13 34.2 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.497 -0.752 . . . . 0.0 110.572 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 122.17 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.99 -47.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.886 1.466 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.371 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 98' ' ' GLU . 20.6 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.236 0.541 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 9.0 t90 -174.15 155.33 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.079 HG11 ' SD ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -81.25 -163.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.818 -1.176 . . . . 0.0 109.221 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 11' ' ' VAL . 2.7 p 12.15 61.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.235 0.541 . . . . 0.0 112.013 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.9 m -102.35 -33.03 0.22 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -74.97 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 122.729 0.857 . . . . 0.0 110.948 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.86 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.295 0.569 . . . . 0.0 111.706 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 12' ' ' VAL . 22.6 mt-10 -46.67 -61.02 2.02 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.26 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -53.42 -37.11 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.94 -1.1 . . . . 0.0 109.745 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -68.96 -49.99 53.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.449 -0.782 . . . . 0.0 109.392 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -55.3 -29.72 58.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.525 -0.734 . . . . 0.0 109.456 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.673 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 7.0 m-85 -88.36 -47.61 8.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.003 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 4.0 t70 -49.27 -33.72 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.411 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 3.5 mm-40 -77.3 -39.26 48.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.425 -0.797 . . . . 0.0 108.913 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.766 HG22 ' OG1' ' A' ' 27' ' ' THR . 30.6 mt -67.37 -37.15 78.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.435 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 57.8 t80 -48.92 -36.46 17.33 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.278 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.64 -26.97 68.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 10.7 mtmt -100.86 -14.27 18.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.061 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.18 -55.11 3.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 30.7 t70 -72.08 88.36 1.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 109.07 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' ' OE2' ' A' ' 39' ' ' GLU . 4.1 mttm -86.11 -6.07 59.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.962 -1.086 . . . . 0.0 111.665 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' MET . 66.7 m-20 -91.23 12.42 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.873 -1.142 . . . . 0.0 110.709 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' ASP . 7.7 mmt 41.69 35.54 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 13.8 p-10 -112.39 12.18 20.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.177 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.04 12.78 68.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.417 ' C ' ' OD1' ' A' ' 28' ' ' ASP . 1.1 m-85 -148.12 112.17 5.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 110.42 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.017 HG21 HG22 ' A' ' 27' ' ' THR . 14.1 p -89.43 135.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 108.9 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.592 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -88.23 152.3 22.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.371 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -46.82 -24.62 1.96 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -68.94 -30.31 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.363 -1.08 . . . . 0.0 110.799 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.3 mt-10 -86.67 -60.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.793 -1.192 . . . . 0.0 108.066 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 36' ' ' SER . 1.2 p -56.15 -16.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 45' ' ' LEU . 4.5 ttt180 -42.24 -73.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 110.016 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . 2.6 mt-10 -44.32 -46.87 9.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 108.777 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.061 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -55.86 -42.71 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.105 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.812 ' HB3' HD22 ' A' ' 54' ' ' LEU . 2.9 m-30 -80.58 -24.16 39.37 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.566 -0.709 . . . . 0.0 109.38 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.1 mt -73.5 -19.77 60.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.294 -0.879 . . . . 0.0 108.848 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 34.6 mtpt -81.79 -9.52 59.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.424 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.891 ' O ' HD22 ' A' ' 85' ' ' LEU . 52.0 p -68.41 -17.72 64.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.812 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 82.01 21.02 61.88 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' CD2' ' A' ' 53' ' ' LEU . 7.5 mp -102.64 171.61 5.08 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.674 -0.898 . . . . 0.0 110.372 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.3 Cg_endo -80.92 -163.95 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.866 1.456 . . . . 0.0 109.943 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -62.38 1.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.957 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -45.95 -42.86 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.697 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.2 tp -56.48 -55.58 31.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 44' ' ' PHE . 19.4 mt -57.24 -36.92 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.385 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.56 76.95 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.842 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.497 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 6.3 t60 -66.29 -25.25 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG21 ' CG1' ' A' ' 81' ' ' ILE . 1.8 mt -82.11 -32.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 20.3 t-105 -62.81 -38.67 91.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 p -76.0 -25.4 55.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 94' ' ' VAL . 7.0 mt -77.08 -9.63 58.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.219 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.773 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.4 p -116.18 -29.37 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.146 -0.971 . . . . 0.0 109.238 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -74.48 52.54 0.5 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.51 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 1.4 p -51.86 -28.92 17.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.123 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HG3' ' CG ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -59.06 -15.22 12.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 0.0 110.414 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 43.88 55.68 5.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.98 5.92 5.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.51 -12.12 61.89 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HD3' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -120.45 -172.68 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -1.196 . . . . 0.0 110.493 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -122.99 102.37 7.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.4 -0.812 . . . . 0.0 109.783 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -58.84 -172.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.447 -1.408 . . . . 0.0 109.374 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.627 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.95 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.958 -1.089 . . . . 0.0 109.991 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' OD2' ' CH2' ' A' ' 10' ' ' TRP . 5.0 t70 -43.73 -32.8 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.386 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.565 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -59.68 -57.38 13.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 110.323 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.852 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.4 t80 -50.49 -30.38 12.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.944 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -76.33 -6.96 53.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.673 HD21 ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -84.89 -40.49 17.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -64.09 -38.18 90.14 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.743 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.673 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 3.7 m-85 -58.35 -31.13 67.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.181 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' C ' HD23 ' A' ' 80' ' ' LEU . 47.9 t-80 -61.21 -27.76 68.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.151 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.05 -57.59 2.31 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.671 HD12 ' CE1' ' A' ' 44' ' ' PHE . 40.3 mt -47.53 -31.22 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.486 0.66 . . . . 0.0 109.391 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 6.8 t -58.88 -53.49 57.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.728 -0.608 . . . . 0.0 110.935 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -66.85 -7.44 21.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.97 . . . . 0.0 110.697 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.637 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -90.72 -12.63 36.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.005 . . . . 0.0 110.897 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 47' ' ' THR . 6.3 mt -90.63 -66.78 0.9 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 111.204 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.2 mm -89.91 -34.29 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.875 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD12 ' A' ' 89' ' ' ILE . 7.9 mmpt? -89.36 -25.3 21.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.945 . . . . 0.0 110.36 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 67.77 5.46 38.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.5 mt -72.87 153.1 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 120.914 -1.345 . . . . 0.0 110.06 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -82.21 176.77 3.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.739 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 42.2 Cg_endo -70.81 168.31 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.984 1.518 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.601 ' HD2' HD13 ' A' ' 60' ' ' LEU . 52.8 Cg_endo -78.84 38.37 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.048 1.552 . . . . 0.0 111.33 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.508 ' O ' HD21 ' A' ' 60' ' ' LEU . 84.9 m-70 55.97 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.06 . . . . 0.0 111.043 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.699 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.2 m -116.83 -161.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.68 -1.262 . . . . 0.0 111.795 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.652 ' CD2' HD23 ' A' ' 60' ' ' LEU . 2.9 mm? -96.45 149.18 22.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.551 ' OG1' ' HG3' ' A' ' 99' ' ' MET . 0.8 OUTLIER -117.19 173.46 3.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.3 Cg_endo -72.91 -12.17 26.02 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.593 1.312 . . . . 0.0 110.153 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -97.39 -7.37 31.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.676 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.079 ' SD ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -116.1 10.84 15.11 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.053 -1.029 . . . . 0.0 108.955 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 96' ' ' THR 0.25 19.5 mt -106.48 138.24 19.67 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.638 -0.663 . . . . 0.0 110.828 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 48.3 Cg_endo -75.69 134.65 16.93 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.13 107.16 2.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.877 1.461 . . . . 0.0 110.424 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.044 -179.807 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -124.53 144.88 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.471 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.5 m -66.1 -42.4 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.916 0.865 . . . . 0.0 109.31 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 6.1 p -111.99 159.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER 171.28 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.684 -1.26 . . . . 0.0 111.696 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 44.2 Cg_endo -67.92 -149.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.528 1.278 . . . . 0.0 110.612 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.69 -44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.266 0.555 . . . . 0.0 111.813 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.5 mt-10 -53.08 -62.09 1.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.669 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.01 -37.75 61.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.013 . . . . 0.0 109.915 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.87 64.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.792 . . . . 0.0 109.696 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.1 ttpt -53.37 -29.27 33.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.09 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 3.7 m-85 -91.07 -52.92 4.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 110.102 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' TYR . 30.9 t70 -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.862 . . . . 0.0 109.551 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 66.5 mm-40 -75.26 -37.35 61.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.479 -0.763 . . . . 0.0 108.964 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.775 HG22 ' OG1' ' A' ' 27' ' ' THR . 64.7 mt -74.27 -38.15 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.441 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 74.8 t80 -48.65 -40.11 26.64 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.913 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 3.9 mt -64.4 -23.48 67.3 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.459 -0.897 . . . . 0.0 108.721 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' ILE . 37.6 mttt -102.62 -11.27 18.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.71 . . . . 0.0 109.134 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.059 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 m -88.87 -54.78 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 21.4 t0 -68.0 89.5 0.3 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 26' ' ' LYS . 2.3 mttt -93.55 -12.43 29.6 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.998 -1.064 . . . . 0.0 112.591 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 31' ' ' MET . 25.5 p-10 -96.16 -12.39 24.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.61 -1.306 . . . . 0.0 110.755 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 62.0 63.76 1.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 27.2 p30 -120.14 -4.42 10.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.752 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.55 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 122.77 -41.56 1.78 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -140.22 154.07 46.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.961 . . . . 0.0 109.042 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -88.25 127.21 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.598 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -79.49 149.56 31.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.348 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -40.17 -27.84 0.15 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -59.13 -46.06 89.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.847 -0.796 . . . . 0.0 111.562 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.917 ' HB2' HG23 ' A' ' 35' ' ' VAL . 2.2 mt-10 -81.13 -52.41 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.404 -1.435 . . . . 0.0 108.7 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG13 ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -65.27 -10.38 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.796 0.808 . . . . 0.0 109.384 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -45.8 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 110.692 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.19 -37.28 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -62.35 -50.11 81.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -73.5 -33.83 64.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 108.902 178.453 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 91.7 mt -65.1 -16.79 63.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.791 . . . . 0.0 109.367 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -86.76 -11.58 50.63 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.425 -0.797 . . . . 0.0 109.783 179.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.792 HG21 HD13 ' A' ' 81' ' ' ILE . 68.1 p -68.25 -17.87 64.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.51 13.95 69.32 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 85' ' ' LEU . 10.4 mp -84.26 166.52 32.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.974 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 53' ' ' LEU . 49.0 Cg_endo -77.19 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.086 1.572 . . . . 0.0 109.271 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -94.54 -70.82 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.848 -1.157 . . . . 0.0 110.323 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -42.38 -57.59 2.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.669 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.3 tp -43.5 -52.25 6.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.894 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 49' ' ' LEU . 1.2 tp -57.66 -46.57 84.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.022 . . . . 0.0 109.503 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.9 -33.29 75.37 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 30.1 t-80 -73.04 -43.84 61.51 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 3.1 mt -63.41 -24.06 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.626 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 61.9 t-105 -66.59 -52.26 47.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.94 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.583 ' O ' HD21 ' A' ' 95' ' ' LEU . 27.8 t -63.85 -33.94 76.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.839 ' O ' HD11 ' A' ' 95' ' ' LEU . 3.7 tp -64.46 -32.19 73.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.633 -0.667 . . . . 0.0 109.731 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.721 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.6 p -96.02 -36.25 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.721 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 55.3 t0 -68.03 56.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.523 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.6 -31.05 70.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.121 -0.987 . . . . 0.0 109.65 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -58.55 -15.12 9.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 44.18 55.08 5.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 110.158 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 -39.85 2.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.16 -13.06 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 34' ' ' PHE . 3.5 mttm -139.71 -169.45 2.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.325 -1.103 . . . . 0.0 109.315 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 74' ' ' PHE . 3.6 mt -108.5 122.69 47.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 111.304 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.571 ' CB ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -73.82 -172.97 1.4 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.05 -1.031 . . . . 0.0 109.178 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.16 -89.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.75 -1.219 . . . . 0.0 110.282 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -47.84 -36.28 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 110.105 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.571 ' HG3' ' CB ' ' A' ' 70' ' ' SER . 5.5 mm-40 -60.05 -35.06 74.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.997 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.939 ' HA ' HD22 ' A' ' 69' ' ' LEU . 25.9 t80 -71.09 -32.11 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 108.918 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -69.18 -8.12 42.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.826 HD21 ' HG3' ' A' ' 99' ' ' MET . 3.9 tt -90.42 -36.92 14.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 110.54 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.22 -46.15 75.95 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.002 -1.061 . . . . 0.0 109.716 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 11.5 m-85 -60.43 -34.38 73.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 110.162 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 76.7 t60 -53.15 -21.43 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.802 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.764 HD13 HD23 ' A' ' 60' ' ' LEU . 4.4 mt -98.18 -24.78 15.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 0.0 108.784 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 13.1 mt -69.94 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' ILE . 9.4 t -40.98 -32.14 0.22 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.704 -0.623 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -75.16 -24.99 57.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.919 -1.113 . . . . 0.0 110.314 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ILE . 20.5 tptt -90.07 -18.0 26.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 111.331 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HD11 ' A' ' 49' ' ' LEU . 5.3 mt -88.76 -62.8 1.4 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.953 -1.092 . . . . 0.0 111.282 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 86' ' ' ILE . 17.0 mm -92.7 -19.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.112 -0.993 . . . . 0.0 111.337 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.013 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.5 mmpt? -108.43 -7.86 15.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.989 -1.069 . . . . 0.0 110.843 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.07 20.91 4.95 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.013 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.5 mt -90.32 134.95 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.2 p-10 -71.38 169.92 13.65 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.872 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 53' ' ' LEU . 42.9 Cg_endo -71.43 155.79 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.846 1.445 . . . . 0.0 110.644 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.63 ' CD ' HD22 ' A' ' 80' ' ' LEU . 40.4 Cg_endo -67.53 59.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.566 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER 37.32 -93.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.673 -0.642 . . . . 0.0 111.617 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.769 ' C ' HD11 ' A' ' 60' ' ' LEU . 13.1 m -106.92 -164.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.249 -0.907 . . . . 0.0 111.476 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.839 HD11 ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -76.28 163.34 27.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.793 0.806 . . . . 0.0 111.256 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.615 ' O ' HD12 ' A' ' 100' ' ' ILE . 50.5 p -140.57 167.02 19.15 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -69.4 -26.65 29.07 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.434 1.229 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 11' ' ' VAL . 16.1 mp0 -79.44 -20.14 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 108.886 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.826 ' HG3' HD21 ' A' ' 76' ' ' LEU . 29.9 ttm -98.29 -6.21 31.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.644 -0.66 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 96' ' ' THR . 38.5 mt -102.88 107.81 56.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.397 -0.814 . . . . 0.0 110.428 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.664 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 42.1 Cg_endo -73.27 -29.61 11.26 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.897 1.472 . . . . 0.0 112.942 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.4 Cg_endo -71.6 -170.75 0.55 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.559 0.768 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.959 HG22 ' HA ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.168 0.509 . . . . 0.0 110.188 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER 60.5 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.802 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.009 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.5 m -71.67 -159.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.009 -1.057 . . . . 0.0 109.197 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 76' ' ' LEU . 9.9 t 49.1 101.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.064 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.29 -67.35 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.744 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.768 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 48.8 Cg_endo -67.97 -149.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.366 1.193 . . . . 0.0 112.068 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.79 -51.06 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.963 -0.461 . . . . 0.0 112.142 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -40.34 -61.98 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 110.672 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -56.59 -32.53 65.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.807 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.15 -48.43 43.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 109.749 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -29.66 69.33 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.683 0.754 . . . . 0.0 109.51 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 6.0 m-30 -84.39 -45.76 12.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.613 -0.679 . . . . 0.0 110.681 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -54.91 -39.89 69.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.815 -1.178 . . . . 0.0 109.352 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.3 mm-40 -69.41 -50.35 46.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.29 -0.881 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 26' ' ' LYS . 65.9 mt -63.83 -39.08 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.151 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 71' ' ' LYS . 85.0 t80 -46.74 -36.33 7.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.584 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 22' ' ' GLU . 6.3 mt -68.79 -21.24 64.34 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.383 -0.823 . . . . 0.0 109.163 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 12.2 mttt -101.14 -11.46 19.55 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.585 0.707 . . . . 0.0 109.162 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.933 HG23 HD12 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -89.83 -50.37 6.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.535 0.683 . . . . 0.0 109.801 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 40.1 t0 -66.52 71.04 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.572 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 27' ' ' THR . 3.6 mptp? -62.23 -12.99 23.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.273 -0.892 . . . . 0.0 111.432 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 74.5 m-20 -93.98 -0.31 55.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.911 -1.118 . . . . 0.0 110.474 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.0 mtm 45.29 27.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.813 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.57 ' OD2' ' CZ ' ' A' ' 34' ' ' PHE . 12.1 p-10 -90.22 2.86 54.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.6 12.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.735 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 38.9 p90 -150.47 162.51 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.143 . . . . 0.0 110.525 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.916 HG21 HG22 ' A' ' 27' ' ' THR . 2.4 p -99.86 146.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.445 -0.785 . . . . 0.0 110.995 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.714 ' O ' HG12 ' A' ' 40' ' ' VAL . 80.6 p -94.57 155.16 17.03 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' ' CH2' ' A' ' 58' ' ' TRP . . . -52.94 -18.41 5.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 38' ' ' LEU . 5.8 mt -73.5 -30.46 63.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 111.024 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.824 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.2 mt-10 -87.68 -60.16 2.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -54.3 -17.44 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.672 0.749 . . . . 0.0 109.659 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -46.66 -75.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.315 -0.866 . . . . 0.0 110.087 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.772 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.8 mt-10 -44.57 -37.29 3.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.551 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.933 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -61.6 -46.94 95.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.644 -0.66 . . . . 0.0 109.392 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -79.76 -27.32 40.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 109.469 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 42' ' ' GLU . 62.2 mt -60.07 -16.7 33.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.858 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 25.5 mtpp -80.39 -25.19 39.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.707 -0.62 . . . . 0.0 109.938 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' HG21 ' A' ' 81' ' ' ILE . 69.9 p -52.63 -26.44 13.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.9 -11.56 71.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.6 mp -67.96 167.28 17.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.465 -1.02 . . . . 0.0 110.136 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' HD22 ' A' ' 53' ' ' LEU . 44.5 Cg_endo -72.15 153.37 56.99 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.855 1.45 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 52' ' ' THR . 19.0 t -59.04 -63.2 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.605 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 51' ' ' SER . 51.7 m -40.07 -48.66 2.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.573 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -55.39 -56.49 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.936 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.2 mt -54.22 -36.88 63.97 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.264 -0.897 . . . . 0.0 109.052 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.56 85.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -68.08 -26.6 65.91 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 81' ' ' ILE . 3.3 mt -76.64 -29.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.768 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 50.2 t-105 -64.34 -45.85 86.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.179 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.422 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -70.52 -37.58 74.13 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.961 HD23 HD22 ' A' ' 95' ' ' LEU . 5.3 mt -66.29 -14.57 62.22 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.981 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.2 t -110.04 -41.69 4.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.771 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.8 t0 -62.92 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.667 -0.646 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.4 p -65.06 -35.49 81.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.11 -0.994 . . . . 0.0 110.36 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -56.28 -17.05 6.5 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.924 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 49.63 52.95 13.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -128.78 8.85 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.136 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.24 27.48 57.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.735 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -150.52 173.6 13.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -1.111 . . . . 0.0 110.036 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.981 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.1 mt -114.99 93.37 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 21.0 p -50.73 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.463 -0.773 . . . . 0.0 110.635 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -68.19 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.94 -1.1 . . . . 0.0 111.111 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 73' ' ' GLN . 2.3 p30 -42.57 -28.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 110.825 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.592 ' HB3' HD23 ' A' ' 69' ' ' LEU . 14.9 mt-30 -64.11 -59.17 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.072 -1.017 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 27' ' ' THR . 41.9 t80 -45.74 -29.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.834 -1.167 . . . . 0.0 109.778 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.809 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -80.41 -13.82 58.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.051 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -89.87 -34.23 16.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.529 -0.732 . . . . 0.0 110.313 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.58 -46.93 85.88 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.904 -1.123 . . . . 0.0 110.379 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 10.6 m-85 -59.39 -31.61 69.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.186 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.952 ' HB2' HG22 ' A' ' 12' ' ' VAL . 22.2 t-80 -57.43 -25.8 60.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 109.927 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -90.31 -29.48 18.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.604 HD12 ' CD1' ' A' ' 44' ' ' PHE . 1.3 mm -74.09 -50.33 28.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.592 0.711 . . . . 0.0 109.1 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -27.31 33.33 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.638 -0.664 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -72.59 -24.59 61.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 0.0 110.269 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -29.03 20.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 111.421 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -76.79 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.978 -1.077 . . . . 0.0 110.832 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -93.8 -15.64 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.428 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.775 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mptt -117.45 -11.54 10.52 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 51.68 21.97 7.76 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.775 HD12 ' HB3' ' A' ' 87' ' ' LYS . 18.5 mt -89.94 143.97 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.533 -0.981 . . . . 0.0 109.718 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.0 m-20 -82.33 165.74 40.76 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 38.3 Cg_endo -66.37 157.5 59.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.053 1.554 . . . . 0.0 110.821 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' VAL . 44.9 Cg_endo -72.69 56.56 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.196 1.629 . . . . 0.0 111.134 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.495 ' O ' HD11 ' A' ' 60' ' ' LEU . 5.4 m-70 38.12 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 111.25 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.653 ' CA ' HD21 ' A' ' 60' ' ' LEU . 6.5 m -106.86 -170.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.117 -0.989 . . . . 0.0 111.286 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.961 HD22 HD23 ' A' ' 60' ' ' LEU . 4.1 mm? -75.37 167.83 21.15 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.927 0.87 . . . . 0.0 111.863 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.027 ' O ' HD12 ' A' ' 100' ' ' ILE . 23.2 p -145.5 166.61 16.95 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.4 Cg_endo -69.52 -29.18 25.44 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.479 1.252 . . . . 0.0 109.831 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.959 ' HA ' HG22 ' A' ' 9' ' ' THR . 1.5 mt-10 -75.33 -20.32 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 108.79 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 95' ' ' LEU . 6.5 ttm -94.73 -46.6 6.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 110.501 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.027 HD12 ' O ' ' A' ' 96' ' ' THR . 1.6 mt -51.82 142.77 24.01 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.409 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.878 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 57.0 Cg_endo -70.96 -118.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 O-C-N 123.964 1.507 . . . . 0.0 108.249 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.878 ' CD ' ' HB2' ' A' ' 101' ' ' PRO . 47.0 Cg_endo -70.52 -165.4 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 121.845 1.694 . . . . 0.0 110.164 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.12 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.282 0.563 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -146.17 157.08 43.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.944 -1.097 . . . . 0.0 110.365 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.3 m -89.96 -159.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.011 -1.055 . . . . 0.0 111.413 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 75' ' ' ALA . 8.6 p 34.87 62.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 111.362 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -102.42 -39.61 0.21 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 0.0 113.222 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -78.94 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.109 1.057 . . . . 0.0 112.029 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.83 -53.16 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 12' ' ' VAL . 12.8 mt-10 -39.53 -58.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.476 -0.765 . . . . 0.0 110.315 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -54.49 -38.3 66.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.019 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.52 -47.09 74.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -62.51 -29.15 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.637 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 17.5 m-85 -85.94 -38.27 18.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.483 -0.761 . . . . 0.0 109.589 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -53.53 -39.72 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.082 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.1 mm-40 -69.43 -41.71 75.95 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.423 -0.798 . . . . 0.0 109.042 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.6 mt -66.5 -40.2 85.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 60.6 t80 -48.56 -36.89 16.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.162 -0.961 . . . . 0.0 108.799 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.8 mt -65.32 -21.85 66.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -99.92 -14.88 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.098 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.6 -55.13 3.77 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.565 0.698 . . . . 0.0 109.621 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -66.33 76.73 0.1 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.671 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -61.91 -9.68 7.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.0 111.449 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 11.2 m-20 -105.16 -4.51 21.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.789 -1.195 . . . . 0.0 110.415 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 31' ' ' MET . 1.0 OUTLIER 57.87 25.39 11.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 11.9 p30 -92.59 19.28 7.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.58 13.54 58.84 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.62 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -151.02 108.25 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -1.086 . . . . 0.0 110.867 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.982 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -89.11 140.85 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.867 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 t -96.75 161.62 13.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.771 -1.205 . . . . 0.0 110.632 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 41' ' ' ARG . . . -55.21 -16.74 9.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.0 mm? -74.86 -29.7 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.704 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.5 mt-10 -91.92 -64.02 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.999 -1.063 . . . . 0.0 108.828 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.867 HG12 ' O ' ' A' ' 36' ' ' SER . 1.3 p -52.27 -20.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.012 0.91 . . . . 0.0 109.579 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -41.71 -60.53 1.32 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.672 -0.643 . . . . 0.0 110.977 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -58.06 -41.39 83.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.924 -1.11 . . . . 0.0 108.975 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 HG23 ' A' ' 27' ' ' THR . 1.2 mt -56.56 -36.18 47.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.366 0.603 . . . . 0.0 109.414 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.77 -23.03 25.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.865 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 25.8 mt -78.51 -23.99 46.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 109.219 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.06 -4.38 58.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.736 . . . . 0.0 109.987 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.761 HG21 HD13 ' A' ' 81' ' ' ILE . 66.6 p -72.94 -15.78 61.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 91.02 18.51 46.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 85' ' ' LEU . 9.0 mp -95.74 172.72 4.97 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.763 -0.845 . . . . 0.0 110.366 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -84.68 -157.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.156 1.608 . . . . 0.0 109.76 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.982 -1.074 . . . . 0.0 110.639 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -59.1 -54.68 44.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.567 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.0 -42.25 5.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 0.0 110.407 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.597 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 1.1 mp -62.97 -52.5 62.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 109.537 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.51 70.13 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.432 ' NE2' HD11 ' A' ' 60' ' ' LEU . 67.1 t60 -73.44 -32.76 64.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.769 HG21 ' CE1' ' A' ' 44' ' ' PHE . 5.2 mt -77.34 -29.86 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.712 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 55.5 t-105 -63.97 -43.84 94.56 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.831 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -71.85 -28.95 63.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.4 mt -71.42 -11.46 60.9 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 69' ' ' LEU . 5.3 t -118.87 -41.7 2.76 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.474 -0.766 . . . . 0.0 109.316 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.07 69.17 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.9 p -59.89 -37.56 79.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.653 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -59.39 -13.9 10.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.452 -0.78 . . . . 0.0 109.922 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.9 p-10 38.62 50.2 1.55 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.423 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -10.08 9.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.567 -0.708 . . . . 0.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.8 -11.72 27.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 mttm -115.96 -171.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -1.137 . . . . 0.0 110.098 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.031 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -129.91 108.67 10.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -53.66 -170.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -78.92 -78.29 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.06 . . . . 0.0 110.515 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -44.34 -46.47 9.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 76' ' ' LEU . 2.1 mt-30 -50.84 -52.98 36.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.098 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.1 t80 -44.73 -34.85 2.41 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.212 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.003 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.06 -14.39 59.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.088 -1.007 . . . . 0.0 109.741 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.962 HD21 ' CG ' ' A' ' 99' ' ' MET . 7.3 tt -85.19 -23.35 28.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.682 -0.636 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -69.39 -54.62 13.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 109.587 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.736 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 19.1 m-85 -52.76 -34.03 51.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.661 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 6.5 t-80 -51.43 -21.81 2.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 57' ' ' ILE . 2.9 mt -98.48 -22.96 15.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 108.924 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 14.3 mt -73.51 -52.69 20.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.592 -0.693 . . . . 0.0 110.282 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ILE . 4.1 mt-30 -71.69 -25.03 61.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -90.08 -19.9 23.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 111.214 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 49' ' ' LEU . 5.6 mt -84.92 -60.8 1.94 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.114 . . . . 0.0 111.402 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.9 mm -95.91 -35.95 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.073 -1.017 . . . . 0.0 110.999 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -89.41 -13.96 36.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.045 -1.034 . . . . 0.0 110.813 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 53.83 18.8 8.97 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.6 mt -86.61 161.28 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.16 -1.2 . . . . 0.0 109.721 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 2.7 p-10 -90.39 169.35 12.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -70.21 156.25 62.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.88 1.463 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' HIS . 42.7 Cg_endo -70.13 62.93 2.0 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.125 1.592 . . . . 0.0 111.365 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.709 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.8 OUTLIER 40.08 -112.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 111.001 179.239 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 ' ND1' ' A' ' 93' ' ' HIS . 3.8 m -101.97 -172.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.744 -1.222 . . . . 0.0 111.245 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.679 HD13 ' H ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -62.94 164.37 8.26 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 111.396 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 95' ' ' LEU . 30.0 p -145.85 167.88 13.15 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -70.09 -23.17 29.62 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.486 1.256 . . . . 0.0 109.266 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.027 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.0 mt-10 -82.41 -2.11 52.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.423 -0.798 . . . . 0.0 109.127 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.962 ' CG ' HD21 ' A' ' 76' ' ' LEU . 30.7 ttm -119.08 5.09 11.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 95' ' ' LEU 0.253 33.4 mt -108.47 100.53 38.49 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.665 -0.647 . . . . 0.0 110.486 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.654 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 40.3 Cg_endo -72.96 -30.45 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.759 1.4 . . . . 0.0 113.017 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 50.4 Cg_endo -73.01 145.08 39.18 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.574 0.776 . . . . 0.0 110.342 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.931 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.445 0.641 . . . . 0.0 111.243 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.72 ' CZ3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 61.89 93.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.749 . . . . 0.0 109.65 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 98' ' ' GLU . 2.4 m -70.92 -32.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -0.872 . . . . 0.0 109.804 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.72 HG13 ' CZ3' ' A' ' 10' ' ' TRP . 2.4 p -123.65 146.34 29.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -167.02 -59.64 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.845 -1.16 . . . . 0.0 112.675 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 15' ' ' ALA . 40.9 Cg_endo -63.24 -141.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.34 1.179 . . . . 0.0 110.807 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.83 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 112.217 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -36.28 -63.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -52.21 -33.81 42.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.086 . . . . 0.0 110.418 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.54 -48.16 70.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -56.27 -31.0 63.2 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.6 m-85 -91.65 -52.06 4.94 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.704 -0.623 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 10.3 t0 -42.74 -39.77 2.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.649 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.3 mt-10 -71.66 -35.5 70.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.407 -0.808 . . . . 0.0 109.072 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 27' ' ' THR . 31.7 mt -72.43 -41.75 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.805 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 71' ' ' LYS . 47.1 t80 -46.44 -28.58 1.41 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.543 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 22' ' ' GLU . 12.8 mt -73.08 -33.16 65.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 23' ' ' ILE . 24.3 mttp -93.72 -10.05 35.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.081 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.53 -58.84 2.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 55.2 t0 -66.13 82.59 0.08 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -75.41 11.41 1.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.93 -1.106 . . . . 0.0 112.332 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 2.9 m-20 -116.67 5.74 13.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.3 mmt 46.08 35.52 2.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 111.055 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.8 p30 -108.06 12.78 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.55 12.47 80.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -150.84 109.93 3.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.286 . . . . 0.0 110.8 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.933 HG21 HG22 ' A' ' 27' ' ' THR . 13.2 p -89.6 137.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.982 . . . . 0.0 108.495 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.2 p -85.87 153.59 22.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.103 -0.998 . . . . 0.0 111.172 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -50.99 -21.7 5.53 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 mt -73.07 -32.31 64.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -1.054 . . . . 0.0 110.42 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 36.6 mt-10 -82.67 -54.06 5.44 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -66.86 -14.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.342 0.591 . . . . 0.0 109.735 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -47.24 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.154 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.71 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -43.61 -44.5 6.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.081 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -50.75 -40.95 20.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.783 ' HB3' HD22 ' A' ' 54' ' ' LEU . 1.6 m-30 -83.2 -38.65 22.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.3 mt -55.86 -18.5 8.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.356 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 83.0 mttt -79.61 -13.57 59.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 109.323 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.823 HG21 HG21 ' A' ' 81' ' ' ILE . 64.1 p -66.23 -16.77 64.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.26 66.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -100.13 171.94 5.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.641 -0.917 . . . . 0.0 110.085 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.621 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.4 Cg_endo -77.19 155.64 33.2 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.723 1.381 . . . . 0.0 110.073 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.02 67.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.967 . . . . 0.0 110.995 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -45.38 73.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.995 . . . . 0.0 111.24 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.621 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -54.99 -51.17 67.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.89 -1.131 . . . . 0.0 110.478 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.3 mt -59.85 -36.6 77.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.34 -48.19 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -60.56 -37.77 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.796 HD13 HG13 ' A' ' 81' ' ' ILE . 12.8 mt -64.74 -37.25 79.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 40.3 t-105 -57.13 -52.84 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -33.59 71.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.168 -0.957 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.757 HD11 ' C ' ' A' ' 94' ' ' VAL . 15.9 tp -67.0 -23.62 65.95 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.253 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 56.0 m -105.74 -36.09 7.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 68' ' ' LYS . 51.8 t0 -67.01 58.37 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 109.155 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.4 p -53.76 -29.57 40.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -62.69 -11.1 15.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.436 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.7 p30 37.02 55.49 1.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.615 -0.678 . . . . 0.0 110.465 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.73 -11.18 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.18 -21.09 27.49 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 16.3 mmtm -114.68 -176.41 2.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.406 -1.055 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -114.54 108.57 17.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.933 -1.105 . . . . 0.0 110.562 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -64.56 167.69 6.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 109.373 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -56.04 -72.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.558 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -44.42 -37.52 3.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 110.637 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 44.4 mm-40 -67.33 -49.6 63.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.037 -1.04 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 27' ' ' THR . 8.9 t80 -56.61 -26.92 57.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.72 -1.238 . . . . 0.0 108.588 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.52 -11.4 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.598 0.713 . . . . 0.0 109.277 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.816 HD21 ' CG ' ' A' ' 99' ' ' MET . 6.1 tp -88.64 -42.41 12.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 110.087 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.579 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -62.89 -26.39 68.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.298 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 1.4 m-85 -76.12 -20.36 57.7 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.741 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.642 ' C ' HD23 ' A' ' 80' ' ' LEU . 82.3 t60 -73.29 -22.56 60.34 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.557 -0.714 . . . . 0.0 109.172 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -99.72 -38.46 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.435 -0.79 . . . . 0.0 108.894 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 47' ' ' THR . 76.6 mt -66.66 -46.99 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -62.69 -16.76 58.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.492 -0.755 . . . . 0.0 109.915 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -77.8 -24.01 48.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 110.032 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -10.52 47.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 6.0 mt -89.99 -55.37 3.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.065 -1.022 . . . . 0.0 110.749 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.2 mm -108.9 -17.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.092 -1.005 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -108.44 -2.73 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.949 -1.094 . . . . 0.0 110.45 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 42.22 53.93 4.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.4 mt -125.63 168.37 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.302 -1.117 . . . . 0.0 109.832 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.7 m-20 -113.32 171.54 4.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.452 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 40.8 Cg_endo -70.46 151.68 65.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.897 1.472 . . . . 0.0 109.999 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.6 Cg_endo -70.85 51.64 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.938 1.494 . . . . 0.0 111.168 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.739 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 50.2 -83.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.426 -0.796 . . . . 0.0 111.679 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.757 ' C ' HD11 ' A' ' 60' ' ' LEU . 11.5 m -108.36 -162.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 60' ' ' LEU . 2.0 mm? -86.71 144.0 27.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.739 0.781 . . . . 0.0 111.243 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.877 ' O ' HD12 ' A' ' 100' ' ' ILE . 39.3 p -111.12 168.09 8.09 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.7 Cg_endo -68.38 -38.43 11.6 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 123.289 1.152 . . . . 0.0 109.863 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 9' ' ' THR . 1.7 mt-10 -71.26 -27.2 63.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 108.611 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.816 ' CG ' HD21 ' A' ' 76' ' ' LEU . 24.1 ttm -84.66 -25.52 28.41 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.422 0.63 . . . . 0.0 109.624 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 96' ' ' THR . 7.5 mt -87.01 135.82 34.71 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.097 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.44 ' HG3' ' HE3' ' A' ' 64' ' ' LYS . 41.6 Cg_endo -69.56 116.82 4.72 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.771 1.406 . . . . 0.0 109.695 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.45 -91.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.797 1.419 . . . . 0.0 111.107 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 110.45 -179.465 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.251 0.548 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -134.6 139.94 45.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.7 m -58.07 -44.71 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' ' CE3' ' A' ' 10' ' ' TRP . 3.0 p -115.66 166.13 10.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER 167.06 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.074 -1.016 . . . . 0.0 111.926 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 13' ' ' SER . 45.6 Cg_endo -66.28 -146.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.263 1.139 . . . . 0.0 110.81 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.96 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 111.524 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 43.7 mt-10 -54.09 -64.13 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -54.04 -32.67 55.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.902 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.46 -52.31 16.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.32 -30.15 62.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.007 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.6 m-30 -89.56 -50.51 6.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 8.9 t0 -43.27 -40.64 3.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 109.41 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.2 mt-10 -69.25 -34.96 75.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 108.882 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HE2' ' A' ' 74' ' ' PHE . 60.6 mt -74.66 -38.77 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.459 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 70' ' ' SER . 68.4 t80 -50.1 -33.08 17.5 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 18.0 mt -65.87 -24.86 66.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.69 -16.09 19.14 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.96 ' CG2' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.75 -52.98 4.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.502 -0.749 . . . . 0.0 109.8 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 67.6 t0 -67.14 63.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 109.29 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 11.1 mttm -65.5 -3.82 4.97 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.383 -0.823 . . . . 0.0 111.966 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 39' ' ' GLU . 45.9 m-20 -103.36 -11.06 18.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.683 -1.261 . . . . 0.0 110.672 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 57.42 37.45 27.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 19.5 p30 -103.11 1.32 33.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 110.68 -32.56 6.49 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -135.68 147.08 48.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.96 HG21 ' CG2' ' A' ' 27' ' ' THR . 1.4 p -88.94 135.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.344 -0.848 . . . . 0.0 108.733 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 40' ' ' VAL . 7.8 p -86.58 151.02 23.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 0.0 110.426 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -24.95 0.45 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 80.9 mt -65.07 -41.28 95.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -1.06 . . . . 0.0 111.591 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.859 ' HB2' HG23 ' A' ' 35' ' ' VAL . 5.5 mt-10 -81.03 -58.4 3.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.195 . . . . 0.0 108.769 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -57.01 -16.43 4.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.547 0.689 . . . . 0.0 109.639 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -43.94 -76.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.476 -0.765 . . . . 0.0 110.823 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.7 mt-10 -44.63 -46.58 10.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.071 . . . . 0.0 108.59 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.863 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -53.09 -37.27 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.9 m-30 -85.76 -45.79 11.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.655 -0.653 . . . . 0.0 109.438 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 42' ' ' GLU . 27.2 mt -51.48 -27.58 10.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 3.2 ptmt -73.86 -5.37 40.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.662 -0.649 . . . . 0.0 109.751 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 44' ' ' PHE . 65.3 p -78.97 -18.06 54.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.844 . . . . 0.0 110.015 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.85 86.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.8 mp -81.01 166.99 35.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -78.36 176.5 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.915 1.481 . . . . 0.0 110.56 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -44.03 61.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.636 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 53' ' ' LEU . 5.3 m -65.6 -59.0 4.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.702 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -44.54 -39.71 5.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.97 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 54' ' ' LEU . 33.3 mt -65.38 -53.24 46.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.38 68.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 13.9 t-80 -74.97 -38.41 61.68 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.526 HD13 ' CG1' ' A' ' 81' ' ' ILE . 3.8 mt -71.68 -28.51 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.761 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 71.7 t-105 -61.56 -44.24 97.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.274 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.2 t -71.12 -33.67 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.26 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.895 HD23 HD22 ' A' ' 95' ' ' LEU . 12.3 mt -67.05 -27.53 67.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.566 -0.709 . . . . 0.0 109.466 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.93 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 19.4 p -102.12 -35.13 9.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.447 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 45.7 t0 -75.4 57.13 0.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.582 -0.699 . . . . 0.0 110.004 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.6 p -52.49 -33.04 43.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -63.03 -12.38 25.83 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.67 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 4.1 t70 40.81 53.84 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.789 . . . . 0.0 110.139 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.85 7.9 10.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.453 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.55 -12.69 62.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.584 ' CA ' ' HZ2' ' A' ' 58' ' ' TRP . 32.4 mttt -126.43 175.44 7.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.177 . . . . 0.0 109.766 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.761 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 2.9 mt -113.35 114.88 27.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.809 -1.182 . . . . 0.0 111.707 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.638 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -64.02 -172.85 0.07 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.983 -1.073 . . . . 0.0 110.219 179.153 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -70.5 -46.2 64.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 111.361 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.24 -3.28 58.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.072 -1.018 . . . . 0.0 111.199 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.638 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 34.3 mm-40 -89.03 -43.69 10.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.901 -1.124 . . . . 0.0 109.596 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE2' HG22 ' A' ' 23' ' ' ILE . 14.6 t80 -61.38 -24.72 66.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.23 -13.96 58.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.514 -0.741 . . . . 0.0 109.084 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.8 tp -90.33 -49.15 6.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.477 -0.764 . . . . 0.0 109.415 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -48.0 -46.54 32.97 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 3.1 m-85 -51.91 -39.76 59.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.543 ' C ' HD23 ' A' ' 80' ' ' LEU . 44.6 t-80 -51.38 -24.87 5.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.06 -34.89 9.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 0.0 109.247 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 45.8 mt -77.63 -35.16 21.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.528 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 2.8 p -67.77 -29.74 69.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 110.079 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.87 -5.49 59.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.077 -1.015 . . . . 0.0 109.982 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.487 ' HD3' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.9 -24.65 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.406 -0.809 . . . . 0.0 110.91 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -90.0 -71.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.0 111.299 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 mm -82.08 3.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.795 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.956 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -126.81 -47.27 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.941 -1.099 . . . . 0.0 110.573 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 87.1 6.19 79.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.956 HD12 ' HB3' ' A' ' 87' ' ' LYS . 3.5 mt -77.42 139.37 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.231 -1.158 . . . . 0.0 109.823 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.2 170.96 13.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.217 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 40.4 Cg_endo -70.88 158.29 55.91 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.191 1.627 . . . . 0.0 110.675 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 94' ' ' VAL . 46.7 Cg_endo -75.06 47.02 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.098 1.578 . . . . 0.0 111.676 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 54.08 -85.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.077 -1.015 . . . . 0.0 111.643 178.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.681 ' HA ' HD21 ' A' ' 60' ' ' LEU . 33.4 m -117.47 -163.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.607 -1.308 . . . . 0.0 112.208 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.895 HD22 HD23 ' A' ' 60' ' ' LEU . 4.0 mm? -81.03 165.1 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.785 0.802 . . . . 0.0 111.603 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.981 ' O ' HD12 ' A' ' 100' ' ' ILE . 35.7 p -147.15 170.25 8.06 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.6 Cg_endo -69.6 -38.03 8.71 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.183 1.097 . . . . 0.0 109.527 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.957 ' O ' HG13 ' A' ' 11' ' ' VAL . 13.4 mt-10 -70.08 -10.83 60.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 108.96 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.709 ' CG ' HD21 ' A' ' 76' ' ' LEU . 28.0 ttm -102.54 -38.21 7.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -64.68 143.13 98.66 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.864 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 100' ' ' ILE . 44.6 Cg_endo -71.49 120.84 7.22 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.891 1.469 . . . . 0.0 110.706 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.55 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.923 1.486 . . . . 0.0 110.377 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 179.804 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 10' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.295 0.569 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.893 ' CZ3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 69.15 98.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.909 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.679 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.09 -20.85 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 110.104 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.893 HG13 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -139.04 73.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 109.787 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 t -102.73 -31.67 0.21 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -76.38 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 122.756 0.872 . . . . 0.0 111.101 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.67 -61.28 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.904 -0.497 . . . . 0.0 112.197 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.73 ' HB3' HG23 ' A' ' 12' ' ' VAL . 15.2 mt-10 -38.65 -57.33 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.73 . . . . 0.0 110.64 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.18 -35.17 64.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.97 . . . . 0.0 109.867 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.29 -48.61 69.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -29.42 64.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.529 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 12.2 m-85 -87.95 -51.69 5.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.558 -0.714 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -45.56 -39.56 7.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.927 -1.108 . . . . 0.0 109.356 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 5.6 mm-40 -67.51 -47.27 70.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 108.99 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.762 HG22 ' OG1' ' A' ' 27' ' ' THR . 26.1 mt -62.26 -40.5 87.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 29.4 t80 -46.95 -27.65 1.35 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 70.3 mt -70.64 -31.72 68.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -97.83 -12.8 21.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.845 . . . . 0.0 108.82 178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.045 HG23 HD12 ' A' ' 43' ' ' ILE . 1.3 m -89.06 -51.43 5.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 31' ' ' MET . 23.0 t70 -65.04 82.53 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -62.44 0.07 0.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 44.8 p-10 -122.77 3.47 9.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.219 -1.55 . . . . 0.0 110.787 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.471 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 1.2 mmt 55.92 39.08 30.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.294 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 3.9 p-10 -110.35 26.44 10.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.34 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.48 11.17 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.86 99.49 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -1.104 . . . . 0.0 110.309 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 27' ' ' THR . 10.8 p -89.71 135.66 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.94 -1.1 . . . . 0.0 109.004 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.512 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 82.6 p -90.06 147.81 23.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 110.825 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -42.94 -27.59 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.7 mp -65.04 -30.59 71.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.108 . . . . 0.0 110.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.547 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 mt-10 -86.84 -62.24 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.891 -1.131 . . . . 0.0 108.306 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -58.49 -15.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.29 0.566 . . . . 0.0 110.023 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.618 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.58 -44.67 4.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.008 . . . . 0.0 109.82 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.045 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -51.27 -40.01 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.55 -0.719 . . . . 0.0 109.072 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.4 m-85 -87.28 -28.45 22.29 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.592 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 42' ' ' GLU . 72.1 mt -68.06 -17.38 64.37 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 108.961 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CD ' ' HA ' ' A' ' 43' ' ' ILE . 10.2 mtpt -75.75 -21.32 57.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.559 0.695 . . . . 0.0 109.49 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.586 ' OG1' ' HG ' ' A' ' 49' ' ' LEU . 39.1 p -50.2 -58.14 6.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.698 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 118.43 21.41 4.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -101.05 -172.34 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.511 -0.994 . . . . 0.0 108.542 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.0 Cg_endo -74.3 -171.64 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.388 1.204 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -47.8 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.859 -1.151 . . . . 0.0 111.328 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -63.14 -32.11 73.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.673 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.995 HD23 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -59.87 -62.68 1.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 110.819 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.995 HD22 HD23 ' A' ' 53' ' ' LEU . 2.8 mm? -50.08 -29.71 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.816 -1.178 . . . . 0.0 108.953 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -79.65 -39.36 31.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 21.3 t60 -67.49 -24.58 65.6 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CD1' HD13 ' A' ' 81' ' ' ILE . 4.9 mt -78.3 -23.04 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 69' ' ' LEU . 19.5 t-105 -71.48 -45.63 61.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -69.44 -27.61 65.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 108.645 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 92' ' ' PRO . 9.0 mt -74.68 -4.65 38.58 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 76' ' ' LEU . 61.6 m -128.58 -35.48 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.75 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.9 t70 -65.81 59.35 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.63 -0.669 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' CYS . 24.7 p -55.54 -36.84 67.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -0.991 . . . . 0.0 109.881 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' CD ' ' OE1' ' A' ' 73' ' ' GLN . 11.7 mptt -56.25 -16.98 6.24 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 110.04 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.08 54.76 2.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 110.438 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.0 t -123.13 -13.96 7.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.311 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.24 -0.25 25.24 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.608 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 3.7 mtmt -129.78 -176.25 3.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.133 -1.216 . . . . 0.0 110.087 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -123.7 97.94 5.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.099 -1.001 . . . . 0.0 111.163 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -55.56 172.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.746 -1.221 . . . . 0.0 109.34 178.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -56.46 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.958 -1.089 . . . . 0.0 110.544 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' LYS . 32.3 m-20 -39.38 -42.65 1.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.594 -0.691 . . . . 0.0 110.549 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 25.9 mt-30 -61.03 -49.49 77.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.687 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.2 t80 -54.76 -37.43 65.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.786 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -73.42 -6.75 48.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.636 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -90.35 -40.52 12.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.373 -0.829 . . . . 0.0 110.071 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HB3' ' HZ ' ' A' ' 44' ' ' PHE . . . -64.63 -58.84 5.23 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.238 -0.913 . . . . 0.0 109.041 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.2 m-85 -45.67 -32.17 2.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.603 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 11.3 t-80 -66.22 -30.41 70.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 76' ' ' LEU . 14.2 mt -84.8 -16.79 40.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 109.187 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 54' ' ' LEU . 13.6 mm -73.51 -57.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.48 -0.763 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -47.98 -32.39 6.45 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.444 -0.785 . . . . 0.0 109.982 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -64.64 -24.18 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.687 ' HG2' HD22 ' A' ' 49' ' ' LEU . 2.9 tppt? -91.13 -21.48 21.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.222 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 49' ' ' LEU . 5.2 mt -89.43 -67.71 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -82.19 -10.04 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.0 110.873 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.854 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.48 -7.32 10.18 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.927 -1.108 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 47.23 24.49 2.3 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HB3' ' A' ' 87' ' ' LYS . 16.2 mt -97.16 173.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.496 -1.002 . . . . 0.0 109.858 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.551 ' N ' HG22 ' A' ' 89' ' ' ILE . 25.0 m-20 -115.37 164.79 15.97 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 110.256 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 43.5 Cg_endo -70.47 153.91 65.32 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.16 1.61 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.877 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.7 Cg_endo -71.92 151.93 57.1 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.013 1.533 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.32 -59.76 2.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.166 -0.959 . . . . 0.0 110.277 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.53 ' CA ' HD21 ' A' ' 60' ' ' LEU . 30.4 m -125.87 -166.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 111.264 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.847 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -89.89 -175.81 4.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.897 0.856 . . . . 0.0 111.564 -179.111 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.035 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -143.07 -179.23 0.91 Allowed Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 46.6 Cg_endo -76.17 -5.77 16.59 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.332 1.175 . . . . 0.0 109.929 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 11' ' ' VAL . 20.9 mt-10 -93.66 -23.11 18.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 109.277 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.929 ' HB3' HD11 ' A' ' 76' ' ' LEU . 2.4 mtp -86.37 -36.19 19.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.992 0.901 . . . . 0.0 108.698 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.035 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mt -65.23 124.77 87.84 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.883 -0.51 . . . . 0.0 110.654 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 47.7 Cg_endo -73.76 174.89 11.54 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.931 1.49 . . . . 0.0 109.906 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 42.5 Cg_endo -68.63 179.48 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.781 1.411 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.524 -179.828 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.4 m . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.96 0.886 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.674 HG11 ' HA ' ' A' ' 76' ' ' LEU . 2.3 p -115.57 156.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 174.36 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.731 -1.231 . . . . 0.0 112.335 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' SER . 48.5 Cg_endo -67.43 -145.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.272 1.143 . . . . 0.0 110.559 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.2 -49.67 0.08 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.455 0.645 . . . . 0.0 111.588 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 4.9 mt-10 -49.13 -60.79 2.49 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.418 -0.801 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.3 tmtp? -54.24 -32.96 57.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.964 -1.085 . . . . 0.0 109.981 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.45 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 108.95 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' ILE . 6.1 ttpt -54.53 -28.93 48.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.579 -0.7 . . . . 0.0 109.393 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 4.2 m-30 -90.59 -52.19 5.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 110.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 20' ' ' TYR . 53.1 t0 -45.28 -33.82 2.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 25' ' ' LEU . 30.7 mm-40 -76.39 -32.54 58.61 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.334 -0.854 . . . . 0.0 108.906 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.832 HG22 ' OG1' ' A' ' 27' ' ' THR . 46.9 mt -77.77 -41.87 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.388 -0.82 . . . . 0.0 110.073 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HE1' HG12 ' A' ' 35' ' ' VAL . 59.9 t80 -48.67 -32.68 8.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.571 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.832 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.0 mt -65.52 -28.91 69.52 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -100.18 -12.71 19.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 2.6 m -89.74 -55.74 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.745 . . . . 0.0 109.372 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.534 ' HA ' HG23 ' A' ' 35' ' ' VAL . 38.3 t0 -63.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.703 -0.623 . . . . 0.0 109.361 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.7 mmtt -51.8 -17.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 111.219 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.0 m-20 -98.23 1.68 47.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 mtm 43.26 45.35 4.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.706 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.2 p30 -115.8 26.5 9.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 109.956 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.92 12.77 44.43 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.17 100.82 2.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -1.058 . . . . 0.0 110.111 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.0 HG21 HG22 ' A' ' 27' ' ' THR . 14.5 p -88.86 139.42 17.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.925 -1.109 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 t -95.31 151.85 18.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.067 -1.021 . . . . 0.0 110.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.71 -25.16 0.82 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 38' ' ' LEU . 3.1 mm? -67.49 -29.96 69.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.218 -1.166 . . . . 0.0 110.975 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.578 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 19.4 mt-10 -91.05 -61.7 1.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.829 -1.169 . . . . 0.0 108.306 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.614 ' HA ' HG23 ' A' ' 27' ' ' THR . 1.1 p -53.02 -18.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -42.21 -75.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.705 -0.622 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.3 mt-10 -43.23 -47.97 6.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 108.717 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR . 2.2 mt -55.44 -41.28 62.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.85 ' CE1' HD12 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -77.25 -28.27 53.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 42' ' ' GLU . 19.1 mt -73.76 -23.68 59.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -0.928 . . . . 0.0 109.003 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 49.0 mttt -81.27 -13.77 58.11 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.546 0.688 . . . . 0.0 109.489 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' ILE . 45.4 p -65.2 -54.07 35.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 0.0 109.969 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.42 14.68 7.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.9 mm? -93.5 153.71 41.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.479 -1.012 . . . . 0.0 110.663 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 40.7 Cg_endo -66.13 147.64 84.22 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.945 1.498 . . . . 0.0 110.623 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 52' ' ' THR . 82.3 p -44.86 -64.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.726 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 51' ' ' SER . 13.7 m -42.47 -58.09 2.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.967 . . . . 0.0 110.878 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -52.64 -50.2 63.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 0.0 110.342 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 22.9 mt -57.11 -39.46 75.12 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.307 -0.87 . . . . 0.0 109.295 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.52 65.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 20.4 t60 -73.15 -29.63 63.0 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.903 HD13 HG13 ' A' ' 81' ' ' ILE . 8.8 mt -77.33 -28.51 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.662 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 48.3 t-105 -65.1 -42.93 93.54 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.811 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.67 59.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.947 HD23 HD13 ' A' ' 80' ' ' LEU . 7.0 tp -74.46 -17.04 60.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.835 ' HA ' HD22 ' A' ' 76' ' ' LEU . 22.4 p -115.16 -35.5 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.456 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 12.2 t70 -66.61 56.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 110.551 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 61' ' ' CYS . 0.7 OUTLIER -60.43 -24.01 64.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -61.09 -16.11 40.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.664 -0.648 . . . . 0.0 110.337 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.6 t0 39.84 51.19 2.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 110.325 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.88 -14.5 6.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.853 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.68 -1.32 27.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 14.1 mttt -136.33 171.23 14.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -1.222 . . . . 0.0 110.601 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.1 mt -107.5 101.4 10.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.13 -179.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.602 -1.311 . . . . 0.0 110.511 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.88 -52.47 43.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 14.8 p-10 -79.37 -15.23 58.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.904 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.58 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 42.2 mm-40 -77.51 -40.16 43.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.927 -1.108 . . . . 0.0 110.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.763 ' N ' HD22 ' A' ' 69' ' ' LEU . 17.0 t80 -63.87 -17.54 63.28 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.279 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.7 -18.56 37.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.421 -0.8 . . . . 0.0 109.034 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CG ' ' A' ' 99' ' ' MET . 9.6 tt -84.27 -21.92 30.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -75.41 -46.45 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.172 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.4 m-85 -57.28 -29.64 64.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 108.81 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 50.7 t60 -54.2 -22.59 11.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.947 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -99.67 -60.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.903 HG13 HD13 ' A' ' 57' ' ' ILE . 9.9 mt -48.33 -52.26 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.821 -0.549 . . . . 0.0 109.84 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -52.42 -40.01 61.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 88' ' ' GLY . 5.1 mt-30 -60.02 -21.2 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.588 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.85 -18.01 25.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.0 110.788 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -88.52 -38.46 14.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 111.172 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.6 mm -119.88 -14.67 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.997 . . . . 0.0 110.737 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.2 mmpt? -119.17 -2.5 10.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 110.616 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 41.34 59.36 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.803 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -126.36 132.59 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.087 -1.243 . . . . 0.0 110.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 15.6 p-10 -60.08 170.25 1.29 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.508 ' HD3' HD11 ' A' ' 53' ' ' LEU . 43.8 Cg_endo -79.32 152.08 23.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.772 1.406 . . . . 0.0 110.374 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.59 ' C ' ' CG ' ' A' ' 93' ' ' HIS . 42.8 Cg_endo -68.78 63.91 1.27 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.01 1.532 . . . . 0.0 110.38 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.59 ' CG ' ' C ' ' A' ' 92' ' ' PRO . 8.8 p-80 35.94 -109.63 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.72 -0.613 . . . . 0.0 111.099 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.645 ' C ' HD11 ' A' ' 60' ' ' LEU . 5.3 m -102.71 -165.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.93 -1.106 . . . . 0.0 111.218 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.594 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -69.5 147.86 50.28 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.735 0.778 . . . . 0.0 111.414 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.945 ' O ' HD12 ' A' ' 100' ' ' ILE . 68.9 p -125.71 166.97 18.1 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.0 Cg_endo -67.32 -23.28 44.84 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.477 1.251 . . . . 0.0 109.638 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.656 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -82.21 -18.31 43.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.971 ' CG ' HD21 ' A' ' 76' ' ' LEU . 35.4 ttm -92.21 -47.1 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.72 0.771 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 96' ' ' THR . 1.1 mt -50.05 134.48 22.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.545 -0.722 . . . . 0.0 110.212 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.694 -179.641 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 121.117 0.484 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.605 HG12 ' C ' ' A' ' 11' ' ' VAL . 7.7 p 36.76 66.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.578 -0.701 . . . . 0.0 111.122 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.2 t -107.12 -41.62 0.14 Allowed Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 13' ' ' SER . 51.8 Cg_endo -77.13 -147.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 122.928 0.962 . . . . 0.0 111.959 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.78 -59.13 0.11 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -37.77 -54.76 1.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.0 110.49 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.62 -42.93 68.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 109.797 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.76 -46.59 84.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.742 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -56.37 -29.18 61.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.524 -0.735 . . . . 0.0 109.971 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 13.3 m-85 -89.46 -52.38 5.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.429 -0.795 . . . . 0.0 110.05 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 5.5 t70 -44.53 -31.23 1.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.8 mt-10 -80.13 -34.75 37.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 26' ' ' LYS . 39.5 mt -78.91 -37.22 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.482 -0.761 . . . . 0.0 110.285 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 52.6 t80 -48.85 -30.6 5.99 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.356 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.4 mt -67.76 -25.76 65.78 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -98.74 -13.74 20.07 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.081 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.25 -55.47 3.66 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.729 0.776 . . . . 0.0 109.23 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 59.1 t0 -72.48 68.27 0.78 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 3.5 mttm -55.98 -13.82 2.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.493 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -96.6 13.83 26.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.563 -1.335 . . . . 0.0 110.96 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.4 mtm 43.16 26.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 34.4 p30 -98.56 22.37 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 56.49 19.85 28.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.46 105.46 3.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -1.146 . . . . 0.0 110.754 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.957 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -89.0 130.01 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.865 -1.147 . . . . 0.0 109.018 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.637 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -87.15 152.66 22.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.092 -1.005 . . . . 0.0 109.808 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.74 -22.68 0.79 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 38' ' ' LEU . 2.9 mm? -65.34 -37.32 86.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 111.263 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 35' ' ' VAL . 15.1 mt-10 -86.45 -62.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.861 -1.149 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -50.83 -20.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.623 0.725 . . . . 0.0 109.491 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -44.92 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 110.645 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.6 mt-10 -44.04 -38.37 3.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.23 -0.919 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -58.61 -42.56 85.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 110.265 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.9 m-85 -80.95 -29.65 35.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.163 -0.961 . . . . 0.0 110.166 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 42' ' ' GLU . 17.0 mt -65.85 -15.38 62.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.989 -1.069 . . . . 0.0 109.386 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 59.8 mttt -82.86 -13.51 56.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.502 ' O ' HD13 ' A' ' 49' ' ' LEU . 82.8 p -63.04 -10.86 15.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.75 . . . . 0.0 110.793 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.33 69.39 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 107.734 -2.146 . . . . 0.0 107.734 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.733 HD23 ' CD2' ' A' ' 53' ' ' LEU . 4.4 mp -100.51 173.11 3.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.866 -0.785 . . . . 0.0 110.679 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HD2' HD22 ' A' ' 53' ' ' LEU . 40.7 Cg_endo -67.86 -153.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.217 1.64 . . . . 0.0 109.711 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.5 t -104.58 -65.11 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.216 . . . . 0.0 111.484 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -54.12 -38.1 65.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.082 -1.011 . . . . 0.0 111.284 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -47.62 -53.21 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.089 -1.007 . . . . 0.0 111.399 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 53' ' ' LEU . 2.5 mm? -62.54 -46.37 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.021 -1.05 . . . . 0.0 109.35 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.94 81.95 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' THR . 28.5 t60 -72.41 -29.32 63.62 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.718 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 6.9 mt -76.65 -22.46 15.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.598 ' HZ3' HG11 ' A' ' 40' ' ' VAL . 48.1 t-105 -65.32 -45.06 85.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 108.9 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -31.63 64.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.399 -0.813 . . . . 0.0 109.119 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.062 HD23 HD13 ' A' ' 80' ' ' LEU . 5.8 tp -71.39 -22.1 61.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.76 . . . . 0.0 109.259 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.776 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 15.9 p -105.13 -30.77 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 49.6 t0 -74.71 54.32 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.744 ' CG2' HD22 ' A' ' 95' ' ' LEU . 5.4 p -54.83 -34.32 62.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.076 -1.015 . . . . 0.0 109.077 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 7.6 mptt -56.5 -17.09 7.17 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.604 -0.685 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 48.2 m-20 41.94 54.65 3.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.766 . . . . 0.0 110.155 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 41.4 t -119.99 8.6 11.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.16 -16.76 50.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 25.3 mttt -123.9 179.2 4.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 110.157 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -111.76 118.17 34.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.008 . . . . 0.0 110.713 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -75.34 175.46 8.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.952 -1.093 . . . . 0.0 109.369 179.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.51 -84.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.431 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 71' ' ' LYS . 3.6 m-20 -42.12 -38.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 110.849 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 46.4 mm-40 -60.8 -60.08 4.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.056 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 27' ' ' THR . 28.5 t80 -51.14 -33.16 25.51 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -77.63 -10.52 59.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.011 HD21 ' CG ' ' A' ' 99' ' ' MET . 5.6 tt -90.54 -35.34 15.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.434 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -58.91 -37.94 77.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.746 -1.221 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.676 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 29.0 m-85 -64.09 -35.31 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 79.1 t60 -51.36 -23.11 3.38 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.366 -0.834 . . . . 0.0 108.835 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.062 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -95.91 -22.72 17.25 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 57' ' ' ILE . 8.3 mm -75.04 -54.13 14.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -37.54 10.92 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.593 -0.692 . . . . 0.0 110.389 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' ILE . 3.8 mt-30 -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 109.97 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -90.95 -20.95 21.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 0.0 110.313 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.5 mt -90.45 -59.78 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 111.439 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.7 mm -92.88 -6.02 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.02 . . . . 0.0 111.626 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.97 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -125.88 -19.46 4.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.625 -1.297 . . . . 0.0 110.712 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.05 3.4 64.53 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.97 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.8 mt -81.95 160.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.293 -1.122 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 11.6 p-10 -102.81 166.34 12.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 109.841 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 41.2 Cg_endo -68.0 145.86 69.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.679 1.358 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.705 ' O ' HD21 ' A' ' 60' ' ' LEU . 40.8 Cg_endo -68.6 127.88 16.24 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.037 1.546 . . . . 0.0 109.935 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.502 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -28.14 -67.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.137 0.494 . . . . 0.0 111.513 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.647 ' C ' HD11 ' A' ' 60' ' ' LEU . 10.7 m -115.36 -165.61 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.965 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -93.74 163.42 13.54 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.044 ' O ' HD12 ' A' ' 100' ' ' ILE . 70.6 p -122.55 169.06 10.37 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.8 Cg_endo -67.38 -15.02 44.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.343 1.18 . . . . 0.0 109.62 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 mp0 -88.42 -16.5 32.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 108.854 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.011 ' CG ' HD21 ' A' ' 76' ' ' LEU . 31.4 ttm -96.98 -31.61 12.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.044 HD12 ' O ' ' A' ' 96' ' ' THR . 2.5 mt -72.08 139.0 82.01 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.609 -0.682 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 45.6 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.384 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.719 HG21 ' O ' ' A' ' 75' ' ' ALA . 7.7 p 31.27 99.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.565 0.697 . . . . 0.0 111.209 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.621 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.25 -62.18 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.869 -1.144 . . . . 0.0 113.509 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 13' ' ' SER . 40.6 Cg_endo -61.98 -143.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 122.936 0.966 . . . . 0.0 111.818 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.65 -60.74 0.1 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.735 -0.603 . . . . 0.0 112.552 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 23.0 mt-10 -37.49 -60.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.57 -0.706 . . . . 0.0 111.145 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 13' ' ' SER . 1.8 tmtt? -54.65 -34.4 62.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.99 -1.069 . . . . 0.0 110.1 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.86 -46.89 70.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.6 ttpt -57.26 -30.43 64.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.646 -0.659 . . . . 0.0 110.197 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.1 m-85 -84.77 -50.01 7.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.8 t70 -50.31 -32.6 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 0.0 109.597 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.7 mm-40 -78.96 -35.01 43.81 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.203 -0.935 . . . . 0.0 108.974 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.85 HG22 ' OG1' ' A' ' 27' ' ' THR . 62.9 mt -77.74 -41.06 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.775 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.629 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 49.2 t80 -48.55 -26.57 2.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.042 -1.036 . . . . 0.0 108.809 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 17.6 mt -76.88 -28.62 55.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -98.53 -9.06 25.52 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 3.1 m -90.9 -57.24 2.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.236 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.3 80.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.664 -0.647 . . . . 0.0 109.708 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 1.1 mttt -78.48 12.32 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 111.798 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 68.4 m-20 -109.31 12.31 24.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.823 -1.173 . . . . 0.0 110.411 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 42.68 34.85 0.61 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.173 -0.954 . . . . 0.0 110.21 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 26.5 p30 -111.21 4.09 18.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.168 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 13.67 70.13 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -147.77 105.47 3.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -1.047 . . . . 0.0 110.323 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.992 HG21 HG22 ' A' ' 27' ' ' THR . 9.6 p -89.78 135.65 25.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 108.696 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.635 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -103.83 176.22 5.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.0 111.096 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -69.3 54.66 0.62 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 37' ' ' GLY . 26.2 mt -139.93 -41.08 0.44 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 12.4 mt-10 -91.08 -61.67 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 36' ' ' SER . 1.1 p -51.71 -22.82 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 1.2 ptt180 -47.36 -54.4 11.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.615 -0.678 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.735 ' HA ' HD12 ' A' ' 45' ' ' LEU . 3.0 tt0 -60.85 -43.11 98.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.238 . . . . 0.0 107.753 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR 0.256 1.1 mt -54.13 -40.79 48.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.87 -46.17 31.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.735 HD12 ' HA ' ' A' ' 42' ' ' GLU . 13.5 mt -50.83 -24.11 3.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 108.967 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 44.3 mttm -73.3 -16.33 61.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.204 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 44' ' ' PHE . 58.9 p -70.07 -19.54 63.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.409 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.14 26.94 67.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 85' ' ' LEU . 6.5 mp -96.08 164.59 18.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.713 -0.875 . . . . 0.0 110.428 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.742 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.9 Cg_endo -74.05 172.87 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.976 1.514 . . . . 0.0 110.476 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 t -66.84 -67.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.612 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' LEU . 26.0 m -43.01 -62.59 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -0.86 . . . . 0.0 111.165 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.742 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -42.51 -55.68 3.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.182 -0.949 . . . . 0.0 110.936 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' A' ' 49' ' ' LEU . 94.9 mt -52.87 -35.58 57.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.637 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -76.95 -33.77 57.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 108.739 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.435 ' NE2' HD11 ' A' ' 60' ' ' LEU . 69.3 t60 -73.7 -34.12 64.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -72.85 -19.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 57.6 t-105 -70.83 -44.56 66.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.471 -0.768 . . . . 0.0 109.948 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -70.34 -28.38 65.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.06 179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 93' ' ' HIS . 45.4 mt -73.98 -12.68 60.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 17.1 p -116.06 -31.9 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.138 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 19.7 t0 -84.33 54.79 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.73 ' CG2' HD22 ' A' ' 95' ' ' LEU . 16.6 p -50.73 -31.66 17.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 70' ' ' SER . 9.1 mmtt -49.97 -21.09 1.08 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.425 0.631 . . . . 0.0 110.167 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 45.66 51.92 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.842 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.7 -5.09 7.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.29 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.97 58.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 11.4 mttm -116.4 -178.12 3.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -1.188 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -118.47 99.2 6.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.458 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.572 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.85 -171.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 110.296 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.32 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.056 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.49 -20.92 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 110.722 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.557 ' HG3' ' HG3' ' A' ' 64' ' ' LYS . 4.6 mm100 -72.98 -49.63 27.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.775 ' N ' HD22 ' A' ' 69' ' ' LEU . 9.5 t80 -61.21 -26.52 67.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.026 . . . . 0.0 109.467 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.719 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.39 -13.85 59.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.591 -0.693 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.861 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.8 tt -90.61 -28.74 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 110.759 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.59 -51.61 64.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 110.052 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 81' ' ' ILE . 13.5 m-85 -51.38 -34.02 32.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 109.795 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.4 t60 -57.51 -20.94 34.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.324 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 2.7 mt -99.42 -31.61 11.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.226 -0.922 . . . . 0.0 109.16 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CE1' ' A' ' 44' ' ' PHE . 68.2 mt -63.18 -58.29 8.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.2 -37.03 1.96 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.596 -0.69 . . . . 0.0 110.785 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -58.78 -30.95 67.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.929 -1.107 . . . . 0.0 110.555 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -90.47 -21.76 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.793 -1.192 . . . . 0.0 111.023 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.777 HD11 HG22 ' A' ' 81' ' ' ILE . 5.0 mt -86.73 -47.49 9.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 111.496 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' HA ' HD13 ' A' ' 86' ' ' ILE . 3.1 mm -110.97 -10.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.917 -1.114 . . . . 0.0 111.194 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -118.3 -10.28 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.797 -1.189 . . . . 0.0 110.459 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 62.47 11.87 36.84 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.1 mt -90.6 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.253 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' ' 89' ' ' ILE . 1.4 m-20 -114.7 162.73 22.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 43.1 Cg_endo -68.03 158.58 56.79 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.982 1.517 . . . . 0.0 110.315 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.1 Cg_endo -72.04 178.66 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.867 1.456 . . . . 0.0 110.157 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -64.08 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.1 -1.0 . . . . 0.0 109.67 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' HD21 ' A' ' 60' ' ' LEU . 13.5 m -117.74 -165.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CG2' ' A' ' 63' ' ' THR . 11.7 mt -77.18 152.33 34.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.834 0.826 . . . . 0.0 111.687 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.013 ' O ' HD12 ' A' ' 100' ' ' ILE . 45.1 p -123.7 169.95 9.41 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.5 Cg_endo -66.06 -26.31 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.297 1.157 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.964 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.1 mt-10 -79.34 -6.97 57.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 108.924 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.861 ' CG ' HD21 ' A' ' 76' ' ' LEU . 33.6 ttm -107.6 -32.66 7.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.013 HD12 ' O ' ' A' ' 96' ' ' THR . 2.4 mt -69.6 111.83 10.14 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.627 -0.67 . . . . 0.0 109.705 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 43.9 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 124.03 1.542 . . . . 0.0 114.108 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.975 HG23 HG12 ' A' ' 12' ' ' VAL . 1.1 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.19 0.519 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 11' ' ' VAL . 3.4 p 21.48 80.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-O 121.296 0.57 . . . . 0.0 112.166 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.546 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -109.45 -40.57 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 113.398 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 13' ' ' SER . 55.4 Cg_endo -80.05 -152.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 122.836 0.914 . . . . 0.0 112.35 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.94 -54.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HB3' HG23 ' A' ' 12' ' ' VAL . 40.1 mt-10 -37.98 -60.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.679 -0.638 . . . . 0.0 110.572 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -55.95 -36.75 68.15 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.633 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.07 -48.82 67.08 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.702 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -55.33 -30.96 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.449 -0.782 . . . . 0.0 109.561 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.8 m-85 -85.37 -38.06 19.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.62 -35.6 74.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.458 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 31.4 mt-10 -75.9 -40.96 53.37 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.693 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.2 mt -69.25 -38.1 77.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.519 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 47.5 t80 -46.78 -31.32 2.93 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.491 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.7 mt -70.2 -32.0 69.71 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 23' ' ' ILE . 11.9 mtmt -89.73 -15.91 31.49 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.999 HG22 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -89.53 -51.86 5.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 20.7 t0 -71.4 56.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 97.6 mttt -44.57 -23.78 0.14 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.91 . . . . 0.0 111.618 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.6 m-20 -89.58 1.13 56.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.134 . . . . 0.0 110.571 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt 47.16 53.76 10.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.484 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 3.0 p30 -125.42 23.28 7.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.943 . . . . 0.0 109.951 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 64.9 12.09 52.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -151.02 108.44 3.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.238 . . . . 0.0 111.381 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -92.98 134.16 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.065 -1.022 . . . . 0.0 109.081 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.748 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.5 t -87.32 153.67 21.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.91 -26.18 1.91 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.38 -41.99 99.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.43 -1.041 . . . . 0.0 111.636 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.8 mt-10 -81.24 -61.76 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 108.887 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -52.56 -20.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.533 0.683 . . . . 0.0 109.436 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -46.81 -73.15 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.2 -42.38 4.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -58.81 -44.86 91.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.2 m-85 -80.45 -31.58 37.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.61 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 42' ' ' GLU . 57.9 mt -60.9 -16.78 45.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.0 109.357 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mttt -80.17 -22.44 41.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.194 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 44' ' ' PHE . 33.2 p -56.37 -25.39 49.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 110.472 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.95 83.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.602 ' CD2' HG23 ' A' ' 81' ' ' ILE . 3.1 mp -88.91 160.6 43.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.966 . . . . 0.0 110.436 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 40.8 Cg_endo -67.83 132.39 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.953 1.502 . . . . 0.0 110.226 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -39.33 -54.72 1.83 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.723 . . . . 0.0 110.862 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -47.98 -52.17 20.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 110.277 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.598 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -55.77 -51.54 67.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.853 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 44' ' ' PHE . 53.8 mt -58.92 -40.14 83.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -45.75 69.08 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.443 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 41.4 t60 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 81' ' ' ILE . 3.1 mt -80.37 -27.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.653 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 22.9 t-105 -68.61 -47.98 65.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 108.968 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -61.48 -28.67 69.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.981 HD23 HD13 ' A' ' 80' ' ' LEU . 1.6 tp -67.61 -47.5 69.48 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 17.6 p -80.97 -35.02 32.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.012 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.501 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 39.2 t0 -65.5 59.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.501 -0.749 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.1 p -64.61 -30.34 71.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 1.4 mptp? -66.14 -10.78 44.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 t70 42.43 54.87 4.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 m -120.66 4.82 10.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.35 -10.93 69.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -120.91 -170.8 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.28 -1.129 . . . . 0.0 109.949 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.741 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -122.55 109.47 14.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.988 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -61.7 -178.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 109.459 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.1 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.45 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.3 m-20 -46.14 -25.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 110.277 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 64' ' ' LYS . 9.5 mt-30 -68.75 -57.04 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.878 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.855 ' CE2' HG21 ' A' ' 27' ' ' THR . 17.3 t80 -52.57 -21.42 3.84 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.347 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -85.85 -10.08 55.95 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.19 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.6 tp -91.33 -43.61 9.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.481 -0.762 . . . . 0.0 110.324 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.06 -31.4 67.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.998 -1.064 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 20.0 m-85 -72.39 -35.26 68.4 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.225 -0.922 . . . . 0.0 108.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 73.5 t60 -53.44 -23.85 11.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.121 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.981 HD13 HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -93.19 -42.2 9.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.659 HG22 HD11 ' A' ' 85' ' ' LEU . 1.2 mm -55.28 -56.41 11.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.581 -0.699 . . . . 0.0 109.307 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -46.73 6.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 110.585 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.9 mt-30 -55.38 -24.61 30.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.974 -1.078 . . . . 0.0 110.007 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -90.22 -18.59 25.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.695 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.659 HD11 HG22 ' A' ' 81' ' ' ILE . 5.4 mt -90.73 -47.01 7.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.49 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.6 -18.86 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.932 -1.105 . . . . 0.0 111.232 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.022 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -109.72 -17.35 13.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.934 -1.104 . . . . 0.0 110.645 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 69.74 11.84 66.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -93.22 141.86 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.337 -1.096 . . . . 0.0 110.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.587 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -81.78 -172.0 0.33 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 0.0 108.79 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 90' ' ' ASP . 43.4 Cg_endo -78.33 158.93 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.415 1.219 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.7 Cg_endo -72.9 47.01 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.879 1.463 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 19.1 m170 55.89 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.272 -0.893 . . . . 0.0 111.003 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -117.23 -161.75 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 110.58 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.76 164.23 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.114 0.959 . . . . 0.0 111.175 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.857 ' O ' HD12 ' A' ' 100' ' ' ILE . 1.5 p -127.96 -177.83 0.69 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.1 Cg_endo -75.05 -5.17 16.44 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.253 1.133 . . . . 0.0 109.667 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 11' ' ' VAL . 11.5 mt-10 -96.07 -18.33 20.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.855 0.836 . . . . 0.0 109.113 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.735 ' SD ' HG23 ' A' ' 96' ' ' THR . 4.0 mtp -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.855 0.836 . . . . 0.0 108.897 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 96' ' ' THR . 2.0 mt -61.0 128.65 89.55 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.887 -0.508 . . . . 0.0 109.743 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 C--N 1.306 -1.702 0 O-C-N 123.833 1.438 . . . . 0.0 110.635 -179.454 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.8 m . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.466 0.65 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG23 ' HB3' ' A' ' 16' ' ' GLU . 1.4 p -143.33 70.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.503 -0.748 . . . . 0.0 110.182 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -104.89 -31.96 0.2 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.192 -0.943 . . . . 0.0 113.49 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 13' ' ' SER . 53.2 Cg_endo -75.09 -150.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 122.575 0.776 . . . . 0.0 110.788 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.9 -46.57 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.803 -0.561 . . . . 0.0 111.903 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.924 ' HB3' HG23 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -51.79 -59.55 4.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 9.1 tmtt? -52.16 -40.85 62.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 109.816 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -30.22 60.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 109.682 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 18.6 m-85 -88.59 -41.66 12.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.422 -0.799 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD2' ' NZ ' ' A' ' 17' ' ' LYS . 8.6 t70 -50.59 -39.79 50.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.252 -0.905 . . . . 0.0 109.178 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.42 -47.2 64.87 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' LYS . 20.3 mt -63.65 -39.26 84.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.432 -0.792 . . . . 0.0 109.413 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 66.7 t80 -49.24 -24.62 1.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.73 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.29 -26.07 60.92 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 1.8 tttt -97.95 -15.44 20.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.001 HG22 HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.83 -55.77 3.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 20.9 t0 -69.57 58.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 0.3 OUTLIER -36.72 -46.0 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.521 -0.737 . . . . 0.0 112.729 -178.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' MET . 5.1 p-10 -94.52 15.6 17.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.617 -1.302 . . . . 0.0 111.994 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 30' ' ' ASP . 9.5 mtm 35.08 56.04 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.481 -0.762 . . . . 0.0 111.271 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 13.6 p30 -101.49 4.38 41.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 110.241 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.14 -33.22 4.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 1.3 p90 -146.76 146.46 30.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -1.094 . . . . 0.0 110.74 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.001 HG21 HG22 ' A' ' 27' ' ' THR . 1.3 p -90.45 127.99 42.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.699 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -74.7 151.82 39.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.599 -1.313 . . . . 0.0 109.588 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -45.5 -23.88 0.95 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.3 mt -61.56 -46.39 90.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.755 -0.85 . . . . 0.0 111.805 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.828 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.3 mt-10 -80.39 -57.17 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.455 -1.403 . . . . 0.0 109.171 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -56.88 -20.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.848 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -43.16 -75.97 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 110.152 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HA ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp0 -42.78 -46.47 5.2 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.761 0.791 . . . . 0.0 109.021 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -52.27 -37.82 23.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -80.99 -43.78 19.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.785 . . . . 0.0 109.145 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 42' ' ' GLU . 14.0 mt -52.65 -23.76 7.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 24.4 mtpt -78.55 -5.64 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.695 . . . . 0.0 109.817 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 44' ' ' PHE . 43.5 p -76.76 -7.99 56.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.866 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.93 15.65 79.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.721 ' HB3' HD13 ' A' ' 54' ' ' LEU . 9.4 mp -88.21 165.26 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.996 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.2 Cg_endo -74.93 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.983 1.517 . . . . 0.0 109.225 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.99 -73.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.949 -1.094 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 53' ' ' LEU . 1.3 m -41.42 -58.0 2.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 111.088 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -40.86 -50.34 3.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.145 -0.972 . . . . 0.0 110.843 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -57.22 -41.61 79.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.862 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.21 92.85 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.829 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.428 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 82.0 t60 -64.36 -40.11 95.2 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD11 ' HE2' ' A' ' 84' ' ' LYS . 2.4 mt -69.0 -31.28 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.352 -0.842 . . . . 0.0 108.827 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.85 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 53.9 t-105 -63.19 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.544 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -74.84 -25.61 59.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.818 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -74.78 -25.53 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.825 . . . . 0.0 109.317 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 29.8 p -100.78 -32.74 10.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 108.692 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.616 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 53.2 t0 -72.52 61.0 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.716 -0.615 . . . . 0.0 109.899 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 1.5 p -51.65 -34.95 40.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -60.51 -13.7 15.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.459 -0.775 . . . . 0.0 110.053 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 40.75 56.32 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.516 -0.74 . . . . 0.0 110.293 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 7.58 3.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.85 75.2 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.689 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -127.55 170.12 12.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.323 -1.104 . . . . 0.0 109.987 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.85 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 1.1 mt -118.2 98.58 6.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.082 -1.011 . . . . 0.0 110.512 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 1.2 p -46.18 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.333 -0.855 . . . . 0.0 109.407 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.54 -56.98 10.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.504 -1.373 . . . . 0.0 109.628 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -64.25 -49.0 73.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 110.704 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.616 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 26.0 mt-30 -44.45 -42.98 7.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 111.184 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.931 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.2 t80 -55.02 -44.93 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.15 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -68.6 -9.49 50.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.988 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 76' ' ' LEU . 2.8 tt -90.81 -35.29 14.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 111.219 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.64 -46.09 87.87 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 17.6 m-85 -56.74 -37.34 70.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.996 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 49.3 t60 -49.39 -21.66 0.94 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.07 -1.019 . . . . 0.0 109.65 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.8 mt -98.29 -24.6 15.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.807 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.949 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 18.3 mt -74.51 -58.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -30.44 7.62 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.603 -0.686 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -69.12 -21.98 63.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.968 ' HE2' HD11 ' A' ' 57' ' ' ILE . 9.3 mttm -90.99 -25.74 19.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' HD23 ' A' ' 85' ' ' LEU . 5.1 mt -86.39 -65.49 1.01 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mm -84.64 -6.08 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.001 . . . . 0.0 110.703 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.975 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mmtt -126.68 -28.89 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.933 -1.104 . . . . 0.0 110.491 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 68.55 18.79 72.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.975 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.7 mt -89.31 141.22 14.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.276 -1.132 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.27 167.51 33.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.558 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' HE3' ' A' ' 84' ' ' LYS . 44.4 Cg_endo -75.25 146.68 32.06 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.184 1.623 . . . . 0.0 110.574 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.745 ' O ' HD21 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -72.25 102.0 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.989 1.52 . . . . 0.0 110.289 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.578 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -5.07 -70.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.586 ' CA ' HD11 ' A' ' 60' ' ' LEU . 4.5 m -122.13 -173.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.086 -1.009 . . . . 0.0 110.977 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -84.33 170.78 13.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 111.815 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.664 HG23 ' SD ' ' A' ' 99' ' ' MET . 1.3 p -135.03 177.26 2.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.0 Cg_endo -70.99 -12.62 30.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.324 1.17 . . . . 0.0 110.2 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.595 ' O ' HG13 ' A' ' 11' ' ' VAL . 81.7 mt-10 -87.38 -18.34 30.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 108.711 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.822 ' HB2' HD23 ' A' ' 95' ' ' LEU . 4.4 mtp -90.12 -43.19 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.719 0.771 . . . . 0.0 109.073 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' THR . 1.3 mt -53.34 137.16 50.23 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.772 -0.58 . . . . 0.0 109.98 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.082 1.57 . . . . 0.0 110.75 -179.498 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 98' ' ' GLU . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.692 HG23 ' CG2' ' A' ' 11' ' ' VAL . 2.3 t -97.44 161.43 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.551 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 170.96 -54.61 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.354 -0.841 . . . . 0.0 111.156 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.4 Cg_endo -71.83 -153.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.716 1.377 . . . . 0.0 110.45 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.89 -56.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.448 0.642 . . . . 0.0 111.408 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -39.42 -64.57 0.46 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.664 -0.648 . . . . 0.0 110.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 8.0 tmtm? -50.91 -44.27 60.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -44.84 89.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -61.67 -26.85 68.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.434 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.612 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 11.5 m-85 -90.47 -51.09 5.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.623 -0.673 . . . . 0.0 109.978 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -45.62 -36.84 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.632 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 25' ' ' LEU . 71.5 mt-10 -74.66 -40.29 61.54 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.692 HG22 ' OG1' ' A' ' 27' ' ' THR . 36.5 mt -70.09 -35.18 62.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.842 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 73.3 t80 -48.82 -38.93 23.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.739 -1.225 . . . . 0.0 108.04 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.3 mt -62.79 -26.67 68.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.15 -13.72 20.77 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.04 HG22 HG21 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -89.2 -55.47 3.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 34' ' ' PHE . 21.5 t0 -63.29 73.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 65.9 mmtt -52.45 -19.79 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.303 -0.873 . . . . 0.0 111.22 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -97.0 3.15 52.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 110.793 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.76 27.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 34' ' ' PHE . 7.6 p-10 -92.92 11.5 27.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.125 -0.984 . . . . 0.0 110.194 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.34 5.45 89.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 70' ' ' SER . 1.9 m-85 -147.26 109.3 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 0.0 110.316 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.04 HG21 HG22 ' A' ' 27' ' ' THR . 4.2 p -88.86 126.59 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.49 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -81.82 148.63 28.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 110.136 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.19 -26.44 0.54 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.489 -1.007 . . . . 0.0 110.857 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.9 mt-10 -85.98 -58.79 2.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.774 -1.204 . . . . 0.0 108.927 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.544 HG11 ' HZ3' ' A' ' 58' ' ' TRP . 1.5 p -58.54 -13.84 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.503 0.668 . . . . 0.0 109.815 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.678 ' HG3' HD11 ' A' ' 45' ' ' LEU . 10.6 ttm180 -50.93 -70.27 0.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.638 -0.664 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -45.0 -44.17 9.72 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.024 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -59.13 -41.27 83.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.881 ' CE2' HD11 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.29 -19.94 52.57 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.592 -0.692 . . . . 0.0 109.211 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 42' ' ' GLU . 12.9 mt -76.42 -29.8 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.149 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 19.3 mttm -73.76 -9.61 58.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.507 -0.746 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.711 ' OG1' HD23 ' A' ' 49' ' ' LEU . 72.3 p -64.85 -51.53 61.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.76 21.01 5.87 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.711 HD23 ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.63 172.94 7.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.941 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.767 ' HD2' HD22 ' A' ' 53' ' ' LEU . 39.2 Cg_endo -66.16 -93.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.777 1.409 . . . . 0.0 110.596 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -158.66 -73.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.863 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -59.66 -29.73 68.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.767 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.1 tp -51.18 -60.1 3.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.66 HD13 HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -52.6 -35.12 53.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 108.974 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' THR . . . -68.6 -38.47 80.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 21.7 t60 -68.84 -35.12 76.56 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 mt -69.84 -23.03 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.66 -46.28 79.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.483 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.479 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -68.57 -29.59 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.567 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 94' ' ' VAL . 1.2 mp -74.89 -18.45 60.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.904 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 14.0 p -108.22 -30.04 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.179 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 63' ' ' THR . 67.0 t0 -78.64 49.02 0.84 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.572 -0.705 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 2.4 p -46.99 -29.18 1.93 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -55.01 -19.42 6.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.302 0.573 . . . . 0.0 109.605 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 m-20 38.85 55.27 2.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.579 -0.7 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.4 t -128.54 -30.4 2.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.97 0.99 4.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -142.51 170.62 15.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.174 -1.192 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.6 mt -104.15 104.07 13.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.421 -0.799 . . . . 0.0 110.094 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.08 -168.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 110.004 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.618 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.45 -67.98 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.722 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.52 -21.42 65.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.844 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 12.2 mm100 -69.29 -56.0 8.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.873 -1.142 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.86 ' N ' HD22 ' A' ' 69' ' ' LEU . 29.6 t80 -51.56 -22.0 2.93 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.226 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.24 -13.12 55.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.133 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.68 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.2 tp -90.03 -42.98 10.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.904 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.81 -49.12 74.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.064 -1.022 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 1.2 m-85 -50.2 -36.42 30.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB2' HG22 ' A' ' 12' ' ' VAL . 59.2 t60 -56.69 -30.49 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.504 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.577 HD22 ' CD ' ' A' ' 92' ' ' PRO . 8.3 mt -87.1 -24.01 24.7 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 44' ' ' PHE . 3.0 mm -76.65 -62.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -51.12 -26.03 6.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 110.342 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.533 ' OE1' HG21 ' A' ' 89' ' ' ILE . 3.4 mt-30 -64.85 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 110.446 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.25 -12.41 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 111.109 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.0 mt -87.19 -47.71 8.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.9 mm -111.48 -25.71 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.038 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.1 mmpt? -104.33 -2.59 25.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.643 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 45.54 35.02 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.038 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -106.31 130.42 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.154 -1.203 . . . . 0.0 110.089 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.4 p-10 -70.95 -175.79 0.33 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 43.0 Cg_endo -81.72 155.39 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.641 1.338 . . . . 0.0 110.044 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.577 ' CD ' HD22 ' A' ' 80' ' ' LEU . 43.4 Cg_endo -70.56 56.31 1.72 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.032 1.543 . . . . 0.0 110.598 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 1.3 m-70 42.58 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.497 -0.752 . . . . 0.0 110.793 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.7 ' HA ' HD11 ' A' ' 60' ' ' LEU . 6.0 m -104.56 -169.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.667 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 60' ' ' LEU . 4.3 mm? -74.0 162.12 29.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.999 ' O ' HD12 ' A' ' 100' ' ' ILE . 43.6 p -138.57 165.21 34.47 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.0 Cg_endo -65.98 -41.18 14.19 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.555 1.292 . . . . 0.0 108.752 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.3 tt0 -67.55 -7.37 25.49 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.641 -0.662 . . . . 0.0 109.438 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.68 ' CG ' HD21 ' A' ' 76' ' ' LEU . 13.7 ttm -111.56 -26.84 8.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.77 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 96' ' ' THR . 3.3 mt -78.0 116.76 61.27 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.432 -0.793 . . . . 0.0 110.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.536 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 47.5 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.896 1.472 . . . . 0.0 110.201 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 120.985 0.421 . . . . 0.0 109.892 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.876 HG21 ' O ' ' A' ' 75' ' ' ALA . 14.9 p 33.41 100.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 111.525 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.96 -68.47 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 112.107 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 40.3 Cg_endo -62.87 -141.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.392 1.207 . . . . 0.0 112.354 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.6 -57.41 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.685 -0.634 . . . . 0.0 112.351 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 12' ' ' VAL . 17.6 mt-10 -40.59 -63.45 0.64 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.426 -0.796 . . . . 0.0 110.599 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.81 -30.95 66.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.121 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.19 -44.57 45.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.572 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -61.17 -28.27 69.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 109.604 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.0 m-85 -87.01 -53.1 5.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.856 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -46.8 -28.74 1.65 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.002 . . . . 0.0 108.96 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -80.74 -42.58 21.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' LYS . 30.7 mt -71.38 -33.89 51.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ILE . 48.8 t80 -48.62 -33.03 9.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.468 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.4 -24.74 67.29 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 23' ' ' ILE . 35.0 mtpt -100.76 -12.89 18.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.474 -0.766 . . . . 0.0 108.969 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.995 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.23 -53.87 4.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.67 0.748 . . . . 0.0 109.076 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 49.9 t0 -67.8 62.17 0.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.632 -0.667 . . . . 0.0 109.37 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 5.2 mptp? -47.78 -25.08 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.172 -0.955 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 4.8 m-20 -91.39 7.59 40.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.788 -1.195 . . . . 0.0 111.142 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 mtt 46.65 31.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.206 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 3.9 p-10 -100.39 19.84 15.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 110.287 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 65.28 12.56 55.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 2.0 m-85 -150.2 108.83 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 0.0 110.664 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.26 132.56 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.051 -1.03 . . . . 0.0 108.623 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.772 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -88.46 156.74 18.94 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.848 -1.158 . . . . 0.0 109.979 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -49.68 -21.32 3.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 38' ' ' LEU . 2.4 mm? -68.49 -35.19 77.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.13 . . . . 0.0 111.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.705 ' HB2' HG23 ' A' ' 35' ' ' VAL . 25.5 mt-10 -88.19 -60.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.581 0.705 . . . . 0.0 109.283 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.71 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.762 -0.586 . . . . 0.0 110.601 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.1 mt-10 -45.28 -43.33 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -54.1 -42.47 55.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 m-85 -83.77 -28.6 28.05 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 42' ' ' GLU . 40.7 mt -63.72 -22.3 66.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 21.7 mtpp -75.81 -8.82 57.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.641 -0.662 . . . . 0.0 109.467 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 44' ' ' PHE . 54.0 p -68.46 -45.16 73.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 110.152 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.27 15.07 10.88 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -97.71 167.62 11.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.559 -0.965 . . . . 0.0 110.553 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.2 Cg_endo -73.85 169.34 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 52' ' ' THR . 55.4 p -67.18 -55.67 13.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.261 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.7 m -49.14 -65.51 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.612 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -41.9 -54.7 3.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 50' ' ' PRO . 50.9 mt -59.14 -44.15 92.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.852 . . . . 0.0 109.693 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.51 -41.91 98.51 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 7.2 t60 -64.95 -30.31 71.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.757 ' CD1' HD13 ' A' ' 81' ' ' ILE . 7.6 mt -73.16 -24.91 21.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.684 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 36.0 t-105 -66.59 -48.48 69.42 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.047 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.42 -33.91 76.77 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.019 -1.05 . . . . 0.0 108.408 178.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.925 HD21 ' O ' ' A' ' 92' ' ' PRO . 2.4 tp -70.76 -5.95 33.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.783 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 3.1 p -118.3 -35.58 3.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 59' ' ' SER . 4.4 p-10 -71.07 50.72 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.738 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.807 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.8 p -51.41 -29.07 14.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.747 -1.221 . . . . 0.0 108.266 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE3' ' NE2' ' A' ' 73' ' ' GLN . 6.6 mmtt -53.59 -19.4 3.85 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.464 0.649 . . . . 0.0 109.996 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 44.63 53.1 7.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 t -126.28 -12.33 6.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.471 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.39 -7.48 37.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 6.0 ptpt -129.98 -172.0 2.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -1.191 . . . . 0.0 110.342 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -123.41 103.46 8.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.146 -0.971 . . . . 0.0 111.063 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.34 -169.15 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.668 -1.27 . . . . 0.0 109.851 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -62.61 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.349 -0.844 . . . . 0.0 110.639 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' ALA . 4.0 m-20 -41.98 -67.43 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.531 ' CG ' ' OG1' ' A' ' 63' ' ' THR . 15.5 mp0 -39.75 -39.34 0.77 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.518 -0.739 . . . . 0.0 111.2 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.651 ' CA ' HD22 ' A' ' 69' ' ' LEU . 14.8 t80 -66.73 -35.61 80.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.744 -1.222 . . . . 0.0 108.683 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.876 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -74.79 -6.75 50.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 109.375 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.77 HD21 ' HG2' ' A' ' 99' ' ' MET . 4.2 tp -90.36 -44.43 9.67 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.358 -0.839 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -52.12 -51.88 55.08 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.703 -1.248 . . . . 0.0 109.815 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 9.7 m-85 -54.45 -36.75 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 110.262 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.525 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 78.4 t60 -53.92 -20.21 5.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.902 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.621 HD13 HD23 ' A' ' 60' ' ' LEU . 3.1 mt -100.22 -19.57 16.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 0.0 109.034 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.757 HD13 ' CD1' ' A' ' 57' ' ' ILE . 18.1 mm -72.38 -66.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' ILE . 79.0 p -41.01 -29.91 0.12 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.737 -0.602 . . . . 0.0 110.107 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 10.8 mt-30 -61.94 -38.7 89.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 110.04 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 49' ' ' LEU . 10.3 tptt -85.72 -14.51 45.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.929 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 49' ' ' LEU . 4.4 mt -83.84 -64.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.984 -1.073 . . . . 0.0 110.719 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG22 ' HE3' ' A' ' 87' ' ' LYS . 10.4 mm -95.89 -35.92 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.205 -0.935 . . . . 0.0 110.73 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.047 ' HB3' HD12 ' A' ' 89' ' ' ILE . 3.6 mmpt? -90.06 -0.99 57.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 43.91 24.99 0.56 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.047 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.5 mt -95.19 150.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.817 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.1 m-20 -92.91 159.6 35.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.007 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 44.7 Cg_endo -71.25 154.9 61.45 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.948 1.499 . . . . 0.0 109.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.925 ' O ' HD21 ' A' ' 60' ' ' LEU . 43.2 Cg_endo -70.43 142.14 44.22 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.988 1.52 . . . . 0.0 110.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 92' ' ' PRO . 4.1 m-70 -40.72 -57.92 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 110.444 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.602 ' CA ' HD11 ' A' ' 60' ' ' LEU . 15.1 m -124.51 -162.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 110.884 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -95.5 132.99 40.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.535 -0.728 . . . . 0.0 111.492 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 43.6 p -87.44 167.66 20.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.6 Cg_endo -66.81 -16.89 51.39 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.406 1.214 . . . . 0.0 109.403 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 11' ' ' VAL . 6.3 mt-10 -85.87 -27.31 25.12 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.77 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.8 ttm -83.86 -12.57 55.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.532 0.682 . . . . 0.0 109.306 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.17 115.19 65.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.621 -0.674 . . . . 0.0 110.081 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 C--N 1.304 -1.813 0 O-C-N 123.759 1.399 . . . . 0.0 110.32 179.707 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.725 ' CG2' HG12 ' A' ' 12' ' ' VAL . 4.1 m . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -160.31 72.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.212 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 94.5 p -108.43 -22.36 0.17 Allowed Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 13' ' ' SER . 56.8 Cg_endo -76.62 -157.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 122.294 0.628 . . . . 0.0 111.473 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.22 -51.77 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.325 0.583 . . . . 0.0 111.671 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 55.2 mt-10 -39.42 -63.09 0.59 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -57.75 -32.12 67.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 110.069 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.31 -41.13 61.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -29.7 69.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.425 -0.797 . . . . 0.0 109.552 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.8 m-30 -81.29 -41.06 22.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.468 -0.77 . . . . 0.0 109.414 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.41 -31.54 15.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.58 -35.78 52.67 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.618 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.1 mt -74.5 -42.17 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 53.1 t80 -45.83 -28.92 1.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.464 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.0 -34.53 77.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 38.0 mtmt -93.68 -9.47 37.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.895 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.56 -56.01 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.718 0.771 . . . . 0.0 109.018 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 51.1 t0 -70.13 70.43 0.38 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.628 -0.67 . . . . 0.0 109.313 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 76.1 mttt -62.34 -8.13 5.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 111.588 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -95.25 -2.94 48.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.879 -1.138 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mmt 57.08 18.61 4.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 110.16 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 24.7 p30 -92.28 18.96 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.193 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 63.68 15.81 58.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.595 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.84 112.61 4.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.083 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.892 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.63 130.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.017 -1.052 . . . . 0.0 109.587 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.9 p -85.3 148.93 25.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 109.391 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.05 -26.53 0.5 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -62.0 -35.31 78.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.643 -0.916 . . . . 0.0 111.019 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.7 mt-10 -89.13 -63.35 1.3 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.648 -1.283 . . . . 0.0 109.192 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.847 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.2 p -49.07 -21.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.321 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.768 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -43.02 -62.1 1.12 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.9 mt-10 -51.94 -45.87 64.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 108.476 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.895 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -54.65 -33.54 27.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.847 ' CD2' HG22 ' A' ' 40' ' ' VAL . 2.7 m-85 -85.17 -35.39 21.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 109.558 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 42' ' ' GLU . 11.2 mt -60.3 -15.36 24.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 38.8 mttt -85.4 -10.19 56.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.653 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.537 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 44.6 p -73.68 -55.82 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.08 -7.98 9.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.753 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.7 mm? -69.89 161.92 71.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.369 -1.077 . . . . 0.0 110.245 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 43.5 Cg_endo -71.72 143.36 41.6 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' PRO . 56.2 p -40.41 -46.99 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.377 -0.827 . . . . 0.0 110.982 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.2 m -62.53 -61.57 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.981 . . . . 0.0 110.952 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.753 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -44.89 -47.6 11.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.561 HD22 ' CD1' ' A' ' 44' ' ' PHE . 65.4 mt -55.9 -37.56 69.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.018 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.88 -43.55 75.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.484 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 20.7 t60 -61.36 -37.78 84.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.394 -0.816 . . . . 0.0 108.799 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 81' ' ' ILE . 13.8 mt -71.84 -28.51 30.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.551 -0.718 . . . . 0.0 109.079 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.687 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 15.2 t-105 -64.85 -37.8 88.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.552 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' CG ' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -75.14 -25.08 58.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 108.973 179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' A' ' 95' ' ' LEU . 1.1 mp -77.67 -17.99 57.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.344 -0.847 . . . . 0.0 108.784 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.76 ' SG ' HD21 ' A' ' 69' ' ' LEU . 14.7 p -104.69 -29.38 10.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.751 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HA ' ' A' ' 59' ' ' SER . 5.5 p-10 -71.08 55.42 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.948 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -50.58 -30.07 12.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 109.524 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -63.99 -10.25 20.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.52 -0.737 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.28 56.64 2.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.375 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 t -128.0 -31.01 2.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.43 -5.64 7.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -127.0 172.67 10.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -1.147 . . . . 0.0 109.659 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -108.43 111.13 22.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.03 -1.044 . . . . 0.0 111.017 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.595 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -62.82 -178.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.992 . . . . 0.0 110.164 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.626 ' HE2' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.8 -77.66 0.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 111.322 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.403 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 35.7 m-20 -54.31 -28.02 39.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.195 -0.941 . . . . 0.0 111.032 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' CG ' ' OG ' ' A' ' 70' ' ' SER . 36.1 mm-40 -66.08 -47.32 74.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 110.459 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.779 ' CE1' HG21 ' A' ' 27' ' ' THR . 23.9 t80 -56.5 -30.17 62.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.439 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -76.92 -13.82 59.94 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.57 0.7 . . . . 0.0 109.413 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.03 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.52 -32.96 19.13 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.51 -0.744 . . . . 0.0 109.657 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.73 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.55 -51.0 67.31 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 109.62 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 5.2 m-85 -47.65 -41.7 22.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.917 . . . . 0.0 109.627 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -52.07 -29.21 20.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.613 HD12 HG23 ' A' ' 57' ' ' ILE . 2.7 mt -83.89 -30.93 25.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -0.993 . . . . 0.0 108.726 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 57' ' ' ILE . 8.3 mm -65.12 -57.64 10.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.454 0.645 . . . . 0.0 109.315 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.62 -36.19 2.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.593 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 45.1 mt-30 -58.06 -33.59 69.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.837 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -89.12 -28.85 19.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.0 111.224 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 85' ' ' LEU . 4.2 mt -77.4 -63.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.929 -1.107 . . . . 0.0 110.865 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.92 -12.99 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.965 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -122.45 -17.02 7.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 110.943 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 84' ' ' LYS . . . 58.51 25.05 57.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.965 HD12 ' HB3' ' A' ' 87' ' ' LYS . 17.1 mt -98.48 165.74 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -1.06 . . . . 0.0 110.05 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 4.6 m-20 -96.19 164.1 19.27 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -69.49 162.89 40.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.186 1.624 . . . . 0.0 110.694 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -71.48 69.05 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.114 1.586 . . . . 0.0 111.779 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.543 ' O ' HD11 ' A' ' 60' ' ' LEU . 3.2 m170 32.41 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.772 -0.58 . . . . 0.0 111.87 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 60' ' ' LEU . 3.2 m -110.66 -164.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.171 -0.956 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.718 HD13 ' SD ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -72.29 151.87 42.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.82 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.935 ' O ' HD12 ' A' ' 100' ' ' ILE . 60.8 p -129.32 163.02 49.09 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.304 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 45.2 Cg_endo -71.39 -6.27 18.81 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.832 1.438 . . . . 0.0 110.682 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.691 ' C ' HG13 ' A' ' 11' ' ' VAL . 11.5 mt-10 -95.96 -28.93 14.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.718 ' SD ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -94.5 -12.57 27.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 110.031 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 96' ' ' THR . 5.5 mt -79.36 142.17 58.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 100' ' ' ILE . 42.4 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.857 1.451 . . . . 0.0 110.175 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.121 0.486 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -152.24 67.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 111.012 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -105.72 -28.85 0.2 Allowed Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.9 Cg_endo -75.84 -155.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.577 0.777 . . . . 0.0 111.459 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.98 -48.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.432 0.634 . . . . 0.0 111.905 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 12' ' ' VAL . 9.9 mt-10 -46.35 -60.97 2.0 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -52.67 -41.46 63.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.06 . . . . 0.0 110.063 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.41 96.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.465 -0.772 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.3 ttpt -58.91 -30.43 67.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.498 -0.751 . . . . 0.0 109.801 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 5.8 m-85 -85.07 -49.65 8.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.728 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -44.09 -36.68 2.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.879 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 25' ' ' LEU . 22.3 mt-10 -71.91 -36.8 70.09 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.653 HG22 ' HG1' ' A' ' 27' ' ' THR . 45.2 mt -72.32 -40.84 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.491 -0.756 . . . . 0.0 109.84 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.501 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 31.3 t80 -48.12 -37.4 15.33 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.201 -1.0 . . . . 0.0 108.538 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.3 mt -64.09 -23.18 67.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' ILE . 3.0 mmmt -102.86 -14.2 16.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.095 HG23 HD12 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -88.76 -56.69 3.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.621 -0.675 . . . . 0.0 109.354 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.33 77.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.663 -0.648 . . . . 0.0 109.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' THR . 5.8 mttm -67.04 -1.63 4.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.184 -0.948 . . . . 0.0 112.236 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.507 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 90.9 m-20 -104.65 -2.78 24.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.707 -1.246 . . . . 0.0 110.631 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mmt 57.56 18.27 4.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 110.899 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.7 p30 -90.24 0.08 57.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.093 . . . . 0.0 110.091 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 12.98 77.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -147.43 105.02 3.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 110.065 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.978 HG21 HG22 ' A' ' 27' ' ' THR . 8.8 p -89.19 133.79 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.034 -1.041 . . . . 0.0 109.502 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -86.72 157.17 19.69 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.047 -1.033 . . . . 0.0 110.196 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -51.22 -21.81 6.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.5 mm? -72.75 -31.84 65.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -1.039 . . . . 0.0 111.352 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.564 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.5 mt-10 -83.05 -55.27 4.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.68 -1.263 . . . . 0.0 108.373 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -61.05 -10.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -50.55 -73.06 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -42.5 -41.27 2.91 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.095 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -60.14 -41.94 88.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.724 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 m-30 -81.9 -32.57 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.424 -0.797 . . . . 0.0 109.308 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.696 HD11 ' CG ' ' A' ' 41' ' ' ARG . 32.6 mt -58.58 -26.63 63.83 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.109 -0.994 . . . . 0.0 108.649 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -70.98 -8.88 56.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.513 -0.742 . . . . 0.0 109.076 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.7 p -78.36 -35.66 47.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.508 -0.745 . . . . 0.0 110.195 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 95.01 34.12 6.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.617 HD13 ' OG1' ' A' ' 47' ' ' THR . 10.1 mp -105.63 157.12 35.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.828 -0.807 . . . . 0.0 110.717 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.4 Cg_endo -75.2 178.16 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.803 1.423 . . . . 0.0 110.201 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -57.79 3.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.123 -0.986 . . . . 0.0 111.06 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -52.1 -45.32 64.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -57.86 -51.38 69.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 110.005 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 11.3 mt -55.28 -41.32 72.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.195 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 60' ' ' LEU . 13.1 t60 -69.08 -36.04 77.15 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 80' ' ' LEU . 6.9 mt -71.65 -34.48 52.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.591 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 38.6 t-105 -65.1 -47.41 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 109.879 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -31.19 72.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.197 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 ' O ' ' A' ' 93' ' ' HIS . 14.8 mt -71.02 -9.82 58.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 109.184 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' THR . 29.4 m -119.57 -36.63 3.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 109.909 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.542 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 13.0 t0 -66.06 61.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.604 -0.685 . . . . 0.0 109.672 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 1.022 HG22 HD21 ' A' ' 95' ' ' LEU . 11.6 p -58.33 -36.03 72.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.376 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -55.33 -16.2 3.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.04 53.12 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 -34.05 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -0.44 4.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 34' ' ' PHE . 9.9 mttt -132.7 175.55 9.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -1.164 . . . . 0.0 109.988 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.982 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -105.64 110.86 23.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.53 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -62.81 179.09 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.327 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HE3' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.31 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 110.654 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 3.8 m-20 -52.89 -43.37 66.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.979 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 22.0 mt-30 -43.6 -62.72 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.021 -1.049 . . . . 0.0 110.355 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.982 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.9 t80 -49.17 -36.11 18.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.837 -1.164 . . . . 0.0 109.016 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -69.57 -6.14 29.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.421 -0.8 . . . . 0.0 109.66 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.94 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.1 tt -90.34 -38.55 13.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.505 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -55.92 -39.83 72.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 110.196 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 53.1 m-85 -57.33 -29.43 63.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 45.3 t60 -63.73 -26.55 68.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.79 -48.28 4.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.67 HG21 HG21 ' A' ' 47' ' ' THR . 82.4 mt -60.67 -33.6 55.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.734 -0.603 . . . . 0.0 110.338 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 21.0 t -72.36 -18.67 61.73 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.212 -0.93 . . . . 0.0 111.005 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -90.52 -14.71 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.024 -1.048 . . . . 0.0 111.459 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 1.4 tptt -90.37 -15.27 31.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.664 -1.272 . . . . 0.0 111.136 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 47' ' ' THR . 6.8 mt -90.26 -56.65 3.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 111.554 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.62 -19.74 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.924 -1.11 . . . . 0.0 110.676 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.024 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -109.08 -16.07 14.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.754 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 60.05 36.89 91.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.024 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.6 mt -104.61 154.38 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.273 . . . . 0.0 109.468 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.29 165.27 15.12 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 110.598 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 47.3 Cg_endo -72.34 155.04 56.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.191 1.627 . . . . 0.0 110.236 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.429 ' O ' HD11 ' A' ' 60' ' ' LEU . 42.1 Cg_endo -69.35 -179.34 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.981 1.517 . . . . 0.0 110.003 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.764 ' O ' HD21 ' A' ' 60' ' ' LEU . 54.0 m-70 -64.46 -99.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.9 -1.125 . . . . 0.0 110.19 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 60' ' ' LEU . 7.4 m -108.26 -168.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 120.987 -1.071 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 HG22 ' A' ' 63' ' ' THR . 2.0 tp -61.79 148.27 43.64 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.91 0.862 . . . . 0.0 111.458 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.063 ' O ' HD12 ' A' ' 100' ' ' ILE . 71.0 p -130.08 166.73 24.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.0 Cg_endo -67.86 -25.38 39.18 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.511 1.269 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -80.59 -12.01 59.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 109.101 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.94 ' CG ' HD21 ' A' ' 76' ' ' LEU . 32.5 ttm -103.9 -30.23 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.639 -0.663 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 96' ' ' THR . 3.0 mt -74.54 126.66 88.49 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.487 -0.758 . . . . 0.0 110.405 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.827 1.435 . . . . 0.0 110.458 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.99 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.99 HG23 ' CG2' ' A' ' 11' ' ' VAL . 37.6 t 57.65 121.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.5 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t -157.41 -64.91 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.685 -1.26 . . . . 0.0 112.438 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 46.7 Cg_endo -68.42 -149.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.494 1.26 . . . . 0.0 110.82 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.71 -43.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.31 0.576 . . . . 0.0 111.516 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 6.3 mt-10 -44.66 -62.78 1.08 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 109.864 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -56.69 -30.63 63.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -70.1 -51.32 32.64 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' HE2' ' CA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -57.23 -32.49 66.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.28 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.67 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 8.3 m-30 -83.21 -28.11 29.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.671 -0.643 . . . . 0.0 110.483 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 11.2 t0 -72.07 -32.84 67.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 2.7 mt-10 -81.85 -26.9 33.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -0.91 . . . . 0.0 108.577 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' OG1' ' A' ' 27' ' ' THR . 65.4 mt -82.31 -42.15 18.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.647 -0.658 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.642 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 53.2 t80 -49.98 -25.03 2.94 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.69 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 20.1 mt -71.93 -26.96 62.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 23' ' ' ILE . 13.2 mttt -101.28 -12.59 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.994 HG22 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -89.05 -55.38 3.71 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 4.0 t0 -70.62 81.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.4 mttt -81.17 10.31 5.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.066 -1.021 . . . . 0.0 112.179 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 73.5 m-20 -111.78 10.46 20.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 110.024 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.1 mtm 48.19 23.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.088 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 28.6 p30 -97.85 15.79 22.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.85 52.46 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.08 112.45 4.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -1.042 . . . . 0.0 110.009 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.994 HG21 HG22 ' A' ' 27' ' ' THR . 2.3 p -88.72 133.19 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.94 -1.1 . . . . 0.0 109.889 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.664 ' O ' HG12 ' A' ' 40' ' ' VAL . 17.2 t -90.93 153.45 20.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 110.095 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -43.54 -25.52 0.54 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.6 mt -64.88 -38.73 91.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -1.117 . . . . 0.0 111.693 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.796 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.4 mt-10 -85.13 -55.82 3.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.862 -1.149 . . . . 0.0 108.974 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -59.77 -13.74 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.698 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -56.28 -67.59 0.29 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 109.751 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.982 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.7 mm-40 -45.24 -32.19 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.884 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HG23 ' A' ' 27' ' ' THR 0.268 1.3 mt -69.89 -41.83 79.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.24 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.921 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -74.58 -29.55 61.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.055 . . . . 0.0 109.196 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.982 HD12 ' HA ' ' A' ' 42' ' ' GLU . 15.1 mt -64.4 -18.48 64.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -79.58 -8.01 58.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 108.864 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.3 p -79.84 -23.16 42.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 110.413 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.51 -17.09 58.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HB3' HD13 ' A' ' 54' ' ' LEU . 7.2 mp -54.82 168.62 0.48 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.698 -0.883 . . . . 0.0 110.569 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.1 Cg_endo -81.58 -175.1 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.933 1.491 . . . . 0.0 109.392 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -61.6 1.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.422 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 53' ' ' LEU . 17.2 m -46.89 -64.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -40.53 -44.82 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.372 -0.83 . . . . 0.0 110.666 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -58.95 -43.37 91.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -66.18 -38.55 88.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 108.889 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 74.9 t60 -66.78 -41.79 87.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.48 -0.762 . . . . 0.0 108.95 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.611 HG21 ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt -67.2 -29.81 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 21.4 t-105 -63.93 -44.61 92.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.556 ' O ' HD11 ' A' ' 95' ' ' LEU . 5.5 t -70.29 -33.62 71.78 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 108.898 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.808 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.1 tp -67.28 -21.65 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 109.809 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.879 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 18.1 p -106.62 -29.46 9.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD2' ' CZ2' ' A' ' 58' ' ' TRP . 26.1 t0 -80.47 52.59 1.66 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 110.042 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.807 HG22 HD22 ' A' ' 95' ' ' LEU . 7.7 p -46.25 -29.83 1.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.043 0.925 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.561 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 2.3 mmtm -58.92 -17.49 24.88 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.227 0.537 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 37.33 56.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.676 -0.64 . . . . 0.0 110.612 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 9.84 6.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.521 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.14 -18.27 54.48 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 34' ' ' PHE . 14.8 pttt -125.1 175.03 7.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.053 -1.263 . . . . 0.0 110.03 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.769 HD12 ' CZ3' ' A' ' 58' ' ' TRP . 1.4 mt -111.73 118.03 34.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.942 . . . . 0.0 111.028 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.643 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -64.32 -172.02 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.181 . . . . 0.0 109.459 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.43 -80.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 111.078 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -53.13 -18.62 2.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.514 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.561 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 10.1 mm100 -74.44 -40.64 61.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.886 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.3 t80 -65.15 -23.0 67.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.083 . . . . 0.0 109.041 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 20' ' ' TYR . . . -78.4 -12.37 60.0 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.504 -0.748 . . . . 0.0 109.736 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.07 HD11 ' CG ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -85.69 -38.36 18.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 110.61 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.879 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -57.06 -44.48 83.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 6.4 m-85 -60.38 -23.49 64.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.626 ' HB2' HG22 ' A' ' 12' ' ' VAL . 83.6 t60 -64.28 -20.33 66.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 0.0 109.611 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD13 HD23 ' A' ' 60' ' ' LEU . 1.7 mt -99.69 -31.09 11.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 109.036 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.921 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 36.2 mt -61.11 -57.32 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.175 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -39.19 -34.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.695 -0.628 . . . . 0.0 110.828 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' ILE . 21.0 mt-30 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.838 -1.164 . . . . 0.0 110.714 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' ILE . 19.9 tptp -89.89 -10.31 45.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.671 HD11 HG22 ' A' ' 81' ' ' ILE . 7.3 mt -88.37 -58.7 2.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.073 . . . . 0.0 110.918 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.07 -25.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 0.0 110.794 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.065 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -103.62 -8.7 19.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.973 . . . . 0.0 110.422 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 50.85 20.82 4.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.065 HD12 ' HB3' ' A' ' 87' ' ' LYS . 4.6 mt -86.67 142.0 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.972 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 7.5 p-10 -80.16 164.55 51.87 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HD3' HD11 ' A' ' 53' ' ' LEU . 38.6 Cg_endo -66.45 159.8 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.042 1.548 . . . . 0.0 110.278 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.17 58.57 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 0.0 110.616 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.617 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER 39.35 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.631 -0.668 . . . . 0.0 111.235 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 92' ' ' PRO . 5.7 m -101.67 -164.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 111.305 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.808 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -95.3 164.84 12.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.878 0.847 . . . . 0.0 111.802 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.617 ' O ' HD12 ' A' ' 100' ' ' ILE . 14.6 p -133.65 171.65 8.73 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.3 Cg_endo -68.94 -36.19 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.291 1.153 . . . . 0.0 109.632 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.67 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 tt0 -63.4 -18.41 63.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.218 -0.926 . . . . 0.0 109.106 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.07 ' CG ' HD11 ' A' ' 76' ' ' LEU . 24.4 ttm -97.04 -26.42 15.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.456 -0.777 . . . . 0.0 109.526 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 96' ' ' THR . 6.0 mt -82.29 115.3 57.02 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.304 -1.81 0 O-C-N 123.955 1.503 . . . . 0.0 110.309 179.896 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 12' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.582 0.706 . . . . 0.0 109.127 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 11' ' ' VAL . 6.2 t -103.75 159.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.588 -0.695 . . . . 0.0 109.693 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 169.25 -52.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.197 -0.939 . . . . 0.0 111.839 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 52.4 Cg_endo -70.51 -153.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.534 1.281 . . . . 0.0 110.819 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.23 -48.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.272 0.558 . . . . 0.0 111.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.559 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 1.6 mt-10 -50.97 -60.4 3.13 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.302 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -53.48 -36.3 61.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -67.6 -50.84 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.395 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -53.75 -29.58 40.43 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.51 -0.743 . . . . 0.0 109.546 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 10.9 m-85 -90.47 -47.85 7.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 12.9 t70 -49.76 -31.59 11.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 25' ' ' LEU . 32.6 mt-10 -78.41 -36.23 45.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.835 HG22 ' OG1' ' A' ' 27' ' ' THR . 37.7 mt -76.66 -39.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 70' ' ' SER . 74.7 t80 -47.21 -31.66 3.84 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.365 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.0 mt -68.02 -31.52 71.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' ILE . 2.3 tttt -97.0 -10.18 26.71 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.025 HG22 HG21 ' A' ' 35' ' ' VAL . 1.5 m -90.22 -46.49 8.4 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.596 0.712 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 32' ' ' ASP . 27.6 t0 -73.47 62.25 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.227 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -45.87 -20.91 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.126 -0.983 . . . . 0.0 111.354 -178.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 7.5 m-20 -88.94 -5.15 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.929 -1.107 . . . . 0.0 110.363 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.05 44.58 29.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 14.8 p-10 -120.7 24.47 10.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.15 47.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -150.39 99.27 2.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -1.201 . . . . 0.0 110.639 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.025 HG21 HG22 ' A' ' 27' ' ' THR . 7.4 p -90.73 142.09 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 0.0 109.354 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.759 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.28 152.47 19.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.069 -1.02 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.21 -26.49 0.93 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' SER . 71.2 mt -66.11 -41.23 90.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.474 -1.016 . . . . 0.0 110.891 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 19.9 mt-10 -78.6 -58.85 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.35 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 36' ' ' SER . 1.7 p -61.08 -14.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.279 0.561 . . . . 0.0 110.141 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -45.41 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.441 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -42.71 -42.6 3.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 0.0 109.233 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.952 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -55.7 -48.24 78.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.891 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -73.33 -38.88 65.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD23 ' CD1' ' A' ' 54' ' ' LEU . 76.2 mt -60.25 -21.66 62.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.48 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -73.6 -20.09 60.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.225 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.865 HG21 HD13 ' A' ' 81' ' ' ILE . 61.2 p -55.38 -24.45 29.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.21 56.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.9 mp -90.94 170.88 9.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 110.299 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.4 Cg_endo -74.03 -159.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.85 1.447 . . . . 0.0 110.309 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -94.05 -55.7 3.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.741 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.8 m -56.7 -57.12 13.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.694 HD11 ' HD3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -41.25 -46.48 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.601 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.759 HD22 ' HD1' ' A' ' 44' ' ' PHE . 25.0 mt -60.48 -42.05 95.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.954 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -65.7 -43.25 89.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.13 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.531 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 12.9 t60 -65.22 -32.15 73.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG21 ' CE1' ' A' ' 44' ' ' PHE . 4.2 mt -73.64 -27.87 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.799 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 29.6 t-105 -64.72 -43.67 92.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.487 ' O ' HD21 ' A' ' 95' ' ' LEU . 25.5 m -67.52 -35.23 78.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.126 -0.983 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.946 HD13 ' HG2' ' A' ' 92' ' ' PRO . 17.9 mt -67.59 -23.06 65.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.2 p -102.66 -35.48 8.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.06 -1.025 . . . . 0.0 108.866 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 61.1 t0 -70.25 54.4 0.14 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -56.74 -22.29 34.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.048 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 22.6 mmmt -57.03 -16.21 6.66 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.338 0.59 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.44 48.99 8.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.0 t -128.45 -22.1 3.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.357 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.28 -11.12 14.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.0 mtpt -124.81 -177.06 3.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -1.116 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.858 HD13 ' HD1' ' A' ' 74' ' ' PHE . 2.8 mt -116.81 107.26 14.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.628 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -58.65 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.48 -1.388 . . . . 0.0 109.994 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -76.57 -68.1 0.63 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.373 -0.829 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -61.95 -66.97 0.46 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.369 -0.832 . . . . 0.0 112.289 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -39.83 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 0.0 111.516 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.9 t80 -72.39 -38.66 68.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.476 -1.39 . . . . 0.0 108.692 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -67.04 -8.87 33.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.476 0.655 . . . . 0.0 109.554 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -85.85 -45.38 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.448 -0.782 . . . . 0.0 110.02 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB1' ' CZ ' ' A' ' 44' ' ' PHE . . . -42.35 -47.34 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 66.8 m-85 -61.36 -25.7 67.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 66.1 t60 -62.21 -20.98 64.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.446 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 57' ' ' ILE . 4.7 mt -94.92 -21.77 18.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 44' ' ' PHE . 11.4 mt -73.4 -62.69 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -39.39 -33.47 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.811 -0.556 . . . . 0.0 110.33 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 24.4 mt-30 -59.61 -36.69 76.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' ILE . 5.3 tptp -89.86 -16.57 29.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.896 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 81' ' ' ILE . 8.0 mt -81.33 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.015 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.88 -33.15 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.495 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.002 ' HB3' HD12 ' A' ' 89' ' ' ILE . 2.3 mmpt? -94.93 -2.84 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.434 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 47.81 22.21 1.86 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.002 HD12 ' HB3' ' A' ' 87' ' ' LYS . 12.2 mt -92.76 170.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -1.192 . . . . 0.0 109.791 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -102.65 172.73 4.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 110.109 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HD3' HD11 ' A' ' 53' ' ' LEU . 45.8 Cg_endo -71.13 158.73 54.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.064 1.56 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.946 ' HG2' HD13 ' A' ' 60' ' ' LEU . 42.0 Cg_endo -68.73 173.59 9.81 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.959 1.505 . . . . 0.0 109.502 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -74.62 -50.68 16.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.994 -1.067 . . . . 0.0 109.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.614 ' HA ' HD21 ' A' ' 60' ' ' LEU . 27.9 m -141.67 -159.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.86 HD11 ' O ' ' A' ' 60' ' ' LEU . 3.9 mm? -82.21 176.53 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.793 0.806 . . . . 0.0 110.894 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 95' ' ' LEU . 30.9 p -150.96 166.64 14.63 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -70.59 -12.86 31.98 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 123.575 1.303 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.711 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.2 mt-10 -96.89 -19.53 18.78 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.748 0.785 . . . . 0.0 109.081 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.568 ' CG ' HD21 ' A' ' 76' ' ' LEU . 14.1 ttm -101.44 -6.62 23.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 110.224 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' THR . 10.6 mt -86.05 112.82 48.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.545 -0.722 . . . . 0.0 110.151 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 99' ' ' MET . 41.9 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 O-C-N 123.765 1.402 . . . . 0.0 113.322 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.423 0.63 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -140.43 67.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 109.969 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.2 t -103.49 -27.81 0.21 Allowed Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.8 Cg_endo -76.11 -156.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 122.559 0.768 . . . . 0.0 110.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.55 -57.33 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.305 0.574 . . . . 0.0 111.625 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.661 ' HB3' HG23 ' A' ' 12' ' ' VAL . 13.2 mt-10 -39.78 -63.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.694 -0.629 . . . . 0.0 110.74 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' CE ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.36 -45.19 88.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -28.04 68.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.766 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 23.5 m-85 -89.38 -48.46 7.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -47.25 -34.81 6.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.573 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.659 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.3 mt-10 -75.5 -36.05 60.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.011 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 ' OG1' ' A' ' 27' ' ' THR . 41.5 mt -69.82 -39.4 77.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.442 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -48.56 -33.48 9.76 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.645 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 22' ' ' GLU . 15.3 mt -67.8 -25.37 65.55 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' ILE . 9.4 mttp -98.9 -12.73 20.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.986 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.91 -54.52 4.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.563 -0.711 . . . . 0.0 109.508 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.46 90.27 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 108.666 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -83.45 -17.98 40.2 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.054 -1.029 . . . . 0.0 112.6 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -92.23 13.16 19.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.632 -1.293 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.6 mtm 53.05 36.47 22.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 4.1 p-10 -113.05 22.63 14.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 110.348 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' ASP . . . 47.88 26.47 4.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.85 101.1 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.88 -0.776 . . . . 0.0 109.926 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 27' ' ' THR . 3.0 p -88.93 125.37 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.979 -1.075 . . . . 0.0 109.321 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -83.17 157.6 22.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 109.819 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.75 -25.13 0.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 36' ' ' SER . 4.3 mp -59.63 -48.27 82.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -1.02 . . . . 0.0 111.964 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.2 mt-10 -78.65 -57.88 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.624 -1.298 . . . . 0.0 109.237 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.709 HG22 ' CD2' ' A' ' 44' ' ' PHE . 2.1 p -56.93 -16.76 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.983 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 1.4 ttt-85 -50.05 -77.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.003 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -41.12 -37.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.906 0.86 . . . . 0.0 108.954 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 27' ' ' THR 0.251 1.0 OUTLIER -64.74 -51.02 72.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.201 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.709 ' CD2' HG22 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -72.68 -41.18 65.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.051 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.581 HD12 ' HA ' ' A' ' 42' ' ' GLU . 87.5 mt -49.5 -24.17 1.93 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -72.71 -19.81 61.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.612 -0.68 . . . . 0.0 109.558 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.686 ' CG2' HG21 ' A' ' 81' ' ' ILE . 61.9 p -64.39 -13.86 53.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.385 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.34 23.78 70.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.1 mp -100.11 163.99 17.26 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 110.414 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -76.18 140.73 22.63 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.039 1.547 . . . . 0.0 110.338 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -45.63 -46.58 14.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -57.37 -52.83 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.637 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.617 ' CD2' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -53.25 -41.5 65.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.03 . . . . 0.0 110.023 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 44' ' ' PHE . 24.1 mt -66.2 -41.49 90.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.935 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -64.14 -41.01 97.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -70.63 -35.03 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 81' ' ' ILE . 4.8 mt -73.89 -22.52 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 37.5 t-105 -68.98 -44.82 72.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.534 -0.729 . . . . 0.0 109.534 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -69.83 -28.88 66.07 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.144 -0.973 . . . . 0.0 108.69 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.2 mt -72.86 -10.25 59.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.519 -0.738 . . . . 0.0 109.084 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 13.7 p -117.46 -34.4 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.736 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 23.5 t0 -65.63 60.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.454 -0.779 . . . . 0.0 109.961 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.713 HG23 HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -58.98 -27.81 65.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' HG2' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -68.35 -5.81 20.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.059 -1.026 . . . . 0.0 110.771 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 3.4 p-10 37.85 54.78 1.59 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.45 -0.781 . . . . 0.0 111.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 -24.66 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.102 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.5 -9.89 8.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 62.8 mttp -125.0 -174.47 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 0.0 110.127 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.76 HD13 ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -115.53 113.26 23.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.145 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.522 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -77.12 -177.24 4.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.114 . . . . 0.0 110.276 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.25 -33.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.559 ' CD ' ' N ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -58.36 -40.84 83.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.6 t80 -66.52 -41.54 88.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -63.57 -10.86 20.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.832 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -80.2 -43.27 21.79 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -64.4 -52.18 59.49 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 5.5 m-85 -49.05 -39.41 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.78 . . . . 0.0 109.618 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.62 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 33.6 t60 -54.67 -25.68 28.61 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 57' ' ' ILE . 6.9 mt -90.54 -23.82 20.79 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.803 HD11 HG21 ' A' ' 57' ' ' ILE . 17.3 mm -73.86 -56.58 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.806 -0.757 . . . . 0.0 108.985 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -46.79 -28.19 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.526 -0.734 . . . . 0.0 110.027 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -77.2 -22.59 52.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.102 -0.999 . . . . 0.0 110.187 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -91.63 -30.96 16.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.9 mt -81.02 -58.93 2.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.066 -1.021 . . . . 0.0 111.018 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.544 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -80.18 -42.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.953 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.077 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -94.34 -35.45 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 111.202 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 85.84 3.43 85.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.077 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.5 mt -66.86 165.5 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.186 -1.185 . . . . 0.0 109.885 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -102.31 164.12 16.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 0.0 110.292 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 53' ' ' LEU . 47.5 Cg_endo -74.51 145.33 33.34 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.721 ' O ' HD11 ' A' ' 60' ' ' LEU . 43.9 Cg_endo -71.45 177.52 6.64 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.993 1.522 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.738 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -64.7 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 110.01 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.527 ' CA ' HD21 ' A' ' 60' ' ' LEU . 5.2 m -109.81 -167.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 110.274 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -81.88 175.33 10.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 111.299 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.955 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -139.71 179.44 1.28 Allowed Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.5 Cg_endo -71.1 -20.39 28.69 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.189 1.1 . . . . 0.0 109.626 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.781 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.8 mt-10 -75.01 -28.34 60.46 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.729 ' CA ' HD21 ' A' ' 76' ' ' LEU . 2.9 mtt -80.77 -49.27 11.35 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.024 0.916 . . . . 0.0 108.733 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 96' ' ' THR . 3.2 mt -56.71 136.31 78.23 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.779 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.302 -1.871 0 O-C-N 123.952 1.501 . . . . 0.0 109.949 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.103 HG23 HG12 ' A' ' 12' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.103 HG12 HG23 ' A' ' 11' ' ' VAL . 2.6 p 15.21 69.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -103.96 -35.68 0.2 Allowed Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -75.85 -153.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 122.825 0.908 . . . . 0.0 111.999 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.01 -52.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.706 ' HB3' HG23 ' A' ' 12' ' ' VAL . 34.7 mt-10 -38.47 -62.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.667 -0.645 . . . . 0.0 110.273 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.633 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -55.92 -34.58 65.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.081 -1.012 . . . . 0.0 109.44 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -68.95 -49.12 60.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 110.137 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -60.44 -30.82 69.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 7.8 m-30 -81.52 -48.57 11.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.516 -0.74 . . . . 0.0 109.813 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 25.1 t0 -46.39 -31.53 2.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.95 . . . . 0.0 109.046 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -78.51 -36.64 44.68 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.61 HG22 ' OG1' ' A' ' 27' ' ' THR . 43.6 mt -74.47 -40.3 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 58.7 t80 -50.72 -24.52 3.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.177 -0.952 . . . . 0.0 108.876 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 38.6 mt -72.37 -24.74 61.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' ILE . 72.9 mttt -102.11 -13.64 17.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.978 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 53.9 t0 -68.35 91.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 109.516 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -88.39 0.9 55.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.041 -1.037 . . . . 0.0 111.747 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 34.9 m-20 -110.36 5.27 21.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.884 -1.135 . . . . 0.0 110.93 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 44.97 26.19 0.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 109.957 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 34' ' ' PHE . 2.5 p30 -90.18 -4.9 56.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.421 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.7 -16.45 23.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD2' ' CB ' ' A' ' 68' ' ' LYS . 2.3 p90 -148.82 151.64 35.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.267 -1.137 . . . . 0.0 110.649 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.899 HG21 HG22 ' A' ' 27' ' ' THR . 1.6 p -97.42 128.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.3 t -79.56 151.04 30.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.329 -1.482 . . . . 0.0 109.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.25 -25.9 0.31 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 7.4 mp -62.02 -39.24 91.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -1.086 . . . . 0.0 111.288 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.9 mt-10 -86.63 -55.23 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.481 -1.387 . . . . 0.0 109.513 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -58.82 -15.63 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.635 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -44.34 -72.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 110.308 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.682 ' HA ' HD12 ' A' ' 45' ' ' LEU . 4.7 tt0 -44.39 -44.19 8.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.978 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -58.27 -48.63 84.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.804 ' HZ ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -71.17 -27.7 63.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 42' ' ' GLU . 34.9 mt -70.87 -16.78 62.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 109.87 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 8.4 mtpp -86.95 -4.87 59.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.646 ' CG2' HG21 ' A' ' 81' ' ' ILE . 81.9 p -72.01 -15.06 62.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.872 . . . . 0.0 111.126 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.89 5.15 83.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 47' ' ' THR . 8.6 mp -77.19 173.91 6.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -80.55 -160.33 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.85 1.448 . . . . 0.0 110.075 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -93.87 -49.81 5.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.005 -1.06 . . . . 0.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -63.81 -51.96 62.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD23 HD23 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -46.69 -52.39 13.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 111.04 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.626 HD11 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.8 -43.47 76.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.942 -1.099 . . . . 0.0 109.307 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.37 85.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.677 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 67.4 t60 -71.24 -37.75 71.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 81' ' ' ILE . 8.6 mt -70.46 -26.55 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.777 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 38.4 t-105 -63.29 -39.37 94.38 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.836 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' HD23 ' A' ' 95' ' ' LEU . 2.3 t -72.16 -29.05 63.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.408 -0.808 . . . . 0.0 109.566 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.777 ' HA ' HD22 ' A' ' 95' ' ' LEU . 3.8 mt -72.6 -18.85 61.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.26 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 21.2 p -112.19 -28.31 8.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 109.108 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.592 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 30.6 t0 -78.09 52.25 1.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.462 -0.774 . . . . 0.0 109.662 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -52.35 -22.08 4.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 109.755 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HG2' ' NE2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -45.25 -26.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.735 0.778 . . . . 0.0 109.117 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.81 50.18 10.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.562 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 68' ' ' LYS . 11.9 t -150.01 -30.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.577 -0.702 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.03 13.91 2.34 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.239 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.668 ' CB ' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -132.4 177.3 7.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.083 -1.245 . . . . 0.0 110.044 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.777 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -120.29 94.04 4.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.297 -179.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.631 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -44.77 173.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.725 -1.235 . . . . 0.0 110.112 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.63 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 0.0 111.055 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 23.6 p-10 -53.85 -30.9 47.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.04 -1.037 . . . . 0.0 110.399 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.611 ' HB3' HD23 ' A' ' 69' ' ' LEU . 8.1 mt-30 -56.32 -53.45 57.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.472 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.744 ' N ' HD22 ' A' ' 69' ' ' LEU . 42.1 t80 -50.01 -31.9 13.95 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.759 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -76.75 -11.73 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 109.795 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.822 HD21 ' HG3' ' A' ' 99' ' ' MET . 6.0 tt -89.18 -21.72 23.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 110.458 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.804 ' HB1' ' HZ ' ' A' ' 44' ' ' PHE . . . -72.9 -53.24 11.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.044 -1.035 . . . . 0.0 109.577 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 6.8 m-85 -49.54 -32.39 12.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.927 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 12' ' ' VAL . 85.1 t60 -55.23 -26.18 37.94 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.509 -0.745 . . . . 0.0 109.453 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.9 HD12 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -93.8 -32.53 13.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 57' ' ' ILE . 2.8 mm -69.27 -54.43 19.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.9 -30.65 1.04 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.85 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.2 mp0 -78.08 -19.27 54.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 110.428 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 81' ' ' ILE . 22.0 tptp -90.41 -21.9 21.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 110.673 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 49' ' ' LEU . 3.4 mt -89.45 -59.45 2.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.102 -0.999 . . . . 0.0 110.527 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.557 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.4 -25.02 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 111.425 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.016 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.05 -14.82 9.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.764 -1.21 . . . . 0.0 111.376 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 58.49 28.03 61.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.016 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -88.05 156.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -1.17 . . . . 0.0 109.668 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 10.9 m-20 -89.54 164.85 27.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' LEU . 47.3 Cg_endo -73.51 158.18 48.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.954 1.502 . . . . 0.0 110.451 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.513 ' HG3' ' HE1' ' A' ' 99' ' ' MET . 47.0 Cg_endo -72.29 58.29 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.697 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.581 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 5.9 m170 45.65 -98.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 110.588 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.9 m -109.1 -163.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 111.249 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.47 155.52 40.59 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.651 0.738 . . . . 0.0 111.635 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.033 ' O ' HD12 ' A' ' 100' ' ' ILE . 59.0 p -133.56 166.58 28.23 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -68.18 -28.94 33.59 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.446 1.235 . . . . 0.0 109.848 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.921 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.33 -9.83 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.099 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 76' ' ' LEU . 25.3 ttm -106.33 -28.17 10.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -71.52 115.13 34.2 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.497 -0.752 . . . . 0.0 110.572 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 -179.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.079 HG11 ' SD ' ' A' ' 99' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 11' ' ' VAL . 2.7 p 12.15 61.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.235 0.541 . . . . 0.0 112.013 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.9 m -102.35 -33.03 0.22 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -74.97 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 122.729 0.857 . . . . 0.0 110.948 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.86 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.295 0.569 . . . . 0.0 111.706 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 12' ' ' VAL . 22.6 mt-10 -46.67 -61.02 2.02 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.26 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -53.42 -37.11 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.94 -1.1 . . . . 0.0 109.745 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -68.96 -49.99 53.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.449 -0.782 . . . . 0.0 109.392 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -55.3 -29.72 58.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.525 -0.734 . . . . 0.0 109.456 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.673 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 7.0 m-85 -88.36 -47.61 8.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.003 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 4.0 t70 -49.27 -33.72 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.411 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 3.5 mm-40 -77.3 -39.26 48.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.425 -0.797 . . . . 0.0 108.913 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.766 HG22 ' OG1' ' A' ' 27' ' ' THR . 30.6 mt -67.37 -37.15 78.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.435 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 57.8 t80 -48.92 -36.46 17.33 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.278 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.64 -26.97 68.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 10.7 mtmt -100.86 -14.27 18.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.061 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.18 -55.11 3.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 30.7 t70 -72.08 88.36 1.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 109.07 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' ' OE2' ' A' ' 39' ' ' GLU . 4.1 mttm -86.11 -6.07 59.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.962 -1.086 . . . . 0.0 111.665 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' MET . 66.7 m-20 -91.23 12.42 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.873 -1.142 . . . . 0.0 110.709 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' ASP . 7.7 mmt 41.69 35.54 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 13.8 p-10 -112.39 12.18 20.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.177 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.04 12.78 68.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.417 ' C ' ' OD1' ' A' ' 28' ' ' ASP . 1.1 m-85 -148.12 112.17 5.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 110.42 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.017 HG21 HG22 ' A' ' 27' ' ' THR . 14.1 p -89.43 135.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 108.9 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.592 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -88.23 152.3 22.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.371 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -46.82 -24.62 1.96 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -68.94 -30.31 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.363 -1.08 . . . . 0.0 110.799 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.3 mt-10 -86.67 -60.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.793 -1.192 . . . . 0.0 108.066 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 36' ' ' SER . 1.2 p -56.15 -16.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 45' ' ' LEU . 4.5 ttt180 -42.24 -73.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 110.016 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . 2.6 mt-10 -44.32 -46.87 9.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 108.777 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.061 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -55.86 -42.71 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.105 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.812 ' HB3' HD22 ' A' ' 54' ' ' LEU . 2.9 m-30 -80.58 -24.16 39.37 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.566 -0.709 . . . . 0.0 109.38 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.1 mt -73.5 -19.77 60.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.294 -0.879 . . . . 0.0 108.848 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 34.6 mtpt -81.79 -9.52 59.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.424 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.891 ' O ' HD22 ' A' ' 85' ' ' LEU . 52.0 p -68.41 -17.72 64.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.812 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 82.01 21.02 61.88 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' CD2' ' A' ' 53' ' ' LEU . 7.5 mp -102.64 171.61 5.08 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.674 -0.898 . . . . 0.0 110.372 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.3 Cg_endo -80.92 -163.95 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.866 1.456 . . . . 0.0 109.943 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -62.38 1.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.957 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -45.95 -42.86 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.697 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.2 tp -56.48 -55.58 31.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 44' ' ' PHE . 19.4 mt -57.24 -36.92 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.385 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.56 76.95 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.842 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.497 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 6.3 t60 -66.29 -25.25 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG21 ' CG1' ' A' ' 81' ' ' ILE . 1.8 mt -82.11 -32.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 20.3 t-105 -62.81 -38.67 91.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 p -76.0 -25.4 55.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 94' ' ' VAL . 7.0 mt -77.08 -9.63 58.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.219 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.773 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.4 p -116.18 -29.37 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.146 -0.971 . . . . 0.0 109.238 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -74.48 52.54 0.5 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.51 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 1.4 p -51.86 -28.92 17.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.123 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HG3' ' CG ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -59.06 -15.22 12.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 0.0 110.414 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 43.88 55.68 5.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.98 5.92 5.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.51 -12.12 61.89 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HD3' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -120.45 -172.68 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -1.196 . . . . 0.0 110.493 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -122.99 102.37 7.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.4 -0.812 . . . . 0.0 109.783 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -58.84 -172.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.447 -1.408 . . . . 0.0 109.374 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.627 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.95 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.958 -1.089 . . . . 0.0 109.991 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 5.0 t70 -43.73 -32.8 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.386 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.565 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -59.68 -57.38 13.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 110.323 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.852 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.4 t80 -50.49 -30.38 12.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.944 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -76.33 -6.96 53.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.673 HD21 ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -84.89 -40.49 17.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -64.09 -38.18 90.14 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.743 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.673 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 3.7 m-85 -58.35 -31.13 67.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.181 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' C ' HD23 ' A' ' 80' ' ' LEU . 81.1 t60 -61.21 -27.76 68.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.151 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.05 -57.59 2.31 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.671 HD12 ' CE1' ' A' ' 44' ' ' PHE . 40.3 mt -47.53 -31.22 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.486 0.66 . . . . 0.0 109.391 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 6.8 t -58.88 -53.49 57.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.728 -0.608 . . . . 0.0 110.935 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -66.85 -7.44 21.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.97 . . . . 0.0 110.697 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.637 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -90.72 -12.63 36.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.005 . . . . 0.0 110.897 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 47' ' ' THR . 6.3 mt -90.63 -66.78 0.9 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 111.204 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.2 mm -89.91 -34.29 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.875 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD12 ' A' ' 89' ' ' ILE . 7.9 mmpt? -89.36 -25.3 21.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.945 . . . . 0.0 110.36 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 67.77 5.46 38.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.5 mt -72.87 153.1 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 120.914 -1.345 . . . . 0.0 110.06 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -82.21 176.77 3.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.739 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 42.2 Cg_endo -70.81 168.31 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.984 1.518 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.601 ' HD2' HD13 ' A' ' 60' ' ' LEU . 52.8 Cg_endo -78.84 38.37 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.048 1.552 . . . . 0.0 111.33 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.508 ' O ' HD21 ' A' ' 60' ' ' LEU . 84.9 m-70 55.97 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.06 . . . . 0.0 111.043 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.699 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.2 m -116.83 -161.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.68 -1.262 . . . . 0.0 111.795 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.652 ' CD2' HD23 ' A' ' 60' ' ' LEU . 2.9 mm? -96.45 149.18 22.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.551 ' OG1' ' HG3' ' A' ' 99' ' ' MET . 0.8 OUTLIER -117.19 173.46 3.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.3 Cg_endo -72.91 -12.17 26.02 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.593 1.312 . . . . 0.0 110.153 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -97.39 -7.37 31.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.676 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.079 ' SD ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -116.1 10.84 15.11 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.053 -1.029 . . . . 0.0 108.955 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 96' ' ' THR 0.25 19.5 mt -106.48 138.24 19.67 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.638 -0.663 . . . . 0.0 110.828 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 48.3 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.5 m . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.916 0.865 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 6.1 p -111.99 159.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER 171.28 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.684 -1.26 . . . . 0.0 111.696 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 44.2 Cg_endo -67.92 -149.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.528 1.278 . . . . 0.0 110.612 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.69 -44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.266 0.555 . . . . 0.0 111.813 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.5 mt-10 -53.08 -62.09 1.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.669 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.01 -37.75 61.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.013 . . . . 0.0 109.915 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.87 64.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.792 . . . . 0.0 109.696 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.1 ttpt -53.37 -29.27 33.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.09 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 3.7 m-85 -91.07 -52.92 4.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 110.102 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' TYR . 30.9 t70 -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.862 . . . . 0.0 109.551 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 66.5 mm-40 -75.26 -37.35 61.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.479 -0.763 . . . . 0.0 108.964 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.775 HG22 ' OG1' ' A' ' 27' ' ' THR . 64.7 mt -74.27 -38.15 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.441 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 74.8 t80 -48.65 -40.11 26.64 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.913 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 3.9 mt -64.4 -23.48 67.3 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.459 -0.897 . . . . 0.0 108.721 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' ILE . 37.6 mttt -102.62 -11.27 18.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.71 . . . . 0.0 109.134 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.059 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 m -88.87 -54.78 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 21.4 t0 -68.0 89.5 0.3 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 26' ' ' LYS . 2.3 mttt -93.55 -12.43 29.6 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.998 -1.064 . . . . 0.0 112.591 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 31' ' ' MET . 25.5 p-10 -96.16 -12.39 24.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.61 -1.306 . . . . 0.0 110.755 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 62.0 63.76 1.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 27.2 p30 -120.14 -4.42 10.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.752 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.55 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 122.77 -41.56 1.78 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -140.22 154.07 46.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.961 . . . . 0.0 109.042 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -88.25 127.21 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.598 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -79.49 149.56 31.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.348 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -40.17 -27.84 0.15 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -59.13 -46.06 89.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.847 -0.796 . . . . 0.0 111.562 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.917 ' HB2' HG23 ' A' ' 35' ' ' VAL . 2.2 mt-10 -81.13 -52.41 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.404 -1.435 . . . . 0.0 108.7 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG13 ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -65.27 -10.38 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.796 0.808 . . . . 0.0 109.384 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -45.8 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 110.692 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.19 -37.28 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -62.35 -50.11 81.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -73.5 -33.83 64.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 108.902 178.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 91.7 mt -65.1 -16.79 63.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.791 . . . . 0.0 109.367 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -86.76 -11.58 50.63 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.425 -0.797 . . . . 0.0 109.783 179.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.792 HG21 HD13 ' A' ' 81' ' ' ILE . 68.1 p -68.25 -17.87 64.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.51 13.95 69.32 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 85' ' ' LEU . 10.4 mp -84.26 166.52 32.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.974 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 53' ' ' LEU . 49.0 Cg_endo -77.19 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.086 1.572 . . . . 0.0 109.271 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -94.54 -70.82 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.848 -1.157 . . . . 0.0 110.323 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -42.38 -57.59 2.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.669 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.3 tp -43.5 -52.25 6.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.894 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 49' ' ' LEU . 1.2 tp -57.66 -46.57 84.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.022 . . . . 0.0 109.503 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.9 -33.29 75.37 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.584 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 70.7 t60 -73.04 -43.84 61.51 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 3.1 mt -63.41 -24.06 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.626 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 61.9 t-105 -66.59 -52.26 47.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.94 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.583 ' O ' HD21 ' A' ' 95' ' ' LEU . 27.8 t -63.85 -33.94 76.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.839 ' O ' HD11 ' A' ' 95' ' ' LEU . 3.7 tp -64.46 -32.19 73.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.633 -0.667 . . . . 0.0 109.731 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.721 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.6 p -96.02 -36.25 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.721 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 55.3 t0 -68.03 56.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.523 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.6 -31.05 70.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.121 -0.987 . . . . 0.0 109.65 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -58.55 -15.12 9.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 44.18 55.08 5.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 110.158 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 -39.85 2.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.16 -13.06 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 34' ' ' PHE . 3.5 mttm -139.71 -169.45 2.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.325 -1.103 . . . . 0.0 109.315 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 74' ' ' PHE . 3.6 mt -108.5 122.69 47.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 111.304 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.571 ' CB ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -73.82 -172.97 1.4 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.05 -1.031 . . . . 0.0 109.178 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.16 -89.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.75 -1.219 . . . . 0.0 110.282 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -47.84 -36.28 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 110.105 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.571 ' HG3' ' CB ' ' A' ' 70' ' ' SER . 5.5 mm-40 -60.05 -35.06 74.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.997 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.939 ' HA ' HD22 ' A' ' 69' ' ' LEU . 25.9 t80 -71.09 -32.11 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 108.918 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -69.18 -8.12 42.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.826 HD21 ' HG3' ' A' ' 99' ' ' MET . 3.9 tt -90.42 -36.92 14.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 110.54 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.22 -46.15 75.95 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.002 -1.061 . . . . 0.0 109.716 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 11.5 m-85 -60.43 -34.38 73.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 110.162 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 76.7 t60 -53.15 -21.43 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.802 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.764 HD13 HD23 ' A' ' 60' ' ' LEU . 4.4 mt -98.18 -24.78 15.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 0.0 108.784 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 13.1 mt -69.94 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' ILE . 9.4 t -40.98 -32.14 0.22 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.704 -0.623 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -75.16 -24.99 57.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.919 -1.113 . . . . 0.0 110.314 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ILE . 20.5 tptt -90.07 -18.0 26.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 111.331 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HD11 ' A' ' 49' ' ' LEU . 5.3 mt -88.76 -62.8 1.4 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.953 -1.092 . . . . 0.0 111.282 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 86' ' ' ILE . 17.0 mm -92.7 -19.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.112 -0.993 . . . . 0.0 111.337 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 1.013 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.5 mmpt? -108.43 -7.86 15.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.989 -1.069 . . . . 0.0 110.843 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.07 20.91 4.95 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.013 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.5 mt -90.32 134.95 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.2 p-10 -71.38 169.92 13.65 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.872 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 53' ' ' LEU . 42.9 Cg_endo -71.43 155.79 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.846 1.445 . . . . 0.0 110.644 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.63 ' CD ' HD22 ' A' ' 80' ' ' LEU . 40.4 Cg_endo -67.53 59.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.584 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER 37.32 -93.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.673 -0.642 . . . . 0.0 111.617 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.769 ' C ' HD11 ' A' ' 60' ' ' LEU . 13.1 m -106.92 -164.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.249 -0.907 . . . . 0.0 111.476 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.839 HD11 ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -76.28 163.34 27.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.793 0.806 . . . . 0.0 111.256 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.615 ' O ' HD12 ' A' ' 100' ' ' ILE . 50.5 p -140.57 167.02 19.15 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -69.4 -26.65 29.07 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.434 1.229 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 11' ' ' VAL . 16.1 mp0 -79.44 -20.14 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 108.886 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.826 ' HG3' HD21 ' A' ' 76' ' ' LEU . 29.9 ttm -98.29 -6.21 31.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.644 -0.66 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 96' ' ' THR . 38.5 mt -102.88 107.81 56.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.397 -0.814 . . . . 0.0 110.428 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 O-C-N 123.897 1.472 . . . . 0.0 112.942 179.683 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.009 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 76' ' ' LEU . 9.9 t 49.1 101.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.064 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.29 -67.35 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.744 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.768 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 48.8 Cg_endo -67.97 -149.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.366 1.193 . . . . 0.0 112.068 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.79 -51.06 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.963 -0.461 . . . . 0.0 112.142 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -40.34 -61.98 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 110.672 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -56.59 -32.53 65.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.807 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.15 -48.43 43.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 109.749 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -29.66 69.33 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.683 0.754 . . . . 0.0 109.51 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 6.0 m-30 -84.39 -45.76 12.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.613 -0.679 . . . . 0.0 110.681 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -54.91 -39.89 69.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.815 -1.178 . . . . 0.0 109.352 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.3 mm-40 -69.41 -50.35 46.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.29 -0.881 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 26' ' ' LYS . 65.9 mt -63.83 -39.08 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.151 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 71' ' ' LYS . 85.0 t80 -46.74 -36.33 7.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.584 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 22' ' ' GLU . 6.3 mt -68.79 -21.24 64.34 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.383 -0.823 . . . . 0.0 109.163 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 12.2 mttt -101.14 -11.46 19.55 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.585 0.707 . . . . 0.0 109.162 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.933 HG23 HD12 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -89.83 -50.37 6.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.535 0.683 . . . . 0.0 109.801 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 40.1 t0 -66.52 71.04 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.572 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 27' ' ' THR . 3.6 mptp? -62.23 -12.99 23.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.273 -0.892 . . . . 0.0 111.432 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 74.5 m-20 -93.98 -0.31 55.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.911 -1.118 . . . . 0.0 110.474 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.0 mtm 45.29 27.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.813 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.57 ' OD2' ' CZ ' ' A' ' 34' ' ' PHE . 12.1 p-10 -90.22 2.86 54.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.6 12.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.735 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 38.9 p90 -150.47 162.51 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.143 . . . . 0.0 110.525 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.916 HG21 HG22 ' A' ' 27' ' ' THR . 2.4 p -99.86 146.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.445 -0.785 . . . . 0.0 110.995 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.714 ' O ' HG12 ' A' ' 40' ' ' VAL . 80.6 p -94.57 155.16 17.03 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' ' CH2' ' A' ' 58' ' ' TRP . . . -52.94 -18.41 5.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 38' ' ' LEU . 5.8 mt -73.5 -30.46 63.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 111.024 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.824 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.2 mt-10 -87.68 -60.16 2.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -54.3 -17.44 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.672 0.749 . . . . 0.0 109.659 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -46.66 -75.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.315 -0.866 . . . . 0.0 110.087 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.772 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.8 mt-10 -44.57 -37.29 3.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.551 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.933 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -61.6 -46.94 95.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.644 -0.66 . . . . 0.0 109.392 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -79.76 -27.32 40.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 109.469 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 42' ' ' GLU . 62.2 mt -60.07 -16.7 33.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.858 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 25.5 mtpp -80.39 -25.19 39.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.707 -0.62 . . . . 0.0 109.938 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' HG21 ' A' ' 81' ' ' ILE . 69.9 p -52.63 -26.44 13.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.9 -11.56 71.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.6 mp -67.96 167.28 17.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.465 -1.02 . . . . 0.0 110.136 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' HD22 ' A' ' 53' ' ' LEU . 44.5 Cg_endo -72.15 153.37 56.99 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.855 1.45 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 52' ' ' THR . 19.0 t -59.04 -63.2 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.605 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 51' ' ' SER . 51.7 m -40.07 -48.66 2.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.573 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -55.39 -56.49 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.936 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.2 mt -54.22 -36.88 63.97 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.264 -0.897 . . . . 0.0 109.052 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.56 85.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -68.08 -26.6 65.91 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 81' ' ' ILE . 3.3 mt -76.64 -29.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.768 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 50.2 t-105 -64.34 -45.85 86.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.179 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.422 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -70.52 -37.58 74.13 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.961 HD23 HD22 ' A' ' 95' ' ' LEU . 5.3 mt -66.29 -14.57 62.22 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.981 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.2 t -110.04 -41.69 4.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.771 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.8 t0 -62.92 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.667 -0.646 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.4 p -65.06 -35.49 81.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.11 -0.994 . . . . 0.0 110.36 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -56.28 -17.05 6.5 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.924 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 49.63 52.95 13.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -128.78 8.85 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.136 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.24 27.48 57.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.735 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -150.52 173.6 13.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -1.111 . . . . 0.0 110.036 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.981 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.1 mt -114.99 93.37 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 21.0 p -50.73 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.463 -0.773 . . . . 0.0 110.635 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -68.19 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.94 -1.1 . . . . 0.0 111.111 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 73' ' ' GLN . 2.3 p30 -42.57 -28.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 110.825 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.592 ' HB3' HD23 ' A' ' 69' ' ' LEU . 14.9 mt-30 -64.11 -59.17 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.072 -1.017 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 27' ' ' THR . 41.9 t80 -45.74 -29.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.834 -1.167 . . . . 0.0 109.778 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.809 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -80.41 -13.82 58.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.051 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -89.87 -34.23 16.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.529 -0.732 . . . . 0.0 110.313 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.58 -46.93 85.88 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.904 -1.123 . . . . 0.0 110.379 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 10.6 m-85 -59.39 -31.61 69.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.186 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.952 ' HB2' HG22 ' A' ' 12' ' ' VAL . 40.1 t60 -57.43 -25.8 60.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 109.927 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.632 HD23 ' HD2' ' A' ' 79' ' ' HIS . 1.3 mt -90.31 -29.48 18.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.604 HD12 ' CD1' ' A' ' 44' ' ' PHE . 1.3 mm -74.09 -50.33 28.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.592 0.711 . . . . 0.0 109.1 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -27.31 33.33 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.638 -0.664 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -72.59 -24.59 61.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 0.0 110.269 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -29.03 20.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 111.421 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -76.79 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.978 -1.077 . . . . 0.0 110.832 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -93.8 -15.64 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.428 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.775 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mptt -117.45 -11.54 10.52 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 51.68 21.97 7.76 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.775 HD12 ' HB3' ' A' ' 87' ' ' LYS . 18.5 mt -89.94 143.97 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.533 -0.981 . . . . 0.0 109.718 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.0 m-20 -82.33 165.74 40.76 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 38.3 Cg_endo -66.37 157.5 59.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.053 1.554 . . . . 0.0 110.821 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' VAL . 44.9 Cg_endo -72.69 56.56 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.196 1.629 . . . . 0.0 111.134 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.495 ' O ' HD11 ' A' ' 60' ' ' LEU . 5.4 m-70 38.12 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 111.25 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.653 ' CA ' HD21 ' A' ' 60' ' ' LEU . 6.5 m -106.86 -170.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.117 -0.989 . . . . 0.0 111.286 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.961 HD22 HD23 ' A' ' 60' ' ' LEU . 4.1 mm? -75.37 167.83 21.15 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.927 0.87 . . . . 0.0 111.863 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.027 ' O ' HD12 ' A' ' 100' ' ' ILE . 23.2 p -145.5 166.61 16.95 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.4 Cg_endo -69.52 -29.18 25.44 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.479 1.252 . . . . 0.0 109.831 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.605 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.5 mt-10 -75.33 -20.32 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 108.79 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 95' ' ' LEU . 6.5 ttm -94.73 -46.6 6.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 110.501 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.027 HD12 ' O ' ' A' ' 96' ' ' THR . 1.6 mt -51.82 142.77 24.01 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.409 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HD3' HG21 ' A' ' 63' ' ' THR . 57.0 Cg_endo . . . . . 0 CA--C 1.56 1.821 0 O-C-N 123.964 1.507 . . . . 0.0 108.249 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.3 m . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.573 0.701 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 75' ' ' ALA . 8.6 p 34.87 62.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 111.362 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -102.42 -39.61 0.21 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 0.0 113.222 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -78.94 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.109 1.057 . . . . 0.0 112.029 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.83 -53.16 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 12' ' ' VAL . 12.8 mt-10 -39.53 -58.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.476 -0.765 . . . . 0.0 110.315 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -54.49 -38.3 66.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.019 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.52 -47.09 74.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -62.51 -29.15 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.637 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 17.5 m-85 -85.94 -38.27 18.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.483 -0.761 . . . . 0.0 109.589 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -53.53 -39.72 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.082 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.1 mm-40 -69.43 -41.71 75.95 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.423 -0.798 . . . . 0.0 109.042 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.6 mt -66.5 -40.2 85.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 60.6 t80 -48.56 -36.89 16.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.162 -0.961 . . . . 0.0 108.799 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.8 mt -65.32 -21.85 66.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -99.92 -14.88 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.098 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.6 -55.13 3.77 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.565 0.698 . . . . 0.0 109.621 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -66.33 76.73 0.1 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.671 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -61.91 -9.68 7.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.0 111.449 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 11.2 m-20 -105.16 -4.51 21.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.789 -1.195 . . . . 0.0 110.415 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 31' ' ' MET . 1.0 OUTLIER 57.87 25.39 11.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 11.9 p30 -92.59 19.28 7.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.58 13.54 58.84 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.62 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -151.02 108.25 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -1.086 . . . . 0.0 110.867 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.982 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -89.11 140.85 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.867 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 t -96.75 161.62 13.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.771 -1.205 . . . . 0.0 110.632 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 41' ' ' ARG . . . -55.21 -16.74 9.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.0 mm? -74.86 -29.7 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.704 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.5 mt-10 -91.92 -64.02 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.999 -1.063 . . . . 0.0 108.828 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.867 HG12 ' O ' ' A' ' 36' ' ' SER . 1.3 p -52.27 -20.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.012 0.91 . . . . 0.0 109.579 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -41.71 -60.53 1.32 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.672 -0.643 . . . . 0.0 110.977 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -58.06 -41.39 83.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.924 -1.11 . . . . 0.0 108.975 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 HG23 ' A' ' 27' ' ' THR . 1.2 mt -56.56 -36.18 47.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.366 0.603 . . . . 0.0 109.414 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.77 -23.03 25.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.865 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 25.8 mt -78.51 -23.99 46.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 109.219 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.06 -4.38 58.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.736 . . . . 0.0 109.987 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.761 HG21 HD13 ' A' ' 81' ' ' ILE . 66.6 p -72.94 -15.78 61.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 91.02 18.51 46.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 85' ' ' LEU . 9.0 mp -95.74 172.72 4.97 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.763 -0.845 . . . . 0.0 110.366 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -84.68 -157.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.156 1.608 . . . . 0.0 109.76 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.982 -1.074 . . . . 0.0 110.639 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -59.1 -54.68 44.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.567 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.0 -42.25 5.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 0.0 110.407 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.597 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 1.1 mp -62.97 -52.5 62.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 109.537 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.51 70.13 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.432 ' NE2' HD11 ' A' ' 60' ' ' LEU . 67.1 t60 -73.44 -32.76 64.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.769 HG21 ' CE1' ' A' ' 44' ' ' PHE . 5.2 mt -77.34 -29.86 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.712 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 55.5 t-105 -63.97 -43.84 94.56 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.831 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -71.85 -28.95 63.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.4 mt -71.42 -11.46 60.9 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 69' ' ' LEU . 5.3 t -118.87 -41.7 2.76 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.474 -0.766 . . . . 0.0 109.316 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.07 69.17 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.9 p -59.89 -37.56 79.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.653 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -59.39 -13.9 10.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.452 -0.78 . . . . 0.0 109.922 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.9 p-10 38.62 50.2 1.55 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.423 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -10.08 9.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.567 -0.708 . . . . 0.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.8 -11.72 27.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 mttm -115.96 -171.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -1.137 . . . . 0.0 110.098 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.031 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -129.91 108.67 10.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -53.66 -170.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -78.92 -78.29 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.06 . . . . 0.0 110.515 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -44.34 -46.47 9.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 76' ' ' LEU . 2.1 mt-30 -50.84 -52.98 36.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.098 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.1 t80 -44.73 -34.85 2.41 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.212 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.003 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.06 -14.39 59.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.088 -1.007 . . . . 0.0 109.741 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.962 HD21 ' CG ' ' A' ' 99' ' ' MET . 7.3 tt -85.19 -23.35 28.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.682 -0.636 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -69.39 -54.62 13.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 109.587 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.736 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 19.1 m-85 -52.76 -34.03 51.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.661 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 17.2 t60 -51.43 -21.81 2.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 57' ' ' ILE . 2.9 mt -98.48 -22.96 15.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 108.924 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 14.3 mt -73.51 -52.69 20.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.592 -0.693 . . . . 0.0 110.282 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ILE . 4.1 mt-30 -71.69 -25.03 61.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -90.08 -19.9 23.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 111.214 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 49' ' ' LEU . 5.6 mt -84.92 -60.8 1.94 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.114 . . . . 0.0 111.402 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.9 mm -95.91 -35.95 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.073 -1.017 . . . . 0.0 110.999 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -89.41 -13.96 36.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.045 -1.034 . . . . 0.0 110.813 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 53.83 18.8 8.97 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.6 mt -86.61 161.28 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.16 -1.2 . . . . 0.0 109.721 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 2.7 p-10 -90.39 169.35 12.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -70.21 156.25 62.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.88 1.463 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' HIS . 42.7 Cg_endo -70.13 62.93 2.0 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.125 1.592 . . . . 0.0 111.365 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.709 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.8 OUTLIER 40.08 -112.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 111.001 179.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 ' ND1' ' A' ' 93' ' ' HIS . 3.8 m -101.97 -172.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.744 -1.222 . . . . 0.0 111.245 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.679 HD13 ' H ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -62.94 164.37 8.26 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 111.396 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 95' ' ' LEU . 30.0 p -145.85 167.88 13.15 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -70.09 -23.17 29.62 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.486 1.256 . . . . 0.0 109.266 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.027 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.0 mt-10 -82.41 -2.11 52.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.423 -0.798 . . . . 0.0 109.127 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.962 ' CG ' HD21 ' A' ' 76' ' ' LEU . 30.7 ttm -119.08 5.09 11.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 95' ' ' LEU 0.253 33.4 mt -108.47 100.53 38.49 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.665 -0.647 . . . . 0.0 110.486 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 O-C-N 123.759 1.4 . . . . 0.0 113.017 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 98' ' ' GLU . 2.4 m . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.786 0.803 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 16' ' ' GLU . 2.4 p -123.65 146.34 29.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -167.02 -59.64 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.845 -1.16 . . . . 0.0 112.675 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 15' ' ' ALA . 40.9 Cg_endo -63.24 -141.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.34 1.179 . . . . 0.0 110.807 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.83 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 112.217 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -36.28 -63.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -52.21 -33.81 42.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.086 . . . . 0.0 110.418 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.54 -48.16 70.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -56.27 -31.0 63.2 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.6 m-85 -91.65 -52.06 4.94 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.704 -0.623 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 10.3 t0 -42.74 -39.77 2.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.649 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.3 mt-10 -71.66 -35.5 70.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.407 -0.808 . . . . 0.0 109.072 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 27' ' ' THR . 31.7 mt -72.43 -41.75 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.805 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 71' ' ' LYS . 47.1 t80 -46.44 -28.58 1.41 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.543 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 22' ' ' GLU . 12.8 mt -73.08 -33.16 65.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 23' ' ' ILE . 24.3 mttp -93.72 -10.05 35.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.081 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.53 -58.84 2.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 55.2 t0 -66.13 82.59 0.08 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -75.41 11.41 1.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.93 -1.106 . . . . 0.0 112.332 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 2.9 m-20 -116.67 5.74 13.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.3 mmt 46.08 35.52 2.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 111.055 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.8 p30 -108.06 12.78 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.55 12.47 80.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -150.84 109.93 3.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.286 . . . . 0.0 110.8 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.933 HG21 HG22 ' A' ' 27' ' ' THR . 13.2 p -89.6 137.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.982 . . . . 0.0 108.495 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.2 p -85.87 153.59 22.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.103 -0.998 . . . . 0.0 111.172 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -50.99 -21.7 5.53 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 mt -73.07 -32.31 64.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -1.054 . . . . 0.0 110.42 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 36.6 mt-10 -82.67 -54.06 5.44 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -66.86 -14.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.342 0.591 . . . . 0.0 109.735 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -47.24 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.154 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.71 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -43.61 -44.5 6.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.081 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -50.75 -40.95 20.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.783 ' HB3' HD22 ' A' ' 54' ' ' LEU . 1.6 m-30 -83.2 -38.65 22.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.3 mt -55.86 -18.5 8.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.356 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 83.0 mttt -79.61 -13.57 59.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 109.323 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.823 HG21 HG21 ' A' ' 81' ' ' ILE . 64.1 p -66.23 -16.77 64.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.26 66.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -100.13 171.94 5.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.641 -0.917 . . . . 0.0 110.085 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.621 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.4 Cg_endo -77.19 155.64 33.2 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.723 1.381 . . . . 0.0 110.073 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.02 67.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.967 . . . . 0.0 110.995 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -45.38 73.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.995 . . . . 0.0 111.24 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.621 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -54.99 -51.17 67.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.89 -1.131 . . . . 0.0 110.478 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.3 mt -59.85 -36.6 77.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.34 -48.19 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -60.56 -37.77 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.796 HD13 HG13 ' A' ' 81' ' ' ILE . 12.8 mt -64.74 -37.25 79.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 40.3 t-105 -57.13 -52.84 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -33.59 71.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.168 -0.957 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.757 HD11 ' C ' ' A' ' 94' ' ' VAL . 15.9 tp -67.0 -23.62 65.95 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.253 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 56.0 m -105.74 -36.09 7.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 68' ' ' LYS . 51.8 t0 -67.01 58.37 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 109.155 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.4 p -53.76 -29.57 40.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -62.69 -11.1 15.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.436 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.7 p30 37.02 55.49 1.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.615 -0.678 . . . . 0.0 110.465 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.73 -11.18 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.18 -21.09 27.49 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 16.3 mmtm -114.68 -176.41 2.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.406 -1.055 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -114.54 108.57 17.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.933 -1.105 . . . . 0.0 110.562 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -64.56 167.69 6.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 109.373 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -56.04 -72.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.558 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -44.42 -37.52 3.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 110.637 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 44.4 mm-40 -67.33 -49.6 63.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.037 -1.04 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 27' ' ' THR . 8.9 t80 -56.61 -26.92 57.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.72 -1.238 . . . . 0.0 108.588 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.52 -11.4 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.598 0.713 . . . . 0.0 109.277 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.816 HD21 ' CG ' ' A' ' 99' ' ' MET . 6.1 tp -88.64 -42.41 12.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 110.087 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.579 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -62.89 -26.39 68.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.298 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 1.4 m-85 -76.12 -20.36 57.7 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.741 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.642 ' C ' HD23 ' A' ' 80' ' ' LEU . 82.3 t60 -73.29 -22.56 60.34 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.557 -0.714 . . . . 0.0 109.172 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -99.72 -38.46 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.435 -0.79 . . . . 0.0 108.894 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 47' ' ' THR . 76.6 mt -66.66 -46.99 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -62.69 -16.76 58.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.492 -0.755 . . . . 0.0 109.915 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -77.8 -24.01 48.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 110.032 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -10.52 47.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 6.0 mt -89.99 -55.37 3.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.065 -1.022 . . . . 0.0 110.749 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.447 ' HA ' HD13 ' A' ' 86' ' ' ILE . 7.2 mm -108.9 -17.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.092 -1.005 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -108.44 -2.73 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.949 -1.094 . . . . 0.0 110.45 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 42.22 53.93 4.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.4 mt -125.63 168.37 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.302 -1.117 . . . . 0.0 109.832 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.7 m-20 -113.32 171.54 4.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.452 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 40.8 Cg_endo -70.46 151.68 65.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.897 1.472 . . . . 0.0 109.999 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.6 Cg_endo -70.85 51.64 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.938 1.494 . . . . 0.0 111.168 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.739 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 50.2 -83.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.426 -0.796 . . . . 0.0 111.679 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.757 ' C ' HD11 ' A' ' 60' ' ' LEU . 11.5 m -108.36 -162.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 60' ' ' LEU . 2.0 mm? -86.71 144.0 27.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.739 0.781 . . . . 0.0 111.243 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.877 ' O ' HD12 ' A' ' 100' ' ' ILE . 39.3 p -111.12 168.09 8.09 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.7 Cg_endo -68.38 -38.43 11.6 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 123.289 1.152 . . . . 0.0 109.863 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.486 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.7 mt-10 -71.26 -27.2 63.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 108.611 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.816 ' CG ' HD21 ' A' ' 76' ' ' LEU . 24.1 ttm -84.66 -25.52 28.41 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.422 0.63 . . . . 0.0 109.624 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 96' ' ' THR . 7.5 mt -87.01 135.82 34.71 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.097 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.44 ' HG3' ' HE3' ' A' ' 64' ' ' LYS . 41.6 Cg_endo . . . . . 0 C--N 1.302 -1.879 0 O-C-N 123.771 1.406 . . . . 0.0 109.695 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.7 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.701 0.763 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 76' ' ' LEU . 3.0 p -115.66 166.13 10.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER 167.06 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.074 -1.016 . . . . 0.0 111.926 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 13' ' ' SER . 45.6 Cg_endo -66.28 -146.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.263 1.139 . . . . 0.0 110.81 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.96 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 111.524 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 43.7 mt-10 -54.09 -64.13 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -54.04 -32.67 55.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.902 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.46 -52.31 16.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.32 -30.15 62.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.007 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.6 m-30 -89.56 -50.51 6.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 8.9 t0 -43.27 -40.64 3.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 109.41 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.2 mt-10 -69.25 -34.96 75.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 108.882 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HE2' ' A' ' 74' ' ' PHE . 60.6 mt -74.66 -38.77 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.459 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 70' ' ' SER . 68.4 t80 -50.1 -33.08 17.5 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 18.0 mt -65.87 -24.86 66.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.69 -16.09 19.14 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.96 ' CG2' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.75 -52.98 4.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.502 -0.749 . . . . 0.0 109.8 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 67.6 t0 -67.14 63.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 109.29 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 11.1 mttm -65.5 -3.82 4.97 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.383 -0.823 . . . . 0.0 111.966 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 39' ' ' GLU . 45.9 m-20 -103.36 -11.06 18.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.683 -1.261 . . . . 0.0 110.672 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 57.42 37.45 27.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 19.5 p30 -103.11 1.32 33.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 110.68 -32.56 6.49 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -135.68 147.08 48.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.96 HG21 ' CG2' ' A' ' 27' ' ' THR . 1.4 p -88.94 135.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.344 -0.848 . . . . 0.0 108.733 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 40' ' ' VAL . 7.8 p -86.58 151.02 23.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 0.0 110.426 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -24.95 0.45 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 80.9 mt -65.07 -41.28 95.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -1.06 . . . . 0.0 111.591 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.859 ' HB2' HG23 ' A' ' 35' ' ' VAL . 5.5 mt-10 -81.03 -58.4 3.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.195 . . . . 0.0 108.769 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -57.01 -16.43 4.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.547 0.689 . . . . 0.0 109.639 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -43.94 -76.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.476 -0.765 . . . . 0.0 110.823 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.7 mt-10 -44.63 -46.58 10.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.071 . . . . 0.0 108.59 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.863 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -53.09 -37.27 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.9 m-30 -85.76 -45.79 11.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.655 -0.653 . . . . 0.0 109.438 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 42' ' ' GLU . 27.2 mt -51.48 -27.58 10.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 3.2 ptmt -73.86 -5.37 40.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.662 -0.649 . . . . 0.0 109.751 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 44' ' ' PHE . 65.3 p -78.97 -18.06 54.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.844 . . . . 0.0 110.015 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.85 86.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.8 mp -81.01 166.99 35.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -78.36 176.5 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.915 1.481 . . . . 0.0 110.56 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -44.03 61.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.636 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 53' ' ' LEU . 5.3 m -65.6 -59.0 4.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.702 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -44.54 -39.71 5.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.97 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 54' ' ' LEU . 33.3 mt -65.38 -53.24 46.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.38 68.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -74.97 -38.41 61.68 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.526 HD13 ' CG1' ' A' ' 81' ' ' ILE . 3.8 mt -71.68 -28.51 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.761 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 71.7 t-105 -61.56 -44.24 97.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.274 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.2 t -71.12 -33.67 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.26 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.895 HD23 HD22 ' A' ' 95' ' ' LEU . 12.3 mt -67.05 -27.53 67.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.566 -0.709 . . . . 0.0 109.466 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.93 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 19.4 p -102.12 -35.13 9.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.447 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.567 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 45.7 t0 -75.4 57.13 0.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.582 -0.699 . . . . 0.0 110.004 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.6 p -52.49 -33.04 43.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -63.03 -12.38 25.83 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.67 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 4.1 t70 40.81 53.84 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.789 . . . . 0.0 110.139 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.85 7.9 10.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.453 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.55 -12.69 62.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.584 ' CA ' ' HZ2' ' A' ' 58' ' ' TRP . 32.4 mttt -126.43 175.44 7.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.177 . . . . 0.0 109.766 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.761 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 2.9 mt -113.35 114.88 27.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.809 -1.182 . . . . 0.0 111.707 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.638 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -64.02 -172.85 0.07 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.983 -1.073 . . . . 0.0 110.219 179.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -70.5 -46.2 64.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 111.361 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.24 -3.28 58.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.072 -1.018 . . . . 0.0 111.199 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.638 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 34.3 mm-40 -89.03 -43.69 10.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.901 -1.124 . . . . 0.0 109.596 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE2' HG22 ' A' ' 23' ' ' ILE . 14.6 t80 -61.38 -24.72 66.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.23 -13.96 58.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.514 -0.741 . . . . 0.0 109.084 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.8 tp -90.33 -49.15 6.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.477 -0.764 . . . . 0.0 109.415 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -48.0 -46.54 32.97 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 3.1 m-85 -51.91 -39.76 59.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.543 ' C ' HD23 ' A' ' 80' ' ' LEU . 83.3 t60 -51.38 -24.87 5.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.06 -34.89 9.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 0.0 109.247 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 45.8 mt -77.63 -35.16 21.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.528 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 2.8 p -67.77 -29.74 69.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 110.079 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.87 -5.49 59.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.077 -1.015 . . . . 0.0 109.982 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.487 ' HD3' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.9 -24.65 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.406 -0.809 . . . . 0.0 110.91 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -90.0 -71.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.0 111.299 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 mm -82.08 3.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.795 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.956 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -126.81 -47.27 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.941 -1.099 . . . . 0.0 110.573 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 87.1 6.19 79.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.956 HD12 ' HB3' ' A' ' 87' ' ' LYS . 3.5 mt -77.42 139.37 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.231 -1.158 . . . . 0.0 109.823 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.2 170.96 13.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.217 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 40.4 Cg_endo -70.88 158.29 55.91 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.191 1.627 . . . . 0.0 110.675 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 94' ' ' VAL . 46.7 Cg_endo -75.06 47.02 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.098 1.578 . . . . 0.0 111.676 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 54.08 -85.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.077 -1.015 . . . . 0.0 111.643 178.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.681 ' HA ' HD21 ' A' ' 60' ' ' LEU . 33.4 m -117.47 -163.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.607 -1.308 . . . . 0.0 112.208 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.895 HD22 HD23 ' A' ' 60' ' ' LEU . 4.0 mm? -81.03 165.1 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.785 0.802 . . . . 0.0 111.603 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.981 ' O ' HD12 ' A' ' 100' ' ' ILE . 35.7 p -147.15 170.25 8.06 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.6 Cg_endo -69.6 -38.03 8.71 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.183 1.097 . . . . 0.0 109.527 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.957 ' O ' HG13 ' A' ' 11' ' ' VAL . 13.4 mt-10 -70.08 -10.83 60.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 108.96 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.709 ' CG ' HD21 ' A' ' 76' ' ' LEU . 28.0 ttm -102.54 -38.21 7.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -64.68 143.13 98.66 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.864 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 100' ' ' ILE . 44.6 Cg_endo . . . . . 0 C--N 1.304 -1.783 0 O-C-N 123.891 1.469 . . . . 0.0 110.706 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.679 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.453 0.644 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -139.04 73.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 109.787 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 t -102.73 -31.67 0.21 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -76.38 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 122.756 0.872 . . . . 0.0 111.101 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.67 -61.28 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.904 -0.497 . . . . 0.0 112.197 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.73 ' HB3' HG23 ' A' ' 12' ' ' VAL . 15.2 mt-10 -38.65 -57.33 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.73 . . . . 0.0 110.64 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.18 -35.17 64.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.97 . . . . 0.0 109.867 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.29 -48.61 69.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -29.42 64.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.529 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 12.2 m-85 -87.95 -51.69 5.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.558 -0.714 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -45.56 -39.56 7.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.927 -1.108 . . . . 0.0 109.356 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 5.6 mm-40 -67.51 -47.27 70.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 108.99 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.762 HG22 ' OG1' ' A' ' 27' ' ' THR . 26.1 mt -62.26 -40.5 87.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 29.4 t80 -46.95 -27.65 1.35 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 70.3 mt -70.64 -31.72 68.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -97.83 -12.8 21.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.845 . . . . 0.0 108.82 178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.045 HG23 HD12 ' A' ' 43' ' ' ILE . 1.3 m -89.06 -51.43 5.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 31' ' ' MET . 23.0 t70 -65.04 82.53 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -62.44 0.07 0.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 44.8 p-10 -122.77 3.47 9.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.219 -1.55 . . . . 0.0 110.787 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.471 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 1.2 mmt 55.92 39.08 30.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.294 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 3.9 p-10 -110.35 26.44 10.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.34 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.48 11.17 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.86 99.49 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -1.104 . . . . 0.0 110.309 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 27' ' ' THR . 10.8 p -89.71 135.66 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.94 -1.1 . . . . 0.0 109.004 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.512 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 82.6 p -90.06 147.81 23.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 110.825 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -42.94 -27.59 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.7 mp -65.04 -30.59 71.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.108 . . . . 0.0 110.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.547 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 mt-10 -86.84 -62.24 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.891 -1.131 . . . . 0.0 108.306 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -58.49 -15.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.29 0.566 . . . . 0.0 110.023 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.618 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.58 -44.67 4.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.008 . . . . 0.0 109.82 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.045 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -51.27 -40.01 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.55 -0.719 . . . . 0.0 109.072 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.4 m-85 -87.28 -28.45 22.29 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.592 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 42' ' ' GLU . 72.1 mt -68.06 -17.38 64.37 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 108.961 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CD ' ' HA ' ' A' ' 43' ' ' ILE . 10.2 mtpt -75.75 -21.32 57.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.559 0.695 . . . . 0.0 109.49 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.586 ' OG1' ' HG ' ' A' ' 49' ' ' LEU . 39.1 p -50.2 -58.14 6.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.698 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 118.43 21.41 4.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -101.05 -172.34 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.511 -0.994 . . . . 0.0 108.542 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.0 Cg_endo -74.3 -171.64 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.388 1.204 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -47.8 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.859 -1.151 . . . . 0.0 111.328 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -63.14 -32.11 73.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.673 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.995 HD23 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -59.87 -62.68 1.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 110.819 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.995 HD22 HD23 ' A' ' 53' ' ' LEU . 2.8 mm? -50.08 -29.71 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.816 -1.178 . . . . 0.0 108.953 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -79.65 -39.36 31.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 21.3 t60 -67.49 -24.58 65.6 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CD1' HD13 ' A' ' 81' ' ' ILE . 4.9 mt -78.3 -23.04 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 69' ' ' LEU . 19.5 t-105 -71.48 -45.63 61.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -69.44 -27.61 65.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 108.645 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 92' ' ' PRO . 9.0 mt -74.68 -4.65 38.58 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 76' ' ' LEU . 61.6 m -128.58 -35.48 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.75 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.9 t70 -65.81 59.35 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.63 -0.669 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' CYS . 24.7 p -55.54 -36.84 67.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -0.991 . . . . 0.0 109.881 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' CD ' ' OE1' ' A' ' 73' ' ' GLN . 11.7 mptt -56.25 -16.98 6.24 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 110.04 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.08 54.76 2.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 110.438 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.0 t -123.13 -13.96 7.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.311 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.24 -0.25 25.24 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.608 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 3.7 mtmt -129.78 -176.25 3.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.133 -1.216 . . . . 0.0 110.087 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -123.7 97.94 5.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.099 -1.001 . . . . 0.0 111.163 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -55.56 172.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.746 -1.221 . . . . 0.0 109.34 178.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -56.46 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.958 -1.089 . . . . 0.0 110.544 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' LYS . 32.3 m-20 -39.38 -42.65 1.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.594 -0.691 . . . . 0.0 110.549 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 25.9 mt-30 -61.03 -49.49 77.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.687 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.2 t80 -54.76 -37.43 65.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.786 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -73.42 -6.75 48.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.636 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -90.35 -40.52 12.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.373 -0.829 . . . . 0.0 110.071 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HB3' ' HZ ' ' A' ' 44' ' ' PHE . . . -64.63 -58.84 5.23 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.238 -0.913 . . . . 0.0 109.041 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.2 m-85 -45.67 -32.17 2.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.603 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 47.2 t60 -66.22 -30.41 70.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 76' ' ' LEU . 14.2 mt -84.8 -16.79 40.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 109.187 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 54' ' ' LEU . 13.6 mm -73.51 -57.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.48 -0.763 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -47.98 -32.39 6.45 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.444 -0.785 . . . . 0.0 109.982 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -64.64 -24.18 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.687 ' HG2' HD22 ' A' ' 49' ' ' LEU . 2.9 tppt? -91.13 -21.48 21.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.222 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 49' ' ' LEU . 5.2 mt -89.43 -67.71 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -82.19 -10.04 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.0 110.873 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.854 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.48 -7.32 10.18 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.927 -1.108 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 47.23 24.49 2.3 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HB3' ' A' ' 87' ' ' LYS . 16.2 mt -97.16 173.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.496 -1.002 . . . . 0.0 109.858 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.551 ' N ' HG22 ' A' ' 89' ' ' ILE . 25.0 m-20 -115.37 164.79 15.97 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 110.256 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 43.5 Cg_endo -70.47 153.91 65.32 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.16 1.61 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.877 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.7 Cg_endo -71.92 151.93 57.1 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.013 1.533 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.32 -59.76 2.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.166 -0.959 . . . . 0.0 110.277 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.53 ' CA ' HD21 ' A' ' 60' ' ' LEU . 30.4 m -125.87 -166.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 111.264 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.847 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -89.89 -175.81 4.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.897 0.856 . . . . 0.0 111.564 -179.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.035 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -143.07 -179.23 0.91 Allowed Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 46.6 Cg_endo -76.17 -5.77 16.59 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.332 1.175 . . . . 0.0 109.929 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 11' ' ' VAL . 20.9 mt-10 -93.66 -23.11 18.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 109.277 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.929 ' HB3' HD11 ' A' ' 76' ' ' LEU . 2.4 mtp -86.37 -36.19 19.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.992 0.901 . . . . 0.0 108.698 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.035 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mt -65.23 124.77 87.84 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.883 -0.51 . . . . 0.0 110.654 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HG2' ' NZ ' ' A' ' 64' ' ' LYS . 47.7 Cg_endo . . . . . 0 C--N 1.305 -1.732 0 O-C-N 123.931 1.49 . . . . 0.0 109.906 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.285 0.564 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -175.0 129.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 110.265 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.4 m -49.55 -40.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.96 0.886 . . . . 0.0 109.422 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.674 HG11 ' HA ' ' A' ' 76' ' ' LEU . 2.3 p -115.57 156.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 174.36 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.731 -1.231 . . . . 0.0 112.335 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' SER . 48.5 Cg_endo -67.43 -145.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.272 1.143 . . . . 0.0 110.559 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.2 -49.67 0.08 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.455 0.645 . . . . 0.0 111.588 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 4.9 mt-10 -49.13 -60.79 2.49 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.418 -0.801 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.3 tmtp? -54.24 -32.96 57.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.964 -1.085 . . . . 0.0 109.981 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.45 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 108.95 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' ILE . 6.1 ttpt -54.53 -28.93 48.89 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.579 -0.7 . . . . 0.0 109.393 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 4.2 m-30 -90.59 -52.19 5.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 110.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 20' ' ' TYR . 53.1 t0 -45.28 -33.82 2.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 25' ' ' LEU . 30.7 mm-40 -76.39 -32.54 58.61 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.334 -0.854 . . . . 0.0 108.906 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.832 HG22 ' OG1' ' A' ' 27' ' ' THR . 46.9 mt -77.77 -41.87 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.388 -0.82 . . . . 0.0 110.073 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HE1' HG12 ' A' ' 35' ' ' VAL . 59.9 t80 -48.67 -32.68 8.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.571 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.832 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.0 mt -65.52 -28.91 69.52 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -100.18 -12.71 19.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 2.6 m -89.74 -55.74 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.745 . . . . 0.0 109.372 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.534 ' HA ' HG23 ' A' ' 35' ' ' VAL . 38.3 t0 -63.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.703 -0.623 . . . . 0.0 109.361 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.7 mmtt -51.8 -17.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 111.219 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.0 m-20 -98.23 1.68 47.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 mtm 43.26 45.35 4.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.706 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 4.2 p30 -115.8 26.5 9.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 109.956 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.92 12.77 44.43 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.17 100.82 2.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -1.058 . . . . 0.0 110.111 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.0 HG21 HG22 ' A' ' 27' ' ' THR . 14.5 p -88.86 139.42 17.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.925 -1.109 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 t -95.31 151.85 18.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.067 -1.021 . . . . 0.0 110.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.71 -25.16 0.82 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 38' ' ' LEU . 3.1 mm? -67.49 -29.96 69.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.218 -1.166 . . . . 0.0 110.975 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.578 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 19.4 mt-10 -91.05 -61.7 1.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.829 -1.169 . . . . 0.0 108.306 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.614 ' HA ' HG23 ' A' ' 27' ' ' THR . 1.1 p -53.02 -18.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -42.21 -75.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.705 -0.622 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.3 mt-10 -43.23 -47.97 6.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 108.717 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR . 2.2 mt -55.44 -41.28 62.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.85 ' CE1' HD12 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -77.25 -28.27 53.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 42' ' ' GLU . 19.1 mt -73.76 -23.68 59.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -0.928 . . . . 0.0 109.003 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 49.0 mttt -81.27 -13.77 58.11 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.546 0.688 . . . . 0.0 109.489 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' ILE . 45.4 p -65.2 -54.07 35.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 0.0 109.969 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.42 14.68 7.44 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.9 mm? -93.5 153.71 41.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.479 -1.012 . . . . 0.0 110.663 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 40.7 Cg_endo -66.13 147.64 84.22 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.945 1.498 . . . . 0.0 110.623 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 52' ' ' THR . 82.3 p -44.86 -64.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.726 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.441 ' N ' ' OG ' ' A' ' 51' ' ' SER . 13.7 m -42.47 -58.09 2.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.967 . . . . 0.0 110.878 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -52.64 -50.2 63.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.026 -1.046 . . . . 0.0 110.342 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 54' ' ' LEU . 22.9 mt -57.11 -39.46 75.12 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.307 -0.87 . . . . 0.0 109.295 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.52 65.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 20.4 t60 -73.15 -29.63 63.0 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.903 HD13 HG13 ' A' ' 81' ' ' ILE . 8.8 mt -77.33 -28.51 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.662 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 48.3 t-105 -65.1 -42.93 93.54 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.811 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.67 59.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.947 HD23 HD13 ' A' ' 80' ' ' LEU . 7.0 tp -74.46 -17.04 60.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.835 ' HA ' HD22 ' A' ' 76' ' ' LEU . 22.4 p -115.16 -35.5 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.456 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 12.2 t70 -66.61 56.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 110.551 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 61' ' ' CYS . 0.7 OUTLIER -60.43 -24.01 64.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -61.09 -16.11 40.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.664 -0.648 . . . . 0.0 110.337 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.6 t0 39.84 51.19 2.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 110.325 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.88 -14.5 6.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.853 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.68 -1.32 27.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 14.1 mttt -136.33 171.23 14.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -1.222 . . . . 0.0 110.601 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.1 mt -107.5 101.4 10.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB3' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.13 -179.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.602 -1.311 . . . . 0.0 110.511 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.88 -52.47 43.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 14.8 p-10 -79.37 -15.23 58.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.904 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.58 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 42.2 mm-40 -77.51 -40.16 43.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.927 -1.108 . . . . 0.0 110.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.763 ' N ' HD22 ' A' ' 69' ' ' LEU . 17.0 t80 -63.87 -17.54 63.28 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.279 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.7 -18.56 37.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.421 -0.8 . . . . 0.0 109.034 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CG ' ' A' ' 99' ' ' MET . 9.6 tt -84.27 -21.92 30.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -75.41 -46.45 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.172 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.4 m-85 -57.28 -29.64 64.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 108.81 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 50.7 t60 -54.2 -22.59 11.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.947 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -99.67 -60.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.903 HG13 HD13 ' A' ' 57' ' ' ILE . 9.9 mt -48.33 -52.26 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.821 -0.549 . . . . 0.0 109.84 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -52.42 -40.01 61.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 88' ' ' GLY . 5.1 mt-30 -60.02 -21.2 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.588 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.85 -18.01 25.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.0 110.788 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -88.52 -38.46 14.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.092 -1.005 . . . . 0.0 111.172 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.6 mm -119.88 -14.67 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.997 . . . . 0.0 110.737 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.2 mmpt? -119.17 -2.5 10.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 110.616 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 41.34 59.36 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.803 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -126.36 132.59 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.087 -1.243 . . . . 0.0 110.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 15.6 p-10 -60.08 170.25 1.29 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' HD3' HD11 ' A' ' 53' ' ' LEU . 43.8 Cg_endo -79.32 152.08 23.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.772 1.406 . . . . 0.0 110.374 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' C ' ' CG ' ' A' ' 93' ' ' HIS . 42.8 Cg_endo -68.78 63.91 1.27 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.01 1.532 . . . . 0.0 110.38 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.59 ' CG ' ' C ' ' A' ' 92' ' ' PRO . 8.8 p-80 35.94 -109.63 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.72 -0.613 . . . . 0.0 111.099 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.645 ' C ' HD11 ' A' ' 60' ' ' LEU . 5.3 m -102.71 -165.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.93 -1.106 . . . . 0.0 111.218 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.594 ' CD2' ' HA ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -69.5 147.86 50.28 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.735 0.778 . . . . 0.0 111.414 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.945 ' O ' HD12 ' A' ' 100' ' ' ILE . 68.9 p -125.71 166.97 18.1 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.0 Cg_endo -67.32 -23.28 44.84 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.477 1.251 . . . . 0.0 109.638 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.656 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -82.21 -18.31 43.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.971 ' CG ' HD21 ' A' ' 76' ' ' LEU . 35.4 ttm -92.21 -47.1 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.72 0.771 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.945 HD12 ' O ' ' A' ' 96' ' ' THR . 1.1 mt -50.05 134.48 22.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.545 -0.722 . . . . 0.0 110.212 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.69 164.72 31.61 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.694 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.97 142.45 17.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.058 1.557 . . . . 0.0 110.215 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 110.127 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.779 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -80.45 149.15 30.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.061 -1.024 . . . . 0.0 109.36 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER -69.67 -168.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.973 -1.079 . . . . 0.0 109.78 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.605 HG12 ' C ' ' A' ' 11' ' ' VAL . 7.7 p 36.76 66.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.578 -0.701 . . . . 0.0 111.122 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.2 t -107.12 -41.62 0.14 Allowed Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 13' ' ' SER . 51.8 Cg_endo -77.13 -147.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 122.928 0.962 . . . . 0.0 111.959 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 16' ' ' GLU . . . -27.78 -59.13 0.11 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -37.77 -54.76 1.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.0 110.49 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -53.62 -42.93 68.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 109.797 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.76 -46.59 84.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.742 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -56.37 -29.18 61.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.524 -0.735 . . . . 0.0 109.971 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 13.3 m-85 -89.46 -52.38 5.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.429 -0.795 . . . . 0.0 110.05 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 5.5 t70 -44.53 -31.23 1.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.8 mt-10 -80.13 -34.75 37.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 26' ' ' LYS . 39.5 mt -78.91 -37.22 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.482 -0.761 . . . . 0.0 110.285 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 52.6 t80 -48.85 -30.6 5.99 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.651 -1.22 . . . . 0.0 108.356 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.4 mt -67.76 -25.76 65.78 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -98.74 -13.74 20.07 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.081 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.25 -55.47 3.66 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.729 0.776 . . . . 0.0 109.23 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 59.1 t0 -72.48 68.27 0.78 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 3.5 mttm -55.98 -13.82 2.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.493 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -96.6 13.83 26.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.563 -1.335 . . . . 0.0 110.96 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.4 mtm 43.16 26.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 34.4 p30 -98.56 22.37 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 56.49 19.85 28.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.46 105.46 3.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -1.146 . . . . 0.0 110.754 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.957 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -89.0 130.01 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.865 -1.147 . . . . 0.0 109.018 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.637 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -87.15 152.66 22.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.092 -1.005 . . . . 0.0 109.808 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.74 -22.68 0.79 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 38' ' ' LEU . 2.9 mm? -65.34 -37.32 86.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 111.263 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 35' ' ' VAL . 15.1 mt-10 -86.45 -62.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.861 -1.149 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -50.83 -20.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.623 0.725 . . . . 0.0 109.491 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -44.92 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 110.645 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.6 mt-10 -44.04 -38.37 3.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.23 -0.919 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -58.61 -42.56 85.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 110.265 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.9 m-85 -80.95 -29.65 35.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.163 -0.961 . . . . 0.0 110.166 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.9 HD12 ' HA ' ' A' ' 42' ' ' GLU . 17.0 mt -65.85 -15.38 62.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.989 -1.069 . . . . 0.0 109.386 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 59.8 mttt -82.86 -13.51 56.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.502 ' O ' HD13 ' A' ' 49' ' ' LEU . 82.8 p -63.04 -10.86 15.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.75 . . . . 0.0 110.793 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.33 69.39 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 107.734 -2.146 . . . . 0.0 107.734 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.733 HD23 ' CD2' ' A' ' 53' ' ' LEU . 4.4 mp -100.51 173.11 3.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.866 -0.785 . . . . 0.0 110.679 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.673 ' HD2' HD22 ' A' ' 53' ' ' LEU . 40.7 Cg_endo -67.86 -153.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.217 1.64 . . . . 0.0 109.711 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.5 t -104.58 -65.11 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.216 . . . . 0.0 111.484 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -54.12 -38.1 65.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.082 -1.011 . . . . 0.0 111.284 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -47.62 -53.21 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.089 -1.007 . . . . 0.0 111.399 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 53' ' ' LEU . 2.5 mm? -62.54 -46.37 88.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.021 -1.05 . . . . 0.0 109.35 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.94 81.95 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' THR . 28.5 t60 -72.41 -29.32 63.62 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.718 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 6.9 mt -76.65 -22.46 15.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.598 ' HZ3' HG11 ' A' ' 40' ' ' VAL . 48.1 t-105 -65.32 -45.06 85.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 108.9 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -31.63 64.36 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.399 -0.813 . . . . 0.0 109.119 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.062 HD23 HD13 ' A' ' 80' ' ' LEU . 5.8 tp -71.39 -22.1 61.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.76 . . . . 0.0 109.259 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.776 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 15.9 p -105.13 -30.77 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 49.6 t0 -74.71 54.32 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.569 -0.707 . . . . 0.0 110.852 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.744 ' CG2' HD22 ' A' ' 95' ' ' LEU . 5.4 p -54.83 -34.32 62.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.076 -1.015 . . . . 0.0 109.077 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 7.6 mptt -56.5 -17.09 7.17 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.604 -0.685 . . . . 0.0 110.219 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 48.2 m-20 41.94 54.65 3.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.766 . . . . 0.0 110.155 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 41.4 t -119.99 8.6 11.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.16 -16.76 50.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 25.3 mttt -123.9 179.2 4.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 110.157 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -111.76 118.17 34.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.008 . . . . 0.0 110.713 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -75.34 175.46 8.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.952 -1.093 . . . . 0.0 109.369 179.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.51 -84.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 110.431 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 71' ' ' LYS . 3.6 m-20 -42.12 -38.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 110.849 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.519 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 46.4 mm-40 -60.8 -60.08 4.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.056 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 27' ' ' THR . 28.5 t80 -51.14 -33.16 25.51 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -77.63 -10.52 59.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.011 HD21 ' CG ' ' A' ' 99' ' ' MET . 5.6 tt -90.54 -35.34 15.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.434 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -58.91 -37.94 77.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.746 -1.221 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.676 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 29.0 m-85 -64.09 -35.31 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.522 -0.736 . . . . 0.0 109.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 79.1 t60 -51.36 -23.11 3.38 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.366 -0.834 . . . . 0.0 108.835 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.062 HD13 HD23 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -95.91 -22.72 17.25 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 57' ' ' ILE . 8.3 mm -75.04 -54.13 14.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -37.54 10.92 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.593 -0.692 . . . . 0.0 110.389 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' ILE . 3.8 mt-30 -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 109.97 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -90.95 -20.95 21.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 0.0 110.313 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 5.5 mt -90.45 -59.78 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 111.439 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.7 mm -92.88 -6.02 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.02 . . . . 0.0 111.626 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.97 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -125.88 -19.46 4.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.625 -1.297 . . . . 0.0 110.712 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.05 3.4 64.53 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.97 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.8 mt -81.95 160.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.293 -1.122 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 11.6 p-10 -102.81 166.34 12.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 109.841 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 41.2 Cg_endo -68.0 145.86 69.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.679 1.358 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.705 ' O ' HD21 ' A' ' 60' ' ' LEU . 40.8 Cg_endo -68.6 127.88 16.24 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.037 1.546 . . . . 0.0 109.935 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.502 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -28.14 -67.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.137 0.494 . . . . 0.0 111.513 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.647 ' C ' HD11 ' A' ' 60' ' ' LEU . 10.7 m -115.36 -165.61 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.965 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -93.74 163.42 13.54 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.044 ' O ' HD12 ' A' ' 100' ' ' ILE . 70.6 p -122.55 169.06 10.37 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.8 Cg_endo -67.38 -15.02 44.61 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.343 1.18 . . . . 0.0 109.62 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 mp0 -88.42 -16.5 32.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 108.854 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.011 ' CG ' HD21 ' A' ' 76' ' ' LEU . 31.4 ttm -96.98 -31.61 12.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.044 HD12 ' O ' ' A' ' 96' ' ' THR . 2.5 mt -72.08 139.0 82.01 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.609 -0.682 . . . . 0.0 110.375 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.512 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 45.6 Cg_endo -73.83 175.33 10.92 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.384 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 44.7 Cg_endo -71.91 -160.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 102' ' ' PRO . 24.5 t . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 9' ' ' THR . 3.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -51.55 163.53 0.28 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.138 -0.976 . . . . 0.0 110.081 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 98' ' ' GLU . 0.9 OUTLIER -83.13 -167.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.011 -1.055 . . . . 0.0 109.816 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.719 HG21 ' O ' ' A' ' 75' ' ' ALA . 7.7 p 31.27 99.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.565 0.697 . . . . 0.0 111.209 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.621 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.25 -62.18 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.869 -1.144 . . . . 0.0 113.509 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 13' ' ' SER . 40.6 Cg_endo -61.98 -143.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 O-C-N 122.936 0.966 . . . . 0.0 111.818 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.65 -60.74 0.1 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.735 -0.603 . . . . 0.0 112.552 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 23.0 mt-10 -37.49 -60.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.57 -0.706 . . . . 0.0 111.145 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 13' ' ' SER . 1.8 tmtt? -54.65 -34.4 62.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.99 -1.069 . . . . 0.0 110.1 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.86 -46.89 70.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.6 ttpt -57.26 -30.43 64.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.646 -0.659 . . . . 0.0 110.197 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.1 m-85 -84.77 -50.01 7.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.8 t70 -50.31 -32.6 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 0.0 109.597 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.7 mm-40 -78.96 -35.01 43.81 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.203 -0.935 . . . . 0.0 108.974 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.85 HG22 ' OG1' ' A' ' 27' ' ' THR . 62.9 mt -77.74 -41.06 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.775 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.629 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 49.2 t80 -48.55 -26.57 2.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.042 -1.036 . . . . 0.0 108.809 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 17.6 mt -76.88 -28.62 55.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -98.53 -9.06 25.52 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.017 HG23 HD12 ' A' ' 43' ' ' ILE . 3.1 m -90.9 -57.24 2.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.236 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.3 80.39 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.664 -0.647 . . . . 0.0 109.708 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 1.1 mttt -78.48 12.32 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 111.798 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 68.4 m-20 -109.31 12.31 24.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.823 -1.173 . . . . 0.0 110.411 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER 42.68 34.85 0.61 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.173 -0.954 . . . . 0.0 110.21 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 26.5 p30 -111.21 4.09 18.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.168 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 13.67 70.13 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -147.77 105.47 3.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -1.047 . . . . 0.0 110.323 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.992 HG21 HG22 ' A' ' 27' ' ' THR . 9.6 p -89.78 135.65 25.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 108.696 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.635 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -103.83 176.22 5.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.901 -1.124 . . . . 0.0 111.096 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -69.3 54.66 0.62 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 37' ' ' GLY . 26.2 mt -139.93 -41.08 0.44 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 12.4 mt-10 -91.08 -61.67 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 36' ' ' SER . 1.1 p -51.71 -22.82 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 1.2 ptt180 -47.36 -54.4 11.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.615 -0.678 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.735 ' HA ' HD12 ' A' ' 45' ' ' LEU . 3.0 tt0 -60.85 -43.11 98.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.238 . . . . 0.0 107.753 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.017 HD12 HG23 ' A' ' 27' ' ' THR 0.256 1.1 mt -54.13 -40.79 48.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.87 -46.17 31.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.583 -0.698 . . . . 0.0 109.386 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.735 HD12 ' HA ' ' A' ' 42' ' ' GLU . 13.5 mt -50.83 -24.11 3.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 108.967 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 44.3 mttm -73.3 -16.33 61.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.204 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 44' ' ' PHE . 58.9 p -70.07 -19.54 63.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.409 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.14 26.94 67.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 85' ' ' LEU . 6.5 mp -96.08 164.59 18.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.713 -0.875 . . . . 0.0 110.428 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.742 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.9 Cg_endo -74.05 172.87 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.976 1.514 . . . . 0.0 110.476 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 t -66.84 -67.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.612 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' LEU . 26.0 m -43.01 -62.59 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -0.86 . . . . 0.0 111.165 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.742 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -42.51 -55.68 3.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.182 -0.949 . . . . 0.0 110.936 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' A' ' 49' ' ' LEU . 94.9 mt -52.87 -35.58 57.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.637 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -76.95 -33.77 57.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 108.739 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.435 ' NE2' HD11 ' A' ' 60' ' ' LEU . 69.3 t60 -73.7 -34.12 64.71 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -72.85 -19.87 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 57.6 t-105 -70.83 -44.56 66.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.471 -0.768 . . . . 0.0 109.948 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -70.34 -28.38 65.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.06 179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 93' ' ' HIS . 45.4 mt -73.98 -12.68 60.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 17.1 p -116.06 -31.9 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.138 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 19.7 t0 -84.33 54.79 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.73 ' CG2' HD22 ' A' ' 95' ' ' LEU . 16.6 p -50.73 -31.66 17.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 70' ' ' SER . 9.1 mmtt -49.97 -21.09 1.08 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.425 0.631 . . . . 0.0 110.167 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 45.66 51.92 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.842 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.7 -5.09 7.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.29 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.97 58.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 11.4 mttm -116.4 -178.12 3.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -1.188 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.775 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -118.47 99.2 6.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.458 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.572 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.85 -171.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 110.296 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -66.32 -81.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.056 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -49.49 -20.92 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 110.722 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.557 ' HG3' ' HG3' ' A' ' 64' ' ' LYS . 4.6 mm100 -72.98 -49.63 27.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.775 ' N ' HD22 ' A' ' 69' ' ' LEU . 9.5 t80 -61.21 -26.52 67.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.026 . . . . 0.0 109.467 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.719 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.39 -13.85 59.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.591 -0.693 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.861 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.8 tt -90.61 -28.74 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 110.759 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.59 -51.61 64.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 110.052 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 81' ' ' ILE . 13.5 m-85 -51.38 -34.02 32.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 109.795 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 82.4 t60 -57.51 -20.94 34.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.324 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 2.7 mt -99.42 -31.61 11.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.226 -0.922 . . . . 0.0 109.16 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CE1' ' A' ' 44' ' ' PHE . 68.2 mt -63.18 -58.29 8.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.503 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.2 -37.03 1.96 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.596 -0.69 . . . . 0.0 110.785 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -58.78 -30.95 67.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.929 -1.107 . . . . 0.0 110.555 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -90.47 -21.76 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.793 -1.192 . . . . 0.0 111.023 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.777 HD11 HG22 ' A' ' 81' ' ' ILE . 5.0 mt -86.73 -47.49 9.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.999 -1.063 . . . . 0.0 111.496 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.1 mm -110.97 -10.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.917 -1.114 . . . . 0.0 111.194 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -118.3 -10.28 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.797 -1.189 . . . . 0.0 110.459 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 62.47 11.87 36.84 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.1 mt -90.6 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.253 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' ' 89' ' ' ILE . 1.4 m-20 -114.7 162.73 22.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 43.1 Cg_endo -68.03 158.58 56.79 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.982 1.517 . . . . 0.0 110.315 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.1 Cg_endo -72.04 178.66 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.867 1.456 . . . . 0.0 110.157 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -64.08 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.1 -1.0 . . . . 0.0 109.67 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' HD21 ' A' ' 60' ' ' LEU . 13.5 m -117.74 -165.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CG2' ' A' ' 63' ' ' THR . 11.7 mt -77.18 152.33 34.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.834 0.826 . . . . 0.0 111.687 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.013 ' O ' HD12 ' A' ' 100' ' ' ILE . 45.1 p -123.7 169.95 9.41 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.5 Cg_endo -66.06 -26.31 50.68 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.297 1.157 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.964 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.1 mt-10 -79.34 -6.97 57.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 108.924 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.861 ' CG ' HD21 ' A' ' 76' ' ' LEU . 33.6 ttm -107.6 -32.66 7.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.013 HD12 ' O ' ' A' ' 96' ' ' THR . 2.4 mt -69.6 111.83 10.14 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.627 -0.67 . . . . 0.0 109.705 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.639 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 43.9 Cg_endo -75.03 -29.07 8.57 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.03 1.542 . . . . 0.0 114.108 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 43.9 Cg_endo -70.17 93.38 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 122.466 0.719 . . . . 0.0 110.673 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.678 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.548 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -169.16 152.93 5.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 110.163 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.975 HG23 HG12 ' A' ' 12' ' ' VAL . 1.1 m -80.1 -158.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.239 -0.913 . . . . 0.0 111.108 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 11' ' ' VAL . 3.4 p 21.48 80.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-O 121.296 0.57 . . . . 0.0 112.166 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.546 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -109.45 -40.57 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 113.398 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 13' ' ' SER . 55.4 Cg_endo -80.05 -152.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 122.836 0.914 . . . . 0.0 112.35 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -27.94 -54.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.641 ' HB3' HG23 ' A' ' 12' ' ' VAL . 40.1 mt-10 -37.98 -60.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.679 -0.638 . . . . 0.0 110.572 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.541 ' HG3' ' CZ2' ' A' ' 10' ' ' TRP . 7.3 tmtt? -55.95 -36.75 68.15 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.633 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -67.07 -48.82 67.08 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.702 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -55.33 -30.96 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.449 -0.782 . . . . 0.0 109.561 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.8 m-85 -85.37 -38.06 19.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.62 -35.6 74.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.458 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 25' ' ' LEU . 31.4 mt-10 -75.9 -40.96 53.37 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.693 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.2 mt -69.25 -38.1 77.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.519 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 47.5 t80 -46.78 -31.32 2.93 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.491 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.7 mt -70.2 -32.0 69.71 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 23' ' ' ILE . 11.9 mtmt -89.73 -15.91 31.49 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.999 HG22 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -89.53 -51.86 5.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.428 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 20.7 t0 -71.4 56.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 97.6 mttt -44.57 -23.78 0.14 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.91 . . . . 0.0 111.618 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 7.6 m-20 -89.58 1.13 56.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.134 . . . . 0.0 110.571 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt 47.16 53.76 10.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.484 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 3.0 p30 -125.42 23.28 7.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.943 . . . . 0.0 109.951 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 64.9 12.09 52.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -151.02 108.44 3.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.238 . . . . 0.0 111.381 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 27' ' ' THR . 2.0 p -92.98 134.16 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.065 -1.022 . . . . 0.0 109.081 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.748 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.5 t -87.32 153.67 21.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -45.91 -26.18 1.91 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.38 -41.99 99.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.43 -1.041 . . . . 0.0 111.636 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.8 mt-10 -81.24 -61.76 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 108.887 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -52.56 -20.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.533 0.683 . . . . 0.0 109.436 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -46.81 -73.15 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.2 -42.38 4.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -58.81 -44.86 91.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.2 m-85 -80.45 -31.58 37.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.61 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 42' ' ' GLU . 57.9 mt -60.9 -16.78 45.73 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.0 109.357 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 25.5 mttt -80.17 -22.44 41.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.194 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 44' ' ' PHE . 33.2 p -56.37 -25.39 49.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 110.472 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.95 83.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.602 ' CD2' HG23 ' A' ' 81' ' ' ILE . 3.1 mp -88.91 160.6 43.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.966 . . . . 0.0 110.436 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 40.8 Cg_endo -67.83 132.39 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.953 1.502 . . . . 0.0 110.226 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -39.33 -54.72 1.83 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.723 . . . . 0.0 110.862 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -47.98 -52.17 20.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 110.277 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.598 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -55.77 -51.54 67.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.853 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 44' ' ' PHE . 53.8 mt -58.92 -40.14 83.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -45.75 69.08 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.443 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 41.4 t60 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 81' ' ' ILE . 3.1 mt -80.37 -27.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.653 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 22.9 t-105 -68.61 -47.98 65.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 108.968 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -61.48 -28.67 69.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.981 HD23 HD13 ' A' ' 80' ' ' LEU . 1.6 tp -67.61 -47.5 69.48 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 17.6 p -80.97 -35.02 32.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.012 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 39.2 t0 -65.5 59.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.501 -0.749 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.1 p -64.61 -30.34 71.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 1.4 mptp? -66.14 -10.78 44.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 t70 42.43 54.87 4.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 m -120.66 4.82 10.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.35 -10.93 69.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -120.91 -170.8 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.28 -1.129 . . . . 0.0 109.949 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.741 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -122.55 109.47 14.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.988 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -61.7 -178.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 109.459 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.1 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.45 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.3 m-20 -46.14 -25.5 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 110.277 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 64' ' ' LYS . 9.5 mt-30 -68.75 -57.04 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.878 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.855 ' CE2' HG21 ' A' ' 27' ' ' THR . 17.3 t80 -52.57 -21.42 3.84 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.347 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -85.85 -10.08 55.95 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.19 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.6 tp -91.33 -43.61 9.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.481 -0.762 . . . . 0.0 110.324 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.06 -31.4 67.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.998 -1.064 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE1' ' CZ ' ' A' ' 44' ' ' PHE . 20.0 m-85 -72.39 -35.26 68.4 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.225 -0.922 . . . . 0.0 108.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 73.5 t60 -53.44 -23.85 11.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.121 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.981 HD13 HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -93.19 -42.2 9.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.659 HG22 HD11 ' A' ' 85' ' ' LEU . 1.2 mm -55.28 -56.41 11.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.581 -0.699 . . . . 0.0 109.307 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -46.73 6.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 110.585 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.9 mt-30 -55.38 -24.61 30.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.974 -1.078 . . . . 0.0 110.007 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -90.22 -18.59 25.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.695 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.659 HD11 HG22 ' A' ' 81' ' ' ILE . 5.4 mt -90.73 -47.01 7.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.49 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.6 -18.86 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.932 -1.105 . . . . 0.0 111.232 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.022 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -109.72 -17.35 13.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.934 -1.104 . . . . 0.0 110.645 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 69.74 11.84 66.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -93.22 141.86 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.337 -1.096 . . . . 0.0 110.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.587 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -81.78 -172.0 0.33 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 0.0 108.79 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 90' ' ' ASP . 43.4 Cg_endo -78.33 158.93 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.415 1.219 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.7 Cg_endo -72.9 47.01 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.879 1.463 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 19.1 m170 55.89 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.272 -0.893 . . . . 0.0 111.003 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 92' ' ' PRO . 4.5 m -117.23 -161.75 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 110.58 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.76 164.23 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.114 0.959 . . . . 0.0 111.175 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.857 ' O ' HD12 ' A' ' 100' ' ' ILE . 1.5 p -127.96 -177.83 0.69 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.1 Cg_endo -75.05 -5.17 16.44 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.253 1.133 . . . . 0.0 109.667 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 11.5 mt-10 -96.07 -18.33 20.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.855 0.836 . . . . 0.0 109.113 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.735 ' SD ' HG23 ' A' ' 96' ' ' THR . 4.0 mtp -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.855 0.836 . . . . 0.0 108.897 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 96' ' ' THR . 2.0 mt -61.0 128.65 89.55 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.887 -0.508 . . . . 0.0 109.743 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.12 141.03 42.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.833 1.438 . . . . 0.0 110.635 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 103' ' ' SER . 47.2 Cg_endo -76.21 -90.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.127 1.593 . . . . 0.0 110.471 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 102' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.404 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.153 0.502 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CZ3' ' HG3' ' A' ' 17' ' ' LYS . 5.1 t90 -76.41 128.96 35.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.8 m -57.62 -19.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.252 -0.905 . . . . 0.0 109.888 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG23 ' HB3' ' A' ' 16' ' ' GLU . 1.4 p -143.33 70.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.503 -0.748 . . . . 0.0 110.182 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -104.89 -31.96 0.2 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.192 -0.943 . . . . 0.0 113.49 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 13' ' ' SER . 53.2 Cg_endo -75.09 -150.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 122.575 0.776 . . . . 0.0 110.788 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.9 -46.57 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.803 -0.561 . . . . 0.0 111.903 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.924 ' HB3' HG23 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -51.79 -59.55 4.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.592 ' HG3' ' CZ3' ' A' ' 10' ' ' TRP . 9.1 tmtt? -52.16 -40.85 62.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 109.816 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -30.22 60.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 109.682 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 18.6 m-85 -88.59 -41.66 12.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.422 -0.799 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD2' ' NZ ' ' A' ' 17' ' ' LYS . 8.6 t70 -50.59 -39.79 50.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.252 -0.905 . . . . 0.0 109.178 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.42 -47.2 64.87 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' LYS . 20.3 mt -63.65 -39.26 84.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.432 -0.792 . . . . 0.0 109.413 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 71' ' ' LYS . 66.7 t80 -49.24 -24.62 1.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.73 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.29 -26.07 60.92 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 1.8 tttt -97.95 -15.44 20.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.001 HG22 HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.83 -55.77 3.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 20.9 t0 -69.57 58.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 0.3 OUTLIER -36.72 -46.0 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.521 -0.737 . . . . 0.0 112.729 -178.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' MET . 5.1 p-10 -94.52 15.6 17.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.617 -1.302 . . . . 0.0 111.994 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 30' ' ' ASP . 9.5 mtm 35.08 56.04 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.481 -0.762 . . . . 0.0 111.271 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 13.6 p30 -101.49 4.38 41.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 110.241 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.14 -33.22 4.96 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 1.3 p90 -146.76 146.46 30.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -1.094 . . . . 0.0 110.74 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.001 HG21 HG22 ' A' ' 27' ' ' THR . 1.3 p -90.45 127.99 42.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.699 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -74.7 151.82 39.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.599 -1.313 . . . . 0.0 109.588 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -45.5 -23.88 0.95 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 36' ' ' SER . 26.3 mt -61.56 -46.39 90.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.755 -0.85 . . . . 0.0 111.805 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.828 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.3 mt-10 -80.39 -57.17 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.455 -1.403 . . . . 0.0 109.171 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -56.88 -20.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.848 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -43.16 -75.97 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 110.152 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.807 ' HA ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp0 -42.78 -46.47 5.2 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.761 0.791 . . . . 0.0 109.021 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -52.27 -37.82 23.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -80.99 -43.78 19.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.785 . . . . 0.0 109.145 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 42' ' ' GLU . 14.0 mt -52.65 -23.76 7.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 24.4 mtpt -78.55 -5.64 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.695 . . . . 0.0 109.817 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 44' ' ' PHE . 43.5 p -76.76 -7.99 56.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.866 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.93 15.65 79.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.721 ' HB3' HD13 ' A' ' 54' ' ' LEU . 9.4 mp -88.21 165.26 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.996 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.763 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.2 Cg_endo -74.93 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.983 1.517 . . . . 0.0 109.225 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.99 -73.38 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.949 -1.094 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 53' ' ' LEU . 1.3 m -41.42 -58.0 2.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 111.088 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -40.86 -50.34 3.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.145 -0.972 . . . . 0.0 110.843 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -57.22 -41.61 79.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.862 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.21 92.85 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.829 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.428 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 82.0 t60 -64.36 -40.11 95.2 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD11 ' HE2' ' A' ' 84' ' ' LYS . 2.4 mt -69.0 -31.28 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.352 -0.842 . . . . 0.0 108.827 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.85 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 53.9 t-105 -63.19 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.544 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -74.84 -25.61 59.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.818 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -74.78 -25.53 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.825 . . . . 0.0 109.317 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 29.8 p -100.78 -32.74 10.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 108.692 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.616 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 53.2 t0 -72.52 61.0 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.716 -0.615 . . . . 0.0 109.899 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 1.5 p -51.65 -34.95 40.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -60.51 -13.7 15.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.459 -0.775 . . . . 0.0 110.053 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 40.75 56.32 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.516 -0.74 . . . . 0.0 110.293 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 7.58 3.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.85 75.2 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.689 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -127.55 170.12 12.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.323 -1.104 . . . . 0.0 109.987 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.85 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 1.1 mt -118.2 98.58 6.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.082 -1.011 . . . . 0.0 110.512 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 1.2 p -46.18 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.333 -0.855 . . . . 0.0 109.407 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.54 -56.98 10.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.504 -1.373 . . . . 0.0 109.628 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -64.25 -49.0 73.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 110.704 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.616 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 26.0 mt-30 -44.45 -42.98 7.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 111.184 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.931 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.2 t80 -55.02 -44.93 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.15 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -68.6 -9.49 50.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.988 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 76' ' ' LEU . 2.8 tt -90.81 -35.29 14.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 111.219 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.64 -46.09 87.87 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 17.6 m-85 -56.74 -37.34 70.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.996 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 49.3 t60 -49.39 -21.66 0.94 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.07 -1.019 . . . . 0.0 109.65 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.8 mt -98.29 -24.6 15.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.807 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.949 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 18.3 mt -74.51 -58.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -30.44 7.62 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.603 -0.686 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -69.12 -21.98 63.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.968 ' HE2' HD11 ' A' ' 57' ' ' ILE . 9.3 mttm -90.99 -25.74 19.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.316 -0.865 . . . . 0.0 110.249 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' HD23 ' A' ' 85' ' ' LEU . 5.1 mt -86.39 -65.49 1.01 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mm -84.64 -6.08 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.001 . . . . 0.0 110.703 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.975 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mmtt -126.68 -28.89 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.933 -1.104 . . . . 0.0 110.491 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 68.55 18.79 72.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.975 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.7 mt -89.31 141.22 14.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.276 -1.132 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.27 167.51 33.84 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.558 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD3' ' HE3' ' A' ' 84' ' ' LYS . 44.4 Cg_endo -75.25 146.68 32.06 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.184 1.623 . . . . 0.0 110.574 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.745 ' O ' HD21 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -72.25 102.0 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.989 1.52 . . . . 0.0 110.289 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.578 ' C ' ' O ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -5.07 -70.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.586 ' CA ' HD11 ' A' ' 60' ' ' LEU . 4.5 m -122.13 -173.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.086 -1.009 . . . . 0.0 110.977 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -84.33 170.78 13.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 111.815 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.664 HG23 ' SD ' ' A' ' 99' ' ' MET . 1.3 p -135.03 177.26 2.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.0 Cg_endo -70.99 -12.62 30.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.324 1.17 . . . . 0.0 110.2 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.595 ' O ' HG13 ' A' ' 11' ' ' VAL . 81.7 mt-10 -87.38 -18.34 30.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 108.711 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.822 ' HB2' HD23 ' A' ' 95' ' ' LEU . 4.4 mtp -90.12 -43.19 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.719 0.771 . . . . 0.0 109.073 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' THR . 1.3 mt -53.34 137.16 50.23 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.772 -0.58 . . . . 0.0 109.98 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.26 113.07 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.082 1.57 . . . . 0.0 110.75 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.63 168.57 24.44 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.46 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 179.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 98' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.833 0.825 . . . . 0.0 111.223 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.544 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.9 t90 -150.5 136.95 18.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.35 0.595 . . . . 0.0 109.732 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 98' ' ' GLU . 3.1 m -69.01 -36.69 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.773 . . . . 0.0 110.493 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.692 HG23 ' CG2' ' A' ' 11' ' ' VAL . 2.3 t -97.44 161.43 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.551 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 170.96 -54.61 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.354 -0.841 . . . . 0.0 111.156 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.4 Cg_endo -71.83 -153.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.716 1.377 . . . . 0.0 110.45 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.89 -56.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.448 0.642 . . . . 0.0 111.408 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -39.42 -64.57 0.46 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.664 -0.648 . . . . 0.0 110.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 8.0 tmtm? -50.91 -44.27 60.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -44.84 89.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -61.67 -26.85 68.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.434 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.612 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 11.5 m-85 -90.47 -51.09 5.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.623 -0.673 . . . . 0.0 109.978 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -45.62 -36.84 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.632 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 25' ' ' LEU . 71.5 mt-10 -74.66 -40.29 61.54 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.692 HG22 ' OG1' ' A' ' 27' ' ' THR . 36.5 mt -70.09 -35.18 62.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.842 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 73.3 t80 -48.82 -38.93 23.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.739 -1.225 . . . . 0.0 108.04 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 22' ' ' GLU . 8.3 mt -62.79 -26.67 68.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.15 -13.72 20.77 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.04 HG22 HG21 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -89.2 -55.47 3.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 34' ' ' PHE . 21.5 t0 -63.29 73.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 65.9 mmtt -52.45 -19.79 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.303 -0.873 . . . . 0.0 111.22 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -97.0 3.15 52.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 110.793 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.76 27.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 34' ' ' PHE . 7.6 p-10 -92.92 11.5 27.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.125 -0.984 . . . . 0.0 110.194 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.34 5.45 89.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 70' ' ' SER . 1.9 m-85 -147.26 109.3 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 0.0 110.316 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.04 HG21 HG22 ' A' ' 27' ' ' THR . 4.2 p -88.86 126.59 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.49 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -81.82 148.63 28.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 110.136 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.19 -26.44 0.54 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.85 -32.68 74.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.489 -1.007 . . . . 0.0 110.857 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.9 mt-10 -85.98 -58.79 2.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.774 -1.204 . . . . 0.0 108.927 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.544 HG11 ' HZ3' ' A' ' 58' ' ' TRP . 1.5 p -58.54 -13.84 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.503 0.668 . . . . 0.0 109.815 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.678 ' HG3' HD11 ' A' ' 45' ' ' LEU . 10.6 ttm180 -50.93 -70.27 0.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.638 -0.664 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -45.0 -44.17 9.72 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.024 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -59.13 -41.27 83.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.881 ' CE2' HD11 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.29 -19.94 52.57 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.592 -0.692 . . . . 0.0 109.211 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 42' ' ' GLU . 12.9 mt -76.42 -29.8 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.149 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 19.3 mttm -73.76 -9.61 58.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.507 -0.746 . . . . 0.0 109.655 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.711 ' OG1' HD23 ' A' ' 49' ' ' LEU . 72.3 p -64.85 -51.53 61.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.76 21.01 5.87 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.711 HD23 ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.63 172.94 7.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.941 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.767 ' HD2' HD22 ' A' ' 53' ' ' LEU . 39.2 Cg_endo -66.16 -93.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.777 1.409 . . . . 0.0 110.596 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -158.66 -73.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.863 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -59.66 -29.73 68.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.767 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.1 tp -51.18 -60.1 3.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.66 HD13 HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -52.6 -35.12 53.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 108.974 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' THR . . . -68.6 -38.47 80.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 21.7 t60 -68.84 -35.12 76.56 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 mt -69.84 -23.03 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 48.3 t-105 -65.66 -46.28 79.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.483 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.479 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -68.57 -29.59 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.567 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 94' ' ' VAL . 1.2 mp -74.89 -18.45 60.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.904 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 14.0 p -108.22 -30.04 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.179 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 63' ' ' THR . 67.0 t0 -78.64 49.02 0.84 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.572 -0.705 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 2.4 p -46.99 -29.18 1.93 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -55.01 -19.42 6.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.302 0.573 . . . . 0.0 109.605 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' LYS . 24.9 m-20 38.85 55.27 2.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.579 -0.7 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.4 t -128.54 -30.4 2.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.97 0.99 4.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -142.51 170.62 15.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.174 -1.192 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 74' ' ' PHE . 1.6 mt -104.15 104.07 13.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.421 -0.799 . . . . 0.0 110.094 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.08 -168.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 110.004 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.618 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.45 -67.98 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.722 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.52 -21.42 65.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.844 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 12.2 mm100 -69.29 -56.0 8.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.873 -1.142 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.86 ' N ' HD22 ' A' ' 69' ' ' LEU . 29.6 t80 -51.56 -22.0 2.93 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.226 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.24 -13.12 55.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.133 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.68 HD21 ' CG ' ' A' ' 99' ' ' MET . 2.2 tp -90.03 -42.98 10.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.904 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.81 -49.12 74.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.064 -1.022 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 1.2 m-85 -50.2 -36.42 30.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.965 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HB2' HG22 ' A' ' 12' ' ' VAL . 59.2 t60 -56.69 -30.49 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.504 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.577 HD22 ' CD ' ' A' ' 92' ' ' PRO . 8.3 mt -87.1 -24.01 24.7 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 44' ' ' PHE . 3.0 mm -76.65 -62.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -51.12 -26.03 6.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 110.342 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.533 ' OE1' HG21 ' A' ' 89' ' ' ILE . 3.4 mt-30 -64.85 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 110.446 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.25 -12.41 38.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 111.109 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 7.0 mt -87.19 -47.71 8.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 86' ' ' ILE . 3.9 mm -111.48 -25.71 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.038 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.1 mmpt? -104.33 -2.59 25.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 0.0 110.643 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 45.54 35.02 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.038 HD12 ' HB3' ' A' ' 87' ' ' LYS . 7.5 mt -106.31 130.42 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.154 -1.203 . . . . 0.0 110.089 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.4 p-10 -70.95 -175.79 0.33 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.291 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 43.0 Cg_endo -81.72 155.39 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.641 1.338 . . . . 0.0 110.044 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.577 ' CD ' HD22 ' A' ' 80' ' ' LEU . 43.4 Cg_endo -70.56 56.31 1.72 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.032 1.543 . . . . 0.0 110.598 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 1.3 m-70 42.58 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.497 -0.752 . . . . 0.0 110.793 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.7 ' HA ' HD11 ' A' ' 60' ' ' LEU . 6.0 m -104.56 -169.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.667 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 60' ' ' LEU . 4.3 mm? -74.0 162.12 29.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.999 ' O ' HD12 ' A' ' 100' ' ' ILE . 43.6 p -138.57 165.21 34.47 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.0 Cg_endo -65.98 -41.18 14.19 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.555 1.292 . . . . 0.0 108.752 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.3 tt0 -67.55 -7.37 25.49 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.641 -0.662 . . . . 0.0 109.438 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.68 ' CG ' HD21 ' A' ' 76' ' ' LEU . 13.7 ttm -111.56 -26.84 8.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.77 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 96' ' ' THR . 3.3 mt -78.0 116.76 61.27 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.432 -0.793 . . . . 0.0 110.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.536 ' CG ' ' OE1' ' A' ' 73' ' ' GLN . 47.5 Cg_endo -82.19 118.18 2.94 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.896 1.472 . . . . 0.0 110.201 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 103' ' ' SER . 48.6 Cg_endo -80.65 -70.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.905 1.476 . . . . 0.0 111.163 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 102' ' ' PRO . 1.4 t . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.34 -0.85 . . . . 0.0 110.82 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.13 0.49 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.568 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 1.4 p-90 -51.37 136.17 25.77 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.354 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' CG2' HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -55.55 -173.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.314 -0.866 . . . . 0.0 109.892 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.876 HG21 ' O ' ' A' ' 75' ' ' ALA . 14.9 p 33.41 100.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 111.525 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.96 -68.47 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 112.107 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 40.3 Cg_endo -62.87 -141.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.392 1.207 . . . . 0.0 112.354 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.6 -57.41 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.685 -0.634 . . . . 0.0 112.351 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' A' ' 12' ' ' VAL . 17.6 mt-10 -40.59 -63.45 0.64 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.426 -0.796 . . . . 0.0 110.599 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -57.81 -30.95 66.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.121 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.19 -44.57 45.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.572 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -61.17 -28.27 69.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 109.604 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.0 m-85 -87.01 -53.1 5.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.856 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -46.8 -28.74 1.65 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.002 . . . . 0.0 108.96 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -80.74 -42.58 21.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' LYS . 30.7 mt -71.38 -33.89 51.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ILE . 48.8 t80 -48.62 -33.03 9.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.468 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.4 -24.74 67.29 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 23' ' ' ILE . 35.0 mtpt -100.76 -12.89 18.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.474 -0.766 . . . . 0.0 108.969 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.995 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.23 -53.87 4.37 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.67 0.748 . . . . 0.0 109.076 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 33' ' ' GLY . 49.9 t0 -67.8 62.17 0.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.632 -0.667 . . . . 0.0 109.37 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 5.2 mptp? -47.78 -25.08 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.172 -0.955 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 4.8 m-20 -91.39 7.59 40.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.788 -1.195 . . . . 0.0 111.142 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 mtt 46.65 31.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.206 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' OD1' ' A' ' 28' ' ' ASP . 3.9 p-10 -100.39 19.84 15.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 110.287 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 65.28 12.56 55.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 2.0 m-85 -150.2 108.83 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 0.0 110.664 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.26 132.56 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.051 -1.03 . . . . 0.0 108.623 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.772 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -88.46 156.74 18.94 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.848 -1.158 . . . . 0.0 109.979 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -49.68 -21.32 3.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 38' ' ' LEU . 2.4 mm? -68.49 -35.19 77.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.13 . . . . 0.0 111.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.705 ' HB2' HG23 ' A' ' 35' ' ' VAL . 25.5 mt-10 -88.19 -60.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.581 0.705 . . . . 0.0 109.283 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -45.71 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.762 -0.586 . . . . 0.0 110.601 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.1 mt-10 -45.28 -43.33 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.041 -1.037 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -54.1 -42.47 55.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 m-85 -83.77 -28.6 28.05 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 42' ' ' GLU . 40.7 mt -63.72 -22.3 66.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 21.7 mtpp -75.81 -8.82 57.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.641 -0.662 . . . . 0.0 109.467 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 44' ' ' PHE . 54.0 p -68.46 -45.16 73.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 110.152 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.27 15.07 10.88 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -97.71 167.62 11.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.559 -0.965 . . . . 0.0 110.553 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.2 Cg_endo -73.85 169.34 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 52' ' ' THR . 55.4 p -67.18 -55.67 13.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.261 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.7 m -49.14 -65.51 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.612 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -41.9 -54.7 3.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 50' ' ' PRO . 50.9 mt -59.14 -44.15 92.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.852 . . . . 0.0 109.693 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.51 -41.91 98.51 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 7.2 t60 -64.95 -30.31 71.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.757 ' CD1' HD13 ' A' ' 81' ' ' ILE . 7.6 mt -73.16 -24.91 21.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.684 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 36.0 t-105 -66.59 -48.48 69.42 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.047 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.42 -33.91 76.77 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.019 -1.05 . . . . 0.0 108.408 178.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.925 HD21 ' O ' ' A' ' 92' ' ' PRO . 2.4 tp -70.76 -5.95 33.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.783 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 3.1 p -118.3 -35.58 3.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 59' ' ' SER . 4.4 p-10 -71.07 50.72 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.738 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.807 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.8 p -51.41 -29.07 14.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.747 -1.221 . . . . 0.0 108.266 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE3' ' NE2' ' A' ' 73' ' ' GLN . 6.6 mmtt -53.59 -19.4 3.85 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.464 0.649 . . . . 0.0 109.996 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 44.63 53.1 7.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 t -126.28 -12.33 6.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.471 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.39 -7.48 37.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 6.0 ptpt -129.98 -172.0 2.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -1.191 . . . . 0.0 110.342 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -123.41 103.46 8.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.146 -0.971 . . . . 0.0 111.063 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.34 -169.15 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.668 -1.27 . . . . 0.0 109.851 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -62.61 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.349 -0.844 . . . . 0.0 110.639 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' ALA . 4.0 m-20 -41.98 -67.43 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.531 ' CG ' ' OG1' ' A' ' 63' ' ' THR . 15.5 mp0 -39.75 -39.34 0.77 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.518 -0.739 . . . . 0.0 111.2 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.651 ' CA ' HD22 ' A' ' 69' ' ' LEU . 14.8 t80 -66.73 -35.61 80.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.744 -1.222 . . . . 0.0 108.683 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.876 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -74.79 -6.75 50.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 109.375 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.77 HD21 ' HG2' ' A' ' 99' ' ' MET . 4.2 tp -90.36 -44.43 9.67 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.358 -0.839 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -52.12 -51.88 55.08 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.703 -1.248 . . . . 0.0 109.815 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 9.7 m-85 -54.45 -36.75 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 110.262 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.525 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 78.4 t60 -53.92 -20.21 5.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.902 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.621 HD13 HD23 ' A' ' 60' ' ' LEU . 3.1 mt -100.22 -19.57 16.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 0.0 109.034 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.757 HD13 ' CD1' ' A' ' 57' ' ' ILE . 18.1 mm -72.38 -66.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' ILE . 79.0 p -41.01 -29.91 0.12 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.737 -0.602 . . . . 0.0 110.107 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 10.8 mt-30 -61.94 -38.7 89.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 110.04 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 49' ' ' LEU . 10.3 tptt -85.72 -14.51 45.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.929 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HD21 ' A' ' 49' ' ' LEU . 4.4 mt -83.84 -64.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.984 -1.073 . . . . 0.0 110.719 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG22 ' HE3' ' A' ' 87' ' ' LYS . 10.4 mm -95.89 -35.92 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.205 -0.935 . . . . 0.0 110.73 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.047 ' HB3' HD12 ' A' ' 89' ' ' ILE . 3.6 mmpt? -90.06 -0.99 57.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 43.91 24.99 0.56 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.047 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.5 mt -95.19 150.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.817 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.1 m-20 -92.91 159.6 35.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.007 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 44.7 Cg_endo -71.25 154.9 61.45 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.948 1.499 . . . . 0.0 109.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.925 ' O ' HD21 ' A' ' 60' ' ' LEU . 43.2 Cg_endo -70.43 142.14 44.22 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.988 1.52 . . . . 0.0 110.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 92' ' ' PRO . 4.1 m-70 -40.72 -57.92 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 110.444 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.602 ' CA ' HD11 ' A' ' 60' ' ' LEU . 15.1 m -124.51 -162.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 110.884 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -95.5 132.99 40.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.535 -0.728 . . . . 0.0 111.492 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 97' ' ' PRO . 43.6 p -87.44 167.66 20.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 39.6 Cg_endo -66.81 -16.89 51.39 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.406 1.214 . . . . 0.0 109.403 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 11' ' ' VAL . 6.3 mt-10 -85.87 -27.31 25.12 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.77 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.8 ttm -83.86 -12.57 55.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.532 0.682 . . . . 0.0 109.306 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.9 mt -96.17 115.19 65.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.621 -0.674 . . . . 0.0 110.081 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.48 154.73 60.36 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.759 1.399 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.0 158.69 51.98 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.945 1.497 . . . . 0.0 110.521 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 110.537 -179.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.711 ' O ' HG22 ' A' ' 9' ' ' THR . 15.9 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.133 0.492 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.604 ' CZ3' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -96.87 161.56 13.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.791 -1.193 . . . . 0.0 110.042 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.725 ' CG2' HG12 ' A' ' 12' ' ' VAL . 4.1 m -89.25 -8.36 10.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.35 -0.844 . . . . 0.0 110.549 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -160.31 72.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.212 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 94.5 p -108.43 -22.36 0.17 Allowed Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 13' ' ' SER . 56.8 Cg_endo -76.62 -157.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 122.294 0.628 . . . . 0.0 111.473 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.22 -51.77 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.325 0.583 . . . . 0.0 111.671 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 55.2 mt-10 -39.42 -63.09 0.59 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.586 -0.696 . . . . 0.0 110.409 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -57.75 -32.12 67.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 110.069 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.31 -41.13 61.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -29.7 69.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.425 -0.797 . . . . 0.0 109.552 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 8.8 m-30 -81.29 -41.06 22.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.468 -0.77 . . . . 0.0 109.414 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.41 -31.54 15.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.58 -35.78 52.67 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.618 HG22 ' OG1' ' A' ' 27' ' ' THR . 42.1 mt -74.5 -42.17 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 121.551 -0.718 . . . . 0.0 109.948 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 53.1 t80 -45.83 -28.92 1.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.464 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.0 -34.53 77.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' ILE . 38.0 mtmt -93.68 -9.47 37.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.895 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.56 -56.01 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.718 0.771 . . . . 0.0 109.018 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 51.1 t0 -70.13 70.43 0.38 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.628 -0.67 . . . . 0.0 109.313 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 76.1 mttt -62.34 -8.13 5.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 111.588 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -95.25 -2.94 48.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.879 -1.138 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mmt 57.08 18.61 4.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 110.16 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 24.7 p30 -92.28 18.96 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.193 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 28' ' ' ASP . . . 63.68 15.81 58.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.595 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.84 112.61 4.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.083 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.892 HG21 ' CG2' ' A' ' 27' ' ' THR . 2.1 p -89.63 130.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.017 -1.052 . . . . 0.0 109.587 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.9 p -85.3 148.93 25.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 109.391 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.05 -26.53 0.5 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -62.0 -35.31 78.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.643 -0.916 . . . . 0.0 111.019 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.843 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.7 mt-10 -89.13 -63.35 1.3 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.648 -1.283 . . . . 0.0 109.192 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.847 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.2 p -49.07 -21.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.321 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.768 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -43.02 -62.1 1.12 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.9 mt-10 -51.94 -45.87 64.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 108.476 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.895 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -54.65 -33.54 27.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.847 ' CD2' HG22 ' A' ' 40' ' ' VAL . 2.7 m-85 -85.17 -35.39 21.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 109.558 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 42' ' ' GLU . 11.2 mt -60.3 -15.36 24.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 38.8 mttt -85.4 -10.19 56.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.653 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.537 ' HB ' ' CD2' ' A' ' 49' ' ' LEU . 44.6 p -73.68 -55.82 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.08 -7.98 9.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.753 ' HB3' HD23 ' A' ' 53' ' ' LEU . 1.7 mm? -69.89 161.92 71.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.369 -1.077 . . . . 0.0 110.245 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HG2' ' CB ' ' A' ' 53' ' ' LEU . 43.5 Cg_endo -71.72 143.36 41.6 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.992 1.522 . . . . 0.0 110.413 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' PRO . 56.2 p -40.41 -46.99 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.377 -0.827 . . . . 0.0 110.982 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.2 m -62.53 -61.57 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.981 . . . . 0.0 110.952 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.753 HD23 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -44.89 -47.6 11.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.561 HD22 ' CD1' ' A' ' 44' ' ' PHE . 65.4 mt -55.9 -37.56 69.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.018 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.88 -43.55 75.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.484 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 20.7 t60 -61.36 -37.78 84.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.394 -0.816 . . . . 0.0 108.799 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 81' ' ' ILE . 13.8 mt -71.84 -28.51 30.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.551 -0.718 . . . . 0.0 109.079 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.687 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 15.2 t-105 -64.85 -37.8 88.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.552 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' CG ' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -75.14 -25.08 58.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 0.0 108.973 179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' A' ' 95' ' ' LEU . 1.1 mp -77.67 -17.99 57.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.344 -0.847 . . . . 0.0 108.784 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.76 ' SG ' HD21 ' A' ' 69' ' ' LEU . 14.7 p -104.69 -29.38 10.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.751 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HA ' ' A' ' 59' ' ' SER . 5.5 p-10 -71.08 55.42 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.948 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -50.58 -30.07 12.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 109.524 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -63.99 -10.25 20.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.52 -0.737 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.28 56.64 2.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.375 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 t -128.0 -31.01 2.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.43 -5.64 7.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -127.0 172.67 10.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -1.147 . . . . 0.0 109.659 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.0 OUTLIER -108.43 111.13 22.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.03 -1.044 . . . . 0.0 111.017 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.595 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -62.82 -178.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.992 . . . . 0.0 110.164 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.626 ' HE2' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.8 -77.66 0.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 111.322 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.403 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 35.7 m-20 -54.31 -28.02 39.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.195 -0.941 . . . . 0.0 111.032 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' CG ' ' OG ' ' A' ' 70' ' ' SER . 36.1 mm-40 -66.08 -47.32 74.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 110.459 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.779 ' CE1' HG21 ' A' ' 27' ' ' THR . 23.9 t80 -56.5 -30.17 62.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.439 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -76.92 -13.82 59.94 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.57 0.7 . . . . 0.0 109.413 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.03 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.52 -32.96 19.13 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.51 -0.744 . . . . 0.0 109.657 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.73 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -63.55 -51.0 67.31 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 109.62 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 5.2 m-85 -47.65 -41.7 22.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.917 . . . . 0.0 109.627 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -52.07 -29.21 20.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.613 HD12 HG23 ' A' ' 57' ' ' ILE . 2.7 mt -83.89 -30.93 25.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.112 -0.993 . . . . 0.0 108.726 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.932 HD13 HD13 ' A' ' 57' ' ' ILE . 8.3 mm -65.12 -57.64 10.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.454 0.645 . . . . 0.0 109.315 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.62 -36.19 2.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.593 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 45.1 mt-30 -58.06 -33.59 69.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.837 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -89.12 -28.85 19.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.0 111.224 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 85' ' ' LEU . 4.2 mt -77.4 -63.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.929 -1.107 . . . . 0.0 110.865 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mm -86.92 -12.99 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.965 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -122.45 -17.02 7.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 110.943 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 84' ' ' LYS . . . 58.51 25.05 57.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.965 HD12 ' HB3' ' A' ' 87' ' ' LYS . 17.1 mt -98.48 165.74 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -1.06 . . . . 0.0 110.05 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 4.6 m-20 -96.19 164.1 19.27 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -69.49 162.89 40.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.186 1.624 . . . . 0.0 110.694 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 60' ' ' LEU . 45.2 Cg_endo -71.48 69.05 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.114 1.586 . . . . 0.0 111.779 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.543 ' O ' HD11 ' A' ' 60' ' ' LEU . 3.2 m170 32.41 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.772 -0.58 . . . . 0.0 111.87 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 60' ' ' LEU . 3.2 m -110.66 -164.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.171 -0.956 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.718 HD13 ' SD ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -72.29 151.87 42.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.82 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.935 ' O ' HD12 ' A' ' 100' ' ' ILE . 60.8 p -129.32 163.02 49.09 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.304 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 45.2 Cg_endo -71.39 -6.27 18.81 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.832 1.438 . . . . 0.0 110.682 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.691 ' C ' HG13 ' A' ' 11' ' ' VAL . 11.5 mt-10 -95.96 -28.93 14.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.718 ' SD ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -94.5 -12.57 27.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.0 110.031 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 96' ' ' THR . 5.5 mt -79.36 142.17 58.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 42.4 Cg_endo -68.49 172.57 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.857 1.451 . . . . 0.0 110.175 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 44.3 Cg_endo -71.56 134.97 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.966 1.508 . . . . 0.0 110.828 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.385 -0.822 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.001 0.429 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CZ3' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.76 160.45 32.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.88 -1.138 . . . . 0.0 109.897 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.3 m -90.93 -14.47 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.712 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -152.24 67.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 111.012 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -105.72 -28.85 0.2 Allowed Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.9 Cg_endo -75.84 -155.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.577 0.777 . . . . 0.0 111.459 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.98 -48.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.432 0.634 . . . . 0.0 111.905 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.664 ' HB3' HG23 ' A' ' 12' ' ' VAL . 9.9 mt-10 -46.35 -60.97 2.0 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -52.67 -41.46 63.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.005 -1.06 . . . . 0.0 110.063 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.41 96.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.465 -0.772 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.3 ttpt -58.91 -30.43 67.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.498 -0.751 . . . . 0.0 109.801 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 5.8 m-85 -85.07 -49.65 8.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.728 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -44.09 -36.68 2.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.879 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 25' ' ' LEU . 22.3 mt-10 -71.91 -36.8 70.09 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.653 HG22 ' HG1' ' A' ' 27' ' ' THR . 45.2 mt -72.32 -40.84 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.491 -0.756 . . . . 0.0 109.84 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.501 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 31.3 t80 -48.12 -37.4 15.33 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.201 -1.0 . . . . 0.0 108.538 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.3 mt -64.09 -23.18 67.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' ILE . 3.0 mmmt -102.86 -14.2 16.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.095 HG23 HD12 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -88.76 -56.69 3.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.621 -0.675 . . . . 0.0 109.354 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.33 77.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.663 -0.648 . . . . 0.0 109.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' THR . 5.8 mttm -67.04 -1.63 4.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.184 -0.948 . . . . 0.0 112.236 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 90.9 m-20 -104.65 -2.78 24.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.707 -1.246 . . . . 0.0 110.631 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mmt 57.56 18.27 4.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 110.899 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.7 p30 -90.24 0.08 57.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.093 . . . . 0.0 110.091 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 12.98 77.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -147.43 105.02 3.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 110.065 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.978 HG21 HG22 ' A' ' 27' ' ' THR . 8.8 p -89.19 133.79 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.034 -1.041 . . . . 0.0 109.502 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -86.72 157.17 19.69 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.047 -1.033 . . . . 0.0 110.196 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -51.22 -21.81 6.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.5 mm? -72.75 -31.84 65.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -1.039 . . . . 0.0 111.352 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.564 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.5 mt-10 -83.05 -55.27 4.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.68 -1.263 . . . . 0.0 108.373 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -61.05 -10.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -50.55 -73.06 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -42.5 -41.27 2.91 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.095 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -60.14 -41.94 88.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.724 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 m-30 -81.9 -32.57 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.424 -0.797 . . . . 0.0 109.308 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.696 HD11 ' CG ' ' A' ' 41' ' ' ARG . 32.6 mt -58.58 -26.63 63.83 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.109 -0.994 . . . . 0.0 108.649 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -70.98 -8.88 56.37 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.513 -0.742 . . . . 0.0 109.076 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.7 p -78.36 -35.66 47.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.508 -0.745 . . . . 0.0 110.195 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 95.01 34.12 6.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.617 HD13 ' OG1' ' A' ' 47' ' ' THR . 10.1 mp -105.63 157.12 35.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.828 -0.807 . . . . 0.0 110.717 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HD22 ' A' ' 53' ' ' LEU . 45.4 Cg_endo -75.2 178.16 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.803 1.423 . . . . 0.0 110.201 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -57.79 3.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.123 -0.986 . . . . 0.0 111.06 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -52.1 -45.32 64.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -57.86 -51.38 69.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.964 -1.085 . . . . 0.0 110.005 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 44' ' ' PHE . 11.3 mt -55.28 -41.32 72.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.221 -0.924 . . . . 0.0 109.195 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 60' ' ' LEU . 13.1 t60 -69.08 -36.04 77.15 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 80' ' ' LEU . 6.9 mt -71.65 -34.48 52.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.591 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 38.6 t-105 -65.1 -47.41 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 109.879 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -31.19 72.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.197 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 ' O ' ' A' ' 93' ' ' HIS . 14.8 mt -71.02 -9.82 58.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 109.184 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' THR . 29.4 m -119.57 -36.63 3.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 109.909 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.542 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 13.0 t0 -66.06 61.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.604 -0.685 . . . . 0.0 109.672 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 1.022 HG22 HD21 ' A' ' 95' ' ' LEU . 11.6 p -58.33 -36.03 72.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.376 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 0.4 OUTLIER -55.33 -16.2 3.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.04 53.12 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 -34.05 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -0.44 4.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 34' ' ' PHE . 9.9 mttt -132.7 175.55 9.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -1.164 . . . . 0.0 109.988 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.982 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -105.64 110.86 23.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.53 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -62.81 179.09 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.327 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HE3' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -53.31 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 110.654 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 3.8 m-20 -52.89 -43.37 66.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.979 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 22.0 mt-30 -43.6 -62.72 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.021 -1.049 . . . . 0.0 110.355 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.982 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.9 t80 -49.17 -36.11 18.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.837 -1.164 . . . . 0.0 109.016 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -69.57 -6.14 29.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.421 -0.8 . . . . 0.0 109.66 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.94 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.1 tt -90.34 -38.55 13.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.505 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -55.92 -39.83 72.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 110.196 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 53.1 m-85 -57.33 -29.43 63.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 45.3 t60 -63.73 -26.55 68.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.79 -48.28 4.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.67 HG21 HG21 ' A' ' 47' ' ' THR . 82.4 mt -60.67 -33.6 55.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.734 -0.603 . . . . 0.0 110.338 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 21.0 t -72.36 -18.67 61.73 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.212 -0.93 . . . . 0.0 111.005 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -90.52 -14.71 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.024 -1.048 . . . . 0.0 111.459 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 1.4 tptt -90.37 -15.27 31.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.664 -1.272 . . . . 0.0 111.136 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 47' ' ' THR . 6.8 mt -90.26 -56.65 3.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 111.554 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.62 -19.74 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.924 -1.11 . . . . 0.0 110.676 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.024 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -109.08 -16.07 14.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.754 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 60.05 36.89 91.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.024 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.6 mt -104.61 154.38 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.273 . . . . 0.0 109.468 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.29 165.27 15.12 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 110.598 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CD2' ' A' ' 56' ' ' HIS . 47.3 Cg_endo -72.34 155.04 56.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.191 1.627 . . . . 0.0 110.236 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' O ' HD11 ' A' ' 60' ' ' LEU . 42.1 Cg_endo -69.35 -179.34 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.981 1.517 . . . . 0.0 110.003 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.764 ' O ' HD21 ' A' ' 60' ' ' LEU . 54.0 m-70 -64.46 -99.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.9 -1.125 . . . . 0.0 110.19 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 60' ' ' LEU . 7.4 m -108.26 -168.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 120.987 -1.071 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 HG22 ' A' ' 63' ' ' THR . 2.0 tp -61.79 148.27 43.64 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.91 0.862 . . . . 0.0 111.458 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.063 ' O ' HD12 ' A' ' 100' ' ' ILE . 71.0 p -130.08 166.73 24.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.0 Cg_endo -67.86 -25.38 39.18 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.511 1.269 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -80.59 -12.01 59.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 109.101 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.94 ' CG ' HD21 ' A' ' 76' ' ' LEU . 32.5 ttm -103.9 -30.23 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.639 -0.663 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 96' ' ' THR . 3.0 mt -74.54 126.66 88.49 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.487 -0.758 . . . . 0.0 110.405 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.57 162.99 34.87 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.827 1.435 . . . . 0.0 110.458 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.96 154.34 47.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.028 1.541 . . . . 0.0 110.109 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.905 . . . . 0.0 110.394 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 98' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -53.67 120.4 6.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 108.963 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.99 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -64.44 -173.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.861 -1.149 . . . . 0.0 108.707 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.99 HG23 ' CG2' ' A' ' 11' ' ' VAL . 37.6 t 57.65 121.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.5 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.587 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t -157.41 -64.91 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.685 -1.26 . . . . 0.0 112.438 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 46.7 Cg_endo -68.42 -149.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.494 1.26 . . . . 0.0 110.82 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.71 -43.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.31 0.576 . . . . 0.0 111.516 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 6.3 mt-10 -44.66 -62.78 1.08 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 109.864 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -56.69 -30.63 63.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 109.393 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -70.1 -51.32 32.64 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' HE2' ' CA ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -57.23 -32.49 66.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.28 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.67 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 8.3 m-30 -83.21 -28.11 29.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.671 -0.643 . . . . 0.0 110.483 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 11.2 t0 -72.07 -32.84 67.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 2.7 mt-10 -81.85 -26.9 33.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -0.91 . . . . 0.0 108.577 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' OG1' ' A' ' 27' ' ' THR . 65.4 mt -82.31 -42.15 18.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.647 -0.658 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.642 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 53.2 t80 -49.98 -25.03 2.94 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.69 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 20.1 mt -71.93 -26.96 62.5 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 23' ' ' ILE . 13.2 mttt -101.28 -12.59 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.994 HG22 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -89.05 -55.38 3.71 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 4.0 t0 -70.62 81.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.4 mttt -81.17 10.31 5.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.066 -1.021 . . . . 0.0 112.179 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 73.5 m-20 -111.78 10.46 20.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 110.024 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.1 mtm 48.19 23.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.088 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 28.6 p30 -97.85 15.79 22.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.85 52.46 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -150.08 112.45 4.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -1.042 . . . . 0.0 110.009 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.994 HG21 HG22 ' A' ' 27' ' ' THR . 2.3 p -88.72 133.19 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.94 -1.1 . . . . 0.0 109.889 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.664 ' O ' HG12 ' A' ' 40' ' ' VAL . 17.2 t -90.93 153.45 20.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 110.095 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -43.54 -25.52 0.54 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.6 mt -64.88 -38.73 91.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -1.117 . . . . 0.0 111.693 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.796 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.4 mt-10 -85.13 -55.82 3.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.862 -1.149 . . . . 0.0 108.974 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 36' ' ' SER . 1.6 p -59.77 -13.74 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.698 ' HG3' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -56.28 -67.59 0.29 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 109.751 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.982 ' HA ' HD12 ' A' ' 45' ' ' LEU . 11.7 mm-40 -45.24 -32.19 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 108.884 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HG23 ' A' ' 27' ' ' THR 0.268 1.3 mt -69.89 -41.83 79.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.24 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.921 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -74.58 -29.55 61.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.055 . . . . 0.0 109.196 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.982 HD12 ' HA ' ' A' ' 42' ' ' GLU . 15.1 mt -64.4 -18.48 64.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.328 -0.858 . . . . 0.0 108.968 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -79.58 -8.01 58.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 108.864 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 44' ' ' PHE . 28.3 p -79.84 -23.16 42.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 110.413 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.51 -17.09 58.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HB3' HD13 ' A' ' 54' ' ' LEU . 7.2 mp -54.82 168.62 0.48 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.698 -0.883 . . . . 0.0 110.569 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.1 Cg_endo -81.58 -175.1 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.933 1.491 . . . . 0.0 109.392 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -61.6 1.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.422 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 53' ' ' LEU . 17.2 m -46.89 -64.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -40.53 -44.82 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.372 -0.83 . . . . 0.0 110.666 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -58.95 -43.37 91.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -66.18 -38.55 88.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 108.889 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 74.9 t60 -66.78 -41.79 87.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.48 -0.762 . . . . 0.0 108.95 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.611 HG21 ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt -67.2 -29.81 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.769 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 21.4 t-105 -63.93 -44.61 92.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.556 ' O ' HD11 ' A' ' 95' ' ' LEU . 5.5 t -70.29 -33.62 71.78 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 108.898 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.808 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.1 tp -67.28 -21.65 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 109.809 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.879 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 18.1 p -106.62 -29.46 9.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD2' ' CZ2' ' A' ' 58' ' ' TRP . 26.1 t0 -80.47 52.59 1.66 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 110.042 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.807 HG22 HD22 ' A' ' 95' ' ' LEU . 7.7 p -46.25 -29.83 1.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.043 0.925 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.561 ' CG ' ' HG3' ' A' ' 73' ' ' GLN . 2.3 mmtm -58.92 -17.49 24.88 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.227 0.537 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 37.33 56.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.676 -0.64 . . . . 0.0 110.612 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 9.84 6.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.521 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.14 -18.27 54.48 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 34' ' ' PHE . 14.8 pttt -125.1 175.03 7.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.053 -1.263 . . . . 0.0 110.03 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.769 HD12 ' CZ3' ' A' ' 58' ' ' TRP . 1.4 mt -111.73 118.03 34.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.942 . . . . 0.0 111.028 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.643 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -64.32 -172.02 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.81 -1.181 . . . . 0.0 109.459 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.43 -80.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 111.078 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -53.13 -18.62 2.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.514 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.561 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 10.1 mm100 -74.44 -40.64 61.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.886 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.3 t80 -65.15 -23.0 67.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.083 . . . . 0.0 109.041 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 20' ' ' TYR . . . -78.4 -12.37 60.0 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.504 -0.748 . . . . 0.0 109.736 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.07 HD11 ' CG ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -85.69 -38.36 18.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 110.61 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.879 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -57.06 -44.48 83.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 20' ' ' TYR . 6.4 m-85 -60.38 -23.49 64.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.626 ' HB2' HG22 ' A' ' 12' ' ' VAL . 83.6 t60 -64.28 -20.33 66.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 0.0 109.611 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.699 HD13 HD23 ' A' ' 60' ' ' LEU . 1.7 mt -99.69 -31.09 11.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 109.036 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.921 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 36.2 mt -61.11 -57.32 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.175 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -39.19 -34.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.695 -0.628 . . . . 0.0 110.828 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' ILE . 21.0 mt-30 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.838 -1.164 . . . . 0.0 110.714 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' ILE . 19.9 tptp -89.89 -10.31 45.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.671 HD11 HG22 ' A' ' 81' ' ' ILE . 7.3 mt -88.37 -58.7 2.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.073 . . . . 0.0 110.918 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.07 -25.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 0.0 110.794 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.065 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -103.62 -8.7 19.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.973 . . . . 0.0 110.422 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 50.85 20.82 4.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.065 HD12 ' HB3' ' A' ' 87' ' ' LYS . 4.6 mt -86.67 142.0 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.972 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 7.5 p-10 -80.16 164.55 51.87 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HD3' HD11 ' A' ' 53' ' ' LEU . 38.6 Cg_endo -66.45 159.8 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.042 1.548 . . . . 0.0 110.278 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' VAL . 45.2 Cg_endo -71.17 58.57 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 0.0 110.616 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.617 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER 39.35 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.631 -0.668 . . . . 0.0 111.235 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 92' ' ' PRO . 5.7 m -101.67 -164.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 111.305 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.808 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -95.3 164.84 12.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.878 0.847 . . . . 0.0 111.802 -178.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.617 ' O ' HD12 ' A' ' 100' ' ' ILE . 14.6 p -133.65 171.65 8.73 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 40.3 Cg_endo -68.94 -36.19 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.291 1.153 . . . . 0.0 109.632 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.67 ' O ' HG13 ' A' ' 11' ' ' VAL . 1.1 tt0 -63.4 -18.41 63.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.218 -0.926 . . . . 0.0 109.106 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.07 ' CG ' HD11 ' A' ' 76' ' ' LEU . 24.4 ttm -97.04 -26.42 15.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.456 -0.777 . . . . 0.0 109.526 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 96' ' ' THR . 6.0 mt -82.29 115.3 57.02 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -75.58 163.2 34.5 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.955 1.503 . . . . 0.0 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.59 94.99 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.983 1.518 . . . . 0.0 110.426 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.332 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 9' ' ' THR . 30.0 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' HH2' ' HB3' ' A' ' 75' ' ' ALA . 8.7 t90 -88.56 137.67 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 110.428 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 12' ' ' VAL . 2.4 m -62.1 -31.13 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.078 -1.014 . . . . 0.0 109.127 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 11' ' ' VAL . 6.2 t -103.75 159.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.588 -0.695 . . . . 0.0 109.693 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 169.25 -52.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.197 -0.939 . . . . 0.0 111.839 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 52.4 Cg_endo -70.51 -153.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.534 1.281 . . . . 0.0 110.819 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.23 -48.42 0.07 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.272 0.558 . . . . 0.0 111.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.559 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 1.6 mt-10 -50.97 -60.4 3.13 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.302 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -53.48 -36.3 61.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -67.6 -50.84 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.395 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -53.75 -29.58 40.43 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.51 -0.743 . . . . 0.0 109.546 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 10.9 m-85 -90.47 -47.85 7.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.479 -0.763 . . . . 0.0 109.745 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 12.9 t70 -49.76 -31.59 11.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.152 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 25' ' ' LEU . 32.6 mt-10 -78.41 -36.23 45.99 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.835 HG22 ' OG1' ' A' ' 27' ' ' THR . 37.7 mt -76.66 -39.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' O ' ' A' ' 70' ' ' SER . 74.7 t80 -47.21 -31.66 3.84 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.365 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 22' ' ' GLU . 19.0 mt -68.02 -31.52 71.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' ILE . 2.3 tttt -97.0 -10.18 26.71 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.025 HG22 HG21 ' A' ' 35' ' ' VAL . 1.5 m -90.22 -46.49 8.4 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.596 0.712 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 32' ' ' ASP . 27.6 t0 -73.47 62.25 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.227 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -45.87 -20.91 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.126 -0.983 . . . . 0.0 111.354 -178.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 7.5 m-20 -88.94 -5.15 58.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.929 -1.107 . . . . 0.0 110.363 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.05 44.58 29.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 14.8 p-10 -120.7 24.47 10.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.15 47.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -150.39 99.27 2.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -1.201 . . . . 0.0 110.639 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.025 HG21 HG22 ' A' ' 27' ' ' THR . 7.4 p -90.73 142.09 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 0.0 109.354 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.759 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.28 152.47 19.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.069 -1.02 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -44.21 -26.49 0.93 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' SER . 71.2 mt -66.11 -41.23 90.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.474 -1.016 . . . . 0.0 110.891 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 19.9 mt-10 -78.6 -58.85 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.35 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 36' ' ' SER . 1.7 p -61.08 -14.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.279 0.561 . . . . 0.0 110.141 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -45.41 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.441 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -42.71 -42.6 3.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 0.0 109.233 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.952 HD12 HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -55.7 -48.24 78.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.891 ' CE1' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -73.33 -38.88 65.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD23 ' CD1' ' A' ' 54' ' ' LEU . 76.2 mt -60.25 -21.66 62.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.48 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -73.6 -20.09 60.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.225 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.865 HG21 HD13 ' A' ' 81' ' ' ILE . 61.2 p -55.38 -24.45 29.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.21 56.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.9 mp -90.94 170.88 9.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 110.299 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 53' ' ' LEU . 46.4 Cg_endo -74.03 -159.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.85 1.447 . . . . 0.0 110.309 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -94.05 -55.7 3.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.741 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.8 m -56.7 -57.12 13.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.694 HD11 ' HD3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -41.25 -46.48 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.601 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.759 HD22 ' HD1' ' A' ' 44' ' ' PHE . 25.0 mt -60.48 -42.05 95.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.954 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -65.7 -43.25 89.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.13 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.531 ' CD2' ' CG ' ' A' ' 91' ' ' PRO . 12.9 t60 -65.22 -32.15 73.68 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG21 ' CE1' ' A' ' 44' ' ' PHE . 4.2 mt -73.64 -27.87 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.799 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 29.6 t-105 -64.72 -43.67 92.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.487 ' O ' HD21 ' A' ' 95' ' ' LEU . 25.5 m -67.52 -35.23 78.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.126 -0.983 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.946 HD13 ' HG2' ' A' ' 92' ' ' PRO . 17.9 mt -67.59 -23.06 65.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.2 p -102.66 -35.48 8.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.06 -1.025 . . . . 0.0 108.866 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 61.1 t0 -70.25 54.4 0.14 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.487 -0.758 . . . . 0.0 110.055 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -56.74 -22.29 34.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.048 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 22.6 mmmt -57.03 -16.21 6.66 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.338 0.59 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.44 48.99 8.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.0 t -128.45 -22.1 3.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.357 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.28 -11.12 14.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.0 mtpt -124.81 -177.06 3.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -1.116 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.858 HD13 ' HD1' ' A' ' 74' ' ' PHE . 2.8 mt -116.81 107.26 14.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.628 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -58.65 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.48 -1.388 . . . . 0.0 109.994 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -76.57 -68.1 0.63 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.373 -0.829 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' N ' ' OE1' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -61.95 -66.97 0.46 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.369 -0.832 . . . . 0.0 112.289 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -39.83 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 0.0 111.516 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 27' ' ' THR . 30.9 t80 -72.39 -38.66 68.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.476 -1.39 . . . . 0.0 108.692 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HH2' ' A' ' 10' ' ' TRP . . . -67.04 -8.87 33.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.476 0.655 . . . . 0.0 109.554 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -85.85 -45.38 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.448 -0.782 . . . . 0.0 110.02 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB1' ' CZ ' ' A' ' 44' ' ' PHE . . . -42.35 -47.34 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 66.8 m-85 -61.36 -25.7 67.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 66.1 t60 -62.21 -20.98 64.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 109.446 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 57' ' ' ILE . 4.7 mt -94.92 -21.77 18.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 44' ' ' PHE . 11.4 mt -73.4 -62.69 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -39.39 -33.47 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.811 -0.556 . . . . 0.0 110.33 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 24.4 mt-30 -59.61 -36.69 76.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' ILE . 5.3 tptp -89.86 -16.57 29.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.896 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.756 HD11 HG22 ' A' ' 81' ' ' ILE . 8.0 mt -81.33 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.015 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.88 -33.15 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.495 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.002 ' HB3' HD12 ' A' ' 89' ' ' ILE . 2.3 mmpt? -94.93 -2.84 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.434 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 47.81 22.21 1.86 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.002 HD12 ' HB3' ' A' ' 87' ' ' LYS . 12.2 mt -92.76 170.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -1.192 . . . . 0.0 109.791 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -102.65 172.73 4.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 110.109 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HD3' HD11 ' A' ' 53' ' ' LEU . 45.8 Cg_endo -71.13 158.73 54.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.064 1.56 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.946 ' HG2' HD13 ' A' ' 60' ' ' LEU . 42.0 Cg_endo -68.73 173.59 9.81 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.959 1.505 . . . . 0.0 109.502 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -74.62 -50.68 16.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.994 -1.067 . . . . 0.0 109.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.614 ' HA ' HD21 ' A' ' 60' ' ' LEU . 27.9 m -141.67 -159.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.86 HD11 ' O ' ' A' ' 60' ' ' LEU . 3.9 mm? -82.21 176.53 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.793 0.806 . . . . 0.0 110.894 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 95' ' ' LEU . 30.9 p -150.96 166.64 14.63 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -70.59 -12.86 31.98 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 123.575 1.303 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.711 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.2 mt-10 -96.89 -19.53 18.78 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.748 0.785 . . . . 0.0 109.081 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.568 ' CG ' HD21 ' A' ' 76' ' ' LEU . 14.1 ttm -101.44 -6.62 23.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 110.224 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.608 HG23 ' HD2' ' A' ' 102' ' ' PRO . 10.6 mt -86.05 112.82 48.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.545 -0.722 . . . . 0.0 110.151 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.9 Cg_endo -73.65 -29.01 11.19 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.765 1.402 . . . . 0.0 113.322 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 49.3 Cg_endo -74.75 170.3 20.64 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 122.613 0.796 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.93 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.433 0.635 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.744 ' CZ3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 177.34 101.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.0 m -78.16 -14.72 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.382 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.1 p -140.43 67.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 109.969 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.2 t -103.49 -27.81 0.21 Allowed Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.8 Cg_endo -76.11 -156.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 122.559 0.768 . . . . 0.0 110.949 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -29.55 -57.33 0.16 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.305 0.574 . . . . 0.0 111.625 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.661 ' HB3' HG23 ' A' ' 12' ' ' VAL . 13.2 mt-10 -39.78 -63.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.694 -0.629 . . . . 0.0 110.74 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' CE ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.36 -45.19 88.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -28.04 68.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.766 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 23.5 m-85 -89.38 -48.46 7.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CE ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -47.25 -34.81 6.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.956 . . . . 0.0 109.573 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.659 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.3 mt-10 -75.5 -36.05 60.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.011 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 ' OG1' ' A' ' 27' ' ' THR . 41.5 mt -69.82 -39.4 77.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.442 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -48.56 -33.48 9.76 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.645 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 22' ' ' GLU . 15.3 mt -67.8 -25.37 65.55 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' ILE . 9.4 mttp -98.9 -12.73 20.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.986 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -89.91 -54.52 4.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.563 -0.711 . . . . 0.0 109.508 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.46 90.27 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 108.666 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -83.45 -17.98 40.2 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.054 -1.029 . . . . 0.0 112.6 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -92.23 13.16 19.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.632 -1.293 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.6 mtm 53.05 36.47 22.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 4.1 p-10 -113.05 22.63 14.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 110.348 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' ASP . . . 47.88 26.47 4.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -150.85 101.1 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.88 -0.776 . . . . 0.0 109.926 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 27' ' ' THR . 3.0 p -88.93 125.37 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.979 -1.075 . . . . 0.0 109.321 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -83.17 157.6 22.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 109.819 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -44.75 -25.13 0.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 36' ' ' SER . 4.3 mp -59.63 -48.27 82.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -1.02 . . . . 0.0 111.964 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 35' ' ' VAL . 12.2 mt-10 -78.65 -57.88 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.624 -1.298 . . . . 0.0 109.237 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.709 HG22 ' CD2' ' A' ' 44' ' ' PHE . 2.1 p -56.93 -16.76 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.983 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 1.4 ttt-85 -50.05 -77.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.003 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -41.12 -37.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.906 0.86 . . . . 0.0 108.954 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 27' ' ' THR 0.251 1.0 OUTLIER -64.74 -51.02 72.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.201 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.709 ' CD2' HG22 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -72.68 -41.18 65.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.051 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.581 HD12 ' HA ' ' A' ' 42' ' ' GLU . 87.5 mt -49.5 -24.17 1.93 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 29.2 mttm -72.71 -19.81 61.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.612 -0.68 . . . . 0.0 109.558 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.686 ' CG2' HG21 ' A' ' 81' ' ' ILE . 61.9 p -64.39 -13.86 53.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.385 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.34 23.78 70.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 53' ' ' LEU . 6.1 mp -100.11 163.99 17.26 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 110.414 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -76.18 140.73 22.63 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.039 1.547 . . . . 0.0 110.338 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -45.63 -46.58 14.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -57.37 -52.83 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.637 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.617 ' CD2' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -53.25 -41.5 65.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.03 . . . . 0.0 110.023 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 44' ' ' PHE . 24.1 mt -66.2 -41.49 90.1 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.935 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -64.14 -41.01 97.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -70.63 -35.03 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 81' ' ' ILE . 4.8 mt -73.89 -22.52 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 37.5 t-105 -68.98 -44.82 72.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.534 -0.729 . . . . 0.0 109.534 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -69.83 -28.88 66.07 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.144 -0.973 . . . . 0.0 108.69 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.2 mt -72.86 -10.25 59.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.519 -0.738 . . . . 0.0 109.084 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 13.7 p -117.46 -34.4 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.736 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 23.5 t0 -65.63 60.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.454 -0.779 . . . . 0.0 109.961 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.713 HG23 HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -58.98 -27.81 65.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.518 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' HG2' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -68.35 -5.81 20.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.059 -1.026 . . . . 0.0 110.771 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 65' ' ' ASP . 3.4 p-10 37.85 54.78 1.59 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.45 -0.781 . . . . 0.0 111.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 -24.66 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 110.102 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.5 -9.89 8.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 62.8 mttp -125.0 -174.47 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 0.0 110.127 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.76 HD13 ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -115.53 113.26 23.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.145 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.522 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -77.12 -177.24 4.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.114 . . . . 0.0 110.276 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.25 -33.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -58.36 -40.84 83.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.6 t80 -66.52 -41.54 88.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.074 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -63.57 -10.86 20.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.832 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -80.2 -43.27 21.79 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.538 -0.726 . . . . 0.0 109.851 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -64.4 -52.18 59.49 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CE2' ' CZ ' ' A' ' 74' ' ' PHE . 5.5 m-85 -49.05 -39.41 27.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.78 . . . . 0.0 109.618 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.62 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 33.6 t60 -54.67 -25.68 28.61 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 57' ' ' ILE . 6.9 mt -90.54 -23.82 20.79 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.803 HD11 HG21 ' A' ' 57' ' ' ILE . 17.3 mm -73.86 -56.58 8.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.806 -0.757 . . . . 0.0 108.985 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -46.79 -28.19 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.526 -0.734 . . . . 0.0 110.027 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -77.2 -22.59 52.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.102 -0.999 . . . . 0.0 110.187 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -91.63 -30.96 16.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -81.02 -58.93 2.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.066 -1.021 . . . . 0.0 111.018 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.544 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -80.18 -42.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.953 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.077 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -94.34 -35.45 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 111.202 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 85.84 3.43 85.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.077 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.5 mt -66.86 165.5 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.186 -1.185 . . . . 0.0 109.885 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -102.31 164.12 16.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 0.0 110.292 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 53' ' ' LEU . 47.5 Cg_endo -74.51 145.33 33.34 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.721 ' O ' HD11 ' A' ' 60' ' ' LEU . 43.9 Cg_endo -71.45 177.52 6.64 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.993 1.522 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.738 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -64.7 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 110.01 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.527 ' CA ' HD21 ' A' ' 60' ' ' LEU . 5.2 m -109.81 -167.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 110.274 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -81.88 175.33 10.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 111.299 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.955 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -139.71 179.44 1.28 Allowed Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.5 Cg_endo -71.1 -20.39 28.69 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.189 1.1 . . . . 0.0 109.626 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.781 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.8 mt-10 -75.01 -28.34 60.46 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.729 ' CA ' HD21 ' A' ' 76' ' ' LEU . 2.9 mtt -80.77 -49.27 11.35 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.024 0.916 . . . . 0.0 108.733 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 96' ' ' THR . 3.2 mt -56.71 136.31 78.23 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.779 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 39.3 Cg_endo -66.49 175.42 5.13 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.952 1.501 . . . . 0.0 109.949 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 41.2 Cg_endo -67.0 72.84 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.802 1.422 . . . . 0.0 110.639 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.209 0.528 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.684 ' CZ2' HD12 ' A' ' 76' ' ' LEU . 6.8 t90 -162.64 140.23 8.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.125 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.103 HG23 HG12 ' A' ' 12' ' ' VAL . 1.2 m -72.21 -156.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.103 -0.998 . . . . 0.0 109.797 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.103 HG12 HG23 ' A' ' 11' ' ' VAL . 2.6 p 15.21 69.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -103.96 -35.68 0.2 Allowed Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -75.85 -153.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 122.825 0.908 . . . . 0.0 111.999 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.01 -52.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.706 ' HB3' HG23 ' A' ' 12' ' ' VAL . 34.7 mt-10 -38.47 -62.12 0.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.667 -0.645 . . . . 0.0 110.273 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.633 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -55.92 -34.58 65.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.081 -1.012 . . . . 0.0 109.44 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -68.95 -49.12 60.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 110.137 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -60.44 -30.82 69.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 16' ' ' GLU . 7.8 m-30 -81.52 -48.57 11.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.516 -0.74 . . . . 0.0 109.813 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 25.1 t0 -46.39 -31.53 2.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.95 . . . . 0.0 109.046 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -78.51 -36.64 44.68 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.61 HG22 ' OG1' ' A' ' 27' ' ' THR . 43.6 mt -74.47 -40.3 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 58.7 t80 -50.72 -24.52 3.46 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.177 -0.952 . . . . 0.0 108.876 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 38.6 mt -72.37 -24.74 61.31 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' ILE . 72.9 mttt -102.11 -13.64 17.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.978 HG23 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 53.9 t0 -68.35 91.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 109.516 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -88.39 0.9 55.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.041 -1.037 . . . . 0.0 111.747 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 34.9 m-20 -110.36 5.27 21.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.884 -1.135 . . . . 0.0 110.93 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 44.97 26.19 0.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 109.957 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 34' ' ' PHE . 2.5 p30 -90.18 -4.9 56.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.421 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.7 -16.45 23.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD2' ' CB ' ' A' ' 68' ' ' LYS . 2.3 p90 -148.82 151.64 35.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.267 -1.137 . . . . 0.0 110.649 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.899 HG21 HG22 ' A' ' 27' ' ' THR . 1.6 p -97.42 128.2 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.3 t -79.56 151.04 30.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.329 -1.482 . . . . 0.0 109.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -42.25 -25.9 0.31 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 7.4 mp -62.02 -39.24 91.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -1.086 . . . . 0.0 111.288 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.9 mt-10 -86.63 -55.23 3.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.481 -1.387 . . . . 0.0 109.513 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.6 p -58.82 -15.63 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.635 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -44.34 -72.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 110.308 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.682 ' HA ' HD12 ' A' ' 45' ' ' LEU . 4.7 tt0 -44.39 -44.19 8.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.978 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -58.27 -48.63 84.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.804 ' HZ ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -71.17 -27.7 63.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.537 -0.727 . . . . 0.0 110.131 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 42' ' ' GLU . 34.9 mt -70.87 -16.78 62.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 109.87 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 8.4 mtpp -86.95 -4.87 59.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.646 ' CG2' HG21 ' A' ' 81' ' ' ILE . 81.9 p -72.01 -15.06 62.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.872 . . . . 0.0 111.126 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.89 5.15 83.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 47' ' ' THR . 8.6 mp -77.19 173.91 6.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 44.5 Cg_endo -80.55 -160.33 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.85 1.448 . . . . 0.0 110.075 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -93.87 -49.81 5.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.005 -1.06 . . . . 0.0 110.729 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -63.81 -51.96 62.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD23 HD23 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -46.69 -52.39 13.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 111.04 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.626 HD11 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.8 -43.47 76.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.942 -1.099 . . . . 0.0 109.307 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.37 85.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.677 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 67.4 t60 -71.24 -37.75 71.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 81' ' ' ILE . 8.6 mt -70.46 -26.55 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.777 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 38.4 t-105 -63.29 -39.37 94.38 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.836 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' HD23 ' A' ' 95' ' ' LEU . 2.3 t -72.16 -29.05 63.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.408 -0.808 . . . . 0.0 109.566 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.777 ' HA ' HD22 ' A' ' 95' ' ' LEU . 3.8 mt -72.6 -18.85 61.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.26 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 77' ' ' ALA . 21.2 p -112.19 -28.31 8.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 109.108 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.592 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 30.6 t0 -78.09 52.25 1.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.462 -0.774 . . . . 0.0 109.662 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -52.35 -22.08 4.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 109.755 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HG2' ' NE2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -45.25 -26.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.735 0.778 . . . . 0.0 109.117 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.81 50.18 10.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.562 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 68' ' ' LYS . 11.9 t -150.01 -30.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.577 -0.702 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.03 13.91 2.34 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.239 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.668 ' CB ' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -132.4 177.3 7.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.083 -1.245 . . . . 0.0 110.044 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.777 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -120.29 94.04 4.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.297 -179.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.631 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -44.77 173.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.725 -1.235 . . . . 0.0 110.112 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.63 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 0.0 111.055 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 23.6 p-10 -53.85 -30.9 47.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.04 -1.037 . . . . 0.0 110.399 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.611 ' HB3' HD23 ' A' ' 69' ' ' LEU . 8.1 mt-30 -56.32 -53.45 57.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.472 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.744 ' N ' HD22 ' A' ' 69' ' ' LEU . 42.1 t80 -50.01 -31.9 13.95 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.759 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -76.75 -11.73 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.0 109.795 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.822 HD21 ' HG3' ' A' ' 99' ' ' MET . 6.0 tt -89.18 -21.72 23.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 110.458 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.804 ' HB1' ' HZ ' ' A' ' 44' ' ' PHE . . . -72.9 -53.24 11.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.044 -1.035 . . . . 0.0 109.577 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 6.8 m-85 -49.54 -32.39 12.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.927 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 12' ' ' VAL . 85.1 t60 -55.23 -26.18 37.94 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.509 -0.745 . . . . 0.0 109.453 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.9 HD12 HG23 ' A' ' 57' ' ' ILE . 1.3 mt -93.8 -32.53 13.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 57' ' ' ILE . 2.8 mm -69.27 -54.43 19.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.9 -30.65 1.04 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.85 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.2 mp0 -78.08 -19.27 54.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 110.428 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 81' ' ' ILE . 22.0 tptp -90.41 -21.9 21.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 110.673 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 49' ' ' LEU . 3.4 mt -89.45 -59.45 2.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.102 -0.999 . . . . 0.0 110.527 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.557 ' CG2' ' HE2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.4 -25.02 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 111.425 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.016 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.05 -14.82 9.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.764 -1.21 . . . . 0.0 111.376 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 58.49 28.03 61.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.016 HD12 ' HB3' ' A' ' 87' ' ' LYS . 1.6 mt -88.05 156.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -1.17 . . . . 0.0 109.668 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 10.9 m-20 -89.54 164.85 27.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' LEU . 47.3 Cg_endo -73.51 158.18 48.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.954 1.502 . . . . 0.0 110.451 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.513 ' HG3' ' HE1' ' A' ' 99' ' ' MET . 47.0 Cg_endo -72.29 58.29 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.697 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.581 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 5.9 m170 45.65 -98.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 110.588 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.9 m -109.1 -163.48 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 111.249 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.47 155.52 40.59 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.651 0.738 . . . . 0.0 111.635 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.033 ' O ' HD12 ' A' ' 100' ' ' ILE . 59.0 p -133.56 166.58 28.23 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -68.18 -28.94 33.59 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.446 1.235 . . . . 0.0 109.848 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.921 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.33 -9.83 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.099 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 76' ' ' LEU . 25.3 ttm -106.33 -28.17 10.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -71.52 115.13 34.2 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.497 -0.752 . . . . 0.0 110.572 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 122.17 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.074 1.565 . . . . 0.0 110.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.99 -47.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.886 1.466 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.371 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 98' ' ' GLU . 20.6 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.236 0.541 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 9.0 t90 -174.15 155.33 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.079 HG11 ' SD ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -81.25 -163.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.818 -1.176 . . . . 0.0 109.221 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 11' ' ' VAL . 2.7 p 12.15 61.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.235 0.541 . . . . 0.0 112.013 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.9 m -102.35 -33.03 0.22 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -74.97 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 122.729 0.857 . . . . 0.0 110.948 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.86 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.295 0.569 . . . . 0.0 111.706 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 12' ' ' VAL . 22.6 mt-10 -46.67 -61.02 2.02 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.26 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -53.42 -37.11 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.94 -1.1 . . . . 0.0 109.745 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' GLU . . . -68.96 -49.99 53.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.449 -0.782 . . . . 0.0 109.392 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -55.3 -29.72 58.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.525 -0.734 . . . . 0.0 109.456 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.673 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 7.0 m-85 -88.36 -47.61 8.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.003 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 4.0 t70 -49.27 -33.72 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.411 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 3.5 mm-40 -77.3 -39.26 48.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.425 -0.797 . . . . 0.0 108.913 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.766 HG22 ' OG1' ' A' ' 27' ' ' THR . 30.6 mt -67.37 -37.15 78.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.435 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 57.8 t80 -48.92 -36.46 17.33 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.278 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.64 -26.97 68.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 10.7 mtmt -100.86 -14.27 18.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.061 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.18 -55.11 3.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 30.7 t70 -72.08 88.36 1.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.526 -0.734 . . . . 0.0 109.07 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' ' OE2' ' A' ' 39' ' ' GLU . 4.1 mttm -86.11 -6.07 59.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.962 -1.086 . . . . 0.0 111.665 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' MET . 66.7 m-20 -91.23 12.42 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.873 -1.142 . . . . 0.0 110.709 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' ASP . 7.7 mmt 41.69 35.54 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 30' ' ' ASP . 13.8 p-10 -112.39 12.18 20.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.177 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.04 12.78 68.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.417 ' C ' ' OD1' ' A' ' 28' ' ' ASP . 1.1 m-85 -148.12 112.17 5.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 110.42 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.017 HG21 HG22 ' A' ' 27' ' ' THR . 14.1 p -89.43 135.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 108.9 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.592 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -88.23 152.3 22.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.371 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -46.82 -24.62 1.96 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -68.94 -30.31 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.363 -1.08 . . . . 0.0 110.799 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 23.3 mt-10 -86.67 -60.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.793 -1.192 . . . . 0.0 108.066 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 36' ' ' SER . 1.2 p -56.15 -16.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 45' ' ' LEU . 4.5 ttt180 -42.24 -73.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 110.016 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . 2.6 mt-10 -44.32 -46.87 9.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 108.777 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.061 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -55.86 -42.71 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.105 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.812 ' HB3' HD22 ' A' ' 54' ' ' LEU . 2.9 m-30 -80.58 -24.16 39.37 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.566 -0.709 . . . . 0.0 109.38 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.1 mt -73.5 -19.77 60.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.294 -0.879 . . . . 0.0 108.848 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 34.6 mtpt -81.79 -9.52 59.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.424 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.891 ' O ' HD22 ' A' ' 85' ' ' LEU . 52.0 p -68.41 -17.72 64.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.812 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 82.01 21.02 61.88 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' CD2' ' A' ' 53' ' ' LEU . 7.5 mp -102.64 171.61 5.08 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.674 -0.898 . . . . 0.0 110.372 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.3 Cg_endo -80.92 -163.95 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.866 1.456 . . . . 0.0 109.943 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -62.38 1.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.957 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -45.95 -42.86 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.697 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.2 tp -56.48 -55.58 31.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 44' ' ' PHE . 19.4 mt -57.24 -36.92 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.385 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.56 76.95 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.842 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.497 ' NE2' ' HG2' ' A' ' 91' ' ' PRO . 6.3 t60 -66.29 -25.25 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG21 ' CG1' ' A' ' 81' ' ' ILE . 1.8 mt -82.11 -32.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 20.3 t-105 -62.81 -38.67 91.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 p -76.0 -25.4 55.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 94' ' ' VAL . 7.0 mt -77.08 -9.63 58.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.219 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.773 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 16.4 p -116.18 -29.37 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.146 -0.971 . . . . 0.0 109.238 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -74.48 52.54 0.5 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.51 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 1.4 p -51.86 -28.92 17.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.123 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HG3' ' CG ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -59.06 -15.22 12.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 0.0 110.414 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 43.88 55.68 5.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.98 5.92 5.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.51 -12.12 61.89 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HD3' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -120.45 -172.68 2.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -1.196 . . . . 0.0 110.493 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.8 OUTLIER -122.99 102.37 7.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.4 -0.812 . . . . 0.0 109.783 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -58.84 -172.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.447 -1.408 . . . . 0.0 109.374 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.627 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.95 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.958 -1.089 . . . . 0.0 109.991 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' OD2' ' CH2' ' A' ' 10' ' ' TRP . 5.0 t70 -43.73 -32.8 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.386 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.565 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -59.68 -57.38 13.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 110.323 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.852 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.4 t80 -50.49 -30.38 12.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.944 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -76.33 -6.96 53.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.673 HD21 ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -84.89 -40.49 17.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -64.09 -38.18 90.14 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.743 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.673 ' CD2' ' CE1' ' A' ' 20' ' ' TYR . 3.7 m-85 -58.35 -31.13 67.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.181 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' C ' HD23 ' A' ' 80' ' ' LEU . 81.1 t60 -61.21 -27.76 68.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.151 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -96.05 -57.59 2.31 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.671 HD12 ' CE1' ' A' ' 44' ' ' PHE . 40.3 mt -47.53 -31.22 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.486 0.66 . . . . 0.0 109.391 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 6.8 t -58.88 -53.49 57.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.728 -0.608 . . . . 0.0 110.935 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -66.85 -7.44 21.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.97 . . . . 0.0 110.697 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.637 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -90.72 -12.63 36.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.005 . . . . 0.0 110.897 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 47' ' ' THR . 6.3 mt -90.63 -66.78 0.9 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 111.204 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.2 mm -89.91 -34.29 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.875 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD12 ' A' ' 89' ' ' ILE . 7.9 mmpt? -89.36 -25.3 21.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.945 . . . . 0.0 110.36 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 67.77 5.46 38.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.5 mt -72.87 153.1 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 120.914 -1.345 . . . . 0.0 110.06 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -82.21 176.77 3.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.739 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 42.2 Cg_endo -70.81 168.31 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.984 1.518 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.601 ' HD2' HD13 ' A' ' 60' ' ' LEU . 52.8 Cg_endo -78.84 38.37 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.048 1.552 . . . . 0.0 111.33 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.508 ' O ' HD21 ' A' ' 60' ' ' LEU . 84.9 m-70 55.97 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.06 . . . . 0.0 111.043 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.699 ' HA ' HD21 ' A' ' 60' ' ' LEU . 12.2 m -116.83 -161.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.68 -1.262 . . . . 0.0 111.795 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.652 ' CD2' HD23 ' A' ' 60' ' ' LEU . 2.9 mm? -96.45 149.18 22.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.465 0.65 . . . . 0.0 111.343 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.551 ' OG1' ' HG3' ' A' ' 99' ' ' MET . 0.8 OUTLIER -117.19 173.46 3.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 44.3 Cg_endo -72.91 -12.17 26.02 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.593 1.312 . . . . 0.0 110.153 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -97.39 -7.37 31.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.676 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.079 ' SD ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -116.1 10.84 15.11 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.053 -1.029 . . . . 0.0 108.955 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 96' ' ' THR 0.25 19.5 mt -106.48 138.24 19.67 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.638 -0.663 . . . . 0.0 110.828 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HG3' ' NE2' ' A' ' 73' ' ' GLN . 48.3 Cg_endo -75.69 134.65 16.93 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.13 107.16 2.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.877 1.461 . . . . 0.0 110.424 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.044 -179.807 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -124.53 144.88 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.471 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.5 m -66.1 -42.4 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.916 0.865 . . . . 0.0 109.31 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 6.1 p -111.99 159.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER 171.28 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.684 -1.26 . . . . 0.0 111.696 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 13' ' ' SER . 44.2 Cg_endo -67.92 -149.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.528 1.278 . . . . 0.0 110.612 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.69 -44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.266 0.555 . . . . 0.0 111.813 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.5 mt-10 -53.08 -62.09 1.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.669 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.01 -37.75 61.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.013 . . . . 0.0 109.915 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.87 64.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.792 . . . . 0.0 109.696 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 23' ' ' ILE . 3.1 ttpt -53.37 -29.27 33.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.09 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 3.7 m-85 -91.07 -52.92 4.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 110.102 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' TYR . 30.9 t70 -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.862 . . . . 0.0 109.551 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 66.5 mm-40 -75.26 -37.35 61.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.479 -0.763 . . . . 0.0 108.964 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.775 HG22 ' OG1' ' A' ' 27' ' ' THR . 64.7 mt -74.27 -38.15 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.441 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CD2' ' HE3' ' A' ' 71' ' ' LYS . 74.8 t80 -48.65 -40.11 26.64 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.913 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 3.9 mt -64.4 -23.48 67.3 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.459 -0.897 . . . . 0.0 108.721 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' ILE . 37.6 mttt -102.62 -11.27 18.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.71 . . . . 0.0 109.134 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.059 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 m -88.87 -54.78 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' CA ' ' HB ' ' A' ' 35' ' ' VAL . 21.4 t0 -68.0 89.5 0.3 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 26' ' ' LYS . 2.3 mttt -93.55 -12.43 29.6 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.998 -1.064 . . . . 0.0 112.591 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 31' ' ' MET . 25.5 p-10 -96.16 -12.39 24.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.61 -1.306 . . . . 0.0 110.755 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 62.0 63.76 1.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 27.2 p30 -120.14 -4.42 10.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.752 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.55 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 122.77 -41.56 1.78 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -140.22 154.07 46.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.961 . . . . 0.0 109.042 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -88.25 127.21 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.598 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -79.49 149.56 31.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.348 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -40.17 -27.84 0.15 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -59.13 -46.06 89.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.847 -0.796 . . . . 0.0 111.562 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.917 ' HB2' HG23 ' A' ' 35' ' ' VAL . 2.2 mt-10 -81.13 -52.41 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.404 -1.435 . . . . 0.0 108.7 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG13 ' HA2' ' A' ' 37' ' ' GLY . 1.6 p -65.27 -10.38 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.796 0.808 . . . . 0.0 109.384 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -45.8 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 110.692 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -43.19 -37.28 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 HG23 ' A' ' 27' ' ' THR . 1.4 mt -62.35 -50.11 81.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -73.5 -33.83 64.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 108.902 178.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 91.7 mt -65.1 -16.79 63.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.791 . . . . 0.0 109.367 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -86.76 -11.58 50.63 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.425 -0.797 . . . . 0.0 109.783 179.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.792 HG21 HD13 ' A' ' 81' ' ' ILE . 68.1 p -68.25 -17.87 64.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.51 13.95 69.32 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 85' ' ' LEU . 10.4 mp -84.26 166.52 32.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.974 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 53' ' ' LEU . 49.0 Cg_endo -77.19 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.086 1.572 . . . . 0.0 109.271 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -94.54 -70.82 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.848 -1.157 . . . . 0.0 110.323 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -42.38 -57.59 2.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.148 -0.97 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.669 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.3 tp -43.5 -52.25 6.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.894 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 49' ' ' LEU . 1.2 tp -57.66 -46.57 84.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.022 . . . . 0.0 109.503 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -63.9 -33.29 75.37 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.584 ' CE1' ' O ' ' A' ' 93' ' ' HIS . 70.7 t60 -73.04 -43.84 61.51 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 3.1 mt -63.41 -24.06 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.626 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 61.9 t-105 -66.59 -52.26 47.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.94 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.583 ' O ' HD21 ' A' ' 95' ' ' LEU . 27.8 t -63.85 -33.94 76.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.839 ' O ' HD11 ' A' ' 95' ' ' LEU . 3.7 tp -64.46 -32.19 73.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.633 -0.667 . . . . 0.0 109.731 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.721 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.6 p -96.02 -36.25 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.721 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 55.3 t0 -68.03 56.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.523 ' OG1' ' NE2' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -60.6 -31.05 70.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.121 -0.987 . . . . 0.0 109.65 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HD3' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -58.55 -15.12 9.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 44.18 55.08 5.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 110.158 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 -39.85 2.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.16 -13.06 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 34' ' ' PHE . 3.5 mttm -139.71 -169.45 2.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.325 -1.103 . . . . 0.0 109.315 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 74' ' ' PHE . 3.6 mt -108.5 122.69 47.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 111.304 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.571 ' CB ' ' HG3' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -73.82 -172.97 1.4 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.05 -1.031 . . . . 0.0 109.178 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HE3' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -64.16 -89.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.75 -1.219 . . . . 0.0 110.282 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -47.84 -36.28 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 110.105 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.571 ' HG3' ' CB ' ' A' ' 70' ' ' SER . 5.5 mm-40 -60.05 -35.06 74.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.997 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.939 ' HA ' HD22 ' A' ' 69' ' ' LEU . 25.9 t80 -71.09 -32.11 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 108.918 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 17' ' ' LYS . . . -69.18 -8.12 42.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.826 HD21 ' HG3' ' A' ' 99' ' ' MET . 3.9 tt -90.42 -36.92 14.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 110.54 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -55.22 -46.15 75.95 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.002 -1.061 . . . . 0.0 109.716 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 11.5 m-85 -60.43 -34.38 73.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 110.162 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 76.7 t60 -53.15 -21.43 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.802 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.764 HD13 HD23 ' A' ' 60' ' ' LEU . 4.4 mt -98.18 -24.78 15.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 0.0 108.784 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 13.1 mt -69.94 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' ILE . 9.4 t -40.98 -32.14 0.22 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.704 -0.623 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -75.16 -24.99 57.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.919 -1.113 . . . . 0.0 110.314 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ILE . 20.5 tptt -90.07 -18.0 26.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 111.331 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HD11 ' A' ' 49' ' ' LEU . 5.3 mt -88.76 -62.8 1.4 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.953 -1.092 . . . . 0.0 111.282 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 86' ' ' ILE . 17.0 mm -92.7 -19.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.112 -0.993 . . . . 0.0 111.337 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.013 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.5 mmpt? -108.43 -7.86 15.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.989 -1.069 . . . . 0.0 110.843 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.07 20.91 4.95 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.013 HD12 ' HB3' ' A' ' 87' ' ' LYS . 6.5 mt -90.32 134.95 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.2 p-10 -71.38 169.92 13.65 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.872 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 53' ' ' LEU . 42.9 Cg_endo -71.43 155.79 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.846 1.445 . . . . 0.0 110.644 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.63 ' CD ' HD22 ' A' ' 80' ' ' LEU . 40.4 Cg_endo -67.53 59.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.584 ' O ' ' CE1' ' A' ' 56' ' ' HIS . 0.7 OUTLIER 37.32 -93.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.673 -0.642 . . . . 0.0 111.617 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.769 ' C ' HD11 ' A' ' 60' ' ' LEU . 13.1 m -106.92 -164.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.249 -0.907 . . . . 0.0 111.476 -178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.839 HD11 ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -76.28 163.34 27.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.793 0.806 . . . . 0.0 111.256 -179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.615 ' O ' HD12 ' A' ' 100' ' ' ILE . 50.5 p -140.57 167.02 19.15 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 43.3 Cg_endo -69.4 -26.65 29.07 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.434 1.229 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 11' ' ' VAL . 16.1 mp0 -79.44 -20.14 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 108.886 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.826 ' HG3' HD21 ' A' ' 76' ' ' LEU . 29.9 ttm -98.29 -6.21 31.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.644 -0.66 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 96' ' ' THR . 38.5 mt -102.88 107.81 56.13 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.397 -0.814 . . . . 0.0 110.428 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.664 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 42.1 Cg_endo -73.27 -29.61 11.26 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.897 1.472 . . . . 0.0 112.942 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.4 Cg_endo -71.6 -170.75 0.55 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.559 0.768 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.959 HG22 ' HA ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.168 0.509 . . . . 0.0 110.188 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER 60.5 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 109.802 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.009 ' CG2' HG23 ' A' ' 12' ' ' VAL . 1.5 m -71.67 -159.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.009 -1.057 . . . . 0.0 109.197 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 76' ' ' LEU . 9.9 t 49.1 101.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.064 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -131.29 -67.35 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.744 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.768 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 13' ' ' SER . 48.8 Cg_endo -67.97 -149.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.366 1.193 . . . . 0.0 112.068 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.79 -51.06 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.963 -0.461 . . . . 0.0 112.142 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 5.3 mt-10 -40.34 -61.98 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 110.672 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -56.59 -32.53 65.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.807 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -72.15 -48.43 43.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 109.749 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -29.66 69.33 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.683 0.754 . . . . 0.0 109.51 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 6.0 m-30 -84.39 -45.76 12.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.613 -0.679 . . . . 0.0 110.681 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -54.91 -39.89 69.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.815 -1.178 . . . . 0.0 109.352 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 25' ' ' LEU . 3.3 mm-40 -69.41 -50.35 46.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.29 -0.881 . . . . 0.0 109.072 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 26' ' ' LYS . 65.9 mt -63.83 -39.08 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.151 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 71' ' ' LYS . 85.0 t80 -46.74 -36.33 7.1 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.584 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 22' ' ' GLU . 6.3 mt -68.79 -21.24 64.34 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.383 -0.823 . . . . 0.0 109.163 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' ILE . 12.2 mttt -101.14 -11.46 19.55 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.585 0.707 . . . . 0.0 109.162 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.933 HG23 HD12 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -89.83 -50.37 6.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.535 0.683 . . . . 0.0 109.801 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 40.1 t0 -66.52 71.04 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.572 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 27' ' ' THR . 3.6 mptp? -62.23 -12.99 23.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.273 -0.892 . . . . 0.0 111.432 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 74.5 m-20 -93.98 -0.31 55.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.911 -1.118 . . . . 0.0 110.474 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.0 mtm 45.29 27.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.813 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.57 ' OD2' ' CZ ' ' A' ' 34' ' ' PHE . 12.1 p-10 -90.22 2.86 54.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.6 12.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.735 ' CD2' ' HB2' ' A' ' 68' ' ' LYS . 38.9 p90 -150.47 162.51 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.143 . . . . 0.0 110.525 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.916 HG21 HG22 ' A' ' 27' ' ' THR . 2.4 p -99.86 146.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.445 -0.785 . . . . 0.0 110.995 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.714 ' O ' HG12 ' A' ' 40' ' ' VAL . 80.6 p -94.57 155.16 17.03 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' N ' ' CH2' ' A' ' 58' ' ' TRP . . . -52.94 -18.41 5.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 38' ' ' LEU . 5.8 mt -73.5 -30.46 63.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 111.024 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.824 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.2 mt-10 -87.68 -60.16 2.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -54.3 -17.44 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.672 0.749 . . . . 0.0 109.659 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -46.66 -75.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.315 -0.866 . . . . 0.0 110.087 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.772 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.8 mt-10 -44.57 -37.29 3.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.551 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.933 HD12 HG23 ' A' ' 27' ' ' THR . 1.1 mt -61.6 -46.94 95.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.644 -0.66 . . . . 0.0 109.392 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -79.76 -27.32 40.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 109.469 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 42' ' ' GLU . 62.2 mt -60.07 -16.7 33.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.858 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 25.5 mtpp -80.39 -25.19 39.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.707 -0.62 . . . . 0.0 109.938 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' HG21 ' A' ' 81' ' ' ILE . 69.9 p -52.63 -26.44 13.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.9 -11.56 71.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 4.6 mp -67.96 167.28 17.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.465 -1.02 . . . . 0.0 110.136 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' HD22 ' A' ' 53' ' ' LEU . 44.5 Cg_endo -72.15 153.37 56.99 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.855 1.45 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 52' ' ' THR . 19.0 t -59.04 -63.2 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.605 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 51' ' ' SER . 51.7 m -40.07 -48.66 2.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.573 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -55.39 -56.49 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.936 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.2 mt -54.22 -36.88 63.97 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.264 -0.897 . . . . 0.0 109.052 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.56 85.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -68.08 -26.6 65.91 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 81' ' ' ILE . 3.3 mt -76.64 -29.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.768 ' CZ3' HD12 ' A' ' 69' ' ' LEU . 50.2 t-105 -64.34 -45.85 86.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.179 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.422 ' O ' HD21 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -70.52 -37.58 74.13 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.961 HD23 HD22 ' A' ' 95' ' ' LEU . 5.3 mt -66.29 -14.57 62.22 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.981 ' SG ' HD21 ' A' ' 69' ' ' LEU . 17.2 t -110.04 -41.69 4.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.466 -0.771 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.8 t0 -62.92 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.667 -0.646 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.4 p -65.06 -35.49 81.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.11 -0.994 . . . . 0.0 110.36 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HD3' ' OE1' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -56.28 -17.05 6.5 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.924 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 49.63 52.95 13.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -128.78 8.85 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.136 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.24 27.48 57.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.735 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -150.52 173.6 13.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -1.111 . . . . 0.0 110.036 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.981 HD21 ' SG ' ' A' ' 61' ' ' CYS . 1.1 mt -114.99 93.37 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 34' ' ' PHE . 21.0 p -50.73 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.463 -0.773 . . . . 0.0 110.635 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -68.19 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.94 -1.1 . . . . 0.0 111.111 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 73' ' ' GLN . 2.3 p30 -42.57 -28.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 110.825 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.592 ' HB3' HD23 ' A' ' 69' ' ' LEU . 14.9 mt-30 -64.11 -59.17 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.072 -1.017 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 27' ' ' THR . 41.9 t80 -45.74 -29.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.834 -1.167 . . . . 0.0 109.778 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.809 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -80.41 -13.82 58.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.051 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -89.87 -34.23 16.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.529 -0.732 . . . . 0.0 110.313 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -58.58 -46.93 85.88 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.904 -1.123 . . . . 0.0 110.379 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 10.6 m-85 -59.39 -31.61 69.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.186 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.952 ' HB2' HG22 ' A' ' 12' ' ' VAL . 40.1 t60 -57.43 -25.8 60.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 109.927 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.632 HD23 ' HD2' ' A' ' 79' ' ' HIS . 1.3 mt -90.31 -29.48 18.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.604 HD12 ' CD1' ' A' ' 44' ' ' PHE . 1.3 mm -74.09 -50.33 28.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.592 0.711 . . . . 0.0 109.1 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -27.31 33.33 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.638 -0.664 . . . . 0.0 110.364 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -72.59 -24.59 61.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 0.0 110.269 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -29.03 20.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 111.421 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -76.79 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.978 -1.077 . . . . 0.0 110.832 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -93.8 -15.64 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.428 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.775 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 mptt -117.45 -11.54 10.52 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 51.68 21.97 7.76 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.775 HD12 ' HB3' ' A' ' 87' ' ' LYS . 18.5 mt -89.94 143.97 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.533 -0.981 . . . . 0.0 109.718 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.0 m-20 -82.33 165.74 40.76 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 38.3 Cg_endo -66.37 157.5 59.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.053 1.554 . . . . 0.0 110.821 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' VAL . 44.9 Cg_endo -72.69 56.56 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.196 1.629 . . . . 0.0 111.134 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.495 ' O ' HD11 ' A' ' 60' ' ' LEU . 5.4 m-70 38.12 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 111.25 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.653 ' CA ' HD21 ' A' ' 60' ' ' LEU . 6.5 m -106.86 -170.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.117 -0.989 . . . . 0.0 111.286 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.961 HD22 HD23 ' A' ' 60' ' ' LEU . 4.1 mm? -75.37 167.83 21.15 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.927 0.87 . . . . 0.0 111.863 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.027 ' O ' HD12 ' A' ' 100' ' ' ILE . 23.2 p -145.5 166.61 16.95 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.4 Cg_endo -69.52 -29.18 25.44 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.479 1.252 . . . . 0.0 109.831 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.959 ' HA ' HG22 ' A' ' 9' ' ' THR . 1.5 mt-10 -75.33 -20.32 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 108.79 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 95' ' ' LEU . 6.5 ttm -94.73 -46.6 6.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 110.501 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.027 HD12 ' O ' ' A' ' 96' ' ' THR . 1.6 mt -51.82 142.77 24.01 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 110.409 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.878 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 57.0 Cg_endo -70.96 -118.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 O-C-N 123.964 1.507 . . . . 0.0 108.249 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.878 ' CD ' ' HB2' ' A' ' 101' ' ' PRO . 47.0 Cg_endo -70.52 -165.4 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 121.845 1.694 . . . . 0.0 110.164 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.12 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.282 0.563 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -146.17 157.08 43.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.944 -1.097 . . . . 0.0 110.365 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 98' ' ' GLU . 2.3 m -89.96 -159.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.011 -1.055 . . . . 0.0 111.413 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 75' ' ' ALA . 8.6 p 34.87 62.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 111.362 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -102.42 -39.61 0.21 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 0.0 113.222 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 13' ' ' SER . 55.2 Cg_endo -78.94 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.109 1.057 . . . . 0.0 112.029 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -27.83 -53.16 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 12' ' ' VAL . 12.8 mt-10 -39.53 -58.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.476 -0.765 . . . . 0.0 110.315 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -54.49 -38.3 66.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.019 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.52 -47.09 74.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -62.51 -29.15 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.637 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 17.5 m-85 -85.94 -38.27 18.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.483 -0.761 . . . . 0.0 109.589 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -53.53 -39.72 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.082 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.1 mm-40 -69.43 -41.71 75.95 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.423 -0.798 . . . . 0.0 109.042 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 26' ' ' LYS . 37.6 mt -66.5 -40.2 85.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HG2' ' A' ' 71' ' ' LYS . 60.6 t80 -48.56 -36.89 16.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.162 -0.961 . . . . 0.0 108.799 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 22' ' ' GLU . 13.8 mt -65.32 -21.85 66.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -99.92 -14.88 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.098 HG21 ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -89.6 -55.13 3.77 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.565 0.698 . . . . 0.0 109.621 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -66.33 76.73 0.1 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.671 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -61.91 -9.68 7.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.0 111.449 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.51 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 11.2 m-20 -105.16 -4.51 21.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.789 -1.195 . . . . 0.0 110.415 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 31' ' ' MET . 1.0 OUTLIER 57.87 25.39 11.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 30' ' ' ASP . 11.9 p30 -92.59 19.28 7.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.58 13.54 58.84 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.62 ' CE1' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -151.02 108.25 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -1.086 . . . . 0.0 110.867 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.982 HG21 HG22 ' A' ' 27' ' ' THR . 2.1 p -89.11 140.85 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.867 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 t -96.75 161.62 13.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.771 -1.205 . . . . 0.0 110.632 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 41' ' ' ARG . . . -55.21 -16.74 9.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.0 mm? -74.86 -29.7 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.704 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.5 mt-10 -91.92 -64.02 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.999 -1.063 . . . . 0.0 108.828 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.867 HG12 ' O ' ' A' ' 36' ' ' SER . 1.3 p -52.27 -20.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.012 0.91 . . . . 0.0 109.579 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -41.71 -60.53 1.32 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.672 -0.643 . . . . 0.0 110.977 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -58.06 -41.39 83.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.924 -1.11 . . . . 0.0 108.975 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 HG23 ' A' ' 27' ' ' THR . 1.2 mt -56.56 -36.18 47.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.366 0.603 . . . . 0.0 109.414 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.987 ' CZ ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.77 -23.03 25.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.865 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' ' HG3' ' A' ' 41' ' ' ARG . 25.8 mt -78.51 -23.99 46.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 109.219 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.06 -4.38 58.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.736 . . . . 0.0 109.987 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.761 HG21 HD13 ' A' ' 81' ' ' ILE . 66.6 p -72.94 -15.78 61.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 49' ' ' LEU . . . 91.02 18.51 46.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 85' ' ' LEU . 9.0 mp -95.74 172.72 4.97 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.763 -0.845 . . . . 0.0 110.366 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 53' ' ' LEU . 49.0 Cg_endo -84.68 -157.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.156 1.608 . . . . 0.0 109.76 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.982 -1.074 . . . . 0.0 110.639 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -59.1 -54.68 44.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.778 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.567 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -44.0 -42.25 5.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 0.0 110.407 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.597 ' HG ' ' CD1' ' A' ' 44' ' ' PHE . 1.1 mp -62.97 -52.5 62.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 109.537 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.51 70.13 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.432 ' NE2' HD11 ' A' ' 60' ' ' LEU . 67.1 t60 -73.44 -32.76 64.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.769 HG21 ' CE1' ' A' ' 44' ' ' PHE . 5.2 mt -77.34 -29.86 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.712 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 55.5 t-105 -63.97 -43.84 94.56 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.831 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.4 t -71.85 -28.95 63.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 93' ' ' HIS . 11.4 mt -71.42 -11.46 60.9 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 69' ' ' LEU . 5.3 t -118.87 -41.7 2.76 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.474 -0.766 . . . . 0.0 109.316 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.07 69.17 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.9 p -59.89 -37.56 79.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.653 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -59.39 -13.9 10.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.452 -0.78 . . . . 0.0 109.922 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.9 p-10 38.62 50.2 1.55 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 110.423 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -10.08 9.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.567 -0.708 . . . . 0.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.8 -11.72 27.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 mttm -115.96 -171.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -1.137 . . . . 0.0 110.098 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.031 HD21 ' SG ' ' A' ' 61' ' ' CYS . 0.6 OUTLIER -129.91 108.67 10.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -53.66 -170.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -78.92 -78.29 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.06 . . . . 0.0 110.515 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -44.34 -46.47 9.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 76' ' ' LEU . 2.1 mt-30 -50.84 -52.98 36.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.098 ' CE1' HG21 ' A' ' 27' ' ' THR . 63.1 t80 -44.73 -34.85 2.41 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.212 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.003 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -78.06 -14.39 59.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.088 -1.007 . . . . 0.0 109.741 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.962 HD21 ' CG ' ' A' ' 99' ' ' MET . 7.3 tt -85.19 -23.35 28.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.682 -0.636 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -69.39 -54.62 13.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 109.587 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.736 ' HZ ' HG23 ' A' ' 43' ' ' ILE . 19.1 m-85 -52.76 -34.03 51.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.661 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 17.2 t60 -51.43 -21.81 2.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 57' ' ' ILE . 2.9 mt -98.48 -22.96 15.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 108.924 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.987 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 14.3 mt -73.51 -52.69 20.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.592 -0.693 . . . . 0.0 110.282 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ILE . 4.1 mt-30 -71.69 -25.03 61.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -90.08 -19.9 23.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 111.214 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 49' ' ' LEU . 5.6 mt -84.92 -60.8 1.94 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.114 . . . . 0.0 111.402 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.9 mm -95.91 -35.95 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.073 -1.017 . . . . 0.0 110.999 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.5 OUTLIER -89.41 -13.96 36.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.045 -1.034 . . . . 0.0 110.813 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 53.83 18.8 8.97 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 87' ' ' LYS . 23.6 mt -86.61 161.28 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.16 -1.2 . . . . 0.0 109.721 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 2.7 p-10 -90.39 169.35 12.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 41.6 Cg_endo -70.21 156.25 62.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.88 1.463 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' HIS . 42.7 Cg_endo -70.13 62.93 2.0 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.125 1.592 . . . . 0.0 111.365 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.709 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.8 OUTLIER 40.08 -112.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 111.001 179.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 ' ND1' ' A' ' 93' ' ' HIS . 3.8 m -101.97 -172.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.744 -1.222 . . . . 0.0 111.245 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.679 HD13 ' H ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -62.94 164.37 8.26 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 111.396 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.679 ' H ' HD13 ' A' ' 95' ' ' LEU . 30.0 p -145.85 167.88 13.15 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 41.9 Cg_endo -70.09 -23.17 29.62 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.486 1.256 . . . . 0.0 109.266 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.027 ' O ' HG13 ' A' ' 11' ' ' VAL . 2.0 mt-10 -82.41 -2.11 52.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.423 -0.798 . . . . 0.0 109.127 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.962 ' CG ' HD21 ' A' ' 76' ' ' LEU . 30.7 ttm -119.08 5.09 11.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 95' ' ' LEU 0.253 33.4 mt -108.47 100.53 38.49 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.665 -0.647 . . . . 0.0 110.486 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.654 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 40.3 Cg_endo -72.96 -30.45 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.759 1.4 . . . . 0.0 113.017 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 50.4 Cg_endo -73.01 145.08 39.18 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 122.574 0.776 . . . . 0.0 110.342 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.931 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.445 0.641 . . . . 0.0 111.243 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.72 ' CZ3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 61.89 93.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.749 . . . . 0.0 109.65 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 98' ' ' GLU . 2.4 m -70.92 -32.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -0.872 . . . . 0.0 109.804 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.72 HG13 ' CZ3' ' A' ' 10' ' ' TRP . 2.4 p -123.65 146.34 29.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -167.02 -59.64 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.845 -1.16 . . . . 0.0 112.675 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 15' ' ' ALA . 40.9 Cg_endo -63.24 -141.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.34 1.179 . . . . 0.0 110.807 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.83 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 112.217 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 2.1 mt-10 -36.28 -63.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.636 -0.665 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -52.21 -33.81 42.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.086 . . . . 0.0 110.418 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.54 -48.16 70.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -56.27 -31.0 63.2 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 9.6 m-85 -91.65 -52.06 4.94 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.704 -0.623 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 10.3 t0 -42.74 -39.77 2.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.649 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.3 mt-10 -71.66 -35.5 70.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.407 -0.808 . . . . 0.0 109.072 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 27' ' ' THR . 31.7 mt -72.43 -41.75 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.805 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 71' ' ' LYS . 47.1 t80 -46.44 -28.58 1.41 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.543 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 22' ' ' GLU . 12.8 mt -73.08 -33.16 65.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 23' ' ' ILE . 24.3 mttp -93.72 -10.05 35.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.081 HG23 HD12 ' A' ' 43' ' ' ILE . 1.1 m -89.53 -58.84 2.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 55.2 t0 -66.13 82.59 0.08 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -75.41 11.41 1.25 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.93 -1.106 . . . . 0.0 112.332 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 2.9 m-20 -116.67 5.74 13.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.3 mmt 46.08 35.52 2.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 111.055 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 34' ' ' PHE . 2.8 p30 -108.06 12.78 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.55 12.47 80.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -150.84 109.93 3.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.286 . . . . 0.0 110.8 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.933 HG21 HG22 ' A' ' 27' ' ' THR . 13.2 p -89.6 137.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.982 . . . . 0.0 108.495 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.2 p -85.87 153.59 22.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.103 -0.998 . . . . 0.0 111.172 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -50.99 -21.7 5.53 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 mt -73.07 -32.31 64.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -1.054 . . . . 0.0 110.42 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 36.6 mt-10 -82.67 -54.06 5.44 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 36' ' ' SER . 1.4 p -66.86 -14.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.342 0.591 . . . . 0.0 109.735 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -47.24 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.154 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.71 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -43.61 -44.5 6.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.081 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -50.75 -40.95 20.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.783 ' HB3' HD22 ' A' ' 54' ' ' LEU . 1.6 m-30 -83.2 -38.65 22.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 42' ' ' GLU . 43.3 mt -55.86 -18.5 8.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.356 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 83.0 mttt -79.61 -13.57 59.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 109.323 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.823 HG21 HG21 ' A' ' 81' ' ' ILE . 64.1 p -66.23 -16.77 64.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.26 66.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 53' ' ' LEU . 3.1 mp -100.13 171.94 5.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.641 -0.917 . . . . 0.0 110.085 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.621 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.4 Cg_endo -77.19 155.64 33.2 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.723 1.381 . . . . 0.0 110.073 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.02 67.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.967 . . . . 0.0 110.995 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -45.38 73.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.995 . . . . 0.0 111.24 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.621 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -54.99 -51.17 67.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.89 -1.131 . . . . 0.0 110.478 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 44' ' ' PHE . 35.3 mt -59.85 -36.6 77.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -68.34 -48.19 65.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -60.56 -37.77 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.796 HD13 HG13 ' A' ' 81' ' ' ILE . 12.8 mt -64.74 -37.25 79.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.613 ' CZ3' ' HG ' ' A' ' 69' ' ' LEU . 40.3 t-105 -57.13 -52.84 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -33.59 71.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.168 -0.957 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.757 HD11 ' C ' ' A' ' 94' ' ' VAL . 15.9 tp -67.0 -23.62 65.95 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.253 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 56.0 m -105.74 -36.09 7.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 68' ' ' LYS . 51.8 t0 -67.01 58.37 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 109.155 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' CYS . 1.4 p -53.76 -29.57 40.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HD3' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -62.69 -11.1 15.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.436 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 64' ' ' LYS . 3.7 p30 37.02 55.49 1.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.615 -0.678 . . . . 0.0 110.465 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.73 -11.18 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.18 -21.09 27.49 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 16.3 mmtm -114.68 -176.41 2.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.406 -1.055 . . . . 0.0 109.584 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' HG ' ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -114.54 108.57 17.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.933 -1.105 . . . . 0.0 110.562 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -64.56 167.69 6.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 109.373 179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -56.04 -72.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.558 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -44.42 -37.52 3.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 110.637 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 44.4 mm-40 -67.33 -49.6 63.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.037 -1.04 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 27' ' ' THR . 8.9 t80 -56.61 -26.92 57.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.72 -1.238 . . . . 0.0 108.588 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.52 -11.4 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.598 0.713 . . . . 0.0 109.277 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.816 HD21 ' CG ' ' A' ' 99' ' ' MET . 6.1 tp -88.64 -42.41 12.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 110.087 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.579 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . -62.89 -26.39 68.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.298 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 1.4 m-85 -76.12 -20.36 57.7 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.741 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.642 ' C ' HD23 ' A' ' 80' ' ' LEU . 82.3 t60 -73.29 -22.56 60.34 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.557 -0.714 . . . . 0.0 109.172 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -99.72 -38.46 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.435 -0.79 . . . . 0.0 108.894 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 47' ' ' THR . 76.6 mt -66.66 -46.99 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -62.69 -16.76 58.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.492 -0.755 . . . . 0.0 109.915 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -77.8 -24.01 48.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 110.032 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -10.52 47.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 81' ' ' ILE . 6.0 mt -89.99 -55.37 3.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.065 -1.022 . . . . 0.0 110.749 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 86' ' ' ILE . 7.2 mm -108.9 -17.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.092 -1.005 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -108.44 -2.73 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.949 -1.094 . . . . 0.0 110.45 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 42.22 53.93 4.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 87' ' ' LYS . 2.4 mt -125.63 168.37 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.302 -1.117 . . . . 0.0 109.832 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 89' ' ' ILE . 1.7 m-20 -113.32 171.54 4.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.452 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 40.8 Cg_endo -70.46 151.68 65.25 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.897 1.472 . . . . 0.0 109.999 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 94' ' ' VAL . 43.6 Cg_endo -70.85 51.64 1.25 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.938 1.494 . . . . 0.0 111.168 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.739 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 50.2 -83.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.426 -0.796 . . . . 0.0 111.679 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.757 ' C ' HD11 ' A' ' 60' ' ' LEU . 11.5 m -108.36 -162.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 60' ' ' LEU . 2.0 mm? -86.71 144.0 27.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.739 0.781 . . . . 0.0 111.243 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.877 ' O ' HD12 ' A' ' 100' ' ' ILE . 39.3 p -111.12 168.09 8.09 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.7 Cg_endo -68.38 -38.43 11.6 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 123.289 1.152 . . . . 0.0 109.863 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 9' ' ' THR . 1.7 mt-10 -71.26 -27.2 63.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 108.611 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.816 ' CG ' HD21 ' A' ' 76' ' ' LEU . 24.1 ttm -84.66 -25.52 28.41 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.422 0.63 . . . . 0.0 109.624 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 96' ' ' THR . 7.5 mt -87.01 135.82 34.71 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.097 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.44 ' HG3' ' HE3' ' A' ' 64' ' ' LYS . 41.6 Cg_endo -69.56 116.82 4.72 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.771 1.406 . . . . 0.0 109.695 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.45 -91.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.797 1.419 . . . . 0.0 111.107 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 110.45 -179.465 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.251 0.548 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -134.6 139.94 45.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 98' ' ' GLU . 1.7 m -58.07 -44.71 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' ' CE3' ' A' ' 10' ' ' TRP . 3.0 p -115.66 166.13 10.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER 167.06 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.074 -1.016 . . . . 0.0 111.926 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 13' ' ' SER . 45.6 Cg_endo -66.28 -146.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.263 1.139 . . . . 0.0 110.81 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -28.96 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 111.524 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 43.7 mt-10 -54.09 -64.13 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -54.04 -32.67 55.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.902 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.46 -52.31 16.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.32 -30.15 62.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.007 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 7.6 m-30 -89.56 -50.51 6.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 8.9 t0 -43.27 -40.64 3.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 109.41 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.2 mt-10 -69.25 -34.96 75.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 108.882 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 ' HE2' ' A' ' 74' ' ' PHE . 60.6 mt -74.66 -38.77 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.459 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 70' ' ' SER . 68.4 t80 -50.1 -33.08 17.5 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.53 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' GLU . 18.0 mt -65.87 -24.86 66.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.69 -16.09 19.14 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.96 ' CG2' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -88.75 -52.98 4.84 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.502 -0.749 . . . . 0.0 109.8 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' N ' ' HB ' ' A' ' 35' ' ' VAL . 67.6 t0 -67.14 63.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 109.29 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 11.1 mttm -65.5 -3.82 4.97 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.383 -0.823 . . . . 0.0 111.966 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 39' ' ' GLU . 45.9 m-20 -103.36 -11.06 18.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.683 -1.261 . . . . 0.0 110.672 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 57.42 37.45 27.89 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 19.5 p30 -103.11 1.32 33.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' C ' ' CD1' ' A' ' 34' ' ' PHE . . . 110.68 -32.56 6.49 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -135.68 147.08 48.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.96 HG21 ' CG2' ' A' ' 27' ' ' THR . 1.4 p -88.94 135.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.344 -0.848 . . . . 0.0 108.733 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 40' ' ' VAL . 7.8 p -86.58 151.02 23.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 0.0 110.426 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CG1' ' A' ' 40' ' ' VAL . . . -43.54 -24.95 0.45 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 80.9 mt -65.07 -41.28 95.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -1.06 . . . . 0.0 111.591 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.859 ' HB2' HG23 ' A' ' 35' ' ' VAL . 5.5 mt-10 -81.03 -58.4 3.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.787 -1.195 . . . . 0.0 108.769 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' SER . 1.5 p -57.01 -16.43 4.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.547 0.689 . . . . 0.0 109.639 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -43.94 -76.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.476 -0.765 . . . . 0.0 110.823 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.7 mt-10 -44.63 -46.58 10.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.071 . . . . 0.0 108.59 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.863 HD12 HG23 ' A' ' 27' ' ' THR . 1.5 mt -53.09 -37.27 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 1.9 m-30 -85.76 -45.79 11.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.655 -0.653 . . . . 0.0 109.438 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 42' ' ' GLU . 27.2 mt -51.48 -27.58 10.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 3.2 ptmt -73.86 -5.37 40.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.662 -0.649 . . . . 0.0 109.751 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 44' ' ' PHE . 65.3 p -78.97 -18.06 54.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.844 . . . . 0.0 110.015 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.85 86.56 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 6.8 mp -81.01 166.99 35.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.44 -1.035 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' HD2' HD22 ' A' ' 53' ' ' LEU . 48.0 Cg_endo -78.36 176.5 9.85 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.915 1.481 . . . . 0.0 110.56 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -44.03 61.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.636 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 53' ' ' LEU . 5.3 m -65.6 -59.0 4.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.702 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -44.54 -39.71 5.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.97 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 54' ' ' LEU . 33.3 mt -65.38 -53.24 46.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.38 68.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -74.97 -38.41 61.68 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.526 HD13 ' CG1' ' A' ' 81' ' ' ILE . 3.8 mt -71.68 -28.51 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.761 ' HZ3' HD12 ' A' ' 69' ' ' LEU . 71.7 t-105 -61.56 -44.24 97.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.274 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' HD21 ' A' ' 95' ' ' LEU . 1.2 t -71.12 -33.67 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.26 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.895 HD23 HD22 ' A' ' 95' ' ' LEU . 12.3 mt -67.05 -27.53 67.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.566 -0.709 . . . . 0.0 109.466 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.93 ' CB ' ' HB2' ' A' ' 77' ' ' ALA . 19.4 p -102.12 -35.13 9.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.447 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' H ' ' HG ' ' A' ' 61' ' ' CYS . 45.7 t0 -75.4 57.13 0.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.582 -0.699 . . . . 0.0 110.004 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 100' ' ' ILE . 4.6 p -52.49 -33.04 43.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -63.03 -12.38 25.83 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.67 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' LYS . 4.1 t70 40.81 53.84 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.789 . . . . 0.0 110.139 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.85 7.9 10.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.453 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.55 -12.69 62.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.584 ' CA ' ' HZ2' ' A' ' 58' ' ' TRP . 32.4 mttt -126.43 175.44 7.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.177 . . . . 0.0 109.766 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.761 HD12 ' HZ3' ' A' ' 58' ' ' TRP . 2.9 mt -113.35 114.88 27.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.809 -1.182 . . . . 0.0 111.707 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.638 ' CB ' ' HG2' ' A' ' 73' ' ' GLN . 0.3 OUTLIER -64.02 -172.85 0.07 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.983 -1.073 . . . . 0.0 110.219 179.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -70.5 -46.2 64.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 111.361 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.24 -3.28 58.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.072 -1.018 . . . . 0.0 111.199 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.638 ' HG2' ' CB ' ' A' ' 70' ' ' SER . 34.3 mm-40 -89.03 -43.69 10.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.901 -1.124 . . . . 0.0 109.596 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE2' HG22 ' A' ' 23' ' ' ILE . 14.6 t80 -61.38 -24.72 66.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HB1' ' HG2' ' A' ' 17' ' ' LYS . . . -80.23 -13.96 58.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.514 -0.741 . . . . 0.0 109.084 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 99' ' ' MET . 1.8 tp -90.33 -49.15 6.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.477 -0.764 . . . . 0.0 109.415 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB2' ' CB ' ' A' ' 61' ' ' CYS . . . -48.0 -46.54 32.97 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 3.1 m-85 -51.91 -39.76 59.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.543 ' C ' HD23 ' A' ' 80' ' ' LEU . 83.3 t60 -51.38 -24.87 5.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -100.06 -34.89 9.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 0.0 109.247 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 45.8 mt -77.63 -35.16 21.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.528 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 2.8 p -67.77 -29.74 69.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 110.079 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -83.87 -5.49 59.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.077 -1.015 . . . . 0.0 109.982 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.487 ' HD3' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -90.9 -24.65 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.406 -0.809 . . . . 0.0 110.91 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.9 mt -90.0 -71.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.0 111.299 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 mm -82.08 3.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.795 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.956 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -126.81 -47.27 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.941 -1.099 . . . . 0.0 110.573 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLN . . . 87.1 6.19 79.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.956 HD12 ' HB3' ' A' ' 87' ' ' LYS . 3.5 mt -77.42 139.37 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.231 -1.158 . . . . 0.0 109.823 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.2 170.96 13.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.217 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 40.4 Cg_endo -70.88 158.29 55.91 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.191 1.627 . . . . 0.0 110.675 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 94' ' ' VAL . 46.7 Cg_endo -75.06 47.02 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.098 1.578 . . . . 0.0 111.676 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 54.08 -85.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.077 -1.015 . . . . 0.0 111.643 178.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.681 ' HA ' HD21 ' A' ' 60' ' ' LEU . 33.4 m -117.47 -163.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.607 -1.308 . . . . 0.0 112.208 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.895 HD22 HD23 ' A' ' 60' ' ' LEU . 4.0 mm? -81.03 165.1 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.785 0.802 . . . . 0.0 111.603 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.981 ' O ' HD12 ' A' ' 100' ' ' ILE . 35.7 p -147.15 170.25 8.06 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 42.6 Cg_endo -69.6 -38.03 8.71 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.183 1.097 . . . . 0.0 109.527 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.957 ' O ' HG13 ' A' ' 11' ' ' VAL . 13.4 mt-10 -70.08 -10.83 60.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 108.96 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.709 ' CG ' HD21 ' A' ' 76' ' ' LEU . 28.0 ttm -102.54 -38.21 7.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.981 HD12 ' O ' ' A' ' 96' ' ' THR . 2.3 mt -64.68 143.13 98.66 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.864 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 100' ' ' ILE . 44.6 Cg_endo -71.49 120.84 7.22 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.891 1.469 . . . . 0.0 110.706 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.55 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.923 1.486 . . . . 0.0 110.377 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 179.804 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 10' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.295 0.569 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.893 ' CZ3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 69.15 98.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.909 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.679 ' CG2' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.09 -20.85 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 110.104 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.893 HG13 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -139.04 73.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 109.787 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 t -102.73 -31.67 0.21 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 13' ' ' SER . 54.8 Cg_endo -76.38 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 122.756 0.872 . . . . 0.0 111.101 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -28.67 -61.28 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.904 -0.497 . . . . 0.0 112.197 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.73 ' HB3' HG23 ' A' ' 12' ' ' VAL . 15.2 mt-10 -38.65 -57.33 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.531 -0.73 . . . . 0.0 110.64 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.18 -35.17 64.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.97 . . . . 0.0 109.867 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . -66.29 -48.61 69.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -29.42 64.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.529 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 78' ' ' PHE . 12.2 m-85 -87.95 -51.69 5.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.558 -0.714 . . . . 0.0 110.094 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -45.56 -39.56 7.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.927 -1.108 . . . . 0.0 109.356 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 5.6 mm-40 -67.51 -47.27 70.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 108.99 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.762 HG22 ' OG1' ' A' ' 27' ' ' THR . 26.1 mt -62.26 -40.5 87.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.604 -0.685 . . . . 0.0 109.472 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 29.4 t80 -46.95 -27.65 1.35 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' GLU . 70.3 mt -70.64 -31.72 68.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -97.83 -12.8 21.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.845 . . . . 0.0 108.82 178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.045 HG23 HD12 ' A' ' 43' ' ' ILE . 1.3 m -89.06 -51.43 5.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 31' ' ' MET . 23.0 t70 -65.04 82.53 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -62.44 0.07 0.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 32' ' ' ASP . 44.8 p-10 -122.77 3.47 9.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.219 -1.55 . . . . 0.0 110.787 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.471 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 1.2 mmt 55.92 39.08 30.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.294 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 30' ' ' ASP . 3.9 p-10 -110.35 26.44 10.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.34 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.48 11.17 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CD1' ' CB ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -150.86 99.49 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -1.104 . . . . 0.0 110.309 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 27' ' ' THR . 10.8 p -89.71 135.66 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.94 -1.1 . . . . 0.0 109.004 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.512 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 82.6 p -90.06 147.81 23.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 110.825 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 40' ' ' VAL . . . -42.94 -27.59 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' SER . 3.7 mp -65.04 -30.59 71.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.108 . . . . 0.0 110.503 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.547 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 mt-10 -86.84 -62.24 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.891 -1.131 . . . . 0.0 108.306 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG22 ' CD2' ' A' ' 44' ' ' PHE . 1.4 p -58.49 -15.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.29 0.566 . . . . 0.0 110.023 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -43.16 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.618 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -42.58 -44.67 4.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.008 . . . . 0.0 109.82 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.045 HD12 HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -51.27 -40.01 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.55 -0.719 . . . . 0.0 109.072 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 40' ' ' VAL . 1.4 m-85 -87.28 -28.45 22.29 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.592 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 42' ' ' GLU . 72.1 mt -68.06 -17.38 64.37 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 108.961 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CD ' ' HA ' ' A' ' 43' ' ' ILE . 10.2 mtpt -75.75 -21.32 57.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.559 0.695 . . . . 0.0 109.49 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.586 ' OG1' ' HG ' ' A' ' 49' ' ' LEU . 39.1 p -50.2 -58.14 6.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.698 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 118.43 21.41 4.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -101.05 -172.34 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.511 -0.994 . . . . 0.0 108.542 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HD2' HD22 ' A' ' 53' ' ' LEU . 43.0 Cg_endo -74.3 -171.64 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.388 1.204 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -47.8 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.859 -1.151 . . . . 0.0 111.328 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.7 OUTLIER -63.14 -32.11 73.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.673 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.995 HD23 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -59.87 -62.68 1.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 110.819 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.995 HD22 HD23 ' A' ' 53' ' ' LEU . 2.8 mm? -50.08 -29.71 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.816 -1.178 . . . . 0.0 108.953 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' TRP . . . -79.65 -39.36 31.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 21.3 t60 -67.49 -24.58 65.6 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CD1' HD13 ' A' ' 81' ' ' ILE . 4.9 mt -78.3 -23.04 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 69' ' ' LEU . 19.5 t-105 -71.48 -45.63 61.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 p -69.44 -27.61 65.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 108.645 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 92' ' ' PRO . 9.0 mt -74.68 -4.65 38.58 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 76' ' ' LEU . 61.6 m -128.58 -35.48 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.75 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HA ' ' NE2' ' A' ' 73' ' ' GLN . 17.9 t70 -65.81 59.35 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.63 -0.669 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' CYS . 24.7 p -55.54 -36.84 67.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -0.991 . . . . 0.0 109.881 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' CD ' ' OE1' ' A' ' 73' ' ' GLN . 11.7 mptt -56.25 -16.98 6.24 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 110.04 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 40.08 54.76 2.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -0.756 . . . . 0.0 110.438 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.0 t -123.13 -13.96 7.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.311 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.24 -0.25 25.24 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.608 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . 3.7 mtmt -129.78 -176.25 3.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.133 -1.216 . . . . 0.0 110.087 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -123.7 97.94 5.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.099 -1.001 . . . . 0.0 111.163 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -55.56 172.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.746 -1.221 . . . . 0.0 109.34 178.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -56.46 -76.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.958 -1.089 . . . . 0.0 110.544 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' LYS . 32.3 m-20 -39.38 -42.65 1.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.594 -0.691 . . . . 0.0 110.549 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' A' ' 62' ' ' ASP . 25.9 mt-30 -61.03 -49.49 77.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.687 ' N ' HD22 ' A' ' 69' ' ' LEU . 11.2 t80 -54.76 -37.43 65.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.786 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -73.42 -6.75 48.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.636 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -90.35 -40.52 12.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.373 -0.829 . . . . 0.0 110.071 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HB3' ' HZ ' ' A' ' 44' ' ' PHE . . . -64.63 -58.84 5.23 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.238 -0.913 . . . . 0.0 109.041 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.2 m-85 -45.67 -32.17 2.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.603 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 47.2 t60 -66.22 -30.41 70.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 76' ' ' LEU . 14.2 mt -84.8 -16.79 40.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 109.187 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 54' ' ' LEU . 13.6 mm -73.51 -57.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.48 -0.763 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -47.98 -32.39 6.45 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.444 -0.785 . . . . 0.0 109.982 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -64.64 -24.18 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.687 ' HG2' HD22 ' A' ' 49' ' ' LEU . 2.9 tppt? -91.13 -21.48 21.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.222 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.653 HD21 HD21 ' A' ' 49' ' ' LEU . 5.2 mt -89.43 -67.71 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -82.19 -10.04 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.0 110.873 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.854 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -119.48 -7.32 10.18 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.927 -1.108 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 87' ' ' LYS . . . 47.23 24.49 2.3 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HB3' ' A' ' 87' ' ' LYS . 16.2 mt -97.16 173.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.496 -1.002 . . . . 0.0 109.858 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.551 ' N ' HG22 ' A' ' 89' ' ' ILE . 25.0 m-20 -115.37 164.79 15.97 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 110.256 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 43.5 Cg_endo -70.47 153.91 65.32 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.16 1.61 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.877 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.7 Cg_endo -71.92 151.93 57.1 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.013 1.533 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.32 -59.76 2.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.166 -0.959 . . . . 0.0 110.277 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.53 ' CA ' HD21 ' A' ' 60' ' ' LEU . 30.4 m -125.87 -166.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 111.264 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.847 HD23 ' HB2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -89.89 -175.81 4.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.897 0.856 . . . . 0.0 111.564 -179.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.035 ' O ' HD12 ' A' ' 100' ' ' ILE . 2.2 p -143.07 -179.23 0.91 Allowed Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 96' ' ' THR . 46.6 Cg_endo -76.17 -5.77 16.59 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.332 1.175 . . . . 0.0 109.929 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 11' ' ' VAL . 20.9 mt-10 -93.66 -23.11 18.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.0 109.277 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.929 ' HB3' HD11 ' A' ' 76' ' ' LEU . 2.4 mtp -86.37 -36.19 19.36 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.992 0.901 . . . . 0.0 108.698 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.035 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mt -65.23 124.77 87.84 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.883 -0.51 . . . . 0.0 110.654 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 47.7 Cg_endo -73.76 174.89 11.54 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.931 1.49 . . . . 0.0 109.906 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 101' ' ' PRO . 42.5 Cg_endo -68.63 179.48 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.781 1.411 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.524 -179.828 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_